PT J
AU Wang, S
   Song, T
   Wang, SP
AF Wang, Shuai
   Song, Tao
   Wang, Suping
TI Mitochondrial DNA 10158T&gt;C mutation in a patient with mitochondrial encephalomyopathy with lactic acidosis, and stroke-like episodes syndrome A case-report and literature review (CARE-complaint)
SO MEDICINE
LA English
DT Review
DE M.10158T > C mutation; mitochondrial encephalomyopathy with lactic acidosis; and stroke-like episodes; mitochondrial disorder
ID melas; encephalopathy; myopathy; gene; manifestations; disease
AB Rationale: Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome is caused by mitochondrial respiratory chain dysfunction and oxidative phosphorylation disorder. It is a rare clinical metabolic disease involved with multiple systems. Patient concerns: A 22-year-old patient presented with limb convulsion accompanied by loss of consciousness, headache, partial blindness, blurred vision, and so on. Diagnoses: Brain magnetic resonance imaging showed a high-intensity area in bilateral occipital cortex, left parietal lobe and cerebellum on diffusion-weighted imaging. These focus did not distribute as vascular territory. The pathological examination of skeletal muscle revealed several succinate dehydrogenase reactive vessels with overreaction and increased content of lipid droplets in some muscle fibers. Genetic testing showed that the patient carried m.10158T>C mutation. Interventions: She was provided with traditional arginine hydrochloride therapy and orally medication of coenzyme Q (10 mg). Outcomes: Mitochondrial DNA of blood and hair follicle of patient carried m.10158T>C mutation Lessons: For the suspected patients of MELAS syndrome, if the hot-spot mutation test is negative, more detection sites should be selected.
C1 [Wang, Shuai; Song, Tao; Wang, Suping] Third Peoples Hosp Qingdao, Dept Neurol Rehabil, 29 Yongping Rd, Qingdao 266041, Peoples R China.
RP Wang, SP (corresponding author), Third Peoples Hosp Qingdao, Dept Neurol Rehabil, 29 Yongping Rd, Qingdao 266041, Peoples R China.
EM supingwangqd@sina.com
CR El-Hattab AW, 2017, J NUTR, V147, P1251, DOI 10.3945/jn.117.248435
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   El-Hattab AW, 2014, MITOCHONDRION, V18, P63, DOI 10.1016/j.mito.2014.07.008
   Finsterer J, 2015, J CHILD NEUROL, V30, P1553, DOI 10.1177/0883073814567539
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grosso S, 2017, BRAIN DEV-JPN, V39, P261, DOI 10.1016/j.braindev.2016.09.013
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Kondo H, 2018, PEDIATR INT, V60, P300, DOI 10.1111/ped.13472
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Mukai M, 2015, NEUROL CLIN NEUROSCI, V3, P153, DOI 10.1111/ncn3.173
   Mukai M, 2017, INTERNAL MED, V56, P95, DOI 10.2169/internalmedicine.56.7301
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001
   Tzoulis C, 2009, STROKE, V40, PE15, DOI 10.1161/STROKEAHA.108.523118
   Vandana VP, 2016, CLIN NEUROL NEUROSUR, V148, P17, DOI 10.1016/j.clineuro.2016.04.024
   Vodopivec I, 2016, NEUROLOGIST, V21, P61, DOI 10.1097/NRL.0000000000000084
NR 19
TC 4
Z9 5
U1 1
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD JUN 15
PY 2020
VL 99
IS 24
BP 
EP 
DI 10.1097/MD.0000000000020310
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA MM0WU
UT WOS:000549881200009
PM 32541454
DA 2024-11-01
ER

PT J
AU Cicero, AFG
   Fogacci, F
   Bove, M
   Borghi, C
AF Cicero, Arrigo F. G.
   Fogacci, Federica
   Bove, Marilisa
   Borghi, Claudio
TI Successful treatment of a patient with mitochondrial myopathy with alirocumab
SO JOURNAL OF CLINICAL LIPIDOLOGY
LA English
DT Article
DE Mitochondrial myopathy; Hypercholesterolemia; PCSK9 inhibitor; Alirocumab
ID skeletal-muscle
AB A 48-year-old man presented to our lipid clinic with statin intolerance and elevated serum creatine kinase levels, being affected by mitochondrial myopathy because of heteroplasmic mitochondrial DNA missense mutation in MTC01 gene (m.7671T>A). He had just been treated with a coronary artery bypass 4 years before because of acute coronary syndrome, and he had consistently high levels of both low-density lipoprotein cholesterol and triglycerides. Dyslipidemia was successfully treated using 75 mg of alirocumab subcutaneously every 2 weeks, 10 mg of ezetimibe daily, 2 g of marine omega-3 fatty acids daily, and 145 mg of micronized fenofibrate every 2 days. Although muscle weakness persisted, myalgia did not reoccur and serum creatine kinase levels remained almost stable over the time. (C) 2020 National Lipid Association. All rights reserved.
C1 [Cicero, Arrigo F. G.; Fogacci, Federica; Bove, Marilisa; Borghi, Claudio] Univ Bologna, Med & Surg Sci Dept, Bologna, Italy.
C3 University of Bologna
RP Cicero, AFG (corresponding author), St Orsola Malpighi Univ Hosp, Med & Surg Sci Dept, Via Albertoni 15, I-40138 Bologna, Italy.
EM arrigo.cicero@unibo.it
CR DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Hanna MG, 1999, CELL MOL LIFE SCI, V55, P691, DOI 10.1007/s000180050327
   INO H, 1991, LANCET, V337, P234, DOI 10.1016/0140-6736(91)92196-9
   Parker BA, 2012, AM J CARDIOL, V109, P282, DOI 10.1016/j.amjcard.2012.01.369
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Pulkes T, 2005, NEUROMUSCULAR DISORD, V15, P364, DOI 10.1016/j.nmd.2005.01.006
   Quadir A, 2019, NEUROL-GENET, V5, P0, DOI 10.1212/NXG.0000000000000339
   Sirvent P, 2005, BIOCHEM BIOPH RES CO, V338, P1426, DOI 10.1016/j.bbrc.2005.10.108
   Strilchuck L, 2019, EXPERT OPIN DRUG SAF, V18, P611, DOI 10.1080/14740338.2019.1620730
   Thompson PD, 1997, METABOLISM, V46, P1206, DOI 10.1016/S0026-0495(97)90218-3
   Vavlukis Marija, 2018, DRUGS CONTEXT, V7, P212534, DOI 10.7573/dic.212534
NR 11
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1933-2874
EI 1876-4789
J9 J CLIN LIPIDOL
JI J. Clin. Lipidol.
PD SEP-OCT 15
PY 2020
VL 14
IS 5
BP 646
EP 648
DI 10.1016/j.jacl.2020.07.007
PG 3
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA OJ2UV
UT WOS:000583822800009
PM 32800583
DA 2024-11-01
ER

PT J
AU Kade, G
   Spaleniak, SK
   Brodacki, B
   Pollak, A
   Moczulski, D
   Oldak, M
   Saracyn, M
AF Kade, Grzegorz
   Spaleniak, Sebastian Krzysztof
   Brodacki, Bogdan
   Pollak, Agnieszka
   Moczulski, Dariusz
   Oldak, Monika
   Saracyn, Marek
TI Maternally inherited diabetes and deafness (MIDD) syndrome with m.3243A&gt;G mutation associated with renal failure - a case report
SO CLINICAL DIABETOLOGY
LA English
DT Article
DE mitochondrial diabetes; sensorineural deafness; m.3243A > G mutation; renal failure; incomplete distal renal tubular acidosis
ID mitochondrial; melas
AB Maternally-inherited diabetes with deafness (MIDD) is a rare form of monogenic diabetes that results, in most cases, from an A-to-G transition at position 3243 of mitochondrial DNA (m.3243A>G). The clinical presentation of m.3243A>G mutation is variable, ranging from mild to severe phenotypes. Diabetes is often accompanied by sensorineural deafness, cardiomyopathy, neuromuscular, psychiatric disorders, macular dystrophy and renal failure (kidney manifestations in adults presenting with this mutation remain poorly defined). The study presents a case of a 40-years-old woman with a history of bilateral sensorineural deafness, renal failure and diabetes that was diagnosed due to increasing muscle weakness during exercise. MIDD was diagnosed based on the clinical picture and the results of laboratory studies including genetic testing. As far as we know, glomerulopathy with incomplete distal renal tubular acidosis has never been described before as a cause of renal failure in MIDD patients.
C1 [Kade, Grzegorz] Mil Inst Med, Dept Internal Med Nephrol & Dialysis, Warsaw, Poland.
   [Spaleniak, Sebastian Krzysztof; Moczulski, Dariusz] Med Univ Lodz, Dept Internal Med & Nephrodiabetol, Zeromskiego 113, PL-90549 Lodz, Poland.
   [Brodacki, Bogdan] Mil Inst Med, Neurol Clin, Warsaw, Poland.
   [Pollak, Agnieszka; Oldak, Monika] Inst Physiol & Pathol Hearing, Dept Genet, Warsaw, Poland.
   [Saracyn, Marek] Mil Inst Med, Dept Endocrinol & Isotope Therapy, Warsaw, Poland.
C3 Military Institute of Aviation Medicine; Medical University Lodz; Military Institute of Aviation Medicine; Institute of Physiology & Hearing Pathology; Military Institute of Aviation Medicine
RP Spaleniak, SK (corresponding author), Med Univ Lodz, Dept Internal Med & Nephrodiabetol, Zeromskiego 113, PL-90549 Lodz, Poland.
EM sebastian19860@op.pl
CR BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Dinour D, 2004, CLIN NEPHROL, V62, P149
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Iwanicka-Pronicka K, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044054
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Malecki Maciej, 2008, POL ARCH MED WEWN, V118, P435
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181
   Takeshima T, 2005, INTERNAL MED, V44, P276, DOI 10.2169/internalmedicine.44.276
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
NR 15
TC 0
Z9 0
U1 0
U2 1
PU VIA MEDICA
PI GDANSK
PA UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND
SN 2450-8187
EI 
J9 CLIN DIABETOL
JI Clin. Diabetol.
PD JUN 15
PY 2020
VL 9
IS 6
BP 475
EP 478
DI 10.5603/DK.2020.0058
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA PN7ZG
UT WOS:000604692300014
DA 2024-11-01
ER

PT J
AU Handzel, O
   Ungar, OJ
   Lee, DJ
   Nadol, JB
AF Handzel, Ophir
   Ungar, Omer J.
   Lee, Dan J.
   Nadol, Joseph B., Jr.
TI Temporal bone histopathology in MELAS syndrome
SO LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY
LA English
DT Article
DE genetics; MELAS syndrome; otology; otopathology; sensorineural hearing loss
ID profoundly deaf patient; cochlear implantation; mitochondrial-dna
AB Objectives Describe the histopathology of the temporal bones in MELAS (myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) syndrome. The syndrome results from a known point mutation in mitochondrial DNA. Methods Histopathology analysis of a pair of temporal bones from the oldest surviving MELAS syndrome temporal bone donor. Histopathologic findings were correlated with known premortem clinical data. Results The inner ears showed severe but incomplete atrophy of the stria vascularis for the length of the cochleae. In contrast, the organ of Corti and inner hair cells appeared intact with some loss of outer hair cells. Other than moderate loss at the basal turn, spiral ganglion cells numbers were normal. The vestibular neuroepithelium was mostly normal with the exception of moderate degeneration of the macula sacculi and partial collapse of the saccular wall on the right. The cerebral cortex had infarct-like lesions with adjacent gliosis. Conclusion This is an analysis of the oldest patient with MELAS syndrome to date, an addition to only two previously published patients. It supports the notion that hearing loss is a result of dysfunction of the stria vascularis and not loss of hair cells or neurons. Patterns of vestibular pathology are in agreement to in-vivo measurements. These findings support auditory rehabilitation with cochlear implants and may be relevant to hearing loss due to other mitochondrial mutations. Level of evidence 4
C1 [Handzel, Ophir] Tel Aviv Univ, Dept Otolaryngol Head Neck & Maxillofacial Surg, Cochlear Implant Ctr, Tel Aviv Sourasky Med Ctr,Sackler Fac Med, Tel Aviv, Israel.
   [Ungar, Omer J.] Tel Aviv Univ, Dept Otolaryngol Head Neck & Maxillofacial Surg, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Tel Aviv, Israel.
   [Lee, Dan J.; Nadol, Joseph B., Jr.] Harvard Med Sch, Dept Otolaryngol Head & Neck Surg, Otopathol Lab, Massachusetts Eye & Ear, Boston, MA 02115 USA.
C3 Tel Aviv University; Tel Aviv Sourasky Medical Center; Tel Aviv University; Tel Aviv Sourasky Medical Center; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary
RP Handzel, O (corresponding author), Tel Aviv Univ, Dept Otolaryngol Head & Neck & Maxillofacial Surg, Tel Aviv Sourasky Med Ctr, Cochlear Implant Program,Sackler Fac Med, 6 Weizmann St, IL-6423906 Tel Aviv, Israel.
EM ophir.handzel@ozen.co.il
FU Margaret and Leo Meyer and Hans M. Hirsch Foundation
CR Corrado A, 2014, GENETIC NEUROMUSCULA, V0, P233
   Di Stadio A, 2018, ORPHANET J RARE DIS, V13, P0, DOI 10.1186/s13023-018-0770-1
   Hill D, 2001, J NEUROL NEUROSUR PS, V71, P281, DOI 10.1136/jnnp.71.2.281
   Karkos PD, 2005, EUR ARCH OTO-RHINO-L, V262, P322, DOI 10.1007/s00405-004-0817-x
   Koda H, 2010, ACTA OTO-LARYNGOL, V130, P344, DOI 10.1080/00016480903148282
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Merchant SN, 2010, SCHUKNECHTS PATHOLOG, V3e, P29
   Nadol JB, 2001, INT J PEDIATR OTORHI, V61, P1, DOI 10.1016/S0165-5876(01)00546-8
   Rosenthal EL, 1999, AM J OTOL, V20, P187
   Scaglia F, 2017, J. INBORN. ERRORS. METAB. SCREEN, V5, P0, DOI 10.1177/
   Scarpelli M, 2012, GENET RES INT, V2012, P0, DOI 10.1155/2012/287432
   Sinnathuray AR, 2002, J NEUROL NEUROSUR PS, V73, P97, DOI 10.1136/jnnp.73.1.97
   Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010
   Takahashi K, 2003, LARYNGOSCOPE, V113, P1362, DOI 10.1097/00005537-200308000-00018
   van der Wijst MGP, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-00263-z
   Vandana VP, 2016, CLIN NEUROL NEUROSUR, V148, P17, DOI 10.1016/j.clineuro.2016.04.024
NR 16
TC 6
Z9 6
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2378-8038
EI 
J9 LARYNGOSCOPE INVEST
JI Laryngoscope Investig. Otol.
PD FEB 15
PY 2020
VL 5
IS 1
BP 152
EP 156
DI 10.1002/lio2.344
EA JAN 2020
PG 5
WC Otorhinolaryngology
SC Otorhinolaryngology
GA KO9AG
UT WOS:000505883100001
PM 32128442
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Zarrouk-Mahjoub, S
AF Finsterer, J.
   Zarrouk-Mahjoub, S.
TI The heart in m.3243A&gt;G carriers
SO HERZ
LA English
DT Review
DE DNA; mitochondrial; MELAS syndrome; Maternally inherited diabetes and deafness; Arrhythmias; Cardiomyopathy
ID progressive external ophthalmoplegia; melas syndrome; myocardial dysfunction; mitochondrial; cardiomyopathy; mutation; adults; manifestation; involvement; prevalence
AB Objectives Little is known about cardiac involvement in m.3243A>G variant carriers. Thus, this study aimed to assess type and frequency of cardiac disease in symptomatic and asymptomatic m.3243A>G carriers. Methods Systematic literature review. Results The m.3243A>G variant may manifest phenotypically as mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), maternally inherited diabetes and deafness (MIDD), myoclonic epilepsy with ragged red fiber (MERRF), Leigh syndrome, or MELAS/KSS (Kearns-Sayre syndrome) overlap. Only few systematic studies which prospectively investigated m.3243A>G carriers for cardiac involvement were found. Cardiac abnormalities reported in m.3243A>G carriers include myocardial abnormalities, arrhythmias, or conduction defects. Myocardial abnormalities include myocardial thickening, hypertrophic cardiomyopathy, dilated cardiomyopathy, noncompaction, myocardial fibrosis, systolic dysfunction, heart failure, or arterial hypertension. Arrhythmias reported in m.3243A>G carriers include paroxysmal supraventricular or ventricular arrhythmias, including sinus tachycardia, atrial fibrillation and nonsustained ventricular tachycardia, and sudden cardiac death. Conduction defects in this group of patients include Wolff-Parkinson-White syndrome and left/right bundle branch block. Asymptomatic m.3243A>G carriers usually do not develop clinical or subclinical cardiac disease. Conclusions Cardiac involvement in m.3243A>G carriers has been only rarely systematically studied, which is perhaps why the incidence of cardiac diseases in MELAS is lower than would be expected. Myocardial abnormalities are much more frequent than arrhythmias or conduction defects. All symptomatic and asymptomatic m.3243A>G carriers should be systematically investigated for cardiac disease.
C1 [Finsterer, J.] Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
   [Zarrouk-Mahjoub, S.] Univ Tunis El Manar, Pasteur Inst Tunis, Tunis, Tunisia.
   [Zarrouk-Mahjoub, S.] Genom Platform, Tunis, Tunisia.
C3 Rudolfstiftung Hospital; Pasteur Network; Universite de Tunis-El-Manar; Institut Pasteur Tunis
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Alila OF, 2016, MITOCHONDRIAL DNA A, V27, P2873, DOI 10.3109/19401736.2015.1060417
   Bates MGD, 2013, EUR HEART J-CARD IMG, V14, P650, DOI 10.1093/ehjci/jes226
   Benyamine A, 2016, REV MED INTERNE, V37, P779, DOI 10.1016/j.revmed.2016.06.007
   Bhati RS, 2005, J HEART LUNG TRANSPL, V24, P2286, DOI 10.1016/j.healun.2005.05.012
   Brackmann F, 2012, EUR J PEDIATR, V171, P859, DOI 10.1007/s00431-011-1662-8
   Cristofari M, 1995, G ITAL CARDIOL, V25, P69
   de Laat P, 2016, BBA CLIN, V6, P19, DOI 10.1016/j.bbacli.2016.04.007
   DiMauro S, 2001, GENE REV, V0, P0
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Florian A, 2015, J CARDIOVASC MAGN R, V17, P0, DOI 10.1186/s12968-015-0145-x
   Gal Aniko, 2008, ORVOSI HETILAP, V149, P1593, DOI 10.1556/OH.2008.28398
   Gallego-Delgado M, 2015, REV ESP CARDIOL, V68, P153, DOI 10.1016/j.rec.2014.09.007
   Hannah-Shmouni F, 2014, JIMD REP, V12, P17, DOI 10.1007/8904_2013_239
   Hollingsworth KG, 2012, NEUROMUSCULAR DISORD, V22, P592, DOI 10.1016/j.nmd.2012.03.001
   Hsu YHR, 2016, HEART FAIL REV, V21, P103, DOI 10.1007/s10741-015-9524-5
   Jose T, 2011, INT J CARDIOL, V149, PE24, DOI 10.1016/j.ijcard.2009.03.057
   Koene S, 2017, J INHERIT METAB DIS, V40, P247, DOI 10.1007/s10545-016-0001-7
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Lindroos MM, 2016, J INHERIT METAB DIS, V39, P67, DOI 10.1007/s10545-015-9865-1
   Ma YY, 2013, MITOCHONDR DNA, V24, P297, DOI 10.3109/19401736.2012.760071
   Majamaa-Voltti Kirsi, 2002, BMC CARDIOVASC DISORD, V2, P12
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Narumi K, 2018, NEPHRON, V138, P243, DOI 10.1159/000485109
   Nemes A, 2009, SWISS MED WKLY, V139, P117, DOI smw-12390
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   Okhuijsen-Kroes EJ, 2001, NEUROPEDIATRICS, V32, P183, DOI 10.1055/s-2001-17372
   Rosseel L, 2017, EUR HEART J-CARD IMG, V18, P112, DOI 10.1093/ehjci/jew184
   Rudnicki M, 2016, AM J KIDNEY DIS, V68, P949, DOI 10.1053/j.ajkd.2016.06.027
   Salles JE, 2006, DIABETES RES CLIN PR, V72, P100, DOI 10.1016/j.diabres.2005.09.005
   Seitun S, 2016, CASE REP CARDIOL, V2016, P0, DOI 10.1155/2016/1490181
   Sproule D M, 2008, J INHERIT METAB DIS, V31 Suppl 3, P497, DOI 10.1007/s10545-007-0735-3
   Taniguchi Akira, 2002, NIHON RINSHO, V60 Suppl 4, P606
   Thomas T, 2015, MOLEC GENET METAB RE, V4, P9, DOI 10.1016/j.ymgmr.2015.05.002
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Wilichowski E, 1998, J NEUROL SCI, V157, P206, DOI 10.1016/S0022-510X(98)00068-9
   Youssef AA, 2016, INT J CARDIOL, V203, P1020, DOI 10.1016/j.ijcard.2015.10.054
   Yu Nian, 2016, ENEUROLOGICALSCI, V4, P15, DOI 10.1016/j.ensci.2016.04.006
   Zhou Y, 2018, INT J NEUROSCI, V128, P231, DOI 10.1080/00207454.2017.1387113
NR 41
TC 18
Z9 20
U1 0
U2 3
PU URBAN & VOGEL
PI MUNICH
PA NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY
SN 0340-9937
EI 1615-6692
J9 HERZ
JI Herz
PD JUN 15
PY 2020
VL 45
IS 4
BP 356
EP 361
DI 10.1007/s00059-018-4739-6
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LX9MU
UT WOS:000540149400014
PM 30128910
DA 2024-11-01
ER

PT J
AU Bakis, H
   Trimouille, A
   Vermorel, A
   Redonnet, I
   Goizet, C
   Boulestreau, R
   Laconnbe, D
   Connbe, C
   Martin-Négrier, ML
   Rigothier, C
AF Bakis, Hugo
   Trimouille, Aurelien
   Vermorel, Agathe
   Redonnet, Isabelle
   Goizet, Cyril
   Boulestreau, Romain
   Laconnbe, Didier
   Connbe, Christian
   Martin-Negrier, Marie-Laure
   Rigothier, Claire
TI Adult onset tubulo-interstitial nephropathy in MT-ND5-related phenotypes
SO CLINICAL GENETICS
LA English
DT Article
DE adult; complex I; mitochondrial disorder; MT-ND5; tubulo-interstitial nephropathy
ID mitochondrial-dna; leigh-syndrome; g13513a mutation; frequent cause; dysfunction; melas; gene; nd5
AB Kidney is a highly adenosine triphosphate dependent organ in human body. Healthy and functional mitochondria are essential for normal kidney function. Clinical and genetic variability are the hallmarks of mitochondrial disorders. We report here the involvement of two MT-ND5 pathogenic variants encoding for ND5 subunit of respiratory chain complex I, the m.13513G>A and the m.13514A>G, in adult-onset kidney disease in three unrelated patients. The first patient had myopathy encephalopathy lactic acidosis and stroke syndrome, left ventricular hypertrophy with Wolff-Parkinson-White syndrome and tubulo-interstitial kidney disease. The second presented Leber hereditary optic neuropathy associated with tubulo-interstitial kidney disease. The third presented with an isolated chronic tubulo-interstitial kidney disease. These mutations have never been associated with adulthood mitochondrial nephropathy. These case reports highlight the importance to consider mitochondrial dysfunction in tubulo-interstitial kidney disease.
C1 [Bakis, Hugo; Connbe, Christian; Rigothier, Claire] CHU Bordeaux, Serv Nephrol Transplantat Dialyse & Aphereses, Bordeaux, France.
   [Trimouille, Aurelien; Goizet, Cyril; Laconnbe, Didier] CHU Bordeaux, Serv Genet Med, Bordeaux, France.
   [Redonnet, Isabelle; Goizet, Cyril] CHU Bordeaux, Lab Biochim, Bordeaux, France.
   [Vermorel, Agathe; Martin-Negrier, Marie-Laure] CHU Bordeaux, Serv Pathol, Bordeaux, France.
   [Boulestreau, Romain] CHU Bordeaux, Serv Cardiol & Hypertens Arterielle, Bordeaux, France.
   [Redonnet, Isabelle; Laconnbe, Didier; Martin-Negrier, Marie-Laure] CHU Bordeaux, Ctr Reference Malad Mitochondriales Enfant Adulte, Bordeaux, France.
   [Trimouille, Aurelien; Redonnet, Isabelle; Goizet, Cyril; Laconnbe, Didier] Univ Bordeaux, INSERM, U1211, Bordeaux, France.
   [Connbe, Christian; Rigothier, Claire] INSERM, U1026, Tissue Bioengn, Bordeaux, France.
   [Martin-Negrier, Marie-Laure] Univ Bordeaux, UMR5293, Bordeaux, France.
C3 CHU Bordeaux; Universite de Bordeaux; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux; Universite de Bordeaux; Universite de Bordeaux; CHU Bordeaux; Universite de Bordeaux; CHU Bordeaux; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)
RP Rigothier, C (corresponding author), CHU Bordeaux, Serv Nephrol Transplantat Dialyse & Aphereses, Bordeaux, France.
EM claire.rigothier@chu-bordeaux.fr
CR Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   Blackwood JK, 2010, BIOCHEM BIOPH RES CO, V393, P740, DOI 10.1016/j.bbrc.2010.02.072
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6
   Finsterer J, 2017, BIOMED REP, V6, P487, DOI 10.3892/br.2017.892
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Magistroni R, 2003, J AM SOC NEPHROL, V14, P1164, DOI 10.1097/01.ASN.0000061774.90975.25
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   Monlleo-Neila L, 2013, J CHILD NEUROL, V28, P1531, DOI 10.1177/0883073812460580
   Motoda Atsuko, 2013, RINSHO SHINKEIGAKU, V53, P446
   OConnor PM, 2006, CLIN EXP PHARMACOL P, V33, P961, DOI 10.1111/j.1440-1681.2006.04475.x
   OToole JF, 2014, INT J NEPHROL RENOV, V7, P57, DOI 10.2147/IJNRD.S37887
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Wang Shi-Bing, 2008, PEDIATRICS AND NEONATOLOGY, V49, P145, DOI 10.1016/S1875-9572(08)60030-3
   Wang ZM, 2010, AM J CLIN NUTR, V92, P1369, DOI 10.3945/ajcn.2010.29885
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 21
TC 12
Z9 12
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9163
EI 1399-0004
J9 CLIN GENET
JI Clin. Genet.
PD APR 15
PY 2020
VL 97
IS 4
BP 628
EP 633
DI 10.1111/cge.13670
EA JAN 2020
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA KT8CI
UT WOS:000506303300001
PM 31713837
DA 2024-11-01
ER

PT J
AU Wang, XB
   Cui, NH
   Liu, XN
   Liu, X
AF Wang, Xue-bin
   Cui, Ning-hua
   Liu, Xia'nan
   Liu, Xin
TI Joint effects of mitochondrial DNA<SUP>4977</SUP> deletion and serum folate deficiency on coronary artery disease in type 2 diabetes mellitus
SO CLINICAL NUTRITION
LA English
DT Article
DE mtDNA(4977) deletion; Folate deficiency; Coronary artery disease; Type 2 diabetes mellitus
ID smooth-muscle-cells; dna copy number; cardiovascular-disease; oxidative stress; follow-up; risk; mortality; damage; atherosclerosis; adults
AB Background & aims: The 4977-bp mitochondrial deletion (mtDNA(4977) deletion), as a hallmark of mitochondrial oxidative damage, may play an important role in coronary artery disease (CAD), but its interaction with folate deficiency among diabetic patients is largely unknown. We aimed to explore the joint association of leukocyte mtDNA(4977) deletion and serum folate status with obstructive CAD in Chinese adults with type 2 diabetes. Methods: We cross-sectionally analyzed the angiographic data of 2017 diabetic patients without B-vitamin supplementation. Of the 2017 participants, 756 who received percutaneous coronary intervention (PCI) completed prospective follow-up of one year. In vitro, we explored the mediation effects of mitochondrial reactive oxygen species (mtROS) in folic acid (FA)-deficient human aortic smooth muscle cells (HASMCs) under hyperglycemic conditions. Results: Cross-sectionally, the multivariate odds ratios (ORs) for obstructive CAD were 1.41 (95% CI: 1.29-1.55) for greater mtDNA(4977) deletion, and 1.15 (95% CI: 1.05-1.25) for lower folate levels. Particularly, the combination of high mtDNA(4977) deletion (top tertile) and folate deficiency (serum folate < 6 ng/mL) was associated with more than 2-fold increased odds of having obstructive CAD and higher degrees of coronary stenosis. Prospectively, the hazard ratio for all-cause death at 1-year after PCI was up to 2.37 (95% CI: 1.21-4.63) for folate-deficient participants in the top tertile of mtDNA(4977) deletion. In HASMCs, the adverse effects of FA deficiency were aggravated by induction of mtROS, and attenuated by scavenging of mtROS. Conclusions: The risk of obstructive CAD may be greatly increased by the interaction between greater mtDNA(4977) deletion and folate deficiency among diabetic patients. (C) 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
C1 [Wang, Xue-bin; Liu, Xia'nan; Liu, Xin] Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Lab, Jianshe East Rd 1, Zhengzhou 450000, Henan, Peoples R China.
   [Cui, Ning-hua] Zhengzhou Univ, Childrens Hosp, Zhengzhou Key Lab Childrens Infect & Immun, Zhengzhou 450000, Henan, Peoples R China.
C3 Zhengzhou University; Zhengzhou University
RP Wang, XB (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Lab, Jianshe East Rd 1, Zhengzhou 450000, Henan, Peoples R China.
EM xbwang2017@163.com
FU National Basic Research Program of China [81800317]; Union Program of the Key Scientific and Technological Project of Henan Province [2018020008]
CR Afriyie-Gyawu E, 2016, NUTRITION, V32, P468, DOI 10.1016/j.nut.2015.10.021
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, PS81, DOI 10.2337/dc11-S062
   Bhattacharjee A, 2018, ENVIRON TOXICOL, V33, P988, DOI 10.1002/tox.22586
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Borghini A, 2019, EUR J PREV CARDIOL, V26, P976, DOI 10.1177/2047487319831495
   Chen TF, 2011, BRIT J NUTR, V105, P1294, DOI 10.1017/S0007114510005052
   Cheng Y, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.254
   Chou YF, 2007, J NUTR, V137, P2036, DOI 10.1093/jn/137.9.2036
   Dang SN, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0112586
   Ding ZF, 2016, ANTIOXID REDOX SIGN, V25, P997, DOI 10.1089/ars.2016.6631
   Faria A, 2017, PHARMACOL THERAPEUT, V172, P50, DOI 10.1016/j.pharmthera.2016.11.013
   Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI 10.1016/j.jacc.2013.11.005
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198
   Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761
   Izzotti A, 2007, MUTAT RES-FUND MOL M, V621, P119, DOI 10.1016/j.mrfmmm.2006.12.012
   James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427
   Jhund PS, 2015, EUR HEART J, V36, P2463, DOI 10.1093/eurheartj/ehv295
   Johnson JL, 2014, CARDIOVASC RES, V103, P452, DOI 10.1093/cvr/cvu171
   Kitazawa M, 2019, METABOLISM, V101, P0, DOI 10.1016/j.metabol.2019.153991
   Kolb AF, 2019, BIOCHEM J, V476, P2769, DOI 10.1042/BCJ20190275
   Kyte B, 2015, NUTR METAB CARDIOVAS, V25, P997, DOI 10.1016/j.numecd.2015.08.007
   Li Z, 2018, CLIN NUTR, V37, P1700, DOI 10.1016/j.clnu.2017.07.008
   Loria CM, 2000, ARCH INTERN MED, V160, P3258, DOI 10.1001/archinte.160.21.3258
   Maddox TM, 2014, JAMA-J AM MED ASSOC, V312, P1754, DOI 10.1001/jama.2014.14681
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Montorsi P, 2006, EUR HEART J, V27, P2632, DOI 10.1093/eurheartj/ehl142
   Niu CG, 2016, J AM HEART ASSOC, V5, P0, DOI 10.1161/JAHA.116.004099
   Ouellette ML, 2018, J AM HEART ASSOC, V7, P0, DOI 10.1161/JAHA.117.007965
   Pak O, 2018, EUR RESPIR J, V51, P0, DOI 10.1183/13993003.01024-2017
   Peng Y, 2016, INT J CARDIOL, V219, P136, DOI 10.1016/j.ijcard.2016.06.024
   Petrie JR, 2018, CAN J CARDIOL, V34, P575, DOI 10.1016/j.cjca.2017.12.005
   Rampidis GP, 2019, ATHEROSCLEROSIS, V287, P181, DOI 10.1016/j.atherosclerosis.2019.05.012
   Siasos G, 2018, ANN TRANSL MED, V6, P0, DOI 10.21037/atm.2018.06.21
   Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335
   Su SC, 2019, J BIOMED SCI, V26, P0, DOI 10.1186/s12929-019-0550-9
   Suzuki S, 1999, DIABETES RES CLIN PR, V45, P161, DOI 10.1016/S0168-8227(99)00046-7
   Valle JA, 2019, JAMA CARDIOL, V4, P727, DOI 10.1001/jamacardio.2019.1923
   Vecoli C, 2018, ATHEROSCLEROSIS, V276, P91, DOI 10.1016/j.atherosclerosis.2018.07.015
   Wang XB, 2020, CARDIOVASC DIABETOL, V19, P0, DOI 10.1186/s12933-020-00998-6
   Wang XB, 2019, ATHEROSCLEROSIS, V284, P165, DOI 10.1016/j.atherosclerosis.2019.03.010
   Westermeier F, 2015, BBA-MOL CELL RES, V1853, P1113, DOI 10.1016/j.bbamcr.2015.02.005
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Zhang C, 2019, EUR HEART J, V40, P3397, DOI 10.1093/eurheartj/ehz394
   Zheng YX, 2018, CELL, V175, P1546, DOI 10.1016/j.cell.2018.09.041
   Zhou ZY, 2018, STROKE, V49, P114, DOI 10.1161/strokeaha.117.018273
NR 46
TC 6
Z9 6
U1 0
U2 4
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0261-5614
EI 1532-1983
J9 CLIN NUTR
JI Clin. Nutr.
PD DEC 15
PY 2020
VL 39
IS 12
BP 3771
EP 3778
DI 10.1016/j.clnu.2020.04.006
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA PH6YQ
UT WOS:000600555900026
PM 32334879
DA 2024-11-01
ER

PT J
AU Lujan, SA
   Longley, MJ
   Humble, MH
   Lavender, CA
   Burkholder, A
   Blakely, EL
   Alston, CL
   Gorman, GS
   Turnbull, DM
   McFarland, R
   Taylor, RW
   Kunkel, TA
   Copeland, WC
AF Lujan, Scott A.
   Longley, Matthew J.
   Humble, Margaret H.
   Lavender, Christopher A.
   Burkholder, Adam
   Blakely, Emma L.
   Alston, Charlotte L.
   Gorman, Grainne S.
   Turnbull, Doug M.
   McFarland, Robert
   Taylor, Robert W.
   Kunkel, Thomas A.
   Copeland, William C.
TI Ultrasensitive deletion detection links mitochondrial DNA replication, disease, and aging
SO GENOME BIOLOGY
LA English
DT Article
ID human skeletal-muscle; progressive external ophthalmoplegia; polymerase-gamma; satellite cells; body-composition; point mutations; copy number; mtdna; complementation; accumulation
AB Background: Acquired human mitochondrial genome (mtDNA) deletions are symptoms and drivers of focal mitochondrial respiratory deficiency, a pathological hallmark of aging and late-onset mitochondrial disease. Results: To decipher connections between these processes, we create LostArc, an ultrasensitive method for quantifying deletions in circular mtDNA molecules. LostArc reveals 35 million deletions (similar to 470,000 unique spans) in skeletal muscle from 22 individuals with and 19 individuals without pathogenic variants in POLG. This nuclear gene encodes the catalytic subunit of replicative mitochondrial DNA polymerase gamma. Ablation, the deleted mtDNA fraction, suffices to explain skeletal muscle phenotypes of aging and POLG-derived disease. Unsupervised bioinformatic analyses reveal distinct age- and disease-correlated deletion patterns. Conclusions:These patterns implicate replication by DNA polymerase gamma as the deletion driver and suggest little purifying selection against mtDNA deletions by mitophagy in postmitotic muscle fibers. Observed deletion patterns are best modeled as mtDNA deletions initiated by replication fork stalling during strand displacement mtDNA synthesis.
C1 [Lujan, Scott A.; Kunkel, Thomas A.] NIEHS, Genome Integr & Struct Biol Lab, DNA Replicat Fidel Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Longley, Matthew J.; Humble, Margaret H.; Copeland, William C.] NIEHS, Genome Integr & Struct Biol Lab, Mitochondrial DNA Replicat Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Lavender, Christopher A.; Burkholder, Adam] NIEHS, Integrat Bioinformat, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Blakely, Emma L.; Alston, Charlotte L.; Gorman, Grainne S.; Turnbull, Doug M.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Blakely, Emma L.; Alston, Charlotte L.; Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP Copeland, WC (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, Mitochondrial DNA Replicat Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU Division of Intramural Research of the NIH, NIEHS [Z01 ES065070, Z01 ES065078, Z01 ES065080]; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council International Centre for Genomic Medicine in Neuromuscular Disease, Mitochondrial Disease Patient Cohort (UK) [G0800674]; UK National Institute for Health Research (NIHR) Biomedical Research Centre for Ageing and Age-related disease award; MRC/EPSRC Molecular Pathology Node; Lily Foundation; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; NIHR [PDF-2018-11-ST2-02]; MRC [G0800674] Funding Source: UKRI
CR Adey A, 2010, GENOME BIOL, V11, P0, DOI 10.1186/gb-2010-11-12-r119
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Bailey LJ, 2017, BIOCHEM SOC T, V45, P513, DOI 10.1042/BST20160162
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1821-7
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burkholder AB, 2018, BMC GENOMICS, V19, P0, DOI 10.1186/s12864-018-4753-3
   Chen XJ, 2018, MITOCHONDRION, V38, P17, DOI 10.1016/j.mito.2017.07.009
   Chinnery Patrick F, 2008, NEUROMUSCUL DISORD, V18, P259, DOI 10.1016/j.nmd.2007.11.005
   Chinnery PF, 2002, TRENDS GENET, V18, P173, DOI 10.1016/S0168-9525(01)02636-1
   CHOWDHURY B, 1994, INT J OBESITY, V18, P219
   Chrysostomou A, 2016, NEUROPATH APPL NEURO, V42, P477, DOI 10.1111/nan.12282
   Ciesielski GL, 2016, ENZYMES, V39, P255, DOI 10.1016/bs.enz.2016.03.006
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Cristea A, 2010, AGING CELL, V9, P685, DOI 10.1111/j.1474-9726.2010.00594.x
   Damas J, 2014, NUCLEIC ACIDS RES, V42, PD1261, DOI 10.1093/nar/gkt982
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gouzi F, 2013, J APPL PHYSIOL, V115, P346, DOI 10.1152/japplphysiol.01352.2012
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Gustafson MA, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0221829
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Hjelm BE, 2019, NUCLEIC ACIDS RES, V47, P0, DOI 10.1093/nar/gkz164
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310
   Joers P, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0053249
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202. Article published online before March 2002
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   KUNKEL TA, 1986, J BIOL CHEM, V261, P3581
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, PD1062, DOI 10.1093/nar/gkx1153
   Lavender CA, 2020, ROTLA READER LOST AR, V0, P0
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595
   Lewis SC, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1004985
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   LONN L, 1994, METABOLISM, V43, P1517, DOI 10.1016/0026-0495(94)90010-8
   Lott MT, 2013, CURR PROTOC BIOINF, V44, P1231, DOI 10.1002/0471250953.BI0123S44
   Lujan SA, 2020, DNA DATASETS, V0, P0
   Lujan SA, 2016, TRENDS CELL BIOL, V26, P640, DOI 10.1016/j.tcb.2016.04.012
   Martin M, 2011, EMBNET.JOURNAL, V17, P10, DOI 10.14806/ej.17.1.200
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/s1415-47572013000300002
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Ng YS, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000181
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Persson Ö, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Phillips NR, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep03887
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   ROBBERSODL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Sajko S, 2004, J HISTOCHEM CYTOCHEM, V52, P179, DOI 10.1177/002215540405200205
   Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587
   Sato A, 2009, BIOFACTORS, V35, P130, DOI 10.1002/biof.14
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon EA, 2010, BBA-GEN SUBJECTS, V1800, P245, DOI 10.1016/j.bbagen.2009.07.007
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Tengan CH, 1996, BIOCHEM MOL MED, V58, P130, DOI 10.1006/bmme.1996.0040
   Teo SM, 2012, BIOINFORMATICS, V28, P2711, DOI 10.1093/bioinformatics/bts535
   Torregrosa-Muñumer R, 2017, P NATL ACAD SCI USA, V114, P11398, DOI 10.1073/pnas.1705367114
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Verdijk LB, 2014, AGE, V36, P545, DOI 10.1007/s11357-013-9583-2
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   Yasukawa T, 2018, J BIOCHEM, V164, P183, DOI 10.1093/jb/mvy058
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Zhao LL, 2019, ENZYMES, V45, P311, DOI 10.1016/bs.enz.2019.08.004
NR 106
TC 42
Z9 45
U1 1
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
EI 
J9 GENOME BIOL
JI Genome Biol.
PD SEP 17
PY 2020
VL 21
IS 1
BP 
EP 
DI 10.1186/s13059-020-02138-5
PG 34
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA NV9FG
UT WOS:000574617200001
PM 32943091
DA 2024-11-01
ER

PT J
AU Malinska, D
   Testoni, G
   Duran, J
   Brudnicka, A
   Guinovart, JJ
   Duszynski, J
AF Malinska, Dominika
   Testoni, Giorgia
   Duran, Jordi
   Brudnicka, Alicja
   Guinovart, Joan J.
   Duszynski, Jerzy
TI Hallmarks of oxidative stress in the livers of aged mice with mild glycogen branching enzyme deficiency
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Glycogen; Glycogen branching enzyme; Oxidative stress
ID mitochondrial-dna damage; skeletal-muscle; metabolism; glutathione; disease
AB Glycogen branching enzyme (GBE1) introduces branching points in the glycogen molecule during its synthesis. Pathogenic GBE1 gene mutations lead to glycogen storage disease type IV (GSD IV), which is characterized by excessive intracellular accumulation of abnormal, poorly branched glycogen in affected tissues and organs, mostly in the liver. Using heterozygous Gbe1 knock-out mice (Gbe1(+/)), we analyzed the effects of moderate GBE1 deficiency on oxidative stress in the liver. The livers of aged Gbe1(+/) mice (22 months old) had decreased GBE1 protein levels, which caused a mild decrease in the degree of glycogen branching, but did not affect the tissue glycogen content. GBE1 deficiency was accompanied by increased protein carbonylation and elevated oxidation of the glutathione pool, indicating the existence of oxidative stress. Furthermore, we have observed increased levels of glutathione peroxidase and decreased activity of respiratory complex I in Gbe1(+/) livers. Our data indicate that even mild changes in the degree of glycogen branching, which did not lead to excessive glycogen accumulation, may have broader effects on cellular bioenergetics and redox homeostasis. In young animals cellular homeostatic mechanisms are able to counteract those changes, while in aged tissues the changes may lead to increased oxidative stress.
C1 [Malinska, Dominika; Brudnicka, Alicja; Duszynski, Jerzy] Polish Acad Sci, Nencki Inst Expt Biol, Pasteur St 3, PL-02093 Warsaw, Poland.
   [Testoni, Giorgia; Duran, Jordi; Guinovart, Joan J.] Barcelona Inst Sci & Technol BIST, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.
   [Duran, Jordi; Guinovart, Joan J.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28029, Spain.
   [Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biomed, Barcelona 08028, Spain.
C3 Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona
RP Malinska, D (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, Pasteur St 3, PL-02093 Warsaw, Poland.
EM d.malinska@nencki.edu.pl
FU Human Frontier Science Program, France [RGP0027/2011]; Polish Ministry of Science and Higher Education, Poland [SPUB W100/HFSC/2011]; Polish National Science Center, Poland [2011/03/B/NZ3/04433]; "La Caixa" PhD Fellowship Program; NIH [U01HG004085, U01HG004080]
CR Aguilera G, 2018, ANTIOXID REDOX SIGN, V28, P1626, DOI 10.1089/ars.2017.7099
   Angin Y, 2016, EXPERIENTIA SUPPL, V107, P23, DOI 10.1007/978-3-319-43589-3_2
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Tung BT, 2014, J GERONTOL A-BIOL, V69, P398, DOI 10.1093/gerona/glt102
   Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333
   Cho CS, 2010, ANTIOXID REDOX SIGN, V12, P1235, DOI 10.1089/ars.2009.2701
   Díaz A, 2011, J BIOL CHEM, V286, P18505, DOI 10.1074/jbc.M111.236109
   Dröse S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6
   Ellingwood SS, 2018, J ENDOCRINOL, V238, PR131, DOI 10.1530/JOE-18-0120
   Feng ZY, 2016, ONCOTARGET, V7, P15410, DOI 10.18632/oncotarget.7645
   Froese DS, 2015, HUM MOL GENET, V24, P5667, DOI 10.1093/hmg/ddv280
   Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214
   Graham TE, 2010, ACTA PHYSIOL, V199, P489, DOI 10.1111/j.1748-1716.2010.02131.x
   Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, PE1, DOI 10.1152/ajpendo.00652.2005
   Gusarov I, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15868
   Haran M, 2014, MITOCHONDRION, V19, P3, DOI 10.1016/j.mito.2014.09.007
   Hedberg-Oldfors C, 2015, MOL ASPECTS MED, V46, P85, DOI 10.1016/j.mam.2015.08.006
   Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200
   Janecek S, 2019, BIOTECHNOL ADV, V37, P0, DOI 10.1016/j.biotechadv.2019.107451
   Janzen NR, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19113344
   Kaczor JJ, 2017, MOL GENET METAB REP, V12, P69, DOI 10.1016/j.ymgmr.2017.05.009
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kitaoka Y, 2013, MOL GENET METAB, V110, P297, DOI 10.1016/j.ymgme.2013.06.022
   KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3
   Kudryavtseva AV, 2016, ONCOTARGET, V7, P44879, DOI 10.18632/oncotarget.9821
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Lim JA, 2015, AUTOPHAGY, V11, P385, DOI 10.1080/15548627.2015.1009779
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586
   Massarsky A, 2017, CHEMOSPHERE, V168, P707, DOI 10.1016/j.chemosphere.2016.11.004
   Melendez R, 1997, J MOL EVOL, V45, P446, DOI 10.1007/PL00006249
   Moses Shimon W, 2002, CURRENT MOLECULAR MEDICINE (HILVERSUM), V2, P177, DOI 10.2174/1566524024605815
   Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006
   Park HJ, 2010, ANAL BIOCHEM, V407, P151, DOI 10.1016/j.ab.2010.08.012
   Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416
   Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33
   Sato Y, 2017, STEM CELL TRANSL MED, V6, P31, DOI 10.5966/sctm.2015-0409
   Stapleton D, 2013, PROTEOME SCI, V11, P0, DOI 10.1186/1477-5956-11-11
   Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628
   Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X
   Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854
   Winiarska K, 2008, BIOCHIMIE, V90, P450, DOI 10.1016/j.biochi.2007.11.010
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yiu WH, 2010, LAB INVEST, V90, P620, DOI 10.1038/labinvest.2010.38
NR 46
TC 7
Z9 7
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 30
PY 2020
VL 695
IS 
BP 
EP 
DI 10.1016/j.abb.2020.108626
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA OY3SY
UT WOS:000594170700008
PM 33049291
DA 2024-11-01
ER

PT J
AU Habbane, M
   Llobet, L
   Bayona-Bafaluy, MP
   Bárcena, JE
   Ceberio, L
   Gómez-Díaz, C
   Gort, L
   Artuch, R
   Montoya, J
   Ruiz-Pesini, E
AF Habbane, Mouna
   Llobet, Laura
   Bayona-Bafaluy, M. Pilar
   Barcena, Jose E.
   Ceberio, Leticia
   Gomez-Diaz, Covadonga
   Gort, Laura
   Artuch, Rafael
   Montoya, Julio
   Ruiz-Pesini, Eduardo
TI Leigh Syndrome in a Pedigree Harboring the m.1555A&gt;G Mutation in the Mitochondrial 12S rRNA
SO GENES
LA English
DT Article
DE Leigh syndrome; hearing loss; mitochondrial DNA; ribosomal RNA; pathologic mutation; penetrance
ID hearing-loss; a1555g mutation; deafness; cardiomyopathy; gene; pathogenicity; patient; muscle
AB Background: Leigh syndrome (LS) is a serious genetic disease that can be caused by mutations in dozens of different genes. Methods: Clinical study of a deafness pedigree in which some members developed LS. Cellular, biochemical and molecular genetic analyses of patients' tissues and cybrid cell lines were performed. Results: mitochondrial DNA (mtDNA) m.1555A>G/MT-RNR1 and m.9541T>C/MT-CO3 mutations were found. The first one is a well-known pathologic mutation. However, the second one does not appear to contribute to the high hearing loss penetrance and LS phenotype observed in this family. Conclusion: The m.1555A>G pathological mutation, accompanied with an unknown nuclear DNA (nDNA) factor, could be the cause of the phenotypic manifestations in this pedigree.
C1 [Habbane, Mouna; Llobet, Laura; Bayona-Bafaluy, M. Pilar; Montoya, Julio; Ruiz-Pesini, Eduardo] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza 50013, Spain.
   [Habbane, Mouna] Univ Hassan 2, Fac Sci Ben MSik, Lab Biol & Sante, Casablanca 20670, Morocco.
   [Bayona-Bafaluy, M. Pilar; Montoya, Julio; Ruiz-Pesini, Eduardo] Inst Invest Sanitaria IIS Aragon, Zaragoza 50009, Spain.
   [Bayona-Bafaluy, M. Pilar; Gort, Laura; Montoya, Julio; Ruiz-Pesini, Eduardo] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28029, Spain.
   [Barcena, Jose E.] Hosp Univ Cruces, Serv Neurol, Baracaldo 48903, Vizcaya, Spain.
   [Ceberio, Leticia] Hosp Univ Cruces, Serv Med Interna, Baracaldo 48903, Vizcaya, Spain.
   [Gomez-Diaz, Covadonga] Hosp Univ Miguel Servet, Serv Otorrinolaringol, Zaragoza 50009, Spain.
   [Gort, Laura] IDIBAPS, Hosp Clin, CDB, Errors Congenits Metab,Serv Bioquim & Genet Mol, Barcelona 08036, Spain.
   [Artuch, Rafael] Inst Recerca St Joan de Deu, Serv Bioquim Clin, Barcelona 08950, Spain.
   [Ruiz-Pesini, Eduardo] Fdn Araid, Zaragoza 50018, Spain.
C3 University of Zaragoza; Hassan II University of Casablanca; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario Cruces; Hospital Universitario Cruces; Miguel Servet University Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS
RP Ruiz-Pesini, E (corresponding author), Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza 50013, Spain.; Ruiz-Pesini, E (corresponding author), Inst Invest Sanitaria IIS Aragon, Zaragoza 50009, Spain.; Ruiz-Pesini, E (corresponding author), Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28029, Spain.; Ruiz-Pesini, E (corresponding author), Fdn Araid, Zaragoza 50018, Spain.
EM mounahabbane@gmail.com; laurals@unizar.es; pbayona@unizar.es; joseeulalio.barcenallona@osakidetza.eus; leticia.ceberiohualde@osakidetza.eus; covagd@gmail.com; lgort@clinic.cat; rartuch@sjdhospitalbarcelona.org; jmontoya@unizar.es; eduruiz@unizar.es
FU Instituto de Salud Carlos III [FIS-PI17/00021, PI17/00109, PI17/00166]; Fundacion Mutua Madrilena [MMA17/01]; Precipita-FECYT crowdfunding program [PR194]; Gobierno de Aragon (Grupos Consolidados) [B33_17R]; FEDER 2014-2020 "Construyendo Europa desde Aragon"; Asociacion de Enfermos de Patologia Mitocondrial (AEPMI); CERCA Programme/Generalitat de Catalunya; CIBERER is an initiative of the ISCIII
CR Alila-Fersi O, 2017, BIOCHEM BIOPH RES CO, V484, P71, DOI 10.1016/j.bbrc.2017.01.070
   Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Campos Y, 2002, MUSCLE NERVE, V25, P185, DOI 10.1002/mus.10012.abs
   Chen H, 2012, EUR J HUM GENET, V20, P607, DOI 10.1038/ejhg.2011.259
   Czajkowski A, 2019, CELL MOL LIFE SCI, V76, P627, DOI 10.1007/s00018-018-2950-5
   Deguine O, 1996, NEUROREPORT, V7, P2435, DOI 10.1097/00001756-199611040-00006
   Emperador S, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00061
   Emperador S, 2015, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00469
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Herrero-Martin Maria D, 2008, HUM MUTAT, V29, PE112, DOI 10.1002/humu.20800
   Kouzaki H, 2007, J CLIN NEUROSCI, V14, P603, DOI 10.1016/j.jocn.2005.10.012
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   López-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   López-Gallardo E, 2014, HUM MOL GENET, V23, P6191, DOI 10.1093/hmg/ddu339
   Mantovani A, 2001, CURR PHARM DESIGN, V7, P859, DOI 10.2174/1381612013397717
   Martín-Navarro A, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1562-7
   Meng FL, 2018, J BIOL CHEM, V293, P3321, DOI 10.1074/jbc.RA117.000530
   Mezghani N, 2013, BIOCHEM BIOPH RES CO, V431, P670, DOI 10.1016/j.bbrc.2013.01.063
   Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003
   Nye JS, 2000, TERATOLOGY, V61, P165, DOI 10.1002/(SICI)1096-9926(200003)61:3<165::AID-TERA3>3.3.CO;2-5
   Pacheu-Grau D, 2012, EUR ARCH OTO-RHINO-L, V269, P2003, DOI 10.1007/s00405-012-2066-8
   Pereira L, 2011, AM J HUM GENET, V88, P433, DOI 10.1016/j.ajhg.2011.03.006
   Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Santorelli FM, 1999, AM J HUM GENET, V64, P295, DOI 10.1086/302188
   Skou AS, 2014, J PEDIATR-US, V164, P413, DOI 10.1016/j.jpeds.2013.10.024
   Thorburn DR, 2017, MITOCHONDRIAL DNA AS, V0, P0
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367
   Yamasoba T, 2002, NEUROMUSCULAR DISORD, V12, P506, DOI 10.1016/S0960-8966(01)00329-7
   Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133
NR 34
TC 7
Z9 7
U1 1
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD SEP 15
PY 2020
VL 11
IS 9
BP 
EP 
DI 10.3390/genes11091007
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA OG9BQ
UT WOS:000582170500001
PM 32867169
DA 2024-11-01
ER

PT J
AU Guo, L
   Wang, X
   Ji, HT
AF Guo, Luo
   Wang, Xin
   Ji, Haiting
TI Clinical Phenotype and Genetic Features of a Pair of Chinese Twins with Kearns-Sayre Syndrome
SO DNA AND CELL BIOLOGY
LA English
DT Article
DE mitochondrial disease; deletion; Kearns-Sayre Syndrome
ID progressive external ophthalmoplegia; mitochondrial-dna deletions; common deletion; disease; mutations
AB Kearns-Sayre Syndrome (KSS) is a severe mitochondrial disorder involving the central nervous system, eyes, ears, skeletal muscles, and heart. The mitochondrial DNA (mtDNA) rearrangements, especially the deletions, are present in almost all KSS patients and considered as the disease-causing factor. However, the size and position of mtDNA deletions are distinct in different individuals. In this study, we report the case of a pair of Chinese twins with KSS. The twin patients revealed typical KSS clinical symptoms, including heart block, bilateral sensorineural hearing loss, progressive external ophthalmoplegia, exercise intolerance, proximal limb weakness, and endocrine disorders. Using long-range polymerase chain reactions (long-range PCR) and next-generation sequencing (NGS), the genetic features of the twin patients were investigated. A large 6600 bp mtDNA deletion, ranging from position 8702 to 15,302, was detected in both patients. To our knowledge, this kind of mtDNA deletion has never been described previously. Our study enriched the mutation spectrum of KSS and showed that NGS is a powerful tool for detecting mtDNA large variants.
C1 [Guo, Luo; Ji, Haiting] Fudan Univ, State Key Lab Med Neurobiol, ENT Inst, Eye & ENT Hosp, Shanghai, Peoples R China.
   [Guo, Luo; Ji, Haiting] Fudan Univ, MOE Frontiers Ctr Brain Sci, ENT Inst, Eye & ENT Hosp, Shanghai, Peoples R China.
   [Guo, Luo; Ji, Haiting] Fudan Univ, Otorhinolaryngol Dept, Eye & ENT Hosp, Shanghai, Peoples R China.
   [Guo, Luo; Ji, Haiting] Fudan Univ, NHC Key Lab Hearing Med, Shanghai, Peoples R China.
   [Wang, Xin] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China.
   [Wang, Xin] Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China.
   [Wang, Xin] Nantong Univ, Minist Educ, Nantong, Peoples R China.
   [Ji, Haiting] Fudan Univ, Dept Otorhinolaryngol, Affiliated Eye & ENT Hosp, Shanghai 200031, Peoples R China.
C3 Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Nantong University; Nantong University; Fudan University
RP Ji, HT (corresponding author), Fudan Univ, Dept Otorhinolaryngol, Affiliated Eye & ENT Hosp, Shanghai 200031, Peoples R China.
EM hj11@fudan.edu.cn
FU National Natural Science Foundation of China [81600816]
CR Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Cherry C, 2016, TRENDS MOL MED, V22, P391, DOI 10.1016/j.molmed.2016.03.009
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Emma F, 2006, PEDIATR NEPHROL, V21, P355, DOI 10.1007/s00467-005-2092-5
   Fisher N, 2001, EUR J BIOCHEM, V268, P1155, DOI 10.1046/j.1432-1327.2001.02010.x
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   KLOPSTOCK T, 1995, ACTA NEUROPATHOL, V90, P126
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Lertrit P, 1999, HUM GENET, V105, P127, DOI 10.1007/s004390051074
   Maeda K, 2016, JAMA NEUROL, V73, P990, DOI 10.1001/jamaneurol.2016.0886
   Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Puoti G, 2003, J MED GENET, V40, P858, DOI 10.1136/jmg.40.11.858
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   SCHON EA, 1988, ANN NY ACAD SCI, V550, P348, DOI 10.1111/j.1749-6632.1988.tb35349.x
   Seyrantepe V, 1999, BRAIN DEV-JPN, V21, P413, DOI 10.1016/S0387-7604(99)00035-2
   Sokolova VA, 2002, MITOCHONDRION, V1, P479, DOI 10.1016/S1567-7249(02)00014-4
   Wei YH, 1996, ANN NY ACAD SCI, V786, P82, DOI 10.1111/j.1749-6632.1996.tb39054.x
   Yan XK, 2011, J MED GENET, V48, P682, DOI 10.1136/jmedgenet-2011-100219
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 26
TC 7
Z9 9
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD AUG 1
PY 2020
VL 39
IS 8
BP 1449
EP 1457
DI 10.1089/dna.2019.5010
EA JUN 2020
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA MU1AS
UT WOS:000547119100001
PM 32609007
DA 2024-11-01
ER

PT J
AU Papadopoulos, C
   Wahbi, K
   Behin, A
   Bougouin, W
   Stojkovic, T
   Leonard-Louis, S
   Berber, N
   Lombès, A
   Duboc, D
   Jardel, C
   Eymard, B
   Laforêt, P
AF Papadopoulos, Constantinos
   Wahbi, Karim
   Behin, Anthony
   Bougouin, Wulfran
   Stojkovic, Tanya
   Leonard-Louis, Sarah
   Berber, Nawal
   Lombes, Anne
   Duboc, Denis
   Jardel, Claude
   Eymard, Bruno
   Laforet, Pascal
TI Incidence and predictors of total mortality in 267 adults presenting with mitochondrial diseases
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
DE cohort studies; mitochondrial disorders; mortality; prognosis
ID lactic-acidosis; mutation; death; melas; 3243a-greater-than-g; statement; diagnosis; prognosis; myopathy; spectrum
AB Assessing long-term mortality and identifying predictors of death in adults with mitochondrial diseases. We retrospectively included adult patients with genetically proven mitochondrial diseases referred to our centre between January 2000 and June 2016, and collected information relative to their genetic testing, clinical assessments, and vital status. We performed single and multiple variable analyses in search of predictors of total mortality, and calculated hazard ratios (HR) and 95% confidence intervals (CI). We included 267 patients (women 59%; median age 43.3 [31.3-54.2] years), including 111 with mitochondrial DNA (mtDNA) single large-scale deletions, 65 with m.3243A>G, 24 with m.8344A>G, 32 with other mtDNA point mutations, and 36 patients with nuclear genes mutations. Over a median follow-up of 8.9 years (0.3 to 18.7), 61 patients (22.8%) died, at a median age of 50.7 (37.9-51.9) years. Primary cause of death was cardiovascular disease in 16 patients (26.2%), respiratory in 11 (18.0%), and gastrointestinal in 5 (8.1%). By multiple variable analysis, diabetes (HR 2.75; 95% CI 1.46-5.18), intraventricular cardiac conduction defects (HR 3.38; 95% CI 1.71-6.76) and focal brain involvement (HR 2.39; 95% CI 1.25-4.57) were independent predictors of death. Adult patients with mitochondrial diseases present high morbidity that can be independently predicted by the presence of diabetes, intraventricular cardiac conduction defects, and focal brain involvement.
C1 [Papadopoulos, Constantinos; Behin, Anthony; Stojkovic, Tanya; Leonard-Louis, Sarah; Berber, Nawal; Eymard, Bruno] Pitie Salpetrere Hosp, AP HP, Myol Inst, Nord Est Ile de France Neuromuscular Reference Ct, Paris, France.
   [Papadopoulos, Constantinos] Natl & Kapodistrian Univ Athens, Eginit Hosp, Med Sch, Dept Neurol 1, Athens, Greece.
   [Wahbi, Karim; Duboc, Denis] Sorbonne Paris Cite Univ, Cochin Hosp, AP HP, FILNEMUS,Cardiol Dept,Paris Descartes, Paris, France.
   [Wahbi, Karim; Bougouin, Wulfran] Paris Cardiovasc Res Ctr PARCC, INSERM Unit 970, Paris, France.
   [Bougouin, Wulfran] Cochin Hosp, AP HP, Med Intens Care Unit, Paris, France.
   [Lombes, Anne] Cochin Hosp, AP HP, INSERM, UMRS 975, Paris, France.
   [Jardel, Claude] Hop La Pitie Salpetriere, AP HP, Biochem Dept, Paris, France.
   [Jardel, Claude] Hop La Pitie Salpetriere, AP HP, Genet Ctr, Paris, France.
   [Jardel, Claude] Inst Cochin, Inserm U 1016, CNRS, UMR 8104, Paris, France.
   [Jardel, Claude] Univ Paris 06, GRC UPMC Neurometab, Paris, France.
   [Laforet, Pascal] Raymond Poincare Teaching Hosp, AP HP, Nord Est Ile de France Neuromuscular Reference Ct, Neurol Dept, Garches, France.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; National & Kapodistrian University of Athens; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP
RP Papadopoulos, C (corresponding author), Natl & Kapodistrian Univ Athens, Eginit Hosp, Med Sch, Dept Neurol 1, Athens, Greece.
EM constantinospapadopoulos@yahoo.com
FU French Alliance against Myopathies
CR Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Barends M, 2016, JIMD REP, V26, P103, DOI 10.1007/8904_2015_449
   CROS D, 1992, CHEST, V101, P824, DOI 10.1378/chest.101.3.824
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2013, NEUROLOGY, V81, P281, DOI 10.1212/WNL.0b013e31829bfe89
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, P0, DOI 10.1136/jnnp.2007.122648
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   MarinGarcia J, 1997, PEDIATR CARDIOL, V18, P251, DOI 10.1007/s002469900169
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Roglic G, 2010, DIABETES RES CLIN PR, V87, P15, DOI 10.1016/j.diabres.2009.10.006
   Roper NA, 2001, BRIT MED J, V322, P1389, DOI 10.1136/bmj.322.7299.1389
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   von Elm E, 2007, BMJ-BRIT MED J, V335, P806
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 26
TC 8
Z9 8
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD MAY 15
PY 2020
VL 43
IS 3
BP 459
EP 466
DI 10.1002/jimd.12185
PG 8
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA LM7PS
UT WOS:000532441300007
PM 31652339
DA 2024-11-01
ER

PT J
AU Zeng, X
   Huang, Q
   Long, SL
   Zhong, QQ
   Mo, ZC
AF Zeng, Xin
   Huang, Qin
   Long, Shuang Lian
   Zhong, Qiaoqing
   Mo, Zhongcheng
TI Mitochondrial Dysfunction in Polycystic Ovary Syndrome
SO DNA AND CELL BIOLOGY
LA English
DT Article
DE mitochondrion; reproductive metabolism; polycystic ovary syndrome; follicular development
ID insulin-resistance; oxidative stress; skeletal-muscle; granulosa-cells; women; expression; pathway; consequences; inflammation; glutathione
AB Polycystic ovary syndrome (PCOS) is one of the most common female reproductive metabolisms. It is an endocrine disease that affects reproductive women and often exhibits with hyperandrogenemia, insulin resistance (IR), low inflammation, and an increased risk of type 2 diabetes mellitus, metabolic syndrome, and cardiovascular events such as hypertension and dyslipidemia in patients. However, the molecular mechanism of PCOS is still unclear. Recently, an increasing number of studies have shown that the oxidative stress induced by mitochondrial dysfunction has negative effects on IR, lipid metabolism, and follicular development, suggesting that mitochondrial dysfunction plays an essential role in the development of PCOS. Abnormal mitochondrial DNA copy number in patients with PCOS, and mitochondrial gene mutations, has been the focus of research in recent years, and functional mitochondrial diseases have been gradually accepted as a related factor in PCOS. This review is intended to summarize and discuss previous and recent studies and findings on the connections between mitochondrial dysfunction and PCOS.
C1 [Zeng, Xin; Huang, Qin; Long, Shuang Lian; Mo, Zhongcheng] Univ South China, Hengyang Med Sch, Clin Anat & Reprod Med Applicat Inst, Dept Histol & Embryol, Hengyang, Hunan, Peoples R China.
   [Zhong, Qiaoqing] Cent South Univ, Xiangya Hosp, Dept Cardiovasc Med, Changsha 410008, Peoples R China.
   [Mo, Zhongcheng] Guilin Med Univ, Inst Basic Med Sci, Guilin 541100, Guangxi, Peoples R China.
C3 University of South China; Central South University; Guilin Medical University
RP Zhong, QQ (corresponding author), Cent South Univ, Xiangya Hosp, Dept Cardiovasc Med, Changsha 410008, Peoples R China.; Mo, ZC (corresponding author), Guilin Med Univ, Inst Basic Med Sci, Guilin 541100, Guangxi, Peoples R China.
EM qiaoqingzhong@csu.edu.cn; zhchmo@hotmail.com
FU Natural Sciences Foundation of Hunan Province [2019JJ40248, 2018JJ2663]; Key Lab for Clinical Anatomy & Reproductive Medicine of Hengyang City [2017KJ182]; Chuanshan Talents Project in the University of South China
CR Anusree SS, 2015, MOL CELL ENDOCRINOL, V413, P120, DOI 10.1016/j.mce.2015.06.018
   Anvari SS, 2019, CELL J, V21, P243, DOI 10.22074/cellj.2019.5952
   Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506
   Baskol G, 2012, ACTA OBSTET GYN SCAN, V91, P326, DOI 10.1111/j.1600-0412.2011.01337.x
   Biary N, 2011, J PHYSIOL-LONDON, V589, P5167, DOI 10.1113/jphysiol.2011.214239
   Budani MC, 2017, ZYGOTE, V25, P296, DOI 10.1017/S0967199417000132
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Civitarese AE, 2008, ENDOCRINOLOGY, V149, P950, DOI 10.1210/en.2007-1444
   Cree-Green M, 2015, AM J PHYSIOL-ENDOC M, V308, PE726, DOI 10.1152/ajpendo.00619.2014
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   De Vecchis D, 2019, J MEMBRANE BIOL, V252, P293, DOI 10.1007/s00232-019-00089-y
   Ding Y, 2018, GENE, V642, P299, DOI 10.1016/j.gene.2017.11.049
   Ding Y, 2017, AM J TRANSL RES, V9, P2984
   Ding Y, 2016, MOL MED REP, V13, P3169, DOI 10.3892/mmr.2016.4916
   Ding Y, 2016, REPROD SCI, V23, P228, DOI 10.1177/1933719115602777
   Dunn JD, 2015, REDOX BIOL, V6, P472, DOI 10.1016/j.redox.2015.09.005
   Eriksen MB, 2011, J CLIN ENDOCR METAB, V96, PE1298, DOI 10.1210/jc.2011-0278
   Ernst EH, 2018, J ASSIST REPROD GEN, V35, P1787, DOI 10.1007/s10815-018-1240-3
   Gannon AM, 2013, BIOL REPROD, V88, P0, DOI 10.1095/biolreprod.112.106617
   Garcia-Ruiz C, 2006, J GASTROEN HEPATOL, V21, PS3, DOI 10.1111/j.1440-1746.2006.04570.x
   Goodarzi MO, 2005, J CLIN ENDOCR METAB, V90, P310, DOI 10.1210/jc.2004-1006
   Holland O, 2017, PLACENTA, V54, P2, DOI 10.1016/j.placenta.2016.12.012
   Hou S, 2019, J PHYSIOL SCI, V69, P697, DOI 10.1007/s12576-019-00685-6
   Jeanes YM, 2017, NUTR RES REV, V30, P97, DOI 10.1017/S0954422416000287
   Jia LF, 2019, BIOL REPROD, V100, P907, DOI 10.1093/biolre/ioy238
   Jia LF, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep19436
   Khodabandehloo H, 2016, TRANSL RES, V167, P228, DOI 10.1016/j.trsl.2015.08.011
   Konopka AR, 2015, DIABETES, V64, P2104, DOI 10.2337/db14-1701
   Lai QH, 2018, FRONT MED-PRC, V12, P518, DOI 10.1007/s11684-017-0575-y
   Li W, 2017, J HUAZHONG U SCI-MED, V37, P210, DOI 10.1007/s11596-017-1717-9
   Liu HG, 2019, ECOTOX ENVIRON SAFE, V183, P0, DOI 10.1016/j.ecoenv.2019.109544
   Liu HG, 2019, ECOTOX ENVIRON SAFE, V181, P370, DOI 10.1016/j.ecoenv.2019.06.006
   Liu Q, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30561
   Luo QY, 2018, EUR REV MED PHARMACO, V22, P2212, DOI 10.26355/eurrev_201804_14806
   Malin SK, 2014, J CLIN ENDOCR METAB, V99, P322, DOI 10.1210/jc.2013-3177
   Masjedi Fatemeh, 2019, J REPROD INFERTIL, V20, P132
   McBride HM, 2006, CURR BIOL, V16, PR551, DOI 10.1016/j.cub.2006.06.054
   Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298
   Pasquali R, 2018, FRONT HORM RES, V49, P114, DOI 10.1159/000485995
   Pelanis R, 2017, HUM REPROD, V32, P2279, DOI 10.1093/humrep/dex294
   Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233
   Rachek LI, 2014, PROG MOL BIOL TRANSL, V121, P267, DOI 10.1016/B978-0-12-800101-1.00008-9
   RANDLE PJ, 1963, LANCET, V1, P785
   Reddy TV, 2019, MITOCHONDRION, V44, P35, DOI 10.1016/j.mito.2017.12.010
   Roubicek DA, 2017, TOXICOLOGY, V391, P100, DOI 10.1016/j.tox.2017.06.012
   Rubin KH, 2017, J CLIN ENDOCR METAB, V102, P3848, DOI 10.1210/jc.2017-01354
   Ryu Y, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20112720
   Saeed NAAAH, 2019, BMC RES NOTES, V12, P0, DOI 10.1186/s13104-019-4453-3
   Selim LA, 2017, ADV EXP MED BIOL, V1007, P129, DOI 10.1007/978-3-319-60733-7_8
   Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4
   Skov V, 2007, DIABETES, V56, P2349, DOI 10.2337/db07-0275
   Sobinoff AP, 2012, TOXICOL APPL PHARM, V260, P70, DOI 10.1016/j.taap.2012.01.028
   Song Xi, 2018, ONCOTARGET, V9, P11905, DOI 10.18632/oncotarget.24190
   Spritzer PM, 2015, REPRODUCTION, V149, PR219, DOI 10.1530/REP-14-0435
   Tantanavipas S, 2019, BIOMED RES INT, V2019, P0, DOI 10.1155/2019/9047324
   Teede HJ, 2018, HUM REPROD, V33, P1602, DOI 10.1093/humrep/dey256
   Wang CH, 2017, J BIOMED SCI, V24, P0, DOI 10.1186/s12929-017-0375-3
   Wang HD, 2015, J STEROID BIOCHEM, V154, P254, DOI 10.1016/j.jsbmb.2015.09.003
   Wang TR, 2017, AM J REPROD IMMUNOL, V77, P0, DOI 10.1111/aji.12651
   Xin YG, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/3649808
   Yang ZB, 2019, CHEMOSPHERE, V231, P151, DOI 10.1016/j.chemosphere.2019.05.129
   Zhang JS, 2019, REPROD BIOL ENDOCRIN, V17, P0, DOI 10.1186/s12958-019-0509-4
   Zhang M, 2019, CELL DEATH DIS, V10, P0, DOI 10.1038/s41419-019-1799-3
   Zhang M, 2019, AGING-US, V11, P3919, DOI 10.18632/aging.102024
   Zhang YH, 2019, J PHYSIOL-LONDON, V597, P3927, DOI 10.1113/JP277879
   Zhang Yuehui, 2018, ONCOTARGET, V9, P18180, DOI 10.18632/oncotarget.24477
   Zhao N, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0125680
   Zhao Y, 2015, J CLIN ENDOCR METAB, V100, P201, DOI 10.1210/jc.2014-2419
NR 68
TC 27
Z9 31
U1 0
U2 27
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD AUG 1
PY 2020
VL 39
IS 8
BP 1401
EP 1409
DI 10.1089/dna.2019.5172
EA FEB 2020
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA MU1AS
UT WOS:000515272500001
PM 32077751
DA 2024-11-01
ER

PT J
AU Hoyos-Gonzalez, N
   Trasvina-Arenas, CH
   Degiorgi, A
   Castro-Lara, AY
   Peralta-Castro, A
   Jimenez-Sandoval, P
   Diaz-Quezada, C
   Lodi, T
   Baruffini, E
   Brieba, LG
AF Hoyos-Gonzalez, Nallely
   Trasvina-Arenas, Carlos H.
   Degiorgi, Andrea
   Castro-Lara, Atzimaba Y.
   Peralta-Castro, Antolin
   Jimenez-Sandoval, Pedro
   Diaz-Quezada, Corina
   Lodi, Tiziana
   Baruffini, Enrico
   Brieba, Luis G.
TI Modeling of pathogenic variants of mitochondrial DNA polymerase: insight into the replication defects and implication for human disease
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Mitochondrial replication; Mitochondrial DNA polymerase; Structure-function; Mitochondrial dissease
ID progressive external ophthalmoplegia; nonsense-mediated decay; rna-polymerase; saccharomyces-cerevisiae; polg mutations; structural basis; gamma; mechanism; disorder; subunit
AB Background: Mutations in human gene encoding the mitochondrial DNA polymerase gamma (HsPol gamma) are associated with a broad range of mitochondrial diseases. Here we studied the impact on DNA replication by disease variants clustered around residue HsPol gamma-K1191, a residue that in several family-A DNA polymerases interacts with the 3' end of the primer. Methods: Specifically, we examined the effect of HsPol gamma carrying pathogenic variants in residues D1184, I1185, C1188, K1191, D1196, and a stop codon at residue T1199, using as a model the yeast mitochondrial DNA polymerase protein, Mip1p. Results: The introduction of pathogenic variants C1188R (yV945R), and of a stop codon at residue T1199 (yT956X) abolished both polymerization and exonucleolysis in vitro. HsPol gamma substitutions in residues D1184 (yD941), 11185 (y1942), K1191 (yK948) and D1196 (yD953) shifted the balance between polymerization and exonucleolysis in favor of exonucleolysis. HsPol gamma pathogenic variants at residue K1191 (yK948) and D1184 (yD941) were capable of nucleotide incorporation albeit with reduced processivity. Structural analysis of mitochondrial DNAPs showed that residue HsPol gamma-N864 is placed in an optimal distance to interact with the 3' end of the primer and the phosphate backbone previous to the 3' end. Amino acid changes in residue HsPol gamma-N864 to Ala, Ser or Asp result in enzymes that did not decrease their polymerization activity on short templates but exhibited a substantial decrease for processive DNA synthesis. Conclusion: Our data suggest that in mitochondrial DNA polymerases multiple amino acids are involved in the primer-stand stabilization.
C1 [Hoyos-Gonzalez, Nallely; Trasvina-Arenas, Carlos H.; Castro-Lara, Atzimaba Y.; Peralta-Castro, Antolin; Jimenez-Sandoval, Pedro; Diaz-Quezada, Corina; Brieba, Luis G.] IPN, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Apartado Postal 629, Guanajuato 36821, Mexico.
   [Degiorgi, Andrea; Lodi, Tiziana; Baruffini, Enrico] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
   [Trasvina-Arenas, Carlos H.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.
C3 CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; University of Parma; University of California System; University of California Davis
RP Brieba, LG (corresponding author), IPN, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Apartado Postal 629, Guanajuato 36821, Mexico.; Baruffini, E (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
EM enrico.baruffini@unipr.it; luis.brieba@cinvestav.mx
FU Telethon (Italy) [GGP15041, GGP19287, 253737]
CR Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Anderson BJ, 2008, METHOD ENZYMOL, V450, P253, DOI 10.1016/S0076-6879(08)03412-5
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   DeLano WL, 2002, THE PYMOL MOLECULAR GRAPHICS SYSTEM, V0, P0
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   Doublié S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Foury F, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027847
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Germaniuk A, 2002, J BIOL CHEM, V277, P27801, DOI 10.1074/jbc.M201756200
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hug N, 2016, NUCLEIC ACIDS RES, V44, P1483, DOI 10.1093/nar/gkw010
   Huynh Kathy, 2015, CURR PROTOC PROTEIN SCI, V79, P0, DOI 10.1002/0471140864.ps2809s79
   Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015
   Kumar JK, 2001, J BIOL CHEM, V276, P34905, DOI 10.1074/jbc.M104151200
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514
   Lodi T, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00106
   MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4
   McClure W R, 1980, METHODS ENZYMOL, V64, P277
   Montassir H, 2015, BRAIN DEV-JPN, V37, P719, DOI 10.1016/j.braindev.2014.10.013
   Nurminen A, 2017, BBA CLIN, V7, P147, DOI 10.1016/j.bbacli.2017.04.001
   Ramachandran A, 2016, J BIOL CHEM, V291, P16828, DOI 10.1074/jbc.M116.740282
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Sanchez-Sandoval E, 2015, MITOCHONDRION, V24, P22, DOI 10.1016/j.mito.2015.06.004
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Sohl CD, 2013, HUM MOL GENET, V22, P1074, DOI 10.1093/hmg/dds509
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Trasviña-Arenas CH, 2019, MITOCHONDRION, V49, P166, DOI 10.1016/j.mito.2019.08.005
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Viikov K, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0033482
   Viikov K, 2011, MITOCHONDRION, V11, P119, DOI 10.1016/j.mito.2010.08.007
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Young MJ, 2006, YEAST, V23, P101, DOI 10.1002/yea.1344
NR 53
TC 4
Z9 4
U1 0
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD JUL 15
PY 2020
VL 1864
IS 7
BP 
EP 
DI 10.1016/j.bbagen.2020.129608
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA LS1DK
UT WOS:000536132200011
PM 32234506
DA 2024-11-01
ER

PT J
AU Panadés-de Oliveira, L
   Montoya, J
   Emperador, S
   Ruiz-Pesini, E
   Jericó, I
   Arenas, J
   Hernández-Lain, A
   Blázquez, A
   Martín, MA
   Domínguez-González, C
AF Panades-de Oliveira, Luisa
   Montoya, Julio
   Emperador, Sonia
   Ruiz-Pesini, Eduardo
   Jerico, Ivonne
   Arenas, Joaquin
   Hernandez-Lain, Aurelio
   Blazquez, Alberto
   Martin, Miguel A.
   Dominguez-Gonzalez, Cristina
TI A novel mutation in the mitochondrial <i>MT</i>-<i>ND5</i> gene in a family with MELAS. The relevance of genetic analysis on targeted tissues
SO MITOCHONDRION
LA English
DT Article
DE MELAS syndrome; MTND5 gene; Heteroplasmy; Urine sample; Muscle sample; Mitochondrial diseases
ID g13513a mutation; lactic-acidosis; leigh-syndrome; nd5 gene; dna; myopathy; loads
AB We report the case of two members of the same family with a novel mitochondrial DNA (mtDNA) gene variant in the MT-ND5 gene associated with MELAS syndrome and discuss limitations of genetics studies. The m.13045A > G mutation was detected at very low load in the daughter's urine cells (5%) and at different levels in the skeletal muscle of both mother (50%) and daughter (84%), being absent in blood, hair and saliva. Our findings suggest that non-invasive genetic assessment in urine cells may not be a sensitive diagnostic method neither a good predictor of disease development in relatives of some families with mtDNA-associated MELAS, particularly if involving MT-ND5 gene.
C1 [Panades-de Oliveira, Luisa; Dominguez-Gonzalez, Cristina] Hosp Univ 12 Octubre, Dept Neurol, Madrid, Spain.
   [Montoya, Julio; Emperador, Sonia; Ruiz-Pesini, Eduardo; Arenas, Joaquin; Blazquez, Alberto; Martin, Miguel A.; Dominguez-Gonzalez, Cristina] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.
   [Montoya, Julio; Emperador, Sonia; Ruiz-Pesini, Eduardo] Univ Zaragoza, Dept Biochem, Zaragoza, Spain.
   [Montoya, Julio; Emperador, Sonia; Ruiz-Pesini, Eduardo] IIS Aragon, Zaragoza, Spain.
   [Jerico, Ivonne] Complejo Hosp Navarra, IdisNa Navarra Inst Healthe Res, Dept Neurol, Navarra, Spain.
   [Arenas, Joaquin; Blazquez, Alberto; Martin, Miguel A.] Inst Invest Hosp 12 Octubre i12, Dept Biochem, Lab Mitochondrial Dis, Madrid, Spain.
   [Hernandez-Lain, Aurelio] Hosp Univ 12 Octubre, Dept Pathol Neuropathol, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina] Hosp Univ 12 Octubre, Dept Neurol, Neuromuscular Disorders Unit, Madrid, Spain.
C3 Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Zaragoza; Servicio Navarro de Salud - Osasunbidea; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre
RP Martín, MA (corresponding author), Hosp Univ 12 Octubre, Ave Cordoba S-N, Madrid, Spain.
EM jmontoya@unizar.es; seortiz@unizar.es; eduruiz@unizar.es; ijericop@cfnavarra.es; joaquin.arenas@salud.madrid.org; aurelio.hlain@salud.madrid.org; mamcasanueva.imas12@h12o.es; cdgonzalez@salud.madrid.org
FU Instituto de Salud Carlos III, Spain [PI18/01374, PI17/00021]; Comunidad de Madrid, Spain [B2017/BMD-3721]; Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon [B33_17R]; FEDER; European Union
CR Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Blok MJ, 2007, J MED GENET, V44, P0, DOI 10.1136/jmg.2006.045716
   Crimi M, 2003, NEUROLOGY, V60, P1857, DOI 10.1212/01.WNL.0000066048.72780.69
   Emperador S, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00061
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lin J, 2014, MITOCHONDR DNA, V25, P56, DOI 10.3109/19401736.2013.779259
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Liu AH, 2014, CNS NEUROSCI THER, V20, P509, DOI 10.1111/cns.12257
   Ng YS, 2018, EBIOMEDICINE, V30, P86, DOI 10.1016/j.ebiom.2018.02.010
   OCallaghan MM, 2015, MITOCHONDRION, V22, P17, DOI 10.1016/j.mito.2015.03.001
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   SWEENEY MG, 1993, Q J MED, V86, P709
   Wang YX, 2015, CHINESE MED J-PEKING, V128, P1820, DOI 10.4103/0366-6999.159360
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 17
TC 6
Z9 6
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN 15
PY 2020
VL 50
IS 
BP 14
EP 18
DI 10.1016/j.mito.2019.10.001
PG 5
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA KE0YP
UT WOS:000508287400002
PM 31639449
DA 2024-11-01
ER

PT J
AU Danhelovska, T
   Kolarova, H
   Zeman, J
   Hansikova, H
   Vaneckova, M
   Lambert, L
   Kucerova-Vidrova, V
   Berankova, K
   Honzik, T
   Tesarova, M
AF Danhelovska, Tereza
   Kolarova, Hana
   Zeman, Jiri
   Hansikova, Hana
   Vaneckova, Manuela
   Lambert, Lukas
   Kucerova-Vidrova, Vendula
   Berankova, Kamila
   Honzik, Tomas
   Tesarova, Marketa
TI Multisystem mitochondrial diseases due to mutations in mtDNA-encoded subunits of complex I
SO BMC PEDIATRICS
LA English
DT Article
DE mtDNA; MT-ND genes; Complex I; Leigh syndrome; MELAS syndrome; MEGS; Mitochondria
ID cytochrome-c-oxidase; dna g13513a mutation; stroke-like episodes; leigh-syndrome; 13513g-greater-than-a mutation; muscle mitochondria; lactic-acidosis; atp synthase; melas; gene
AB Background Maternally inherited complex I deficiencies due to mutations in MT-ND genes represent a heterogeneous group of multisystem mitochondrial disorders (MD) with a unfavourable prognosis. The aim of the study was to characterize the impact of the mutations in MT-ND genes, including the novel m.13091 T > C variant, on the course of the disease, and to analyse the activities of respiratory chain complexes, the amount of protein subunits, and the mitochondrial energy-generating system (MEGS) in available muscle biopsies and cultivated fibroblasts. Methods The respiratory chain complex activities were measured by spectrophotometry, MEGS were analysed using radiolabelled substrates, and protein amount by SDS-PAGE or BN-PAGE in muscle or fibroblasts. Results In our cohort of 106 unrelated families carrying different mtDNA mutations, we found heteroplasmic mutations in the genes MT-ND1, MT-ND3, and MT-ND5, including the novel variant m.13091 T > C, in 13 patients with MD from 12 families. First symptoms developed between early childhood and adolescence and progressed to multisystem disease with a phenotype of Leigh or MELAS syndromes. MRI revealed bilateral symmetrical involvement of deep grey matter typical of Leigh syndrome in 6 children, cortical/white matter stroke-like lesions suggesting MELAS syndrome in 3 patients, and a combination of cortico-subcortical lesions and grey matter involvement in 4 patients. MEGS indicated mitochondrial disturbances in all available muscle samples, as well as a significantly decreased oxidation of [1-C-14] pyruvate in fibroblasts. Spectrophotometric analyses revealed a low activity of complex I and/or complex I + III in all muscle samples except one, but the activities in fibroblasts were mostly normal. No correlation was found between complex I activities and mtDNA mutation load, but higher levels of heteroplasmy were generally found in more severely affected patients. Conclusions Maternally inherited complex I deficiencies were found in 11% of families with mitochondrial diseases in our region. Six patients manifested with Leigh, three with MELAS. The remaining four patients presented with an overlap between these two syndromes. MEGS, especially the oxidation of [1-C-14] pyruvate in fibroblasts might serve as a sensitive indicator of functional impairment due to MT-ND mutations. Early onset of the disease and higher level of mtDNA heteroplasmy were associated with a worse prognosis.
C1 [Danhelovska, Tereza; Kolarova, Hana; Zeman, Jiri; Hansikova, Hana; Kucerova-Vidrova, Vendula; Berankova, Kamila; Honzik, Tomas; Tesarova, Marketa] Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Danhelovska, Tereza; Kolarova, Hana; Zeman, Jiri; Hansikova, Hana; Vaneckova, Manuela; Lambert, Lukas; Kucerova-Vidrova, Vendula; Berankova, Kamila; Honzik, Tomas; Tesarova, Marketa] Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Vaneckova, Manuela; Lambert, Lukas] Charles Univ Prague, Fac Med 1, Dept Radiol, Prague, Czech Republic.
C3 Charles University Prague; General University Hospital Prague; Charles University Prague; Charles University Prague
RP Tesarova, M (corresponding author), Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.; Tesarova, M (corresponding author), Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic.
EM marketa.tesarova@lf1.cuni.cz
FU Ministry of Health of the Czech Republic [AZV 17-30965A, RVO VFN 64165]; Charles University (Progress Q26/LF1) [UNCE 204064, SVV260367]
CR Alston CL, 2018, AM J HUM GENET, V103, P592, DOI 10.1016/j.ajhg.2018.08.013
   Angerer H, 2011, BIOCHEM J, V437, P279, DOI 10.1042/BJ20110359
   Blok MJ, 2007, J MED GENET, V44, P0, DOI 10.1136/jmg.2006.045716
   Brautbar A, 2008, MOL GENET METAB, V94, P485, DOI 10.1016/j.ymgme.2008.04.004
   Cameron JM, 2004, MITOCHONDRION, V4, P387, DOI 10.1016/j.mito.2004.07.039
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   Fassone E, 2012, J MED GENET, V49, P668, DOI 10.1136/jmedgenet-2012-101159corr1
   Finsterer J, 2018, NEURORADIOL J, V31, P596, DOI 10.1177/1971400918786054
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Ganetzky RD, 2018, MOL GENET METAB, V123, P301, DOI 10.1016/j.ymgme.2018.01.010
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012
   Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9
   Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   KNEPPER LE, 1989, STROKE, V20, P1730, DOI 10.1161/01.STR.20.12.1730
   Kolarova H, 2016, OPHTHALMIC GENET, V37, P419, DOI 10.3109/13816810.2015.1092045
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   Leng YL, 2015, MITOCHONDR DNA, V26, P208, DOI 10.3109/19401736.2014.905860
   Lerman-Sagie T, 2005, MOL GENET METAB, V84, P127, DOI 10.1016/j.ymgme.2004.09.008
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Ma YY, 2018, MEDICINE, V97, P0, DOI 10.1097/MD.0000000000011606
   MAKINEN MW, 1968, ARCH BIOCHEM BIOPHYS, V126, P75, DOI 10.1016/0003-9861(68)90561-4
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Mascalchi M, 2018, ESSAYS BIOCHEM, V62, P409, DOI 10.1042/EBC20170109
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Napolitano A, 2000, NEUROL SCI, V21, PS981, DOI 10.1007/s100720070015
   Ng YS, 2018, EBIOMEDICINE, V30, P86, DOI 10.1016/j.ebiom.2018.02.010
   Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217
   Petruzzella V, 2003, NEUROLOGY, V61, P1017, DOI 10.1212/01.WNL.0000080363.10902.E9
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Smits P, 2011, EUR J HUM GENET, V19, P275, DOI 10.1038/ejhg.2010.208
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Srere PA, 1969, METHODS IN ENZYMOLOGY, V13, P3
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Tzoulis C, 2012, BRAIN, V135, P3627, DOI 10.1093/brain/aws223
   Vondrackova A, 2012, J HUM GENET, V57, P442, DOI 10.1038/jhg.2012.49
   Wang Shi-Bing, 2008, PEDIATRICS AND NEONATOLOGY, V49, P145, DOI 10.1016/S1875-9572(08)60030-3
   Yahata N, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-15871-y
NR 56
TC 25
Z9 25
U1 2
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2431
J9 BMC PEDIATR
JI BMC Pediatr.
PD JAN 29
PY 2020
VL 20
IS 1
BP 
EP 
DI 10.1186/s12887-020-1912-x
PG 13
WC Pediatrics
SC Pediatrics
GA KM1ND
UT WOS:000513885200006
PM 31996177
DA 2024-11-01
ER

PT J
AU Kocken, JMM
   Martins, PDA
AF Kocken, Jordy M. M.
   da Costa Martins, Paula A.
TI Epigenetic Regulation of Pulmonary Arterial Hypertension-Induced Vascular and Right Ventricular Remodeling: New Opportunities?
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE right ventricle remodeling; hypertrophy; pulmonary arterial hypertension; non-coding RNAs; epigenetics
ID long noncoding rna; nitric-oxide synthase; histone h3 phosphorylation; smooth-muscle-cells; circular rna; dna methylation; messenger-rna; mitochondrial dysfunction; chromatin modification; molecular-mechanisms
AB Pulmonary artery hypertension (PAH) is a rare chronic disease with high impact on patients' quality of life and currently no available cure. PAH is characterized by constant remodeling of the pulmonary artery by increased proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs), fibroblasts (FBs) and endothelial cells (ECs). This remodeling eventually leads to increased pressure in the right ventricle (RV) and subsequent right ventricle hypertrophy (RVH) which, when left untreated, progresses into right ventricle failure (RVF). PAH can not only originate from heritable mutations, but also develop as a consequence of congenital heart disease, exposure to drugs or toxins, HIV, connective tissue disease or be idiopathic. While much attention was drawn into investigating and developing therapies related to the most well understood signaling pathways in PAH, in the last decade, a shift towards understanding the epigenetic mechanisms driving the disease occurred. In this review, we reflect on the different epigenetic regulatory factors that are associated with the pathology of RV remodeling, and on their relevance towards a better understanding of the disease and subsequently, the development of new and more efficient therapeutic strategies.
C1 [Kocken, Jordy M. M.; da Costa Martins, Paula A.] Maastricht Univ, Fac Sci & Engn, Dept Mol Genet, NL-6229 ER Maastricht, Netherlands.
   [Kocken, Jordy M. M.; da Costa Martins, Paula A.] Maastricht Univ, Fac Hlth Med & Life Sci, CARIM Sch Cardiovasc Dis, NL-6229 ER Maastricht, Netherlands.
   [da Costa Martins, Paula A.] Univ Porto, Fac Med, Dept Cirurgia & Fisiol, Unidade Invest Cardiovasc, P-4200319 Porto, Portugal.
C3 Maastricht University; Maastricht University; Universidade do Porto
RP Martins, PDA (corresponding author), Maastricht Univ, Fac Sci & Engn, Dept Mol Genet, NL-6229 ER Maastricht, Netherlands.; Martins, PDA (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, CARIM Sch Cardiovasc Dis, NL-6229 ER Maastricht, Netherlands.; Martins, PDA (corresponding author), Univ Porto, Fac Med, Dept Cirurgia & Fisiol, Unidade Invest Cardiovasc, P-4200319 Porto, Portugal.
EM j.kocken@maastrichtuniversity.nl; p.dacostamartins@maastrichtuniversity.nl
FU Dutch CardioVascular Alliance (DCVA); Impulse Grant 2018 [CVON-2018-29]; Portuguese Foundation for Science and Technology Grant [PTDC/BIM-MEC/4578/2014]; Dutch Heart Foundation [NHS2015T066]; Fundação para a Ciência e a Tecnologia [PTDC/BIM-MEC/4578/2014] Funding Source: FCT
CR ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786
   Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567
   Anastasiadou E, 2018, NAT REV CANCER, V18, P5, DOI 10.1038/nrc.2017.99
   Ando M, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-09937-w
   Antigny F, 2016, CIRCULATION, V133, P1371, DOI 10.1161/CIRCULATIONAHA.115.020951
   Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006
   Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098
   Arrigo Mattia, 2019, CARD FAIL REV, V5, P140, DOI 10.15420/cfr.2019.15.2
   Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019
   Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D
   Avazmohammadi R, 2019, J BIOMECH ENG-T ASME, V141, P0, DOI 10.1115/1.4044174
   Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577
   Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22
   Barnes H, 2019, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD012785.pub2
   Batkai S, 2017, CARDIOVASC RES, V113, P1433, DOI 10.1093/cvr/cvx153
   Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x
   Bewick AJ, 2016, P NATL ACAD SCI USA, V113, P9111, DOI 10.1073/pnas.1604666113
   Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651
   Bogaard HJ, 2011, AM J RESP CRIT CARE, V183, P1402, DOI 10.1164/rccm.201007-1106OC
   Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939
   BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28
   BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I
   BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M
   Caley DP, 2010, THESCIENTIFICWORLDJO, V10, P90, DOI 10.1100/tsw.2010.7
   Campian ME, 2010, EUR J HEART FAIL, V12, P653, DOI 10.1093/eurjhf/hfq066
   Cao YA, 2018, BIOMED PHARMACOTHER, V106, P1108, DOI 10.1016/j.biopha.2018.07.057
   Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591
   Cavasin MA, 2012, CIRC RES, V110, P739, DOI 10.1161/CIRCRESAHA.111.258426
   Chang WT, 2018, ACTA CARDIOL SIN, V34, P511, DOI 10.6515/ACS.201811_34(6).20180613A
   Chen CN, 2013, VASC PHARMACOL, V58, P211, DOI 10.1016/j.vph.2012.09.001
   Chen DW, 2015, HYPERTENSION, V65, P821, DOI 10.1161/HYPERTENSIONAHA.114.04585
   Chen F, 2016, FREE RADICAL BIO MED, V99, P167, DOI 10.1016/j.freeradbiomed.2016.08.003
   Cheng GS, 2020, MOL CELL BIOCHEM, V475, P239, DOI 10.1007/s11010-020-03877-6
   Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7
   Choi HS, 2005, CANCER RES, V65, P5818, DOI 10.1158/0008-5472.CAN-05-0197
   Clapp LH, 2002, AM J RESP CELL MOL, V26, P194, DOI 10.1165/ajrcmb.26.2.4695
   Condon David F, 2019, F1000RES, V8, P0, DOI 10.12688/f1000research.18811.1
   Connolly M, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0229409
   Cowley PM, 2019, AM J PHYSIOL-HEART C, V316, PH224, DOI 10.1152/ajpheart.00507.2018
   CRICK F H, 1958, SYMP SOC EXP BIOL, V12, P138
   Dalvi P, 2013, ARTERIOSCL THROM VAS, V33, P2585, DOI 10.1161/ATVBAHA.113.302054
   Dancy BM, 2015, CHEM REV, V115, P2419, DOI 10.1021/cr500452k
   de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882
   Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049
   Dhir A, 2015, NAT STRUCT MOL BIOL, V22, P319, DOI 10.1038/nsmb.2982
   Di Salvo TG, 2015, PULM CIRC, V5, P135, DOI 10.1086/679721
   Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108
   Do E, 1997, J MOL CELL CARDIOL, V29, P1903, DOI 10.1006/jmcc.1997.0429
   Durrington HJ, 2010, J BIOL CHEM, V285, P37641, DOI 10.1074/jbc.M110.132415
   Elliott CG, 2006, CIRCULATION, V113, P2509, DOI 10.1161/CIRCULATIONAHA.105.601930
   Evans JDW, 2016, LANCET RESP MED, V4, P129, DOI 10.1016/S2213-2600(15)00544-5
   Fagan KA, 1999, J CLIN INVEST, V103, P291, DOI 10.1172/JCI3862
   Faisal M, 2014, PULM MED, V2014, P0, DOI 10.1155/2014/528783
   Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106
   FLORA LM, 2006, CURR MED CHEM, V13, P1655
   Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401
   Fox B, 2013, CAN J CARDIOL, V29, P672, DOI 10.1016/j.cjca.2012.05.013
   FRELIN C, 1994, CARDIOVASC RES, V28, P1613, DOI 10.1093/cvr/28.11.1613
   Gajecki D, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/7265487
   Galiè N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510
   Galiè N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
   Galletti M, 2014, BIOCHEM PHARMACOL, V91, P181, DOI 10.1016/j.bcp.2014.07.011
   GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403
   Gomez-Arroyo J, 2013, CIRC-HEART FAIL, V6, P136, DOI 10.1161/CIRCHEARTFAILURE.111.966127
   Grammatikakis I, 2014, AGING-US, V6, P992, DOI 10.18632/aging.100710
   Gray GA, 1996, PHARMACOL THERAPEUT, V72, P109, DOI 10.1016/S0163-7258(96)00101-5
   Grunig G, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.00955
   Guo JL, 2020, LIFE SCI, V262, P0, DOI 10.1016/j.lfs.2020.118420
   Han P, 2015, RNA BIOL, V12, P1094, DOI 10.1080/15476286.2015.1063770
   Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993
   Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155
   He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130
   HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x
   Hewer RC, 2011, J MOL CELL CARDIOL, V50, P87, DOI 10.1016/j.yjmcc.2010.10.010
   HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338
   Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619
   Hoeper MM, 2019, EUR RESPIR J, V53, P0, DOI 10.1183/13993003.01906-2018
   Hoeper MM, 2017, EUR RESPIR J, V50, P0, DOI 10.1183/13993003.00740-2017
   Hsiao KY, 2017, EXP BIOL MED, V242, P1136, DOI 10.1177/1535370217708978
   Hurdman J, 2012, EUR RESPIR J, V39, P945, DOI 10.1183/09031936.00078411
   Huusko J, 2012, MOL THER, V20, P2212, DOI 10.1038/mt.2012.145
   Jambhekar A, 2019, NAT REV MOL CELL BIO, V20, P625, DOI 10.1038/s41580-019-0151-1
   Jeoung NH, 2015, DIABETES METAB J, V39, P188
   Jiang SD, 2017, JOINT BONE SPINE, V84, P553, DOI 10.1016/j.jbspin.2016.09.006
   Johnson EK, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-32154-2
   Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965
   Joshi SR, 2016, AM J PHYSIOL-HEART C, V311, PH689, DOI 10.1152/ajpheart.00264.2016
   Kelly RG, 2014, CSH PERSPECT MED, V4, P0, DOI 10.1101/cshperspect.a015750
   Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106
   Kim HJ, 2011, AM J TRANSL RES, V3, P166
   Kitagawa M, 2013, CELL MOL LIFE SCI, V70, P4785, DOI 10.1007/s00018-013-1423-0
   Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750
   Kolb TM, 2015, MICROCIRCULATION, V22, P724, DOI 10.1111/micc.12247
   Koop AMC, 2018, EUR HEART J, V39, P1035
   Krajewski WA, 1998, P NATL ACAD SCI USA, V95, P1540, DOI 10.1073/pnas.95.4.1540
   Lan Norris S H, 2018, DISEASES, V6, P0, DOI 10.3390/diseases6020038
   Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792
   Lang IM, 2015, EUR RESPIR REV, V24, P630, DOI 10.1183/16000617.0067-2015
   Lanouette S, 2014, MOL SYST BIOL, V10, P0, DOI 10.1002/msb.134974
   Lau ATY, 2011, J BIOL CHEM, V286, P26628, DOI 10.1074/jbc.M110.215590
   Lau EMT, 2015, NAT REV CARDIOL, V12, P143, DOI 10.1038/nrcardio.2014.191
   Le Ribeuz H, 2020, RESP RES, V21, P0, DOI 10.1186/s12931-020-01444-7
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910
   Lee YH, 2013, KOREAN J INTERN MED, V28, P701, DOI 10.3904/kjim.2013.28.6.701
   Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017
   Lehners M, 2018, J CARDIOVASC DEV DIS, V5, P0, DOI 10.3390/jcdd5020020
   Lei S, 2020, AM J PHYSIOL-HEART C, V319, PH377, DOI 10.1152/ajpheart.00717.2019
   Leuchte HH, 2004, CHEST, V125, P580, DOI 10.1378/chest.125.2.580
   Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959
   Liang WC, 2019, GENOME BIOL, V20, P0, DOI 10.1186/s13059-019-1685-4
   Liu LT, 2016, CARDIOVASC RES, V111, P56, DOI 10.1093/cvr/cvw078
   Liu Y, 2018, J CELL PHYSIOL, V233, P4801, DOI 10.1002/jcp.26279
   Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9
   Lorell BH, 2000, CIRCULATION, V102, P470
   Luo L, 2020, AGING-US, V12, P9014, DOI 10.18632/aging.103163
   MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895
   Machida Y, 2001, J BIOCHEM, V129, P43, DOI 10.1093/oxfordjournals.jbchem.a002834
   Maenner S, 2012, BIOCHIMIE, V94, P1490, DOI 10.1016/j.biochi.2011.12.026
   Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126
   Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, PL548, DOI 10.1152/ajplung.00428.2006
   Mathiyalagan P, 2010, CELL CYCLE, V9, P612, DOI 10.4161/cc.9.3.10612
   Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928
   Miao RY, 2020, LIFE SCI, V257, P0, DOI 10.1016/j.lfs.2020.117919
   Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224
   Moe GW, 2004, AM J PHYSIOL-HEART C, V287, PH1813, DOI 10.1152/ajpheart.00036.2004
   Moris D, 2017, ANN TRANSL MED, V5, P0, DOI 10.21037/atm.2017.06.27
   Morrell NW, 2019, EUR RESPIR J, V53, P0, DOI 10.1183/13993003.01899-2018
   Müller C, 2001, CURR OPIN GENET DEV, V11, P167, DOI 10.1016/S0959-437X(00)00175-1
   MURAD F, 1994, RECENT PROG HORM RES, V49, P239
   Murray FS, 2020, AM J RESP CRIT CARE, V201, P0
   Nascimben L, 2004, HYPERTENSION, V44, P662, DOI 10.1161/01.HYP.0000144292.69599.0c
   Negi V, 2017, JCI INSIGHT, V2, P0, DOI 10.1172/jci.insight.91327
   Nergui S, 2014, CIRC J, V78, P1465, DOI 10.1253/circj.CJ-13-1586
   NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S
   Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676
   Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705
   Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6
   Omura J, 2019, EUR RESPIR J, V54, P0
   Otani J, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082961
   Ou MH, 2020, MOL THER NUCL ACIDS, V21, P542, DOI 10.1016/j.omtn.2020.05.022
   Oudiz RJ, 2013, AM J RESP CRIT CARE, V188, P269, DOI 10.1164/rccm.201305-0898ED
   PALMER RMJ, 1988, BIOCHEM BIOPH RES CO, V153, P1251, DOI 10.1016/S0006-291X(88)81362-7
   Pamudurti NR, 2017, MOL CELL, V66, P9, DOI 10.1016/j.molcel.2017.02.021
   Patten M, 2001, PFLUG ARCH EUR J PHY, V442, P920
   Piao L, 2010, J MOL MED, V88, P47, DOI 10.1007/s00109-009-0524-6
   Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605
   Piunti A, 2016, SCIENCE, V352, P0, DOI 10.1126/science.aad9780
   Poller W, 2018, EUR HEART J, V39, P2704, DOI 10.1093/eurheartj/ehx165
   POLLOCK DM, 1995, FASEB J, V9, P1196, DOI 10.1096/fasebj.9.12.7672512
   Power AS, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0214740
   Prins KW, 2016, CARDIOL CLIN, V34, P363, DOI 10.1016/j.ccl.2016.04.001
   Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917
   Qin YJ, 2012, INT J MED SCI, V9, P413, DOI 10.7150/ijms.4514
   Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506
   Reddy S, 2015, CIRCULATION, V132, P1734, DOI 10.1161/CIRCULATIONAHA.114.012975
   Redout EM, 2007, CARDIOVASC RES, V75, P770, DOI 10.1016/j.cardiores.2007.05.012
   Reis A, 2018, BIOMED RES INT, V2018, P0, DOI 10.1155/2018/3924517
   Rich JD, 2014, CIRCULATION, V130, P1820, DOI 10.1161/CIRCULATIONAHA.114.006971
   Ringvold H C, 2017, ADV PHARMACOL, V78, P203, DOI 10.1016/bs.apha.2016.06.002
   Rondelet B, 2012, EUR HEART J, V33, P1017, DOI 10.1093/eurheartj/ehr111
   Rossetto D, 2012, EPIGENETICS-US, V7, P1098, DOI 10.4161/epi.21975
   Rothbart SB, 2013, GENE DEV, V27, P1288, DOI 10.1101/gad.220467.113
   Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212
   Russo VEA, 1996, EPIGENETIC MECHANISMS OF GENE REGULATION, V0, P0
   Salguero KL, 2002, PULM PHARMACOL THER, V15, P1, DOI 10.1006/pupt.2001.0311
   SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852
   Sawicka A, 2012, BIOCHIMIE, V94, P2193, DOI 10.1016/j.biochi.2012.04.018
   Saxena A, 2011, BIOESSAYS, V33, P830, DOI 10.1002/bies.201100084
   Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006
   Seto E, 2014, CSH PERSPECT BIOL, V6, P0, DOI 10.1101/cshperspect.a018713
   Shimony A, 2011, AM J CARDIOL, V108, P460, DOI 10.1016/j.amjcard.2011.03.066
   Sikirica M, 2014, BMC HEALTH SERV RES, V14, P0, DOI 10.1186/s12913-014-0676-0
   Simonneau G, 2019, EUR RESPIR J, V53, P0, DOI 10.1183/13993003.01913-2018
   Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716
   Su H, 2018, RESP RES, V19, P0, DOI 10.1186/s12931-018-0956-z
   Sun ZX, 2019, BIOMED PHARMACOTHER, V115, P0, DOI 10.1016/j.biopha.2019.108933
   Suzuki S, 2017, TRANSCR-AUSTIN, V8, P26, DOI 10.1080/21541264.2016.1246076
   Sztrymf B, 2008, AM J RESP CRIT CARE, V177, P1377, DOI 10.1164/rccm.200712-1807OC
   Tan L, 2013, MOL NEUROBIOL, V47, P382, DOI 10.1007/s12035-012-8359-5
   Tello K, 2019, HERZ, V44, P509, DOI 10.1007/s00059-019-4815-6
   Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X
   Thum T, 2014, PULM CIRC, V4, P185, DOI 10.1086/675981
   Tielemans B, 2019, DRUG DISCOV TODAY, V24, P703, DOI 10.1016/j.drudis.2018.12.001
   Tsutsui H, 2001, CARDIOVASC RES, V49, P103, DOI 10.1016/S0008-6363(00)00197-8
   Tuder RM, 2001, AM J PATHOL, V159, P382, DOI 10.1016/S0002-9440(10)61705-1
   Tuder RM, 2013, J AM COLL CARDIOL, V62, PD4, DOI 10.1016/j.jacc.2013.10.025
   Tuomainen T, 2017, EXP CELL RES, V360, P12, DOI 10.1016/j.yexcr.2017.03.052
   Vance KW, 2014, TRENDS GENET, V30, P348, DOI 10.1016/j.tig.2014.06.001
   Verdone Loredana, 2006, BRIEFINGS IN FUNCTIONAL GENOMICS & PROTEOMICS, V5, P209, DOI 10.1093/bfgp/ell028
   Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184
   Wang DP, 2019, INT J MOL MED, V44, P871, DOI 10.3892/ijmm.2019.4256
   Wang F, 2019, ROY SOC OPEN SCI, V6, P0, DOI 10.1098/rsos.190338
   Wang H, 2020, SHOCK, V53, P723, DOI 10.1097/SHK.0000000000001410
   Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992
   Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154
   Wijeratne DT, 2018, CIRC-CARDIOVASC QUAL, V11, P0, DOI 10.1161/CIRCOUTCOMES.117.003973
   Xiao MS, 2020, TRENDS CELL BIOL, V30, P226, DOI 10.1016/j.tcb.2019.12.004
   Xu F, 2017, BIOMED PHARMACOTHER, V90, P888, DOI 10.1016/j.biopha.2017.03.103
   Xu SW, 2001, J INVEST DERMATOL, V116, P417, DOI 10.1046/j.1523-1747.2001.01256.x
   XUE C, 1995, NEW ENGL J MED, V333, P1642
   Yang YY, 2014, NUCLEIC ACIDS RES, V42, P10460, DOI 10.1093/nar/gku776
   Zehendner CM, 2020, AM J RESP CRIT CARE, V202, P1445, DOI 10.1164/rccm.201910-2041OC
   Zhang LY, 2014, J HYPERTENS, V32, P2188, DOI 10.1097/HJH.0000000000000309
   Zhang R, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-32635-4
   Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017
   Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147
   Zhao L, 2012, CIRCULATION, V126, P455, DOI 10.1161/CIRCULATIONAHA.112.103176
   Zhou GF, 2015, AM J RESP CELL MOL, V52, P139, DOI 10.1165/rcmb.2014-0166TR
   Zhou SJ, 2019, MOL THER-NUCL ACIDS, V18, P275, DOI 10.1016/j.omtn.2019.08.026
   Zhu TT, 2017, LIFE SCI, V174, P35, DOI 10.1016/j.lfs.2017.02.016
NR 211
TC 18
Z9 19
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC 15
PY 2020
VL 21
IS 23
BP 
EP 
DI 10.3390/ijms21238901
PG 26
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA PD9QG
UT WOS:000598009600001
PM 33255338
DA 2024-11-01
ER

PT J
AU Fontana, GA
   Gahlon, HL
AF Fontana, Gabriele A.
   Gahlon, Hailey L.
TI Mechanisms of replication and repair in mitochondrial DNA deletion formation
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID progressive external ophthalmoplegia; multiple mtdna deletions; base excision-repair; large-scale deletions; human skeletal-muscle; double-strand breaks; mammalian mitochondria; polymerase gamma; oxidative stress; molecular-mechanisms
AB Deletions in mitochondrial DNA (mtDNA) are associated with diverse human pathologies including cancer, aging and mitochondrial disorders. Large-scale deletions span kilobases in length and the loss of these associated genes contributes to crippled oxidative phosphorylation and overall decline in mitochondrial fitness. There is not a united view for how mtDNA deletions are generated and the molecular mechanisms underlying this process are poorly understood. This review discusses the role of replication and repair in mtDNA deletion formation as well as nucleic acid motifs such as repeats, secondary structures, and DNA damage associated with deletion formation in the mitochondrial genome. We propose that while erroneous replication and repair can separately contribute to deletion formation, crosstalk between these pathways is also involved in generating deletions.
C1 [Fontana, Gabriele A.; Gahlon, Hailey L.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Schmelzbergstr 9, CH-8092 Zurich, Switzerland.
C3 Swiss Federal Institutes of Technology Domain; ETH Zurich
RP Gahlon, HL (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Schmelzbergstr 9, CH-8092 Zurich, Switzerland.
EM hailey.gahlon@hest.ethz.ch
FU Federation of Migros Cooperatives; ETH Zurich Foundation; World Food System Center at ETH Zurich; ETH Zurich
CR Aamann MD, 2010, FASEB J, V24, P2334, DOI 10.1096/fj.09-147991
   ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Antes A, 2010, NUCLEIC ACIDS RES, V38, P6466, DOI 10.1093/nar/gkq493
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Barrientos A, 1996, AM J HUM GENET, V58, P963
   Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006
   Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345
   Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073
   Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296
   Boldinova EO, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20133279
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Canugovi C, 2010, DNA REPAIR, V9, P1080, DOI 10.1016/j.dnarep.2010.07.009
   Capra JA, 2010, PLOS COMPUT BIOL, V6, P0, DOI 10.1371/journal.pcbi.1000861
   Chatre L, 2013, NUCLEIC ACIDS RES, V41, P3068, DOI 10.1093/nar/gkt015
   Chattopadhyay R, 2006, NUCLEIC ACIDS RES, V34, P2067, DOI 10.1093/nar/gkl177
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chen T, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-8
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Coffey G, 1999, NUCLEIC ACIDS RES, V27, P3348, DOI 10.1093/nar/27.16.3348
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORMIER V, 1990, J PEDIATR-US, V117, P599, DOI 10.1016/S0022-3476(05)80698-5
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   Croteau DL, 1997, J BIOL CHEM, V272, P27338, DOI 10.1074/jbc.272.43.27338
   Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169
   DAurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   Dahal S, 2018, CELL MOL LIFE SCI, V75, P1641, DOI 10.1007/s00018-017-2702-y
   Damas J, 2014, NUCLEIC ACIDS RES, V42, PD1261, DOI 10.1093/nar/gkt982
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Dani Maria Angela C, 2004, GENET MOL RES, V3, P395
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Dmitrieva NI, 2011, AM J PHYSIOL-REG I, V301, PR632, DOI 10.1152/ajpregu.00853.2010
   Dong DW, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-677
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Falabella M, 2019, CURR MED CHEM, V26, P2918, DOI 10.2174/0929867325666180228165527
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   Fu Y, 2020, NAT STRUCT MOL BIOL, V27, P687, DOI 10.1038/s41594-020-0474-9
   Fuke S, 2014, ANN CLIN TRANSL NEUR, V1, P909, DOI 10.1002/acn3.133
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Habano W, 1998, ONCOGENE, V17, P1931, DOI 10.1038/sj.onc.1202112
   He Q, 2013, MITOCHONDRION, V13, P592, DOI 10.1016/j.mito.2013.08.003
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233
   Kalifa L, 2012, GENETICS, V190, P951, DOI 10.1534/genetics.111.138214
   Kamenisch Y, 2010, J EXP MED, V207, P379, DOI 10.1084/jem.20091834
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kauppila JHK, 2018, NUCLEIC ACIDS RES, V46, P6642, DOI 10.1093/nar/gky456
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kazak L, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0062340
   Kitts C, 2012, IEEE-ASME T MECH, V17, P1, DOI 10.1109/TMECH.2011.2177855
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2010, ESSAYS BIOCHEM, V47, P139, DOI 10.1042/BSE0470139
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198
   Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lia D, 2018, J CELL SCI, V131, P0, DOI 10.1242/jcs.213538
   Liu J, 2015, NUCLEIC ACIDS RES, V43, P5476, DOI 10.1093/nar/gkv472
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   Mason PA, 2003, FEBS LETT, V554, P6, DOI 10.1016/S0014-5793(03)01169-4
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   Matic S, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03552-x
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Mitra S, 2007, DNA REPAIR, V6, P461, DOI 10.1016/j.dnarep.2006.10.010
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moretton A, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0176795
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750
   Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   Pavicic WH, 2009, MUTAT RES-FUND MOL M, V670, P99, DOI 10.1016/j.mrfmmm.2009.07.009
   Peeva V, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04131-w
   Persson Ö, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pohjoismäki JLO, 2012, NUCLEIC ACIDS RES, V40, P6595, DOI 10.1093/nar/gks301
   Pohjoismäki JLO, 2011, MITOCHONDRION, V11, P630, DOI 10.1016/j.mito.2011.04.002
   Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076
   ROBBERSODL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   ROTIG A, 1989, LANCET, V1, P902
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723
   Sasaki T, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-10843-8
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006
   Shao JY, 2004, WORLD J GASTROENTERO, V10, P1560, DOI 10.3748/wjg.v10.i11.1560
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   SOONG NW, 1992, NAT GENET, V2, P318
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Szczesny B, 2014, NUCLEIC ACIDS RES, V42, P13161, DOI 10.1093/nar/gku1089
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103
   Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wisnovsky S, 2016, NAT CHEM BIOL, V12, P567, DOI 10.1038/nchembio.2102
   Xu WY, 2019, P NATL ACAD SCI USA, V116, P17792, DOI 10.1073/pnas.1911252116
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Yasukawa T, 2018, J BIOCHEM, V164, P183, DOI 10.1093/jb/mvy058
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Yusoff AAM, 2019, ONCOL REV, V13, P54, DOI 10.4081/oncol.2019.409
   Zhu WZ, 2004, CANCER DETECT PREV, V28, P119, DOI 10.1016/j.cdp.2003.11.008
NR 140
TC 115
Z9 128
U1 1
U2 32
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD NOV 18
PY 2020
VL 48
IS 20
BP 11244
EP 11258
DI 10.1093/nar/gkaa804
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA PP7DK
UT WOS:000606018600009
PM 33021629
DA 2024-11-01
ER

PT J
AU Schlieben, LD
   Prokisch, H
AF Schlieben, Lea D.
   Prokisch, Holger
TI The Dimensions of Primary Mitochondrial Disorders
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE mitochondrial disease; genetics; mutation; diagnostic; challenges
ID mutations cause; disease; diagnosis; dna; genetics; muscle; onset; deletions; defect
AB The concept of a mitochondrial disorder was initially described in 1962, in a patient with altered energy metabolism. Over time, mitochondrial energy metabolism has been discovered to be influenced by a vast number of proteins with a multitude of functional roles. Amongst these, defective oxidative phosphorylation arose as the hallmark of mitochondrial disorders. In the premolecular era, the diagnosis of mitochondrial disease was dependent on biochemical criteria, with inherent limitations such as tissue availability and specificity, preanalytical and analytical artifacts, and secondary effects. With the identification of the first mitochondrial disease-causing mutations, the genetic complexity of mitochondrial disorders began to unravel. Mitochondrial dysfunctions can be caused by pathogenic variants in genes encoded by the mitochondrial DNA or the nuclear DNA, and can display heterogenous phenotypic manifestations. The application of next generation sequencing methodologies in diagnostics is proving to be pivotal in finding the molecular diagnosis and has been instrumental in the discovery of a growing list of novel mitochondrial disease genes. In the molecular era, the diagnosis of a mitochondrial disorder, suspected on clinical grounds, is increasingly based on variant detection and associated statistical support, while invasive biopsies and biochemical assays are conducted to an ever-decreasing extent. At present, there is no uniform biochemical or molecular definition for the designation of a disease as a "mitochondrial disorder". Such designation is currently dependent on the criteria applied, which may encompass clinical, genetic, biochemical, functional, and/or mitochondrial protein localization criteria. Given this variation, numerous gene lists emerge, ranging from 270 to over 400 proposed mitochondrial disease genes. Herein we provide an overview of the mitochondrial disease associated genes and their accompanying challenges.
C1 [Schlieben, Lea D.; Prokisch, Holger] Tech Univ Munich, Sch Med, Inst Human Genet, Munich, Germany.
   [Schlieben, Lea D.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Neurogenom, Munich, Germany.
C3 Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health
RP Prokisch, H (corresponding author), Tech Univ Munich, Sch Med, Inst Human Genet, Munich, Germany.; Prokisch, H (corresponding author), Helmholtz Zentrum Munchen, Inst Neurogenom, Munich, Germany.
EM prokisch@helmholtz-muenchen.de
FU BMBF (German Federal Ministry of Education and Research) through mitoNET German Network for Mitochondrial Diseases [01GM1906B]; PerMiM Personalized Mitochondrial Medicine [01KU2016A]; GENOMIT European Network for Mitochondrial Disease [01GM1920A]
CR Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Chen YF, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-49663-3
   Cole LW, 2016, FRONT CELL DEV BIOL, V4, P0, DOI 10.3389/fcell.2016.00085
   Cummings BB, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aal5209
   Di Nottia M, 2020, NEUROBIOL DIS, V141, P0, DOI 10.1016/j.nbd.2020.104880
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   DiMauro S, 2010, DEV DISABIL RES REV, V16, P106, DOI 10.1002/ddrr.102
   Distelmaier F, 2017, BRAIN, V140, P0, DOI 10.1093/brain/aww303
   Duchen Michael R, 2004, MOLECULAR ASPECTS OF MEDICINE, V25, P365, DOI 10.1016/j.mam.2004.03.001
   ENDO H, 1989, AM J HUM GENET, V44, P358
   Falk MJ, 2020, MITOCHONDRIAL DISEASE GENES COMPENDIUM: FROM GENES TO CLINICAL MANIFESTATIONS, V0, P0
   Ferreira CR, 2019, GENET MED, V21, P102, DOI 10.1038/s41436-018-0022-8
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   French CE, 2019, INTENS CARE MED, V45, P627, DOI 10.1007/s00134-019-05552-x
   Fresard L, 2019, NAT MED, V25, P911, DOI 10.1038/s41591-019-0457-8
   Gonorazky HD, 2019, AM J HUM GENET, V104, P466, DOI 10.1016/j.ajhg.2019.01.012
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Grier J, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000230
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holzerova E, 2016, BRAIN, V139, P346, DOI 10.1093/brain/awv350
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Khan NA, 2015, INDIAN J MED RES, V141, P13
   Koch J, 2017, BRAIN, V140, P279, DOI 10.1093/brain/aww300
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Kohda M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005679
   Kopajtich R, 2016, AM J HUM GENET, V99, P414, DOI 10.1016/j.ajhg.2016.05.027
   Kremer LS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15824
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lee HN, 2020, GENET MED, V22, P490, DOI 10.1038/s41436-019-0672-1
   Lott MT, 2013, CURR PROTOC BIOINF, V44, P1231, DOI 10.1002/0471250953.BI0123S44
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Papa S, 2012, ADV EXP MED BIOL, V942, P3, DOI 10.1007/978-94-007-2869-1_1
   Parikh S, 2019, J MED GENET, V56, P123, DOI 10.1136/jmedgenet-2018-105800
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Phadke R, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6070064
   Pitceathly RDS, 2021, J INHERIT METAB DIS, V44, P22, DOI 10.1002/jimd.12281
   Powel CA, 2015, AM J HUM GENET, V97, P319, DOI 10.1016/j.ajhg.2015.06.011
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Rahman J, 2017, ANN NEUROL, V81, P9, DOI 10.1002/ana.24835
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tan J, 2020, EBIOMEDICINE, V54, P0, DOI 10.1016/j.ebiom.2020.102730
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Udhayabanu T, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6050052
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wetterstrand K, 2020, DNA SEQUENCING COSTS: DATA FROM THE NHGRI GENOME SEQUENCING PROGRAM (GSP), V0, P0
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 73
TC 48
Z9 50
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
EI 
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD NOV 26
PY 2020
VL 8
IS 
BP 
EP 
DI 10.3389/fcell.2020.600079
PG 11
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA PC2OS
UT WOS:000596847100001
PM 33324649
DA 2024-11-01
ER

PT J
AU Moore, TM
   Zhou, ZQ
   Strumwasser, AR
   Cohn, W
   Lin, AJ
   Cory, K
   Whitney, K
   Ho, T
   Ho, T
   Lee, JL
   Rucker, DH
   Hoang, AN
   Widjaja, K
   Abrishami, AD
   Charugundla, S
   Stiles, L
   Whitelegge, JP
   Turcotte, LP
   Wanagat, J
   Hevener, AL
AF Moore, Timothy M.
   Zhou, Zhenqi
   Strumwasser, Alexander R.
   Cohn, Whitaker
   Lin, Amanda J.
   Cory, Kevin
   Whitney, Kate
   Ho, Theodore
   Ho, Timothy
   Lee, Joseph L.
   Rucker, Daniel H.
   Hoang, Austin N.
   Widjaja, Kevin
   Abrishami, Aaron D.
   Charugundla, Sarada
   Stiles, Linsey
   Whitelegge, Julian P.
   Turcotte, Lorraine P.
   Wanagat, Jonathan
   Hevener, Andrea L.
TI Age-induced mitochondrial DNA point mutations are inadequate to alter metabolic homeostasis in response to nutrient challenge
SO AGING CELL
LA English
DT Article
DE aging; insulin resistance; metabolism; mitochondria; mitochondrial DNA; obesity; POLG
ID skeletal-muscle; endurance; dysfunction; biogenesis; disease; mice; heteroplasmy; resistance; defects; program
AB Mitochondrial dysfunction is frequently associated with impairment in metabolic homeostasis and insulin action, and is thought to underlie cellular aging. However, it is unclear whether mitochondrial dysfunction is a cause or consequence of insulin resistance in humans. To determine the impact of intrinsic mitochondrial dysfunction on metabolism and insulin action, we performed comprehensive metabolic phenotyping of the polymerase gamma (PolG) D257A "mutator" mouse, a model known to accumulate supraphysiological mitochondrial DNA (mtDNA) point mutations. We utilized the heterozygous PolG mutator mouse (PolG(+/mut)) because it accumulates mtDNA point mutations similar to 500-fold > wild-type mice (WT), but fails to develop an overt progeria phenotype, unlike PolG(mut/mut) animals. To determine whether mtDNA point mutations induce metabolic dysfunction, we examined male PolG(+/mut) mice at 6 and 12 months of age during normal chow feeding, after 24-hr starvation, and following high-fat diet (HFD) feeding. No marked differences were observed in glucose homeostasis, adiposity, protein/gene markers of metabolism, or oxygen consumption in muscle between WT and PolG(+/mut) mice during any of the conditions or ages studied. However, proteomic analyses performed on isolated mitochondria from 12-month-old PolG(+/mut) mouse muscle revealed alterations in the expression of mitochondrial ribosomal proteins, electron transport chain components, and oxidative stress-related factors compared with WT. These findings suggest that mtDNA point mutations at levels observed in mammalian aging are insufficient to disrupt metabolic homeostasis and insulin action in male mice.
C1 [Moore, Timothy M.; Turcotte, Lorraine P.] Univ Southern Calif, Dept Biol Sci, Dana & David Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90007 USA.
   [Moore, Timothy M.; Zhou, Zhenqi; Strumwasser, Alexander R.; Lin, Amanda J.; Cory, Kevin; Whitney, Kate; Ho, Theodore; Ho, Timothy; Lee, Joseph L.; Rucker, Daniel H.; Hoang, Austin N.; Widjaja, Kevin; Stiles, Linsey; Wanagat, Jonathan; Hevener, Andrea L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA.
   [Cohn, Whitaker; Whitelegge, Julian P.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.
   [Cohn, Whitaker; Whitelegge, Julian P.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.
   [Abrishami, Aaron D.; Charugundla, Sarada] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA.
   [Hevener, Andrea L.] Univ Calif Los Angeles, Iris Cantor UCLA Womens Hlth Ctr, Los Angeles, CA 90095 USA.
C3 University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles
RP Hevener, AL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Hlth Sci, Div Endocrinol Diabet & Hypertens,Dept Med,Mol En, 650 Charles E Young Dr South,STE 34-115, Los Angeles, CA 90095 USA.
EM ahevener@mednet.ucla.edu
FU Kirschstein-NRSA predoctoral fellowship from NIDDK [F31DK108657]; Carl V. Gisolfi Memorial Research grant from the American College of Sports Medicine; Dornsife College at the University of Southern California; UCLA Department of Medicine; UCLA Iris Cantor Women's Health Foundation; UCLA CTSI [ULTR000124]; UCLA Claude D. Pepper Older Americans Independence Center; National Institutes of Health [DK109724, P30DK063491, U54DK120342, NURSA NDSP U24DK097748]; NIH T32 Neuroendocrinology, Sex Differences, and Reproduction Training Grant [5T32HD007228]; Center for Duchenne Muscular Dystrophy Training Grant [T32AR065972]; Molecular, Cellular, and Integrative Physiology Training Grant [T32GM065823]; American College of Sports Medicine-NASA Space Physiology Research Grant; UCLA Claude Pepper Older Americans Independence Center - National Institute of Aging [5P30AG028748]; NIH/NCATS UCLA CTSI Grant [UL1TR000124]; UCLA Center for Duchenne Muscular Dystrophy-NIH NIAMS Wellstone Center of Excellence Training Fellowship [U54 AR052646]; American Federation for Aging Research; Glenn Foundation for Medical Research; UCLA Hartford Center of Excellence; National Institute on Aging [AG059847, AG055518]; UCLA Older Americans Independence Center [P30 AG028748]; UCSD/UCLA Diabetes Research Center Pilot and Feasibility Grant [DK063491]; University of Southern California Women in Science and Engineering program
CR Ahlqvist KJ, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7494
   Avital G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/hmg/dds245
   Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Civelek M, 2017, AM J HUM GENET, V100, P428, DOI 10.1016/j.ajhg.2017.01.027
   Coleman V, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-20901-4
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Crilly MJ, 2016, J APPL PHYSIOL, V121, P730, DOI 10.1152/japplphysiol.00042.2016
   Czajka A, 2015, EBIOMEDICINE, V2, P499, DOI 10.1016/j.ebiom.2015.04.002
   Drew BG, 2014, DIABETES, V63, P1488, DOI 10.2337/db13-0665
   DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0
   Fan WW, 2017, CELL METAB, V25, P1186, DOI 10.1016/j.cmet.2017.04.006
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, PG914, DOI 10.1152/ajpgi.00402.2011
   Gilkerson R, 2016, DIABETES-METAB RES, V32, P672, DOI 10.1002/dmrr.2833
   Graham JM, 2001, CURR PROTEC CELL BIO, V4, P0
   Haroon S, 2018, CELL REP, V22, P3115, DOI 10.1016/j.celrep.2018.02.099
   He Q, 2013, MITOCHONDRION, V13, P592, DOI 10.1016/j.mito.2013.08.003
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104
   Hicks S, 2013, AM J PHYSIOL-HEART C, V304, PH903, DOI 10.1152/ajpheart.00567.2012
   Hu DL, 2018, ISCIENCE, V9, P84, DOI 10.1016/j.isci.2018.10.012
   Huang DD, 2019, EXP GERONTOL, V119, P61, DOI 10.1016/j.exger.2019.01.022
   Jacobs HT, 2003, HUM MOL GENET, V12, PR293, DOI 10.1093/hmg/ddg285
   Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659
   Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849
   Joseph AM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069327
   Joseph AM, 2012, EXP DIABETES RES, V0, P0, DOI DOI 10.1155/2012/642038
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Krishnan KC, 2018, CELL SYST, V6, P103, DOI 10.1016/j.cels.2017.12.006
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Mandillo S, 2014, DIS MODEL MECH, V7, P397, DOI 10.1242/dmm.013946
   McManus MJ, 2019, CELL METAB, V29, P78, DOI 10.1016/j.cmet.2018.08.002
   Merry TL, 2016, J PHYSIOL-LONDON, V594, P5195, DOI 10.1113/JP271957
   Monickaraj F, 2012, MOL CELL BIOCHEM, V365, P343, DOI 10.1007/s11010-012-1276-0
   Montgomery MK, 2015, ENDOCR CONNECT, V4, P0, DOI 10.1530/EC-14-0092
   Nile DL, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0115433
   Nomiyama T, 2002, DIABETOLOGIA, V45, P1577, DOI 10.1007/s00125-002-0893-7
   Nurminen A, 2017, BBA CLIN, V7, P147, DOI 10.1016/j.bbacli.2017.04.001
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261
   Ribas V, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aad3815
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Ross JM, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Saleem A, 2015, MITOCHONDRION, V21, P19, DOI 10.1016/j.mito.2014.12.001
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Tranah GJ, 2011, MITOCHONDRION, V11, P855, DOI 10.1016/j.mito.2011.04.005
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Uruno A, 2016, MOL CELL BIOL, V36, P1655, DOI 10.1128/MCB.01095-15
   Valente WJ, 2016, NUCLEIC ACIDS RES, V44, P8513, DOI 10.1093/nar/gkw716
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wanagat J, 2016, CURR OPIN GENET DEV, V38, P118, DOI 10.1016/j.gde.2016.05.007
   Wang SJ, 2013, GENE, V531, P472, DOI 10.1016/j.gene.2013.09.019
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Yuzefovych LV, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054059
   Zabielski P, 2016, DIABETES, V65, P561, DOI 10.2337/db15-0823
   Zappia MP, 2019, CELL REP, V26, P702, DOI 10.1016/j.celrep.2018.12.080
NR 72
TC 6
Z9 5
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD NOV 15
PY 2020
VL 19
IS 11
BP 
EP 
DI 10.1111/acel.13166
EA OCT 2020
PG 18
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA PA5EA
UT WOS:000579083000001
PM 33049094
DA 2024-11-01
ER

PT J
AU Liu, HH
   Mercieca, K
   Prokosch, V
AF Liu, Hanhan
   Mercieca, Karl
   Prokosch, Verena
TI Mitochondrial Markers in Aging and Primary Open-Angle Glaucoma
SO JOURNAL OF GLAUCOMA
LA English
DT Review
DE primary open-angle glaucoma; molecular markers; mitochondria
ID retinal ganglion-cells; oxidative stress; trabecular meshwork; coenzyme q(10); skeletal-muscle; pgc-1-alpha expression; parkinsons-disease; visual impairment; dna mutations; muller cells
AB This review focuses on recent progress in understanding the role of mitochondrial markers in the context of mitochondrial dysfunction in glaucoma and discussing new therapeutic approaches to modulate mitochondrial function and potentially lead to improved outcomes in glaucoma.
C1 [Liu, Hanhan; Prokosch, Verena] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Expt Ophthalmol, Mainz, Germany.
   [Mercieca, Karl] Univ Manchester, Manchester Royal Eye Hosp, Manchester Univ Hosp NHS Trust, Manchester, Lancs, England.
   [Mercieca, Karl] Univ Manchester, Sch Hlth Sci, Fac Biol Med & Hlth, Manchester, Lancs, England.
C3 Johannes Gutenberg University of Mainz; Manchester Royal Eye Hospital; University of Manchester; University of Manchester
RP Prokosch, V (corresponding author), Johannes Gutenberg Univ Mainz, Univ Eye Hosp Mainz, Langenbeckstr 1, D-55131 Mainz, Germany.
EM vprokosch@gmx.de
CR Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639
   Alamri A, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20061387
   Albarracin R, 2011, INVEST OPHTH VIS SCI, V52, P3582, DOI 10.1167/iovs.10-6664
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Alexiou A, 2018, CURR PROTEIN PEPT SC, V19, P850, DOI 10.2174/1389203718666170810150151
   ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   [Anonymous], 1995, WEBVISION ORG RETINA, V0, P0
   Ao J, 2018, CLIN EXP OPHTHALMOL, V46, P670, DOI 10.1111/ceo.13121
   Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662
   Babenko VA, 2018, MOLECULES, V0, P23
   Barron MJ, 2004, BRIT J OPHTHALMOL, V88, P286, DOI 10.1136/bjo.2003.027664
   Barron MJ, 2001, INVEST OPHTH VIS SCI, V42, P3016
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Bell J, 2005, CLIN DRUG INVEST, V25, P555, DOI 10.2165/00044011-200525090-00001
   Boukelmoune N, 2018, ACTA NEUROPATHOL COM, V6, P0, DOI 10.1186/s40478-018-0644-8
   Brown EE, 2019, REDOX BIOL, V24, P0, DOI 10.1016/j.redox.2019.101201
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   Brown SP, 2000, NEURON, V27, P371, DOI 10.1016/S0896-6273(00)00044-1
   Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Caruana M, 2011, FEBS LETT, V585, P1113, DOI 10.1016/j.febslet.2011.03.046
   Cheng YX, 2008, NEUROSCI LETT, V441, P16, DOI 10.1016/j.neulet.2008.05.116
   Chi ZL, 2010, HUM MOL GENET, V19, P2606, DOI 10.1093/hmg/ddq146
   Dai Y, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-017-0146-9
   Dairam A, 2008, J AGR FOOD CHEM, V56, P3350, DOI 10.1021/jf0734931
   Di Carlo M, 2012, FREE RADICAL RES, V46, P1327, DOI 10.3109/10715762.2012.714466
   DIETZMANN K, 1987, EXP PATHOL-JENA, V31, P47, DOI 10.1016/S0232-1513(87)80092-0
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015
   Duberley KE, 2014, INT J BIOCHEM CELL B, V50, P60, DOI 10.1016/j.biocel.2014.02.003
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033
   Evans RD, 2013, J NEUROSCI RES, V91, P1044, DOI 10.1002/jnr.23229
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, P884S, DOI 10.3945/ajcn.110.001917
   Filler K, 2014, BBA CLIN, V1, P12, DOI 10.1016/j.bbacli.2014.04.001
   Fredenburg AM, 1996, TOXICOLOGY, V108, P191, DOI 10.1016/0300-483X(95)03301-U
   Giordano S, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044610
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Gottanka J, 2005, INVEST OPHTH VIS SCI, V46, P4170, DOI 10.1167/iovs.05-0289
   GROUSELLE M, 1990, BIOCHEM J, V271, P269, DOI 10.1042/bj2710269
   Grubman A, 2014, BRIT J PHARMACOL, V171, P2159, DOI 10.1111/bph.12513
   Grygiel-Górniak B, 2014, NUTR J, V13, P0, DOI 10.1186/1475-2891-13-17
   Guedes Guilherme, 2011, CURR AGING SCI, V4, P110
   Guo XX, 2014, AM J PATHOL, V184, P1017, DOI 10.1016/j.ajpath.2013.12.012
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Hargreaves I P, 2014, INT J BIOCHEM CELL BIOL, V49, P105, DOI 10.1016/j.biocel.2014.01.020
   Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242
   Hass DT, 2019, J NEUROSCI, V39, P3582, DOI 10.1523/JNEUROSCI.2702-18.2019
   HAYAKAWA M, 1993, MOL CELL BIOCHEM, V119, P95, DOI 10.1007/BF00926859
   He Y, 2008, INVEST OPHTH VIS SCI, V49, P4912, DOI 10.1167/iovs.08-2192
   Hikosaka K, 2021, NUTR NEUROSCI, V24, P371, DOI 10.1080/1028415X.2019.1637504
   Holmes D, 2018, NATURE, V561, PS1, DOI 10.1038/d41586-018-06110-z
   Horstink MWIM, 2003, ARCH NEUROL-CHICAGO, V60, P1170, DOI 10.1001/archneur.60.8.1170-b
   Hu XX, 2018, FRONT MOL NEUROSCI, V11, P0, DOI 10.3389/fnmol.2018.00350
   Hu Xinxin, 2017, MOL VIS, V23, P447
   Indrieri A, 2019, EMBO MOL MED, V11, P0, DOI 10.15252/emmm.201708734
   Inoue Y, 2007, EXP EYE RES, V85, P234, DOI 10.1016/j.exer.2007.04.007
   Izzotti A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0014567
   Izzotti A, 2010, ARCH OPHTHALMOL-CHIC, V128, P724, DOI 10.1001/archophthalmol.2010.87
   Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI 10.1042/BSE0470069
   Ju WK, 2007, INVEST OPHTH VIS SCI, V48, P2145, DOI 10.1167/iovs.06-0573
   Ju WK, 2009, MOL VIS, V15, P120
   Kaarniranta K, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19082317
   Kakhlon O, 2008, BLOOD, V112, P5219, DOI 10.1182/blood-2008-06-161919
   Kamel K, 2017, MITOCHONDRION, V35, P44, DOI 10.1016/j.mito.2017.05.004
   Kaufmann P, 2009, ANN NEUROL, V66, P235, DOI 10.1002/ana.21743
   Kemper MF, 2014, EUR J PHARMACOL, V723, P322, DOI 10.1016/j.ejphar.2013.11.009
   Kicic A, 2003, J NEUROSCI, V23, P7742
   Kieburtz K, 2001, NEUROLOGY, V57, P397
   Kimball EC, 2018, EXP EYE RES, V172, P78, DOI 10.1016/j.exer.2018.04.001
   Kimball EC, 2017, EXP EYE RES, V160, P106, DOI 10.1016/j.exer.2017.04.003
   Kong GYX, 2009, J GLAUCOMA, V18, P93, DOI 10.1097/IJG.0b013e318181284f
   Krishnamoorthy RR, 2013, INVEST OPHTH VIS SCI, V54, P5712, DOI 10.1167/iovs.13-12085
   Kroeber M, 2006, EXP EYE RES, V82, P1075, DOI 10.1016/j.exer.2005.11.004
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lee D, 2014, APOPTOSIS, V19, P603, DOI 10.1007/s10495-013-0956-x
   Lee S, 2012, INVEST OPHTH VIS SCI, V53, P2431, DOI 10.1167/iovs.12-9596
   Lee S, 2011, EXP EYE RES, V93, P204, DOI 10.1016/j.exer.2010.07.015
   Lefevere E, 2017, MITOCHONDRION, V36, P66, DOI 10.1016/j.mito.2017.03.006
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998
   Li X, 2018, J ALLERGY CLIN IMMUN, V141, P1634, DOI 10.1016/j.jaci.2017.08.017
   Liddell JR, 2015, NEURODEGENER DIS MAN, V5, P345, DOI 10.2217/NMT.15.19
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   Lulli M, 2012, INVEST OPHTH VIS SCI, V53, P8295, DOI 10.1167/iovs.12-10374
   Lulli M, 2012, J RADIAT RES, V53, P695, DOI 10.1093/jrr/rrs025
   Lv JJ, 2018, AGEING RES REV, V44, P8, DOI 10.1016/j.arr.2018.03.004
   Mages K, 2019, J NEUROINFLAMM, V16, P0, DOI 10.1186/s12974-019-1424-5
   Mäkelä J, 2016, NEUROPHARMACOLOGY, V102, P266, DOI 10.1016/j.neuropharm.2015.11.020
   Mensink M, 2007, INT J OBESITY, V31, P1302, DOI 10.1038/sj.ijo.0803567
   Mezzaroba L, 2019, NEUROTOXICOLOGY, V74, P230, DOI 10.1016/j.neuro.2019.07.007
   Milenkovic VM, 2019, INT J MOL SCI, V0, P20
   Minegishi Y, 2016, PROG RETIN EYE RES, V55, P149, DOI 10.1016/j.preteyeres.2016.08.002
   Moran EP, 2015, PPAR RES, V2015, P0, DOI 10.1155/2015/595426
   Morgan JE, 2012, CLIN EXP OPHTHALMOL, V40, P364, DOI 10.1111/j.1442-9071.2012.02789.x
   Morrison BM, 2015, EXP NEUROL, V263, P325, DOI 10.1016/j.expneurol.2014.10.018
   Nakajima Y, 2008, BRAIN RES, V1226, P226, DOI 10.1016/j.brainres.2008.06.026
   Negida A, 2016, CNS NEUROL DISORD-DR, V15, P45, DOI 10.2174/1871527314666150821103306
   Nucci C, 2007, INT REV NEUROBIOL, V82, P397, DOI 10.1016/S0074-7742(07)82022-8
   Osborne NN, 2010, EXP EYE RES, V90, P750, DOI 10.1016/j.exer.2010.03.008
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Park JS, 2018, CURR NEUROL NEUROSCI, V18, P0, DOI 10.1007/s11910-018-0829-3
   Pearsall EA, 2017, BMC BIOL, V15, P0, DOI 10.1186/s12915-017-0451-x
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Pierrel F, 2007, BIOMETALS, V20, P675, DOI 10.1007/s10534-006-9052-9
   Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Pulliero A, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0098106
   Qiang W, 2007, EXP MOL MED, V39, P535, DOI 10.1038/emm.2007.59
   Qu JF, 2009, INVEST OPHTH VIS SCI, V50, P1814, DOI 10.1167/iovs.08-2656
   Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389
   QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009
   Rajdev K, 2019, CNS NEUROL DISORD-DR, V18, P446, DOI 10.2174/1871527318666190610101144
   Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108
   Rasgon NL, 2005, NEUROBIOL AGING, V26, P229, DOI 10.1016/j.neurobiolaging.2004.03.003
   Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210
   Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901
   Rines AK, 2013, J MOL CELL CARDIOL, V55, P50, DOI 10.1016/j.yjmcc.2012.05.014
   Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797
   Rose J, 2017, TOXICOLOGY, V391, P109, DOI 10.1016/j.tox.2017.06.011
   Runkoa AP, 2008, FEBS LETT, V582, P715, DOI 10.1016/j.febslet.2008.01.046
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   Saccà SC, 2008, PROG BRAIN RES, V173, P385, DOI 10.1016/S0079-6123(08)01127-8
   Saccà SC, 2014, CELL MOL LIFE SCI, V71, P2197, DOI 10.1007/s00018-013-1493-z
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sarzi E, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-20838-8
   Satish S, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/9248640
   Sayyad Z, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-17241-0
   Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006
   Schultz R, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-22887-5
   Shim MS, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep33830
   Sirohi K, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0138289
   Skytt DM, 2016, BIOMED RES INT, V2016, P0, DOI 10.1155/2016/1087647
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Stecker MM, 2015, NEUROSCIENCE, V284, P653, DOI 10.1016/j.neuroscience.2014.10.048
   Sundaresan P, 2015, GENET MED, V17, P279, DOI 10.1038/gim.2014.121
   Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135
   Swarup G, 2018, FRONT IMMUNOL, V9, P0, DOI 10.3389/fimmu.2018.01287
   Tanwar M, 2010, MOL VIS, V16, P518
   Tezel G, 2009, INVEST OPHTH VIS SCI, V50, P1001, DOI 10.1167/iovs.08-2717
   Toft-Kehler AK, 2017, MITOCHONDRION, V36, P43, DOI 10.1016/j.mito.2017.02.002
   Toft-Kehler AK, 2016, INVEST OPHTH VIS SCI, V57, P2721, DOI 10.1167/iovs.16-19275
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tseng HC, 2015, NEUROBIOL AGING, V36, P2201, DOI 10.1016/j.neurobiolaging.2015.02.012
   Van Bergen NJ, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0140919
   Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003
   Wang N, 2019, AGING-US, V11, P3117, DOI 10.18632/aging.101966
   Weber JJ, 2019, BIOCHEM PHARMACOL, V168, P305, DOI 10.1016/j.bcp.2019.07.002
   Wei QQ, 2019, DISCOV MED, V27, P189
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wiederholt M, 2000, PROG RETIN EYE RES, V19, P271, DOI 10.1016/S1350-9462(99)00015-4
   Williams Pete A, 2018, COMMUN INTEGR BIOL, V11, Pe1356956, DOI 10.1080/19420889.2017.1356956
   Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092
   Xu L, 2018, P NATL ACAD SCI USA, V115, P10475, DOI 10.1073/pnas.1802724115
   Yin F, 2014, ANTIOXID REDOX SIGN, V20, P353, DOI 10.1089/ars.2012.4774
   Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6
   Yu-Wai-Man P, 2010, J MED GENET, V47, P120, DOI 10.1136/jmg.2009.067512
   Zhang X, 2018, LIFE SCI, V207, P234, DOI 10.1016/j.lfs.2018.06.010
   Zhang X, 2017, CURR MED CHEM, V24, P4329, DOI 10.2174/0929867324666170801100516
   Zhu ZG, 2017, NEUROL SCI, V38, P215, DOI 10.1007/s10072-016-2757-9
NR 168
TC 8
Z9 8
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1057-0829
EI 1536-481X
J9 J GLAUCOMA
JI J. Glaucoma
PD APR 15
PY 2020
VL 29
IS 4
BP 295
EP 303
DI 10.1097/IJG.0000000000001448
PG 9
WC Ophthalmology
SC Ophthalmology
GA LE6KK
UT WOS:000526832300017
PM 31977544
DA 2024-11-01
ER

PT J
AU Kerr, M
   Hume, S
   Omar, F
   Koo, D
   Barnes, H
   Khan, M
   Aman, S
   Wei, XC
   Alfuhaid, H
   McDonald, R
   McDonald, L
   Newell, C
   Sparkes, R
   Hittel, D
   Khan, A
AF Kerr, Marina
   Hume, Stacey
   Omar, Fadya
   Koo, Desmond
   Barnes, Heather
   Khan, Maida
   Aman, Suhaib
   Wei, Xing-Chang
   Alfuhaid, Hanen
   McDonald, Roman
   McDonald, Liam
   Newell, Christopher
   Sparkes, Rebecca
   Hittel, Dustin
   Khan, Aneal
TI MITO-FIND: A study in 390 patients to determine a diagnostic strategy for mitochondrial disease
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
ID respiratory-chain disorders; muscle biopsy; multiple deletions; skeletal-muscle; dna mutations; nuclear genes; genome; exome; pathology; criteria
AB Mitochondrial diseases, due to nuclear or mitochondrial genome mutations causing mitochondrial dysfunction, have a wide range of clinical features involving neurologic, muscular, cardiac, hepatic, visual, and auditory symptoms. Making a diagnosis of a mitochondrial disease is often challenging since there is no gold standard and traditional testing methods have required tissue biopsy which presents technical challenges and most patients prefer a non-invasive approach. Since a diagnosis invariably involves finding a disease-causing DNA variant, new approaches such as next generation sequencing (NGS) have the potential to make it easier to make a diagnosis. We evaluated the ability of our traditional diagnostic pathway (metabolite analysis, tissue neuropathology and respiratory chain enzyme activity) in 390 patients. The traditional diagnostic pathway provided a diagnosis of mitochondrial disease in 115 patients (29.50%). Analysis of mtDNA, tissue neuropathology, skin electron microscopy, respiratory chain enzyme analysis using inhibitor assays, blue native polyacrylamide gel electrophoresis were all statistically significant in distinguishing patients between a mitochondrial and non-mitochondrial diagnosis. From these 390 patients who underwent traditional analysis, we recruited 116 patients for the NGS part of the study (36 patients who had a mitochondrial diagnosis (MITO) and 80 patients who had no diagnosis (No-Dx)). In the group of 36 MITO patients, nuclear whole exome sequencing (nWES) provided a second diagnosis in 2 cases who already had a pathogenic variant in mtDNA, and a revised diagnosis (GLUL) in one case that had abnormal pathology but no pathogenic mtDNA variant. In the 80 NO-Dx patients, nWES found non-mitochondrial diagnosis in 26 patients and a mitochondrial diagnosis in 1 patient. A genetic diagnosis was obtained in 53/116 (45.70%) cases that were recruited for NGS, but not in 11/116 (9.48%) of cases with abnormal mitochondrial neuropathology. Our results show that a non-invasive, bigenomic sequencing (BGS) approach (using both a nWES and optimized mtDNA analysis to include large deletions) should be the first step in investigating for mitochondrial diseases. There may still be a role for tissue biopsy in unsolved cases or when the diagnosis is still not clear after NGS studies.
C1 [Kerr, Marina; Omar, Fadya; Koo, Desmond; Barnes, Heather; Khan, Maida; Aman, Suhaib; Alfuhaid, Hanen; McDonald, Roman; McDonald, Liam; Newell, Christopher; Sparkes, Rebecca; Khan, Aneal] Univ Calgary, Alberta Childrens Hosp, Cumming Sch Med, Dept Med Genet,Res Inst, Calgary, AB, Canada.
   [Hume, Stacey] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.
   [Wei, Xing-Chang] Univ Calgary, Alberta Childrens Hosp, Cumming Sch Med, Dept Radiol, Calgary, AB, Canada.
   [Hittel, Dustin] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada.
C3 Alberta Childrens Hospital; University of Calgary; University of Alberta; University of Calgary; Alberta Childrens Hospital; University of Calgary
RP Khan, A (corresponding author), Univ Calgary, Alberta Childrens Hosp, Cumming Sch Med, Dept Med Genet,Res Inst, Calgary, AB, Canada.
EM khaa@ucalgary.ca
FU MitoCanada; Alberta Children's Hospital Research Foundation; Alberta Children's Hospital Research Institute; Alberta Health Services; University of Calgary Cumming School of Medicine
CR Abicht A, 2018, MOL GENET GENOM MED, V6, P1188, DOI 10.1002/mgg3.500
   Adzhubei Ivan, 2013, CURR PROTOC HUM GENET, VChapter 7, P0, DOI 10.1002/0471142905.hg0720s76
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bennett J, 2020, MOL GENET METAB REP, V24, P0, DOI 10.1016/j.ymgmr.2020.100616
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Carta A, 2000, ARCH OPHTHALMOL-CHIC, V118, P1441
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249
   Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144
   Dames S, 2013, J MOL DIAGN, V15, P526, DOI 10.1016/j.jmoldx.2013.03.005
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DiMauro S, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20225643
   Dinwiddie DL, 2013, GENOMICS, V102, P148, DOI 10.1016/j.ygeno.2013.04.013
   Driessen J, 2007, PEDIATR ANESTH, V17, P16, DOI 10.1111/j.1460-9592.2006.02043.x
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   ERNSTER L, 1959, NATURE, V184, P1851, DOI 10.1038/1841851a0
   Falk MJ, 2012, DISCOV MED, V14, P389
   FERNANDEZSOLA J, 1992, POSTGRAD MED J, V68, P212, DOI 10.1136/pgmj.68.797.212
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   HALTIA M, 1992, BRAIN PATHOL, V2, P133, DOI 10.1111/j.1750-3639.1992.tb00681.x
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Harvey NR, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0224847
   Heighton JN, 2019, MITOCHONDRION, V49, P227, DOI 10.1016/j.mito.2019.09.002
   Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   KELLEY RI, 1993, CLIN CHIM ACTA, V220, P157, DOI 10.1016/0009-8981(93)90044-5
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Khan A, 2019, CHILD NEUROL OPEN, V6, P0
   Köhler S, 2019, NUCLEIC ACIDS RES, V47, PD1018, DOI 10.1093/nar/gky1105
   Krusche P, 2019, NAT BIOTECHNOL, V37, P567, DOI 10.1038/s41587-019-0108-0
   Krusche P, 2019, NAT BIOTECHNOL, V37, P555, DOI 10.1038/s41587-019-0054-x
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, PD1062, DOI 10.1093/nar/gkx1153
   LINDAL S, 1992, ULTRASTRUCT PATHOL, V16, P263, DOI 10.3109/01913129209061355
   Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932
   Mancuso M, 2007, BIOSCIENCE REP, V27, P31, DOI 10.1007/s10540-007-9035-2
   Marquis J, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-3695-5
   Miyamoto Y, 2016, MITOCHONDRION, V26, P26, DOI 10.1016/j.mito.2015.11.004
   Morava E, 2015, J INHERIT METAB DIS, V38, P387, DOI 10.1007/s10545-015-9852-6
   Newell C, 2019, NEUROL-GENET, V5, P0, DOI 10.1212/NXG.0000000000000336
   Newell C, 2018, MOL GENET METAB, V125, P332, DOI 10.1016/j.ymgme.2018.10.002
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   Paik K, 2019, CAN J NEUROL SCI, V46, P717, DOI 10.1017/cjn.2019.240
   Palculict ME, 2016, METHODS MOL BIOL, V1351, P3, DOI 10.1007/978-1-4939-3040-1_1
   Parikh S, 2019, J MED GENET, V56, P123, DOI 10.1136/jmedgenet-2018-105800
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Plutino M, 2018, BMC MED GENET, V19, P0, DOI 10.1186/s12881-018-0568-y
   Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, PD886, DOI 10.1093/nar/gky1016
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   Ryzhkova AI, 2018, THER CLIN RISK MANAG, V14, P1933, DOI 10.2147/TCRM.S154863
   Sarnat HB, 2012, NEUROPATHOLOGY, V32, P617, DOI 10.1111/j.1440-1789.2012.01308.x
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Shanske S, 2004, MITOCHONDRION, V4, P403, DOI 10.1016/j.mito.2004.07.026
   Sim NL, 2012, NUCLEIC ACIDS RES, V40, PW452, DOI 10.1093/nar/gks539
   Singleton MV, 2014, AM J HUM GENET, V94, P599, DOI 10.1016/j.ajhg.2014.03.010
   Sleigh K, 2011, MUSCLE NERVE, V43, P795, DOI 10.1002/mus.21962
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   TRIJBELS JMF, 1988, EUR J PEDIATR, V148, P92, DOI 10.1007/BF00445910
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   Uusimaa J, 2000, PEDIATRICS, V105, P598, DOI 10.1542/peds.105.3.598
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Witters P, 2018, GENET MED, V20, P444, DOI 10.1038/gim.2017.125
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wong LJC, 1997, CLIN CHEM, V43, P1857
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
   Zook JM, 2019, NAT BIOTECHNOL, V37, P561, DOI 10.1038/s41587-019-0074-6
NR 82
TC 18
Z9 18
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD SEP-OCT 15
PY 2020
VL 131
IS 1-2
BP 66
EP 82
DI 10.1016/j.ymgme.2020.08.009
PG 17
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA PH7ZV
UT WOS:000600626600006
PM 32980267
DA 2024-11-01
ER

PT J
AU Chen, JY
   Zheng, QZ
   Peiffer, LB
   Hicks, JL
   Haffner, MC
   Rosenberg, AZ
   Levi, M
   Wang, XXX
   Ozbek, B
   Baena-Del Valle, J
   Yegnasubramanian, S
   De Marzo, AM
AF Chen, Jiayu
   Zheng, Qizhi
   Peiffer, Lauren B.
   Hicks, Jessica L.
   Haffner, Michael C.
   Rosenberg, Avi Z.
   Levi, Moshe
   Wang, Xiaoxin X.
   Ozbek, Busra
   Baena-Del Valle, Javier
   Yegnasubramanian, Srinivasan
   De Marzo, Angelo M.
TI An <i>in Situ</i> Atlas of Mitochondrial DNA in Mammalian Tissues Reveals High Content in Stem and Proliferative Compartments
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID copy number; transcription factor; skeletal-muscle; down-regulation; gene; replication; depletion; mutations; target; mtdna
AB Mitochondria regulate ATP production, metabolism, and cell death. Alterations in mitochondrial DNA (mtDNA) sequence and copy number are implicated in aging and organ dysfunction in diverse inherited and sporadic diseases. Because most measurements of mtDNA use homogenates of complex tissues, little is known about cell-type-specific mtDNA copy number heterogeneity in normal physiology, aging, and disease. Thus, the precise cell types whose loss of mitochondrial activity and altered mtDNA copy number that result in organ dysfunction in aging and disease have often not been clarified. Here, an in situ hybridization approach to generate a single-cell-resolution atlas of mtDNA content in mammalian tissues was validated. In hierarchically organized self-renewing tissues, higher levels of mtDNA were observed in stem/proliferative compartments compared with differentiated compartments. Striking zonal patterns of mtDNA levels in the liver reflected the known oxygen tension gradient. In the kidney, proximal and distal tubules had markedly higher mtDNA levels compared with cells within glomeruli and collecting duct epithelial cells. In mice, decreased mtDNA levels were visualized in renal tubules as a function of aging, which was prevented by calorie restriction. This study provides a novel approach for quantifying species- and cell-type-specific mtDNA copy number and dynamics in any normal or diseased tissue that can be used for monitoring the effects of interventions in animal and human studies.
C1 [Chen, Jiayu; Zheng, Qizhi; Peiffer, Lauren B.; Hicks, Jessica L.; Haffner, Michael C.; Rosenberg, Avi Z.; Ozbek, Busra; Baena-Del Valle, Javier; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Pathol, CRB 2 Room 144,1550 Orleans St, Baltimore, MD 21231 USA.
   [Peiffer, Lauren B.; Yegnasubramanian, Srinivasan; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21231 USA.
   [Yegnasubramanian, Srinivasan; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Urol & Oncol, Baltimore, MD 21231 USA.
   [Haffner, Michael C.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.
   [Levi, Moshe; Wang, Xiaoxin X.] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC USA.
C3 Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Georgetown University
RP De Marzo, AM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, CRB 2 Room 144,1550 Orleans St, Baltimore, MD 21231 USA.
EM ademarz@jhmi.edu
FU NIH/National Cancer Institute (NCI) Specialized Programs of Research Excellence (SPORE) in Prostate Cancer grant [P50CA58236]; NIH/NCI [P30 CA006973, U01 CA196390]; U.S. Department of Defense Prostate Cancer Research Program (PCRP) [W81XWH-18-2-0015]; National Institute of Diabetes and Digestive and kidney diseases (NIDDK) [R01 DK116567]; National Institute of Aging (NIA) [R01 AG049493]; Office of the Director of the National Institutes of Health [S10OD016374]
CR Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Ashley N, 2009, BIOCHEM BIOPH RES CO, V378, P450, DOI 10.1016/j.bbrc.2008.11.059
   Baena-Del Valle JA, 2018, J PATHOL, V244, P11, DOI 10.1002/path.4980
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Berger E, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13171
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130
   Brayton C, 2014, TRANSGENIC ANIMAL TE, V1, P431, DOI 10.1016/B978-0-12-410490-7.00016-5
   Brosch M, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06611-5
   Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004
   Chatre Laurent, 2015, METHODS MOL BIOL, V1264, P133, DOI 10.1007/978-1-4939-2257-4_13
   Chatre L, 2013, J CELL SCI, V126, P914, DOI 10.1242/jcs.114322
   Chatre L, 2013, NUCLEIC ACIDS RES, V41, P3068, DOI 10.1093/nar/gkt015
   Choudhury D, 2011, NAT REV NEPHROL, V7, P706, DOI 10.1038/nrneph.2011.104
   Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, PE977, DOI 10.1152/ajpendo.00183.2009
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Derényi I, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms14545
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Ertunc O, 2019, LAB INVEST, V99, P1
   Farmer SR, 2008, CELL, V134, P726, DOI 10.1016/j.cell.2008.08.018
   Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grayson AR, 2014, ONCOGENE, V33, P1736, DOI 10.1038/onc.2013.126
   Haffner MC, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00084-8
   Hirose M, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-24290-6
   Holdhoff M, 2017, CLIN CANCER RES, V23, P3150, DOI 10.1158/1078-0432.CCR-16-1490
   Janes MS, 2004, J HISTOCHEM CYTOCHEM, V52, P1011, DOI 10.1369/jhc.3a6209.2004
   Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Kim JH, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067227
   Koh Cheryl M, 2010, GENES CANCER, V1, P617, DOI 10.1177/1947601910379132
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 1997, HUM MOL GENET, V6, P185, DOI 10.1093/hmg/6.2.185
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Li B, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-29621-1
   Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005
   Liyanage SU, 2017, BLOOD, V129, P2657, DOI 10.1182/blood-2016-10-741207
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Marty L, 1996, J BIOL CHEM, V271, P11468, DOI 10.1074/jbc.271.19.11468
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051
   Meyer JN, 2018, TOXICOL SCI, V162, P15, DOI 10.1093/toxsci/kfy008
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Müller-Höcker J, 2011, J CELL MOL MED, V15, P445, DOI 10.1111/j.1582-4934.2009.00819.x
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06
   Nelson I, 1997, SOMAT CELL MOLEC GEN, V23, P287, DOI 10.1007/BF02674419
   Neuhaus JFG, 2017, NEUROENDOCRINOLOGY, V104, P72, DOI 10.1159/000444680
   Nyska A, 1999, PATHOLOGY MOUSE, V0, P509
   OHara R, 2019, QUANTITATIVE MITOCHO, V0, P0, DOI DOI 10.1101/579789
   OSullivan ED, 2017, J AM SOC NEPHROL, V28, P407, DOI 10.1681/ASN.2015121308
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   Park E, 2016, CLIN CANC RES S, V22, P0
   Rantanen A, 2001, MAMM GENOME, V12, P787, DOI 10.1007/s00335-001-2052-8
   Rantanen A, 2000, HUM REPROD, V15 Suppl 2, P86
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Saely CH, 2012, GERONTOLOGY, V58, P15, DOI 10.1159/000321319
   Schubert S, 2015, INT J MOL SCI, V16, P9850, DOI 10.3390/ijms16059850
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Tang Y, 2016, PEERJ, V4, P0, DOI 10.7717/peerj.1821
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trabzonlu L, 2019, CSH PERSPECT MED, V9, P0, DOI 10.1101/cshperspect.a030403
   Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863
   Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002
   Wang HW, 2014, METHODS MOL BIOL, V1211, P201, DOI 10.1007/978-1-4939-1459-3_16
   Wang XXX, 2017, J BIOL CHEM, V292, P12018, DOI 10.1074/jbc.C117.794982
   Wang XX, 2019, ERR AGONISM REVERSES, V0, P0, DOI DOI 10.1101/755801
   Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200
   Yamagata K, 2002, J AM SOC NEPHROL, V13, P0, DOI 10.1097/01.ASN.0000019772.17954.F8
   Yamazawa T, 2016, MICROSC RES TECHNIQ, V79, P1179, DOI 10.1002/jemt.22773
NR 79
TC 20
Z9 21
U1 2
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD JUL 15
PY 2020
VL 190
IS 7
BP 1565
EP 1579
DI 10.1016/j.ajpath.2020.03.018
PG 15
WC Pathology
SC Pathology
GA MC0AT
UT WOS:000542960200017
PM 32304697
DA 2024-11-01
ER

PT J
AU Decoux-Poullot, AG
   Bannwarth, S
   Procaccio, V
   Lebre, AS
   Jardel, C
   Vialettes, B
   Paquis-Flucklinger, V
   Chevalier, N
AF Decoux-Poullot, Anne-Gaelle
   Bannwarth, Sylvie
   Procaccio, Vincent
   Lebre, Anne-Sophie
   Jardel, Claude
   Vialettes, Bernard
   Paquis-Flucklinger, Veronique
   Chevalier, Nicolas
TI Clinical phenotype of mitochondrial diabetes due to rare mitochondrial DNA mutations
SO ANNALES D ENDOCRINOLOGIE
LA English
DT Article
DE Diabetes; Mitochondrial diabetes; Mitochondrial DNA; Mitochondrial disease; Rare mutation
ID point mutation; t14709c mutation; japanese family; gene-mutations; deafness; mellitus; myopathy; patient; onset; cardiomyopathy
AB Objective. - While the most frequent mutation responsible for mitochondrial diabetes is the point mutation m.3243 A>G of mitochondrial DNA (mtDNA), few data are available about the role of rare mtDNA mutations in the pathophysiology of diabetes. The main objective of our study was to describe the phenotypic characteristics of patients suffering from diabetes linked to rare mtDNA mutations. Research design and methods. - We performed a post-hoc analysis of a prospective multicenter cohort of 743 patients with mitochondrial disorder (previously published by the French Network of Mitochondrial Diseases), associated to a literature review of the PubMed database from 1992 to May 2016. We extracted all reported patients with diabetes and identified rare mtDNA mutations and described their clinical and metabolic phenotypes. Results. - The 50 identified patients (10 from the princeps study; 40 from the review of the literature) showed a heterogeneous metabolic phenotype in terms of age, symptoms prior to diagnosis, treatments, and associated clinical and biological signs. However, neurological symptoms were more frequent in case of rare mtDNA mutations compared to the classical m.3243 A> G mutation (A=0.024). In contrast, deafness (65% vs. 95%, P= 3.7E-5), macular pattern dystrophy (20% vs. 86%, P= 1.6E-10) and nephropathy (8% vs. 28%, P= 0.018) were significantly less frequent than in case of the classical m.3243 A>G mutation. Conclusion. - Although no specific metabolic phenotype could be identified suggesting or eliminating implication of rare mtDNA mutations in diabetes, clinical phenotypes featured more frequent neurological signs. (C) 2020 Elsevier Masson SAS. All rights reserved.
C1 [Decoux-Poullot, Anne-Gaelle; Chevalier, Nicolas] Univ Cote Azur, CHU Nice, Hop Archet 2, Serv Endocrinol Diabetol & Med Reprod, Nice, France.
   [Bannwarth, Sylvie; Paquis-Flucklinger, Veronique] Univ Cote Azur, CHU Nice, IRCAN, Inserm,CNRS, Nice, France.
   [Procaccio, Vincent] CHU Angers, IBS Lab Genet, Angers, France.
   [Lebre, Anne-Sophie] Univ Paris 05, Hop Necker Enfants Malad, Serv Genet, Inserm U781, Paris, France.
   [Jardel, Claude] Grp Hosp Pitie Salpetriere, Ctr Genet Mol & Chromosom, Biochim Metab, Paris, France.
   [Vialettes, Bernard] CHU Marseille, Hop Concept, Serv Endocrinol Diabet Malad Metab, F-13385 Marseille 5, France.
   [Chevalier, Nicolas] Univ Cote Azur, CHU Nice,Ctr Mediterraneen Med Mol C3M, Equipe Cellular Basis & Signaling Tumor Metab 5, Inst Natl Sante & Rech Med Inserm,UMR U1065,UNS, Nice, France.
C3 CHU Nice; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Cote d'Azur; CHU Nice; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Chevalier, N (corresponding author), Hop Archet 2, Dept Endocrinol Diabetol & Med Reprod, 151 Route St Antoine Ginestiere,CS 23079, F-06202 Nice 3, France.
EM chevalier.n@chu-nice.fr
FU French Ministry of Health (PSTIC 2008, Programme de Soutien aux Techniques Innovantes et Couteuses)
CR BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bayreuther C, 2008, DIABETES METAB, V34, P386, DOI 10.1016/j.diabet.2008.02.002
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Chen FL, 2006, MUTAT RES-FUND MOL M, V602, P26, DOI 10.1016/j.mrfmmm.2006.07.006
   Choo-Kang ATW, 2002, DIABETES, V51, P2317, DOI 10.2337/diabetes.51.7.2317
   Damore ME, 1999, J PEDIATR ENDOCR MET, V12, P207
   De Block CEM, 2004, EXP CLIN ENDOCR DIAB, V112, P80, DOI 10.1055/s-2004-815754
   DeFronzo R, 2016, METABOLISM, V65, P20, DOI 10.1016/j.metabol.2015.10.014
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   Gerbitz KD, 1996, DIABETES, V45, P113, DOI 10.2337/diabetes.45.2.113
   GORELICK FS, 1983, YALE J BIOL MED, V56, P271
   Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Hattori Y, 2005, EXP CLIN ENDOCR DIAB, V113, P318, DOI 10.1055/s-2005-865646
   Hattori Y, 2003, DIABETES CARE, V26, P952, DOI 10.2337/diacare.26.3.952
   Hirai M, 1998, J CLIN ENDOCR METAB, V83, P992, DOI 10.1210/jc.83.3.992
   Kameoka K, 1998, DIABETES CARE, V21, P2034, DOI 10.2337/diacare.21.11.2034
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Liu H, 2015, MITOCHONDRION, V21, P49, DOI 10.1016/j.mito.2015.01.004
   Lynn S, 1998, DIABETES, V47, P1800, DOI 10.2337/diabetes.47.11.1800
   Maassen JA, 1996, DIABETOLOGIA, V39, P375
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Meas T, 2010, REV MED INTERNE, V31, P216, DOI 10.1016/j.revmed.2008.11.017
   Mezghani N, 2010, J DIABETES COMPLICAT, V24, P270, DOI 10.1016/j.jdiacomp.2009.11.002
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Mosbah H, 2021, ANN ENDOCRINOL-PARIS, V82, P146, DOI 10.1016/j.ando.2020.03.002
   Nakano S, 1998, ENDOCR J, V45, P625, DOI 10.1507/endocrj.45.625
   Odawara M, 1996, BIOCHEM BIOPH RES CO, V227, P147, DOI 10.1006/bbrc.1996.1481
   Ohkubo K, 2001, CLIN CHEM, V47, P1641
   Perucca-Lostanlen D, 2000, BIOCHEM BIOPH RES CO, V277, P771, DOI 10.1006/bbrc.2000.3751
   Ramachandran R, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6080075
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   Rigoli L, 2001, DIABETIC MED, V18, P334, DOI 10.1046/j.1464-5491.2001.00429-2.x
   Salles JE, 2007, PANCREAS, V34, P133, DOI 10.1097/01.mpa.0000246659.38375.4d
   Sano M, 1996, J NEUROL, V243, P441, DOI 10.1007/BF00900496
   Sollier C, 2020, ANN ENDOCRINOL-PARIS, V81, P51, DOI 10.1016/j.ando.2019.10.003
   Souied EH, 1998, AM J OPHTHALMOL, V125, P100, DOI 10.1016/S0002-9394(99)80243-8
   SUZUKI S, 1994, DIABETES CARE, V17, P1428, DOI 10.2337/diacare.17.12.1428
   Suzuki Y, 1997, DIABETES CARE, V20, P1138, DOI 10.2337/diacare.20.7.1138
   Suzuki Y, 2002, DIABETES CARE, V25, P1097, DOI 10.2337/diacare.25.6.1097
   Suzuki Y, 1996, DIABETES CARE, V19, P1304, DOI 10.2337/diacare.19.11.1304
   Tabebi M, 2015, BIOCHEM BIOPH RES CO, V459, P353, DOI 10.1016/j.bbrc.2015.01.151
   Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269
   Tsukuda K, 1997, DIABETIC MED, V14, P1032, DOI 10.1002/(SICI)1096-9136(199712)14:12<1032::AID-DIA504>3.0.CO;2-Y
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Whittaker RG, 2007, DIABETES CARE, V30, P2238, DOI 10.2337/dc07-0466
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
NR 51
TC 2
Z9 3
U1 0
U2 12
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0003-4266
EI 2213-3941
J9 ANN ENDOCRINOL-PARIS
JI Ann Endocrinol.
PD JUN 15
PY 2020
VL 81
IS 2-3
BP 68
EP 77
DI 10.1016/j.ando.2020.04.007
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA LU2EH
UT WOS:000537572500003
PM 32409007
DA 2024-11-01
ER

PT J
AU Hunt, M
   Payne, BAI
AF Hunt, Matthew
   Payne, Brendan A. I.
TI Mitochondria and ageing with HIV
SO CURRENT OPINION IN HIV AND AIDS
LA English
DT Review
DE ageing; antiretroviral therapy; HIV; mitochondria; mitochondrial DNA
ID dna mutations; skeletal-muscle; cells; lipoatrophy; therapy; association; apoptosis; tenofovir; toxicity; stress
AB Purpose of review Some older people living with HIV (PLWH) exhibit features of unsuccessful ageing, such as frailty. Mitochondrial dysfunction is one of the best characterized ageing mechanisms. There has been recent interest in whether some people ageing with HIV may have an excess of mitochondrial dysfunction. This review aims to address this question through: analogy with ageing and chronic disease; discussion of the key unknowns; suggested ways that measures of mitochondrial dysfunction might be incorporated into HIV research studies. Recent findings Recent data suggest that mitochondrial dysfunction in PLWH may not be wholly a legacy effect of historical nucleoside analog reverse transcriptase inhibitor exposures. Research in the non-HIV setting has altered our understanding of the important mediators of mitochondrial dysfunction in ageing. Mitochondrial dysfunction is a very plausible driver of adverse ageing phenotypes in some older PLWH. As such it may be a target for therapeutic interventions. Currently, however, there remain considerable uncertainties around the extent of this phenomenon, and its relative importance. Current studies are likely to clarify these questions over the next few years.
C1 [Hunt, Matthew; Payne, Brendan A. I.] Newcastle Univ, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Hunt, Matthew] Newcastle Upon Tyne Hosp NHS Fdn Trust, NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England.
   [Payne, Brendan A. I.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Infect & Trop Med, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP Payne, BAI (corresponding author), Med Sch, 4th Floor,Cookson Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM Brendan.Payne@ncl.ac.uk
FU Wellcome Trust [109975/Z/15/Z, 203105/Z/16/Z]; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre; Wellcome Trust [109975/Z/15/Z] Funding Source: Wellcome Trust
CR Al Payne B, 2013, AIDS RES THER, V10, P0, DOI 10.1186/1742-6405-10-27
   Andreux PA, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-26944-x
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Bagkeris E, 2018, INT J EPIDEMIOL, V47, P1391, DOI 10.1093/ije/dyy072
   Barroso S, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0216712
   Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Carr A, 2000, AIDS, V14, PF25, DOI 10.1097/00002030-200002180-00001
   Castellano P, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-39898-5
   Cheung JY, 2019, J CELL PHYSIOL, V234, P4432, DOI 10.1002/jcp.27232
   Clutton G, 2019, CYTOM PART A, V95A, P450, DOI 10.1002/cyto.a.23705
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Cotto B, 2019, PROG NEUROBIOL, V181, P0, DOI 10.1016/j.pneurobio.2019.101616
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Doherty Edward, 2017, REACT OXYG SPECIES (APEX), V4, P275, DOI 10.20455/ros.2017.839
   Elhassan YS, 2019, CELL REP, V28, P1717, DOI 10.1016/j.celrep.2019.07.043
   Funes HA, 2014, J INFECT DIS, V210, P1385, DOI 10.1093/infdis/jiu273
   Gan SK, 2002, DIABETES, V51, P3163, DOI 10.2337/diabetes.51.11.3163
   Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577
   Grunfeld C, 2007, JAIDS-J ACQ IMM DEF, V46, P283, DOI 10.1097/QAI.0b013e31814b94e2
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hendrickson SL, 2009, JAIDS-J ACQ IMM DEF, V51, P111, DOI 10.1097/QAI.0b013e3181a324d6
   Holloway GP, 2018, CELL REP, V22, P2837, DOI 10.1016/j.celrep.2018.02.069
   Hulgan T, 2019, JAIDS-J ACQ IMM DEF, V80, PE95, DOI 10.1097/QAI.0000000000001930
   Jankowski CM, 2019, C RETR OPP INF BOST, V0, P0
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Martin AM, 2003, AM J HUM GENET, V72, P549, DOI 10.1086/367849
   Martinez-Arroyo O, 2019, ANTIVIR RES, V168, P36, DOI 10.1016/j.antiviral.2019.04.015
   McComsey GA, 2005, AIDS, V19, P15, DOI 10.1097/00002030-200501030-00002
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Payne BAI, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0084678
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Payne BA, 2015, ANTIVIR THER, V20, P109, DOI 10.3851/IMP2824
   Pyle A, 2010, INTENS CARE MED, V36, P956, DOI 10.1007/s00134-010-1823-7
   Ramamoorthy H, 2019, HUM EXP TOXICOL, V38, P288, DOI 10.1177/0960327118802619
   Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010
   Roca Bayerri C, 2016, MIT DNA DAM BRAIN AS, V0, P0
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   RONOT X, 1986, BIOL CELL, V57, P1
   Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018
   Samuels R, 2017, AIDS, V31, P1297, DOI 10.1097/QAD.0000000000001466
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   SINNWELL TM, 1995, J CLIN INVEST, V96, P126, DOI 10.1172/JCI118012
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Teodorof-Diedrich C, 2018, J VIROL, V92, P0, DOI 10.1128/JVI.00993-18
   Trenell MI, 2006, MUSCLE NERVE, V33, P524, DOI 10.1002/mus.20484
   Willingham TB, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.00689
   Younes SA, 2018, J CLIN INVEST, V128, P5083, DOI 10.1172/JCI120245
NR 53
TC 8
Z9 8
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1746-630X
EI 1746-6318
J9 CURR OPIN HIV AIDS
JI Curr. Opin. HIV AIDS
PD MAR 15
PY 2020
VL 15
IS 2
BP 101
EP 109
DI 10.1097/COH.0000000000000607
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA LB3HZ
UT WOS:000524529800004
PM 31789674
DA 2024-11-01
ER

PT J
AU Ma, L
   Mao, W
   Xu, EH
   Cai, YN
   Wang, CD
   Chhetri, JK
   Chan, P
AF Ma, Lin
   Mao, Wei
   Xu, Erhe
   Cai, Yanning
   Wang, Chaodong
   Chhetri, Jagadish K.
   Chan, Piu
TI Novel <i>POLG</i> mutation in a patient with early-onset parkinsonism, progressive external ophthalmoplegia and optic atrophy
SO INTERNATIONAL JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE POLG; parkinsonism; external ophthalmoplegia; optic atrophy
ID polymerase
AB Introduction: Mitochondrial DNA polymerase gamma (pol gamma) encoded by POLG plays an indispensable role in the process of mitochondrial DNA replication and repair. The mutation of POLG can result in mitochondrial dysfunction leading to a broad spectrum of disease. Methods: We report a 29-year-old Chinese female presented with levodopa-responsive parkinsonism, external ophthalmoplegia and optic atrophy. We conducted clinical, molecular iconographic, histological and genetic analyses on this patient. Results: Sequencing of the POLG gene revealed compound heterozygote mutations of a novel c.2693T > C (p.I898T) mutation in exon17 and c.2993C > T (p.S998L) in exon19. The mutation c.2693T > C (p.I898T) has never been reported. Also our patient's cardinal symptoms are rare and different from other cases which have been reported. Conclusion: This finding of ours has broadened the spectrum of phenotype caused by the mutation of POLG.
C1 [Ma, Lin; Mao, Wei; Xu, Erhe; Cai, Yanning; Wang, Chaodong; Chhetri, Jagadish K.; Chan, Piu] Capital Med Univ, Beijing Inst Brain Disorders, Dept Neurol Neurobiol & Geriatr, Xuanwu Hosp, Beijing, Peoples R China.
   [Chan, Piu] Capital Med Univ, Clin Ctr Parkinsons Dis, Beijing, Peoples R China.
   [Chan, Piu] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China.
   [Chan, Piu] Natl Clin Res Ctr Geriatr, Beijing, Peoples R China.
C3 Capital Medical University; Capital Medical University
RP Chan, P (corresponding author), 45 Changchun St, Beijing 100053, Peoples R China.
EM pbchan90@gmail.com
FU Beijing Municipal Administration of Hospitals' Mission Plan [SML20150803]; Beijing Municipal Science & Technology Commission [Z161100000216140, Z171100000117013]; Beijing Municipal commission of Health and Family Planning [PXM2018_026283_000002]
CR Bandettini di Poggio Monica, 2013, BMC MED GENET, V14, P105, DOI 10.1186/1471-2350-14-105
   Batabyal D, 2010, J BIOL CHEM, V285, P34191, DOI 10.1074/jbc.M110.156182
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Delgado-Alvarado M, 2015, J NEUROL SCI, V350, P93, DOI 10.1016/j.jns.2015.02.011
   Dolhun R, 2013, BMC NEUROL, V13, P0, DOI 10.1186/1471-2377-13-92
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Martikainen MH, 2010, BMJ CASE REP, V2010, P0
   Milone M, 2011, ARCH NEUROL-CHICAGO, V68, P806, DOI 10.1001/archneurol.2011.124
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
NR 10
TC 9
Z9 10
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0020-7454
EI 1563-5279
J9 INT J NEUROSCI
JI Int. J. Neurosci.
PD APR 2
PY 2020
VL 130
IS 4
BP 319
EP 321
DI 10.1080/00207454.2019.1681422
EA OCT 2019
PG 3
WC Neurosciences
SC Neurosciences & Neurology
GA KW6MO
UT WOS:000494993800001
PM 31613174
DA 2024-11-01
ER

PT J
AU Tawk, A
   HusseinKamarreddine, M
   Dagher, M
   Abboud, G
   Chams, M
   Ghandour-Hajj, F
   Khoury, M
   Farhat, S
AF Tawk, Antonios
   HusseinKamarreddine, Mohammed
   Dagher, Mona
   Abboud, Ghadi
   Chams, Mohamad
   Ghandour-Hajj, Fatmeh
   Khoury, Mounir
   Farhat, Said
TI Clinicopathology and Diagnosis Delay in a 40-Year-Old with Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
SO CASE REPORTS IN GASTROENTEROLOGY
LA English
DT Review
DE Mitochondrial neurogastrointestinal encephalomyopathy; Genetic mutation; Mitochondrial dysfunction; Gastroenterology; Neurogastroenterology
AB Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive and fatal multisystem metabolic disorder. It presents with wide-ranging gastrointestinal and neurologic symptoms. It is caused by a mutation in the TYMP gene which impairs thymidine phosphorylase (TP) activity, therefore leading to the accumulation of thymidine and deoxyuridine in plasma and tissues. Thus, MNGIE can be diagnosed by findings of high levels of thymidine and deoxyuridine. Herein, we present the case of a 40-year-old male who presented with diarrhea, vomiting, and abdominal pain, severe weight loss, neurologic deficits, and distal motor weakness progressing over a period of 13 years. The combination of this broad clinical picture along with results of magnetic resonance imaging, electromyography, colonic biopsies, genetic testing, and elevated plasma and tissue thymidine and deoxyuridine levels confirmed the diagnosis of MNGIE. TYMP gene mutation impairs TP function. TP mutations in the nuclear DNA lead to mitochondrial DNA deletions causing mitochondrial failure and ultimately cell death. Treatment modalities are targeting the restoration of TP activity or aiming to decrease the high levels of thymidine and pyrimide. However, diagnosing this disease is still a challenge and often overdue. This patient's 13-year delay in diagnosis shows the importance of a complete neurological exam and muscle strength testing in patients with gastrointestinal symptoms. The diagnosis of MNGIE requires interdepartmental collaborative work for diagnosis delay prevention and for optimal patient care. (C) 2020 The Author(s) Published by S. Karger AG, Basel
C1 [Tawk, Antonios; HusseinKamarreddine, Mohammed; Dagher, Mona; Chams, Mohamad] Univ Balamand, Fac Med & Med Sci, Beirut, Lebanon.
   [Abboud, Ghadi] Univ Balamand, St George Hosp Univ, Dept Diagnost Radiol, Med Ctr, Beirut, Lebanon.
   [Ghandour-Hajj, Fatmeh] St George Hosp Univ, Dept Pathol, Med Ctr, Beirut, Lebanon.
   [Khoury, Mounir] St George Hosp Univ, Dept Neurol, Med Ctr, Beirut, Lebanon.
   [Farhat, Said] St George Hosp Univ, Dept Gastroenterol, Med Ctr, Beirut 1100, Lebanon.
C3 University Balamand; University Balamand
RP Farhat, S (corresponding author), St George Hosp Univ, Dept Gastroenterol, Med Ctr, Beirut 1100, Lebanon.
EM saidfarhat@hotmail.com
CR Baris Z, 2010, EUR J PEDIATR, V169, P1375, DOI 10.1007/s00431-010-1237-0
   Etienne G, 2012, TRANSL NEUROSCI, V3, P413, DOI 10.2478/s13380-012-0042-9
   Filosto M, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7110389
   Filosto M, 2011, J INHERIT METAB DIS, V34, P1199, DOI 10.1007/s10545-011-9332-6
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   Laforce R, 2009, CLIN NEUROL NEUROSUR, V111, P691, DOI 10.1016/j.clineuro.2009.05.005
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Orphanet, 2019, ORPHANET REPORT SERI, V1, P0
   Pacitti D, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00669
   Patel R, 2019, BMC GASTROENTEROL, V19, P0, DOI 10.1186/s12876-018-0925-5
   Scarpelli M, 2011, CASE REP NEUROL, V4, P248, DOI 10.1159/000346260
   Szigeti K, 2004, J MED GENET, V41, P125, DOI 10.1136/jmg.2003.013789
NR 15
TC 4
Z9 5
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 
EI 1662-0631
J9 CASE REP GASTROENTER
JI Case Rep. Gastroenterol.
PD JAN-APR 15
PY 2020
VL 14
IS 1
BP 124
EP 130
DI 10.1159/000506187
PG 7
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA VK7DU
UT WOS:000744668500018
PM 32355481
DA 2024-11-01
ER

PT J
AU Joshi, PR
   Baty, K
   Hopton, S
   Cordts, I
   Falkous, G
   Schoser, B
   Blakely, EL
   Taylor, RW
   Deschauer, M
AF Joshi, Pushpa Raj
   Baty, Karen
   Hopton, Sila
   Cordts, Isabell
   Falkous, Gavin
   Schoser, Benedikt
   Blakely, Emma L.
   Taylor, Robert W.
   Deschauer, Marcus
TI Progressive external ophthalmoplegia due to a recurrent <i>de novo</i> m.15990C&gt;T <i>MT</i>-<i>TP</i> (mt-tRNA<SUP>Pro</SUP>) gene variant
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondria; Progressive external ophthalmoplegia; tRNA Pro; Pathogenicity; de novo mutation
ID point mutations; mitochondrial
AB Progressive external ophthalmoplegia is typically associated with single or multiple mtDNA deletions but occasionally mtDNA single nucleotide variants within mitochondrial transfer RNAs (mt-tRNAs) are identified. We report a 34-year-old female sporadic patient with progressive external ophthalmoplegia accompanied by exercise intolerance but neither fixed weakness nor multisystemic involvement. Histopathologically, abundant COX-deficient fibres were present in muscle with immunofluorescence analysis confirming the loss of mitochondrial complex I and IV proteins. Molecular genetic analysis identified a rare heteroplasmic m.15990C >T mt-tRNA(Pro) variant reported previously in a single patient with childhood-onset myopathy. The variant in our patient was restricted to muscle. Single muscle fibre analysis identified higher heteroplasmy load in COX-deficient fibres than COX-normal fibres, confirming segregation of high heteroplasmic load with a biochemical defect. Our case highlights the phenotypic variability typically observed with pathogenic mt-tRNA mutations, whilst the identification of a second case with the m.15990C >T mutation not only confirms pathogenicity but shows that de novo mt-tRNA point mutations can arise in multiple, unrelated patients. (C) 2020 The Authors. Published by Elsevier B.V.
C1 [Joshi, Pushpa Raj] Martin Luther Univ Halle Wittenberg, Dept Neurol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.
   [Baty, Karen; Hopton, Sila; Falkous, Gavin; Blakely, Emma L.; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Baty, Karen; Hopton, Sila; Falkous, Gavin; Blakely, Emma L.; Taylor, Robert W.] Newcastle Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
   [Cordts, Isabell; Deschauer, Marcus] Tech Univ Munich, Sch Med, Dept Neurol, Munich, Germany.
   [Schoser, Benedikt] Univ Munich, Dept Neurol, Friedrich Baur Inst, Munich, Germany.
   [Taylor, Robert W.] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Martin Luther University Halle Wittenberg; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Technical University of Munich; University of Munich; Newcastle University - UK
RP Joshi, PR (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Neurol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.
EM pushpa.joshi@medizin.uni-halle.de
FU German Federal Ministry of Education and Research (BMBF); Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease; Mitochondrial Disease Patient Cohort (UK) [G0800674]; Newcastle University Centre for Ageing and Vitality (Biotechnology and Biological Sciences Research Council); Newcastle University Centre for Ageing and Vitality (Medical Research Council) [L016354]; UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; Lily Foundation; UK NHS; MRC [G0800674] Funding Source: UKRI
CR Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   Hardy SA, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000082
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   Nesbitt V, 2012, DEV MED CHILD NEUROL, V54, P500, DOI 10.1111/j.1469-8749.2012.04224.x
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665
   Rocha MC, 2015, SCI REP, V5, P15
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Seneca S, 2000, J INHERIT METAB DIS, V23, P853, DOI 10.1023/A:1026729223050
   Cardena MMSG, 2013, MITOCHONDR DNA, V24, P46, DOI 10.3109/19401736.2012.717933
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
   Wong LJC, 2002, CLIN CHEM, V48, P1901
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Zierz CM, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8060789
NR 25
TC 2
Z9 3
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR 15
PY 2020
VL 30
IS 4
BP 346
EP 350
DI 10.1016/j.nmd.2020.02.020
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA LO4QN
UT WOS:000533614400013
PM 32305257
DA 2024-11-01
ER

PT J
AU Napoli, E
   McLennan, YA
   Schneider, A
   Tassone, F
   Hagerman, RJ
   Giulivi, C
AF Napoli, Eleonora
   McLennan, Yingratana Amabel
   Schneider, Andrea
   Tassone, Flora
   Hagerman, Randi J.
   Giulivi, Cecilia
TI Characterization of the Metabolic, Clinical and Neuropsychological Phenotype of Female Carriers of the Premutation in the X-Linked <i>FMR1</i> Gene
SO FRONTIERS IN MOLECULAR BIOSCIENCES
LA English
DT Article
DE mitochondrial dysfunction; omics; cellular response to stress; oxidative phosphorylation; glycolysis; fragile X-associated primary ovarian insufficiency; fragile X-associated tremor and ataxia syndrome
ID premature ovarian failure; ubiquitin-proteasome system; mitochondrial-dna mutations; respiratory-chain activity; fragile-x; tremor/ataxia syndrome; alzheimers-disease; glucose-metabolism; expanded alleles; skeletal-muscle
AB The X-linked FMR1 premutation (PM) is characterized by a 55-200 CGG triplet expansion in the 5'-untranslated region (UTR). Carriers of the PM were originally thought to be asymptomatic; however, they may present general neuropsychiatric manifestations including learning disabilities, depression and anxiety, among others. With age, both sexes may also develop the neurodegenerative disease fragile X-associated tremor/ataxia syndrome (FXTAS). Among carriers, females are at higher risk for developing immune disorders, hypertension, seizures, endocrine disorders and chronic pain, among others. Some female carriers younger than 40 years old may develop fragile X-associated primary ovarian insufficiency (FXPOI). To date, no studies have addressed the metabolic footprint - that includes mitochondrial metabolism - of female carriers and its link to clinical/cognitive manifestations. To this end, we performed a comprehensive biochemical assessment of 42 female carriers (24-70 years old) compared to sex-matched non-carriers. By applying a multivariable correlation matrix, a generalized bioenergetics impairment was correlated with diagnoses of the PM, FXTAS and its severity, FXPOI and anxiety. Intellectual deficits were strongly correlated with both mitochondrial dysfunction and with CGG repeat length. A combined multi-omics approach identified a down-regulation of RNA and mRNA metabolism, translation, carbon and protein metabolism, unfolded protein response, and up-regulation of glycolysis and antioxidant response. The suboptimal activation of the unfolded protein response (UPR) and endoplasmic-reticulum-associated protein degradation (ERAD) response challenges and further compromises the PM genetic background to withstand other, more severe forms of stress. Mechanistically, some of the deficits were linked to an altered protein expression due to decreased protein translation, but others seemed secondary to oxidative stress originated from the accumulation of either toxic mRNA or RAN-derived protein products or as a result of a direct toxicity of accumulated metabolites from deficiencies in critical enzymes.
C1 [Napoli, Eleonora; Giulivi, Cecilia] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.
   [McLennan, Yingratana Amabel; Schneider, Andrea; Tassone, Flora; Hagerman, Randi J.; Giulivi, Cecilia] Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA.
   [Schneider, Andrea; Hagerman, Randi J.] Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA.
   [Tassone, Flora] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA.
C3 University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis
RP Giulivi, C (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.; Giulivi, C (corresponding author), Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA.
EM cgiulivi@ucdavis.edu
FU National Institutes of Health [HD036071]; MIND Institute Intellectual and Developmental Disabilities Research Center [U54 HD079125]; Health and Human Administration of Developmental Disabilities [90DD0596, UL1 TR001860]
CR Allen EG, 2007, HUM REPROD, V22, P2142, DOI 10.1093/humrep/dem148
   Allen EG, 2020, GENET MED, V22, P758, DOI 10.1038/s41436-019-0733-5
   Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B
   Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799
   Bagni C, 2012, J CLIN INVEST, V122, P4314, DOI 10.1172/JCI63141
   Bailey DB, 2008, AM J MED GENET A, V146A, P2060, DOI 10.1002/ajmg.a.32439
   Belanger HG, 2005, ARCH CLIN NEUROPSYCH, V20, P183, DOI 10.1016/j.acn.2004.05.003
   Bennett CE, 2010, HUM REPROD, V25, P1335, DOI 10.1093/humrep/deq058
   Berry-Kravis E, 2005, ANN NEUROL, V57, P144, DOI 10.1002/ana.20360
   Berry-Kravis E, 2003, ANN NEUROL, V53, P616, DOI 10.1002/ana.10522
   Berry-Kravis E, 2007, MOVEMENT DISORD, V22, P2018, DOI 10.1002/mds.21493
   Berry-Kravis E, 2007, AM J MED GENET A, V143A, P19, DOI 10.1002/ajmg.a.31559
   Besterman AD, 2014, FUTUR NEUROL, V9, P227, DOI 10.2217/FNL.14.11
   Biase FH, 2017, OMICS, V21, P156, DOI 10.1089/omi.2016.0177
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Boffoli D, 1996, BBA-MOL BASIS DIS, V1315, P66, DOI 10.1016/0925-4439(95)00107-7
   Bourgeois JA, 2007, GEN HOSP PSYCHIAT, V29, P349, DOI 10.1016/j.genhosppsych.2007.03.003
   Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791
   BURCH HB, 1963, J BIOL CHEM, V238, P2267
   Burgin HJ, 2020, FEBS LETT, V594, P590, DOI 10.1002/1873-3468.13735
   BYRNE E, 1991, REV NEUROL, V147, P532
   Cagnetta G, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep22925
   Capková M, 2002, INT J OBESITY, V26, P1110, DOI 10.1038/sj.ijo.0802055
   CARDELLACH F, 1989, LANCET, V2, P44
   Chiaravalloti A, 2015, NUCL MED COMMUN, V36, P461, DOI 10.1097/MNM.0000000000000272
   Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8
   Claeys T, 2020, ACTA NEUROL BELG, V120, P181, DOI 10.1007/s13760-019-01237-w
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Demain LAM, 2017, CLIN GENET, V91, P199, DOI 10.1111/cge.12896
   Dioguardi CC, 2016, MOL HUM REPROD, V22, P384, DOI 10.1093/molehr/gaw023
   Drozdick LW, 2012, CONTEMPORARY INTELLECTUAL ASSESSMENT: THEORIES, V0, P0
   Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8
   El Shourbagy SH, 2006, REPRODUCTION, V131, P233, DOI 10.1530/rep.1.00551
   Elizur SE, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0105121
   Elustondo P, 2017, BBA-MOL CELL BIOL L, V1862, P90, DOI 10.1016/j.bbalip.2016.08.012
   Ennis S, 2006, EUR J HUM GENET, V14, P253, DOI 10.1038/sj.ejhg.5201510
   Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101
   Firk C, 2009, CLIN NUTR, V28, P266, DOI 10.1016/j.clnu.2009.03.002
   Fitzsimons PE, 2018, AM J MED GENET A, V176, P1115, DOI 10.1002/ajmg.a.38658
   Freeman FM, 2000, PHARMACOL BIOCHEM BE, V67, P355, DOI 10.1016/S0091-3057(00)00373-7
   FRIEDLAND RP, 1983, J COMPUT ASSIST TOMO, V7, P590, DOI 10.1097/00004728-198308000-00003
   Giulivi C, 2016, FRONT MOL NEUROSCI, V9, P0, DOI 10.3389/fnmol.2016.00071
   Giulivi C, 2013, MEDIAT INFLAMM, V2013, P0, DOI 10.1155/2013/609602
   Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706
   Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296
   Hagerman R, 2013, LANCET NEUROL, V12, P786, DOI 10.1016/S1474-4422(13)70125-X
   Hagerman RJ, 2008, CLIN INTERV AGING, V3, P251, DOI 10.2147/CIA.S1794
   Hagerman RJ, 2018, FRONT PSYCHIATRY, V9, P0, DOI 10.3389/fpsyt.2018.00564
   Hagerman RJ, 2016, NAT REV NEUROL, V12, P403, DOI 10.1038/nrneurol.2016.82
   Hagerman RJ, 2004, AM J HUM GENET, V74, P1051, DOI 10.1086/420700
   Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127
   Höglund E, 2017, BRIT J NUTR, V117, P1351, DOI 10.1017/S0007114517001428
   Hunter JE, 2010, CLIN GENET, V77, P374, DOI 10.1111/j.1399-0004.2009.01317.x
   Hyder F, 2013, P NATL ACAD SCI USA, V110, P3549, DOI 10.1073/pnas.1214912110
   Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321
   Jenkins TA, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8010056
   JOHNSON BD, 1993, NEURON, V10, P797, DOI 10.1016/0896-6273(93)90196-X
   Karimov CB, 2011, HUM REPROD, V26, P2077, DOI 10.1093/humrep/der168
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299
   Lozano R, 2016, CEREBELLUM, V15, P587, DOI 10.1007/s12311-016-0805-x
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Mendelson WB, 2001, NEUROPSYCHOPHARMACOL, V25, PS36, DOI 10.1016/S0893-133X(01)00341-4
   Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114
   Mosconi L, 2006, J NUCL MED, V47, P1778
   Movaghar A, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aaw7195
   MULLERHOCKER J, 1992, BRAIN PATHOL, V2, P149, DOI 10.1111/j.1750-3639.1992.tb00683.x
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   Murray A, 2014, GENET MED, V16, P19, DOI 10.1038/gim.2013.64
   Napoli E, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00338
   Napoli E, 2016, CEREBELLUM, V15, P552, DOI 10.1007/s12311-016-0779-8
   Napoli E, 2016, FASEB J, V30, P3334, DOI 10.1096/fj.201600315R
   Napoli E, 2015, J BIOL CHEM, V290, P23240, DOI 10.1074/jbc.M115.672360
   Napoli E, 2013, HUM MOL GENET, V22, P989, DOI 10.1093/hmg/dds503
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Ossenkoppele R, 2013, NEUROLOGY, V80, P359, DOI 10.1212/WNL.0b013e31827f0889
   Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1
   Pastore LM, 2012, REPROD SCI, V19, P1226, DOI 10.1177/1933719112446074
   Patsalis PC, 1999, AM J MED GENET, V84, P195, DOI 10.1002/(SICI)1096-8628(19990528)84:3<195::AID-AJMG4>3.0.CO;2-1
   Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236
   Pouresmaeili F, 2014, INT J FERTIL STERIL, V8, P1
   Quiles JL, 2002, J BIOENERG BIOMEMBR, V34, P517, DOI 10.1023/A:1022530512096
   Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202
   Reynier P, 2001, MOL HUM REPROD, V7, P425, DOI 10.1093/molehr/7.5.425
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   Rifé M, 2004, AM J MED GENET A, V124A, P129, DOI 10.1002/ajmg.a.20342
   Sakai C, 2015, HUM MUTAT, V36, P232, DOI 10.1002/humu.22730
   Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Schuettler J, 2011, HUM REPROD, V26, P1241, DOI 10.1093/humrep/der018
   SCHWARTZ CE, 1994, AM J MED GENET, V51, P400, DOI 10.1002/ajmg.1320510419
   SKUDER P, 1995, INTELLIGENCE, V21, P1, DOI 10.1016/0160-2896(95)90035-7
   SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942
   Song G, 2016, MOL MED, V22, P548, DOI 10.2119/molmed.2016.00122
   Streuli I, 2009, FERTIL STERIL, V92, P464, DOI 10.1016/j.fertnstert.2008.07.007
   Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, PD607, DOI 10.1093/nar/gky1131
   Tassone F, 1999, AM J MED GENET, V84, P250, DOI 10.1002/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.0.CO;2-4
   Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073
   Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122
   Terracciano A, 2004, EUR J HUM GENET, V12, P333, DOI 10.1038/sj.ejhg.5201154
   Tiosano D, 2019, ENDOCRINOLOGY, V160, P2353, DOI 10.1210/en.2019-00441
   TORII K, 1992, AM J RESP CELL MOL, V6, P88, DOI 10.1165/ajrcmb/6.1.88
   Torres S, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.01168
   Valera AG, 2005, NEUROSCIENTIST, V11, P583, DOI 10.1177/1073858405280639
   VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H
   Voorhuis M, 2014, HUM REPROD, V29, P1585, DOI 10.1093/humrep/deu095
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wallace DC, 1995, LIFE SCI R, V56, P199
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wang LY, 2009, J ZHEJIANG UNIV-SC B, V10, P483, DOI 10.1631/jzus.B0820379
   Watts ME, 2018, FRONT MOL NEUROSCI, V11, P0, DOI 10.3389/fnmol.2018.00216
   Wheeler AC, 2014, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00300
   Wheeler AC, 2014, J NEURODEV DISORD, V6, P0, DOI 10.1186/1866-1955-6-30
   Winarni TI, 2012, AM J MED GENET A, V158A, P2473, DOI 10.1002/ajmg.a.35569
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5
   Zini R, 2002, LIFE SCI, V71, P3091, DOI 10.1016/S0024-3205(02)02161-6
NR 120
TC 12
Z9 12
U1 2
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 2296-889X
J9 FRONT MOL BIOSCI
JI Front. Mol. Biosci.
PD OCT 22
PY 2020
VL 7
IS 
BP 
EP 
DI 10.3389/fmolb.2020.578640
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA OL2TS
UT WOS:000585195400001
PM 33195422
DA 2024-11-01
ER

PT J
AU Hu, CP
   Li, XH
   Zhao, L
   Shi, YY
   Zhou, SZ
   Wang, Y
AF Hu, Chaoping
   Li, Xihua
   Zhao, Lei
   Shi, Yiyun
   Zhou, Shuizhen
   Wang, Yi
TI Clinical Profile and Outcome of Pediatric Mitochondrial Myopathy in China
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE mitochondrial myopathy; gene mutation; treatment; cytochrome-c oxidase; pathology
ID respiratory insufficiency; trna(leu(uur)) mutation; diagnosis; disease; genome; cohort
AB Introduction: Mitochondrial myopathy in children has notable clinical and genetic heterogeneity, but detailed data is lacking. Patients and Methods: In this study, we retrospectively reviewed the clinical presentation, laboratory investigation, genetic and histopathological characteristics, and follow-ups of 21 pediatric mitochondrial myopathy cases from China. Results: Twenty-four patients suspected with mitochondrial myopathy were enrolled initially and 21 were genetically identified. Fourteen patients were found to harbor mitochondrial DNA point mutations (14/21, 66.7%), including m.3243A>G (9/15, 60%), m.3303C>T (2/15, 13.3%), m.3302A>G (1/15, 6.7%), m.3250T>C (1/15, 6.7%), m.3251A>G (1/15, 6.7%), of whom 12 patients presented with progressive proximal mitochondrial myopathy (12/14, 85.7%). Three patients revealed large-scale deletion in blood or muscle tissue (3/21, 14.3%), presenting with Kearns-Sayer syndrome (1/3, 33.3%) or chronic progressive external ophthalmoplegia (2/3, 66.7%). Four patients were found to harbor pathogenic nuclear gene variants (4/21, 19.0%), including five variants in TK2 gene and two variants in SURF1 gene. During the follow-ups up to 7 years, 10 patients developed cardiomyopathy (10/21, 47.6%), 13 patients occurred at least once hypercapnic respiratory failure (13/21, 61.9%), six experienced recurrent respiratory failure and intubation (6/21, 28.6%), eight patients failed to survive (8/21, 38.1%). With nocturnal non-invasive ventilation of BiPAP, three patients recovered from respiratory failure, and led a relative stable and functional life (3/21, 14.3%). Conclusion: Mitochondrial myopathy in children has great clinical, pathological, and genetical heterogeneity. Progressive proximal myopathy is most prevalent. Mitochondrial DNA point mutations are most common. And respiratory failure is a critical risk factor of poor prognosis.
C1 [Hu, Chaoping; Li, Xihua; Zhao, Lei; Shi, Yiyun; Zhou, Shuizhen; Wang, Yi] Fudan Univ, Childrens Hosp, Neurol Dept, Shanghai, Peoples R China.
C3 Fudan University
RP Li, XH; Wang, Y (corresponding author), Fudan Univ, Childrens Hosp, Neurol Dept, Shanghai, Peoples R China.
EM xihual@vip.sina.com; yiwang@shmu.edu.cn
CR Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Avula S, 2014, CURR TREAT OPTION NE, V16, P0, DOI 10.1007/s11940-014-0292-7
   Ballhausen D, 2010, J INHERIT METAB DIS, V33, PS219, DOI 10.1007/s10545-010-9098-2
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Bruno C, 2003, J CHILD NEUROL, V18, P300, DOI 10.1177/08830738030180040401
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P425, DOI 10.1164/ajrccm.164.3.2005110
   Garone C, 2018, BIOCHEM SOC T, V46, P1247, DOI 10.1042/BST20180134
   Hardy SA, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000082
   Houshmand M, 1996, HUM GENET, V97, P269, DOI 10.1007/BF02185750
   Hu CP, 2020, EUR J MED GENET, V63, P0, DOI 10.1016/j.ejmg.2020.103898
   Koo P, 2018, CLIN CHEST MED, V39, P401, DOI 10.1016/j.ccm.2018.02.001
   Lee IC, 2012, HUM MUTAT, V33, P1192, DOI 10.1002/humu.22095
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   Naddaf E, 2017, MUSCLE NERVE, V56, P881, DOI 10.1002/mus.25602
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ogle RF, 1997, J PEDIATR-US, V130, P138, DOI 10.1016/S0022-3476(97)70323-8
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   SWEENEY MG, 1993, Q J MED, V86, P709
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zhou Y, 2018, INT J NEUROSCI, V128, P231, DOI 10.1080/00207454.2017.1387113
NR 27
TC 5
Z9 5
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD SEP 8
PY 2020
VL 11
IS 
BP 
EP 
DI 10.3389/fneur.2020.01000
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA NV7CQ
UT WOS:000574475100001
PM 33013660
DA 2024-11-01
ER

PT J
AU Vecoli, C
   Borghini, A
   Andreassi, MG
AF Vecoli, Cecilia
   Borghini, Andrea
   Andreassi, Maria Grazia
TI The molecular biomarkers of vascular aging and atherosclerosis: telomere length and mitochondrial DNA<SUP>4977</SUP> common deletion
SO MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
LA English
DT Review
DE Telomere length; mtDNA(4977) common deletion; Mitochondria] damage; Aging; Coronary artery disease
ID smooth-muscle-cells; 4977 bp deletion; dna copy number; cardiovascular-disease; oxidative stress; damage; dysfunction; heart; association; mechanisms
AB Age is the dominant risk factor for the most prevalent atherosclerotic vascular diseases, including coronary artery disease, myocardial infarction, cerebrovascular disease and stroke. In human, telomere erosion and mitochondrial DNA (mtDNA) damage play a central role in the mechanisms leading to cellular aging decline. This review summarizes the most relevant findings on the role of telomere shortening and the common mtDNA(4977) deletion in the progression and evolution of atherosclerosis by combining insight from experimental models and human clinical studies. The current evidence shows a link between telomere erosion and compromised mitochondrial function and provides a new perspective regarding their potential role as clinical biomarkers and therapeutic targets. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Vecoli, Cecilia; Borghini, Andrea; Andreassi, Maria Grazia] CNR, Inst Clin Physiol, Via Moruzzi 1, I-56124 Pisa, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)
RP Vecoli, C (corresponding author), CNR, Inst Clin Physiol, Via Moruzzi 1, I-56124 Pisa, Italy.
EM vecoli@ifc.cnr.it
FU National Research Council (CNR) grant, Progetto di Interesse "Invecchiamento"
CR Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372
   Ait-Aissa K, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-43761-y
   Ait-Aissa K, 2016, PHARMACOL RES, V111, P422, DOI 10.1016/j.phrs.2016.07.003
   Aliev Gjumrakch, 2011, RECENT PAT CARDIOVASC DRUG DISCOV, V6, P222
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreassi MG, 2008, J MOL MED, V86, P1033, DOI 10.1007/s00109-008-0358-7
   Arai T, 2003, AGING CLIN EXP RES, V15, P1
   Bär C, 2015, HAEMATOLOGICA, V100, P1267, DOI 10.3324/haematol.2015.129239
   Bär C, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6863
   Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Bar Christian, 2016, F1000RES, V5, P0, DOI 10.12688/f1000research.7020.1
   Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021
   de Jesus BB, 2011, AGING CELL, V10, P604, DOI 10.1111/j.1474-9726.2011.00700.x
   Beyer AM, 2016, CIRC RES, V118, P856, DOI 10.1161/CIRCRESAHA.115.307918
   Bogliolo M, 1999, MUTAGENESIS, V14, P77, DOI 10.1093/mutage/14.1.77
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1821-7
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373
   Calado RT, 2009, BLOOD, V114, P2236, DOI 10.1182/blood-2008-09-178871
   Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   DMello MJJ, 2015, CIRC-CARDIOVASC GENE, V8, P82, DOI 10.1161/CIRCGENETICS.113.000485
   Dabrowska A, 2015, AGING-US, V7, P629, DOI 10.18632/aging.100790
   De Meyer T, 2009, EUR HEART J, V30, P3074, DOI 10.1093/eurheartj/ehp324
   Dow CT, 2016, CLIN OPHTHALMOL, V10, P243, DOI 10.2147/OPTH.S100042
   Epel E, 2012, CANCER PREV RES, V5, P1163, DOI 10.1158/1940-6207.CAPR-12-0370
   Epel ES, 2009, AGING-US, V1, P81
   Fang EF, 2016, NAT REV MOL CELL BIO, V17, P308, DOI 10.1038/nrm.2016.14
   Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026
   FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491
   Fernández-Alvira JM, 2016, J AM COLL CARDIOL, V67, P2467, DOI 10.1016/j.jacc.2016.03.530
   Fyhrquist F, 2013, NAT REV CARDIOL, V10, P274, DOI 10.1038/nrcardio.2013.30
   Germano G, 2012, EUR HEART J, V33, P137
   Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376
   Gonzalez-Ebsen AC, 2017, FRONT BIOSCI-LANDMRK, V22, P117, DOI 10.2741/4475
   Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546
   Hammadah M, 2017, CIRC RES, V120, P1130, DOI 10.1161/CIRCRESAHA.116.309421
   Hao SY, 2015, MOLECULES, V20, P21287, DOI 10.3390/molecules201219764
   Harley CB, 2011, REJUV RES, V14, P45, DOI 10.1089/rej.2010.1085
   Haycock PC, 2014, BMJ-BRIT MED J, V349, P0, DOI 10.1136/bmj.g4227
   Iannilli F, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0066602
   Izzotti A, 2007, MUTAT RES-FUND MOL M, V621, P119, DOI 10.1016/j.mrfmmm.2006.12.012
   Kang YH, 2018, CELL REP, V22, P3493, DOI 10.1016/j.celrep.2018.02.071
   Kelly DP, 2011, NATURE, V470, P342, DOI 10.1038/nature09896
   Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895
   Knight-Lozano CA, 2002, CIRCULATION, V105, P849, DOI 10.1161/hc0702.103977
   Kong CM, 2013, FEBS J, V280, P3180, DOI 10.1111/febs.12326
   Kuznetsova T, 2017, ADV EXP MED BIOL, V982, P347, DOI 10.1007/978-3-319-55330-6_19
   Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705
   Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146
   Lin J, 2012, MUTAT RES-FUND MOL M, V730, P85, DOI 10.1016/j.mrfmmm.2011.08.003
   Liu HY, 2019, NUCLEIC ACIDS RES, V47, P8084, DOI 10.1093/nar/gkz584
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Makino N, 2011, J MOL CELL CARDIOL, V50, P670, DOI 10.1016/j.yjmcc.2010.12.014
   Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1749, DOI 10.1093/ije/dyv171
   Masi S, 2014, EUR HEART J, V35, P3296, DOI 10.1093/eurheartj/ehu226
   Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mercer JR, 2012, FREE RADICAL BIO MED, V52, P841, DOI 10.1016/j.freeradbiomed.2011.11.026
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   National Institute on Aging National Institute of Health World Health Organisation, 2011, NIH PUBLICATION NUMBER, V0, P11
   Okuda K, 2000, ATHEROSCLEROSIS, V152, P391, DOI 10.1016/S0021-9150(99)00482-7
   Passos JF, 2005, EXP GERONTOL, V40, P466, DOI 10.1016/j.exger.2005.04.006
   Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005
   PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818
   Rehkopf DH, 2016, PLOS MED, V13, P0, DOI 10.1371/journal.pmed.1002188
   Richardson GD, 2012, FASEB J, V26, P4832, DOI 10.1096/fj.12-208843
   Rosenthal RA, 2011, ANTI-CANCER AGENT ME, V11, P359
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Sabatino L, 2013, ENVIRON MOL MUTAGEN, V54, P299, DOI 10.1002/em.21783
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Salvador L, 2016, REJUV RES, V19, P478, DOI 10.1089/rej.2015.1793
   Shay JW, 2019, NAT REV GENET, V20, P299, DOI 10.1038/s41576-019-0099-1
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Sobenin IA, 2015, GERONTOLOGY, V61, P343, DOI 10.1159/000368923
   Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thompson RC, 2013, LANCET, V381, P1211, DOI 10.1016/S0140-6736(13)60598-X
   Tian R, 2017, MED SCI MONITOR, V23, P4382, DOI 10.12659/MSM.902106
   Toupance S, 2017, HYPERTENSION, V70, P420, DOI 10.1161/HYPERTENSIONAHA.117.09354
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Vecoli C, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20215508
   Vecoli C, 2018, ATHEROSCLEROSIS, V276, P91, DOI 10.1016/j.atherosclerosis.2018.07.015
   Vogel G, 2009, SCIENCE, V326, P212, DOI 10.1126/science.326_212
   Volobueva A, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9080377
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388
   Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502
   Wang XB, 2019, ATHEROSCLEROSIS, V284, P165, DOI 10.1016/j.atherosclerosis.2019.03.010
   Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005
   Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492
   Yang XY, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.00600
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Zhang YK, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/2876350
   Zheng Q, 2019, FRONT CELL DEV BIOL, V7, P0, DOI 10.3389/fcell.2019.00274
   Zhu XD, 2019, CIRC RES, V125, P707, DOI 10.1161/CIRCRESAHA.119.315529
NR 105
TC 26
Z9 26
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1383-5742
EI 1388-2139
J9 MUTAT RES-REV MUTAT
JI Mutat. Res.-Rev. Mutat. Res.
PD APR-JUN 15
PY 2020
VL 784
IS 
BP 
EP 
DI 10.1016/j.mrrev.2020.108309
PG 10
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA MC0IJ
UT WOS:000542981100005
PM 32430098
DA 2024-11-01
ER

PT J
AU González-Quintana, A
   Trujillo-Tiebas, MJ
   Fernández-Perrone, AL
   Blázquez, A
   Lucia, A
   Morán, M
   Ugalde, C
   Arenas, J
   Ayuso, C
   Martín, MA
AF Gonzalez-Quintana, Adrian
   Trujillo-Tiebas, Maria J.
   Fernandez-Perrone, Ana L.
   Blazquez, Alberto
   Lucia, Alejandro
   Moran, Maria
   Ugalde, Cristina
   Arenas, Joaquin
   Ayuso, Carmen
   Martin, Miguel A.
TI Uniparental isodisomy as a cause of mitochondrial complex I respiratory chain disorder due to a novel splicing NDUFS4 mutation
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondrial diseases; Mitochondrial complex I deficiency; NDUFS4; mitochondrial Supercomplexes; Uniparental Disomy; RNA splicing; Genetic counselling
ID leigh-syndrome; paternal isodisomy; disomy; patient; dna; chromosome-5; deficiency
AB Uniparental disomy (UPD) is an underestimated cause of autosomal recessive disorders. In this study, we aim to raise awareness about the possibility of UPD in mitochondrial disorders where it is a hardly described event-, by functionally characterizing a novel variant in a structural subunit of complex I (CI) of the mitochondrial oxidative phosphorylation system. Using next-generation sequencing, we identified a new intronic homozygous c.350 + 5G > A variant in the NDUFS4 gene in a one-year-old girl (being alive at the age of 7) belonging to a non-consanguineous family presenting with encephalopathy, psychomotor delay, lactic acidosis and a single CI deficiency, a less severe phenotype than those previously reported in most NDUFS4 patients. One parent lacked the variant, and microsatellite genotyping showed complete paternal uniparental isodisomy of the non-imprinted chromosome 5. We demonstrated in patient's skeletal muscle and fibroblasts splicing abnormalities, low expression of NDUFS4, undetectable NDUFS4 protein, defects in cellular respiration (decreased oxygen consumption and ATP production), and impaired assembly or stability of mitochondrial supercomplexes containing CI. Our findings support that c.350 + 5G > A variant is pathogenic, and reinforce that UPD, although rare, should be considered as a possible cause of mitochondrial diseases in order to provide accurate genetic counselling.
C1 [Gonzalez-Quintana, Adrian; Blazquez, Alberto; Moran, Maria; Ugalde, Cristina; Arenas, Joaquin; Martin, Miguel A.] Hosp Univ 12 Octubre, Mitochondrial Dis Lab, Madrid, Spain.
   [Gonzalez-Quintana, Adrian; Trujillo-Tiebas, Maria J.; Blazquez, Alberto; Moran, Maria; Ugalde, Cristina; Arenas, Joaquin; Ayuso, Carmen; Martin, Miguel A.] Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain.
   [Trujillo-Tiebas, Maria J.] UAM, Dept Genet, IIS Fdn Jimenez Diaz Univ Hosp, IIS FJD, Madrid, Spain.
   [Fernandez-Perrone, Ana L.] Hosp Quironsalud, Pediat Neurol Dept, Madrid, Spain.
   [Blazquez, Alberto; Lucia, Alejandro; Moran, Maria; Ugalde, Cristina; Arenas, Joaquin; Ayuso, Carmen; Martin, Miguel A.] Inst Invest Sanitaria Hosp 12 Octubre Imas12, Madrid, Spain.
   [Lucia, Alejandro] Univ Europea Madrid, Fac Sport Sci, Madrid, Spain.
   [Lucia, Alejandro] Ctr Biomed Res Network Frailty & Hlth Aging CIBER, Madrid, Spain.
C3 Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Madrid; Fundacion Jimenez Diaz; quironsalud Group; European University of Madrid
RP Martín, MA (corresponding author), Hosp Univ 12 Octubre, Dept Clin Biochem, Mitochondrial Dis Lab, Madrid, Spain.
EM mamcasanueva.imas12@h12o.es
FU Spanish Instituto de Salud Carlos III (ISCIII)-ERDF grants [PI18/01374, PI18/00139]; RAREGENOMICS - Education Council, Comunidad de Madrid, Spain [B2017/BMD-3721]; AEPMI/FACDM Spanish mitochondrial patient's associations
CR Bravo-Alonso I, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8111811
   Bris C, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000205
   BRZUSTOWICZ LM, 1994, AM J HUM GENET, V54, P482
   Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446
   Daniels EG, 2019, CSH MOL CASE STUD, V5, P0, DOI 10.1101/mcs.a004457
   Ortigoza-Escobar JD, 2016, MITOCHONDRION, V28, P73, DOI 10.1016/j.mito.2016.04.001
   del Gaudio D, 2020, GENET MED, V22, P1133, DOI 10.1038/s41436-020-0782-9
   Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094
   Douglas GV, 2011, J HUM GENET, V56, P834, DOI 10.1038/jhg.2011.112
   Engel E, 2006, EUR J HUM GENET, V14, P1158, DOI 10.1038/sj.ejhg.5201619
   Erger F, 2018, EUR J HUM GENET, V26, P1392, DOI 10.1038/s41431-018-0195-2
   Fujita A, 2013, AM J MED GENET A, V161, P1904, DOI 10.1002/ajmg.a.36026
   Haudry C, 2012, MOL GENET METAB, V107, P700, DOI 10.1016/j.ymgme.2012.10.008
   Hoppman N, 2018, GENET MED, V20, P1522, DOI 10.1038/gim.2018.24
   Lamont RE, 2017, AM J MED GENET A, V173, P596, DOI 10.1002/ajmg.a.37983
   Lin SP, 2007, ARCH DERMATOL RES, V299, P145, DOI 10.1007/s00403-007-0751-z
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   García MM, 2014, AM J MED GENET A, V164, P1075, DOI 10.1002/ajmg.a.36378
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Morán M, 2010, BBA-MOL BASIS DIS, V1802, P443, DOI 10.1016/j.bbadis.2010.02.001
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Nogueira C, 2013, MOL GENET METAB, V110, P493, DOI 10.1016/j.ymgme.2013.09.010
   Numata S, 2014, J INVEST DERMATOL, V134, P849, DOI 10.1038/jid.2013.398
   Reittinger AM, 2017, AM J MED GENET A, V173, P2528, DOI 10.1002/ajmg.a.38344
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Robinson WP, 2000, BIOESSAYS, V22, P452
   Seal JL, 2006, J MED GENET, V43, P887, DOI 10.1136/jmg.2006.043380
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Tiranti V, 1999, J MED GENET, V36, P927
   Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071
   van Riesen AKJ, 2006, NEUROPEDIATRICS, V37, P88, DOI 10.1055/s-2006-924227
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, PW58, DOI 10.1093/nar/gkw233
NR 32
TC 9
Z9 9
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD NOV 15
PY 2020
VL 131
IS 3
BP 341
EP 348
DI 10.1016/j.ymgme.2020.10.008
PG 8
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA PG4PA
UT WOS:000599717700007
PM 33093004
DA 2024-11-01
ER

PT J
AU Ji, KQ
   Wang, W
   Lin, Y
   Xu, XB
   Liu, FC
   Wang, DD
   Zhao, YY
   Yan, CZ
AF Ji, Kunqian
   Wang, Wei
   Lin, Yan
   Xu, Xuebi
   Liu, Fuchen
   Wang, Dongdong
   Zhao, Yuying
   Yan, Chuanzhu
TI Mitochondrial encephalopathy Due to a Novel Pathogenic Mitochondrial tRNA<SUP>Gln</SUP> m.4349C&gt;T Variant
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID transfer-rna mutations; accurate; disease
AB Objective Mitochondrial diseases are a group of genetic diseases caused by mutations in mitochondrial DNA and nuclear DNA, among which, mutations in mitochondrial tRNA genes possessing prominent status. In most of the cases, however, the detailed molecular pathogenesis of these tRNA gene mutations remains unclear. Methods We performed the clinical emulation, muscle histochemistry, northern blotting analysis of tRNA levels, biochemical measurement of respiratory chain complex activities and mitochondrial respirations in muscle tissue and cybrid cells. Results We found a novel m.4349C>T mutation in mitochondrial tRNA(Gln)gene in a patient present with encephalopathy, epilepsy, and deafness. We demonstrated molecular pathomechanisms of this mutation. This mutation firstly disturbed the translation machinery of mitochondrial tRNA(Gln)and impaired mitochondrial respiratory chain complex activities, followed by remarkable mitochondrial dysfunction and ROS production. Interpretation. This study illustrated the pathogenicity of a novel m.4349C>T mutation and provided a better understanding of the phenotype associated with mutations in mitochondrial tRNA(Gln)gene.
C1 [Ji, Kunqian; Wang, Wei; Lin, Yan; Xu, Xuebi; Wang, Dongdong; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Res Inst Neuromuscular & Neurodegenerat Dis, Qilu Hosp, Jinan 250000, Shandong, Peoples R China.
   [Ji, Kunqian; Wang, Wei; Lin, Yan; Xu, Xuebi; Wang, Dongdong; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Dept Neurol, Qilu Hosp, Jinan 250000, Shandong, Peoples R China.
   [Liu, Fuchen] Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06511 USA.
   [Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Qingdao 266035, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250000, Shandong, Peoples R China.
C3 Shandong University; Shandong University; Yale University; Shandong University; Shandong University
RP Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Zhao, YY (corresponding author), Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Jinan 25000, Shandong, Peoples R China.; Zhao, YY (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 25000, Shandong, Peoples R China.
EM zyy72@126.com; chuanzhuyan@163.com
FU National Natural Science Foundation of China [81701237, 81671235]; People's benefit project of science and technology in Qingdao [16-6-2-1-nsh]; Taishan Scholars Program of Shandong Province
CR Bacman SR, 2007, METHOD CELL BIOL, V80, P503, DOI 10.1016/S0091-679X(06)80025-7
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Bris C, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00632
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   Dey R, 2000, NEUROMUSCULAR DISORD, V10, P488, DOI 10.1016/S0960-8966(00)00125-5
   Donnelly PS, 2012, P NATL ACAD SCI USA, V109, P47, DOI 10.1073/pnas.1116227108
   Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015
   González-Vioque E, 2014, MOL GENET GENOM MED, V2, P107, DOI 10.1002/mgg3.47
   Götz A, 2012, PEDIATR RES, V72, P90, DOI 10.1038/pr.2012.43
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Ji KQ, 2014, NEUROMOL MED, V16, P119, DOI 10.1007/s12017-013-8264-8
   Jia ZD, 2019, NUCLEIC ACIDS RES, V47, P2056, DOI 10.1093/nar/gky1241
   Kirino Yohei, 2005, RNA BIOL, V2, P41, DOI 10.4161/rna.2.2.1610
   Kramer PA, 2014, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/51301
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Liu YQ, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-03303-w
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051
   Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pon LA, 2011, MITOCHONDRIA, V0, P0
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Sanderson LE, 2007, RNA, V13, P835, DOI 10.1261/rna.485307
   Schieber M, 2014, CURR BIOL, V24, PR453, DOI 10.1016/j.cub.2014.03.034
   Schimmel P, 2018, NAT REV MOL CELL BIO, V19, P45, DOI 10.1038/nrm.2017.77
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
   Yan JB, 2014, J MOL DIAGN, V16, P431, DOI 10.1016/j.jmoldx.2014.03.005
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Zhang J, 2017, DYN GAMES APPL, V7, P112, DOI 10.1007/s13235-015-0165-z
   Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107
   Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029
NR 42
TC 4
Z9 4
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
EI 
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD JUN 15
PY 2020
VL 7
IS 6
BP 980
EP 991
DI 10.1002/acn3.51069
PG 12
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA MC3DI
UT WOS:000543171600012
PM 32588991
DA 2024-11-01
ER

PT J
AU Pula, S
   Urankar, K
   Norman, A
   Pierre, G
   Langton-Hewer, S
   Selby, V
   Mason, F
   Vijayakumar, K
   McFarland, R
   Taylor, RW
   Majumdar, A
AF Pula, Shpresa
   Urankar, Kathryn
   Norman, Andrew
   Pierre, Germaine
   Langton-Hewer, Simon
   Selby, Victoria
   Mason, Faye
   Vijayakumar, Kayal
   McFarland, Robert
   Taylor, Robert W.
   Majumdar, Anirban
TI A novel <i>de novo ACTA1</i> variant in a patient with nemaline myopathy and mitochondrial Complex I deficiency
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Nemaline myopathy; ACTA1; Mitochondrial dysfunction
ID clinical approach; mutations; mechanisms; diagnosis; phenotype; disease; gene; dna
AB We describe the presentation and follow-up of a three-year-old girl with nemaline myopathy due to a de-novo variant in ACTA1 (encoding skeletal alpha actin) and moderately low enzyme level of Complex I of the mitochondrial respiratory chain. She presented in the neonatal period with hypotonia, followed by weakness in the facial, bulbar, respiratory and neck flexors muscles. A biopsy of her quadriceps muscle at the age of one year showed nemaline rods. Based on her clinical presentation of a congenital myopathy and histopathological features on a muscle biopsy, ACTA1 was sequenced, and this revealed a novel sequence variant, c.760 A >C p. (Asn254His). In addition, mitochondrial respiratory chain enzymatic activity of skeletal muscle biopsy showed a moderately low activity of complex I (nicotinamide adenine dinucleotide (NADH): ubiquinone oxidoreductase). Disturbances of Complex I of the respiratory chain have been reported in patients with nemaline myopathy, although the mechanism remains unclear. Crown Copyright (C) 2019 Published by Elsevier B.V. All rights reserved.
C1 [Pula, Shpresa; Pierre, Germaine; Selby, Victoria; Mason, Faye; Vijayakumar, Kayal; Majumdar, Anirban] Univ Hosp Bristol NHS Fdn Trust, Dept Paediat Neurol, 6th Floor Educ Ctr,Upper Maudlin St, Bristol BS2 8BJ, Avon, England.
   [Urankar, Kathryn] North Bristol Hosp NHS Fdn Trust, Dept Neuropathol, Bristol, Avon, England.
   [Norman, Andrew] Univ Hosp Bristol NHS Fdn Trust, Dept Clin Genet, Bristol, Avon, England.
   [Langton-Hewer, Simon] Univ Hosp Bristol NHS Fdn Trust, Bristol Royal Hosp Children, Dept Paediat Resp Med, Bristol, Avon, England.
   [McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle, England.
C3 University of Bristol; University of Bristol; University of Bristol; Bristol Royal Hospital For Children; Newcastle University - UK
RP Majumdar, A (corresponding author), Univ Hosp Bristol NHS Fdn Trust, Dept Paediat Neurol, 6th Floor Educ Ctr,Upper Maudlin St, Bristol BS2 8BJ, Avon, England.
EM Anirban.Majumdar@uhbristol.nhs.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease, Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre for Ageing and Agerelated disease award; MRC/EPSRC Molecular Pathology Node; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children
CR Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Finsterer J, 2015, PEDIATR NEUROL, V53, P473, DOI 10.1016/j.pediatrneurol.2015.08.014
   Gajda A, 2015, J CHILD NEUROL, V30, P627, DOI 10.1177/0883073813494476
   Gommans IMP, 2002, NEUROMUSCULAR DISORD, V12, P13, DOI 10.1016/S0960-8966(01)00231-0
   Kisler JE, 2010, DEV MED CHILD NEUROL, V52, P422, DOI 10.1111/j.1469-8749.2009.03605.x
   KORNFELD M, 1980, ACTA NEUROPATHOL, V51, P185, DOI 10.1007/BF00687385
   Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059
   Lamont PJ, 2004, NEUROPEDIATRICS, V35, P302, DOI 10.1055/s-2004-821243
   Levesque L, 2013, NEUROMUSCULAR DISORD, V23, P239, DOI 10.1016/j.nmd.2012.12.004
   Lindqvist J, 2013, J NEUROPATH EXP NEUR, V72, P472, DOI 10.1097/NEN.0b013e318293b1cc
   Lornage X, 2017, ANN NEUROL, V81, P467, DOI 10.1002/ana.24900
   Malfatti Edoardo, 2015, J NEUROMUSCUL DIS, V2, P219
   Nilipour Y, 2018, EUR J NEUROL, V25, P841, DOI 10.1111/ene.13607
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   North KN, 2011, SEMIN PEDIATR NEUROL, V18, P216, DOI 10.1016/j.spen.2011.10.002
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Romero NB, 2013, CURR OPIN NEUROL, V26, P519, DOI 10.1097/WCO.0b013e328364d681
   Sandaradura SA, 2018, HUM MUTAT, V39, P383, DOI 10.1002/humu.23385
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Tucker EJ, 2011, IUBMB LIFE, V63, P669, DOI 10.1002/iub.495
   Wallgren-Pettersson C, 2011, SEMIN PEDIATR NEUROL, V18, P230, DOI 10.1016/j.spen.2011.10.004
NR 23
TC 6
Z9 7
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD FEB 15
PY 2020
VL 30
IS 2
BP 159
EP 164
DI 10.1016/j.nmd.2019.11.014
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA LD1XA
UT WOS:000525823700008
PM 32005493
DA 2024-11-01
ER

PT J
AU Orekhov, AN
   Ivanova, EA
   Markin, AM
   Nikiforov, NG
   Sobenin, IA
AF Orekhov, Alexander N.
   Ivanova, Ekaterina A.
   Markin, Alexander M.
   Nikiforov, Nikita G.
   Sobenin, Igor A.
TI Genetics of Arterial-Wall-Specific Mechanisms in Atherosclerosis: Focus on Mitochondrial Mutations
SO CURRENT ATHEROSCLEROSIS REPORTS
LA English
DT Review
DE Atherosclerosis; Nuclear genome; Mitochondria; Mutations; Inflammation; Mitochondrial DNA
ID smooth-muscle-cells; dna-damage; microsatellite instability; somatic mutations; risk-factors; disease; susceptibility; heterozygosity; association; receptor
AB Purpose of ReviewMutations in both nuclear and mitochondrial genes are associated with the development of atherosclerotic lesions in arteries and may provide a partial explanation to the focal nature of lesion distribution in the arterial wall. This review is aimed to discuss the genetic aspects of atherogenesis with a special focus on possible pro-atherogenic variants (mutations) of the nuclear and mitochondrial genomes that may be implicated in atherosclerosis development and progression.Recent FindingsMutations in the nuclear genes generally do not cause a phenotype restricted to a specific vascular wall cell and manifest themselves mostly at the organism level. Such mutations can act as important contributors to changes in lipid metabolism and modulate other risk factors of atherosclerosis. By contrast, mitochondrial DNA (mtDNA) mutations occurring locally in the arterial wall cells or in circulating immune cells may play a site-specific role in atherogenesis. The mosaic distribution of heteroplasmic mtDNA mutations in the arterial wall tissue may explain, at least to some extent, the locality and focality of atherosclerotic lesions distribution.SummaryThe genetic mechanisms of atherogenesis include alterations of both nuclear and mitochondrial genomes. Altered lipid metabolism and inflammatory response of resident arterial wall and circulating immune cells may be related to mtDNA damage and defective mitophagy, which hinders clearance of dysfunctional mitochondria. Mutations of mtDNA can have mosaic distribution and locally affect functionality of endothelial and subendothelial intimal cells in the arterial wall contributing to atherosclerotic lesion development.
C1 [Orekhov, Alexander N.; Sobenin, Igor A.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiiskaya St, Moscow 125315, Russia.
   [Orekhov, Alexander N.; Markin, Alexander M.] Inst Human Morphol, Lab Infect Pathol & Mol Microecol, 3 Tsyurupa St, Moscow 117418, Russia.
   [Ivanova, Ekaterina A.] Inst Atherosclerosis Res, 2-1-207 Osennyaya St, Moscow 121609, Russia.
   [Nikiforov, Nikita G.] Russian Acad Sci, Ctr Collect Usage, Inst Gene Biol, 34-5 Vavilova St, Moscow 119334, Russia.
   [Nikiforov, Nikita G.; Sobenin, Igor A.] Natl Med Res Ctr Cardiol, Inst Expt Cardiol, Lab Med Genet, 15A 3 Rd Cherepkovskaya St, Moscow 121552, Russia.
C3 Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Russian Academy of Medical Sciences; Research Institute of Human Morphology; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; National Medical Research Center of Cardiology
RP Orekhov, AN (corresponding author), Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiiskaya St, Moscow 125315, Russia.; Orekhov, AN (corresponding author), Inst Human Morphol, Lab Infect Pathol & Mol Microecol, 3 Tsyurupa St, Moscow 117418, Russia.; Ivanova, EA (corresponding author), Inst Atherosclerosis Res, 2-1-207 Osennyaya St, Moscow 121609, Russia.
EM a.h.opexob@gmail.com; kate.ivanov@gmail.com
FU Russian Science Foundation [19-15-00297]; Russian Science Foundation [19-15-00297] Funding Source: Russian Science Foundation
CR Andreassi MG, 2000, ENVIRON MOL MUTAGEN, V35, P265, DOI 10.1002/1098-2280(2000)35:4<265::AID-EM1>3.0.CO;2-M
   Andreassi MG, 2003, TRENDS CARDIOVAS MED, V13, P270, DOI 10.1016/S1050-1738(03)00109-9
   Belsky DW, 2013, BIODEMOGR SOC BIOL, V59, P85, DOI 10.1080/19485565.2013.774628
   BENDITT EP, 1973, P NATL ACAD SCI USA, V70, P1753, DOI 10.1073/pnas.70.6.1753
   Binková B, 2002, MUTAT RES-FUND MOL M, V501, P115, DOI 10.1016/S0027-5107(02)00019-2
   Borghini A, 2013, ATHEROSCLEROSIS, V230, P202, DOI 10.1016/j.atherosclerosis.2013.07.038
   Botto N, 2001, MUTAT RES-GEN TOX EN, V493, P23, DOI 10.1016/S1383-5718(01)00162-0
   Brozovich FV, 2016, PHARMACOL REV, V68, P476, DOI 10.1124/pr.115.010652
   Cariou B, 2020, ATHEROSCLEROSIS, V292, P204, DOI 10.1016/j.atherosclerosis.2019.11.010
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Cho DH, 2020, MOL CELLS, V43, P10, DOI 10.14348/molcells.2020.2329
   Chung IM, 1998, AM J PATHOL, V152, P913
   Clark KJ, 2001, ARTERIOSCL THROM VAS, V21, P555, DOI 10.1161/01.ATV.21.4.555
   Craven L, 2017, HUM REPROD UPDATE, V23, P501, DOI 10.1093/humupd/dmx018
   Dandona Sonny, 2009, CURR CARDIOL REP, V11, P282
   De Flora S, 2007, MUTAT RES-FUND MOL M, V621, P5, DOI 10.1016/j.mrfmmm.2006.12.008
   DeFlora S, 1997, FASEB J, V11, P1021, DOI 10.1096/fasebj.11.12.9337155
   DeFlora S, 1996, MUTAT RES-REV GENET, V366, P197, DOI 10.1016/S0165-1110(96)00043-7
   Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480
   den Hoed M, 2015, ATHEROSCLEROSIS, V239, P304, DOI 10.1016/j.atherosclerosis.2015.01.032
   Fiotti N, 2006, ARTERIOSCL THROM VAS, V26, P1330, DOI 10.1161/01.ATV.0000219233.31702.c9
   Fouchier SW, 2014, CIRC RES, V115, P552, DOI 10.1161/CIRCRESAHA.115.304660
   Frades I, 2019, CIRC-GENOM PRECIS ME, V12, P0, DOI 10.1161/CIRCGEN.118.002390
   Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620
   Ghosh P, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21093363
   Goldstein I, 2012, TRENDS ENDOCRIN MET, V23, P567, DOI 10.1016/j.tem.2012.06.007
   Grati FR, 2001, ATHEROSCLEROSIS, V159, P261, DOI 10.1016/S0021-9150(01)00466-X
   Gu HM, 2013, J LIPID RES, V54, P3345, DOI 10.1194/jlr.M041129
   Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585
   Hatzistamou J, 1996, BIOCHEM BIOPH RES CO, V225, P186, DOI 10.1006/bbrc.1996.1151
   Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835
   Holdt LM, 2015, ESC TXB PREVENTIVE C, V0, P0
   Howson JMM, 2017, NAT GENET, V49, P1113, DOI 10.1038/ng.3874
   Huan TX, 2013, ARTERIOSCL THROM VAS, V33, P1427, DOI 10.1161/ATVBAHA.112.300112
   Ioannidis JPA, 2009, CIRC-CARDIOVASC GENE, V2, P7, DOI 10.1161/CIRCGENETICS.108.833392
   Itsara LS, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1003974
   Ivanova EA, 2016, STEM CELLS INT, V2016, P0, DOI 10.1155/2016/7321404
   Ivanova EA, 2015, WORLD J CARDIOL, V7, P583, DOI 10.4330/wjc.v7.i10.583
   Izzotti A, 2001, FASEB J, V15, P752, DOI 10.1096/fj.00-0312com
   Kiaris H, 1996, ATHEROSCLEROSIS, V125, P47, DOI 10.1016/0021-9150(96)05841-8
   Kong YH, 2018, FRONT ENDOCRINOL, V9, P0, DOI 10.3389/fendo.2018.00405
   Lee SH, 2001, TRENDS CARDIOVAS MED, V11, P148, DOI 10.1016/S1050-1738(01)00094-9
   Lee SR, 2017, ADV EXP MED BIOL, V982, P81, DOI 10.1007/978-3-319-55330-6_5
   Li HZ, 2017, BBA-MOL BASIS DIS, V1863, P2266, DOI 10.1016/j.bbadis.2017.05.022
   Li RL, 2001, ATHEROSCLEROSIS, V154, P729, DOI 10.1016/S0021-9150(00)00582-7
   Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146
   Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Malik Q, 2012, FREE RADICAL RES, V46, P554, DOI 10.3109/10715762.2012.663913
   Markowitz SD, 1997, J CLIN INVEST, V100, P2143, DOI 10.1172/JCI119749
   McCaffrey TA, 1997, J CLIN INVEST, V100, P2182, DOI 10.1172/JCI119754
   Millonig G, 2001, LAB INVEST, V81, P639, DOI 10.1038/labinvest.3780273
   Miniati P, 2001, INT J BIOL MARKER, V16, P167, DOI 10.1177/172460080101600302
   Murry CE, 1997, AM J PATHOL, V151, P697
   Orekhov AN, 2015, EXP MOL PATHOL, V99, P672, DOI 10.1016/j.yexmp.2015.11.006
   Orekhov AN, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9040978
   Orekhov AN, 2020, CURR NEUROPHARMACOL, V18, P1064, DOI 10.2174/1570159X17666191118125018
   Orekhov AN, 2018, CURR PHARM DESIGN, V24, P2883, DOI 10.2174/1381612824666180911120726
   Orekhov AN, 2014, CARDIOVASC RES, V103, P438, DOI 10.1093/cvr/cvu168
   Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360
   PARKES JL, 1991, AM J PATHOL, V138, P765
   Peng WX, 2019, DNA CELL BIOL, V38, P597, DOI 10.1089/dna.2018.4552
   Piantadosi CA, 2020, FREE RADICAL BIO MED, V152, P455, DOI 10.1016/j.freeradbiomed.2020.01.013
   Poznyak AV, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9030584
   ROMANOV YA, 1995, ANN NY ACAD SCI, V748, P12
   Ross JS, 2001, ANN NY ACAD SCI, V947, P271
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Skilton MR, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8081201
   Sobenin IA, 2017, GENETIC POLYMORPHISM, V0, P0
   Sobenin IA, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9090455
   Sobenin IA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068070
   Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006
   Sobenin IA, 2012, CLIN DEV IMMUNOL, V0, P0, DOI DOI 10.1155/2012/832464
   Spandidos DA, 1996, BIOCHEM BIOPH RES CO, V220, P137, DOI 10.1006/bbrc.1996.0370
   Strassheim Derek, 2018, VESSEL PLUS, V2, P0, DOI 10.20517/2574-1209.2018.44
   Tabas I, 2001, CIRC RES, V88, P747, DOI 10.1161/hh0801.090536
   Talukdar HA, 2016, CELL SYST, V2, P196, DOI 10.1016/j.cels.2016.02.002
   Tang XQ, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00175
   TERTOV VV, 1992, CIRC RES, V71, P218, DOI 10.1161/01.RES.71.1.218
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Van Schooten FJ, 1998, FASEB J, V12, P1409, DOI 10.1096/fasebj.12.13.1409
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Weakley SM, 2010, EXPERT REV MOL DIAGN, V10, P173, DOI 10.1586/ERM.10.1
   Weinberg RA, 1996, MOL ONCOLOGY, V0, P179
   Wu GZ, 2014, CIRCULATION, V130, P1452, DOI 10.1161/CIRCULATIONAHA.114.011675
   Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008
   Zhelankin A, 2015, J HYPERTENS, V33, PE2, DOI 10.1097/01.hjh.0000467356.04711.50
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 88
TC 10
Z9 11
U1 0
U2 4
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1523-3804
EI 1534-6242
J9 CURR ATHEROSCLER REP
JI Curr. Atheroscleros. Rep.
PD AUG 9
PY 2020
VL 22
IS 10
BP 
EP 
DI 10.1007/s11883-020-00873-5
PG 11
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA ND3KT
UT WOS:000561803400004
PM 32772280
DA 2024-11-01
ER

PT J
AU Lin, Y
   Xu, XB
   Zhao, DD
   Liu, FC
   Luo, YB
   Du, JX
   Wang, DD
   Ji, KQ
   Zhao, YY
   Yan, CZ
AF Lin, Yan
   Xu, Xuebi
   Zhao, Dandan
   Liu, Fuchen
   Luo, Yuebei
   Du, Jixiang
   Wang, Dongdong
   Ji, Kunqian
   Zhao, Yuying
   Yan, Chuanzhu
TI A novel m.11406 T &gt; A mutation in mitochondrial <i>ND4</i> gene causes MELAS syndrome
SO MITOCHONDRION
LA English
DT Article
DE MELAS syndrome; ND4 gene; Complex I; Mitochondrial DNA; Mutation
ID hereditary optic neuropathy; complex i deficiency; exercise intolerance; dna mutations; pathogenicity; dehydrogenase; subunit
AB Pathogenic point mutations of mitochondrial DNA (mtDNA) are associated with a large number of heterogeneous diseases involving multiple systems with which patients may present with a wide range of clinical phenotypes. In this study, we describe a novel heteroplasmic missense mutation, m.11406 T > A, of the ND4 gene encoding the subunit 4 of mitochondrial complex I in a 32-year-old woman with recurrent epileptic seizure, headache and bilateral hearing loss. Skeletal muscle histochemistry demonstrated that approximately 20% of fibers were cytochrome C oxidase (COX) deficient with increased activity of succinate dehydrogenase (SDH). Further investigations in muscle specimens showed significantly reduced level of ND4 protein. It is interesting that the subunits of complex I (ND1 and NDFUB8) and complex IV(CO1) were also remarkably decreased. These findings indicate that ND1, NDFUB8 and COl are more susceptible than other subunits to mutations in the mitochondrial ND4 gene.
C1 [Lin, Yan; Zhao, Dandan; Du, Jixiang; Wang, Dongdong; Ji, Kunqian; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Res Inst Neuromuscular & Neurodegenerat Dis, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Lin, Yan; Zhao, Dandan; Du, Jixiang; Wang, Dongdong; Ji, Kunqian; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Xu, Xuebi] Wenzhou Med Univ, Dept Neurol, Affiliated Hosp 1, Nanbaixiang St, Wenzhou 325000, Peoples R China.
   [Liu, Fuchen] Yale Univ, Dept Neurobiol, Sch Med, New Haven, CT 06511 USA.
   [Luo, Yuebei] Cent South Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Jinan 266035, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Shandong University; Wenzhou Medical University; Yale University; Central South University; Shandong University; Shandong University
RP Ji, KQ; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Res Inst Neuromuscular & Neurodegenerat Dis, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Ji, KQ; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
EM jikunqian@qiluhospital.com; czyan@sdu.edu.cn
FU Shandong Provincial Natural Science Foundation of China [ZR2017BH033]; National Natural Science Foundation of China [81701237, 81671235]; People's benefit project of science and technology in Qingdao [16-6-2-1-nsh]; Taishan Scholars Program of Shandong Province
CR Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295
   Abu-Amero KK, 2005, ONCOGENE, V24, P1455, DOI 10.1038/sj.onc.1208292
   Bacalhau M, 2017, EUR J MED GENET, V60, P172, DOI 10.1016/j.ejmg.2016.12.009
   Barshad G, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-46446-8
   Chakrabarty S, 2018, MITOCHONDRION, V43, P25, DOI 10.1016/j.mito.2018.06.006
   Chalmers RM, 1996, BRAIN, V119, P1481, DOI 10.1093/brain/119.5.1481
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Damm F, 2012, LEUKEMIA, V26, P289, DOI 10.1038/leu.2011.200
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P1, DOI 10.1177/000271623618500112
   Endres D, 2019, FRONT IMMUNOL, V10, P0, DOI 10.3389/fimmu.2019.00412
   Fang HZ, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep10480
   Fedor JG, 2017, P NATL ACAD SCI USA, V114, P12737, DOI 10.1073/pnas.1714074114
   Fiedorczuk K, 2018, TRENDS CELL BIOL, V28, P835, DOI 10.1016/j.tcb.2018.06.006
   Gershoni M, 2010, J MOL BIOL, V404, P158, DOI 10.1016/j.jmb.2010.09.029
   Gorman GS, 2015, CLIN SCI, V128, P895, DOI 10.1042/CS20140705
   Haapanen O, 2018, BBA-BIOENERGETICS, V1859, P510, DOI 10.1016/j.bbabio.2018.04.001
   Hernansanz-Agustín P, 2017, REDOX BIOL, V12, P1040, DOI 10.1016/j.redox.2017.04.025
   Jiang PP, 2015, INVEST OPHTH VIS SCI, V56, P4778, DOI 10.1167/iovs.14-16158
   Kabekkodu SP, 2015, MITOCHONDRION, V24, P93, DOI 10.1016/j.mito.2015.07.008
   Komaki H, 2003, MITOCHONDRION, V2, P293, DOI 10.1016/S1567-7249(03)00003-5
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Leo-Kottler B, 2002, GRAEF ARCH CLIN EXP, V240, P758, DOI 10.1007/s00417-002-0494-7
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   Liu CY, 2018, HUM GENET, V137, P203, DOI 10.1007/s00439-018-1873-4
   Lyu LH, 2019, MITOCHONDRION, V45, P1, DOI 10.1016/j.mito.2018.01.008
   Minocherhomji S, 2012, EPIGENETICS-US, V7, P326, DOI 10.4161/epi.19547
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   OKeefe H, 2018, J MOL EVOL, V86, P395, DOI 10.1007/s00239-018-9855-7
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pereira L, 2011, AM J HUM GENET, V88, P433, DOI 10.1016/j.ajhg.2011.03.006
   Porras CA, 2015, FRONT BIOSCI-LANDMRK, V20, P621, DOI 10.2741/4327
   Rani DS, 2006, FERTIL STERIL, V86, P1783, DOI 10.1016/j.fertnstert.2006.04.044
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Tawata M, 1998, DIABETES, V47, P276, DOI 10.2337/diab.47.2.276
   Vanniarajan A, 2006, ACTA NEUROL SCAND, V114, P350, DOI 10.1111/j.1600-0404.2006.00673.x
   Vartak R, 2013, PROTEIN CELL, V4, P582, DOI 10.1007/s13238-013-3032-y
   Vartak RS, 2014, J BIOENERG BIOMEMBR, V46, P323, DOI 10.1007/s10863-014-9564-x
   Xu B, 2017, J HUM GENET, V62, P291, DOI 10.1038/jhg.2016.127
   Yan WS, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/1202459
   Zhang J, 2015, EUR J HUM GENET, V23, P86, DOI 10.1038/ejhg.2014.52
   Zhou XT, 2006, BIOCHEM BIOPH RES CO, V340, P69, DOI 10.1016/j.bbrc.2005.11.150
NR 48
TC 5
Z9 6
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP 15
PY 2020
VL 54
IS 
BP 57
EP 64
DI 10.1016/j.mito.2020.06.011
PG 8
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA NX5WU
UT WOS:000575782000008
PM 32659360
DA 2024-11-01
ER

PT J
AU Livingston, K
   Schlaak, RA
   Puckett, LL
   Bergom, C
AF Livingston, Katie
   Schlaak, Rachel A.
   Puckett, Lindsay L.
   Bergom, Carmen
TI The Role of Mitochondrial Dysfunction in Radiation-Induced Heart Disease: From Bench to Bedside
SO FRONTIERS IN CARDIOVASCULAR MEDICINE
LA English
DT Review
DE mitochondria; radiation-adverse effects; radiation-induced cardiovascular toxicity; oxidative stress; radiation; cardiomyocyte; endothelial cell; apoptosis
ID inflammatory plaque phenotype; ionizing-radiation; conformal radiotherapy; cardiac-muscle; lung-cancer; dna; irradiation; mechanisms; activation; deletion
AB Radiation is a key modality in the treatment of many cancers; however, it can also affect normal tissues adjacent to the tumor, leading to toxic effects. Radiation to the thoracic region, such as that received as part of treatment for breast and lung cancer, can result in incidental dose to the heart, leading to cardiac dysfunction, such as pericarditis, coronary artery disease, ischemic heart disease, conduction defects, and valvular dysfunction. The underlying mechanisms for these morbidities are currently being studied but are not entirely understood. There has been increasing focus on the role of radiation-induced mitochondrial dysfunction and the ensuing impact on various cardiac functions in both preclinical models and in humans. Cardiomyocyte mitochondria are critical to cardiac function, and mitochondria make up a substantial part of a cardiomyocyte's volume. Mitochondrial dysfunction can also alter other cell types in the heart. This review summarizes several factors related to radiation-induced mitochondrial dysfunction in cardiomyocytes and endothelial cells. These factors include mitochondrial DNA mutations, oxidative stress, alterations in various mitochondrial function-related transcription factors, and apoptosis. Through improved understanding of mitochondria-dependent mechanisms of radiation-induced heart dysfunction, potential therapeutic targets can be developed to assist in prevention and treatment of radiation-induced heart damage.
C1 [Livingston, Katie; Puckett, Lindsay L.; Bergom, Carmen] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA.
   [Livingston, Katie; Schlaak, Rachel A.; Puckett, Lindsay L.; Bergom, Carmen] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA.
   [Schlaak, Rachel A.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.
   [Bergom, Carmen] Med Coll Wisconsin, Cardiovasc Ctr, Milwaukee, WI 53226 USA.
C3 Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin
RP Bergom, C (corresponding author), Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA.; Bergom, C (corresponding author), Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA.; Bergom, C (corresponding author), Med Coll Wisconsin, Cardiovasc Ctr, Milwaukee, WI 53226 USA.
EM cbergom@mcw.edu
FU Medical College of Wisconsin (MCW) Cancer Center; Dr. Nancy Sobczak Fund for Breast Cancer; Mary Kay Foundation [01729]; Susan G. Komen Grant [CCR17483233]; Cardiovascular Center at the Medical College ofWisconsin; NIH/NHLBI [1R01HL147884]; Michael H. Keelan, Jr., MD, Research Foundation Grant
CR Azimzadeh O, 2017, ONCOTARGET, V8, P9067, DOI 10.18632/oncotarget.10424
   Azimzadeh O, 2015, J PROTEOME RES, V14, P1203, DOI 10.1021/pr501141b
   Azimzadeh O, 2013, J PROTEOME RES, V12, P2700, DOI 10.1021/pr400071g
   Azimzadeh O, 2011, PROTEOMICS, V11, P3299, DOI 10.1002/pmic.201100178
   Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1
   Azizova TV, 2015, BRIT J RADIOL, V88, P0, DOI 10.1259/bjr.20150169
   Barjaktarovic Z, 2013, RADIOTHER ONCOL, V106, P404, DOI 10.1016/j.radonc.2013.01.017
   Barjaktarovic Z, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027811
   BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S
   Baselet B, 2019, CELL MOL LIFE SCI, V76, P699, DOI 10.1007/s00018-018-2956-z
   Baselet B, 2016, INT J MOL MED, V38, P1623, DOI 10.3892/ijmm.2016.2777
   Bergom C, 2018, FRONT ONCOL, V8, P0, DOI 10.3389/fonc.2018.00087
   Bergom C, 2012, INT J RADIAT ONCOL, V83, P821, DOI 10.1016/j.ijrobp.2011.08.020
   Bernard ME, 2017, FRONT ONCOL, V7, P0, DOI 10.3389/fonc.2017.00001
   Boerma M, 2011, CARDIOL RES PRACT, V2011, P0, DOI 10.4061/2011/858262
   Boerma M, 2016, MUTAT RES-REV MUTAT, V770, P319, DOI 10.1016/j.mrrev.2016.07.003
   Boerma M, 2015, RADIAT RES, V183, P610, DOI 10.1667/RR13979.1
   Bradley JD, 2015, LANCET ONCOL, V16, P187, DOI 10.1016/S1470-2045(14)71207-0
   Bradley JA, 2018, ANNU REV MED, V69, P277, DOI 10.1146/annurev-med-042716-103422
   BURCH GE, 1968, ARCH INTERN MED, V121, P230, DOI 10.1001/archinte.121.3.230
   Ciccarelli M, 2013, ARTERIOSCL THROM VAS, V33, P2415, DOI 10.1161/ATVBAHA.113.302262
   Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825
   Dess RT, 2017, J CLIN ONCOL, V35, P1395, DOI 10.1200/JCO.2016.71.6142
   Ehrbar S, 2016, RADIOTHER ONCOL, V121, P328, DOI 10.1016/j.radonc.2016.10.011
   Ellulu MS, 2016, INFLAMMOPHARMACOLOGY, V24, P1, DOI 10.1007/s10787-015-0255-y
   Ferreira-Machado SC, 2013, AN ACAD BRAS CIENC, V85, P215, DOI 10.1590/S0001-37652013005000009
   Franco A, 2016, TRANSL MED UNISA, V14, P45
   Franco A, 2018, CELL DEATH DISCOV, V4, P0, DOI 10.1038/s41420-018-0028-7
   Grygiel-Górniak B, 2014, NUTR J, V13, P0, DOI 10.1186/1475-2891-13-17
   Haddy N, 2016, CIRCULATION, V133, P31, DOI 10.1161/CIRCULATIONAHA.115.016686
   Haque W, 2018, INT J RADIAT ONCOL, V100, P470, DOI 10.1016/j.ijrobp.2017.10.031
   Holmstrom Kira M, 2016, CURRENT OPINION IN TOXICOLOGY, V1, P80, DOI 10.1016/j.cotox.2016.10.002
   Hoving S, 2008, INT J RADIAT ONCOL, V71, P848, DOI 10.1016/j.ijrobp.2008.02.031
   Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974
   Kaczmarek A, 2004, STRUCT CHEM, V15, P517, DOI 10.1023/B:STUC.0000037910.26456.59
   Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001
   KHAN MY, 1973, AM J PATHOL, V73, P131
   Koleini N, 2017, ONCOTARGET, V8, P46663, DOI 10.18632/oncotarget.16944
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Lin PH, 2003, FREE RADICAL BIO MED, V35, P1310, DOI 10.1016/j.freeradbiomed.2003.07.002
   Little MP, 2009, J RADIOL PROT, V29, PA43, DOI 10.1088/0952-4746/29/2A/S04
   LJUNGMAN M, 1992, MOL CARCINOGEN, V5, P264, DOI 10.1002/mc.2940050406
   Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c
   Modiri A, 2017, INT J RADIAT ONCOL, V99, P317, DOI 10.1016/j.ijrobp.2017.05.039
   Mulrooney DA, 2009, BMJ-BRIT MED J, V339, P0, DOI 10.1136/bmj.b4606
   Nojiri H, 2006, J BIOL CHEM, V281, P33789, DOI 10.1074/jbc.M602118200
   Piquereau J, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00102
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Richard SM, 2000, CANCER RES, V60, P4231
   Rivas V, 2013, J CLIN INVEST, V123, P4714, DOI 10.1172/JCI67333
   Salata C, 2014, INT J RADIAT BIOL, V90, P284, DOI 10.3109/09553002.2014.887869
   Schilling-Tóth B, 2011, MUTAT RES-FUND MOL M, V716, P33, DOI 10.1016/j.mrfmmm.2011.07.018
   Schlaak RA, 2019, AM J PHYSIOL-HEART C, V316, PH1267, DOI 10.1152/ajpheart.00482.2018
   Simonetto C, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0096309
   Sorriento D, 2019, FRONT PHARMACOL, V10, P0, DOI 10.3389/fphar.2019.00064
   Sorriento D, 2014, TRANSL MED UNISA, V10, P3
   Speirs CK, 2017, J THORAC ONCOL, V12, P293, DOI 10.1016/j.jtho.2016.09.134
   Sridharan V, 2014, RADIAT RES, V181, P324, DOI 10.1667/RR13452.1
   Stewart FA, 2012, ANNALS OF THE ICRP, V41, P72, DOI 10.1016/j.icrp.2012.06.031
   Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409
   STEWART JR, 1984, PROG CARDIOVASC DIS, V27, P173
   Tanno M, 2012, BASIC RES CARDIOL, V107, P0, DOI 10.1007/s00395-012-0273-5
   Tapio S, 2016, J RADIAT RES, V57, P439, DOI 10.1093/jrr/rrw064
   VOS J, 1983, VIRCHOWS ARCH B, V43, P1, DOI 10.1007/BF02932938
   Wang HR, 2019, INT J BIOL SCI, V15, P2128, DOI 10.7150/ijbs.35460
   Wang K, 2017, RADIOTHER ONCOL, V125, P293, DOI 10.1016/j.radonc.2017.10.001
   Wang L, 2007, INT J RADIAT BIOL, V83, P433, DOI 10.1080/09553000701370878
   Wang YY, 2016, RADIAT RES, V186, P153, DOI 10.1667/RR14445.1
   Yegya-Raman N, 2018, J THORAC ONCOL, V13, P1508, DOI 10.1016/j.jtho.2018.05.028
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
NR 70
TC 42
Z9 47
U1 0
U2 14
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2297-055X
EI 
J9 FRONT CARDIOVASC MED
JI Front. Cardiovasc. Med.
PD FEB 21
PY 2020
VL 7
IS 
BP 
EP 
DI 10.3389/fcvm.2020.00020
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KZ8CT
UT WOS:000523487000001
PM 32154269
DA 2024-11-01
ER

PT J
AU Sharma, S
   Aldred, MA
AF Sharma, Samantha
   Aldred, Micheala A.
TI DNA Damage and Repair in Pulmonary Arterial Hypertension
SO GENES
LA English
DT Review
DE pulmonary arterial hypertension; endothelial cells; smooth muscle cells; DNA damage; DNA repair
ID smooth-muscle-cells; oxidative stress; excision-repair; receptor; atr; inflammation; mutations; apoptosis; survival; hypoxia
AB Pulmonary arterial hypertension (PAH) is a complex multifactorial disease with both genetic and environmental dynamics contributing to disease progression. Over the last decade, several studies have demonstrated the presence of genomic instability and increased levels of DNA damage in PAH lung vascular cells, which contribute to their pathogenic apoptosis-resistant and proliferating characteristics. In addition, the dysregulated DNA damage response pathways have been indicated as causal factors for the presence of persistent DNA damage. To understand the significant implications of DNA damage and repair in PAH pathogenesis, the current review summarizes the recent advances made in this field. This includes an overview of the observed DNA damage in the nuclear and mitochondrial genome of PAH patients. Next, the irregularities observed in various DNA damage response pathways and their role in accumulating DNA damage, escaping apoptosis, and proliferation under a DNA damaging environment are discussed. Although the current literature establishes the pertinence of DNA damage in PAH, additional studies are required to understand the temporal sequence of the above-mentioned events. Further, an exploration of different types of DNA damage in conjunction with associated impaired DNA damage response in PAH will potentially stimulate early diagnosis of the disease and development of novel therapeutic strategies.
C1 [Sharma, Samantha; Aldred, Micheala A.] Indiana Univ, Div Pulm Crit Care Sleep & Occupat Med, Dept Med, Sch Med, Indianapolis, IN 46202 USA.
C3 Indiana University System; Indiana University Indianapolis
RP Aldred, MA (corresponding author), Indiana Univ, Div Pulm Crit Care Sleep & Occupat Med, Dept Med, Sch Med, Indianapolis, IN 46202 USA.
EM samshar@iu.edu; maaldred@iu.edu
FU National Heart, Lung, and Blood Institute of the National Institutes of Health [R35HL140019]
CR Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159
   Alastalo TP, 2011, J CLIN INVEST, V121, P3735, DOI 10.1172/JCI43382
   Aldred MA, 2010, AM J RESP CRIT CARE, V182, P1153, DOI 10.1164/rccm.201003-0491OC
   Archer SL, 2008, AM J PHYSIOL-HEART C, V294, PH570, DOI 10.1152/ajpheart.01324.2007
   Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888
   Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460
   Best DH, 2014, CHEST, V145, P231, DOI 10.1378/chest.13-2366
   Boucherat O, 2018, AM J RESP CRIT CARE, V198, P90, DOI 10.1164/rccm.201708-1751OC
   Boucherat O, 2017, PULM CIRC, V7, P285, DOI 10.1177/2045893217701438
   Bourgeois A, 2019, ARTERIOSCL THROM VAS, V39, P1667, DOI 10.1161/ATVBAHA.119.312537
   Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7
   Carrassa L, 2004, CELL CYCLE, V3, P1177
   Chan N, 2014, MOL CANCER RES, V12, P1407, DOI 10.1158/1541-7786.MCR-14-0246
   Chen PI, 2017, JCI INSIGHT, V2, P0, DOI 10.1172/jci.insight.90427
   Cohen-Kaminsky S, 2014, DRUG DISCOV TODAY, V19, P1251, DOI 10.1016/j.drudis.2014.04.007
   Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849
   Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812
   DeMarco VG, 2010, WORLD J CARDIOL, V2, P316, DOI 10.4330/wjc.v2.i10.316
   Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059
   Diebold I, 2015, CELL METAB, V21, P596, DOI 10.1016/j.cmet.2015.03.010
   Drake KM, 2017, PULM CIRC, V7, P421, DOI 10.1177/2045893217700901
   Drake KM, 2015, AM J RESP CRIT CARE, V191, P850, DOI 10.1164/rccm.201411-1985LE
   Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844
   Federici C, 2015, AM J RESP CRIT CARE, V192, P219, DOI 10.1164/rccm.201411-2128OC
   Fessel JP, 2015, PULM CIRC, V5, P599, DOI 10.1086/683814
   GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W
   Gräf S, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03672-4
   Guignabert C, 2009, AM J PHYSIOL-LUNG C, V297, PL1082, DOI 10.1152/ajplung.00199.2009
   Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200
   Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002
   Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015
   Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231
   Heikal AA, 2010, BIOMARK MED, V4, P241, DOI 10.2217/BMM.10.1
   Hoeper MM, 2016, LANCET RESP MED, V4, P323, DOI 10.1016/S2213-2600(15)00542-1
   Hoeper MM, 2016, LANCET RESP MED, V4, P306, DOI 10.1016/S2213-2600(15)00543-3
   Hsu JL, 2012, CANCER LETT, V319, P214, DOI 10.1016/j.canlet.2012.01.004
   Humbert M, 2008, VASC PHARMACOL, V49, P113, DOI 10.1016/j.vph.2008.06.003
   Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0
   Kherbeck N, 2013, CLIN REV ALLERG IMMU, V44, P31, DOI 10.1007/s12016-011-8265-z
   Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040
   Lampron MC, 2020, ARTERIOSCL THROM VAS, V40, P783, DOI 10.1161/ATVBAHA.119.313763
   Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226
   Lau EMT, 2017, NAT REV CARDIOL, V14, P0, DOI 10.1038/nrcardio.2017.84
   Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910
   Li CYG, 2019, CELL REP, V26, P1333, DOI 10.1016/j.celrep.2019.01.013
   Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115
   Li ML, 2014, AM J RESP CELL MOL, V50, P1118, DOI 10.1165/rcmb.2013-0349OC
   Liu QH, 2000, GENE DEV, V14, P1448
   Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877
   Loyd James E, 2011, PROC AM THORAC SOC, V8, P154, DOI 10.1513/pats.201007-047MS
   Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097
   Machado RD, 2005, CIRCULATION, V111, P607, DOI 10.1161/01.CIR.0000154543.07679.08
   Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848
   McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000
   McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004
   Meloche J, 2015, AM J PHYSIOL-CELL PH, V309, PC363, DOI 10.1152/ajpcell.00149.2015
   Meloche J, 2014, CIRCULATION, V129, P786, DOI 10.1161/CIRCULATIONAHA.113.006167
   Modesti M, 2001, GENOME BIOL, V2, P0
   Morrell NW, 2019, EUR RESPIR J, V53, P0, DOI 10.1183/13993003.01899-2018
   Murata MM, 2019, MOL BIOL CELL, V30, P2584, DOI 10.1091/mbc.E18-10-0650
   Paulin R, 2011, AM J PHYSIOL-HEART C, V301, PH1798, DOI 10.1152/ajpheart.00654.2011
   Perez VD, 2011, INT J CLIN PRACT, V65, P8, DOI 10.1111/j.1742-1241.2010.02606.x
   Perez VADJ, 2014, AM J RESP CRIT CARE, V189, P1260, DOI 10.1164/rccm.201310-17490C
   Perros F, 2015, CIRCULATION, V132, P834, DOI 10.1161/CIRCULATIONAHA.115.014207
   Pilié PG, 2019, NAT REV CLIN ONCOL, V16, P81, DOI 10.1038/s41571-018-0114-z
   Potus F, 2014, PULM CIRC, V4, P175, DOI 10.1086/675980
   Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658
   Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609
   Rhodes CJ, 2019, LANCET RESP MED, V7, P227, DOI 10.1016/S2213-2600(18)30409-0
   Ryan JJ, 2015, CIRCULATION, V131, P1691, DOI 10.1161/CIRCULATIONAHA.114.006979
   Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723
   Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355
   Scanlon SE, 2015, DNA REPAIR, V32, P180, DOI 10.1016/j.dnarep.2015.04.030
   Shintani M, 2009, J MED GENET, V46, P331, DOI 10.1136/jmg.2008.062703
   Simonneau G, 2019, EUR RESPIR J, V53, P0, DOI 10.1183/13993003.01913-2018
   Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762
   Tuder RM, 1998, AM J RESP CRIT CARE, V158, P1999, DOI 10.1164/ajrccm.158.6.9805002
   Tuder RM, 2013, J AM COLL CARDIOL, V62, PD4, DOI 10.1016/j.jacc.2013.10.025
   van Houten B, 2015, AM J RESP CRIT CARE, V192, P129, DOI 10.1164/rccm.201505-0904ED
   Vattulainen-Collanus S, 2018, COMMUN BIOL, V1, P0, DOI 10.1038/s42003-018-0152-1
   Voelkel NF, 1998, CHEST, V114, P225S, DOI 10.1378/chest.114.3_Supplement.225S
   Wang YM, 2012, CANCER RES, V72, P4037, DOI 10.1158/0008-5472.CAN-12-0103
   Wang Y, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12226-1
   Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5
   Wilson GJ, 2013, AM J PHYSIOL-ENDOC M, V305, PE1124, DOI 10.1152/ajpendo.00080.2013
   Wood RD, 1999, BIOCHIMIE, V81, P39, DOI 10.1016/S0300-9084(99)80036-4
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yamamoto BK, 2008, J NEUROIMMUNE PHARM, V3, P203, DOI 10.1007/s11481-008-9121-7
   Yeager ME, 2001, CIRC RES, V88, P0
   Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001
   Zhu N, 2019, GENOME MED, V11, P0, DOI 10.1186/s13073-019-0685-z
NR 91
TC 21
Z9 21
U1 1
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD OCT 15
PY 2020
VL 11
IS 10
BP 
EP 
DI 10.3390/genes11101224
PG 18
WC Genetics & Heredity
SC Genetics & Heredity
GA ON7KE
UT WOS:000586874100001
PM 33086628
DA 2024-11-01
ER

PT J
AU Parada-Garza, JD
   López-Valencia, G
   Miranda-Garciá, LA
   Pérez-Garciá, G
   Ruiz-Sandoval, JL
AF Didier Parada-Garza, Juan
   Lopez-Valencia, German
   Adrian Miranda-Garcia, Luis
   Perez-Garcia, Guillermo
   Luis Ruiz-Sandoval, Jose
TI MRI findings in SANDO variety of the ataxia-neuropathy spectrum with a novel mutation in POLG (c.3287G&gt;<i>T</i>): A case report
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Ataxia-neuropathy spectrum; CPEO; Mitochondrial disease; POLG gene; POLG mutation; Ophthalmoparesis; SANDO
AB Sensory ataxic neuropathy with dysarthria and ophthalmoparesis (SANDO) is an adult onset sensory ataxic neuropathy, dysarthria and chronic progressive external ophthalmoplegia associated with mutations in POLG1. We report a 38-year-old woman with a history of progressive gait instability and bilateral ptosis. Neurological examination found ataxia, ophthalmoplegia, and dysarthria. MRI showed bilateral thalamic and cerebellar lesions. A POLG related disorder was suspected and after DNA sequencing a SANDO with a novel mutation in POLG was confirmed. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Didier Parada-Garza, Juan; Lopez-Valencia, German; Adrian Miranda-Garcia, Luis; Luis Ruiz-Sandoval, Jose] Hosp Civil Guadalajara Fray Antonio Alcalde, Dept Neurol, Hosp 278, Guadalajara 44280, Jalisco, Mexico.
   [Perez-Garcia, Guillermo] Univ Guadalajara, CUCS, Dept Neurosci Dr Ruiz Sandoval, Guadalajara, Jalisco, Mexico.
C3 Universidad de Guadalajara
RP Parada-Garza, JD (corresponding author), Hosp Civil Guadalajara Fray Antonio Alcalde, Neuromuscular Disorders Clinic, Hosp 278, Guadalajara 44280, Jalisco, Mexico.
EM j_didiergarza@hotmail.com
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   [Anonymous], 2019, SUBM VAR NM 002693 2, V0, P0
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Habek M, 2012, NEUROLOGIST, V18, P287, DOI 10.1097/NRL.0b013e318266f5a6
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Henao AI, 2016, NEURORADIOL J, V29, P46, DOI 10.1177/1971400915621324
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
NR 9
TC 5
Z9 5
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUL 15
PY 2020
VL 30
IS 7
BP 590
EP 592
DI 10.1016/j.nmd.2020.04.008
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA MQ1VB
UT WOS:000552685000011
PM 32600829
DA 2024-11-01
ER

PT J
AU Barcia, G
   Khirani, S
   Amaddeo, A
   Assouline, Z
   Pennisi, A
   Boddaert, N
   Romero, N
   Desguerre, I
   Schiff, M
   Rötig, A
   Besmond, C
   Bonnefont, JP
   Munnich, A
   Fauroux, B
AF Barcia, Giulia
   Khirani, Sonia
   Amaddeo, Alessandro
   Assouline, Zahra
   Pennisi, Alessandra
   Boddaert, Nathalie
   Romero, Norma
   Desguerre, Isabelle
   Schiff, Manuel
   Rotig, Agnes
   Besmond, Claude
   Bonnefont, Jean-Paul
   Munnich, Arnold
   Fauroux, Brigitte
TI Evidence of diaphragmatic dysfunction with severe alveolar hypoventilation syndrome in mitochondrial respiratory chain deficiency
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial disease; Diaphragmatic dysfunction; mtDNA; MT-CYB; TK2
ID cytochrome-b mutation
AB Diaphragmatic dysfunction has been reported in congenital myopathies, muscular dystrophies, and occasionally, mitochondrial respiratory chain deficiency. Using a minimally invasive procedure in 3 young girls, 1 with a heteroplasmic MT-CYB mutation and 2 with biallelic pathogenic TK2 variants, we provided functional evidence of diaphragmatic dysfunction with global respiratory muscle weakness in mitochondrial respiratory chain deficiency. Analysis of respiratory muscle performance using esogastric pressures revealed paradoxical breathing and severe global inspiratory and expiratory muscle weakness with a sniff esophageal inspiratory pressure and a gastric pressure during cough averaging 50% and 40% of predicted values, respectively. This diaphragmatic dysfunction was responsible for severe undiagnosed nocturnal hypoventilation, requiring noninvasive ventilation. Our results underline the interest of this minimally invasive procedure for the evaluation of respiratory muscle performance and its potential value for the monitoring of future clinical trials in respiratory chain deficiency. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Barcia, Giulia; Assouline, Zahra; Pennisi, Alessandra; Boddaert, Nathalie; Desguerre, Isabelle; Schiff, Manuel; Rotig, Agnes; Bonnefont, Jean-Paul; Munnich, Arnold] Hop Necker Enfants Malad, Federat Genet Med, 149 Rue Sevres, F-75015 Paris, France.
   [Barcia, Giulia; Assouline, Zahra; Pennisi, Alessandra; Boddaert, Nathalie; Desguerre, Isabelle; Schiff, Manuel; Rotig, Agnes; Besmond, Claude; Bonnefont, Jean-Paul; Munnich, Arnold] Univ Paris, Inst IMAGINE, UMR 1163, Paris, France.
   [Khirani, Sonia; Amaddeo, Alessandro; Fauroux, Brigitte] Hop Necker Enfants Malad, Pediat Noninvas Ventilat & Sleep Unit, Paris, France.
   [Khirani, Sonia; Amaddeo, Alessandro; Fauroux, Brigitte] Univ Paris, VIFASOM, Paris, France.
   [Khirani, Sonia] ASV Sante, Gennevilliers, France.
   [Romero, Norma] Hop La Pitie Salpetriere, Neuromuscular Morphol Unit, Paris, France.
   [Romero, Norma] Hop La Pitie Salpetriere, Myol Inst, Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Universite Paris Cite; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite
RP Rötig, A (corresponding author), Hop Necker Enfants Malad, Federat Genet Med, 149 Rue Sevres, F-75015 Paris, France.
EM arnold.munnich@inserm.fr
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Caggiano S, 2017, NEUROMUSCULAR DISORD, V27, P747, DOI 10.1016/j.nmd.2017.04.010
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   Fauroux B, 2018, NEUROMUSCULAR DISORD, V28, P731, DOI 10.1016/j.nmd.2018.06.013
   Finsterer Josef, 2017, OPEN NEUROL J, V11, P1, DOI 10.2174/1874205X01711010001
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Koo P, 2018, CLIN CHEST MED, V39, P401, DOI 10.1016/j.ccm.2018.02.001
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Munnich A, 1996, EUR J PEDIATR, V155, P262
   Osanai S, 2001, RESPIROLOGY, V6, P163, DOI 10.1046/j.1440-1843.2001.00318.x
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   Quijano-Roy S, 2014, NEUROMUSCULAR DISORD, V24, P125, DOI 10.1016/j.nmd.2013.11.002
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   Sommerville EW, 2017, JAMA NEUROL, V74, P686, DOI 10.1001/jamaneurol.2016.4357
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
NR 24
TC 2
Z9 2
U1 2
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUL 15
PY 2020
VL 30
IS 7
BP 593
EP 598
DI 10.1016/j.nmd.2020.06.002
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA MQ1VB
UT WOS:000552685000012
PM 32654952
DA 2024-11-01
ER

PT J
AU Di Nottia, M
   Marchese, M
   Verrigni, D
   Mutti, CD
   Torraco, A
   Oliva, R
   Fernandez-Vizarra, E
   Morani, F
   Trani, G
   Rizza, T
   Ghezzi, D
   Ardissone, A
   Nesti, C
   Vasco, G
   Zeviani, M
   Minczuk, M
   Bertini, E
   Santorelli, FM
   Carrozzo, R
AF Di Nottia, Michela
   Marchese, Maria
   Verrigni, Daniela
   Mutti, Christian Daniel
   Torraco, Alessandra
   Oliva, Romina
   Fernandez-Vizarra, Erika
   Morani, Federica
   Trani, Giulia
   Rizza, Teresa
   Ghezzi, Daniele
   Ardissone, Anna
   Nesti, Claudia
   Vasco, Gessica
   Zeviani, Massimo
   Minczuk, Michal
   Bertini, Enrico
   Santorelli, Filippo Maria
   Carrozzo, Rosalba
TI A homozygous <i>MRPL24</i> mutation causes a complex movement disorder and affects the mitoribosome assembly
SO NEUROBIOLOGY OF DISEASE
LA English
DT Article
DE Mitochondrial disorders; Movement disorder; MRPL24; Mitoribosomes; Mitochondrial protein synthesis; Zebrafish; Molecular modeling; Protein interactions
ID fatty liver-disease; mitochondrial ribosm; subunit; genes; reveals; leads
AB Mitochondrial ribosomal protein large 24 (MRPL24) is 1 of the 82 protein components of mitochondrial ribosomes, playing an essential role in the mitochondrial translation process. We report here on a baby girl with cerebellar atrophy, choreoathetosis of limbs and face, intellectual disability and a combined defect of complexes I and IV in muscle biopsy, caused by a homozygous missense mutation identified in MRPL24. The variant predicts a Leu91Pro substitution at an evolutionarily conserved site. Using human mutant cells and the zebrafish model, we demonstrated the pathological role of the identified variant. In fact, in fibroblasts we observed a significant reduction of MRPL24 protein and of mitochondrial respiratory chain complex I and IV subunits, as well a markedly reduced synthesis of the mtDNA-encoded peptides. In zebrafish we demonstrated that the orthologue gene is expressed in metabolically active tissues, and that gene knockdown induced locomotion impairment, structural defects and low ATP production. The motor phenotype was complemented by human WT but not mutant cRNA. Moreover, sucrose density gradient fractionation showed perturbed assembly of large subunit mitoribosomal proteins, suggesting that the mutation leads to a conformational change in MRPL24, which is expected to cause an aberrant interaction of the protein with other components of the 39S mitoribosomal subunit.
C1 [Di Nottia, Michela; Verrigni, Daniela; Torraco, Alessandra; Trani, Giulia; Rizza, Teresa; Bertini, Enrico; Carrozzo, Rosalba] Bambino Gesu Pediat Hosp, Unit Muscular & Neurodegenerat Disorders, Lab Mol Med, IRCCS, Viale San Paolo 15, I-00146 Rome, Italy.
   [Marchese, Maria; Morani, Federica; Nesti, Claudia; Santorelli, Filippo Maria] IRCCS Fdn Stella Maris, Mol Med & Neurogenet, Pisa, Italy.
   [Mutti, Christian Daniel; Fernandez-Vizarra, Erika; Zeviani, Massimo; Minczuk, Michal] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.
   [Oliva, Romina] Univ Parthenope Naples, Dept Sci & Technol, Naples, Italy.
   [Ghezzi, Daniele] Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, Milan, Italy.
   [Ghezzi, Daniele] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Ardissone, Anna] Fdn IRCCS Ist Neurol Carlo Besta, Child Neurol Unit, Milan, Italy.
   [Ardissone, Anna] Univ Milano Bicocca, Dept Mol & Translat Med DIMET, Milan, Italy.
   [Vasco, Gessica] IRCCS Bambino Gesu Children Hosp, Dept Neurosci, Rome, Italy.
C3 IRCCS Bambino Gesu; IRCCS Fondazione Stella Maris; University of Cambridge; Parthenope University Naples; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Milan; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Milano-Bicocca; IRCCS Bambino Gesu
RP Carrozzo, R (corresponding author), Bambino Gesu Pediat Hosp, Unit Muscular & Neurodegenerat Disorders, Lab Mol Med, IRCCS, Viale San Paolo 15, I-00146 Rome, Italy.
EM rosalba.carrozzo@opbg.net
FU Italian Ministry of Health; Italian Ministry of Health [RF-2016-02361241]; Regione Toscana (RR/NUTRA-FISH); Telethon Foundation [GGP15041]; MIUR-FFABR (Fondo per il Finanziamento Attivita Base di Ricerca); Italian Minister of Health Ricerca Finalizzata; MRC [MC_UU_00015/4, MC_UU_00015/5]; ERC [FP7-322424]; NRJ-Institut de France Grant; MRC [MC_UU_00015/4, MC_UU_00015/8, MC_UU_00015/5] Funding Source: UKRI
CR Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   Baertling F, 2015, NEUROGENETICS, V16, P237, DOI 10.1007/s10048-015-0440-6
   Bieri P, 2018, CURR OPIN STRUC BIOL, V49, P44, DOI 10.1016/j.sbi.2017.12.009
   Bogenhagen DF, 2018, CELL REP, V22, P1935, DOI 10.1016/j.celrep.2018.01.066
   Brodersen DE, 2005, FEBS J, V272, P2098, DOI 10.1111/j.1742-4658.2005.04651.x
   Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Bugiardini E, 2019, HUM MOL GENET, V28, P2711, DOI 10.1093/hmg/ddz093
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Chomyn A, 1996, METHODS ENZYMOL, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   De Silva D, 2015, CELL CYCLE, V14, P2226, DOI 10.1080/15384101.2015.1053672
   DeLano WL, 2002, THE PYMOL MOLECULAR GRAPHICS SYSTEM, V0, P0
   Desmond E, 2011, RES MICROBIOL, V162, P53, DOI 10.1016/j.resmic.2010.10.004
   Distelmaier F, 2015, NEUROGENETICS, V16, P319, DOI 10.1007/s10048-015-0444-2
   Fernández-Silva P, 2007, METHOD CELL BIOL, V80, P571, DOI 10.1016/S0091-679X(06)80028-2
   Fraher D, 2016, CELL REP, V14, P1317, DOI 10.1016/j.celrep.2016.01.016
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Gardeitchik T, 2018, AM J HUM GENET, V102, P685, DOI 10.1016/j.ajhg.2018.02.012
   Gibert Y, 2013, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/4300
   Gopisetty G, 2016, GENE, V589, P27, DOI 10.1016/j.gene.2016.05.008
   Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343
   Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872
   Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895
   Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890
   Howarth DL, 2013, ZEBRAFISH, V10, P199, DOI 10.1089/zeb.2012.0821
   Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356
   Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622
   Kohda M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005679
   Lake NJ, 2018, AM J HUM GENET, V102, P713, DOI 10.1016/j.ajhg.2018.03.015
   Lee WS, 2007, SEMIN LIVER DIS, V27, P259, DOI 10.1055/s-2007-985071
   MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H
   Marchese M, 2016, BIOCHEM BIOPH RES CO, V477, P137, DOI 10.1016/j.bbrc.2016.06.033
   Menezes MJ, 2015, HUM MOL GENET, V24, P2297, DOI 10.1093/hmg/ddu747
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   OBrien TW, 2005, GENE, V354, P147, DOI 10.1016/j.gene.2005.03.026
   OBrien TW, 2000, J BIOL CHEM, V275, P18153, DOI 10.1074/jbc.M909762199
   Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010
   Rizza T, 2009, BIOCHEM BIOPH RES CO, V383, P58, DOI 10.1016/j.bbrc.2009.03.121
   Rorbach J, 2016, P NATL ACAD SCI USA, V113, P12198, DOI 10.1073/pnas.1609338113
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014
   Smith LS, 2013, JOVE-J VIS EXP, V82, P0
   Smits P, 2007, NUCLEIC ACIDS RES, V35, P4686, DOI 10.1093/nar/gkm441
   Smits P, 2011, EUR J HUM GENET, V19, P394, DOI 10.1038/ejhg.2010.214
   Spirina O, 2000, GENE, V261, P229, DOI 10.1016/S0378-1119(00)00504-7
   Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514
   Tolomeo D, 2019, J NEUROL SCI, V399, P69, DOI 10.1016/j.jns.2019.02.010
   Torraco A, 2018, HUM MOL GENET, V27, P3650, DOI 10.1093/hmg/ddy273
   Vacaru AM, 2014, DIS MODEL MECH, V7, P823, DOI 10.1242/dmm.014472
   Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484
   Westerfield M, 2000, ZEBRAFISH BOOK GUIDE, V0, P0
NR 53
TC 25
Z9 25
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 1095-953X
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD JUL 15
PY 2020
VL 141
IS 
BP 
EP 
DI 10.1016/j.nbd.2020.104880
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA MC0EQ
UT WOS:000542971000010
PM 32344152
DA 2024-11-01
ER

PT J
AU Merry, TL
   Chan, A
   Woodhead, JST
   Reynolds, JC
   Kumagai, H
   Kim, SJ
   Lee, C
AF Merry, Troy L.
   Chan, Alex
   Woodhead, Jonathan S. T.
   Reynolds, Joseph C.
   Kumagai, Hiroshi
   Kim, Su-Jeong
   Lee, Changhan
TI Mitochondrial-derived peptides in energy metabolism
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Review
DE aging; humanin; mitochondria; mitochondrial derived peptides; mitokine; MOTS-c; SHLP
ID mots-c levels; ischemia/reperfusion injury; insulin sensitivity; skeletal-muscles; humanin; apoptosis
AB Mitochondrial-derived peptides (MDPs) are small bioactive peptides encoded by short open-reading frames (sORF) in mitochondrial DNA that do not necessarily have traditional hallmarks of protein-coding genes. To date, eight MDPs have been identified, all of which have been shown to have various cyto- or metaboloprotective properties. The 12S ribosomal RNA (MT-RNR1) gene harbors the sequence for MOTS-c, whereas the other seven MDPs [humanin and small humanin-like peptides (SHLP) 1-6] are encoded by the 16S ribosomal RNA gene. Here, we review the evidence that endogenous MDPs are sensitive to changes in metabolism, showing that metabolic conditions like obesity, diabetes, and aging are associated with lower circulating MDPs, whereas in humans muscle MDP expression is upregulated in response to stress that perturbs the mitochondria like exercise, some mtDNA mutation-associated diseases, and healthy aging, which potentially suggests a tissue-specific response aimed at restoring cellular or mitochondrial homeostasis. Consistent with this, treatment of rodents with humanin, MOTS-c, and SHLP2 can enhance insulin sensitivity and offer protection against a range of age-associated metabolic disorders. Furthermore, assessing how mtDNA variants alter the functions of MDPs is beginning to provide evidence that MDPs are metabolic signal transducers in humans. Taken together, MDPs appear to form an important aspect of a retrograde signaling network that communicates mitochondrial status with the wider cell and to distal tissues to modulate adaptative responses to metabolic stress. It remains to be fully determined whether the metaboloprotective properties of MDPs can be harnessed into therapies for metabolic disease.
C1 [Merry, Troy L.; Chan, Alex; Woodhead, Jonathan S. T.] Univ Auckland, Fac Med & Hlth Sci, Discipline Nutr, Auckland, New Zealand.
   [Merry, Troy L.; Woodhead, Jonathan S. T.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand.
   [Reynolds, Joseph C.; Kumagai, Hiroshi; Kim, Su-Jeong; Lee, Changhan] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90007 USA.
   [Kumagai, Hiroshi] Japan Soc Promot Sci, Tokyo, Japan.
   [Kumagai, Hiroshi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan.
   [Lee, Changhan] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA.
   [Lee, Changhan] Ajou Univ, Grad Sch, Biomed Sci, Suwon, South Korea.
C3 University of Auckland; University of Auckland; University of Southern California; Japan Society for the Promotion of Science; Juntendo University; University of Southern California; Ajou University
RP Merry, TL (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Discipline Nutr, Auckland, New Zealand.; Merry, TL (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand.
EM t.merry@auckland.ac.nz
FU Marsden Fast-start grant; Rutherford Discovery Fellowship; NIA [R01AG052258]; Ellison Medical Foundation (EMF); AFAR; Hanson-Thorell Family
CR Bachar AR, 2010, CARDIOVASC RES, V88, P360, DOI 10.1093/cvr/cvq191
   Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Chen J, 2020, SCIENCE, V367, P1140, DOI 10.1126/science.aay0262
   Cobb LJ, 2016, AGING-US, V8, P796, DOI 10.18632/aging.100943
   Conte M, 2019, J GERONTOL A-BIOL, V74, P600, DOI 10.1093/gerona/gly153
   DSouza RF, 2020, AGING-US, V12, P5244, DOI 10.18632/aging.102944
   Du CQ, 2018, PEDIATR DIABETES, V19, P1058, DOI 10.1111/pedi.12685
   Fuku N, 2015, AGING CELL, V14, P921, DOI 10.1111/acel.12389
   Gidlund EK, 2016, PHYSIOL REP, V4, P0, DOI 10.14814/phy2.13063
   Gong ZW, 2015, AM J PHYSIOL-ENDOC M, V309, PE283, DOI 10.1152/ajpendo.00043.2015
   Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627
   Han K, 2018, J CELL BIOCHEM, V119, P3111, DOI 10.1002/jcb.26452
   Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P12854
   Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001
   Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100
   Jiang WX, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-17086-7
   Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5
   Kariya S, 2005, NEUROPEPTIDES, V39, P97, DOI 10.1016/j.npep.2004.11.004
   Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128
   Kim KH, 2018, CELL METAB, V28, P516, DOI 10.1016/j.cmet.2018.06.008
   Kim SJ, 2019, PHYSIOL REP, V7, P0, DOI 10.14814/phy2.14171
   Kim SJ, 2018, AGING-US, V10, P1239, DOI 10.18632/aging.101463
   Kin T, 2006, J HUM GENET, V51, P555, DOI 10.1007/s10038-006-0397-2
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Kuliawat R, 2013, FASEB J, V27, P4890, DOI 10.1096/fj.13-231092
   Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee C, 2014, AGING CELL, V13, P958, DOI 10.1111/acel.12243
   Lee CH, 2013, TRENDS ENDOCRIN MET, V24, P222, DOI 10.1016/j.tem.2013.01.005
   Li QY, 2019, BIOCHEM BIOPH RES CO, V513, P439, DOI 10.1016/j.bbrc.2019.03.194
   Liu C, 2019, AM J PHYSIOL-RENAL, V317, PF1122, DOI 10.1152/ajprenal.00202.2019
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   Lu HY, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20102456
   Lu HY, 2019, J MOL MED, V97, P473, DOI 10.1007/s00109-018-01738-w
   Mangkhang K, 2018, POL J VET SCI, V21, P673, DOI 10.24425/124305
   Mehta HH, 2019, METABOLOMICS, V15, P0, DOI 10.1007/s11306-019-1549-7
   Merry TL, 2016, J PHYSIOL-LONDON, V594, P5195, DOI 10.1113/JP271957
   Merry TL, 2016, FREE RADICAL BIO MED, V98, P123, DOI 10.1016/j.freeradbiomed.2015.11.032
   Miller B, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8040306
   Mottis A, 2019, SCIENCE, V366, P827, DOI 10.1126/science.aax3768
   Muzumdar RH, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0006334
   Oh YK, 2011, ATHEROSCLEROSIS, V219, P65, DOI 10.1016/j.atherosclerosis.2011.06.038
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Qin Q, 2018, INT J CARDIOL, V254, P23, DOI 10.1016/j.ijcard.2017.12.001
   Ramanjaneya M, 2019, FRONT ENDOCRINOL, V10, P0, DOI 10.3389/fendo.2019.00331
   Ramanjaneya M, 2019, CLIN ENDOCRINOL, V91, P278, DOI 10.1111/cen.14007
   Reynolds J, 2019, 201920122022 BIORXIV, V0, P0, DOI DOI 10.1101/2019.12.22.886432
   Cataldo LR, 2018, J INVEST MED, V66, P1019, DOI 10.1136/jim-2017-000681
   Thummasorn S, 2016, CARDIOVASC THER, V34, P404, DOI 10.1111/1755-5922.12210
   Wei M, 2020, CARDIORENAL MED, V10, P42, DOI 10.1159/000503224
   Wei M, 2016, BIOCHEM BIOPH RES CO, V476, P412, DOI 10.1016/j.bbrc.2016.05.135
   Widmer RJ, 2013, AM J PHYSIOL-HEART C, V304, PH393, DOI 10.1152/ajpheart.00765.2012
   Woodhead JST, 2020, J APPL PHYSIOL, V128, P1346, DOI 10.1152/japplphysiol.00032.2020
   Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018
   Yen K, 2020, AGING-US, V12, P11185, DOI 10.18632/aging.103534
   Yen K, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-32616-7
   Zempo H, 2019, BIORXIV695585, V0, P0, DOI DOI 10.1101/
   Zhang X, 2012, LIFE SCI, V91, P199, DOI 10.1016/j.lfs.2012.07.010
   Zhloba A A, 2018, KLIN LAB DIAGN, V63, P466, DOI 10.18821/0869-2084-2018-63-8-466-470
NR 60
TC 73
Z9 75
U1 1
U2 22
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD OCT 15
PY 2020
VL 319
IS 4
BP E659
EP E666
DI 10.1152/ajpendo.00249.2020
PG 8
WC Endocrinology & Metabolism; Physiology
SC Endocrinology & Metabolism; Physiology
GA OG0UA
UT WOS:000581609200001
PM 32776825
DA 2024-11-01
ER

PT J
AU Sabella-Jiménez, V
   Otero-Herrera, C
   Silvera-Redondo, C
   Garavito-Galofre, P
AF Sabella-Jimenez, Vanessa
   Otero-Herrera, Carlos
   Silvera-Redondo, Carlos
   Garavito-Galofre, Pilar
TI Mitochondrial DNA deletion and duplication in Kearns-Sayre Syndrome (KSS) with initial presentation as Pearson Marrow-Pancreas Syndrome (PMPS): Two case reports in Barranquilla, Colombia
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE Kearns-Sayre syndrome; mitochondrial diseases; ophthalmoplegia (MeSH)
ID progressive external ophthalmoplegia; fanconi syndrome; patient; hypoparathyroidism; rearrangements; involvement; glaucoma; features; disease
AB Background: Kearns-Sayre Syndrome (KSS) and Pearson Marrow-Pancreas Syndrome (PMPS) are among the classic phenotypes caused by mitochondrial DNA (mtDNA) deletions. KSS is a rare mitochondrial disease defined by a classic triad of progressive external ophthalmoplegia, atypical pigmentary retinopathy, and onset before 20 years. PMPS presents in the first year of life with bone marrow failure and exocrine pancreatic dysfunction, and can evolve into KSS later in life. Even though an mtDNA deletion is the most frequent mutation in KSS and PMPS, cases of duplications and molecular rearrangements have also been described. In Colombia, few case reports of KSS and PMPS have been published in indexed journals or have been registered in scientific events. Methods: We discuss clinical and genetic aspects of two case reports of pediatric female patients, with initial clinical diagnosis of PMPS who later evolved into KSS, with confirmatory molecular studies of an mtDNA deletion and an mtDNA duplication. Results: A large-scale mtDNA deletion, NC_012920.1:m.8286_14416del, was confirmed by Southern Blot in patient 1. An mtDNA duplication of 7.9 kb was confirmed by MLPA in patient 2. Conclusions: Our findings are compatible with the phenotypic and genetic presentation of PMPS and KSS. We present the first molecularly confirmed case reports of Colombian patients, diagnosed initially with PMPS, who later evolved to KSS.
C1 [Sabella-Jimenez, Vanessa; Otero-Herrera, Carlos] Univ Norte, Genet & Mol Med Res Grp, Barranquilla, Colombia.
   [Silvera-Redondo, Carlos; Garavito-Galofre, Pilar] Univ Norte, Dept Med, Genet & Mol Med Res Grp, Genet, Barranquilla, Colombia.
C3 Universidad del Norte Colombia; Universidad del Norte Colombia
RP Garavito-Galofre, P (corresponding author), Univ Norte, Hlth Sci Div, Dept Med, Km 5 Via Puerto Colombia, Barranquilla, Colombia.
EM mpgaravi@uninorte.edu.co
CR Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639
   Barrera-Ramírez CF, 2005, REV ESP CARDIOL, V58, P443
   BARRIENTOS A, 1995, MED CLIN-BARCELONA, V105, P180
   Becher MW, 1999, HUM PATHOL, V30, P577, DOI 10.1016/S0046-8177(99)90204-6
   Berio A, 2010, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V169, P333
   BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   Cohen BH, 2001, CLEV CLIN J MED, V68, P625, DOI 10.3949/ccjm.68.7.625
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   EVIATAR L, 1990, NEUROLOGY, V40, P1761, DOI 10.1212/WNL.40.11.1761
   Frezzotti P, 2005, EUR J OPHTHALMOL, V15, P809, DOI 10.1177/112067210501500625
   Furuya H, 1997, RINSHO SHINKEIGAKU, V37, P680
   Goldstein A, 2003, MITOCHONDRIAL DNA DE, V0, P0
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Jacobs LJAM, 2004, J INHERIT METAB DIS, V27, P47, DOI 10.1023/B:BOLI.0000016601.49372.18
   KALENAK JW, 1989, AM J OPHTHALMOL, V108, P335, DOI 10.1016/0002-9394(89)90134-7
   Katsanos KH, 2001, AM J NEPHROL, V21, P150, DOI 10.1159/000046239
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Krishna Mani Ram, 2017, INDIAN PACING ELECTROPHYSIOL J, V17, P78, DOI 10.1016/j.ipej.2017.03.003
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Maceluch Jaros Aw, 2006, PEDIATR ENDOCRINOL REV, V4, P117
   Mihai Cristina Maria, 2009, J MED CASE REP, V3, P101, DOI 10.1186/1752-1947-3-101
   Mochizuki H, 1996, CLIN NEPHROL, V46, P347
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORI K, 1991, AM J MED GENET, V38, P583, DOI 10.1002/ajmg.1320380417
   Muraki K, 2001, AM J MED GENET, V98, P205, DOI 10.1002/1096-8628(20010122)98:3<205::AID-AJMG1077>3.0.CO;2-P
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pitchon EM, 2007, KLIN MONATSBL AUGENH, V224, P340, DOI 10.1055/s-2007-962854
   POULTON J, 1994, HUM MOL GENET, V3, P947, DOI 10.1093/hmg/3.6.947
   POULTON J, 1989, LANCET, V1, P236
   POULTON J, 1995, MUSCLE NERVE, V0, PS154
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Simaan EM, 1999, PEDIATR NEUROL, V21, P830, DOI 10.1016/S0887-8994(99)00084-3
   SIMONSZ HJ, 1992, DOC OPHTHALMOL, V82, P73, DOI 10.1007/BF00156996
   SMITH OP, 1995, BRIT J HAEMATOL, V90, P469, DOI 10.1111/j.1365-2141.1995.tb05178.x
   Subbiah RN, 2007, PACE, V30, P137
   SUPERTIFURGA A, 1993, EUR J PEDIATR, V152, P44, DOI 10.1007/BF02072515
   Tesarova M, 2019, PEDIATR BLOOD CANCER, V66, P0, DOI 10.1002/pbc.27591
   Thajeb Peterus, 2006, TAIWAN J OBSTET GYNECOL, V45, P201
   Tzoufi M, 2013, EUR J PEDIATR, V172, P557, DOI 10.1007/s00431-012-1798-1
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wild KT, 2020, AM J MED GENET A, V182, P365, DOI 10.1002/ajmg.a.61433
   Yu M, 2016, CHINESE MED J-PEKING, V129, P1419, DOI 10.4103/0366-6999.183417
   Zarnowski T, 2003, ACTA OPHTHALMOL SCAN, V81, P543, DOI 10.1034/j.1600-0420.2003.00120.x
   Zarnowski T, 2012, CLIN EXP OPHTHALMOL, V40, P218, DOI 10.1111/j.1442-9071.2011.02721.x
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 48
TC 10
Z9 11
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
EI 
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD NOV 15
PY 2020
VL 8
IS 11
BP 
EP 
DI 10.1002/mgg3.1509
EA OCT 2020
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA PV2IX
UT WOS:000575910600001
PM 33030289
DA 2024-11-01
ER

PT J
AU Del Dotto, V
   Ullah, F
   Di Meo, I
   Magini, P
   Gusic, M
   Maresca, A
   Caporali, L
   Palombo, F
   Tagliavini, F
   Baugh, EH
   Macao, B
   Szilagyi, Z
   Peron, C
   Gustafson, MA
   Khan, K
   La Morgia, C
   Barboni, P
   Carbonelli, M
   Valentino, ML
   Liguori, R
   Shashi, V
   Sullivan, J
   Nagaraj, S
   El-Dairi, M
   Iannaccone, A
   Cutcutache, I
   Bertini, E
   Carrozzo, R
   Emma, F
   Diomedi-Camassei, F
   Zanna, C
   Armstrong, M
   Page, M
   Stong, N
   Boesch, S
   Kopajtich, R
   Wortmann, S
   Sperl, W
   Davis, EE
   Copeland, WC
   Seri, M
   Falkenberg, M
   Prokisch, H
   Katsanis, N
   Tiranti, V
   Pippucci, T
   Carelli, V
AF Del Dotto, Valentina
   Ullah, Farid
   Di Meo, Ivano
   Magini, Pamela
   Gusic, Mirjana
   Maresca, Alessandra
   Caporali, Leonardo
   Palombo, Flavia
   Tagliavini, Francesca
   Baugh, Evan Harris
   Macao, Bertil
   Szilagyi, Zsolt
   Peron, Camille
   Gustafson, Margaret A.
   Khan, Kamal
   La Morgia, Chiara
   Barboni, Piero
   Carbonelli, Michele
   Valentino, Maria Lucia
   Liguori, Rocco
   Shashi, Vandana
   Sullivan, Jennifer
   Nagaraj, Shashi
   El-Dairi, Mays
   Iannaccone, Alessandro
   Cutcutache, Ioana
   Bertini, Enrico
   Carrozzo, Rosalba
   Emma, Francesco
   Diomedi-Camassei, Francesca
   Zanna, Claudia
   Armstrong, Martin
   Page, Matthew
   Stong, Nicholas
   Boesch, Sylvia
   Kopajtich, Robert
   Wortmann, Saskia
   Sperl, Wolfgang
   Davis, Erica E.
   Copeland, William C.
   Seri, Marco
   Falkenberg, Maria
   Prokisch, Holger
   Katsanis, Nicholas
   Tiranti, Valeria
   Pippucci, Tommaso
   Carelli, Valerio
TI <i>SSBP1</i> mutations cause mtDNA depletion underlying a complex optic atrophy disorder
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID dna-binding protein; mitochondrial transcription factor; d-loop; opa1; gene; replication; deletions; phosphorylation; instability; twinkle
AB Inherited optic neuropathies include complex phenotypes, mostly driven by mitochondrial dysfunction. We report an optic atrophy spectrum disorder, including retinal macular dystrophy and kidney insufficiency leading to transplantation, associated with mitochondrial DNA (mtDNA) depletion without accumulation of multiple deletions. By whole-exome sequencing, we identified mutations affecting the mitochondrial single-strand binding protein (SSBP1) in 4 families with dominant and 1 with recessive inheritance. We show that SSBP1 mutations in patient-derived fibroblasts variably affect the amount of SSBP1 protein and alter multimer formation, but not the binding to ssDNA. SSBP1 mutations impaired mtDNA, nucleoids, and 7S-DNA amounts as well as mtDNA replication, affecting replisome machinery. The variable mtDNA depletion in cells was reflected in severity of mitochondrial dysfunction, including respiratory efficiency, OXPHOS subunits, and complex amount and assembly. mtDNA depletion and cytochrome c oxidase-negative cells were found ex vivo in biopsies of affected tissues, such as kidney and skeletal muscle. Reduced efficiency of mtDNA replication was also reproduced in vitro, confirming the pathogenic mechanism. Furthermore, ssbp1 suppression in zebrafish induced signs of nephropathy and reduced optic nerve size, the latter phenotype complemented by WT mRNA but not by SSBP1 mutant transcripts. This previously unrecognized disease of mtDNA maintenance implicates SSBP1 mutations as a cause of human pathology.
C1 [Del Dotto, Valentina; La Morgia, Chiara; Copeland, William C.] Univ Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, Neurol Unit, Bologna, Italy.
   [Ullah, Farid; Khan, Kamal; Davis, Erica E.; Copeland, William C.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC USA.
   [Ullah, Farid; Khan, Kamal] Natl Inst Biotechnol & Genet Engn NIBGE, Hlth Biotechnol Div, Human Mol Genet Lab, Faisalabad, Pakistan.
   [Ullah, Farid; Khan, Kamal] PIEAS, Faisalabad, Pakistan.
   [Di Meo, Ivano; Peron, Camille; Tiranti, Valeria] Fdn IRCCS Ist Neurol C Besta, Unit Med Genet & Neurogenet, Milan, Italy.
   [Magini, Pamela; Pippucci, Tommaso] St Orsola Malpighi Univ Hosp, Med Genet Unit, Via Massarenti 9, I-40138 Bologna, Italy.
   [Gusic, Mirjana; Kopajtich, Robert; Wortmann, Saskia; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany.
   [Gusic, Mirjana; Kopajtich, Robert; Wortmann, Saskia; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Munich, Germany.
   [Maresca, Alessandra; Caporali, Leonardo; Palombo, Flavia; Tagliavini, Francesca; La Morgia, Chiara; Carbonelli, Michele; Valentino, Maria Lucia; Liguori, Rocco; Pippucci, Tommaso; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, Via Altura 3, I-40139 Bologna, Italy.
   [Baugh, Evan Harris; Stong, Nicholas] Columbia Univ, Inst Genom Med, New York, NY USA.
   [Macao, Bertil; Szilagyi, Zsolt; Falkenberg, Maria] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
   [Gustafson, Margaret A.] Natl Inst Environm Hlth Sci, Genome Integr & Struct Biol Lab, Res Triangle Pk, NC USA.
   [Barboni, Piero] Studio Oculistico Azeglio, Dept Ophthalmol, Bologna, Italy.
   [Shashi, Vandana; Sullivan, Jennifer] Duke Univ, Sch Med, Div Med Genet, Dept Pediat, Durham, NC USA.
   [Nagaraj, Shashi] Duke Univ, Sch Med, Div Nephrol, Dept Pediat, Durham, NC USA.
   [El-Dairi, Mays] Duke Univ, Sch Med, Neuroophthalmol Serv, Durham, NC USA.
   [Iannaccone, Alessandro] Duke Univ, Sch Med, Ctr Retinal Degenerat & Ophthalm Genet Dis, Durham, NC USA.
   [Iannaccone, Alessandro] Duke Univ, Sch Med, Visual Funct Diagnost Lab, Durham, NC USA.
   [Cutcutache, Ioana; Bertini, Enrico; Page, Matthew] UCB Pharma, Translat Med, Slough, Berks, England.
   [Bertini, Enrico; Carrozzo, Rosalba] IRCCS, Bambino Gesu Childrens Hosp, Dept Neurosci, Unit Muscular & Neurodegenerat Dis, Rome, Italy.
   [Emma, Francesco; Diomedi-Camassei, Francesca] Bambino Gesu Pediat Hosp, Dept Pediat Subspecialties, Div Nephrol, Rome, Italy.
   [Diomedi-Camassei, Francesca] Univ Bologna, Dept Pharm & Biotechnol FABIT, Bologna, Italy.
   [Zanna, Claudia] UCB Pharma, Translat Med, Braine Lalleud, Belgium.
   [Armstrong, Martin] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria.
   [Boesch, Sylvia; Wortmann, Saskia] Salzburger Landeskliniken, Dept Pediat, Salzburg, Austria.
   [Boesch, Sylvia; Wortmann, Saskia] Paracelsus Med Univ, Salzburg, Austria.
   [Sperl, Wolfgang] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy.
   [Seri, Marco] Ann Robert H Lurie Childrens Hosp Chicago, Stanley Manne Childrens Res Inst, Chicago, IL USA.
   [Katsanis, Nicholas] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA.
   [Katsanis, Nicholas] Northwestern Univ, Feinberg Sch Med, Dept Cellular & Mol Biol, Chicago, IL 60611 USA.
C3 University of Bologna; Duke University; Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; Fondazione IRCCS Istituto Neurologico Carlo Besta; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Columbia University; University of Gothenburg; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University; Duke University; Duke University; Duke University; UCB Pharma SA; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Bologna; UCB Pharma SA; Medical University of Innsbruck; Paracelsus Private Medical University; University of Bologna; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine
RP Pippucci, T (corresponding author), St Orsola Malpighi Univ Hosp, Med Genet Unit, Via Massarenti 9, I-40138 Bologna, Italy.; Carelli, V (corresponding author), IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, Via Altura 3, I-40139 Bologna, Italy.
EM tomma-so.pippucci@unibo.it; valerio.carelli@unibo.it
FU Ricerca Corrente from Italian Ministry of Health; Italian Ministry of Health [GR-2016-02361449]; German BMBF [01GM1603, FWF-I 2741-B26, mitoNET 01GM1906B]; Horizon2020 [01GM1603, FWF-I 2741-B26, mitoNET 01GM1906B]; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [ES065078]; Mariani Foundation, Milan; Mitocon, Italy [2018-01]; Associazione Luigi Comini Onlus, Italy; International Research Support Initiative Program fellowship from the Higher Education Commission of Pakistan; Duke University Health System; UCB Celltech
CR Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Anderson BR, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005349
   Antes A, 2010, NUCLEIC ACIDS RES, V38, P6466, DOI 10.1093/nar/gkq493
   Baugh EH, 2016, NUCLEIC ACIDS RES, V44, P2501, DOI 10.1093/nar/gkw120
   Carelli V, 2006, MITOCHONDRIAL MEDICINE, V0, P0, DOI DOI 10.1201/B14623-7
   Carelli V, 2017, HUM MOL GENET, V26, PR139, DOI 10.1093/hmg/ddx273
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carnes MU, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004372
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Ciesielski GL, 2016, METHODS MOL BIOL, V1351, P211, DOI 10.1007/978-1-4939-3040-1_16
   Del Dotto V, 2018, BBA-MOL BASIS DIS, V1864, P3496, DOI 10.1016/j.bbadis.2018.08.004
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Drummond IA, 2016, METHOD CELL BIOL, V134, P391, DOI 10.1016/bs.mcb.2016.03.041
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Fernández-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8
   Fusté JM, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004832
   Genead MA, 2011, INVEST OPHTH VIS SCI, V52, P7298, DOI 10.1167/iovs.11-7762
   Gerber S, 2017, BRAIN, V140, P2586, DOI 10.1093/brain/awx219
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, PF1746, DOI 10.1152/ajprenal.00009.2007
   Hjerpe R, 2010, INT J BIOCHEM CELL B, V42, P725, DOI 10.1016/j.biocel.2010.01.010
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jay JJ, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0160519
   Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Kullar PJ, 2018, BRAIN, V141, P55, DOI 10.1093/brain/awx295
   Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023
   Luo XD, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0125700
   Lyonnais S, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep43992
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Mussini C, 2005, AIDS, V19, P1627, DOI 10.1097/01.aids.0000186019.47297.0d
   Posse V, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1007781
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Reynier P, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.016576
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Samuel A, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep20267
   Sergouniotis PI, 2012, BRIT J OPHTHALMOL, V96, P213, DOI 10.1136/bjo.2011.203638
   Sobreira Nara, 2015, HUM MUTAT, V36, P928, DOI 10.1002/humu.22844
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Sundaram V, 2014, OPHTHALMOLOGY, V121, P234, DOI 10.1016/j.ophtha.2013.08.017
   TIRANTI V, 1995, GENOMICS, V25, P559, DOI 10.1016/0888-7543(95)80058-T
   TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I
   Traynelis J, 2017, GENOME RES, V27, P1715, DOI 10.1101/gr.226589.117
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2016, ACTA NEUROPATHOL, V132, P789, DOI 10.1007/s00401-016-1625-2
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 61
TC 61
Z9 63
U1 0
U2 17
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD JAN 15
PY 2020
VL 130
IS 1
BP 108
EP 125
DI 10.1172/JCI128514
PG 18
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA JZ6IK
UT WOS:000505205000020
PM 31550240
DA 2024-11-01
ER

PT J
AU Kasamo, K
   Nakamura, M
   Daimou, Y
   Sano, A
AF Kasamo, Kei
   Nakamura, Masayuki
   Daimou, Yoko
   Sano, Akira
TI A <i>PRIMPOL</i> mutation and variants in multiple genes may contribute to phenotypes in a familial case with chronic progressive external ophthalmoplegia symptoms
SO NEUROSCIENCE RESEARCH
LA English
DT Article
DE Progressive external ophthalmoplegia; Multiple mitochondrial DNA deletions; Whole-exome sequencing; PRIMPOL
ID mitochondrial; deletions; protein; fever; polg; opa1
AB Chronic progressive external ophthalmoplegia (CPEO) is one of the most common mitochondrial disorders. It is characterized by bilateral, slowly progressing loss of extraocular muscle mobility, orbicularis oculi weakness, ptosis, and other neuromuscular symptoms, which are caused by the accumulation of multiple mitochondrial DNA (mtDNA) deletions. Many mutations in different nuclear genes, such as POLG1, POLG2, ANT1, and others, have been described as causing autosomal-inherited CPEO with multiple mtDNA deletions. Most causative genes are involved in mtDNA replication impairment. Here, we report a family with CPEO-like symptoms characterized by multiple muscle mtDNA deletions, ptosis, diabetes, hearing loss, mental retardation, and emotional instability. We performed genetic analyses to identify nuclear gene mutations in the family. DNA from the proband was analyzed by whole-exome sequencing. In addition to possible pathogenic mutations, rare variants were prioritized for gene-functional phenotype interpretation. We found possible pathogenetic mutations in the PRIMPOL, BRCA1, CPT2, and GJB2 genes, and functional polymorphisms in the CARD8, and MEFV genes. Multiple functional polymorphisms and possible pathogenic mutations may contribute to mitochondrial-disease-like phenotypes in a composite manner. (C) 2019 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.
C1 [Kasamo, Kei; Nakamura, Masayuki; Daimou, Yoko; Sano, Akira] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychiat, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.
C3 Kagoshima University
RP Nakamura, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychiat, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.
EM nakamu36@m.kufm.kagoshima-u.ac.jp
CR Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41
   Abe S, 2001, AM J MED GENET, V103, P334, DOI 10.1002/1096-8628(20011101)103:4<334::AID-AJMG1574>3.0.CO;2-F
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Bernot A, 1997, NAT GENET, V17, P25
   Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035
   Biousse V, 2001, SEMIN NEUROL, V21, P275, DOI 10.1055/s-2001-17945
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   Bonnefont Jean-Paul, 2004, MOLECULAR ASPECTS OF MEDICINE, V25, P495, DOI 10.1016/j.mam.2004.06.004
   Cheung MS, 2017, J IMMUNOL, V198, P2063, DOI 10.4049/jimmunol.1600760
   Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2
   García-Gómez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441
   Ito S, 2014, ARTHRITIS RES THER, V16, P0, DOI 10.1186/ar4483
   Kato M, 2011, NEUROSCI RES, V69, P331, DOI 10.1016/j.neures.2010.12.013
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Keen BA, 2014, NUCLEIC ACIDS RES, V42, P12102, DOI 10.1093/nar/gku879
   Kubota M, 2012, BRAIN DEV-JPN, V34, P20, DOI 10.1016/j.braindev.2010.12.012
   Li JL, 2015, INVEST OPHTH VIS SCI, V56, P1181, DOI 10.1167/iovs.14-16072
   Lin D, 2012, THIRD CONFERENCE ON HORTICULTURE SCIENCE AND TECHNOLOGY (CHST 2012), V0, P1
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Migita K, 2016, ARTHRITIS RES THER, V18, P0, DOI 10.1186/s13075-016-1071-5
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Rudd SG, 2014, MOL CELL ONCOL, V1, P0, DOI 10.4161/23723548.2014.960754
   Samuels J, 1998, MEDICINE, V77, P268, DOI 10.1097/00005792-199807000-00005
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Takata A, 2011, GENOME BIOL BREAST C, V0, P0, DOI DOI 10.3390/ma11061030
   Thuillier L, 2003, HUM MUTAT, V21, P493, DOI 10.1002/humu.10201
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Yao DB, 2008, HUM MUTAT, V29, P718, DOI 10.1002/humu.20717
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang JF, 2013, COMM COM INF SC, V396, P1
   Zhao FX, 2013, HUM GENET, V132, P913, DOI 10.1007/s00439-013-1303-6
NR 37
TC 11
Z9 11
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0168-0102
EI 1872-8111
J9 NEUROSCI RES
JI Neurosci. Res.
PD AUG 15
PY 2020
VL 157
IS 
BP 58
EP 63
DI 10.1016/j.neures.2019.07.006
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA NH3IL
UT WOS:000564567300006
PM 31348995
DA 2024-11-01
ER

PT J
AU Auré, K
   Fayet, G
   Chicherin, I
   Rucheton, B
   Filaut, S
   Heckel, AM
   Eichler, J
   Caillon, F
   Péréon, Y
   Entelis, N
   Tarassov, I
   Lombès, A
AF Aure, Karine
   Fayet, Guillemette
   Chicherin, Ivan
   Rucheton, Benoit
   Filaut, Sandrine
   Heckel, Anne-Marie
   Eichler, Julie
   Caillon, Florence
   Pereon, Yann
   Entelis, Nina
   Tarassov, Ivan
   Lombes, Anne
TI Homoplasmic mitochondrial tRNA<SUP>Pro</SUP> mutation causing exercise-induced muscle swelling and fatigue
SO NEUROLOGY-GENETICS
LA English
DT Article
ID hereditary optic neuropathy; oxidative-phosphorylation; human-cells; dna; expression; defect; mtdna
AB Objective To demonstrate the causal role in disease of the MT-TP m.15992A>T mutation observed in patients from 5 independent families. Methods Lactate measurement, muscle histology, and mitochondrial activities in patients; PCR-based analyses of the size, amount, and sequence of muscle mitochondrial DNA (mtDNA) and proportion of the mutation; respiration, mitochondrial activities, proteins, translation, transfer RNA (tRNA) levels, and base modification state in skin fibroblasts and cybrids; and reactive oxygen species production, proliferation in the absence of glucose, and plasma membrane potential in cybrids. Results All patients presented with severe exercise intolerance and hyperlactatemia. They were associated with prominent exercise-induced muscle swelling, conspicuous in masseter muscles (2 families), and/or with congenital cataract (2 families). MRI confirmed exercise-induced muscle edema. Muscle disclosed severe combined respiratory defect. Muscle mtDNA had normal size and amount. Its sequence was almost identical in all patients, defining the haplotype as J1c10, and sharing 31 variants, only 1 of which, MT-TP m.15992A>T, was likely pathogenic. The mutation was homoplasmic in all tissues and family members. Fibroblasts and cybrids with homoplasmic mutation had defective respiration, low complex III activity, and decreased tRNA(Pro) amount. Their respiratory complexes amount and tRNA(Pro) aminoacylation appeared normal. Low proliferation in the absence of glucose demonstrated the relevance of the defects on cybrid biology while abnormal loss of cell volume when faced to plasma membrane depolarization provided a link to the muscle edema observed in patients. Conclusions The homoplasmic MT-TP m.15992A>T mutation in the J1c10 haplotype causes exercise-induced muscle swelling and fatigue.
C1 [Aure, Karine; Rucheton, Benoit; Lombes, Anne] INSERM, Inst Cochin, U1016, Paris, France.
   [Aure, Karine] Foch Hosp, Dept Neurophysiol, Suresnes, France.
   [Fayet, Guillemette; Pereon, Yann] CHU Nantes, Hotel Dieu AOC, Ctr Reference Malad Neuromusculaires, Nantes, France.
   [Chicherin, Ivan; Heckel, Anne-Marie; Eichler, Julie; Entelis, Nina; Tarassov, Ivan] Univ Strasbourg, CNRS, UMR 7156 GMGM, Strasbourg, France.
   [Rucheton, Benoit; Filaut, Sandrine] CHU Pitie Salpetriere, AP HP, Serv Biochim Metab, Paris, France.
   [Caillon, Florence] CHU Nantes, Hotel Dieu, Serv Radiol & Imagerie Med, Nantes, France.
   [Lombes, Anne] Univ Paris Descartes Paris5, CNRS, UMR 8104, Paris, France.
   [Chicherin, Ivan] MV Lomonossov State Univ, Moscow, Russia.
C3 Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Hospital Foch; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Nantes Universite; CHU de Nantes; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Lomonosov Moscow State University
RP Lombès, A (corresponding author), INSERM, Inst Cochin, U1016, Paris, France.; Tarassov, I (corresponding author), Univ Strasbourg, CNRS, UMR 7156 GMGM, Strasbourg, France.
EM i.tarassov@unistra.fr; anne.lombes@inserm.fr
CR Agier V, 2012, BBA-MOL BASIS DIS, V1822, P1570, DOI 10.1016/j.bbadis.2012.07.002
   [Anonymous], 2013, MUSCLE BIOPSY PRACTI, V0, P0
   Auré K, 2007, NEUROMUSCULAR DISORD, V17, P368, DOI 10.1016/j.nmd.2007.01.019
   Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   de Crécy-Lagard V, 2019, NUCLEIC ACIDS RES, V47, P2143, DOI 10.1093/nar/gkz011
   Fender A, 2004, BIOCHIMIE, V86, P21, DOI 10.1016/j.biochi.2003.11.011
   Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052
   Haraux F, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0221886
   Hogrel JY, 2001, NEUROLOGY, V56, P1733, DOI 10.1212/WNL.56.12.1733
   Howell N, 1997, J BIOENERG BIOMEMBR, V29, P165, DOI 10.1023/A:1022690030664
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Jun AS, 1996, MOL CELL BIOL, V16, P771
   Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546
   Kawahara Y, 2012, NAT PROTOC, V7, P1426, DOI 10.1038/nprot.2012.073
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   POSSEKEL S, 1995, HISTOCHEM CELL BIOL, V103, P59, DOI 10.1007/BF01464476
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898
   REITZER LJ, 1979, J BIOL CHEM, V254, P2669
   Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75
   Rorbach J, 2016, P NATL ACAD SCI USA, V113, P12198, DOI 10.1073/pnas.1609338113
   Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045
   Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Strobbe D, 2018, NEUROBIOL DIS, V114, P129, DOI 10.1016/j.nbd.2018.02.010
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Toompuu M, 1999, HUM MOL GENET, V8, P2275, DOI 10.1093/hmg/8.12.2275
   VARSHNEY U, 1991, J BIOL CHEM, V266, P24712
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11
   Will Y, 2014, EXPERT OPIN DRUG MET, V10, P1061, DOI 10.1517/17425255.2014.939628
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
NR 39
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
EI 
J9 NEUROL-GENET
JI Neurol.-Genet.
PD AUG 15
PY 2020
VL 6
IS 4
BP 
EP 
DI 10.1212/NXG.0000000000000480
PG 10
WC Genetics & Heredity; Clinical Neurology
SC Genetics & Heredity; Neurosciences & Neurology
GA ON2IO
UT WOS:000586531700020
PM 32802947
DA 2024-11-01
ER

PT J
AU Maghbooli, M
   Ghaffarpour, M
   Ghazizadeh, T
   Shalbaf, NA
   MalekMahmoudi, G
AF Maghbooli, Mehdi
   Ghaffarpour, Majid
   Ghazizadeh, Taher
   Shalbaf, Nazanin Azizi
   MalekMahmoudi, Ghazal
TI Clinicogenetical Variants of Progressive External Ophthalmoplegia - An Especial Review of Non-ophthalmic Manifestations
SO NEUROLOGY INDIA
LA English
DT Review
DE Genetic; non-ophthalmic; progressive external ophthalmoplegia plus; progressive external ophthalmoplegiaKey Messages: Progressive external ophthalmoplegia (PEO) as a genetically heterogeneous entity could be accompanied by various non-ophthalmic manifestations such as ataxia; skeletal; bulbar or cardiac myopathy; parkinsonism; hearing loss; neuropathy; endocrinopathy; depression; hepatopathy and even seizure or encephalopathy
ID onset spinocerebellar ataxia; mitochondrial-dna; gene mutation; neuropathy; myopathy; twinkle; diagnosis; deletions; patient; adpeo
AB Progressive external ophthalmoplegia (PEO) is a slowly progressive myopathy characterized by extraocular muscles involvement, leading to frozen eyes without diplopia. The pattern of inheritance may be mitochondrial, autosomal dominant or, rarely, autosomal recessive. Sporadic forms were also reported. Muscular involvement other than extraocular muscles may occur with varying degrees of weakness, but this mostly happens many years after the disease begins. There are also scattered data about systemic signs besides ophthalmoplegia. This article aims to review non-ophthalmic findings of PEO from a clinicogenetical point of view.
C1 [Maghbooli, Mehdi; Ghazizadeh, Taher; Shalbaf, Nazanin Azizi; MalekMahmoudi, Ghazal] Zanjan Univ Med Sci, Dept Neurol, Vali E Asr Hosp, Zanjan, Iran.
   [Ghaffarpour, Majid] Univ Tehran Med Sci, Dept Neurol, Iranian Ctr Neurol Res, Tehran, Iran.
C3 Tehran University of Medical Sciences
RP Maghbooli, M (corresponding author), Zanjan Univ Med Sci, Dept Neurol, Vali E Asr Hosp, Zanjan, Iran.
EM m.maghbooli@zums.ac.ir
CR Berardo A, 2010, NEUROMUSCULAR DISORD, V20, P204, DOI 10.1016/j.nmd.2010.01.006
   Born AP, 2015, EUR J PAEDIATR NEURO, V19, P69, DOI 10.1016/j.ejpn.2014.10.006
   Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066
   Casali C, 1999, J AM COLL CARDIOL, V33, P1584, DOI 10.1016/S0735-1097(99)00079-0
   Challa S, 2004, NEUROL INDIA, V52, P353
   Chaussenot A, 2014, REV NEUROL-FRANCE, V170, P323, DOI 10.1016/j.neurol.2014.03.007
   Chen T, 2014, INT J CLIN EXP PATHO, V7, P8887
   Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151
   Cohen BH, 2018, POLG RELATED DISORDE, V0, P0
   Crippa BL, 2015, AM J MED GENET A, V167, P621, DOI 10.1002/ajmg.a.36939
   Delgado-Alvarado M, 2015, J NEUROL SCI, V350, P93, DOI 10.1016/j.jns.2015.02.011
   Domenis DR, 2011, DIGEST DIS SCI, V56, P2343, DOI 10.1007/s10620-011-1631-0
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Emmanuele V, 2011, J NEUROL SCI, V303, P39, DOI 10.1016/j.jns.2011.01.018
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Findlay AR, 2015, MUSCLE NERVE, V51, P638, DOI 10.1002/mus.24566
   Franzoni F, 2011, ACTA MYOL, V30, P164
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Horváth R, 2003, J MED GENET, V40, P752, DOI 10.1136/jmg.40.10.752
   Houshmand M, 2006, NEUROL INDIA, V54, P182
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Kato M, 2011, NEUROSCI RES, V69, P331, DOI 10.1016/j.neures.2010.12.013
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kiyomoto BH, 2006, J NEUROL NEUROSUR PS, V77, P541, DOI 10.1136/jnnp.2005.079954
   Lam CW, 2015, CLIN CHIM ACTA, V448, P211, DOI 10.1016/j.cca.2015.06.028
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lax NZ, 2012, ARCH NEUROL-CHICAGO, V69, P490, DOI 10.1001/archneurol.2011.2167
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Limongelli G, 2012, FUTUR CARDIOL, V8, P71, DOI 10.2217/fca.11.79
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   LUNDBERG PO, 1962, ACTA NEUROL SCAND, V38, P142
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2013, NEUROMUSCULAR DISORD, V23, P907, DOI 10.1016/j.nmd.2013.07.011
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Oldfors A, 2003, J NEUROPATH EXP NEUR, V62, P217, DOI 10.1093/jnen/62.3.217
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pierce SB, 2016, CSH MOL CASE STUD, V2, P0, DOI 10.1101/mcs.a001107
   Rai NK, 2010, NEUROL INDIA, V58, P790, DOI 10.4103/0028-3886.72176
   Ronchi D, 2011, J NEUROL SCI, V308, P173, DOI 10.1016/j.jns.2011.05.042
   Sharma NK, 2002, J NEUROL NEUROSUR PS, V73, P95, DOI 10.1136/jnnp.73.1.95
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang YX, 2015, CHINESE MED J-PEKING, V128, P1820, DOI 10.4103/0366-6999.159360
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 59
TC 6
Z9 6
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0028-3886
EI 1998-4022
J9 NEUROL INDIA
JI Neurol. India
PD JUL-AUG 15
PY 2020
VL 68
IS 4
BP 760
EP 768
DI 10.4103/0028-3886.293454
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA OO6HZ
UT WOS:000587479900006
PM 32859811
DA 2024-11-01
ER

PT J
AU Chen, C
   Vincent, AE
   Blain, AP
   Smith, AL
   Turnbull, DM
   Reeve, AK
AF Chen, Chun
   Vincent, Amy E.
   Blain, Alasdair P.
   Smith, Anna L.
   Turnbull, Doug M.
   Reeve, Amy K.
TI Investigation of mitochondrial biogenesis defects in single substantia nigra neurons using post-mortem human tissues
SO NEUROBIOLOGY OF DISEASE
LA English
DT Article
DE PD; mtDNA; Mitochondrial disease; POLG mutation; Neurodegeneration; Dopaminergic neuron
ID complex i deficiency; dna deletions; parkinsonism; mutations; phosphorylation; mechanisms; depletion; muscle; tfam
AB Mitochondrial respiratory chain deficiency and mitochondria] DNA deletions are reported in substantia nigra neurons from healthy aged and Parkinson's disease cases, with extensive neuronal loss only seen in the latter. This study aimed to understand the pathological relevance of mitochondrial defects for neuronal survival. Using post-mortem human midbrain, substantia nigra neurons exposed to different types of mitochondrial defects (including mitochondrial DNA point mutations, single and multiple deletions) were compared to neurons from healthy aged and Parkinson's disease cases (either sex) at a single neuronal level. We identified mitochondrial deficiencies in all cases, though these deficiencies were more severe in the mitochondrial disease patients with multiple deletions. A significant reduction in TFAM expression was detected in Parkinson's disease compared to cases with other mitochondria] defects. Higher mitochondrial DNA copy number was detected in healthy aged neurons, despite a deletion level equivalent to Parkinson's disease. Our data support that in individuals with pathogenic mitochondrial defects, neurons respond to mitochondrial defect to survive and such an adaptation may involve TFAM.
C1 [Chen, Chun; Vincent, Amy E.; Blain, Alasdair P.; Smith, Anna L.; Turnbull, Doug M.; Reeve, Amy K.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Chen, Chun; Vincent, Amy E.; Blain, Alasdair P.; Smith, Anna L.; Turnbull, Doug M.; Reeve, Amy K.] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Chen, Chun; Vincent, Amy E.; Smith, Anna L.; Turnbull, Doug M.; Reeve, Amy K.] Newcastle Univ, LLHW Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle University - UK
RP Reeve, AK (corresponding author), Newcastle Univ, Med Sch, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM chun.chen@ncl.ac.uk; amy.vincent@ncl.ac.uk; alasdair.blain@ncl.ac.uk; anna.smith@ncl.ac.uk; doug.turnbull@ncl.ac.uk; amy.reeve@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z16/Z]; MRC as part of the Newcastle Centre for Ageing and Vitality [MR/L016354/1]; senior Parkinson's UK fellowship [F-1401]; MRC [MR/L016354/1, MR/K000608/1, G0800674, G1100540] Funding Source: UKRI
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   di Poggio MB, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-105
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Flones IH, 2018, ACTA NEUROPATHOL, V135, P409, DOI 10.1007/s00401-017-1794-7
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Grünewald A, 2014, J NEUROSCI METH, V232, P143, DOI 10.1016/j.jneumeth.2014.05.026
   Islam H, 2018, METABOLISM, V79, P42, DOI 10.1016/j.metabol.2017.11.001
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Moslemi AR, 1998, NEUROMUSCULAR DISORD, V8, P345, DOI 10.1016/S0960-8966(98)00029-7
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Rempe T, 2016, PARKINSONISM RELAT D, V29, P135, DOI 10.1016/j.parkreldis.2016.04.020
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rygiel KA, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09906
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012
   Team, 2018, R C R LANG ENV STAT, V0, P0
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Zheng B, 2010, SCI TRANSL MED, V2, P0, DOI 10.1126/scitranslmed.3001059
NR 33
TC 29
Z9 29
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 1095-953X
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD FEB 15
PY 2020
VL 134
IS 
BP 
EP 
DI 10.1016/j.nbd.2019.104631
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA KG3BV
UT WOS:000509818400023
PM 31689514
DA 2024-11-01
ER

PT J
AU Heidari, MM
   Keshmirshekan, A
   Bidakhavidi, M
   Khosravi, A
   Bandari, Z
   Khatami, M
   Nafissi, S
AF Heidari, Mohammad Mehdi
   Keshmirshekan, Abolfazl
   Bidakhavidi, Mozhgan
   Khosravi, Azam
   Bandari, Zeinab
   Khatami, Mehri
   Nafissi, Shahriar
TI A novel heteroplasmic mutation in mitochondrial <i>tRNA</i><SUP>Arg</SUP> gene associated with non-dystrophic myotonias
SO ACTA NEUROLOGICA BELGICA
LA English
DT Article
DE Non-dystrophic myotonia; Intracellular ATP; Mitochondrial tRNA genes; Mutation
ID transfer-rna genes; skeletal-muscle channelopathy; essential-hypertension; dna mutations; sequence; prevalence; mtdna; scn4a
AB Non-dystrophic myotonias (NDM) are rare diseases caused by defects in skeletal muscle chloride and sodium ion channels. It is well established that high-energy consuming tissues such as muscular and nervous systems are exclusively dependent on the ATP generation by mitochondria. The mitochondrial dysfunction, which is caused by mitochondrial DNA mutations, played an important role in the pathogenesis of non-dystrophic myotonias. The purpose of this study is to identify mitochondrial tRNA mutations in non-dystrophic myotonias patients. In this study, 45 Iranian patients with non-dystrophic myotonia were investigated for intracellular ATP content and the mutation screening in all the mitochondrial tRNA genes by DNA sequencing. Our findings showed that lymphocyte intracellular ATP is significantly decreased in NDM patients compared with control subjects (p = 0.001). We found nine mutations in mitochondrial tRNA genes, including m.4454 T > C (in the T psi C loop of tRNA(Met)), m.5568 A > G (tRNA(Trp)), m.5794 T > C (in the anticodon loop of tRNA(Cys)), novel m.10438 A > T, and m.10462 T > C (in anticodon loop and ACC stem of tRNA(Arg)), m.12308 A > G (tRNA(Leu(CUN))) and m.15907 A > G, m.15924 A > G, and m.15928 G > A (in the anticodon stem of tRNA(Thr)) in 31 NDM patients. These results suggest that novel m.10438 A > T mutation is involved in NDM patients and reinforces the significant association between this mutation in mitochondrial tRNA(Arg) Gene and NDM patients (p = 0.008).
C1 [Heidari, Mohammad Mehdi; Keshmirshekan, Abolfazl; Bidakhavidi, Mozhgan; Khosravi, Azam; Bandari, Zeinab; Khatami, Mehri] Yazd Univ, Sch Sci, Dept Biol, Yazd, Iran.
   [Nafissi, Shahriar] Univ Tehran Med Sci, Sch Med, Dept Neurol, Tehran, Iran.
C3 University of Yazd; Tehran University of Medical Sciences
RP Heidari, MM (corresponding author), Yazd Univ, Sch Sci, Dept Biol, Yazd, Iran.
EM Heidarimm@yazd.ac.ir
CR Abbott JA, 2014, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00158
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BROWN MD, 1992, AM J HUM GENET, V51, P446
   Cardaioli E, 1999, J SUBMICR CYTOL PATH, V31, P301
   Emery A E, 1991, NEUROMUSCUL DISORD, V1, P19, DOI 10.1016/0960-8966(91)90039-U
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   Heidari MM, 2015, IRAN J NEUROL, V14, P190
   Heidari MM, 2011, IRAN J CHILD NEUROL, V5, P25
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Horga A, 2013, NEUROLOGY, V80, P1472, DOI 10.1212/WNL.0b013e31828cf8d0
   HOUSHMAND M, 1994, BBA-MOL BASIS DIS, V1226, P49, DOI 10.1016/0925-4439(94)90058-2
   LEHMANNHORN F, 1995, CURR OPIN NEUROL, V8, P402, DOI 10.1097/00019052-199510000-00014
   Mayr-Wohlfart U, 1997, EUR J MED RES, V2, P111
   MayrWohlfart U, 1996, ACTA NEUROL SCAND, V94, P167, DOI 10.1111/j.1600-0404.1996.tb07048.x
   Mostafaie N, 2004, J NEURAL TRANSM, V111, P1155, DOI 10.1007/s00702-004-0161-8
   Ryan AM, 2007, CURR OPIN NEUROL, V20, P558, DOI 10.1097/WCO.0b013e3282efc16c
   Sansone Valeria A, 2016, CONTINUUM (MINNEAP MINN), V22, P1889
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Snyder Y, 2015, MUSCLE NERVE, V52, P1013, DOI 10.1002/mus.24684
   Statland Jeffrey M, 2013, CONTINUUM (MINNEAP MINN), V19, P1598, DOI 10.1212/01.CON.0000440661.49298.c8
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Thomas AW, 1996, J MED GENET, V33, P253, DOI 10.1136/jmg.33.3.253
   Trivedi JR, 2013, BRAIN, V136, P2189, DOI 10.1093/brain/awt133
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
   VANDENOUWELAND JMW, 1992, NUCLEIC ACIDS RES, V20, P679, DOI 10.1093/nar/20.4.679
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wang YY, 2014, MITOCHONDR DNA, V25, P124, DOI 10.3109/19401736.2013.786705
   Yang XL, 2017, CHANNELS, V11, P55, DOI 10.1080/19336950.2016.1212140
   YOON KL, 1991, BIOCHEM BIOPH RES CO, V176, P1112, DOI 10.1016/0006-291X(91)90399-R
   Zhu HY, 2009, CLIN CHIM ACTA, V410, P64, DOI 10.1016/j.cca.2009.09.023
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
   ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133
NR 32
TC 4
Z9 5
U1 0
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0300-9009
EI 2240-2993
J9 ACTA NEUROL BELG
JI Acta Neurol. Belg.
PD JUN 15
PY 2020
VL 120
IS 3
BP 573
EP 580
DI 10.1007/s13760-018-1042-5
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA LQ2AU
UT WOS:000534812500008
PM 30430429
DA 2024-11-01
ER

PT J
AU Wang, YT
   Lu, MQ
   Xiong, LP
   Fan, JJ
   Zhou, Y
   Li, HY
   Peng, X
   Zhong, Z
   Wang, YH
   Huang, FX
   Chen, W
   Yu, XQ
   Mao, HP
AF Wang, Yating
   Lu, Miaoqing
   Xiong, Liping
   Fan, Jinjin
   Zhou, Yi
   Li, Huiyan
   Peng, Xuan
   Zhong, Zhong
   Wang, Yihan
   Huang, Fengxian
   Chen, Wei
   Yu, Xueqing
   Mao, Haiping
TI Drp1-mediated mitochondrial fission promotes renal fibroblast activation and fibrogenesis
SO CELL DEATH & DISEASE
LA English
DT Article
ID histone acetylation; dynamics; progression; deficiency; fusion; differentiation; myofibroblasts; involvement; glycolysis; mechanisms
AB Excessive mitochondrial fission acts as a pro-proliferative marker in some cancers and organ fibrosis; its potential role in renal fibroblast activation and fibrogenesis has never been investigated. Here, we showed more pronounced fragmented mitochondria in fibrotic than in non-fibrotic renal fibroblast in humans and mice. In a mouse model of obstructive nephropathy, phosphorylation of Drp1 at serine 616 (p-Drp1S616) and acetylation of H3K27(H3K27ac) was increased in fibrotic kidneys; pharmacological inhibition of mitochondrial fission by mdivi-1 substantially reduced H3K27ac levels, fibroblasts accumulation, and interstitial fibrosis. Moreover, mdivi-1 treatment was able to attenuate the established renal fibrosis. In cultured renal interstitial fibroblasts, targeting Drp1 using pharmacological inhibitor or siRNA suppressed TGF-beta 1-elicited cell activation and proliferation, as evidenced by inhibiting expression of alpha-smooth muscle actin (alpha-SMA) and collagen I, as well as by reducing DNA synthesis. In contrast, Drp1 deletion enhanced cell apoptosis, along with decreased mitochondrial fragmentation, mtROS elevation, and glycolytic shift upon TGF-beta 1 stimulation. In Drp1 deletion fibroblasts, re-expression of wild-type Drp1 rather than Drp1S616A mutant restores the reduction of TGF-beta-induced-Drp1 phosphorylation, H3K27ac, and cell activation. Moreover, TGF-beta 1 treatment increased the enrichment of H3K27ac at the promoters of alpha-SMA and PCNA, which was reversed in Drp1-knockdown fibroblasts co-transfected with empty vector or Drp1S616A, but not wild-type Drp1. Collectively, our results imply that inhibiting p-Drp1S616-mediated mitochondrial fission attenuates fibroblast activation and proliferation in renal fibrosis through epigenetic regulation of fibrosis-related genes transcription and may serve as a therapeutic target for retarding progression of chronic kidney disease.
C1 [Wang, Yating; Xiong, Liping; Fan, Jinjin; Zhou, Yi; Li, Huiyan; Peng, Xuan; Zhong, Zhong; Huang, Fengxian; Chen, Wei; Yu, Xueqing; Mao, Haiping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou, Peoples R China.
   [Wang, Yating; Lu, Miaoqing; Xiong, Liping; Fan, Jinjin; Zhou, Yi; Li, Huiyan; Peng, Xuan; Zhong, Zhong; Huang, Fengxian; Chen, Wei; Yu, Xueqing; Mao, Haiping] NHC Key Lab Nephrol, Guangzhou, Peoples R China.
   [Wang, Yating; Lu, Miaoqing; Xiong, Liping; Fan, Jinjin; Zhou, Yi; Li, Huiyan; Peng, Xuan; Zhong, Zhong; Huang, Fengxian; Chen, Wei; Yu, Xueqing; Mao, Haiping] Guangdong Prov Key Lab Nephrol, Guangzhou, Peoples R China.
   [Lu, Miaoqing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Peoples R China.
   [Wang, Yihan] Lab Kidney Pathol Inc, Nashville, TN USA.
C3 Sun Yat Sen University; Sun Yat Sen University
RP Mao, HP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou, Peoples R China.; Mao, HP (corresponding author), NHC Key Lab Nephrol, Guangzhou, Peoples R China.
EM maohp@mail.sysu.edu.cn
FU National Natural Science Foundation of China [81870464, 81670630, 81270783, 81700583]; Guangzhou Science and Technology Plan [201807010002]; China Postdoctoral Science Foundation [2018M640873]; National Key Research & Development Program of China [2016YFC0906101]; Operational Grant of Guangdong Provincial Key Laboratory [2017B030314019]
CR Anderson GR, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04033-x
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Ayanga BA, 2016, J AM SOC NEPHROL, V27, P2733, DOI 10.1681/ASN.2015101096
   Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829
   Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035
   Cali T, 2018, CURR BIOL, V28, PR73, DOI 10.1016/j.cub.2017.11.040
   Cao SR, 2018, BIOMED RES INT, V2018, P0, DOI 10.1155/2018/2649585
   Carroll PA, 2015, CANCER CELL, V27, P271, DOI 10.1016/j.ccell.2014.11.024
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chattopadhyay E, 2017, FRONT ONCOL, V7, P0, DOI 10.3389/fonc.2017.00043
   Chen HC, 2017, CELL METAB, V26, P39, DOI 10.1016/j.cmet.2017.05.016
   Chen KH, 2018, CIRCULATION, V138, P287, DOI 10.1161/CIRCULATIONAHA.117.031258
   Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107
   Galvan DL, 2019, J CLIN INVEST, V129, P2807, DOI 10.1172/JCI127277
   Hu CX, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18010144
   Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227
   Jiang B, 2017, GENES DIS, V4, P25, DOI 10.1016/j.gendis.2017.02.003
   Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001
   Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762
   Karvonen HM, 2012, LAB INVEST, V92, P1270, DOI 10.1038/labinvest.2012.95
   Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002
   Kraus F, 2017, J CELL SCI, V130, P2953, DOI 10.1242/jcs.199562
   LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218
   Lemos DR, 2018, J AM SOC NEPHROL, V29, P1690, DOI 10.1681/ASN.2017121283
   Li HY, 2016, AUTOPHAGY, V12, P1472, DOI 10.1080/15548627.2016.1190071
   Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149
   Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492
   Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002
   Otera H, 2016, J CELL BIOL, V212, P531, DOI 10.1083/jcb.201508099
   Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011
   Perry HM, 2018, J AM SOC NEPHROL, V29, P194, DOI 10.1681/ASN.2017060659
   Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692
   Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543
   Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003
   Sun YBY, 2016, DIFFERENTIATION, V92, P102, DOI 10.1016/j.diff.2016.05.008
   Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001
   Wang P, 2018, SCI TRANSL MED, V10, P0, DOI 10.1126/scitranslmed.aat2039
   Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009
   Wang YW, 2015, BBA-MOL BASIS DIS, V1852, P34, DOI 10.1016/j.bbadis.2014.11.006
   Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC
   Yuan H, 2013, AM J PHYSIOL-RENAL, V304, PF601, DOI 10.1152/ajprenal.00523.2012
   Zhou Y, 2016, AM J PATHOL, V186, P816, DOI 10.1016/j.ajpath.2015.11.016
NR 42
TC 94
Z9 101
U1 6
U2 37
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
EI 
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JAN 16
PY 2020
VL 11
IS 1
BP 
EP 
DI 10.1038/s41419-019-2218-5
PG 14
WC Cell Biology
SC Cell Biology
GA KI6GN
UT WOS:000511447900005
PM 31949126
DA 2024-11-01
ER

PT J
AU Lu, YY
   Deng, JW
   Zhao, YY
   Zhang, Z
   Hong, DJ
   Yao, S
   Zhao, DH
   Xie, J
   Fang, HZ
   Yuan, Y
   Wang, ZX
AF Lu, Yuanyuan
   Deng, Jianwen
   Zhao, Yuying
   Zhang, Zhe
   Hong, Daojun
   Yao, Sheng
   Zhao, Danhua
   Xie, Jie
   Fang, Hezhi
   Yuan, Yun
   Wang, Zhaoxia
TI Patients with MELAS with negative myopathology for characteristic ragged-red fibers
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE MELAS; Mitochondrial DNA; Diagnosis; Ragged-red fibers; Strongly succinate dehydrogenase-stained vessels
ID stroke-like-episodes; lactic-acidosis; mitochondrial-myopathy; complex-i; clinical-features; muscle biopsy; encephalopathy; dna; mutations; phenotype
AB Background: Muscle pathology usually contributes to mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode (MELAS), even in patients without prominent muscle symptoms. We report a series of patients with MELAS without significant myopathic changes. Methods: Twelve patients without ragged-red fibers (RRFs) on muscle pathology (RRF-negative group) and 99 patients with MELAS and RRFs and/or cytochrome c oxidase (COX)-deficient fibers (control RRF-positive group) were recruited. We analyzed clinical features, neuroimaging and pathological findings, gene mutation data, immunofluorescence assay of key respiratory chain subunits of complexes I and IV and mitochondrial DNA (mtDNA) mutation load in biopsied muscle samples. Results: None of the RRF-negative patients had RRF or COX-negative fibers, but four patients had strongly succinate dehydrogenase-stained vessels (SSVs). There was a lower proportion of m.3243A > G and higher proportion of mitochondria-encoded ND gene mutations in RRF-negative than RRF-positive patients. The proportion of aphasia was relatively higher, while complex I and IV subunit abundance in muscle and mutation load were lower in RRF-negative than in RRF-positive patients. Conclusion: RRF-negative patients had a similar disease course, clinical symptoms, and neuroimaging results to RRF-positive patients with MELAS. SSV is a valuable diagnostic indicator for MELAS. For highly suspected MELAS yet without positive myopathological findings, combined immunofluorescence and genetic studies should be used to achieve final diagnosis.
C1 [Lu, Yuanyuan; Deng, Jianwen; Yuan, Yun; Wang, Zhaoxia] Peking Univ, Dept Neurol, Hosp 1, 8 Xishiku St, Beijing 100034, Peoples R China.
   [Zhao, Yuying] Shandong Univ, Dept Neurol, Qilu Hosp, Jinan, Peoples R China.
   [Zhang, Zhe] Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China.
   [Hong, Daojun] Peking Univ, Dept Neurol, Peoples Hosp, Beijing, Peoples R China.
   [Yao, Sheng] PLA Navy Gen Hosp, Dept Neurol, Beijing, Peoples R China.
   [Zhao, Danhua] Peking Univ, Dept Neurol, Int Hosp, Beijing, Peoples R China.
   [Xie, Jie; Fang, Hezhi] Wenzhou Med Univ, Coll Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Key Lab Lab Med,Minist Educ, Wenzhou, Zhejiang, Peoples R China.
C3 Peking University; Shandong University; Peking University; Sixth Medical Center of Chinese PLA General Hospital; Peking University; Wenzhou Medical University
RP Yuan, Y; Wang, ZX (corresponding author), Peking Univ, Dept Neurol, Hosp 1, 8 Xishiku St, Beijing 100034, Peoples R China.
EM yuanyun2002@126.com; drwangzx@163.com
FU Beijing Municipal Science and Technology Commission [Z151100003915126]
CR Baek MS, 2019, YONSEI MED J, V60, P98, DOI 10.3349/ymj.2019.60.1.98
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   GOTO Y, 1995, MUSCLE NERVE, V0, PS107
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Leng YL, 2015, MITOCHONDR DNA, V26, P208, DOI 10.3109/19401736.2014.905860
   Lim BC, 2009, J CHILD NEUROL, V24, P828, DOI 10.1177/0883073808331085
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Lorenzoni PJ, 2009, ARQ NEURO-PSIQUIAT, V67, P668, DOI 10.1590/S0004-282X2009000400018
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   MIMAKI N, 1991, NO TO HATTATSU, V23, P606
   Moslemi A, 2007, NEUROMUSCULAR DISORD, V17, P771, DOI 10.1016/j.nmd.2007.06.037
   Ozawa M, 1998, J NEUROL SCI, V159, P170, DOI 10.1016/S0022-510X(98)00152-X
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   Tsao CY, 2000, J CHILD NEUROL, V15, P445, DOI 10.1177/088307380001500704
   UJIKE H, 1993, JPN J PSYCHIAT NEUR, V47, P637
   Yan JB, 2014, J MOL DIAGN, V16, P431, DOI 10.1016/j.jmoldx.2014.03.005
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
NR 25
TC 8
Z9 11
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD JAN 15
PY 2020
VL 408
IS 
BP 
EP 
DI 10.1016/j.jns.2019.116499
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA KH9EP
UT WOS:000510952200020
PM 31726383
DA 2024-11-01
ER

PT J
AU Dumic, KK
   Anticevic, D
   Petrinovic-Doresic, J
   Zigman, T
   Zarkovicl, K
   Rokic, F
   Vugrek, O
AF Dumic, Katja K.
   Anticevic, Darko
   Petrinovic-Doresic, Jelena
   Zigman, Tamara
   Zarkovicl, Kamelija
   Rokic, Filip
   Vugrek, Oliver
TI Lowe syndrome - Old and new evidence of secondary mitochondrial dysfunction
SO EUROPEAN JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE Oculocerebrorenal syndrome; Lowe syndrome; OCRL gene; Mitochondriopathy
ID oculocerebrorenal syndrome; ocrl1
AB The oculocerebrorenal syndrome of Lowe (LS) is a rare, progressive, multisystemic X-linked disorder caused by mutations in OCRL gene. Patients classically present with ocular abnormalities including bilateral congenital cataracts and glaucoma, intellectual delay, severe generalized hypotonia with absent tendon reflexes, and proximal renal tubular dysfunction. Congenital bilateral cataracts and hypotonia are present at birth in almost all patients, while other classical symptoms develop gradually with variable severity. Consequently, differential diagnosis in infant period in these patients can be broad including other rare metabolic and neurologic disorders. Herein we present a 4.5 year old boy with Lowe syndrome caused by mutation of OCRL gene, NM_000276.4: c.643C > T; p.(Gln215*), initially diagnosed as having mitochondriopathy due to alteration of mitochondria on electron microscopic examination in different tissues and decreased values of mitochondrial energy metabolism measurements in muscle. No pathogenic mutations in mitochondrial DNA were found on whole exome sequencing. This patient recall historical hypothesis of secondary mitochondrial dysfunction in Lowe syndrome, that may be caused/intensified by some of disease symptoms.
C1 [Dumic, Katja K.] Univ Zagreb, Univ Hosp Ctr Zagreb, Dept Pediat, Div Pediat Endocrinol & Diabet,Med Sch, Zagreb, Croatia.
   [Anticevic, Darko] Specialty Hosp St Catherine, Div Orthoped Surg, Zabok, Croatia.
   [Petrinovic-Doresic, Jelena] Univ Hosp Sveti Duh, Dept Ophthalmol, Zagreb, Croatia.
   [Zigman, Tamara] Univ Hosp Ctr Zagreb, Dept Pediat, Div Genet & Inherited Metab Dis, Zagreb, Croatia.
   [Zarkovicl, Kamelija] Univ Zagreb, Univ Hosp Ctr Zagreb, Dept Pathol, Med Sch, Zagreb, Croatia.
   [Rokic, Filip; Vugrek, Oliver] Rudjer Boskovic Inst, Lab Adv Genom, Zagreb, Croatia.
C3 University of Zagreb; University of Zagreb; University of Zagreb; Rudjer Boskovic Institute
RP Dumic, KK (corresponding author), Univ Hosp Ctr Zagreb, Div Pediat Endocrinol & Diabet, Dept Pediat, Kispaticeva 12, Zagreb 10000, Croatia.
EM katja.dumic@gmail.com
CR Bökenkamp A, 2016, PEDIATR NEPHROL, V31, P2201, DOI 10.1007/s00467-016-3343-3
   Coon BG, 2012, HUM MOL GENET, V21, P1835, DOI 10.1093/hmg/ddr615
   Craigen WJ, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-83
   Festa BP, 2019, HUM MOL GENET, V28, P1931, DOI 10.1093/hmg/ddy449
   GOBERNADO JM, 1984, ARCH NEUROL-CHICAGO, V41, P208, DOI 10.1001/archneur.1984.04050140106037
   Hichri H, 2011, HUM MUTAT, V32, P379, DOI 10.1002/humu.21391
   Lin T, 1999, OPHTHALMOLOGY, V106, P119, DOI 10.1016/S0161-6420(99)90012-X
   Mehta ZB, 2014, TRAFFIC, V15, P471, DOI 10.1111/tra.12160
   Ramos AR, 2019, J LIPID RES, V60, P276, DOI 10.1194/jlr.R087908
   Röschinger W, 2000, MOL GENET METAB, V69, P213, DOI 10.1006/mgme.1999.2955
   SAGEL I, 1970, J PEDIATR-US, V77, P124, DOI 10.1016/S0022-3476(70)80056-7
   SCHOEN EJ, 1959, AM J MED, V27, P781, DOI 10.1016/0002-9343(59)90193-7
   SPEED CJ, 1995, EUR J BIOCHEM, V234, P216, DOI 10.1111/j.1432-1033.1995.216_c.x
NR 13
TC 4
Z9 4
U1 1
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1769-7212
EI 1878-0849
J9 EUR J MED GENET
JI Eur. J. Med. Genet.
PD OCT 15
PY 2020
VL 63
IS 10
BP 
EP 
DI 10.1016/j.ejmg.2020.104022
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA NT7CM
UT WOS:000573094100009
PM 32712215
DA 2024-11-01
ER

PT J
AU Jeppesen, TD
   Duno, M
   Vissing, J
AF Jeppesen, Tina D.
   Duno, Morten
   Vissing, John
TI Mutation Load of Single, Large-Scale Deletions of mtDNA in Mitotic and Postmitotic Tissues
SO FRONTIERS IN GENETICS
LA English
DT Article
DE mtDNA mutation; mtDNA deletion; phenotype-genotype; mitochondrial myopathy; CPEO; chronic progressive external ophthalmoplegia
AB It is generally accepted that patients with chronic progressive ophthalmoplegia caused by single large-scale deletion (SLD) of mitochondrial DNA (mtDNA) only harbor mutation in skeletal and eye muscles. The aim of this study was to investigate the presence and the level of heteroplasmy of mtDNA deletions in mitotic tissues of patients displaying mtDNA deletion of mitotic tissues in patients with SLDs and pure muscle phenotype. MtDNA mutation load was studied in three mitotic (urine epithelial cells, buccal mucosa, and blood) and one postmitotic (skeletal muscle) tissues in 17 patients with SLDs of mtDNA and pure muscle involvement. All patients had mtDNA deletion in skeletal muscle, and 78% of the patients also displayed the mtDNA deletion in mitotic tissues. The mtDNA mutation load was higher in skeletal muscle versus mitotic tissues. The mtDNA mutation load did not correlate with age of sampling of tissues, but there was a correlation between the mtDNA mutations load in skeletal muscle and (1) the site of 5 ' end breaking point of the SLD, (2) the size of SLD, (3) the number of affected tRNAs, and (4) age at onset (r> 0.58,P< 0.05). The findings indicate that mtDNA mutation in mitotic tissue is common in patients with SLDs of mtDNA. The lack of correlation between age of tissue sampling, age at onset, and mtDNA mutation load in mitotic tissues indicates that there is no extensive post-natal modification of mtDNA mutation load in mitotic tissues of patients with pure muscle phenotype.
C1 [Jeppesen, Tina D.; Vissing, John] Univ Copenhagen, Rigshosp, Copenhagen Neuromuscular Ctr, Copenhagen, Denmark.
   [Duno, Morten] Univ Copenhagen, Rigshosp, Dept Clin Genet, Copenhagen, Denmark.
C3 Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet
RP Jeppesen, TD (corresponding author), Univ Copenhagen, Rigshosp, Copenhagen Neuromuscular Ctr, Copenhagen, Denmark.
EM tina.dysgaard.jeppesen.03@regionh.dk
FU Augustinus Fonden; Hartmanns Fond; Lippmann Fonden; Kong Christian den Tiendes Fond; Sara and Ludvig Elsass Foundation; Danish Medical Research Council; NOVO Nordic Foundation; Vanforefonden; University of Copenhagen
CR Akman CI, 2004, J CHILD NEUROL, V19, P258, DOI 10.1177/088307380401900403
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   SOLIGNAC M, 1987, GENETICS, V117, P687
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 11
TC 6
Z9 7
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD OCT 2
PY 2020
VL 11
IS 
BP 
EP 
DI 10.3389/fgene.2020.547638
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA OB3CD
UT WOS:000578349200001
PM 33133144
DA 2024-11-01
ER

PT J
AU Dorison, N
   Gaignard, P
   Bayot, A
   Gelot, A
   Becker, PH
   Fourati, S
   Lebigot, E
   Charles, P
   Wai, T
   Therond, P
   Slama, A
AF Dorison, Nathalie
   Gaignard, Pauline
   Bayot, Aurelien
   Gelot, Antoinette
   Becker, Pierre Hadrien
   Fourati, Salma
   Lebigot, Elise
   Charles, Perrine
   Wai, Timothy
   Therond, Patrice
   Slama, Abdelhamid
TI Mitochondrial dysfunction caused by novel <i>ATAD3A</i> mutations
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondrial disease; ATAD3A; Sensitive motor neuropathy; Congenital cataract
ID recurrent de-novo; membrane-protein; cholesterol; dynamics; atrophy; inner; dna
AB Mitochondrial respiratory chain integrity depends on a number of proteins encoded by nuclear and mitochondrial genomes. Mutations of such factors can result in isolated or combined respiratory chain deficits, some of which can induce abnormal morphology of the mitochondrial network or accumulation of intermediary metabolites. Consequently, affected patients are clinically heterogeneous, presenting with central nervous system, muscular, or neurodegenerative disorders. ATAD3A is a nuclear-encoded ATPase protein of the AAA+ family and has been localized to the inner mitochondrial membrane. Recently reported mutations or large deletions in the ATDA3A gene in patients have been shown to induce altered mitochondrial structure and function and abnormal cholesterol metabolism in a recessive or dominant manner. Here, we report two siblings presenting axonal sensory-motor neuropathy associated with neonatal cataract. Genetic analyses identified two novel mutations in ATAD3A; a point mutation and an intronic 15 bp deletion affecting splicing and leading to exon skipping. Biochemical analysis in patient cells and tissues showed abnormal function of the mitochondrial respiratory chain in muscle and abnormal mitochondrial cristae structure. These new cases underline the large spectrum of biochemical and clinical presentations of ATAD3A deficiency and the different modes of inheritance, making it an atypical mitochondrial disorder.
C1 [Dorison, Nathalie] Fdn Rothschild Hosp, Pediat Neurosurg Unit, Paris, France.
   [Dorison, Nathalie] Univ Paris, Hosp Trousseau, AP HP, Neuropediat Unit, Paris, France.
   [Gaignard, Pauline; Becker, Pierre Hadrien; Fourati, Salma; Lebigot, Elise; Therond, Patrice; Slama, Abdelhamid] Univ Paris Saclay, Hop Bicetre, AP HP, Biochem Dept, F-94275 Le Kremlin Bicetre, France.
   [Bayot, Aurelien; Wai, Timothy] Inst Pasteur, Mitochondrial Biol Grp, CNRS, UMR 3691, Paris, France.
   [Gelot, Antoinette] Hop Trousseau, AP HP, Serv Anat Pathol, 26 Ave Dr Arnold Netter, F-75571 Paris 12, France.
   [Charles, Perrine] Salphriere Hosp, Neurogenet Reference Ctr, Genet Dept, 47 Blvd Hop, F-75013 Paris, France.
   [Gelot, Antoinette] Aix Marseille Univ, INMED, INSERM, Campus Luminy, Marseille, France.
   [Bayot, Aurelien] Nord Univ Paris, Hop Bichat, AP HP, Dept Genet, 46 Rue Henri Huchard, F-75018 Paris, France.
C3 Fondation Adolphe de Rothschild; Assistance Publique Hopitaux Paris (APHP); Sorbonne Universite; Hopital Universitaire Armand-Trousseau - APHP; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Hopital Universitaire Bicetre - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Pasteur Network; Universite Paris Cite; Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Bichat-Claude Bernard - APHP
RP Slama, A (corresponding author), Univ Paris Saclay, Hop Bicetre, AP HP, Biochem Dept, F-94275 Le Kremlin Bicetre, France.
EM abdel.slama@aphp.fr
FU Association des Maladies Mitochondriales (AMMi), France; European Research Council (ERC) [714472]; European Research Council (ERC) [714472] Funding Source: European Research Council (ERC)
CR Al Madhoun A, 2019, APPL CLIN GENET, V12, P163, DOI 10.2147/TACG.S224520
   Bouali N, 2017, FERTIL STERIL, V108, P694, DOI 10.1016/j.fertnstert.2017.07.015
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6
   Cooper HM, 2017, HUM MOL GENET, V26, P1432, DOI 10.1093/hmg/ddx042
   Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094
   Fang HY, 2010, J CELL SCI, V123, P1171, DOI 10.1242/jcs.062034
   Frazier AE, 2020, CLIN TRANSLATIONAL A, V0, PP1, DOI 10.1016/j.medj.2020.06.004
   Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10
   Gunning AC, 2020, AM J HUM GENET, V106, P272, DOI 10.1016/j.ajhg.2020.01.007
   Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007
   Hubstenberger A, 2010, J BIOENERG BIOMEMBR, V42, P143, DOI 10.1007/s10863-010-9269-8
   Lee J, 2016, MOL MED REP, V14, P33, DOI 10.3892/mmr.2016.5209
   Li SJ, 2012, J BIOENERG BIOMEMBR, V44, P189, DOI 10.1007/s10863-012-9424-5
   Peeters-Scholte CMPCD, 2017, BRAIN, V140, P0, DOI 10.1093/brain/awx239
   Peralta S, 2019, MOL GENET METAB, V128, P452, DOI 10.1016/j.ymgme.2019.10.012
   Peralta S, 2018, J CELL SCI, V131, P0, DOI 10.1242/jcs.217075
   Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Zhao JY, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-19849-2
NR 20
TC 19
Z9 21
U1 1
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD SEP-OCT 15
PY 2020
VL 131
IS 1-2
BP 107
EP 113
DI 10.1016/j.ymgme.2020.09.002
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA PH7ZV
UT WOS:000600626600010
PM 32933822
DA 2024-11-01
ER

PT J
AU Viscomi, C
   Zeviani, M
AF Viscomi, C.
   Zeviani, M.
TI Strategies for fighting mitochondrial diseases
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Review
DE AAV; antioxidants; autophagy; experimental therapy; mitochondrial biogenesis; mitochondrial disease
ID gene-therapy; mouse model; respiratory-chain; liver-transplantation; consensus statement; skeletal-muscle; dna; expression; myopathy; deficiency
AB Mitochondrial diseases are extremely heterogeneous genetic conditions characterized by faulty oxidative phosphorylation (OXPHOS). OXPHOS deficiency can be the result of mutation in mtDNA genes, encoding either proteins (13 subunits of the mitochondrial complexes I, III, IV and V) or the tRNA and rRNA components of the in situ mtDNA translation. The remaining mitochondrial disease genes are in the nucleus, encoding proteins with a huge variety of functions, from structural subunits of the mitochondrial complexes, to factors involved in their formation and regulation, components of the mtDNA replication and expression machinery, biosynthetic enzymes for the biosynthesis or incorporation of prosthetic groups, components of the mitochondrial quality control and proteostasis, enzymes involved in the clearance of toxic compounds, factors involved in the formation of the lipid milieu, etc. These different functions represent potential targets for 'general' therapeutic interventions, as they may be adapted to a number of different mitochondrial conditions. This is in contrast with 'tailored', personalized therapeutic approaches, such as gene therapy, cell therapy and organ replacement, that can be useful only for individual conditions. This review will present the most recent concepts emerged from preclinical work and the attempts to translate them into the clinics. The common notion that mitochondrial disorders have no cure is currently challenged by a massive effort of scientists and clinicians, and we do expect that thanks to this intensive investigation work and tangible results for the development of strategies amenable to the treatment of patients with these tremendously difficult conditions are not so far away.
C1 [Viscomi, C.] Univ Padua, Dept Biomed Sci, Padua, Italy.
   [Zeviani, M.] Univ Padua, Dept Neurosci, Padua, Italy.
   [Zeviani, M.] Venetian Inst Mol Med, Padua, Italy.
C3 University of Padua; University of Padua; Veneto Institute Molecular Medicine
RP Zeviani, M (corresponding author), Univ Padua, Dept Neurosci, Padua, Italy.; Zeviani, M (corresponding author), Venetian Inst Mol Med, Padua, Italy.
EM massimo.zeviani@unipd.it
FU MRC [MC_UU_00015/5]; Telethon [GGP19007]; MRC [MC_UU_00015/5] Funding Source: UKRI
CR Abu-Libdeh B, 2017, EUR J HUM GENET, V25, P1142, DOI 10.1038/ejhg.2017.112
   Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Alcázar-Fabra M, 2018, ESSAYS BIOCHEM, V62, P377, DOI 10.1042/EBC20170107
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Awad AM, 2018, ESSAYS BIOCHEM, V62, P361, DOI 10.1042/EBC20170106
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Barriocanal-Casado E, 2019, EBIOMEDICINE, V42, P511, DOI 10.1016/j.ebiom.2019.03.025
   Beyrath J, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-24900-3
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Byrnes J, 2018, NEUROCHEM INT, V117, P23, DOI 10.1016/j.neuint.2017.07.008
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Carelli V, 2017, J NEURO-OPHTHALMOL, V37, P371, DOI 10.1097/WNO.0000000000000570
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chae S, 2013, SCI SIGNAL, V6, P0, DOI 10.1126/scisignal.2003266
   Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Civiletto G, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708799
   Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Costa AL, 2014, HUM MOL GENET, V23, P2106, DOI 10.1093/hmg/ddt603
   Dassa EP, 2009, EMBO MOL MED, V1, P30, DOI 10.1002/emmm.200900001
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   de Haas R, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-09417-5
   Di Meo I, 2017, GENE THER, V24, P661, DOI 10.1038/gt.2017.53
   Di Meo I, 2015, EMBO MOL MED, V7, P1257, DOI 10.15252/emmm.201505040
   Di Meo I, 2012, EMBO MOL MED, V4, P1008, DOI 10.1002/emmm.201201433
   Dillon LM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044335
   Dionisi-Vici C, 2016, BRAIN, V139, P1045, DOI 10.1093/brain/aww013
   Dogan SA, 2018, CELL METAB, V28, P764, DOI 10.1016/j.cmet.2018.07.012
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   El-Khoury R, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003182
   Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, P884S, DOI 10.3945/ajcn.110.001917
   Ferrari M, 2017, P NATL ACAD SCI USA, V114, PE4241, DOI 10.1073/pnas.1621511114
   Finsterer J, 2018, OPHTHALMOLOGY, V125, PE14, DOI 10.1016/j.ophtha.2017.08.040
   Frambach SJCM, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165727
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gammage PA, 2016, METHODS MOL BIOL, V1351, P145, DOI 10.1007/978-1-4939-3040-1_11
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Geffroy G, 2018, BBA-MOL BASIS DIS, V1864, P1596, DOI 10.1016/j.bbadis.2018.02.005
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guy J, 2017, OPHTHALMOLOGY, V124, P1621, DOI 10.1016/j.ophtha.2017.05.016
   Herebian D, 2017, ANN CLIN TRANSL NEUR, V4, P902, DOI 10.1002/acn3.486
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hordeaux J, 2019, MOL THER, V27, P912, DOI 10.1016/j.ymthe.2019.02.013
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Jain IH, 2019, CELL METAB, V30, P824, DOI 10.1016/j.cmet.2019.07.006
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Janssen MCH, 2019, CLIN PHARMACOL THER, V105, P101, DOI 10.1002/cpt.1197
   Jardim FR, 2018, MOL NEUROBIOL, V55, P2085, DOI 10.1007/s12035-017-0448-z
   Johnson SC, 2019, KIDNEY INT, V95, P455, DOI 10.1016/j.kint.2018.08.038
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Kallijärvi J, 2019, EBIOMEDICINE, V42, P30, DOI 10.1016/j.ebiom.2019.03.079
   Karaa A, 2018, NEUROLOGY, V90, PE1212, DOI 10.1212/WNL.0000000000005255
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Koene S, 2017, ORPHANET J RARE DIS, V12, P0
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   López LC, 2014, MOL SYNDROMOL, V5, P163, DOI 10.1159/000360494
   Lopez MJA, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/3904905
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Lynch DR, 2019, ANN CLIN TRANSL NEUR, V6, P15, DOI 10.1002/acn3.660
   Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Peng M, 2015, HUM MOL GENET, V24, P4829, DOI 10.1093/hmg/ddv207
   Perales-Clemente E, 2008, P NATL ACAD SCI USA, V105, P18735, DOI 10.1073/pnas.0810518105
   Polyak E, 2018, MOL GENET METAB, V123, P449, DOI 10.1016/j.ymgme.2018.02.013
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Potgieter M, 2013, NUTR REV, V71, P180, DOI 10.1111/nure.12011
   Raimundo N, 2014, TRENDS MOL MED, V20, P282, DOI 10.1016/j.molmed.2014.01.005
   Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027
   Rajendran J, 2019, EMBO MOL MED, V11, P0, DOI 10.15252/emmm.201809456
   Rocha AG, 2018, SCIENCE, V360, P336, DOI 10.1126/science.aao1785
   Roe CR, 2002, J CLIN INVEST, V110, P259, DOI 10.1172/JCI0215311
   ROTIG A, 1989, LANCET, V1, P902
   Saada Ann, 2009, BIOCHEM J, V422, Pe3, DOI 10.1042/BJ20091194
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sage-Schwaede A, 2019, ANN CLIN TRANSL NEUR, V6, P1877, DOI 10.1002/acn3.50846
   Samanta D, 2017, REDOX BIOL, V13, P331, DOI 10.1016/j.redox.2017.05.022
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107
   Sarzi E, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-20838-8
   Sasaki K, 2017, TRANSPL P, V49, P1097, DOI 10.1016/j.transproceed.2017.03.065
   Saxton RA, 2017, CELL, V168, P960, DOI 10.1016/j.cell.2017.02.004
   Scarpelli M, 2017, APPL CLIN GENET, V10, P21, DOI 10.2147/TACG.S94267
   Schiff M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028823
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Szeto HH, 2014, CLIN PHARMACOL THER, V96, P672, DOI 10.1038/clpt.2014.174
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Torres-Torronteras J, 2018, HUM GENE THER, V29, P708, DOI 10.1089/hum.2017.133
   Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007
   Viscomi C, 2019, CELL METAB, V30, P628, DOI 10.1016/j.cmet.2019.09.004
   Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Voet NBM, 2013, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD003907.pub4
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wan X, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep21587
   Wang A, 2016, ONCOTARGET, V7, P80131, DOI 10.18632/oncotarget.12560
   WATMOUGH NJ, 1990, J CLIN INVEST, V85, P177, DOI 10.1172/JCI114409
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Zhang XD, 2016, ELIFE, V5, P0, DOI 10.7754/eLife.13374
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 120
TC 42
Z9 46
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD JUN 15
PY 2020
VL 287
IS 6
BP 665
EP 684
DI 10.1111/joim.13046
EA APR 2020
PG 20
WC Medicine, General & Internal
SC General & Internal Medicine
GA LS6JN
UT WOS:000526016300001
PM 32100338
DA 2024-11-01
ER

PT J
AU Gonzalez-Freire, M
   Moore, AZ
   Peterson, CA
   Kosmac, K
   McDermott, MM
   Sufit, RL
   Guralnik, JM
   Polonsky, T
   Tian, L
   Kibbe, MR
   Criqui, MH
   Li, LY
   Leeuwenburgh, C
   Ferrucci, L
AF Gonzalez-Freire, Marta
   Moore, A. Zenobia
   Peterson, Charlotte A.
   Kosmac, Kate
   McDermott, Mary M.
   Sufit, Robert L.
   Guralnik, Jack M.
   Polonsky, Tamar
   Tian, Lu
   Kibbe, Melina R.
   Criqui, Michael H.
   Li, Lingyu
   Leeuwenburgh, Christian
   Ferrucci, Luigi
TI Associations of Peripheral Artery Disease With Calf Skeletal Muscle Mitochondrial DNA Heteroplasmy
SO JOURNAL OF THE AMERICAN HEART ASSOCIATION
LA English
DT Article
DE ankle brachial index; D-loop; heteroplasmy; mtDNA; mtDNA copy number; peripheral artery disease
ID ankle-brachial index; mutations; walking; performance; microarray; damage
AB Background Patients with peripheral artery disease (PAD) undergo frequent episodes of ischemia-reperfusion in lower extremity muscles that may negatively affect mitochondrial health and are associated with impaired mobility. We hypothesized that skeletal muscle from PAD patients will show high mitochondrial DNA heteroplasmy, especially in regions more susceptible to oxidative damage, such as the displacement loop, and that the degree of heteroplasmy will be correlated with the severity of ischemia and mobility impairment. Methods and Results Mitochondrial mutations and deletions and their relative abundance were identified by targeted mitochondrial DNA sequencing in biopsy specimens of gastrocnemius muscle from 33 PAD (ankle brachial index <0.9) and 9 non-PAD (ankle brachial index >0.9) subjects aged >= 60 years. The probability of heteroplasmy per DNA base was significantly higher for PAD subjects than non-PAD within each region. In adjusted models, PAD was associated with higher heteroplasmy than non-PAD (P=0.003), but the association was limited to microheteroplasmy, that is heteroplasmy found in 1% to 5% of all mitochondrial genomes (P=0.004). Heteroplasmy in the displacement loop and coding regions were significantly higher for PAD than non-PAD subjects after adjustment for age, sex, race, and diabetes mellitus (P=0.037 and 0.004, respectively). Low mitochondrial damage, defined by both low mitochondrial DNA copy number and low microheteroplasmy, was associated with better walking performance. Conclusions People with PAD have higher "low frequency" heteroplasmy in gastrocnemius muscle compared with people without PAD. Among people with PAD, those who had evidence of least mitochondrial damage, had better walking performance than those with more mitochondrial damage. Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT02246660.
C1 [Gonzalez-Freire, Marta; Moore, A. Zenobia; Ferrucci, Luigi] NIA, NIH, Baltimore, MD 21224 USA.
   [Gonzalez-Freire, Marta] Hlth Res Inst Balearic Isl IdISBa, Palma De Mallorca, Illes Balears, Spain.
   [Peterson, Charlotte A.; Kosmac, Kate] Univ Kentucky, Coll Hlth Sci, Lexington, KY USA.
   [Peterson, Charlotte A.; Kosmac, Kate] Univ Kentucky, Ctr Muscle Biol, Lexington, KY USA.
   [McDermott, Mary M.; Li, Lingyu] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.
   [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
   [Sufit, Robert L.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.
   [Guralnik, Jack M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
   [Polonsky, Tamar] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.
   [Tian, Lu] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA.
   [Kibbe, Melina R.] UNC Sch Med, Dept Surg, Chapel Hill, NC USA.
   [Criqui, Michael H.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.
   [Leeuwenburgh, Christian] Univ Florida, Inst Aging, Dept Aging & Geriatr Res, Gainesville, FL USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Institut Investigacio Sanitaria Illes Balears (IdISBa); University of Kentucky; University of Kentucky; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University System of Maryland; University of Maryland Baltimore; University of Chicago; Stanford University; University of North Carolina School of Medicine; University of California System; University of California San Diego; State University System of Florida; University of Florida
RP Ferrucci, L (corresponding author), NIA, 251 Bayview Blvd, Baltimore, MD 21224 USA.; Gonzalez-Freire, M (corresponding author), Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.
EM martagonzalezfreire@gmail.com; ferruccilu@mail.nih.gov
FU National Institute on Aging [R21-AG047510]; National Heart, Lung, and Blood Institute [R01-HL107510, R01HL109244, R01-HL088589, R01HL122846]; Office of Dietary Supplements; Nathan Shock Center for Aging
CR AlGhatrif M, 2017, J AM HEART ASSOC, V6, P0, DOI 10.1161/JAHA.117.006604
   [Anonymous], 2013, J THORAC DIS S2, V5, P0
   [Anonymous], 2012, DIABETES CARE S1, V35, P0
   [Anonymous], 2018, CURR OPIN TOXICOL, V0, P0
   Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38
   Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662
   Bhat HK, 1999, CIRCULATION, V99, P807, DOI 10.1161/01.CIR.99.6.807
   Brass EP, 2004, VASC MED, V9, P293, DOI 10.1191/1358863x04vm572ra
   Chimienti G, 2018, FREE RADICAL BIO MED, V124, P447, DOI 10.1016/j.freeradbiomed.2018.06.041
   Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Fetterman JL, 2016, CARDIOVASC DIABETOL, V15, P0, DOI 10.1186/s12933-016-0372-y
   Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070
   Hart CR, 2018, EXP PHYSIOL, V103, P838, DOI 10.1113/EP086905
   Hefti E, 2018, MITOCHONDRIAL DNA A, V29, P587, DOI 10.1080/24701394.2017.1325480
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI 10.1042/BSE0470069
   Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504
   McDermott MM, 2008, J AM COLL CARDIOL, V51, P1482, DOI 10.1016/j.jacc.2007.12.034
   McDermott MM, 2007, J AM GERIATR SOC, V55, P400, DOI 10.1111/j.1532-5415.2007.01092.x
   McDermott MM, 2018, VASC MED, V23, P340, DOI 10.1177/1358863X18765667
   McDermott MM, 2017, JAMA CARDIOL, V2, P902, DOI 10.1001/jamacardio.2017.0538
   McDermott MM, 2014, CONTEMP CLIN TRIALS, V38, P121, DOI 10.1016/j.cct.2014.03.009
   McDermott MM, 2011, CIRC-CARDIOVASC IMAG, V4, P246, DOI 10.1161/CIRCIMAGING.110.962183
   McDermott MM, 2015, CIRC RES, V116, P1540, DOI 10.1161/CIRCRESAHA.114.303517
   McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640
   McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008
   McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Pastukh VM, 2016, FREE RADICAL BIO MED, V96, P78, DOI 10.1016/j.freeradbiomed.2016.04.011
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Picca A, 2018, REJUV RES, V21, P350, DOI 10.1089/rej.2017.1989
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Pipinos II, 2006, FREE RADICAL BIO MED, V41, P262, DOI 10.1016/j.freeradbiomed.2006.04.003
   Powers SK, 2011, COMPR PHYSIOL, V1, P941, DOI 10.1002/cphy.c100054
   Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Smigrodzki RM, 2005, REJUV RES, V8, P172, DOI 10.1089/rej.2005.8.172
   Sobenin IA, 2015, GERONTOLOGY, V61, P343, DOI 10.1159/000368923
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stoccoro A, 2018, EPIGENOMICS-UK, V10, P1431, DOI 10.2217/epi-2018-0072
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   White SH, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-1030-6
   Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008
   Zhou TY, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19020417
NR 49
TC 19
Z9 19
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2047-9980
EI 
J9 J AM HEART ASSOC
JI J. Am. Heart Assoc.
PD APR 9
PY 2020
VL 9
IS 7
BP 
EP 
DI 10.1161/JAHA.119.015197
PG 20
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LF7LD
UT WOS:000527597700044
PM 32200714
DA 2024-11-01
ER

PT J
AU Marchet, S
   Legati, A
   Nasca, A
   Di Meo, I
   Spagnolo, M
   Zanetti, N
   Lamantea, E
   Catania, A
   Lamperti, C
   Ghezzi, D
AF Marchet, Silvia
   Legati, Andrea
   Nasca, Alessia
   Di Meo, Ivano
   Spagnolo, Manuela
   Zanetti, Nadia
   Lamantea, Eleonora
   Catania, Alessia
   Lamperti, Costanza
   Ghezzi, Daniele
TI Homozygous mutations in <i>C1QBP</i> as cause of progressive external ophthalmoplegia (PEO) and mitochondrial myopathy with multiple mtDNA deletions
SO HUMAN MUTATION
LA English
DT Article
DE C1QBP; mitochondrial DNA; primary mitochondrial myopathy; progressive external ophthalmoplegia
ID dna deletions; children; defects
AB Biallelic mutations in theC1QBPgene have been associated with mitochondrial cardiomyopathy and combined respiratory-chain deficiencies, with variable onset (including intrauterine or neonatal forms), phenotypes, and severity. We studied two unrelated adult patients from consanguineous families, presenting with progressive external ophthalmoplegia (PEO), mitochondrial myopathy, and without any heart involvement. Muscle biopsies from both patients showed typical mitochondrial alterations and the presence of multiple mitochondrial DNA deletions, whereas biochemical defects of the respiratory chain were present only in one subject. Using next-generation sequencing approaches, we identified homozygous mutations inC1QBP. Immunoblot analyses in patients' muscle samples revealed a strong reduction in the amount of the C1QBP protein and varied impairment of respiratory chain complexes, correlating with disease severity. Despite the original study indicatedC1QBPmutations as causative for mitochondrial cardiomyopathy, our data indicate that mutations inC1QBPhave to be considered in subjects with PEO phenotype or primary mitochondrial myopathy and without cardiomyopathy.
C1 [Marchet, Silvia; Legati, Andrea; Nasca, Alessia; Di Meo, Ivano; Spagnolo, Manuela; Zanetti, Nadia; Lamantea, Eleonora; Catania, Alessia; Lamperti, Costanza; Ghezzi, Daniele] Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, Via Temolo, I-20126 Milan, Italy.
   [Ghezzi, Daniele] Univ Milan, Dipartimento Fisiopatol Med Chirurg & Trapianti, Milan, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Milan
RP Ghezzi, D (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, Via Temolo, I-20126 Milan, Italy.; Ghezzi, D (corresponding author), Univ Milan;, Dept Pathophysiol & Transplantat, Lab Neurogenet & Mitochondrial Disorders, Via Temolo 4, I-20126 Milan, Italy.
EM daniele.ghezzi@istituto-besta.it
FU Fondazione Pierfranco e Luisa Mariani-Center for the Study of Mitochondrial Diseases [CM23]; Ministero della Salute [RF-2016-02361495, RF-2016-02361241]
CR Adzhubei Ivan, 2013, CURR PROTOC HUM GENET, VChapter 7, P0, DOI 10.1002/0471142905.hg0720s76
   Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Constantinides VC, 2018, IN VIVO, V32, P1647, DOI 10.21873/invivo.11427
   Feichtinger RG, 2017, AM J HUM GENET, V101, P525, DOI 10.1016/j.ajhg.2017.08.015
   Heighton JN, 2019, MITOCHONDRION, V49, P227, DOI 10.1016/j.mito.2019.09.002
   Hillman GA, 2019, J BIOL CHEM, V294, P9813, DOI 10.1074/jbc.RA119.008476
   Legati A, 2017, J MED GENET, V54, P815, DOI 10.1136/jmedgenet-2017-104822
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Sadikovic B, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0188610
   Saha SK, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8040513
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Tengan CH, 1996, BIOCHEM MOL MED, V58, P130, DOI 10.1006/bmme.1996.0040
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   Vaser R, 2016, NAT PROTOC, V11, P1, DOI 10.1038/nprot.2015.123
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Xue Y, 2015, GENET MED, V17, P444, DOI 10.1038/gim.2014.122
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
NR 24
TC 14
Z9 14
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD OCT 15
PY 2020
VL 41
IS 10
BP 1745
EP 1750
DI 10.1002/humu.24081
EA JUL 2020
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA NT6FA
UT WOS:000550806100001
PM 32652806
DA 2024-11-01
ER

PT J
AU Warren, C
   McDonald, D
   Capaldi, R
   Deehan, D
   Taylor, RW
   Filby, A
   Turnbull, DM
   Lawless, C
   Vincent, AE
AF Warren, Charlotte
   McDonald, David
   Capaldi, Roderick
   Deehan, David
   Taylor, Robert W.
   Filby, Andrew
   Turnbull, Doug M.
   Lawless, Conor
   Vincent, Amy E.
TI Decoding mitochondrial heterogeneity in single muscle fibres by imaging mass cytometry
SO SCIENTIFIC REPORTS
LA English
DT Article
ID deficiency; mechanisms; proteomics; mutations; iv
AB The study of skeletal muscle continues to support the accurate diagnosis of mitochondrial disease and remains important in delineating molecular disease mechanisms. The heterogeneous expression of oxidative phosphorylation proteins and resulting respiratory deficiency are both characteristic findings in mitochondrial disease, hence the rigorous assessment of these at a single cell level is incredibly powerful. Currently, the number of proteins that can be assessed in individual fibres from a single section by immunohistochemistry is limited but imaging mass cytometry (IMC) enables the quantification of further, discrete proteins in individual cells. We have developed a novel workflow and bespoke analysis for applying IMC in skeletal muscle biopsies from patients with genetically-characterised mitochondrial disease, investigating the distribution of nine mitochondrial proteins in thousands of single muscle fibres. Using a semi-automated analysis pipeline, we demonstrate the accurate quantification of protein levels using IMC, providing an accurate measure of oxidative phosphorylation deficiency for complexes I-V at the single cell level. We demonstrate signatures of oxidative phosphorylation deficiency for common mtDNA variants and nuclear-encoded complex I variants and a compensatory upregulation of unaffected oxidative phosphorylation components. This technique can now be universally applied to evaluate a wide range of skeletal muscle disorders and protein targets.
C1 [Warren, Charlotte; Taylor, Robert W.; Turnbull, Doug M.; Lawless, Conor; Vincent, Amy E.] Newcastle Univ, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [McDonald, David; Filby, Andrew] Newcastle Univ, Biosci Inst, Flow Cytometry Core Facil, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Capaldi, Roderick] Cellstate Biosci, Tucson, AZ 85721 USA.
   [Deehan, David; Turnbull, Doug M.; Vincent, Amy E.] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Taylor, Robert W.] NHS Fdn Trust, Newcastle Upon Tyne Hosp, NHS Highly Specialised Rare Mitochondrial Disorde, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK
RP Lawless, C; Vincent, AE (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Vincent, AE (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM conor.lawless@ncl.ac.uk; amy.vincent@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council Centre for Ageing and Vitality [L016354]; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort [G0800674]; NIHR Newcastle Biomedical Research Centre; UK National Institute for Health Research Biomedical Research Centre in Age and Age Related Diseases; MRC/Engineering and Physical Sciences Research Council Molecular Pathology Node; Lily Foundation; UK NHS Specialist Commissioners Rare Mitochondrial Disorders of Adults and Children Service; Sir Henry Wellcome Fellowship [215888/Z/19/Z]; MRC as part of the Centre for Ageing and Vitality [L016354/1]; Barbour Foundation; MRC [G0800674] Funding Source: UKRI; Wellcome Trust [215888/Z/19/Z] Funding Source: Wellcome Trust
CR Ahmed ST, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-14623-2
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   Giesen C, 2014, HIGHLY MULTIPLEXED I, V11, P0
   Jayaprakash AD, 2015, NUCLEIC ACIDS RES, V43, P2177, DOI 10.1093/nar/gkv052
   Karbanová VH, 2012, BBA-BIOENERGETICS, V1817, P1037, DOI 10.1016/j.bbabio.2012.03.004
   Kovárová N, 2012, BBA-MOL BASIS DIS, V1822, P1114, DOI 10.1016/j.bbadis.2012.03.007
   Lang F, 2018, J PROTEOME RES, V17, P3333, DOI 10.1021/acs.jproteome.8b00093
   Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022
   Murgia M, 2019, CELL REP, V29, P3825, DOI 10.1016/j.celrep.2019.11.055
   Murgia M, 2015, EMBO REP, V16, P387, DOI 10.15252/embr.201439757
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rowan SL, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0029082
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Sardone V, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0194540
   Schilling B, 2006, BBA-MOL BASIS DIS, V1762, P213, DOI 10.1016/j.bbadis.2005.07.003
   Torralba D, 2016, FRONT CELL DEV BIOL, V4, P0, DOI 10.3389/fcell.2016.00107
   Villalta SA, 2014, SCI TRANSL MED, V6, P0, DOI 10.1126/scitranslmed.3009925
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Vincent AE, 2016, NEUROMUSCULAR DISORD, V26, P691, DOI 10.1016/j.nmd.2016.08.004
   Wählby C, 2002, CYTOMETRY, V47, P32, DOI 10.1002/cyto.10026
   Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009
NR 26
TC 14
Z9 15
U1 0
U2 5
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD SEP 18
PY 2020
VL 10
IS 1
BP 
EP 
DI 10.1038/s41598-020-70885-3
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NU6KJ
UT WOS:000573751100020
PM 32948797
DA 2024-11-01
ER

PT J
AU Russell, OM
   Gorman, GS
   Lightowlers, RN
   Turnbull, DM
AF Russell, Oliver M.
   Gorman, Grainne S.
   Lightowlers, Robert N.
   Turnbull, Doug M.
TI Mitochondrial Diseases: Hope for the Future
SO CELL
LA English
DT Review
ID activated protein-kinase; gene-therapy; mouse model; selective elimination; allotopic expression; nad(+) metabolism; dna heteroplasmy; mtdna mutation; nuclear; myopathy
AB Mitochondrial diseases are clinically heterogeneous disorders caused by a wide spectrum of mutations in genes encoded by either the nuclear or the mitochondrial genome. Treatments for mitochondrial diseases are currently focused on symptomatic management rather than improving the biochemical defect caused by a particular mutation. This review focuses on the latest advances in the development of treatments for mitochondrial disease, both small molecules and gene therapies, as well as methods to prevent transmission of mitochondrial disease through the germline.
C1 [Russell, Oliver M.; Gorman, Grainne S.; Lightowlers, Robert N.; Turnbull, Doug M.] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Russell, Oliver M.; Gorman, Grainne S.; Turnbull, Doug M.] Newcastle Univ, Fac Med Sci, Clin & Translat Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Gorman, Grainne S.] NuTH NHS Fdn Trust, NIHR Newcastle BRC, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Lightowlers, Robert N.] Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK
RP Lightowlers, RN; Turnbull, DM (corresponding author), Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Turnbull, DM (corresponding author), Newcastle Univ, Fac Med Sci, Clin & Translat Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Lightowlers, RN (corresponding author), Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.lightowlers@newcastle.ac.uk; doug.turnbull@newcastle.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; MRC Centre for Ageing and Vitality [MR/L016354/1]; MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort [G0800674]; EU Marie Sklodowska-Curie ITN [721757]; UK NIHR Biomedical Research Centre in Age and Age Related Diseases; Lily Foundation; UK NHS Specialist Commissioners "Rare Mitochondrial Disorders of Adults and Children'' Service; Marie Curie Actions (MSCA) [721757] Funding Source: Marie Curie Actions (MSCA); MRC [MR/L016354/1, G0800674] Funding Source: UKRI
CR Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   Augustine EF, 2013, J CHILD NEUROL, V28, P1142, DOI 10.1177/0883073813495959
   Avula S, 2014, CURR TREAT OPTION NE, V16, P0, DOI 10.1007/s11940-014-0292-7
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Barrow JJ, 2016, MOL CELL, V64, P163, DOI 10.1016/j.molcel.2016.08.023
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bax BE, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8081096
   Besouw M, 2013, DRUG DISCOV TODAY, V18, P785, DOI 10.1016/j.drudis.2013.02.003
   Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chatfield KC, 2019, JACC-BASIC TRANSL SC, V4, P147, DOI 10.1016/j.jacbts.2018.12.005
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Civiletto G, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708799
   Colella M, 2018, ACS APPL MATER INTER, V10, P40001, DOI 10.1021/acsami.8b15942
   CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x
   Desai S, 2018, EXP BIOL MED, V243, P554, DOI 10.1177/1535370217752351
   Dillon LM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044335
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Ehinger JK, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms12317
   El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, P884S, DOI 10.3945/ajcn.110.001917
   Ferrari M, 2017, P NATL ACAD SCI USA, V114, PE4241, DOI 10.1073/pnas.1621511114
   Field Marilyn J, 2010, RARE DISEASES AND ORPHAN PRODUCTS: ACCELERATING RESEARCH AND DEVELOPMENT, V0, P0
   Fightaging, 2019, MOR SER TRIAL FAIL G, V0, P0
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Garone C, 2018, BIOCHEM SOC T, V46, P1247, DOI 10.1042/BST20180134
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Gerards M, 2011, BRAIN, V134, P210, DOI 10.1093/brain/awq273
   Golubitzky A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026883
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gorman GS, 2018, LANCET, V392, P1191, DOI 10.1016/S0140-6736(18)31868-3
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Greenfield A, 2017, NAT BIOTECHNOL, V35, P1059, DOI 10.1038/nbt.3997
   Guy J, 2017, OPHTHALMOLOGY, V124, P1621, DOI 10.1016/j.ophtha.2017.05.016
   Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006
   Hudry E, 2019, NEURON, V101, P839, DOI 10.1016/j.neuron.2019.02.017
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jain IH, 2019, CELL METAB, V30, P824, DOI 10.1016/j.cmet.2019.07.006
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Johnson SC, 2016, ONCOTARGET, V7, P44876, DOI 10.18632/oncotarget.10381
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Kandul NP, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13100
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   Katsyuba E, 2017, EMBO J, V36, P2670, DOI 10.15252/embj.201797135
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Klopstock T, 2013, BRAIN, V136, P0, DOI 10.1093/brain/aws279
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koene S, 2018, J INHERIT METAB DIS, V41, P1267, DOI 10.1007/s10545-018-0229-5
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Lee CF, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-39419-4
   Lott Marie T, 2013, CURRENT PROTOCOLS BI, V0, P0
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270
   Madsen KL, 2020, NEUROLOGY, V94, PE687, DOI 10.1212/WNL.0000000000008861
   MCGRATH J, 1983, J EXP ZOOL, V228, P355, DOI 10.1002/jez.1402280218
   McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110
   Murphy MP, 2018, NAT REV DRUG DISCOV, V17, P865, DOI 10.1038/nrd.2018.174
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Newman Jane, 2015, J NEUROMUSCUL DIS, V2, P151
   Ng Yi Shiau, 2019, WELLCOME OPEN RES, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Noe N, 2013, MITOCHONDRION, V13, P417, DOI 10.1016/j.mito.2012.12.003
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Parikh S, 2019, NEUROMUSCULAR DISORD, V29, P895, DOI 10.1016/j.nmd.2019.09.012
   Patgiri A, 2020, NAT BIOTECHNOL, V38, P309, DOI 10.1038/s41587-019-0377-7
   Perales-Clemente E, 2011, NUCLEIC ACIDS RES, V39, P225, DOI 10.1093/nar/gkq769
   Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad
   Pickett SJ, 2019, NEW ENGL J MED, V380, P1971, DOI 10.1056/NEJMc1808565
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Poulton J, 2019, NEUROMUSCULAR DISORD, V29, P725, DOI 10.1016/j.nmd.2019.08.004
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Repp BM, 2018, ORPHANET J RARE DIS, V13, P0, DOI 10.1186/s13023-018-0784-8
   Robinson BH, 2006, MOL GENET METAB, V89, P3, DOI 10.1016/j.ymgme.2006.05.015
   Robledinos-Antón N, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/9372182
   Rudolph G, 2013, J NEURO-OPHTHALMOL, V33, P30, DOI 10.1097/WNO.0b013e318272c643
   Ryan E, 2006, IR MED J, V99, P262
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Saada A, 2019, EBIOMEDICINE, V47, P14, DOI 10.1016/j.ebiom.2019.08.005
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schober P, 2018, ANESTH ANALG, V126, P1068, DOI 10.1213/ANE.0000000000002798
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553
   Steffann J, 2018, CELL STEM CELL, V22, P481, DOI 10.1016/j.stem.2018.01.004
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Taylor RW, 2001, ADV DRUG DELIVER REV, V49, P121, DOI 10.1016/S0169-409X(01)00130-2
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   To TL, 2019, CELL, V179, P1222, DOI 10.1016/j.cell.2019.10.032
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   van de Weijer T, 2015, DIABETES, V64, P1193, DOI 10.2337/db14-0667
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wenz T, 2016, CELL METAB, V24, P889, DOI 10.1016/j.cmet.2016.11.006
   Wenz T, 2016, P NATL ACAD SCI USA, V113, PE8502, DOI 10.1073/pnas.1619713114
   Whitaker RM, 2016, ANNU REV PHARMACOL, V56, P229, DOI 10.1146/annurev-pharmtox-010715-103155
   Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Yang S, 2016, EBIOMEDICINE, V10, P258, DOI 10.1016/j.ebiom.2016.07.002
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Zhang J, 2017, REPROD BIOMED ONLINE, V34, P361, DOI 10.1016/j.rbmo.2017.01.013
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
NR 131
TC 227
Z9 247
U1 3
U2 72
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD APR 2
PY 2020
VL 181
IS 1
BP 168
EP 188
DI 10.1016/j.cell.2020.02.051
PG 21
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA KZ5RI
UT WOS:000523319000020
PM 32220313
DA 2024-11-01
ER

PT J
AU Lim, AZ
   McMacken, G
   Rastelli, F
   Olahova, M
   Baty, K
   Hopton, S
   Falkous, G
   Töpf, A
   Lochmüller, H
   Marini-Bettolo, C
   McFarland, R
   Taylor, RW
AF Lim, Albert Z.
   McMacken, Grace
   Rastelli, Francesca
   Olahova, Monika
   Baty, Karen
   Hopton, Sila
   Falkous, Gavin
   Topf, Ana
   Lochmueller, Hanns
   Marini-Bettolo, Chiara
   McFarland, Robert
   Taylor, Robert W.
TI A novel, pathogenic dinucleotide deletion in the mitochondrial <i>MT-TY</i> gene causing myasthenia-like features
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial disease; Congenital myasthenia syndromes (CMS); MTTY gene; mtDNA tRNA variant; Muscle biopsy
ID transfer-rna mutations; point mutations; diagnosis; myopathy; assay
AB Mitochondrial DNA (mtDNA)-related diseases often pose a diagnostic challenge and require rigorous clinical and laboratory investigation. Pathogenic variants in the mitochondrial tRNA gene MT-TY, which encodes the tRNATyr, are a rare cause of mitochondrial disease. Here we describe a novel m.5860delTA anticodon variant in the MT-TY gene in a patient who initially presented with features akin to a childhood onset myasthenic syndrome. Using histochemical, immunohistochemical and protein studies we demonstrate that this mutation leads to severe biochemical defects of mitochondrial translation, which is reflected in the early onset and progressive phenotype. This case highlights the clinical overlap between mtDNA-related diseases and other neuromuscular disorders, and demonstrates the potential pitfalls in analysis of next generation sequencing results, given whole exome sequencing of a blood DNA sample failed to make a genetics diagnosis. Muscle biopsy remains an important requirement in the diagnosis of mitochondrial disease and in establishing the pathogenicity of novel mtDNA variants. (c) 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license. (http://creativecommons.org/licenses/by/4.0/)
C1 [Lim, Albert Z.; Rastelli, Francesca; Olahova, Monika; Baty, Karen; Hopton, Sila; Falkous, Gavin; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Sch Med, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [McMacken, Grace; Topf, Ana; Marini-Bettolo, Chiara] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England.
   [Baty, Karen; Hopton, Sila; Falkous, Gavin; Taylor, Robert W.] NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne, Tyne & Wear, England.
   [McMacken, Grace] Belfast Hlth & Social Care Trust, Royal Victoria Hosp, Dept Neurosci, Belfast, Antrim, North Ireland.
   [Olahova, Monika] Newcastle Univ, Biosci Inst, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Lochmueller, Hanns] Univ Freiburg, Dept Neuropediatr & Muscle Disorders, Med Ctr, Freiburg, Germany.
   [Lochmueller, Hanns] Barcelona Inst Sci & Technol, Ctr Genom Regulat, Ctr Nacl Anal Genom CNAG CRG, Barcelona, Spain.
   [Lochmueller, Hanns] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada.
   [Lochmueller, Hanns] Ottawa Univ, Dept Med, Div Neurol, Ottawa, ON, Canada.
   [McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Freiburg; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Newcastle University - UK
RP McFarland, R (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England.; McFarland, R (corresponding author), Newcastle Univ, Wellcome Ctr Mitochondrial Res, Newcastle, NSW NE2 4HH, Australia.
EM robert.mcfarland@ncl.ac
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease; Mitochondrial Disease Patient Cohort (UK) [G0800674]; Newcastle University Centre for Ageing and Vitality (Biotechnology and Biological Sciences Research Council ); Newcastle University Centre for Ageing and Vitality (Medical Research Council) [L016354]; UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; Lily Foundation; UK NHS Specialist Commissioners - "Rare Mitochondrial Disorders of Adults and Children" Diagnostic Service in Newcastle upon Tyne; Association of British Neurologists Clinical Research Training Fellowship; Biobanking and Biomedical Resources Research Infrastructure -large prospective cohorts (BBMRILPC) 2016 access call for Whole Exome Sequencing (FP7/2007-2013) [313010]; RD-Connect Genome-Phenome Analysis platform developed under FP7/2007-2013 [305444]; UK NHS Highly Specialised Service for Rare Neuromuscular Disorders in Newcastle upon Tyne; MRC [G0800674] Funding Source: UKRI
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Braz LP, 2019, NEUROMUSCULAR JUNCTI, V0, P0, DOI DOI 10.1212/CPJ.0000000000000795
   Chaouch Amina, 2014, J NEUROMUSCUL DIS, V1, P75
   Guo YR, 2015, NEUROMUSCULAR DISORD, V25, P257, DOI 10.1016/j.nmd.2014.11.017
   Joshi PR, 2020, NEUROMUSCUL DISORD, V0, P0
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kornblum C, 2008, BIOSCIENCE REP, V28, P89, DOI 10.1042/BSR20080004
   KRENDEL DA, 1987, MUSCLE NERVE, V10, P299, DOI 10.1002/mus.880100404
   Lehtokari VL, 2014, HUM MUTAT, V35, P1418, DOI 10.1002/humu.22693
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Plewnia K, 1997, J SUBMICR CYTOL PATH, V29, P335
   Pulkes T, 2000, NEUROLOGY, V55, P1210, DOI 10.1212/WNL.55.8.1210
   Raffelsberger T, 2001, NEUROLOGY, V57, P2298, DOI 10.1212/WNL.57.12.2298
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Sahashi K, 2001, J MED GENET, V38, P703, DOI 10.1136/jmg.38.10.703
   Scaglia F, 2003, AM J MED GENET A, V123A, P172, DOI 10.1002/ajmg.a.20315
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sewry CA, 2019, J MUSCLE RES CELL M, V40, P111, DOI 10.1007/s10974-019-09519-9
   Simoncini C, 2018, CASE REP NEUROL MED, V2018, P0, DOI 10.1155/2018/8406712
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   UKACHOKE C, 1994, CAN J NEUROL SCI, V21, P125, DOI 10.1017/S0317167100049040
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
NR 29
TC 7
Z9 7
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD AUG 15
PY 2020
VL 30
IS 8
BP 661
EP 668
DI 10.1016/j.nmd.2020.06.008
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA NI7OZ
UT WOS:000565539700006
PM 32684384
DA 2024-11-01
ER

PT J
AU Martin, LJ
   Wong, M
AF Martin, Lee J.
   Wong, Margaret
TI Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE rapsyn; motor neuron; DNA damage; aging; TDP-43
ID amyotrophic-lateral-sclerosis; motor-neuron degeneration; cu/zn superoxide-dismutase; single-cell analysis; dna-damage; wild-type; nitric-oxide; mitochondrial-function; oxidative stress; extend survival
AB Amyotrophic lateral sclerosis (ALS) is a fatal heterogeneous neurodegenerative disease that causes motor neuron (MN) loss and skeletal muscle paralysis. It is uncertain whether this degeneration of MNs is triggered intrinsically and is autonomous, or if the disease initiating mechanisms are extrinsic to MNs. We hypothesized that skeletal muscle is a primary site of pathogenesis in ALS that triggers MN degeneration. Some inherited forms of ALS are caused by mutations in the superoxide dismutase-1 (SOD1) gene, that encodes an antioxidant protein, so we created transgenic (tg) mice expressing wild-type-, G37R-, and G93A-human SOD1 gene variants only in skeletal muscle. Presence of human SOD1 (hSOD1) protein in skeletal muscle was verified by western blotting, enzyme activity gels, and immunofluorescence in myofibers and satellite cells. These tg mice developed limb weakness and paresis with motor deficits, limb and chest muscle wasting, diaphragm atrophy, and age-related fatal disease with a lifespan shortening of 10-16%. Brown and white adipose tissue also became wasted. Myofibers of tg mice developed crystalline-like inclusions, individualized sarcomere destruction, mitochondriopathy with vesiculation, DNA damage, and activated p53. Satellite cells became apoptotic. The diaphragm developed severe loss of neuromuscular junction presynaptic and postsynaptic integrity, including decreased innervation, loss of synaptophysin, nitration of synaptophysin, and loss of nicotinic acetylcholine receptor and scaffold protein rapsyn. Co-immunoprecipitation identified hSOD1 interaction with rapsyn. Spinal cords of tg mice developed gross atrophy. Spinal MNs formed cytoplasmic and nuclear inclusions, axonopathy, mitochondriopathy, accumulated DNA damage, activated p53 and cleaved caspase-3, and died. Tg mice had a 40-50% loss of MNs. This work shows that hSOD1 in skeletal muscle is a driver of pathogenesis in ALS, that involves myofiber and satellite cell toxicity, and apparent muscle-adipose tissue disease relationships. It also identifies a non-autonomous mechanism for MN degeneration explaining their selective vulnerability as likely a form of target-deprivation retrograde neurodegeneration.
C1 [Martin, Lee J.; Wong, Margaret] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA.
   [Martin, Lee J.] Johns Hopkins Univ, Sch Med, Pathobiol Grad Training Program, Baltimore, MD 21218 USA.
   [Martin, Lee J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.
   [Martin, Lee J.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.
C3 Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University
RP Martin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA.; Martin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Pathobiol Grad Training Program, Baltimore, MD 21218 USA.; Martin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.; Martin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.
EM martinl@jhmi.edu
FU NIH-NINDS [NS034100, NS052098]
CR Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x
   Aguirre T, 1998, ANN NEUROL, V43, P452, DOI 10.1002/ana.410430407
   Ahmed RM, 2018, J NEUROL NEUROSUR PS, V89, P1013, DOI 10.1136/jnnp-2018-318428
   Al-Abdulla NA, 1998, AM J PATHOL, V153, P447, DOI 10.1016/S0002-9440(10)65588-5
   Argilés JM, 2016, J AM MED DIR ASSOC, V17, P789, DOI 10.1016/j.jamda.2016.04.019
   Banks CJ, 2019, REDOX BIOL, V26, P0, DOI 10.1016/j.redox.2019.101270
   Bauckneht M, 2020, EJNMMI RES, V10, P0, DOI 10.1186/s13550-020-0607-5
   BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0
   Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103
   Bennett JP, 2015, NEURODEGENER DIS MAN, V5, P181, DOI 10.2217/NMT.15.13
   Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511
   BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292
   Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660
   Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499
   Brito MD, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.01205
   Cappello V, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18102092
   Chang CC, 1999, J BIOMED SCI, V6, P368, DOI 10.1159/000025412
   Chargé SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Chen JR, 2001, J BIOCHEM BIOPH METH, V47, P233, DOI 10.1016/S0165-022X(00)00162-7
   Chen K, 2010, BRAIN STRUCT FUNCT, V214, P219, DOI 10.1007/s00429-009-0226-4
   Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2
   Corti S, 2009, J NEUROL SCI, V276, P170, DOI 10.1016/j.jns.2008.09.030
   Cova E, 2006, NEUROSCI LETT, V399, P186, DOI 10.1016/j.neulet.2006.01.057
   DALAKAS MC, 1987, ANN NEUROL, V22, P580, DOI 10.1002/ana.410220504
   DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519
   Derave W, 2003, NEUROBIOL DIS, V13, P264, DOI 10.1016/S0969-9961(03)00041-X
   Desport JC, 2005, NEURODEGENER DIS, V2, P202, DOI 10.1159/000089626
   Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021
   Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002
   Dobrowolny G, 2018, ANTIOXID REDOX SIGN, V28, P1105, DOI 10.1089/ars.2017.7054
   Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101
   Dupuis L, 2006, MUSCLE NERVE, V34, P253, DOI 10.1002/mus.20566
   Dupuis L, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005390
   Echaniz-Laguna A, 2006, EXP NEUROL, V198, P25, DOI 10.1016/j.expneurol.2005.07.020
   Estévez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498
   Farmer SR, 2008, CELL, V134, P726, DOI 10.1016/j.cell.2008.08.018
   Fayzullina S, 2016, J NEUROPATH EXP NEUR, V75, P889, DOI 10.1093/jnen/nlw064
   Fayzullina S, 2014, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/52211
   Fayzullina S, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0093329
   Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004
   Furukawa Y, 2020, TRANSL NEURODEGENER, V9, P0, DOI 10.1186/s40035-020-00209-y
   Gallo V, 2013, NEUROLOGY, V80, P829, DOI 10.1212/WNL.0b013e3182840689
   Gertz B, 2012, J NEUROPATH EXP NEUR, V71, P162, DOI 10.1097/NEN.0b013e318244b635
   Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000
   Gowing G, 2008, J NEUROSCI, V28, P10234, DOI 10.1523/JNEUROSCI.3494-08.2008
   GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258
   Heiduschka P, 1998, NEUROREPORT, V9, P4051
   Huisman MHB, 2015, JAMA NEUROL, V72, P1155, DOI 10.1001/jamaneurol.2015.1584
   Jaarsma D, 2008, J NEUROSCI, V28, P2075, DOI 10.1523/JNEUROSCI.5258-07.2008
   JAYARAMAN L, 1995, CELL, V81, P1021, DOI 10.1016/S0092-8674(05)80007-8
   Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319
   Kim BW, 2020, ACTA NEUROPATHOL COM, V8, P0, DOI 10.1186/s40478-019-0874-4
   Krasnianski A, 2005, BRAIN, V128, P1870, DOI 10.1093/brain/awh540
   Liang JJ, 2012, J BIOL CHEM, V287, P16510, DOI 10.1074/jbc.M112.360891
   Lindauer E, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067783
   Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002
   Liu ZP, 2001, J HISTOCHEM CYTOCHEM, V49, P957, DOI 10.1177/002215540104900804
   Mahoney DJ, 2006, MUSCLE NERVE, V33, P809, DOI 10.1002/mus.20542
   Martin LJ, 2007, J NEUROPATH EXP NEUR, V66, P1002, DOI 10.1097/nen.0b013e318158822b
   Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160
   Martin LJ, 2014, FRONT CELL NEUROSCI, V8, P0, DOI 10.3389/fncel.2014.00433
   Martin LJ, 2011, TOXICOL PATHOL, V39, P220, DOI 10.1177/0192623310389475
   Martin LJ, 2011, J NEUROSCI, V31, P359, DOI 10.1523/JNEUROSCI.2225-10.2011
   Martin LJ, 2010, PHARMACEUTICALS, V3, P839, DOI 10.3390/ph3040839
   Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.0.CO;2-#
   Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005
   Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005
   Martin LJ, 2003, J NEUROCHEM, V85, P234, DOI 10.1046/j.1471-4159.2003.01659.x
   MARTIN LJ, 1994, AM J PATHOL, V145, P1358
   Martin LJ, 2002, NEUROCHEM RES, V27, P1093, DOI 10.1023/A:1020961006216
   Martin LJ, 2002, J NEUROBIOL, V50, P181, DOI 10.1002/neu.10026
   Martin LJ, 2000, NEUROBIOL DIS, V7, P613, DOI 10.1006/nbdi.2000.0314
   Martin LJ, 2001, INT J MOL MED, V7, P455
   Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17
   Mattsson P, 2012, J NEUROL NEUROSUR PS, V83, P390, DOI 10.1136/jnnp.2010.218982
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   McEachern G, 2000, BIOCHEM BIOPH RES CO, V273, P359, DOI 10.1006/bbrc.2000.2933
   Morozova N, 2008, EPIDEMIOLOGY, V19, P324, DOI 10.1097/EDE.0b013e3181632c5d
   Muller FL, 2007, AM J PHYSIOL-REG I, V293, PR1159, DOI 10.1152/ajpregu.00767.2006
   Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876
   Nagel G, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-04706-5
   Nowicka N, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20112616
   Okamoto K, 2007, AMYOTROPH LATERAL SC, V8, P300, DOI 10.1080/17482960701472249
   Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8
   Palamiuc L, 2015, EMBO MOL MED, V7, P526, DOI 10.15252/emmm.201404433
   PETROPOULOS CJ, 1989, MOL CELL BIOL, V9, P3785, DOI 10.1128/MCB.9.9.3785
   Petrov D, 2017, FRONT AGING NEUROSCI, V9, P0, DOI 10.3389/fnagi.2017.00068
   Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001
   PRICE DL, 1992, J NEUROBIOL, V23, P1277, DOI 10.1002/neu.480230916
   PRICE DL, 1990, PROG BRAIN RES, V86, P297
   Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200
   Rao MV, 1996, MOL CELL BIOL, V16, P3909
   Riddoch-Contreras J, 2009, EXP NEUROL, V215, P281, DOI 10.1016/j.expneurol.2008.10.014
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204
   Rotunno MS, 2013, FRONT CELL NEUROSCI, V7, P0, DOI 10.3389/fncel.2013.00253
   Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207
   Sau D, 2007, HUM MOL GENET, V16, P1604, DOI 10.1093/hmg/ddm110
   Schoser BGH, 2001, MUSCLE NERVE, V24, P1083, DOI 10.1002/mus.1114
   Steyn FJ, 2018, J NEUROL NEUROSUR PS, V89, P1016, DOI 10.1136/jnnp-2017-317887
   Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011
   Tsang CK, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4446
   Veldink JH, 2007, J NEUROL NEUROSUR PS, V78, P367, DOI 10.1136/jnnp.2005.083378
   Vielhaber S, 1999, J NEUROL SCI, V169, P133, DOI 10.1016/S0022-510X(99)00236-1
   von Bohlen und Halbach O, 2002, NEUROIMAGE, V15, P633, DOI 10.1006/nimg.2001.1045
   Wang L, 2008, NEUROBIOL DIS, V29, P400, DOI 10.1016/j.nbd.2007.10.004
   Wang Y, 2012, MOL BIOL CELL, V23, P2057, DOI 10.1091/mbc.E12-02-0120
   Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2
   Wong M, 2013, FRONT CELL NEUROSCI, V7, P0, DOI 10.3389/fncel.2013.00279
   Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106
   Xiao Q, 2007, J NEUROCHEM, V102, P2008, DOI 10.1111/j.1471-4159.2007.04677.x
   Yang JW, 2013, J CLIN NEUROL, V9, P125, DOI 10.3988/jcn.2013.9.2.125
   Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709
NR 115
TC 33
Z9 34
U1 1
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD DEC 14
PY 2020
VL 11
IS 
BP 
EP 
DI 10.3389/fneur.2020.592851
PG 26
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA PK8GI
UT WOS:000602675800001
PM 33381076
DA 2024-11-01
ER

PT J
AU Stenton, SL
   Prokisch, H
AF Stenton, Sarah L.
   Prokisch, Holger
TI Genetics of mitochondrial diseases: Identifying mutations to help diagnosis
SO EBIOMEDICINE
LA English
DT Review
DE Mitochondrial disease; Mutation; Diagnostic; Genetic; Multi-omic
ID complex; dna; disorders; pathway; deletions; muscle
AB Mitochondrial diseases are amongst the most genetically and phenotypically diverse groups of inherited diseases. The vast phenotypic overlap with other disease entities together with the absence of reliable biomarkers act as driving forces for the integration of unbiased methodologies early in the diagnostic algorithm, such as whole exome sequencing (WES) and whole genome sequencing (WGS). Such approaches are used in variant discovery and in combination with high-throughput functional assays such as transcriptomics in simultaneous variant discovery and validation. By capturing all genes, they not only increase the diagnostic rate in heterogenous mitochondrial disease patients, but accelerate novel disease gene discovery, and are valuable in side-stepping the risk of overlooking unexpected or even treatable genetic disease diagnoses. (c) 2020 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)
C1 [Stenton, Sarah L.; Prokisch, Holger] Tech Univ Munich, Klinikum Rechts Isar, Inst Humangenet, Trogerstr 32, D-81675 Munich, Germany.
   [Stenton, Sarah L.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Neurogen, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany.
C3 Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health
RP Prokisch, H (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Humangenet, Trogerstr 32, D-81675 Munich, Germany.
EM prokisch@helmholtz-muenchen.de
FU German Federal Ministry of Education and Research (BMBF) [01GM1906B]; German BMBF; Horizon2020 through the E-Rare project GENOMIT [01GM1603]
CR Brechtmann F, 2018, AM J HUM GENET, V103, P907, DOI 10.1016/j.ajhg.2018.10.025
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Clark MM, 2019, SCI TRANSL MED, V11, P0, DOI 10.1126/scitranslmed.aat6177
   Coene KLM, 2018, J INHERIT METAB DIS, V41, P337, DOI 10.1007/s10545-017-0131-6
   Cummings BB, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aal5209
   DaRe JT, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-118
   de la Barca JMC, 2020, HUM MOL GENET, V29, P1319, DOI 10.1093/hmg/ddaa047
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Distelmaier F, 2017, BRAIN, V140, P0, DOI 10.1093/brain/aww303
   Ferreira CR, 2019, GENET MED, V21, P102, DOI 10.1038/s41436-018-0022-8
   French CE, 2019, INTENS CARE MED, V45, P627, DOI 10.1007/s00134-019-05552-x
   Fresard L, 2019, NAT MED, V25, P911, DOI 10.1038/s41591-019-0457-8
   Giordano C, 2016, BRAIN, V139, P0, DOI 10.1093/brain/awv217
   Gonorazky HD, 2019, AM J HUM GENET, V104, P466, DOI 10.1016/j.ajhg.2019.01.012
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Khera AV, 2019, CIRCULATION, V139, P1593, DOI 10.1161/CIRCULATIONAHA.118.035658
   Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z
   Kohda M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005679
   Kremer LS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15824
   Kremer LS, 2017, METHODS MOL BIOL, V1567, P391, DOI 10.1007/978-1-4939-6824-4_24
   Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005
   Lee HN, 2020, GENET MED, V22, P490, DOI 10.1038/s41436-019-0672-1
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Ma M, 2015, BMC GENOMICS, V16, P0, DOI 10.1186/1471-2164-16-S8-S3
   Malicdan MCV, 2018, HUM MUTAT, V39, P69, DOI 10.1002/humu.23345
   Miyaue Noriyuki, 2019, ENEUROLOGICALSCI, V14, P74, DOI 10.1016/j.ensci.2019.01.002
   Nambot S, 2018, GENET MED, V20, P645, DOI 10.1038/gim.2017.162
   Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450
   Oetjens MT, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12869-0
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Puusepp S, 2018, MOL GENET METAB REP, V15, P80, DOI 10.1016/j.ymgmr.2018.03.004
   Rahman J, 2017, ANN NEUROL, V81, P9, DOI 10.1002/ana.24835
   Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013
   Schofield D, 2019, GENET MED, V21, P2586, DOI 10.1038/s41436-019-0534-x
   Skrzypek MS, 2018, NUCLEIC ACIDS RES, V46, PD736, DOI 10.1093/nar/gkx1112
   Sommerville Ewen W, 2014, J NEUROMUSCUL DIS, V1, P119
   Stark Z, 2019, GENET MED, V21, P173, DOI 10.1038/s41436-018-0006-8
   Stendel C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000393
   Stenton SL, 2020, J INHERIT METAB DIS, V43, P25, DOI 10.1002/jimd.12130
   Taliun D, 2019, BIORXIV, V0, PP563866, DOI 10.1101/563866
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Tan J, 2020, EBIOMEDICINE, V54, P0, DOI 10.1016/j.ebiom.2020.102730
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   The NIHR BioResource on behalf of the 100000 Genomes Project, 2019, BIORXIV, V0, P0, DOI DOI 10.1101/507244
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Van Hout CV, 2019, WHOLE EXOME SEQUENCI, V0, P0, DOI DOI 10.1101/572347
   Vasta V, 2012, PEDIATR INT, V54, P585, DOI 10.1111/j.1442-200X.2012.03644.x
   Wagner M, 2019, J INHERIT METAB DIS, V42, P909, DOI 10.1002/jimd.12109
   Wai HA, 2020, GENET MED, V22, P1005, DOI 10.1038/s41436-020-0766-9
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wanders RJA, 2019, J INHERIT METAB DIS, V42, P197, DOI 10.1002/jimd.12008
   Weissig V, 2020, TRENDS MOL MED, V26, P40, DOI 10.1016/j.molmed.2019.09.002
   Wenger AM, 2017, GENET MED, V19, P209, DOI 10.1038/gim.2016.88
   Witters P, 2018, GENET MED, V20, P444, DOI 10.1038/gim.2017.125
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Wright CF, 2018, GENET MED, V20, P1216, DOI 10.1038/gim.2017.246
   Yépez VA, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0199938
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang AH, 2016, BIOMED CHROMATOGR, V30, P7, DOI 10.1002/bmc.3453
NR 73
TC 120
Z9 128
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2352-3964
EI 
J9 EBIOMEDICINE
JI EBioMedicine
PD JUN 15
PY 2020
VL 56
IS 
BP 
EP 
DI 10.1016/j.ebiom.2020.102784
PG 11
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA MH3RP
UT WOS:000546651000006
PM 32454403
DA 2024-11-01
ER

PT J
AU Chae, HW
   Na, JH
   Kim, HS
   Lee, YM
AF Chae, Hyun-Wook
   Na, Ji-Hoon
   Kim, Ho-Seong
   Lee, Young-Mock
TI Mitochondrial diabetes and mitochondrial DNA mutation load in MELAS syndrome
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID insulin sensitivity; cutoff points; gene; pathogenesis; resistance; phenotype; diagnosis; mellitus; deafness; disease
AB Objective: Mitochondria! myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a very rare condition; it encompasses a diverse group of disorders including diabetes. Phenotypic variability can be attributed to heteroplasmy along with varying proportions of mutant and WT mitochondrial DNA (mtDNA). To examine the clinical relationship between mitochondrial diabetes and mutational load, we analyzed the mtDNA of children and young adolescents with MELAS syndrome using next generation sequencing (NGS). Design and methods: Of 57 subjects with suspected MELAS syndrome, 32 children and young adolescents were diagnosed as MELAS syndrome with mtDNA A-to-G transition at nucleotide 3243. Mutation load studies and NGS were performed for 25 subjects. Results: The mean mutation load was 60.4 +/- 18.4% (range: 22.5-100). Of the 25 subjects with NGS results, 15 (60%) were diagnosed with DM and 2 (8%) were diagnosed with impaired glucose tolerance (IGT). The mutational load of subjects inversely correlated with first symptom onset, age at diagnosis of MELAS syndrome, and DM (P < 0.001). However, mutational load did not correlate with the clinical severity or progression of DM/IGT. There was no significant difference in insulin resistance or sensitivity indices between the low- and high-mutation load groups. During the 3.7 years of follow-up, insulin resistance indices were not significantly different between baseline and follow-up. Conclusions: We can infer that the mutation load in the MELAS syndrome is significantly associated with the onset of symptoms and associated diseases, including mitochondrial diabetes. However, it may not influence disease progression.
C1 [Chae, Hyun-Wook; Na, Ji-Hoon; Kim, Ho-Seong; Lee, Young-Mock] Yonsei Univ, Severance Childrens Hosp, Gangnam Severance Hosp, Dept Pediat,Coll Med, Seoul, South Korea.
C3 Yonsei University; Yonsei University Health System
RP Lee, YM (corresponding author), Yonsei Univ, Severance Childrens Hosp, Gangnam Severance Hosp, Dept Pediat,Coll Med, Seoul, South Korea.
EM ymleemd@yuhs.ac
CR Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004
   de Wit HM, 2012, NETH J MED, V70, P460
   DiMauro S, 2013, JAMA NEUROL, V70, P1484, DOI 10.1001/jamaneurol.2013.4401
   Duan MQ, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23020323
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fromont I, 2009, J NEUROL, V256, P1696, DOI 10.1007/s00415-009-5185-4
   Ghasemi A, 2015, ACTA DIABETOL, V52, P905, DOI 10.1007/s00592-015-0730-3
   Henríquez S, 2013, NUTR HOSP, V28, P1594, DOI 10.3305/nh.2013.28.5.6512
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hrebícek J, 2002, J CLIN ENDOCR METAB, V87, P144, DOI 10.1210/jc.87.1.144
   Ikeda T, 2018, HUM GENOME VAR, V5, P0, DOI 10.1038/s41439-018-0026-6
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   Joung KH, 2011, PEDIATR INT, V53, P832, DOI 10.1111/j.1442-200X.2011.03394.x
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z
   Maassen JA, 2002, ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, V110, P186, DOI 10.1076/apab.110.3.186.8294
   Maassen JA, 1996, DIABETOLOGIA, V39, P375
   Maassen JA, 2006, ENDOCRIN METAB CLIN, V35, P385, DOI 10.1016/j.ecl.2006.02.014
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   Motamed N, 2016, J DIABETES COMPLICAT, V30, P269, DOI 10.1016/j.jdiacomp.2015.11.019
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Nsiah-Sefaa A, 2016, BIOSCIENCE REP, V36, P0, DOI 10.1042/BSR20150295
   Piechota Janusz, 2001, JOURNAL OF APPLIED GENETICS, V42, P351
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Skupien Jan, 2006, REVIEW OF DIABETIC STUDIES, V3, P17, DOI 10.1900/RDS.2006.3.17
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tsuruzoe K, 1998, DIABETES, V47, P621, DOI 10.2337/diabetes.47.4.621
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
NR 36
TC 11
Z9 12
U1 1
U2 7
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
SN 0804-4643
EI 1479-683X
J9 EUR J ENDOCRINOL
JI Eur. J. Endocrinol.
PD NOV 15
PY 2020
VL 183
IS 5
BP 505
EP 512
DI 10.1530/EJE-20-0189
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA NZ8AR
UT WOS:000577325000008
PM 33107434
DA 2024-11-01
ER

PT J
AU Lawless, C
   Greaves, L
   Reeve, AK
   Turnbull, DM
   Vincent, AE
AF Lawless, Conor
   Greaves, Laura
   Reeve, Amy K.
   Turnbull, Doug M.
   Vincent, Amy E.
TI The rise and rise of mitochondrial DNA mutations
SO OPEN BIOLOGY
LA English
DT Review
DE clonal expansion; mtDNA; ageing; disease; mutation; heteroplasmy
ID substantia-nigra; skeletal-muscle; parkinsons-disease; individual cells; point mutations; break repair; deletions; mtdna; mechanisms; replication
AB How mitochondrial DNA mutations clonally expand in an individual cell is a question that has perplexed mitochondrial biologists for decades. A growing body of literature indicates that mitochondrial DNA mutations play a major role in ageing, metabolic diseases, neurodegenerative diseases, neuromuscular disorders and cancers. Importantly, this process of clonal expansion occurs for both inherited and somatic mitochondrial DNA mutations. To complicate matters further there are fundamental differences between mitochondrial DNA point mutations and deletions, and between mitotic and post-mitotic cells, that impact this pathogenic process. These differences, along with the challenges of investigating a longitudinal process occurring over decades in humans, have so far hindered progress towards understanding clonal expansion. Here we summarize our current understanding of the clonal expansion of mitochondrial DNA mutations in different tissues and highlight key unanswered questions. We then discuss the various existing biological models, along with their advantages and disadvantages. Finally, we explore what has been achieved with mathematical modelling so far and suggest future work to advance this important area of research.
C1 [Lawless, Conor; Greaves, Laura; Reeve, Amy K.; Turnbull, Doug M.; Vincent, Amy E.] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Clin & Translat Res Inst, Newcastle NE2 4HH, England.
C3 Newcastle University - UK
RP Turnbull, DM; Vincent, AE (corresponding author), Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Clin & Translat Res Inst, Newcastle NE2 4HH, England.
EM doug.turnbull@ncl.ac.uk; amy.vincent@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Sir Henry Wellcome Fellowship [215888/Z/19/Z]; Senior Parkinson's UK Fellowship [F-1401]; Wellcome Trust [215888/Z/19/Z] Funding Source: Wellcome Trust; MRC [G0400074, G0502157, G0900652, G1100540] Funding Source: UKRI
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Baines HL, 2014, AGING CELL, V13, P201, DOI 10.1111/acel.12199
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Blackwood JK, 2011, J PATHOL, V225, P181, DOI 10.1002/path.2965
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Boys RJ, 2008, STAT COMPUT, V18, P125, DOI 10.1007/s11222-007-9043-x
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01
   Chen C, 2020, NEUROBIOL DIS, V134, P0, DOI 10.1016/j.nbd.2019.104631
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859
   Damas J, 2014, NUCLEIC ACIDS RES, V42, PD1261, DOI 10.1093/nar/gkt982
   Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160
   FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283
   Fellous TG, 2009, STEM CELLS, V27, P1410, DOI 10.1002/stem.67
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, PG914, DOI 10.1152/ajpgi.00402.2011
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Golightly A, 2011, INTERFACE FOCUS, V1, P807, DOI 10.1098/rsfs.2011.0047
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Henderson DA, 2009, J AM STAT ASSOC, V104, P76, DOI 10.1198/jasa.2009.0005
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Itoh K, 1997, MOVEMENT DISORD, V12, P9, DOI 10.1002/mds.870120104
   Johnston IG, 2016, AM J HUM GENET, V99, P1150, DOI 10.1016/j.ajhg.2016.09.016
   Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Keeney PM, 2010, MOL NEURODEGENER, V5, P0, DOI 10.1186/1750-1326-5-21
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0
   Konrad A, 2017, MOL BIOL EVOL, V34, P1319, DOI 10.1093/molbev/msx051
   Kowald A, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9030126
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2012, NEUROBIOL AGING, V33, P2210, DOI 10.1016/j.neurobiolaging.2011.08.009
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lakshmanan LN, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12814
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Lehmann D, 2019, NUCLEIC ACIDS RES, V47, P7430, DOI 10.1093/nar/gkz472
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039
   Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027
   Moad M, 2017, CELL REP, V20, P1609, DOI 10.1016/j.celrep.2017.07.061
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Moraes CT, 1999, MOL BIOL CELL, V10, P3345, DOI 10.1091/mbc.10.10.3345
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Nooteboom M, 2010, AGING CELL, V9, P96, DOI 10.1111/j.1474-9726.2009.00531.x
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   NOVICK RP, 1976, BACTERIOL REV, V40, P168, DOI 10.1128/MMBR.40.1.168-189.1976
   OLeary MFN, 2012, AM J PHYSIOL-CELL PH, V303, PC447, DOI 10.1152/ajpcell.00451.2011
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Olsson C, 2001, EUR J HUM GENET, V9, P917, DOI 10.1038/sj.ejhg.5200742
   Persson Ö, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Pistilli D, 2003, HUM PATHOL, V34, P1058, DOI 10.1053/S0046-8177(03)00344-7
   Plummer M, 2003, P 3 INT WORKSH DISTR, V0, P1
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Russell OM, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-20064-2
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Schwartz LM, 2019, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.01887
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SOONG NW, 1992, NAT GENET, V2, P318
   Stamp C, 2018, EBIOMEDICINE, V31, P166, DOI 10.1016/j.ebiom.2018.04.017
   Su TH, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9040182
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Tavare S, 1997, GENETICS, V145, P505
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9
   Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 108
TC 82
Z9 85
U1 0
U2 14
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 
EI 2046-2441
J9 OPEN BIOL
JI Open Biol
PD MAY 20
PY 2020
VL 10
IS 5
BP 
EP 
DI 10.1098/rsob.200061
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA LS6YE
UT WOS:000536526700001
PM 32428418
DA 2024-11-01
ER

PT J
AU Zhunina, OA
   Yabbarov, NG
   Grechko, AV
   Yet, SF
   Sobenin, IA
   Orekhov, AN
AF Zhunina, Olga A.
   Yabbarov, Nikita G.
   Grechko, Andrey, V
   Yet, Shaw-Fang
   Sobenin, Igor A.
   Orekhov, Alexander N.
TI Neurodegenerative Diseases Associated with Mitochondrial DNA Mutations
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE Parkinson disease; alzheimer disease; neuropathy; oxidative stress; mitochondria; DNA damage; reactive oxygen species
ID cytochrome-c-oxidase; parkinsons-disease; alzheimers-disease; oxidative stress; vascular hypoperfusion; myoclonic epilepsy; substantia-nigra; point mutation; cell-death; dysfunction
AB Mitochondrial dysfunction underlies several human chronic pathologies, including cardiovascular disorders, cancers and neurodegenerative diseases. Impaired mitochondrial function associated with oxidative stress can be a result of both nuclear and mitochondrial DNA (mtDNA) mutations. Neurological disorders associated with mtDNA mutations include mitochondrial encephalomyopathy, chronic progressive external ophthalmoplegia, neurogenic weakness, and Leigh syndrome. Moreover, mtDNA mutations were shown to play a role in the development of Parkinson and Alzheimer's diseases. In this review, current knowledge on the distribution and possible roles of mtDNA mutations in the onset and development of various neurodegenerative diseases, with special focus on Parkinson's and Alzheimer's diseases has been discussed.
C1 [Zhunina, Olga A.; Yabbarov, Nikita G.] Russian Res Ctr Mol Diagnost & Therapy, Simferopolsky Blvd 8, Moscow 117149, Russia.
   [Grechko, Andrey, V] Fed Res & Clin Ctr Intens Care Med & Rehabilitol, 14-3 Solyanka St, Moscow 109240, Russia.
   [Yet, Shaw-Fang] Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town, Miaoli County, Taiwan.
   [Sobenin, Igor A.] Natl Med Res Ctr Cardiol, Lab Med Genet, 15A 3rd Cherepkovskaya St, Moscow 121552, Russia.
   [Orekhov, Alexander N.] Inst Human Morphol, 3 Tsyurupa St, Moscow 117418, Russia.
   [Orekhov, Alexander N.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiyskaya St, Moscow 125315, Russia.
C3 Federal Research & Clinical Center of Intensive Care Medicine & Rehabilitology; National Health Research Institutes - Taiwan; National Medical Research Center of Cardiology; Russian Academy of Medical Sciences; Research Institute of Human Morphology; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS
RP Orekhov, AN (corresponding author), Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiyskaya St, Moscow 125315, Russia.
EM a.h.opexob@gmail.com
FU Russian Science Foundation [19-15-00010]
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Akbar M, 2016, BRAIN RES, V1637, P34, DOI 10.1016/j.brainres.2016.02.016
   Aliev G, 2004, MITOCHONDRION, V4, P649, DOI 10.1016/j.mito.2004.07.018
   Aliev G, 2003, NEUROL RES, V25, P665, DOI 10.1179/016164103101201977
   Aliev G, 2002, BRAIN PATHOL, V12, P21
   Aliev G, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/962984
   Aliev Gjumrakch, 2011, RECENT PAT CARDIOVASC DRUG DISCOV, V6, P222
   Aliev G, 2010, PHARMACEUTICALS, V3, P158, DOI 10.3390/ph3010158
   Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608
   Aliev G, 2009, INT J BIOCHEM CELL B, V41, P1989, DOI 10.1016/j.biocel.2009.03.015
   Andalib S, 2014, J NEUROL SCI, V346, P11, DOI 10.1016/j.jns.2014.07.067
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Cassereau J, 2014, REV NEUROL-FRANCE, V170, P366, DOI 10.1016/j.neurol.2013.11.005
   Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Clark J, 2011, PARKINSONS DIS-US, V2011, P0, DOI 10.4061/2011/659694
   Cookson MR, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a009415
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9
   de Vries RLA, 2013, MOL CELL NEUROSCI, V55, P37, DOI 10.1016/j.mcn.2012.07.008
   DeBrosse S, 2012, SEMIN PEDIATR NEUROL, V19, P194, DOI 10.1016/j.spen.2012.09.006
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066
   Eckert GP, 2012, MOL NEUROBIOL, V46, P136, DOI 10.1007/s12035-012-8271-z
   Ehrenkrantz D, 1999, AM J MED GENET, V88, P378, DOI 10.1002/(SICI)1096-8628(19990820)88:4<378::AID-AJMG15>3.0.CO;2-8
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   HARDING AE, 1995, MUSCLE NERVE, V0, PS82
   Haskin J, 2013, HUM MOL GENET, V22, P2083, DOI 10.1093/hmg/ddt058
   Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   Hung KM, 2016, MITOCHONDRION, V31, P9, DOI 10.1016/j.mito.2016.08.015
   HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892
   Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288
   Keeney PM, 2009, EXP NEUROL, V220, P374, DOI 10.1016/j.expneurol.2009.09.025
   Keeney PM, 2009, HUM GENE THER, V20, P897, DOI 10.1089/hum.2009.023
   Khan SM, 2000, ANN NEUROL, V48, P148, DOI 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kozin MS, 2018, BIOCHEMISTRY-MOSCOW+, V83, P813, DOI 10.1134/S0006297918070052
   Liang CL, 2007, EXP NEUROL, V203, P370, DOI 10.1016/j.expneurol.2006.08.015
   LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mancuso Michelangelo, 2008, HUMAN GENOMICS, V3, P71
   Martikainen MH, 2013, MITOCHONDRION, V13, P83, DOI 10.1016/j.mito.2013.01.012
   Martinez MS, 2017, VESSEL PLUS, V1, P130, DOI 10.20517/2574-1209.2017.34
   Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3
   MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479
   Molnár MJ, 2000, NEUROLOGY, V55, P544, DOI 10.1212/WNL.55.4.544
   Moreira PI, 2007, AUTOPHAGY, V3, P614, DOI 10.4161/auto.4872
   Musicco C, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19072076
   Nagashima T, 2001, NEUROMUSCULAR DISORD, V11, P470, DOI 10.1016/S0960-8966(01)00190-0
   Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Otaegui D, 2004, NEUROSCI LETT, V370, P171, DOI 10.1016/j.neulet.2004.08.012
   Oyewole AO, 2015, FASEB J, V29, P4766, DOI 10.1096/fj.15-275404
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PETRUZZELLA V, 1992, BIOCHEM BIOPH RES CO, V186, P491, DOI 10.1016/S0006-291X(05)80834-4
   Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011
   Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8
   Sazonova MA, 2017, VESSEL PLUS, V1, P182, DOI 10.20517/2574-1209.2017.16
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Siciliano G, 2001, J NEUROL NEUROSUR PS, V71, P685, DOI 10.1136/jnnp.71.5.685
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Sinyov V V, 2017, VESSEL PLUS, V0, PP145, DOI 10.20517/2574-1209.2016.04
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010
   Takahashi M, 2019, ANTIOXIDANTS-BASEL, V8, P0, DOI 10.3390/antiox8030061
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105
   Wu WW, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0132499
   Young ML, 2019, MOL CELL NEUROSCI, V101, P0, DOI 10.1016/j.mcn.2019.103409
NR 87
TC 7
Z9 7
U1 0
U2 16
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD JUN 15
PY 2020
VL 26
IS 1
BP 103
EP 109
DI 10.2174/1381612825666191122091320
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KR6VV
UT WOS:000517755600008
PM 31755379
DA 2024-11-01
ER

PT J
AU Liu, GL
   Shen, XY
   Sun, YG
   Lv, Q
   Li, YY
   Du, A
AF Liu, Gailing
   Shen, Xiya
   Sun, Yongan
   Lv, Qing
   Li, Yuanyuan
   Du, Ailian
TI Heteroplasmy and phenotype spectrum of the mitochondrial tRNA<SUP>Leu</SUP> <SUP>(UUR)</SUP> gene m.3243A > G mutation in seven Han Chinese families
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE M.3243A > G mutation; Phenotype spectrum; Life-threatening mitochondrial myopathy; Heteroplasmy; Chinese patients
ID a3243g mutation; retinitis-pigmentosa; diabetes-mellitus; dna mutations; prevalence; myopathy; disease; nuclear; cardiomyopathy; manifestation
AB The m.3243A > G mutation in the mitochondrial tRNA(Leu) ((UUR)) gene is associated with a variety of phenotypic heterogeneity. The clinical spectrum and phenotypic-genotypic correlations in the Chinese patients are poorly understood. In the present study, we reported the clinical and genetic characterization, as well as haplogroups of seven Han Chinese families carrying the m.3243A > G mutation. Of the 39 matrilineal individuals, five suffered from mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), two had life-threatening mitochondrial myopathy (LTMM), and one patient had neuropathy, ataxia, and retinitis pigmentosa (NARP)-like syndrome. The LTMM and NARP like syndromes enriched the phenotypic profile of the m.3243A > G mutation. The heteroplasmy of the m.3243A > G mutation ranged from 16% to 59% in MELAS, 29% to 79% in LTMM, and 57% in a NARP-like syndrome patient. The levels ranged from 0% to 14% in patients that manifested with pure diabetes and pure hearing loss, and 0% to 5% in 13 normal family members. However, we particularly noticed heteroplasmy in four asymptomatic individuals in one LTMM family carried the heteroplasmy mutation ranged from 22% to 78%, implying that there were other modifying factors in this family. The modulation of the phenotype of mtDNA mutations requires further investigation.
C1 [Liu, Gailing; Shen, Xiya; Lv, Qing; Li, Yuanyuan; Du, Ailian] Shanghai Jiao Tong Univ, Tongren Hosp, Dept Neurol, Sch Med, Shanghai 200336, Peoples R China.
   [Sun, Yongan] Perking Univ, Dept Neurol, Hosp 1, Beijing 100034, Peoples R China.
   [Du, Ailian] Zhejiang Univ, Affiliated Hosp 2, Dept Neurol, Sch Med, Hangzhou 310009, Peoples R China.
C3 Shanghai Jiao Tong University; Zhejiang University
RP Du, A (corresponding author), Shanghai Jiao Tong Univ, Tongren Hosp, Dept Neurol, Sch Med, Shanghai 200336, Peoples R China.
EM ailiandu@sjtu.edu.cn
FU National Natural Science Foundation of China [81971181]; Shanghai Natural Science Foundation [19ZR1449200]; Medical and Engineering Crossover Fund of SJTU [YG2017MS67]; Science and Technology Commission Foundation of Shanghai Changning District [CNKW2017Y02, CNKW2018Y01]
CR Al-Gadi IS, 2018, J ENDOCR SOC, V2, P361, DOI 10.1210/js.2017-00434
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   Bruno C, 2003, J CHILD NEUROL, V18, P300, DOI 10.1177/08830738030180040401
   Campos Y, 1996, MUSCLE NERVE, V19, P187, DOI 10.1002/(SICI)1097-4598(199602)19:2<187::AID-MUS10>3.0.CO;2-S
   Cardenas-Robledo S, 2016, J NEURO-OPHTHALMOL, V36, P134, DOI 10.1097/WNO.0000000000000340
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Houshmand M, 1996, HUM GENET, V97, P269, DOI 10.1007/BF02185750
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Jiang PP, 2015, INVEST OPHTH VIS SCI, V56, P4778, DOI 10.1167/iovs.14-16158
   Kerrison JB, 2000, ARCH OPHTHALMOL-CHIC, V118, P298
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Kraya T, 2018, HEADACHE, V58, P45, DOI 10.1111/head.13219
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Liang M, 2014, INVEST OPHTH VIS SCI, V55, P1321, DOI 10.1167/iovs.13-13011
   McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007
   Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374
   Mordel P, 2017, BIOCHEM BIOPH RES CO, V494, P133, DOI 10.1016/j.bbrc.2017.10.066
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Pan XL, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00780
   Picard M, 2016, JAMA NEUROL, V73, P923, DOI 10.1001/jamaneurol.2016.1676
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Pierron D, 2008, BMC MED GENET, V9, P0, DOI 10.1186/1471-2350-9-41
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Wang SJ, 2013, GENE, V531, P472, DOI 10.1016/j.gene.2013.09.019
   Wortmann SB, 2012, EUR J MED GENET, V55, P552, DOI 10.1016/j.ejmg.2012.06.002
   Xia CY, 2016, CHINESE MED J-PEKING, V129, P1945, DOI 10.4103/0366-6999.187845
   Yan JB, 2014, J MOL DIAGN, V16, P431, DOI 10.1016/j.jmoldx.2014.03.005
   Yang CC, 1998, J FORMOS MED ASSOC, V97, P715
   Zhang JJ, 2013, MITOCHONDRION, V13, P772, DOI 10.1016/j.mito.2013.05.002
   Zhou Y, 2018, INT J NEUROSCI, V128, P231, DOI 10.1080/00207454.2017.1387113
NR 36
TC 15
Z9 15
U1 0
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD JAN 15
PY 2020
VL 408
IS 
BP 
EP 
DI 10.1016/j.jns.2019.116562
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA KH9EP
UT WOS:000510952200021
PM 31722256
DA 2024-11-01
ER

PT J
AU Lewis, CJ
   Dixit, B
   Batiuk, E
   Hall, CJ
   O'Connor, MS
   Boominathan, A
AF Lewis, Caitlin J.
   Dixit, Bhavna
   Batiuk, Elizabeth
   Hall, Carter J.
   O'Connor, Matthew S.
   Boominathan, Amutha
TI Codon optimization is an essential parameter for the efficient allotopic expression of mtDNA genes
SO REDOX BIOLOGY
LA English
DT Article
DE Allotopic expression; Mitochondrial DNA (mtDNA); Mitochondrial disease; Gene therapy; Codon optimization; Protein expression; Mitochondrial respiratory chain complex; ATP synthase; Gene transfer
ID mitochondrial-dna mutations; messenger-rna localization; complex i deficiency; atp synthase; yeast mitochondria; oxidative-phosphorylation; harboring mutations; diseases; import; proteins
AB Mutations in mitochondrial DNA can be inherited or occur de novo leading to several debilitating myopathies with no curative option and few or no effective treatments. Allotopic expression of recoded mitochondrial genes from the nucleus has potential as a gene therapy strategy for such conditions, however progress in this field has been hampered by technical challenges. Here we employed codon optimization as a tool to re-engineer the protein-coding genes of the human mitochondrial genome for robust, efficient expression from the nucleus. All 13 codon-optimized constructs exhibited substantially higher protein expression than minimally-recoded genes when expressed transiently, and steady-state mRNA levels for optimized gene constructs were 5-180 fold enriched over recoded versions in stably-selected wildtype cells. Eight of thirteen mitochondria-encoded oxidative phosphorylation (OxPhos) proteins maintained protein expression following stable selection, with mitochondrial localization of expression products. We also assessed the utility of this strategy in rescuing mitochondrial disease cell models and found the rescue capacity of allotopic expression constructs to be gene specific. Allotopic expression of codon optimized ATP8 in disease models could restore protein levels and respiratory function, however, rescue of the pathogenic phenotype for another gene, ND1 was only partially successful. These results imply that though codon-optimization alone is not sufficient for functional allotopic expression of most mitochondrial genes, it is an essential consideration in their design.
C1 [Lewis, Caitlin J.; Dixit, Bhavna; Batiuk, Elizabeth; Hall, Carter J.; O'Connor, Matthew S.; Boominathan, Amutha] SENS Res Fdn, Dept Mitochondrial Res, Mountain View, CA 94041 USA.
   [Batiuk, Elizabeth] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97239 USA.
C3 Oregon Health & Science University
RP O'Connor, MS; Boominathan, A (corresponding author), SENS Res Fdn, Dept Mitochondrial Res, Mountain View, CA 94041 USA.
EM matthew.oconnor@sens.org; amutha.boominathan@sens.org
CR Acín-Pérez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Akouchekian M, 2011, J RES MED SCI, V16, P50
   Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bietenhader M, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002876
   Bokori-Brown M, 2006, REJUV RES, V9, P455, DOI 10.1089/rej.2006.9.455
   Bonnet C, 2008, BBA-MOL CELL RES, V1783, P1707, DOI 10.1016/j.bbamcr.2008.04.018
   Bonnet C, 2007, REJUV RES, V10, P127, DOI 10.1089/rej.2006.0526
   Boominathan A, 2016, NUCLEIC ACIDS RES, V44, P9342, DOI 10.1093/nar/gkw756
   BROWN MD, 1992, AM J HUM GENET, V51, P446
   Calabrese C, 2013, CANCER METAB, V1, P0, DOI 10.1186/2049-3002-1-11
   Campbell A, 1999, P NATL ACAD SCI USA, V96, P9184, DOI 10.1073/pnas.96.16.9184
   Chin RM, 2018, CELL REP, V22, P2818, DOI 10.1016/j.celrep.2018.02.059
   Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0
   CLAROS MG, 1995, EUR J BIOCHEM, V228, P762, DOI 10.1111/j.1432-1033.1995.0762m.x
   Cruz-Torres V, 2012, BBA-BIOENERGETICS, V1817, P2128, DOI 10.1016/j.bbabio.2012.09.006
   Cwerman-Thibault H, 2015, MOL THER-METH CLIN D, V2, P0, DOI 10.1038/mtm.2015.3
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   Eipel C, 2011, LIFE SCI, V88, P343, DOI 10.1016/j.lfs.2010.12.011
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   FARRELL LB, 1988, EUR J BIOCHEM, V173, P131, DOI 10.1111/j.1432-1033.1988.tb13976.x
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   GALANIS M, 1991, FEBS LETT, V282, P425, DOI 10.1016/0014-5793(91)80529-C
   GEARING DP, 1985, BIOCHEM INT, V10, P907
   GEARING DP, 1986, EMBO J, V5, P3651, DOI 10.1002/j.1460-2075.1986.tb04695.x
   Golubitzky A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026883
   González-Halphen D, 2004, ANN NY ACAD SCI, V1019, P232, DOI 10.1196/annals.1297.039
   Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Guy J, 2017, OPHTHALMOLOGY, V124, P1621, DOI 10.1016/j.ophtha.2017.05.016
   Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892
   Inouye S, 2015, PROTEIN EXPRES PURIF, V109, P47, DOI 10.1016/j.pep.2015.02.002
   Iommarini L, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19030764
   Iommarini L, 2014, HUM MOL GENET, V23, P1453, DOI 10.1093/hmg/ddt533
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Johnston IG, 2016, CELL SYST, V2, P101, DOI 10.1016/j.cels.2016.01.013
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kaltimbacher V, 2006, RNA, V12, P1408, DOI 10.1261/rna.18206
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   LAW RHP, 1988, FEBS LETT, V236, P501, DOI 10.1016/0014-5793(88)80086-3
   LAW RHP, 1990, BIOCHIM BIOPHYS ACTA, V1027, P141, DOI 10.1016/0005-2736(90)90077-2
   Lim SC, 2016, FASEB J, V30, P2236, DOI 10.1096/fj.201500137R
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Marella M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0025910
   Marella M, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011472
   Marella M, 2009, J BIOENERG BIOMEMBR, V41, P493, DOI 10.1007/s10863-009-9249-z
   MARGULIS I, 1970, J THEOR BIOL, V26, P337, DOI 10.1016/S0022-5193(70)80023-6
   Mauro VP, 2018, BIODRUGS, V32, P69, DOI 10.1007/s40259-018-0261-x
   Mauro VP, 2014, TRENDS MOL MED, V20, P604, DOI 10.1016/j.molmed.2014.09.003
   McKenzie M, 2014, HUM MUTAT, V35, P1476, DOI 10.1002/humu.22694
   Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010
   Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015
   NAGLEY P, 1989, TRENDS BIOCHEM SCI, V14, P31, DOI 10.1016/0968-0004(89)90087-X
   NAGLEY P, 1988, P NATL ACAD SCI USA, V85, P2091, DOI 10.1073/pnas.85.7.2091
   Oca-Cossio J, 2003, GENETICS, V165, P707
   Ojaimi J, 2002, MOL BIOL CELL, V13, P3836, DOI 10.1091/mbc.E02-05-0306
   Pasi KJ, 2017, NEW ENGL J MED, V377, P819, DOI 10.1056/NEJMoa1616569
   Perales-Clemente E, 2011, NUCLEIC ACIDS RES, V39, P225, DOI 10.1093/nar/gkq769
   Pereira CV, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708084
   Rendón OZ, 2012, HUM MOL GENET, V21, P3815, DOI 10.1093/hmg/dds209
   Roucou X, 1999, EUR J BIOCHEM, V261, P444, DOI 10.1046/j.1432-1327.1999.00289.x
   Rubalcava-Gracia D, 2018, MOL BIOL CELL, V29, P820, DOI 10.1091/mbc.E17-09-0560
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schägger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schröder T, 2016, MOL METAB, V5, P283, DOI 10.1016/j.molmet.2016.01.010
   Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Stachyra A, 2016, VIROL J, V13, P0, DOI 10.1186/s12985-016-0599-y
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Supekova L, 2010, P NATL ACAD SCI USA, V107, P5047, DOI 10.1073/pnas.1000735107
   Sylvestre J, 2003, MOL BIOL CELL, V14, P3848, DOI 10.1091/mbc.E03-02-0074
   Tachibana M, 2018, REPROD MED BIOL, V17, P421, DOI 10.1002/rmb2.12230
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Webster GR, 2017, BIOTECHNOL BIOENG, V114, P492, DOI 10.1002/bit.26183
   Weiss H, 2012, ENDOCRINOLOGY, V153, P4666, DOI 10.1210/en.2012-1296
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Wolf DP, 2017, EMBO J, V36, P2177, DOI 10.15252/embj.201797606
   Yagi T, 2006, REJUV RES, V9, P191, DOI 10.1089/rej.2006.9.191
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yu XH, 2009, HUM MOL GENET, V18, P4689, DOI 10.1093/hmg/ddp432
   Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108
   Zhao F, 2017, NUCLEIC ACIDS RES, V45, P8484, DOI 10.1093/nar/gkx501
NR 96
TC 10
Z9 11
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-2317
EI 
J9 REDOX BIOL
JI Redox Biol.
PD FEB 15
PY 2020
VL 30
IS 
BP 
EP 
DI 10.1016/j.redox.2020.101429
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA KM1PL
UT WOS:000513891900005
PM 31981894
DA 2024-11-01
ER

PT J
AU Khailany, RA
   Gilani, N
   Ozaslan, M
   Safdar, M
   Al-Shamari, I
   Kanabe, BO
   Saadat, KASM
   Homayounvash, J
   Monfaredan, A
   Al-Attar, MS
   Arslan, A
AF Khailany, Rozhgar A.
   Gilani, Naser
   Ozaslan, Mehmet
   Safdar, Muhamad
   Al-Shamari, Ihsan
   Kanabe, Belan O.
   Saadat, Khandakar A. S. M.
   Homayounvash, Javad
   Monfaredan, Amir
   Al-Attar, Mustafa S.
   Arslan, Ahmet
TI Association of a point mutation (m.9176T&gt;G) of the MT-ATP6 gene with Leigh syndrome: A case report
SO BIOMEDICAL RESEARCH AND THERAPY
LA English
DT Article
DE Mitochondrial Genome; MT-ATP6; Leigh Syndrome; Clinical Feature; Mutation
AB Leigh Syndrome (LS) is an uncommon progressive neurodegenerative mitochondrial disorder. The condition is characterized by progressive mental and developmental disabilities (psychomotor regression) and commonly brings about death within a few years of diagnosis, more often due to respiratory failure. In a small number of patients the disorder does not manifest until adulthood. The principal indications of Leigh syndrome found in early stages typically are diarrhea, vomiting, and difficulty swallowing (dysphagia), which disturbs eating. These problems usually result in powerlessness to develop and put on weight under the normal rate (failure to thrive). Serious movement and muscle problems are basic in Leigh syndrome. In this case report, we introduce the molecular and clinical features of a 19-year-old female as proband, and also, we study other members of the family consequently. The m.9176T>G heteroplasmic mutation in the MT-ATP6 gene was detected by high-resolution melt (HRM) and DNA sequencing techniques. Similarly, the m.9176T>G was heteroplasmic in the mother. In conclusion, this report in compliance with previous studies underlines the necessity of further research on prenatal distinguishing proof of the responsible mutations and avoidance of the disease in families with known cases.
C1 [Khailany, Rozhgar A.] Salahaddin Univ Erbil, Dept Biol, Coll Sci, Erbil, Iraq.
   [Khailany, Rozhgar A.] Tishk Int Univ, Dept Biol, Fac Educ, Erbil, Iraq.
   [Gilani, Naser; Ozaslan, Mehmet; Kanabe, Belan O.] Gaziantep Univ, Dept Biol, TR-27310 Gaziantep, Turkey.
   [Safdar, Muhamad] Cholistan Univ Vet & Anim Sci, Dept Breeding & Genet, Bahawalpur, Pakistan.
   [Al-Shamari, Ihsan] Hawler Med Univ, Dept Internal Med, Erbil, Iraq.
   [Saadat, Khandakar A. S. M.] Gaziantep Univ, Dept Med Biol, Fac Med, Gaziantep, Turkey.
   [Homayounvash, Javad] Univ Tehran Med Sci, Fac Med, Tehran, Iran.
   [Monfaredan, Amir] Islamic Univ, Tabriz Branch, Dept Hematol, Fac Med, Tabriz, Iran.
   [Al-Attar, Mustafa S.] Salahaddin Univ Erbil, Dept Environm Sci, Coll Sci, Erbil, Iran.
   [Arslan, Ahmet] Namik Kemal Univ, Dept Med Biol, Fac Med, Tekirdag, Turkey.
C3 Salahaddin University; Tishk International University; Gaziantep University; Hawler Medical University; Gaziantep University; Tehran University of Medical Sciences; Salahaddin University; Namik Kemal University
RP Khailany, RA (corresponding author), Salahaddin Univ Erbil, Dept Biol, Coll Sci, Erbil, Iraq.; Khailany, RA (corresponding author), Tishk Int Univ, Dept Biol, Fac Educ, Erbil, Iraq.
EM rozhgar.mohammed@su.edu.krd
CR Akagi M, 2002, NEUROMUSCULAR DISORD, V12, P53, DOI 10.1016/S0960-8966(01)00242-5
   Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169
   Dinesh P, 2014, INT J SCI STUDY, V2, P93
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006
   López-Gallardo E, 2014, HUM MOL GENET, V23, P6191, DOI 10.1093/hmg/ddu339
   Ronchi D, 2011, BMC NEUROL, V11, P0, DOI 10.1186/1471-2377-11-85
   Shrikhande DY, 2010, ITAL J PEDIATR, V36, P0, DOI 10.1186/1824-7288-36-62
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
NR 9
TC 0
Z9 0
U1 0
U2 4
PU BIOMEDPRESS
PI HO CHI MINH
PA BIOMEDPRESS, HO CHI MINH, 00000, VIETNAM
SN 2198-4093
EI 
J9 BIOMED RES THER
JI Biomed. Res. Ther.
PD JUN 15
PY 2020
VL 7
IS 5
BP 3739
EP 3743
DI 10.15419/bmrat.v7i5.601
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA LS7DM
UT WOS:000536540900001
DA 2024-11-01
ER

PT J
AU Buneeva, O
   Fedchenko, V
   Kopylov, A
   Medvedev, A
AF Buneeva, Olga
   Fedchenko, Valerii
   Kopylov, Arthur
   Medvedev, Alexei
TI Mitochondrial Dysfunction in Parkinson's Disease: Focus on Mitochondrial DNA
SO BIOMEDICINES
LA English
DT Review
DE Parkinson's disease; Parkinson's disease models; mitochondrial dysfunction; mitochondrial DNA; proteins encoded by mitochondrial genes; proteomics
ID complex-i deficiency; stop-codon mutation; oxidative damage; substantia-nigra; point mutations; intramitochondrial fibers; sequence-analysis; glycosylase ogg1; skeletal-muscle; rna-polymerase
AB Mitochondria, the energy stations of the cell, are the only extranuclear organelles, containing their own (mitochondrial) DNA (mtDNA) and the protein synthesizing machinery. The location of mtDNA in close proximity to the oxidative phosphorylation system of the inner mitochondrial membrane, the main source of reactive oxygen species (ROS), is an important factor responsible for its much higher mutation rate than nuclear DNA. Being more vulnerable to damage than nuclear DNA, mtDNA accumulates mutations, crucial for the development of mitochondrial dysfunction playing a key role in the pathogenesis of various diseases. Good evidence exists that some mtDNA mutations are associated with increased risk of Parkinson's disease (PD), the movement disorder resulted from the degenerative loss of dopaminergic neurons of substantia nigra. Although their direct impact on mitochondrial function/dysfunction needs further investigation, results of various studies performed using cells isolated from PD patients or their mitochondria (cybrids) suggest their functional importance. Studies involving mtDNA mutator mice also demonstrated the importance of mtDNA deletions, which could also originate from abnormalities induced by mutations in nuclear encoded proteins needed for mtDNA replication (e.g., polymerase gamma). However, proteomic studies revealed only a few mitochondrial proteins encoded by mtDNA which were downregulated in various PD models. This suggests nuclear suppression of the mitochondrial defects, which obviously involve cross-talk between nuclear and mitochondrial genomes for maintenance of mitochondrial functioning.
C1 [Buneeva, Olga; Fedchenko, Valerii; Kopylov, Arthur; Medvedev, Alexei] Inst Biomed Chem, 10 Pogodinskaya St, Moscow 119121, Russia.
C3 Russian Academy of Medical Sciences; Institute of Biomedical Chemistry
RP Medvedev, A (corresponding author), Inst Biomed Chem, 10 Pogodinskaya St, Moscow 119121, Russia.
EM olbuneeva@gmail.com; valfed38@yandex.ru; a.t.kopylov@gmail.com; professor57@yandex.ru
FU Russian Foundation for Basic Research [19-015-00073a]
CR Agaronyan K, 2015, SCIENCE, V347, P548, DOI 10.1126/science.aaa0986
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x
   Alexeyev M, 2020, MITOCHONDRIAL DNA A, V31, P45, DOI 10.1080/24701394.2020.1734586
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Aomi Y, 2001, BIOCHEM BIOPH RES CO, V280, P265, DOI 10.1006/bbrc.2000.4113
   Arduino Daniela M, 2015, METHODS MOL BIOL, V1265, P415, DOI 10.1007/978-1-4939-2288-8_31
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Buneeva OA, 2011, BIOMEDITSINSKAYA KHIMIYA, V57, P246
   Buneeva O, 2018, CELLS-BASEL, V7, P0, DOI 10.3390/cells7080091
   Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Castegna A, 2015, PHYSIOL GENOMICS, V47, P299, DOI 10.1152/physiolgenomics.00096.2014
   Cavelier L, 2001, HEREDITAS, V135, P65, DOI 10.1111/j.1601-5223.2001.00065.x
   Chen C, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020038
   Chen DX, 2002, J NEUROCHEM, V81, P1273, DOI 10.1046/j.1471-4159.2002.00916.x
   Chen LJ, 2005, J PINEAL RES, V39, P34, DOI 10.1111/j.1600-079X.2005.00209.x
   Chin MH, 2008, J PROTEOME RES, V7, P666, DOI 10.1021/pr070546l
   Choi YS, 2011, MOL BIOSYST, V7, P1523, DOI 10.1039/c0mb00277a
   Collins AR, 2000, FREE RADICAL RES, V32, P333, DOI 10.1080/10715760000300331
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400
   Cui J, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00595
   DAurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200
   DSouza AR, 2018, ESSAYS BIOCHEM, V62, P309, DOI 10.1042/EBC20170102
   Dai Y, 2014, NEUROTOXICOL TERATOL, V46, P62, DOI 10.1016/j.ntt.2014.10.004
   Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484
   Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Deng JH, 2006, MOL CELL BIOL, V26, P1077, DOI 10.1128/MCB.26.3.1077-1086.2006
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Egensperger R, 1997, NEUROPATH APPL NEURO, V23, P315, DOI 10.1046/j.1365-2990.1997.4098040.x
   Esteves AR, 2010, FRONT AGING NEUROSCI, V1, P0, DOI 10.3389/neuro.24.005.2009
   Esteves AR, 2010, J NEUROCHEM, V113, P674, DOI 10.1111/j.1471-4159.2010.06631.x
   Esteves AR, 2010, NEUROBIOL DIS, V37, P723, DOI 10.1016/j.nbd.2009.12.011
   Esteves AR, 2009, ANTIOXID REDOX SIGN, V11, P439, DOI 10.1089/ars.2008.2247
   Esteves ARF, 2008, MITOCHONDRION, V8, P219, DOI 10.1016/j.mito.2008.03.004
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   Farge G, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20112770
   Fukae J, 2005, ACTA NEUROPATHOL, V109, P256, DOI 10.1007/s00401-004-0937-9
   Fusté JM, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004832
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   García-Lozano JR, 2002, EUR NEUROL, V48, P34, DOI 10.1159/000064955
   Gilkerson R, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011080
   Goetz CG, 2011, CSH PERSPECT MED, V1, P0, DOI 10.1101/cshperspect.a008862
   Gonzalo R, 2005, FEBS LETT, V579, P6909, DOI 10.1016/j.febslet.2005.11.034
   Gray MW, 1998, NUCLEIC ACIDS RES, V26, P865, DOI 10.1093/nar/26.4.865
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343
   Gredilla R, 2010, NEUROBIOL AGING, V31, P993, DOI 10.1016/j.neurobiolaging.2008.07.004
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Gusdon AM, 2015, NEUROSCI LETT, V587, P98, DOI 10.1016/j.neulet.2014.12.005
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Han S, 2017, CELL CHEM BIOL, V24, P404, DOI 10.1016/j.chembiol.2017.02.002
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hauser DN, 2015, ENEURO, V2, P0, DOI 10.1523/ENEURO.0075-14.2015
   Hauser DN, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0094646
   He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266
   Hebert SL, 2010, MECH AGEING DEV, V131, P451, DOI 10.1016/j.mad.2010.03.007
   Heinz S, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep45465
   Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Horowitz MP, 2010, J ALZHEIMERS DIS, V20, PS551, DOI 10.3233/JAD-2010-100354
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Houshmand M, 1997, J ASSIST REPROD GEN, V14, P223, DOI 10.1007/BF02766114
   Hsieh CL, 2019, MOL CELL BIOL, V39, P0, DOI 10.1128/MCB.00406-18
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002
   Janetzky B, 1996, EUR NEUROL, V36, P149, DOI 10.1159/000117233
   Jiang S, 2019, EMBO REP, V20, P0, DOI 10.15252/embr.201948101
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kadenbach B, 2015, MITOCHONDRION, V24, P64, DOI 10.1016/j.mito.2015.07.002
   Karthikkeyan G, 2020, ACS OMEGA, V5, P26611, DOI 10.1021/acsomega.0c03420
   Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197
   Keeney PM, 2009, EXP NEUROL, V220, P374, DOI 10.1016/j.expneurol.2009.09.025
   King M P, 1996, METHODS ENZYMOL, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Klein C, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a008888
   Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177
   Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krokan HE, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012583
   Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LANGSTON JW, 1984, ACTA NEUROL SCAND, V70, P49
   Lapkouski M, 2015, NUCLEIC ACIDS RES, V43, P9065, DOI 10.1093/nar/gkv861
   Lauritzen KH, 2011, MECH AGEING DEV, V132, P424, DOI 10.1016/j.mad.2011.02.006
   Lauritzen KH, 2010, MOL CELL BIOL, V30, P1357, DOI 10.1128/MCB.01149-09
   LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6
   Lin XM, 2015, BBA-PROTEINS PROTEOM, V1854, P779, DOI 10.1016/j.bbapap.2015.01.007
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   Mandavilli BS, 2000, BRAIN RES, V885, P45, DOI 10.1016/S0006-8993(00)02926-7
   Marchington DR, 2002, MOL HUM REPROD, V8, P1046, DOI 10.1093/molehr/8.11.1046
   MARET G, 1990, DRUG METAB REV, V22, P291, DOI 10.3109/03602539009041087
   Mayr-Wohlfart U, 1997, EUR J MED RES, V2, P111
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160
   Medvedev AE, 2017, BIOCHEMISTRY-MOSCOW+, V82, P330, DOI 10.1134/S0006297917030117
   Müller-Nedebock AC, 2019, NEUROCHEM INT, V129, P0, DOI 10.1016/j.neuint.2019.104495
   MYTILINEOU C, 1994, J NEURAL TRANSM-PARK, V8, P223, DOI 10.1007/BF02260943
   Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200
   Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   NASS S, 1963, J CELL BIOL, V19, P613, DOI 10.1083/jcb.19.3.613
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637
   Obeso JA, 2017, MOVEMENT DISORD, V32, P1, DOI 10.1002/mds.26904
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   Passamonti M, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-65084-z
   Pilger A, 2006, INT ARCH OCC ENV HEA, V80, P1, DOI 10.1007/s00420-006-0106-7
   Podlesniy P, 2019, EBIOMEDICINE, V48, P554, DOI 10.1016/j.ebiom.2019.09.015
   Posse V, 2017, J BIOL CHEM, V292, P2637, DOI 10.1074/jbc.M116.751008
   Qin JS, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-18202-4
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkp1082
   Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392
   Sanders LH, 2014, NEUROBIOL DIS, V70, P214, DOI 10.1016/j.nbd.2014.06.014
   Santos RX, 2013, ANTIOXID REDOX SIGN, V18, P2444, DOI 10.1089/ars.2012.5039
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043
   Song WH, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/981867
   Sousa JS, 2018, SUBCELL BIOCHEM, V87, P167, DOI 10.1007/978-981-10-7757-9_7
   Spinazzola A, 2009, ADV EXP MED BIOL, V652, P69, DOI 10.1007/978-90-481-2813-6_6
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Swerdlow RH, 2001, EXP NEUROL, V169, P479, DOI 10.1006/exnr.2001.7674
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Swerdlow RH, 2007, J NEUROSCI RES, V85, P3416, DOI 10.1002/jnr.21167
   Swerdlow RH, 2012, ANTIOXID REDOX SIGN, V16, P950, DOI 10.1089/ars.2011.3948
   Taravari A, 2014, BRATISL MED J, V115, P7, DOI 10.4149/BLL_2014_002
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trinkle-Mulcahy Laura, 2019, F1000RES, V8, P0, DOI 10.12688/f1000research.16903.1
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-016-0404-6
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
   Wilkins HM, 2014, REDOX BIOL, V2, P619, DOI 10.1016/j.redox.2014.03.006
   Xia D, 2013, BBA-BIOENERGETICS, V1827, P1278, DOI 10.1016/j.bbabio.2012.11.008
   Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yamaguchi H, 2006, CELL DEATH DIFFER, V13, P551, DOI 10.1038/sj.cdd.4401788
   Yasukawa T, 2018, J BIOCHEM, V164, P183, DOI 10.1093/jb/mvy058
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Zhang J, 2002, PARKINSONISM RELAT D, V8, P165, DOI 10.1016/S1353-8020(01)00041-4
   Zhang X, 2010, J PROTEOME RES, V9, P1496, DOI 10.1021/pr901024z
NR 173
TC 32
Z9 37
U1 1
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD DEC 15
PY 2020
VL 8
IS 12
BP 
EP 
DI 10.3390/biomedicines8120591
PG 22
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy
GA PK1FI
UT WOS:000602198600001
PM 33321831
DA 2024-11-01
ER

PT J
AU Scholle, LM
   Zierz, S
   Mawrin, C
   Wickenhauser, C
   Urban, DL
AF Motlagh Scholle, Leila
   Zierz, Stephan
   Mawrin, Christian
   Wickenhauser, Claudia
   Lehmann Urban, Diana
TI Heteroplasmy and Copy Number in the Common m.3243A&gt;G Mutation-A Post-Mortem Genotype-Phenotype Analysis
SO GENES
LA English
DT Article
DE MELAS-syndrome; genotype-phenotype correlation; mtDNA heteroplasmy; m; 3243A > G
ID stroke-like episodes; mutant mitochondrial-dna; point mutation; lactic-acidosis; tissue distribution; melas subgroup; mtdna mutation; a3243g; gene; encephalopathy
AB Different mitochondrial DNA (mtDNA) mutations have been identified to cause mitochondrial encephalopathy, lactate acidosis and stroke-like episodes (MELAS). The underlying genetic cause leading to an enormous clinical heterogeneity associated with m.3243A>G-related mitochondrial diseases is still poorly understood. Genotype-phenotype correlation (heteroplasmy levels and clinical symptoms) was analysed in 16 patients (15 literature cases and one unreported case) harbouring the m.3243A>G mutation. mtDNA copy numbers were correlated to heteroplasmy levels in 30 different post-mortem tissue samples, including 14 brain samples of a 46-year-old female. In the central nervous system, higher levels of heteroplasmy correlated significantly with lower mtDNA copy numbers. Skeletal muscle levels of heteroplasmy correlated significantly with kidney and liver. There was no significant difference of heteroplasmy levels between clinically affected and unaffected patients. In the patient presented, we found >75% heteroplasmy levels in all central nervous system samples, without harbouring a MELAS phenotype. This underlines previous suggestions, that really high levels in tissues do not automatically lead to a specific phenotype. Missing significant differences of heteroplasmy levels between clinically affected and unaffected patients underline recent suggestions that there are additional factors such as mtDNA copy number and nuclear factors that may also influence disease severity.
C1 [Motlagh Scholle, Leila; Zierz, Stephan] Martin Luther Univ Halle Wittenberg, Dept Neurol, D-06120 Halle, Saale, Germany.
   [Mawrin, Christian] Otto von Guericke Univ, Inst Neuropathol, D-39120 Magdeburg, Germany.
   [Wickenhauser, Claudia] Martin Luther Univ Halle Wittenberg, Inst Pathol, D-06108 Halle, Saale, Germany.
   [Lehmann Urban, Diana] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany.
C3 Martin Luther University Halle Wittenberg; Otto von Guericke University; Martin Luther University Halle Wittenberg; Ulm University
RP Scholle, LM (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Neurol, D-06120 Halle, Saale, Germany.
EM Leila.scholle@medizin.uni-halle.de; stephan.zierz@medizin.uni-halle.de; christian.mawrin@med.ovgu.de; claudia.wickenhauser@uk-halle.de; diana.lehmann@rku.de
FU German Ministry of Education and Research - Hertha-Nathor ff-Programm (HNP) of the Ulm Medical University, Germany
CR Cardaioli E, 1999, J SUBMICR CYTOL PATH, V31, P301
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   ENTER C, 1991, HUM GENET, V88, P233
   Filograna R, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav9824
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Grady JP, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114462
   HAMAZAKI S, 1993, ACTA PATHOL JAPON, V43, P187
   KOBAYASHI Y, 1992, J INHERIT METAB DIS, V15, P803, DOI 10.1007/BF01800025
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Lehmann D, 2015, NEUROMUSCULAR DISORD, V25, P81, DOI 10.1016/j.nmd.2014.09.008
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   OHara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   OBERMAIERKUSSER B, 1991, FEBS LETT, V286, P67, DOI 10.1016/0014-5793(91)80942-V
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Prasad M, 2014, CAN J NEUROL SCI, V41, P210, DOI 10.1017/S0317167100016607
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SHIRAIWA N, 1993, J NEUROL SCI, V120, P174, DOI 10.1016/0022-510X(93)90270-9
   SHOJI Y, 1993, J INHERIT METAB DIS, V16, P27, DOI 10.1007/BF00711311
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006
NR 30
TC 26
Z9 26
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD FEB 15
PY 2020
VL 11
IS 2
BP 
EP 
DI 10.3390/genes11020212
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA KT8OP
UT WOS:000519271500056
PM 32085658
DA 2024-11-01
ER

PT J
AU Anteneová, N
   Kelifová, S
   Kolárová, H
   Vondrácková, A
   Tóthová, I
   Lisková, P
   Magner, M
   Zámecník, J
   Hansíková, H
   Zeman, J
   Tesarová, M
   Honzík, T
AF Anteneova, Nicole
   Kelifova, Silvie
   Kolarova, Hana
   Vondrackova, Alzbeta
   Tothova, Iveta
   Liskova, Petra
   Magner, Martin
   Zamecnik, Josef
   Hansikova, Hana
   Zeman, Jiri
   Tesarova, Marketa
   Honzik, Tomas
TI The Phenotypic Spectrum of 47 Czech Patients with Single, Large-Scale Mitochondrial DNA Deletions
SO BRAIN SCIENCES
LA English
DT Article
DE Kearns-Sayre Syndrome (KSS) Spectrum; Progressive External Ophthalmoplegia (PEO); Pearson Syndrome; mtDNA; Single; Large-Scale Mitochondrial DNA Deletions (SLSMD)
ID kearns-sayre-syndrome; cerebral folate-deficiency; cerebrospinal-fluid; pearson syndrome; ophthalmoplegia; mechanisms; disorders; anemia; plus
AB Background: In this retrospective study, we analysed clinical, biochemical and molecular genetic data of 47 Czech patients with Single, Large-Scale Mitochondrial DNA Deletions (SLSMD). Methods: The diagnosis was based on the long-range PCR (LX-PCR) screening of mtDNA isolated from muscle biopsy in 15 patients, and from the buccal swab, urinary epithelial cells and blood in 32 patients. Results: A total of 57% patients manifested before the age of 16. We did not find any significant difference between paediatric and adult manifestation in either the proportion of patients that would develop extraocular symptoms, or the timespan of its progression. The survival rate in patients with Pearson Syndrome reached 60%. Altogether, five patients manifested with atypical phenotype not fulfilling the latest criteria for SLSMD. No correlation was found between the disease severity and all heteroplasmy levels, lengths of the deletion and respiratory chain activities in muscle. Conclusions: Paediatric manifestation of Progressive External Ophthalmoplegia (PEO) is not associated with a higher risk of multisystemic involvement. Contrary to PEO and Kearns-Sayre Syndrome Spectrum, Pearson Syndrome still contributes to a significant childhood mortality. SLSMD should be considered even in cases with atypical presentation. To successfully identify carriers of SLSMD, a repeated combined analysis of buccal swab and urinary epithelial cells is needed.
C1 [Anteneova, Nicole; Kelifova, Silvie; Kolarova, Hana; Vondrackova, Alzbeta; Tothova, Iveta; Liskova, Petra; Magner, Martin; Hansikova, Hana; Zeman, Jiri; Tesarova, Marketa; Honzik, Tomas] Charles Univ Prague, Fac Med 1, Dept Paediat & Inherited Metab Disorders, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Anteneova, Nicole; Kelifova, Silvie; Kolarova, Hana; Vondrackova, Alzbeta; Tothova, Iveta; Liskova, Petra; Magner, Martin; Hansikova, Hana; Zeman, Jiri; Tesarova, Marketa; Honzik, Tomas] Gen Univ Hosp, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Liskova, Petra] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, U Nemocnice 2, Prague 12808 2, Czech Republic.
   [Liskova, Petra] Gen Univ Hosp, U Nemocnice 2, Prague 12808 2, Czech Republic.
   [Magner, Martin] Charles Univ Prague, Fac Med 1, Dept Paediat, Videnska 800, Prague 14059 4, Czech Republic.
   [Magner, Martin] Thomayer Hosp, Videnska 800, Prague 14059 4, Czech Republic.
   [Zamecnik, Josef] Charles Univ Prague, Fac Med 2, Dept Pathol & Mol Med, V Uvalu 84, Prague 15006 5, Czech Republic.
   [Zamecnik, Josef] Motol Univ Hosp, V Uvalu 84, Prague 15006 5, Czech Republic.
C3 Charles University Prague; General University Hospital Prague; General University Hospital Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; Thomayer Hospital; Motol University Hospital; Charles University Prague; Motol University Hospital
RP Tesarová, M (corresponding author), Charles Univ Prague, Fac Med 1, Dept Paediat & Inherited Metab Disorders, Ke Karlovu 2, Prague 12808 2, Czech Republic.; Tesarová, M (corresponding author), Gen Univ Hosp, Ke Karlovu 2, Prague 12808 2, Czech Republic.
EM nicole.anteneova@vfn.cz; silvie.kelifova@vfn.cz; hana.kolarova@vfn.cz; alzbeta.vondrackova@lf1.cuni.cz; iveta.tothova@vfn.cz; petra.liskova@lf1.cuni.cz; martin.magner@vfn.cz; josef.zamecnik@lfmotol.cuni.cz; hana.hansikova@vfn.cz; jzem@lf1.cuni.cz; marketa.tesarova@vfn.cz; tomas.honzik@vfn.cz
FU Ministry of Health of the Czech Republic [AZV 17-30965A, NU20-07-00182, RVO VFN 64165]; Charles University [Progress Q26/LF1, UNCE 204064, SVV260367]
CR Akman CI, 2004, J CHILD NEUROL, V19, P258, DOI 10.1177/088307380401900403
   ALLEN RJ, 1983, ANN NEUROL, V13, P679, DOI 10.1002/ana.410130620
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Danhelovska T, 2020, BMC PEDIATR, V20, P0, DOI 10.1186/s12887-020-1912-x
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   Farruggia P, 2016, JIMD REP, V26, P37, DOI 10.1007/8904_2015_470
   Garcia-Cazorla A, 2008, NEUROLOGY, V70, P1360, DOI 10.1212/01.wnl.0000309223.98616.e4
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gustafson MA, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0221829
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Lee SJ, 2018, YONSEI MED J, V59, P1190
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Mancuso M, 2019, DIAGNOSIS MANAGEMENT, V0, P141
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   Mazurova S, 2020, J DERMATOL, V47, P663, DOI 10.1111/1346-8138.15317
   Ormazabal A, 2006, CLIN CHIM ACTA, V371, P159, DOI 10.1016/j.cca.2006.03.004
   Ruiz EP, 2019, NEUROLOGIA, V34, P618, DOI 10.1016/j.nrl.2017.01.005
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Quijada-Fraile P, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0217-2
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   ROWLAND LP, 1983, NEUROLOGY, V33, P1179, DOI 10.1212/WNL.33.9.1179
   Sato A, 2007, GENETICS, V177, P2031, DOI 10.1534/genetics.107.081026
   Serrano M, 2010, MITOCHONDRION, V10, P429, DOI 10.1016/j.mito.2010.04.001
   SICILIANO G, 1992, CLIN NEUROL NEUROSUR, V94, P133, DOI 10.1016/0303-8467(92)90070-J
   Tanji K, 2000, J NEUROL SCI, V178, P29, DOI 10.1016/S0022-510X(00)00354-3
   Tesarova M, 2019, PEDIATR BLOOD CANCER, V66, P0, DOI 10.1002/pbc.27591
   Varhaug KN, 2020, ANN CLIN TRANSL NEUR, V7, P1318, DOI 10.1002/acn3.51119
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 36
TC 9
Z9 9
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2076-3425
J9 BRAIN SCI
JI Brain Sci.
PD NOV 15
PY 2020
VL 10
IS 11
BP 
EP 
DI 10.3390/brainsci10110766
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA OX4EO
UT WOS:000593520100001
PM 33105723
DA 2024-11-01
ER

PT J
AU Emperador, S
   Garrido-Pérez, N
   Amezcua-Gil, J
   Gaudó, P
   Andrés-Sanz, JA
   Yubero, D
   Fernández-Marmiesse, A
   O'Callaghan, MM
   Ortigoza-Escobar, JD
   Iriondo, M
   Ruiz-Pesini, E
   García-Cazorla, A
   Gil-Campos, M
   Artuch, R
   Montoya, J
   Bayona-Bafaluy, MP
AF Emperador, Sonia
   Garrido-Perez, Nuria
   Amezcua-Gil, Javier
   Gaudo, Paula
   Alberto Andres-Sanz, Julio
   Yubero, Delia
   Fernandez-Marmiesse, Ana
   O'Callaghan, Maria M.
   Ortigoza-Escobar, Juan D.
   Iriondo, Marti
   Ruiz-Pesini, Eduardo
   Garcia-Cazorla, Angels
   Gil-Campos, Mercedes
   Artuch, Rafael
   Montoya, Julio
   Pilar Bayona-Bafaluy, Maria
TI Molecular Characterization of New FBXL4 Mutations in Patients With mtDNA Depletion Syndrome
SO FRONTIERS IN GENETICS
LA English
DT Article
DE mitochondrial disease; encephalomyopathic mtDNA depletion syndrome 13; F-box leucine-rich repeat protein 4; mitochondrial DNA; mtDNA depletion; mtDNA transcription; oxidative phosphorylation
ID mitochondrial; mechanisms; assays
AB Encephalomyopathic mitochondrial DNA (mtDNA) depletion syndrome 13 (MTDPS13) is a rare genetic disorder caused by defects in F-box leucine-rich repeat protein 4 (FBXL4). Although FBXL4 is essential for the bioenergetic homeostasis of the cell, the precise role of the protein remains unknown. In this study, we report two cases of unrelated patients presenting in the neonatal period with hyperlactacidemia and generalized hypotonia. Severe mtDNA depletion was detected in muscle biopsy in both patients. Genetic analysis showed one patient as having in compound heterozygosis a splice site variant c.858+5G>C and a missense variant c.1510T>C (p.Cys504Arg) in FBXL4. The second patient harbored a frameshift novel variant c.851delC (p.Pro284LeufsTer7) in homozygosis. To validate the pathogenicity of these variants, molecular and biochemical analyses were performed using skin-derived fibroblasts. We observed that the mtDNA depletion was less severe in fibroblasts than in muscle. Interestingly, the cells harboring a nonsense variant in homozygosis showed normal mtDNA copy number. Both patient fibroblasts, however, demonstrated reduced mitochondrial transcript quantity leading to diminished steady state levels of respiratory complex subunits, decreased respiratory complex IV (CIV) activity, and finally, low mitochondrial ATP levels. Both patients also revealed citrate synthase deficiency. Genetic complementation assays established that the deficient phenotype was rescued by the canonical version of FBXL4, confirming the pathological nature of the variants. Further analysis of fibroblasts allowed to establish that increased mitochondrial mass, mitochondrial fragmentation, and augmented autophagy are associated with FBXL4 deficiency in cells, but are probably secondary to a primary metabolic defect affecting oxidative phosphorylation.
C1 [Emperador, Sonia; Garrido-Perez, Nuria; Amezcua-Gil, Javier; Gaudo, Paula; Alberto Andres-Sanz, Julio; Ruiz-Pesini, Eduardo; Montoya, Julio; Pilar Bayona-Bafaluy, Maria] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza, Spain.
   [Emperador, Sonia; Garrido-Perez, Nuria; Ruiz-Pesini, Eduardo; Montoya, Julio; Pilar Bayona-Bafaluy, Maria] IIS Aragon, Zaragoza, Spain.
   [Emperador, Sonia; Garrido-Perez, Nuria; Ruiz-Pesini, Eduardo] Univ Zaragoza, Fdn ARAID, Zaragoza, Spain.
   [Yubero, Delia; O'Callaghan, Maria M.; Ortigoza-Escobar, Juan D.; Iriondo, Marti; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Recerca St Joan de Deu, Clin Biochem Dept, Barcelona, Spain.
   [Yubero, Delia; O'Callaghan, Maria M.; Ortigoza-Escobar, Juan D.; Iriondo, Marti; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Recerca St Joan de Deu, Genet Dept, Barcelona, Spain.
   [Yubero, Delia; O'Callaghan, Maria M.; Ortigoza-Escobar, Juan D.; Iriondo, Marti; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Recerca St Joan de Deu, Pediat Neurol Dept, Barcelona, Spain.
   [Yubero, Delia; O'Callaghan, Maria M.; Ortigoza-Escobar, Juan D.; Iriondo, Marti; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Recerca St Joan de Deu, Neonatal Dept, Barcelona, Spain.
   [Yubero, Delia; O'Callaghan, Maria M.; Ortigoza-Escobar, Juan D.; Iriondo, Marti; Ruiz-Pesini, Eduardo; Garcia-Cazorla, Angels; Artuch, Rafael; Montoya, Julio; Pilar Bayona-Bafaluy, Maria] CIBERER, Madrid, Spain.
   [Fernandez-Marmiesse, Ana] Santiago de Compostela Univ, Mol Med & Chron Dis Res Ctr CiMUS, Genomes & Dis Grp, IDIS, Santiago De Compostela, Spain.
   [Gil-Campos, Mercedes] Univ Cordoba, Reina Sofia Univ Clin Hosp, Inst Maimonides Biomed Invest Cordoba IMIBIC, Metab Unit, Cordoba, Spain.
   [Gil-Campos, Mercedes] CIBEROBN Physiopathol Obes & Nutr CB12 03 30038, Madrid, Spain.
C3 University of Zaragoza; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN
RP Montoya, J; Bayona-Bafaluy, MP (corresponding author), Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza, Spain.; Montoya, J; Bayona-Bafaluy, MP (corresponding author), IIS Aragon, Zaragoza, Spain.; Montoya, J; Bayona-Bafaluy, MP (corresponding author), CIBERER, Madrid, Spain.
EM jmontoya@unizar.es; pbayona@unizar.es
FU Instituto de Salud Carlos III [PI17/00021, PI17/00166, PI/1700109]; Fundacion Mutua Madrilena; Precipita-FECYT Crowdfunding program [PR194]; Gobierno de Aragon [B33_17R]; FEDER 2014-2020 "Construyendo Europa desde Aragon"; Asociacion de Enfermos de Patologia Mitocondrial (AEPMI)
CR Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Antoun G, 2016, JIMD REP, V27, P1, DOI 10.1007/8904_2015_491
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Emperador S, 2015, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00469
   Fernández-Marmiesse A, 2019, BMC MED GENET, V20, P0, DOI 10.1186/s12881-019-0844-5
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163
   Gómez-Durán A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   Jou C, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8010068
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338
   Lewis SC, 2016, SCIENCE, V353, P0, DOI 10.1126/science.aaf5549
   Morton SU, 2017, JIMD REP, V0, PP7, DOI 10.1007/8904_2016_17
   Perales-Clemente E, 2008, P NATL ACAD SCI USA, V105, P18735, DOI 10.1073/pnas.0810518105
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Yubero D, 2016, MITOCHONDRION, V30, P51, DOI 10.1016/j.mito.2016.06.007
NR 25
TC 9
Z9 10
U1 1
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JAN 8
PY 2020
VL 10
IS 
BP 
EP 
DI 10.3389/fgene.2019.01300
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA KF8ZW
UT WOS:000509526800001
PM 31969900
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Aliyev, R
AF Finsterer, Josef
   Aliyev, Rahim
TI Metabolic stroke or stroke-like lesion: Peculiarities of a phenomenon
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Review
DE Stroke-like lesion; MELAS; Mitochondrial; mtDNA; Oxidative phosphorylation; Respiratory chain; Magnetic resonance imaging
ID lactic-acidosis; episodes melas; mitochondrial encephalomyopathy; cytochrome-oxidase; encephalopathy; mutation; phenotype; diffusion; myopathy; disease
AB Objectives: One of the most frequent cerebral lesions in mitochondrial disorders(MIDs) on imaging is the stroke-like lesion(SLL) clinically manifesting as stroke-like episode (SLE, metabolic stroke). This review aims at discussing recent advances concerning the presentation, diagnosis, and treatment of SLLs. Methods: Systematic literature review using appropriate search terms. Results: SLLs are the hallmark of MELAS but occasionally occur in other MIDs. SLLs are best identified on multimodal, cerebral MRI. SLLs may present as uni-/multilocular, symmetric/asymmetric, cortical/subcortical, supra-/infratentorial condition, initially resembling a cytotoxic edema and later a vasogenic edema, or a variable mix between them. SLLs run through an acute and a chronic stage. The acute stage is characterised by a progressively expanding lesion over days, weeks, or months, showing up as increasing hyperintensity on T2/FLAIR, DWI, and PWI and by hyperperfusion, that does not conform to a vascular territory. ADC maps are initially hypointens to become hyperintens during the course. More rarely, a variable mixture of hyper- and hypointensities may be found. The chronic stage is characterised by hypoperfusion, gadolinium enhancement, and regression of hyperintensities to various endpoints. SLLs originate from an initial cortical lesion due to focal metabolic breakdown, which either remains stable or expands within the cortex or to subcortical areas. Some SLLs show spontaneous reversibility (fleeing cortical lesions) suggesting that neuronal/glial damage does not reach the threshold of irreversible cell death. Conclusions: SLLs are a unique feature of various MIDs in particular MELAS. SLLs are dynamic and change their appearance over time. SLLs are accessible to treatment.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Messerli Inst, Vienna, Austria.
   [Aliyev, Rahim] Azerbaijan State Adv Training Inst Doctors, Dept Neurol & Clin Neurophysiol, Baku, Azerbaijan.
C3 Rudolfstiftung Hospital
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Bensaidane MR, 2020, CAN J NEUROL SCI, V47, P117, DOI 10.1017/cjn.2019.317
   Bhatia KD, 2020, AM J NEURORADIOL, V41, P167, DOI 10.3174/ajnr.A6325
   Bindu PS, 2018, CLIN NEUROL NEUROSUR, V164, P182, DOI 10.1016/j.clineuro.2017.12.010
   Cai Stephen S, 2016, RADIOL CASE REP, V11, P425
   Casimiro C, 2012, ACTA MEDICA PORT, V25, P59
   Cheldi A, 2013, BMC NEUROL, V13, P0, DOI 10.1186/1471-2377-13-8
   Chen Wan-Ting, 2019, ACTA NEUROL TAIWAN, V28(2), P46
   El-Hattab AW, 2001, GENEREVIEWS®, V0, P1993
   Finsterer J, 2020, METAB BRAIN DIS, V35, P253, DOI 10.1007/s11011-019-00523-z
   Finsterer Josef, 2024, CAN J OPHTHALMOL, V59, Pe77, DOI 10.1016/j.jcjo.2018.10.019
   Finsterer J, 2019, INTERNAL MED, V58, P3205, DOI 10.2169/internalmedicine.2954-19
   Finsterer J, 2019, J NEUROL SCI, V400, P135, DOI 10.1016/j.jns.2019.03.021
   Finsterer J, 2019, EUR J RADIOL OPEN, V6, P60, DOI 10.1016/j.ejro.2019.01.001
   Finsterer J, 2017, HANDB EXP PHARMACOL, V240, P473, DOI 10.1007/164_2016_2
   Finsterer J, 2016, WORLD J CARDIOL, V8, P333, DOI 10.4330/wjc.v8.i5.333
   Fryer RH, 2016, PEDIATR NEUROL, V56, P59, DOI 10.1016/j.pediatrneurol.2015.12.010
   Fu XL, 2019, WORLD J CLIN CASES, V7, P1066, DOI 10.12998/wjcc.v7.i9.1066
   Fukuda M, 2019, J MED CASE REP, V13, P0, DOI 10.1186/s13256-019-2255-9
   Furuya H, 1997, RINSHO SHINKEIGAKU, V37, P680
   Ganetzky RD, 2018, MOL GENET METAB, V123, P301, DOI 10.1016/j.ymgme.2018.01.010
   HICKS SAMUEL P, 1962, AMER JOUR PATHOL, V40, P615
   Hovsepian DA, 2019, ACTA NEUROL SCAND, V139, P82, DOI 10.1111/ane.13027
   Hynynen J, 2014, LIVER TRANSPLANT, V20, P1402, DOI 10.1002/lt.23965
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ikawa M, 2020, CURR OPIN CLIN NUTR, V23, P17, DOI 10.1097/MCO.0000000000000610
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Kim IO, 1996, AM J ROENTGENOL, V166, P641, DOI 10.2214/ajr.166.3.8623642
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Li YX, 2019, CLIN NEURORADIOL, V29, P321, DOI 10.1007/s00062-018-0662-8
   Maruyama S, 1998, RINSHO SHINKEIGAKU, V38, P641
   Mezuki S, 2017, BMC NEUROL, V17, P0, DOI 10.1186/s12883-017-1001-4
   Miyahara H, 2019, NEUROPATHOLOGY, V39, P212, DOI 10.1111/neup.12551
   Morin C, 1999, ANN NEUROL, V45, P389, DOI 10.1002/1531-8249(199903)45:3<389::AID-ANA16>3.0.CO;2-B
   Namer IJ, 2014, CLIN NUCL MED, V39, PE239, DOI 10.1097/RLU.0b013e318286bd6f
   Paramasiyam A, 2019, MITOCHONDRION, V48, P78, DOI 10.1016/j.mito.2019.08.003
   Pittet MP, 2016, J INHERIT METAB DIS, V39, P465, DOI 10.1007/s10545-016-9929-x
   Rinalduzzi S, 2012, NEUROL SCI, V33, P419, DOI 10.1007/s10072-011-0755-5
   Sacher M, 2005, NEURORADIOLOGY, V47, P241, DOI 10.1007/s00234-004-1314-z
   Santamarina E, 2019, EPILEPSY BEHAV CASE, V11, P92, DOI 10.1016/j.ebcr.2019.01.008
   Santuy A, 2018, CEREB CORTEX, V28, P3673, DOI 10.1093/cercor/bhy159
   Servais A, 2020, J INHERIT METAB DIS, V43, P348, DOI 10.1002/jimd.12164
   Siddiq I, 2015, NEUROLOGY, V85, P197, DOI 10.1212/WNL.0000000000001726
   Steriade C, 2014, PEDIATR NEUROL, V50, P498, DOI 10.1016/j.pediatrneurol.2014.01.009
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Sun XR, 2018, MEDICINE, V97, P0, DOI 10.1097/MD.0000000000013866
   Tsang SH, 2018, ADV EXP MED BIOL, V1085, P163, DOI 10.1007/978-3-319-95046-4_31
   Tsujikawa Koyo, 2014, RINSHO SHINKEIGAKU, V54, P882
   Turner EC, 2016, BRAIN BEHAV EVOLUT, V88, P1, DOI 10.1159/000446762
   Tzoulis C, 2009, STROKE, V40, PE15, DOI 10.1161/STROKEAHA.108.523118
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Vastagh I, 2011, IDEGGYOGY SZEMLE, V64, P399
   Wang ZX, 2012, J NEUROL SCI, V323, P173, DOI 10.1016/j.jns.2012.09.011
   Wei YP, 2018, J NEUROL, V265, P2388, DOI 10.1007/s00415-018-9014-5
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   Whitehead MT, 2017, NEURORADIOLOGY, V59, P813, DOI 10.1007/s00234-017-1866-3
   Whitehead MT, 2017, PEDIATR NEUROL, V75, P61, DOI 10.1016/j.pediatrneurol.2017.06.017
   Wong-Riley M, 2010, EYE BRAIN, V2, P99
   WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3
   Xu WXZ, 2018, J COMPUT ASSIST TOMO, V42, P510, DOI 10.1097/RCT.0000000000000712
   Yamadera M, 2019, NEUROPATHOLOGY, V39, P404, DOI 10.1111/neup.12593
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yeh HL, 2013, BRAIN DEV-JPN, V35, P158, DOI 10.1016/j.braindev.2012.03.017
   Yoshida T, 2013, INTERNAL MED, V52, P1389, DOI 10.2169/internalmedicine.52.0188
   Yu HO, 2019, J NEUROL, V266, P1459, DOI 10.1007/s00415-019-09283-3
   Zerem A, 2019, METAB BRAIN DIS, V34, P1043, DOI 10.1007/s11011-019-00415-2
NR 68
TC 46
Z9 47
U1 1
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAY 15
PY 2020
VL 412
IS 
BP 
EP 
DI 10.1016/j.jns.2020.116726
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA LG6JF
UT WOS:000528204200006
PM 32088469
DA 2024-11-01
ER

PT J
AU Palmieri, F
   Scarcia, P
   Monné, M
AF Palmieri, Ferdinando
   Scarcia, Pasquale
   Monne, Magnus
TI Diseases Caused by Mutations in Mitochondrial Carrier Genes <i>SLC25</i>: A Review
SO BIOMOLECULES
LA English
DT Review
DE disease; error of metabolism; mitochondrial carrier; mitochondrial carrier disease; mitochondrial disease; mitochondrial transporter; membrane transport; mutation; SLC25
ID reconstituted dicarboxylate carrier; carnitine-acylcarnitine translocase; s-adenosylmethionine transporter; adenine-nucleotide translocator; rat-liver mitochondria; de-novo mutations; loss-of-function; functional-characterization; bacterial expression; phosphate-carrier
AB In the 1980s, after the mitochondrial DNA (mtDNA) had been sequenced, several diseases resulting from mtDNA mutations emerged. Later, numerous disorders caused by mutations in the nuclear genes encoding mitochondrial proteins were found. Agroup of these diseases are due to defects of mitochondrial carriers, a family of proteins named solute carrier family 25 (SLC25), that transport a variety of solutes such as the reagents of ATP synthase (ATP, ADP, and phosphate), tricarboxylic acid cycle intermediates, cofactors, amino acids, and carnitine esters of fatty acids. The disease-causing mutations disclosed in mitochondrial carriers range from point mutations, which are often localized in the substrate translocation pore of the carrier, to large deletions and insertions. The biochemical consequences of deficient transport are the compartmentalized accumulation of the substrates and dysfunctional mitochondrial and cellular metabolism, which frequently develop into various forms of myopathy, encephalopathy, or neuropathy. Examples of diseases, due to mitochondrial carrier mutations are: combined D-2- and L-2-hydroxyglutaric aciduria, carnitine-acylcarnitine carrier deficiency, hyperornithinemia-hyperammonemia-homocitrillinuria (HHH) syndrome, early infantile epileptic encephalopathy type 3, Amish microcephaly, aspartate/glutamate isoform 1 deficiency, congenital sideroblastic anemia, Fontaine progeroid syndrome, and citrullinemia type II. Here, we review all the mitochondrial carrier-related diseases known until now, focusing on the connections between the molecular basis, altered metabolism, and phenotypes of these inherited disorders.
C1 [Palmieri, Ferdinando; Scarcia, Pasquale; Monne, Magnus] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Lab Biochem & Mol Biol, Via E Orabona 4, I-70125 Bari, Italy.
   [Monne, Magnus] Univ Basilicata, Dept Sci, Via Ateneo Lucano 10, I-85100 Potenza, Italy.
C3 Universita degli Studi di Bari Aldo Moro; University of Basilicata; Italfarmaco
RP Palmieri, F; Monné, M (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Lab Biochem & Mol Biol, Via E Orabona 4, I-70125 Bari, Italy.; Monné, M (corresponding author), Univ Basilicata, Dept Sci, Via Ateneo Lucano 10, I-85100 Potenza, Italy.
EM ferdpalmieri@gmail.com; pasquale.scarcia@uniba.it; magnus.monne@unibas.it
FU Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Centre of Excellence "Genomics: genes involved in pathopysiological processes in the biomedical and agricultural fields" (CEGBA); Comitato Telethon Fondazione Onlus [GGP11139]; Italian Human ProteomeNet; PRIN 2017 [2017PAB8EM_004]
CR Abrams AJ, 2018, HUM MUTAT, V39, P1995, DOI 10.1002/humu.23639
   Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354
   Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664
   Almannai M, 2018, CLIN GENET, V93, P1097, DOI 10.1111/cge.13210
   Bhoj EJ, 2015, JIMD REP, V19, P59, DOI 10.1007/8904_2014_364
   BISACCIA F, 1988, BIOCHIM BIOPHYS ACTA, V933, P229, DOI 10.1016/0005-2728(88)90030-8
   BISACCIA F, 1984, BIOCHIM BIOPHYS ACTA, V766, P386, DOI 10.1016/0005-2728(84)90254-8
   BISACCIA F, 1989, BIOCHIM BIOPHYS ACTA, V977, P171, DOI 10.1016/S0005-2728(89)80068-4
   BISACCIA F, 1993, BIOCHIM BIOPHYS ACTA, V1142, P139, DOI 10.1016/0005-2728(93)90095-W
   BISACCIA F, 1985, BIOCHIM BIOPHYS ACTA, V810, P362, DOI 10.1016/0005-2728(85)90222-1
   Boczonadi V, 2018, GENET MED, V20, P1224, DOI 10.1038/gim.2017.251
   Bottega R, 2019, J HUM GENET, V64, P1075, DOI 10.1038/s10038-019-0666-5
   Braunisch MC, 2018, CLIN GENET, V93, P255, DOI 10.1111/cge.13084
   Buffet A, 2018, CANCER RES, V78, P1914, DOI 10.1158/0008-5472.CAN-17-2463
   Camacho JA, 1999, NAT GENET, V22, P151, DOI 10.1038/9658
   Camacho JA, 2006, PEDIATR RES, V60, P423, DOI 10.1203/01.pdr.0000238301.25938.f5
   Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220
   Chaouch Amina, 2014, J NEUROMUSCUL DIS, V1, P75
   Cohen I, 2018, AM J MED GENET A, V176, P330, DOI 10.1002/ajmg.a.38574
   CROMPTON M, 1974, FEBS LETT, V46, P247, DOI 10.1016/0014-5793(74)80379-0
   CROMPTON M, 1974, BIOCHEM J, V142, P127, DOI 10.1042/bj1420127
   CROMPTON M, 1975, BIOCHEM J, V146, P667, DOI 10.1042/bj1460667
   Dahlin M, 2015, EPILEPSIA, V56, Pe176, DOI 10.1111/epi.13193
   Dard L, 2020, MOL ASPECTS MED, V71, P0, DOI 10.1016/j.mam.2019.100842
   Davis Ryan L, 2018, HANDB CLIN NEUROL, V147, P125, DOI 10.1016/B978-0-444-63233-3.00010-5
   De Lucas JR, 2008, MOL MEMBR BIOL, V25, P152, DOI 10.1080/09687680701697476
   del Arco A, 2004, J BIOL CHEM, V279, P24701, DOI 10.1074/jbc.M401417200
   Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034
   DOLCE V, 1994, J BIOL CHEM, V269, P10451
   Dolce V, 1996, FEBS LETT, V399, P95, DOI 10.1016/S0014-5793(96)01294-X
   Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Edvardson S, 2013, J MED GENET, V50, P240, DOI 10.1136/jmedgenet-2012-101485
   Eguchi M, 2018, AM J MED GENET A, V176, P351, DOI 10.1002/ajmg.a.38578
   Ehmke N, 2017, AM J HUM GENET, V101, P833, DOI 10.1016/j.ajhg.2017.09.016
   Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911
   Falk MJ, 2014, JIMD REP, V14, P77, DOI 10.1007/8904_2013_287
   Ferrara CT, 2017, J CLIN ENDOCR METAB, V102, P942, DOI 10.1210/jc.2016-3164
   Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200
   Fiermonte G, 2003, J BIOL CHEM, V278, P32778, DOI 10.1074/jbc.M302317200
   Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200
   Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782
   Fiermonte G, 2001, J BIOL CHEM, V276, P8225, DOI 10.1074/jbc.M009607200
   Fiermonte G, 1998, J BIOL CHEM, V273, P24754, DOI 10.1074/jbc.273.38.24754
   FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293
   Fiermonte G, 1992, DNA SEQ, V3, P71, DOI 10.3109/10425179209033999
   Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118
   Gorgoglione R, 2019, BBA-BIOENERGETICS, V1860, P724, DOI 10.1016/j.bbabio.2019.07.010
   Goubert E, 2017, FRONT CELL NEUROSCI, V11, P0, DOI 10.3389/fncel.2017.00149
   Gowda VK, 2019, NEUROPEDIATRICS, V50, P313, DOI 10.1055/s-0039-1693148
   Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359
   Hammer MB, 2017, NEURODEGENER DIS, V17, P208, DOI 10.1159/000464445
   Harborne SPD, 2015, BBA-BIOENERGETICS, V1847, P1245, DOI 10.1016/j.bbabio.2015.07.002
   Hayasaka K, 2018, J INHERIT METAB DIS, V41, P777, DOI 10.1007/s10545-018-0176-1
   Hellebrekers DM, 2017, EUR J HUM GENET, V25, P886, DOI 10.1038/ejhg.2017.62
   Huizing M, 1998, J BIOENERG BIOMEMBR, V30, P277, DOI 10.1023/A:1020501021222
   Huizing M, 1997, AM J HUM GENET, V61, P1239, DOI 10.1086/301628
   Iacobazzi V, 2004, HUM MUTAT, V24, P312, DOI 10.1002/humu.20085
   Ijlst L, 2001, BIOCHEM BIOPH RES CO, V280, P700, DOI 10.1006/bbrc.2000.4178
   INDIVERI C, 1989, BIOCHIM BIOPHYS ACTA, V977, P187, DOI 10.1016/S0005-2728(89)80070-2
   INDIVERI C, 1992, EUR J BIOCHEM, V207, P449, DOI 10.1111/j.1432-1033.1992.tb17070.x
   INDIVERI C, 1987, J BIOL CHEM, V262, P15979
   INDIVERI C, 1989, BIOCHIM BIOPHYS ACTA, V977, P194, DOI 10.1016/S0005-2728(89)80071-4
   Indiveri C, 1997, BIOCHEM J, V327, P349, DOI 10.1042/bj3270349
   INDIVERI C, 1987, BIOCHIM BIOPHYS ACTA, V890, P310, DOI 10.1016/0005-2728(87)90158-7
   Indiveri C, 1997, BIOCHEM J, V321, P713, DOI 10.1042/bj3210713
   Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008
   Iuso Arcangela, 2019, JIMD REP, V44, P1, DOI 10.1007/8904_2018_115
   Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200
   Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Khan S, 2018, BRIT J DERMATOL, V178, P556, DOI 10.1111/bjd.15661
   Kim J, 2018, P NATL ACAD SCI USA, V115, P4690, DOI 10.1073/pnas.1800138115
   King MS, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000256
   Kishita Y, 2015, AM J HUM GENET, V97, P761, DOI 10.1016/j.ajhg.2015.09.013
   KLINGENBERG M, 1979, TRENDS BIOCHEM SCI, V4, P249, DOI 10.1016/0968-0004(79)90215-9
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Köse MD, 2020, J PEDIATR ENDOCR MET, V33, P157, DOI 10.1515/jpem-2019-0377
   Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5
   Kwong JQ, 2014, CELL DEATH DIFFER, V21, P1209, DOI 10.1038/cdd.2014.36
   Lasorsa FM, 2003, J BIOL CHEM, V278, P38686, DOI 10.1074/jbc.M304988200
   Le Rouzic MA, 2017, BLOOD CELL MOL DIS, V66, P11, DOI 10.1016/j.bcmd.2017.07.003
   Lemattre C, 2019, EUR J HUM GENET, V27, P1692, DOI 10.1038/s41431-019-0433-2
   Lindhurst MJ, 2006, P NATL ACAD SCI USA, V103, P15927, DOI 10.1073/pnas.0607661103
   Liu J, 2017, J MOL NEUROSCI, V62, P262, DOI 10.1007/s12031-017-0929-6
   Lunetti P, 2016, J BIOL CHEM, V291, P19746, DOI 10.1074/jbc.M116.736876
   Majd H, 2018, BBA-BIOENERGETICS, V1859, P1, DOI 10.1016/j.bbabio.2017.10.002
   Marobbio CMT, 2008, J BIOL CHEM, V283, P28445, DOI 10.1074/jbc.M804637200
   Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574
   Marobbio CMT, 2002, EMBO J, V21, P5653, DOI 10.1093/emboj/cdf583
   Martinelli D, 2015, ORPHANET J RARE DIS, V10, P0, DOI 10.1186/s13023-015-0242-9
   Matsumoto S, 2019, J HUM GENET, V64, P833, DOI 10.1038/s10038-019-0614-4
   Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788
   Mayr JA, 2011, NEUROMUSCULAR DISORD, V21, P803, DOI 10.1016/j.nmd.2011.06.005
   McCormick EM, 2018, CURR OPIN PEDIATR, V30, P714, DOI 10.1097/MOP.0000000000000686
   MCGIVAN JD, 1971, EUR J BIOCHEM, V20, P392, DOI 10.1111/j.1432-1033.1971.tb01405.x
   Molinari F, 2005, AM J HUM GENET, V76, P334, DOI 10.1086/427564
   Molinari F, 2009, CLIN GENET, V76, P188, DOI 10.1111/j.1399-0004.2009.01236.x
   Monné M, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20184456
   Monné M, 2017, J BIOENERG BIOMEMBR, V49, P369, DOI 10.1007/s10863-017-9721-0
   Monné M, 2014, CURR TOP MEMBR, V73, P289, DOI 10.1016/B978-0-12-800223-0.00008-6
   Monné M, 2013, MOL MEMBR BIOL, V30, P149, DOI 10.3109/09687688.2012.737936
   Monné M, 2012, J BIOL CHEM, V287, P7925, DOI 10.1074/jbc.M111.324855
   Napolioni V, 2011, MOL NEUROBIOL, V44, P83, DOI 10.1007/s12035-011-8192-2
   Nguyen M, 2017, CLIN GENET, V91, P121, DOI 10.1111/cge.12774
   Nota B, 2013, AM J HUM GENET, V92, P627, DOI 10.1016/j.ajhg.2013.03.009
   Ortigoza-Escobar JD, 2017, ANN NEUROL, V82, P317, DOI 10.1002/ana.24998
   PALMIERI F, 1970, EUR J BIOCHEM, V17, P230, DOI 10.1111/j.1432-1033.1970.tb01158.x
   Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7
   Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3
   PALMIERI F, 1972, EUR J BIOCHEM, V26, P587, DOI 10.1111/j.1432-1033.1972.tb01801.x
   PALMIERI F, 1993, J BIOENERG BIOMEMBR, V25, P493, DOI 10.1007/BF01108406
   PALMIERI F, 1971, EUR J BIOCHEM, V22, P66, DOI 10.1111/j.1432-1033.1971.tb01515.x
   PALMIERI F, 1972, EUR J BIOCHEM, V29, P408, DOI 10.1111/j.1432-1033.1972.tb02003.x
   PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7
   Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008
   Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023
   Palmieri F, 2016, BBA-MOL CELL RES, V1863, P2362, DOI 10.1016/j.bbamcr.2016.03.007
   Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5
   Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005
   Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x
   Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI 10.1042/BSE0470037
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Palmieri L, 2001, J BIOL CHEM, V276, P1916, DOI 10.1074/jbc.M004332200
   Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060
   Palmieri L, 2006, PLANT PHYSIOL, V142, P855, DOI 10.1104/pp.106.086975
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Pérez P, 2003, FUNGAL GENET BIOL, V39, P211, DOI 10.1016/S1087-1845(03)00049-5
   Petralla S, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20184486
   Pfeiffer B, 2020, NEUROPEDIATRICS, V51, P160, DOI 10.1055/s-0039-3400976
   Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007
   Pierri CL, 2014, CELL MOL LIFE SCI, V71, P349, DOI 10.1007/s00018-013-1389-y
   Poduri A, 2013, ANN NEUROL, V74, P873, DOI 10.1002/ana.23998
   Pop A, 2018, J INHERIT METAB DIS, V41, P169, DOI 10.1007/s10545-017-0106-7
   Prasun P, 2015, JIMD REP, V19, P111, DOI 10.1007/8904_2014_378
   Profilo E, 2017, BBA-MOL BASIS DIS, V1863, P1422, DOI 10.1016/j.bbadis.2017.02.022
   Prohl C, 2001, MOL CELL BIOL, V21, P1089, DOI 10.1128/MCB.21.4.1089-1097.2001
   Punzi G, 2018, HUM MOL GENET, V27, P499, DOI 10.1093/hmg/ddx419
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Reid ES, 2017, J INHERIT METAB DIS, V40, P385, DOI 10.1007/s10545-017-0025-7
   Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103
   Rosenberg MJ, 2002, NAT GENET, V32, P175, DOI 10.1038/ng948
   Rosenthal EA, 2013, AM J HUM GENET, V93, P1035, DOI 10.1016/j.ajhg.2013.10.019
   RUNSWICK MJ, 1990, BIOCHEMISTRY-US, V29, P11033, DOI 10.1021/bi00502a004
   Ruprecht JJ, 2019, CELL, V176, P435, DOI 10.1016/j.cell.2018.11.025
   Ruprecht JJ, 2014, P NATL ACAD SCI USA, V111, PE426, DOI 10.1073/pnas.1320692111
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Ryu J, 2019, BMC MED GENET, V20, P0, DOI 10.1186/s12881-019-0921-9
   Saheki T, 2002, J HUM GENET, V47, P333, DOI 10.1007/s100380200046
   Saheki T, 2017, GENEREVIEWS NCBI BOO, V0, P0
   Saheki T, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-39627-y
   SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0
   Scarcia P, 2017, MOL GENET METAB, V122, P54, DOI 10.1016/j.ymgme.2017.07.004
   Schiff M, 2016, NEW ENGL J MED, V374, P795, DOI 10.1056/NEJMc1513610
   Shamseldin HE, 2016, HUM GENET, V135, P21, DOI 10.1007/s00439-015-1608-8
   Shelton GD, 2019, J NEUROMUSCULAR DIS, V6, P485, DOI 10.3233/JND-190421
   Smith A, 2016, JIMD REP, V30, P73, DOI 10.1007/8904_2016_536
   Spaan AN, 2005, MOL GENET METAB, V86, P441, DOI 10.1016/j.ymgme.2005.07.014
   Spiegel R, 2009, ANN NEUROL, V66, P419, DOI 10.1002/ana.21752
   Stanley CA, 2013, ONLINE MOL METHODS B, V0, P0
   STANLEY CA, 1992, NEW ENGL J MED, V327, P19, DOI 10.1056/NEJM199207023270104
   Sulaiman RA, 2017, CLIN GENET, V92, P230, DOI 10.1111/cge.12963
   Tabata A, 2008, J HUM GENET, V53, P534, DOI 10.1007/s10038-008-0282-2
   Tessa A, 2009, HUM MUTAT, V30, P741, DOI 10.1002/humu.20930
   Thangaratnarajah C, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6491
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Titus SA, 2000, J BIOL CHEM, V275, P36811, DOI 10.1074/jbc.M005163200
   Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200
   Tonazzi A, 2012, BBA-BIOENERGETICS, V1817, P697, DOI 10.1016/j.bbabio.2012.02.007
   Tosserams A, 2018, MITOCHONDRION, V39, P26, DOI 10.1016/j.mito.2017.08.009
   Trabelsi Y, 2017, GLIA, V65, P401, DOI 10.1002/glia.23099
   Tunali NE, 2014, MOL GENET METAB, V112, P25, DOI 10.1016/j.ymgme.2014.03.002
   Tzagoloff A, 1996, J BIOL CHEM, V271, P7392, DOI 10.1074/jbc.271.13.7392
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   von Renesse Anja, 2019, JIMD REP, V43, P27, DOI 10.1007/8904_2018_93
   Vozza A, 2017, BBA-BIOENERGETICS, V1858, P137, DOI 10.1016/j.bbabio.2016.11.006
   Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111
   Walder K, 1998, HUM MOL GENET, V7, P1431, DOI 10.1093/hmg/7.9.1431
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wan JJ, 2016, BRAIN, V139, P2877, DOI 10.1093/brain/aww212
   Wibom R, 2009, NEW ENGL J MED, V361, P489, DOI 10.1056/NEJMoa0900591
   Writzl K, 2017, AM J HUM GENET, V101, P844, DOI 10.1016/j.ajhg.2017.09.017
   Zara V, 2003, J MOL BIOL, V325, P399, DOI 10.1016/S0022-2836(02)01236-6
   ZARA V, 1992, J BIOL CHEM, V267, P12077
   Zara V, 2009, BIOCHEM J, V419, P369, DOI 10.1042/BJ20082270
   ZARRILLI R, 1989, MOL ENDOCRINOL, V3, P1498, DOI 10.1210/mend-3-9-1498
NR 188
TC 68
Z9 75
U1 1
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2218-273X
J9 BIOMOLECULES
JI Biomolecules
PD APR 15
PY 2020
VL 10
IS 4
BP 
EP 
DI 10.3390/biom10040655
PG 32
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA LW9WG
UT WOS:000539492400159
PM 32340404
DA 2024-11-01
ER

PT J
AU Ng, YS
   Thompson, K
   Loher, D
   Hopton, S
   Falkous, G
   Hardy, SA
   Schaefer, AM
   Shaunak, S
   Roberts, ME
   Lilleker, JB
   Taylor, RW
AF Ng, Yi Shiau
   Thompson, Kyle
   Loher, Daniela
   Hopton, Sila
   Falkous, Gavin
   Hardy, Steven A.
   Schaefer, Andrew M.
   Shaunak, Sandip
   Roberts, Mark E.
   Lilleker, James B.
   Taylor, Robert W.
TI Novel <i>MT-ND</i> Gene Variants Causing Adult-Onset Mitochondrial Disease and Isolated Complex I Deficiency
SO FRONTIERS IN GENETICS
LA English
DT Article
DE mitochondrial DNA; muscle biopsy; myopathy; deafness; tissue segregation
ID exercise intolerance; mutations; assay; mtdna
AB Mitochondrial complex I deficiency is associated with a diverse range of clinical phenotypes and can arise due to either mitochondrial DNA (mtDNA) or nuclear gene defects. We investigated two adult patients who exhibited non-syndromic neurological features and evidence of isolated mitochondrial complex I deficiency in skeletal muscle biopsies. The first presented with indolent myopathy, progressive since age 17, while the second developed deafness around age 20 and other relapsing-remitting neurological symptoms since. A novel, likely de novo, frameshift variant in MT-ND6 (m.14512_14513del) and a novel maternally-inherited transversion mutation in MT-ND1 were identified, respectively. Skewed tissue segregation of mutant heteroplasmy level was observed; the mutant heteroplasmy levels of both variants were greater than 70% in muscle homogenate, however, in blood the MT-ND6 variant was undetectable while the mutant heteroplasmy level of the MT-ND1 variant was low (12%). Assessment of complex I assembly by Blue-Native PAGE demonstrated a decrease in fully assembled complex I in the muscle of both cases. SDS-PAGE and immunoblotting showed decreased levels of mtDNA-encoded ND1 and several nuclear encoded complex I subunits in both cases, consistent with functional pathogenic consequences of the identified variants. Pathogenicity of the m.14512_14513del was further corroborated by single-fiber segregation studies.
C1 [Ng, Yi Shiau; Thompson, Kyle; Loher, Daniela; Hopton, Sila; Falkous, Gavin; Hardy, Steven A.; Schaefer, Andrew M.; Taylor, Robert W.] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England.
   [Ng, Yi Shiau; Schaefer, Andrew M.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Directorate Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Loher, Daniela] Univ Freiburg, Fac Med, Inst Biochem & Mol Biol, ZBMZ, Freiburg, Germany.
   [Hopton, Sila; Falkous, Gavin; Hardy, Steven A.; Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne, Tyne & Wear, England.
   [Shaunak, Sandip] Royal Preston Hosp, Dept Neurol, Preston, Lancs, England.
   [Roberts, Mark E.; Lilleker, James B.] Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Ctr Clin Neurosci, Salford, Lancs, England.
   [Lilleker, James B.] Univ Manchester, Ctr Musculoskeletal Res, Sch Biol Sci, Div Musculoskeletal & Dermatol Sci, Manchester, Lancs, England.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; University of Freiburg; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Royal Preston Hospital; Salford Royal NHS Foundation Trust; University of Manchester
RP Taylor, RW (corresponding author), Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England.; Taylor, RW (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease; Mitochondrial Disease Patient Cohort (UK) [G0800674]; Newcastle University Centre for Ageing and Vitality (Biotechnology and Biological Sciences Research Council); Newcastle University Centre for Ageing and Vitality (Medical Research Council) [L016354]; UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; Lily Foundation; NIHR Clinical Lectureship in Neurology [CL-2016-01-003, NWN/006/025/A]; UK NHS
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Formosa LE, 2018, SEMIN CELL DEV BIOL, V76, P154, DOI 10.1016/j.semcdb.2017.08.011
   Gorman GS, 2015, NEUROMUSCULAR DISORD, V25, P563, DOI 10.1016/j.nmd.2015.03.001
   Gorman GS, 2015, CLIN SCI, V128, P895, DOI 10.1042/CS20140705
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Hardy SA, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000082
   Hoefs SJG, 2012, MITOCHONDRION, V12, P520, DOI 10.1016/j.mito.2012.07.106
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010
   Musumeci O, 2000, AM J HUM GENET, V66, P1900, DOI 10.1086/302927
   Ng YS, 2018, EBIOMEDICINE, V30, P86, DOI 10.1016/j.ebiom.2018.02.010
   OToole JF, 2014, INT J NEPHROL RENOV, V7, P57, DOI 10.2147/IJNRD.S37887
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Zierz CM, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8060789
NR 24
TC 12
Z9 12
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD FEB 25
PY 2020
VL 11
IS 
BP 
EP 
DI 10.3389/fgene.2020.00024
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA LC3DV
UT WOS:000525206400001
PM 32158465
DA 2024-11-01
ER

PT J
AU Kume, K
   Morino, H
   Miyamoto, R
   Matsuda, Y
   Ohsawa, R
   Kanaya, Y
   Tada, Y
   Kurashige, T
   Kawakami, H
AF Kume, Kodai
   Morino, Hiroyuki
   Miyamoto, Ryosuke
   Matsuda, Yukiko
   Ohsawa, Ryosuke
   Kanaya, Yuhei
   Tada, Yui
   Kurashige, Takashi
   Kawakami, Hideshi
TI Middle-age-onset cerebellar ataxia caused by a homozygous <i>TWNK</i> variant: a case report
SO BMC MEDICAL GENETICS
LA English
DT Article
DE TWNK; Cerebellar ataxia; Perrault syndrome
ID perrault syndrome; mutation
AB Background The TWNK gene encodes the twinkle protein, which is a mitochondrial helicase for DNA replication. The dominant TWNK variants cause progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, while the recessive variants cause mitochondrial DNA depletion syndrome 7 and Perrault syndrome 5. Perrault syndrome is characterized by sensorineural hearing loss in both males and females and gonadal dysfunction in females. Patients with Perrault syndrome may present early-onset cerebellar ataxia, whereas middle-age-onset cerebellar ataxia caused by TWNK variants is rare. Case presentation A Japanese female born to consanguineous parents presented hearing loss at age 48, a staggering gait at age 53, and numbness in her distal extremities at age 57. Neurological examination revealed sensorineural hearing loss, cerebellar ataxia, decreased deep tendon reflexes, and sensory disturbance in the distal extremities. Laboratory tests showed no abnormal findings other than a moderate elevation of pyruvate concentration levels. Brain magnetic resonance imaging revealed mild cerebellar atrophy. Using exome sequencing, we identified a homozygous TWNK variant (NM_021830: c.1358G>A, p.R453Q). Conclusions TWNK variants could cause middle-age-onset cerebellar ataxia. Screening for TWNK variants should be considered in cases of cerebellar ataxia associated with deafness and/or peripheral neuropathy, even if the onset is not early.
C1 [Kume, Kodai; Morino, Hiroyuki; Matsuda, Yukiko; Ohsawa, Ryosuke; Kanaya, Yuhei; Tada, Yui; Kawakami, Hideshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Epidemiol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.
   [Miyamoto, Ryosuke] Tokushima Univ, Inst Biomed Sci, Dept Clin Neurosci, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7700042, Japan.
   [Kurashige, Takashi] Natl Hosp Org Kure Med Ctr, Dept Neurol, 3-1 Aoyama Cho, Kure 7370023, Japan.
   [Kurashige, Takashi] Chugoku Canc Ctr, 3-1 Aoyama Cho, Kure 7370023, Japan.
C3 Hiroshima University; Tokushima University
RP Morino, H (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Epidemiol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.
EM morino@hiroshima-u.ac.jp
CR Chatzispyrou IA, 2017, HUM MOL GENET, V26, P2541, DOI 10.1093/hmg/ddx152
   Demain LAM, 2017, CLIN GENET, V91, P302, DOI 10.1111/cge.12776
   Domínguez-Ruiz M, 2019, J TRANSL MED, V17, P0, DOI 10.1186/s12967-019-2041-x
   Fekete B, 2019, BMC MED GENET, V20, P0, DOI 10.1186/s12881-019-0934-4
   Jamali F, 2019, ARCH IRAN MED, V22, P728
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Lerat J, 2016, HUM MUTAT, V37, P1354, DOI 10.1002/humu.23120
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Oldak M, 2017, J TRANSL MED, V15, P0, DOI 10.1186/s12967-017-1129-4
   Pierce SB, 2016, CSH MOL CASE STUD, V2, P0, DOI 10.1101/mcs.a001107
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Schicks J, 2010, MOVEMENT DISORD, V25, P2678, DOI 10.1002/mds.23286
   van der Knaap MS, 2019, NEUROLOGY, V92, PE1225, DOI 10.1212/WNL.0000000000007098
NR 13
TC 10
Z9 10
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2350
J9 BMC MED GENET
JI BMC Med. Genet.
PD MAR 31
PY 2020
VL 21
IS 1
BP 
EP 
DI 10.1186/s12881-020-01002-4
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA LA1KN
UT WOS:000523713900001
PM 32234020
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Update Review about Metabolic Myopathies
SO LIFE-BASEL
LA English
DT Review
DE metabolism; myopathy; neuromuscular; genetics; mitochondrial deoxy-nucleic acid (mtDNA); fat metabolism; mitochondrial
ID polyglucosan body myopathy; palmitoyltransferase-ii deficiency; onset pompe disease; danon disease; phenotypic-expression; mutations; management; disorder; exercise; patient
AB The aim of this review is to summarize and discuss recent findings and new insights in the etiology and phenotype of metabolic myopathies. The review relies on a systematic literature review of recent publications. Metabolic myopathies are a heterogeneous group of disorders characterized by mostly inherited defects of enzymatic pathways involved in muscle cell metabolism. Metabolic myopathies present with either permanent (fixed) or episodic abnormalities, such as weakness, wasting, exercise-intolerance, myalgia, or an increase of muscle breakdown products (creatine-kinase, myoglobin) during exercise. Though limb and respiratory muscles are most frequently affected, facial, extra-ocular, and axial muscles may be occasionally also involved. Age at onset and prognosis vary considerably. There are multiple disease mechanisms and the pathophysiology is complex. Genes most recently related to metabolic myopathy include PGM1, GYG1, RBCK1, VMA21, MTO1, KARS, and ISCA2. The number of metabolic myopathies is steadily increasing. There is limited evidence from the literature that could guide diagnosis and treatment of metabolic myopathies. Treatment is limited to mainly non-invasive or invasive symptomatic measures. In conclusion, the field of metabolic myopathies is evolving with the more widespread availability and application of next generation sequencing technologies worldwide. This will broaden the knowledge about pathophysiology and putative therapeutic strategies for this group of neuromuscular disorders.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Messerli Inst, A-1180 Vienna, Austria.
C3 Rudolfstiftung Hospital
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Messerli Inst, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Al-Hassnan ZN, 2015, J MED GENET, V52, P186, DOI 10.1136/jmedgenet-2014-102592
   Alfadhel M, 2018, EUR J PAEDIATR NEURO, V22, P46, DOI 10.1016/j.ejpn.2017.10.003
   Angelini C, 2016, BBA-MOL BASIS DIS, V1862, P1367, DOI 10.1016/j.bbadis.2016.04.008
   Arnold GL, 2009, MOL GENET METAB, V96, P85, DOI 10.1016/j.ymgme.2008.09.008
   Ashwal S, 1985, PEDIATR NEUROL, V1, P185, DOI 10.1016/0887-8994(85)90062-1
   Balasubramanian M, 2018, MOL GENET METAB REP, V15, P69, DOI 10.1016/j.ymgmr.2018.02.008
   Béhin A, 2016, REV NEUROL-FRANCE, V172, P231, DOI 10.1016/j.neurol.2015.11.008
   Boemer F, 2016, CLIN GENET, V89, P193, DOI 10.1111/cge.12593
   Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457
   Bottillo I, 2016, CARDIOVASC PATHOL, V25, P423, DOI 10.1016/j.carpath.2016.07.005
   Burda P, 2015, CURR OPIN CLIN NUTR, V18, P415, DOI 10.1097/MCO.0000000000000181
   Chan J, 2017, MOL GENET METAB, V120, P163, DOI 10.1016/j.ymgme.2016.12.004
   Chien YH, 2017, MOL GENET METAB REP, V11, P31, DOI 10.1016/j.ymgmr.2017.04.004
   Cohen I, 2018, AM J MED GENET A, V176, P330, DOI 10.1002/ajmg.a.38574
   Comi GP, 2001, ANN NEUROL, V50, P202, DOI 10.1002/ana.1095
   Cucchiari D, 2018, CEN CASE REP, V7, P62, DOI 10.1007/s13730-017-0292-z
   Debashree B, 2018, J NEUROCHEM, V145, P323, DOI 10.1111/jnc.14318
   Desikan M, 2018, NEUROMUSCULAR DISORD, V28, P346, DOI 10.1016/j.nmd.2018.01.002
   Dimauro I, 2018, CELL STRESS CHAPERON, V23, P491, DOI 10.1007/s12192-017-0866-x
   Ding Y, 2018, J PEDIATR ENDOCR MET, V31, P781, DOI 10.1515/jpem-2017-0551
   Dodge JC, 2017, FRONT MOL NEUROSCI, V10, P0, DOI 10.3389/fnmol.2017.00356
   El-Hattab AW, 1993, GENEREVIEWS, V0, P0
   Endo Y, 2015, ACTA NEUROPATHOL, V129, P391, DOI 10.1007/s00401-015-1385-4
   Finsterer J, 2017, ACTA NEUROL SCAND, V136, P558, DOI 10.1111/ane.12758
   Finsterer J, 2011, JATR NEUROL PSYCHIAT, V4, P26
   Finsterer J, 2015, REV MED CHILE, V143, P1210, DOI 10.4067/S0034-98872015000900016
   Finsterer J, 2015, PEDIATR NEUROL, V52, P302, DOI 10.1016/j.pediatrneurol.2014.06.023
   Garone C, 2017, HUM MOL GENET, V26, P4257, DOI 10.1093/hmg/ddx314
   Gourzi P, 2019, EUR J MED GENET, V62, P77, DOI 10.1016/j.ejmg.2018.05.015
   Hansen JS, 2018, ACTA NEUROL SCAND, V137, P85, DOI 10.1111/ane.12811
   Hedberg-Oldfors C, 2018, ACTA NEUROL SCAND, V137, P308, DOI 10.1111/ane.12865
   Hedberg-Oldfors C, 2015, MOL ASPECTS MED, V46, P85, DOI 10.1016/j.mam.2015.08.006
   Horvath JJ, 2012, MOL GENET METAB, V107, P496, DOI 10.1016/j.ymgme.2012.09.025
   Inal-Gültekin G, 2017, NEUROMUSCULAR DISORD, V27, P997, DOI 10.1016/j.nmd.2017.06.004
   Kakkar A, 2018, ULTRASTRUCT PATHOL, V42, P211, DOI 10.1080/01913123.2018.1447624
   Kasapkara ÇS, 2017, J PEDIATR ENDOCR MET, V30, P459, DOI 10.1515/jpem-2016-0317
   Kim J, 2014, TEX HEART I J, V41, P332, DOI 10.14503/THIJ-13-3279
   Koo P, 2018, CLIN CHEST MED, V39, P401, DOI 10.1016/j.ccm.2018.02.001
   Krenn M, 2018, J NEUROL, V265, P394, DOI 10.1007/s00415-017-8710-x
   Kyaw H, 2018, CUREUS J MED SCIENCE, V10, P0, DOI 10.7759/cureus.2155
   Laforêt P, 2017, CURR OPIN NEUROL, V30, P449, DOI 10.1097/WCO.0000000000000484
   Leung Doris G, 2018, J CLIN NEUROMUSCUL DIS, V19, P117, DOI 10.1097/CND.0000000000000200
   Li SC, 2012, J CHILD NEUROL, V27, P204, DOI 10.1177/0883073811415107
   Longo N, 2016, ANN NUTR METAB, V68, P5, DOI 10.1159/000448321
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   Luna-Sánchez M, 2017, EMBO MOL MED, V9, P78, DOI 10.15252/emmm.201606345
   Luo SS, 2014, CLIN NEUROPATHOL, V33, P284, DOI 10.5414/NP300668
   Mamoune A, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004711
   Mantilla C, 2018, BIOMEDICA, V38, P30, DOI 10.7705/biomedica.v38i0.3454
   Marino M, 2016, NEUROMUSCULAR DISORD, V26, P890, DOI 10.1016/j.nmd.2016.09.025
   MATSUISHI T, 1988, BRAIN DEV-JPN, V10, P125, DOI 10.1016/S0387-7604(88)80083-4
   McIntosh P, 2017, AM J MED GENET A, V173, P2628, DOI 10.1002/ajmg.a.38369
   Motzek A, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0151261
   Munteanu I, 2015, NEUROLOGY, V84, P1714, DOI 10.1212/WNL.0000000000001499
   Musumeci O, 2012, NEUROMUSCULAR DISORD, V22, P325, DOI 10.1016/j.nmd.2011.10.022
   Nazari Ferdos, 2018, J CLIN NEUROMUSCUL DIS, V19, P203, DOI 10.1097/CND.0000000000000212
   Nilsson J, 2013, ANN NEUROL, V74, P914, DOI 10.1002/ana.23963
   Nolting K, 2017, MOL GENET METAB REP, V13, P33, DOI 10.1016/j.ymgmr.2017.07.010
   OByrne JJ, 2018, MOL GENET METAB, V123, P28, DOI 10.1016/j.ymgme.2017.11.003
   Obaid A, 2018, JIMD REP, V40, P47, DOI 10.1007/8904_2017_58
   Olpin SE, 2015, J CLIN PATHOL, V68, P410, DOI 10.1136/jclinpath-2014-202808
   Ondruskova N, 2014, NEUROENDOCRINOL LETT, V35, P137
   Phowthongkum P, 2018, JIMD REP, V41, P11, DOI 10.1007/8904_2017_74
   Piekutowska-Abramczuk D, 2018, AM J HUM GENET, V102, P460, DOI 10.1016/j.ajhg.2018.01.008
   Plöckinger U, 2018, HUM GENOMICS, V12, P0, DOI 10.1186/s40246-018-0145-7
   Preisler N, 2017, MOL GENET METAB, V122, P117, DOI 10.1016/j.ymgme.2017.08.007
   Preisler N, 2015, J INHERIT METAB DIS, V38, P551, DOI 10.1007/s10545-014-9771-y
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Reuser AJJ, 2019, HUM MUTAT, V40, P2146, DOI 10.1002/humu.23878
   Rowland TJ, 2016, J CELL SCI, V129, P2135, DOI 10.1242/jcs.184770
   Sakai C, 2015, HUM MUTAT, V36, P232, DOI 10.1002/humu.22730
   Samad F, 2017, INT J CARDIOL, V245, P201, DOI 10.1016/j.ijcard.2017.06.031
   Sentner CP, 2016, J INHERIT METAB DIS, V39, P697, DOI 10.1007/s10545-016-9932-2
   Sharpe AJ, 2018, CELLS-BASEL, V7, P0, DOI 10.3390/cells7060046
   Spiekerkoetter U, 2009, J INHERIT METAB DIS, V32, P498, DOI 10.1007/s10545-009-1126-8
   Tan JZ, 2018, CLIN NEUROL NEUROSUR, V168, P102, DOI 10.1016/j.clineuro.2018.03.001
   Tarnopolsky Mark A, 2016, CONTINUUM (MINNEAP MINN), V22, P1829
   Tasca G, 2016, J NEUROL, V263, P2133, DOI 10.1007/s00415-016-8268-z
   Tonin P, 2009, NEUROMUSCULAR DISORD, V19, P776, DOI 10.1016/j.nmd.2009.08.007
   van Vliet P, 2018, JIMD REP, V38, P101, DOI 10.1007/8904_2017_37
   Verrigni D, 2017, CLIN GENET, V91, P918, DOI 10.1111/cge.12931
   Visuttijai K, 2020, J CLIN ENDOCR METAB, V105, P557, DOI 10.1210/clinem/dgz075
   Vittonatto Elisa, 2017, ACTA MYOL, V36, P191
   Voermans NC, 2017, NEUROMUSCULAR DISORD, V27, P370, DOI 10.1016/j.nmd.2017.01.014
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Wieser T, 2003, NEUROLOGY, V60, P1351, DOI 10.1212/01.WNL.0000055901.58642.48
   Witkowski G, 2018, NEUROL NEUROCHIR POL, V52, P465, DOI 10.1016/j.pjnns.2018.05.002
   Witting N, 2014, JAMA NEUROL, V71, P88, DOI 10.1001/jamaneurol.2013.3209
   Wong SYW, 2016, J PEDIATR-US, V175, P130, DOI 10.1016/j.jpeds.2016.04.021
   Yardeni M, 2017, AM J MED GENET A, V173, P2461, DOI 10.1002/ajmg.a.38320
   Yuan JH, 2013, J CLIN PATHOL, V66, P659, DOI 10.1136/jclinpath-2012-201431
   Yubero D, 2018, EXPERT REV MOL DIAGN, V18, P491, DOI 10.1080/14737159.2018.1478290
   Zhang Y, 2018, BMC MED GENET, V19, P0, DOI 10.1186/s12881-018-0560-6
NR 94
TC 8
Z9 9
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD APR 15
PY 2020
VL 10
IS 4
BP 
EP 
DI 10.3390/life10040043
PG 18
WC Biology; Microbiology
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA LO8OO
UT WOS:000533885500011
PM 32316520
DA 2024-11-01
ER

PT J
AU Urban, DL
   Scholle, LM
   Wagner, M
   Ludolph, AC
   Rosenbohm, A
AF Urban, Diana Lehmann
   Scholle, Leila Motlagh
   Wagner, Matias
   Ludolph, Albert C.
   Rosenbohm, Angela
TI The m.9143T&gt;C Variant: Recurrent Infections and Immunodeficiency as an Extension of the Phenotypic Spectrum in <i>MT-ATP6</i> Mutations?
SO DISEASES
LA English
DT Article
DE MT-ATP6; mitochondrial disease; immune deficiency; phenotypic spectrum
ID mitochondrial; mtdna; dysfunction; disease
AB Pathogenic variants in the MT-ATP6 are a well-known cause for maternally inherited mitochondrial disorders associated with a wide range of clinical phenotypes. Here, we present a 31- year old female with insulin-dependent diabetes mellitus, recurrent lactic acidosis and ketoacidosis recurrent infections with suspected immunodeficiency with T cell lymphopenia and hypogammaglobulinemia as well as proximal tetraparesis with severe muscle and limb pain and rapid physical exhaustion. Muscle biopsy and respiratory chain activities were normal. Single-exome sequencing revealed a variant in the MT-ATP6 gene: m.9143T>C. Analysis of further specimen of the index and mother (segregation studies) revealed the highest mutation load in muscle (99% level of mtDNA heteroplasmy) of the index patient. Interestingly, acute metabolic and physical decompensation during recurrent illness was documented to be a common clinical feature in patients with MT-ATP6 variants. However, it was not mentioned as a key symptom. Thus, we suggest that the clinical spectrum might be expanded in ATP6-associated diseases.
C1 [Urban, Diana Lehmann; Ludolph, Albert C.; Rosenbohm, Angela] Ulm Univ, Dept Neurol, D-89081 Ulm, Germany.
   [Scholle, Leila Motlagh] Univ Halle S, Dept Neurol, D-06120 Halle, Germany.
   [Wagner, Matias] Tech Univ Munich, Sch Med, Inst Human Genet, D-81675 Munich, Germany.
   [Wagner, Matias] Helmholtz Zentrum Munchen, Inst Neurogen, D-85764 Munich, Germany.
C3 Ulm University; Martin Luther University Halle Wittenberg; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health
RP Urban, DL (corresponding author), Ulm Univ, Dept Neurol, D-89081 Ulm, Germany.
EM diana.lehmann@rku.de; leila.scholle@medizin.uni-halle.de; Matias.Wagner@mri.tum.de; albert.ludolph@rku.de; angela.rosenbohm@uni-ulm.de
FU German Research Foundation (DFG)
CR Angajala A, 2018, FRONT IMMUNOL, V9, P0, DOI 10.3389/fimmu.2018.01605
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   CIAFALONI E, 1993, J PEDIATR-US, V122, P419, DOI 10.1016/S0022-3476(05)83431-6
   Eom S, 2017, PEDIATR NEUROL, V66, P82, DOI 10.1016/j.pediatrneurol.2016.10.006
   Ganetzky RD, 2019, HUM MUTAT, V40, P499, DOI 10.1002/humu.23723
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Kapniciz SM, 2018, METABOLISM, V81, P97, DOI 10.1016/j.metabol.2017.11.010
   Mohanty A, 2019, J CELL COMMUN SIGNAL, V13, P303, DOI 10.1007/s12079-019-00507-9
   Scholle LM, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11020212
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Posey JE, 2016, GENET MED, V18, P678, DOI 10.1038/gim.2015.142
   Quadalti C, 2018, BBA-MOL BASIS DIS, V1864, P2131, DOI 10.1016/j.bbadis.2018.03.021
   Ruppert V, 2004, BIOCHEM BIOPH RES CO, V318, P535, DOI 10.1016/j.bbrc.2004.04.061
   Sikorska M, 2009, MUSCLE NERVE, V40, P381, DOI 10.1002/mus.21355
   Stendel C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000393
   Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Thorburn DR, 1993, GENEREVIEWS R, V0, P0
   Tiku V, 2020, TRENDS CELL BIOL, V30, P263, DOI 10.1016/j.tcb.2020.01.006
   Wagner M, 2019, J INHERIT METAB DIS, V42, P909, DOI 10.1002/jimd.12109
NR 23
TC 1
Z9 1
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2079-9721
J9 DISEASES-BASEL
JI Diseases
PD JUN 15
PY 2020
VL 8
IS 2
BP 
EP 
DI 10.3390/diseases8020019
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA TY8EW
UT WOS:000684013600012
PM 32527054
DA 2024-11-01
ER

PT J
AU Zereg, E
   Chaussenot, A
   Morel, G
   Bannwarth, S
   Sacconi, S
   Soriani, MH
   Attarian, S
   Cano, A
   Pouget, J
   Bellance, R
   Tranchant, C
   Lannes, B
   de Paula, AM
   Ait-El-Mkadem, SS
   Chafino, B
   Berthet, M
   Fragaki, K
   Paquis-Flucklinger, V
   Rouzier, C
AF Zereg, Elamine
   Chaussenot, Annabelle
   Morel, Godelieve
   Bannwarth, Sylvie
   Sacconi, Sabrina
   Soriani, Marie-Helene
   Attarian, Shahram
   Cano, Aline
   Pouget, Jean
   Bellance, Remi
   Tranchant, Christine
   Lannes, Beatrice
   de Paula, Andre Maues
   Ait-El-Mkadem, Samira Saadi
   Chafino, Bernadette
   Berthet, Mathieu
   Fragaki, Konstantina
   Paquis-Flucklinger, Veronique
   Rouzier, Cecile
TI Single-fiber studies for assigning pathogenicity of eight mitochondrial DNA variants associated with mitochondrial diseases
SO HUMAN MUTATION
LA English
DT Article
DE ATP6; mitochondrial tRNA; mtDNA heteroplasmy; ND2; single-fiber analysis
ID complex-i; mtdna mutations; trna(asn) gene; phenotype; nuclear; deletions; sequence; genome; leads
AB Whole mitochondrial DNA (mtDNA) sequencing is now systematically used in clinical laboratories to screen patients with a phenotype suggestive of mitochondrial disease. Next Generation Sequencing (NGS) has significantly increased the number of identified pathogenic mtDNA variants. Simultaneously, the number of variants of unknown significance (VUS) has increased even more, thus challenging their interpretation. Correct classification of the variants' pathogenicity is essential for optimal patient management, including treatment and genetic counseling. Here, we used single muscle fiber studies to characterize eight heteroplasmic mtDNA variants, among which were three novel variants. By applying the pathogenicity scoring system, we classified four variants as "definitely pathogenic" (m.590A>G, m.9166T>C, m.12293G>A, and m.15958A>T). Two variants remain "possibly pathogenic" (m.4327T>C and m.5672T>C) but should these be reported in a different family, they would be reclassified as "definitely pathogenic." We also illustrate the contribution of single-fiber studies to the diagnostic approach in patients harboring pathogenic variants with low level heteroplasmy.
C1 [Zereg, Elamine; Chaussenot, Annabelle; Morel, Godelieve; Bannwarth, Sylvie; Ait-El-Mkadem, Samira Saadi; Chafino, Bernadette; Berthet, Mathieu; Fragaki, Konstantina; Paquis-Flucklinger, Veronique; Rouzier, Cecile] Nice Teaching Hosp, Natl Ctr Mitochondrial Dis, Dept Med Genet, Nice, France.
   [Chaussenot, Annabelle; Bannwarth, Sylvie; Ait-El-Mkadem, Samira Saadi; Fragaki, Konstantina; Paquis-Flucklinger, Veronique; Rouzier, Cecile] Univ Cote dAzur, IRCAN, CNRS, Inserm U1081,UMR7284, Nice, France.
   [Sacconi, Sabrina; Soriani, Marie-Helene] Nice Teaching Hosp, Neuromuscular Dis Ctr, Dept Clin Neurosci, Nice, France.
   [Attarian, Shahram; Pouget, Jean] Aix Marseille Univ, Timone Univ Hosp, Referral Ctr ALS & Neuromuscular Dis, Neurol Dept, Marseille, France.
   [Cano, Aline] Timone Hosp, Reference Ctr Inherited Metab Dis, Pediat Neurol Dept, Marseille, France.
   [Bellance, Remi] Fort de France Teaching Hosp, Neuromuscular Reference Ctr, Neuromyol Dept, Fort De France, Martinique, France.
   [Tranchant, Christine] Strasbourg Teaching Hosp, Dept Movement Pathol, Strasbourg, France.
   [Lannes, Beatrice] Hop Univ Strasbourg, Pathol Dept, Hop Hautepierre, Strasbourg, France.
   [de Paula, Andre Maues] Aix Marseille Univ, Timone Univ Hosp, Pathol Dept, Marseille, France.
C3 CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Cote d'Azur; CHU Nice; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; CHU Strasbourg; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille
RP Paquis-Flucklinger, V; Rouzier, C (corresponding author), Hop Archet 2, Lab Biol Mol, Serv Genet Med, Ctr Reference Malad Mitochondriales, 151 Route St Antoine de Ginestiere, F-06200 Nice, France.
EM Veronique.PAQUIS@unice.fr; rouzier.c@chu-nice.fr
FU Centre Hospitalier Universitaire de Nice [AOI [16-AOIP-04], IDRCB: 2017-A00688-45]
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Angebault C, 2015, HUM MOL GENET, V24, P3948, DOI 10.1093/hmg/ddv133
   Bacalhau M, 2017, EUR J MED GENET, V60, P172, DOI 10.1016/j.ejmg.2016.12.009
   Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Ortigoza-Escobar JD, 2016, MITOCHONDRION, V28, P73, DOI 10.1016/j.mito.2016.04.001
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111
   Fragaki K, 2017, MOL GENET METAB, V121, P224, DOI 10.1016/j.ymgme.2017.05.002
   Fu J, 2019, CHINESE MED J-PEKING, V132, P865, DOI 10.1097/CM9.0000000000000151
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   Hiniker A, 2014, ACTA NEUROPATHOL COM, V2, P0, DOI 10.1186/s40478-014-0137-3
   Hoefs SJG, 2011, EUR J HUM GENET, V19, P270, DOI 10.1038/ejhg.2010.204
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Lyu LH, 2018, DATA BRIEF, V17, P1149, DOI 10.1016/j.dib.2018.02.040
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Minoia F, 2017, JIMD REP, V37, P37, DOI 10.1007/8904_2017_9
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Morel G, 2016, NEUROMUSCULAR DISORD, V26, P885, DOI 10.1016/j.nmd.2016.09.012
   Moslemi AR, 2004, NEUROMUSCULAR DISORD, V14, P46, DOI 10.1016/S0960-8966(03)00168-8
   Nishigaki Y, 2010, MITOCHONDRION, V10, P300, DOI 10.1016/j.mito.2010.01.003
   Paul R, 1996, TRENDS GENET, V12, P131
   Plutino M, 2018, BMC MED GENET, V19, P0, DOI 10.1186/s12881-018-0568-y
   Pulkes T, 2005, NEUROLOGY, V64, P1091, DOI 10.1212/01.WNL.0000154471.33156.55
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schägger H, 2001, J BIOL CHEM, V276, P37861
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389
   Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793
   THORBURN DR, 2003, MITOCHONDR DNA, V0, P48
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Vives-Bauza C, 2003, J INHERIT METAB DIS, V26, P507, DOI 10.1023/A:1025133629685
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Weber K, 1997, AM J HUM GENET, V60, P373
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 53
TC 4
Z9 4
U1 0
U2 1
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD AUG 15
PY 2020
VL 41
IS 8
BP 1394
EP 1406
DI 10.1002/humu.24037
EA JUN 2020
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA MQ0WG
UT WOS:000539774700001
PM 32419253
DA 2024-11-01
ER

PT J
AU Fay, A
   Garcia, Y
   Margeta, M
   Maharjan, S
   Jürgensen, C
   Briceño, J
   Garcia, M
   Yin, ST
   Bassaganyas, L
   McMahon, T
   Hou, YM
   Fu, YH
   Ptácek, LJ
AF Fay, Alexander
   Garcia, Yngo
   Margeta, Marta
   Maharjan, Sunita
   Jurgensen, Claudia
   Briceno, Jose
   Garcia, Mariaelena
   Yin, Sitao
   Bassaganyas, Laia
   McMahon, Thomas
   Hou, Ya-Ming
   Fu, Ying-Hui
   Ptacek, Louis J.
TI A MitochondrialtRNAMutation Causes AxonalCMTin a Large Venezuelan Family
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID peripheral neuropathy; optic atrophy; dna instability; mutations; disease; gene; gdap1; pathogenesis; dysfunction; disorders
AB Objective The objective of this study was to identify the genetic cause for progressive peripheral nerve disease in a Venezuelan family. Despite the growing list of genes associated with Charcot-Marie-Tooth disease, many patients with axonal forms lack a genetic diagnosis. Methods A pedigree was constructed, based on family clinical data. Next-generation sequencing of mitochondrial DNA (mtDNA) was performed for 6 affected family members. Muscle biopsies from 4 family members were used for analysis of muscle histology and ultrastructure, mtDNA sequencing, and RNA quantification. Ultrastructural studies were performed on sensory nerve biopsies from 2 affected family members. Results Electrodiagnostic testing showed a motor and sensory axonal polyneuropathy. Pedigree analysis revealed inheritance only through the maternal line, consistent with mitochondrial transmission. Sequencing of mtDNA identified a mutation in the mitochondrial tRNA(Val)(mt-tRNA(Val)) gene, m.1661A>G, present at nearly 100% heteroplasmy, which disrupts a Watson-Crick base pair in the T-stem-loop. Muscle biopsies showed chronic denervation/reinnervation changes, whereas biochemical analysis of electron transport chain (ETC) enzyme activities showed reduction in multiple ETC complexes. Northern blots from skeletal muscle total RNA showed severe reduction in abundance ofmt-tRNA(Val), and mildly increasedmt-tRNA(Phe), in subjects compared with unrelated age- and sex-matched controls. Nerve biopsies from 2 affected family members demonstrated ultrastructural mitochondrial abnormalities (hyperplasia, hypertrophy, and crystalline arrays) consistent with a mitochondrial neuropathy. Conclusion We identify a previously unreported cause of Charcot-Marie-Tooth (CMT) disease, a mutation in themt-tRNA(Val), in a Venezuelan family. This work expands the list of CMT-associated genes from protein-coding genes to a mitochondrialtRNAgene. ANN NEUROL 2020
C1 [Fay, Alexander; McMahon, Thomas; Fu, Ying-Hui; Ptacek, Louis J.] Univ Calif San Francisco, Dept Neurol, 1550 4th St,RH546,MB2922, San Francisco, CA 94143 USA.
   [Garcia, Yngo] Univ Andes, Fac Med, Dept Biochem, Merida 5101, Venezuela.
   [Garcia, Yngo] Med Surg Clin Inst, Neurosurg Serv, Unit Surg, Merida, Venezuela.
   [Margeta, Marta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.
   [Maharjan, Sunita; Yin, Sitao; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.
   [Jurgensen, Claudia; Garcia, Mariaelena] Univ Andes, Fac Sci, Dept Biol, Merida, Venezuela.
   [Briceno, Jose] Univ Hosp Andes, Physiotherapy & Rehabil Serv, Merida, Venezuela.
   [Bassaganyas, Laia] Univ Cambridge, Dept Med Genet, Cambridge, England.
   [Bassaganyas, Laia] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.
C3 University of California System; University of California San Francisco; University of Los Andes Venezuela; University of California System; University of California San Francisco; Jefferson University; University of Los Andes Venezuela; University of Los Andes Venezuela; University of Cambridge; University of California System; University of California San Francisco
RP Fay, A (corresponding author), Univ Calif San Francisco, Dept Neurol, 1550 4th St,RH546,MB2922, San Francisco, CA 94143 USA.; Garcia, Y (corresponding author), Univ Andes, Fac Med, Dept Biochem, Merida 5101, Venezuela.
EM alexander.fay@ucsf.edu; garciayngo@ula.ve
FU C.D.C.H.T, ULA, Merida, Venezuela [NIH-K12NS001692, A123822]; Alma Mater program from OPSU, Caracas, Venezuela [M-869-06-07-B]; Muscular Dystrophy Association [MDA514303];  [NIH-R01GM126210];  [NIH-R01AI139202]
CR Abbott JA, 2014, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00158
   Almutawa W, 2019, EBIOMEDICINE, V45, P379, DOI 10.1016/j.ebiom.2019.06.018
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   Bacalhau M, 2017, EUR J MED GENET, V60, P172, DOI 10.1016/j.ejmg.2016.12.009
   Beerepoot S, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1220-4
   Bernard-Marissal N, 2019, P NATL ACAD SCI USA, V116, P2328, DOI 10.1073/pnas.1810932116
   Brockmann K, 2008, J NEUROL, V255, P1049, DOI 10.1007/s00415-008-0847-1
   Bruni F, 2018, HUM MUTAT, V39, P563, DOI 10.1002/humu.23398
   Campbell PD, 2014, J NEUROSCI, V34, P14717, DOI 10.1523/JNEUROSCI.2770-14.2014
   Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004
   Cassereau J, 2011, EXP NEUROL, V227, P31, DOI 10.1016/j.expneurol.2010.09.006
   Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590
   Echaniz-Laguna A, 2013, NEUROLOGY, V81, P1523, DOI 10.1212/WNL.0b013e3182a4a518
   El Fissi N, 2018, EMBO REP, V19, P0, DOI 10.15252/embr.201745241
   Fraidakis MJ, 2014, MITOCHONDRION, V15, P34, DOI 10.1016/j.mito.2014.03.010
   Glatz C, 2011, MITOCHONDRION, V11, P615, DOI 10.1016/j.mito.2011.04.003
   GRAF WD, 1993, ANN NEUROL, V33, P640, DOI 10.1002/ana.410330613
   Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   Karle KN, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-158
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Landrum MJ, 2018, NUCL ACIDS RES, V0, P0
   Laurá M, 2019, CURR OPIN NEUROL, V32, P641, DOI 10.1097/WCO.0000000000000735
   Lee JR, 2015, HUM MUTAT, V36, P69, DOI 10.1002/humu.22709
   Liao CY, 2017, NEUROLOGY, V88, P131, DOI 10.1212/WNL.0000000000003491
   Linnemann C, 2016, CEREBELLUM, V15, P165, DOI 10.1007/s12311-015-0684-6
   Lott MT, 2013, CURR PROTOC BIOINF, V44, P1231, DOI 10.1002/0471250953.BI0123S44
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Mckinney JL, 2014, MUSCLE NERVE, V49, P451, DOI 10.1002/mus.24108
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   Morral JA, 2010, ACTA NEUROPATHOL, V120, P97, DOI 10.1007/s00401-010-0675-0
   Nelis E, 2002, NEUROLOGY, V59, P1865, DOI 10.1212/01.WNL.0000036272.36047.54
   Niemann A, 2014, BRAIN, V137, P668, DOI 10.1093/brain/awt371
   Orengo JP, 2018, ANN CLIN TRANSL NEUR, V5, P222, DOI 10.1002/acn3.525
   Pareyson D, 2015, NEUROSCI LETT, V596, P66, DOI 10.1016/j.neulet.2015.04.001
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Preston D C, 2005, ELECTROMYOGRAPHY AND NEUROMUSCULAR DISORDERS: CLINICAL-ELECTROPHYSIOLOGIC CORRELATIONS, V0, P0, DOI DOI 10.1002/MUS.23894
   Ranieri M, 2016, CURR TREAT OPTION NE, V18, P0, DOI 10.1007/s11940-016-0414-5
   Rorbach J, 2016, P NATL ACAD SCI USA, V113, P12198, DOI 10.1073/pnas.1609338113
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rumora AE, 2019, INT REV NEUROBIOL, V145, P127, DOI 10.1016/bs.irn.2019.05.002
   Saneto RP, 2017, ADV GENET, V98, P63, DOI 10.1016/bs.adgen.2017.06.002
   Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590
   Stuppia G, 2015, J NEUROL SCI, V356, P7, DOI 10.1016/j.jns.2015.05.033
   Toyoshima Yuka, 2017, BMJ CASE REP, V2017, P0, DOI 10.1136/bcr-2017-220934
   Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236
   Yang Y, 2016, J NEUROL SCI, V365, P46, DOI 10.1016/j.jns.2016.04.007
NR 49
TC 7
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT 15
PY 2020
VL 88
IS 4
BP 830
EP 842
DI 10.1002/ana.25854
EA AUG 2020
PG 13
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA NP5MS
UT WOS:000563637500001
PM 32715519
DA 2024-11-01
ER

PT J
AU Winanto
   Khong, ZJ
   Soh, BS
   Fan, Y
   Ng, SY
AF Winanto
   Khong, Zi Jian
   Soh, Boon-Seng
   Fan, Yong
   Ng, Shi-Yan
TI Organoid cultures of MELAS neural cells reveal hyperactive Notch signaling that impacts neurodevelopment
SO CELL DEATH & DISEASE
LA English
DT Article
ID mitochondrial-dna; neurite outgrowth; maintenance
AB Mutations in mitochondrial DNA (mtDNA), typically maternally inherited, can result in severe neurological conditions. There is currently no cure for mitochondrial DNA diseases and treatments focus on management of the symptoms rather than correcting the defects downstream of the mtDNA mutation. Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) is one such mitochondrial disease that affects many bodily systems, particularly the central nervous system and skeletal muscles. Given the motor deficits seen in MELAS patients, we investigate the contribution of motor neuron pathology to MELAS. Using a spinal cord organoid system derived from induced pluripotent stem cells of a MELAS patient, as well as its isogenically corrected control, we found that high levels of Notch signaling underlie neurogenesis delays and neurite outgrowth defects that are associated with MELAS neural cultures. Furthermore, we demonstrate that the gamma-secretase inhibitor DAPT can reverse these neurodevelopmental defects.
C1 [Winanto; Khong, Zi Jian; Soh, Boon-Seng; Ng, Shi-Yan] A STAR Res Ent, Inst Mol & Cell Biol, Singapore 138673, Singapore.
   [Khong, Zi Jian] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.
   [Soh, Boon-Seng] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.
   [Soh, Boon-Seng; Fan, Yong; Ng, Shi-Yan] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou 510150, Peoples R China.
   [Ng, Shi-Yan] Natl Univ Singapore, Yong Loo Lin Sch Med Physiol, Singapore 117456, Singapore.
   [Ng, Shi-Yan] Natl Neurosci Inst, Singapore 308433, Singapore.
C3 Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nanyang Technological University; National University of Singapore; Guangzhou Medical University; National University of Singapore; National Neuroscience Institute (NNI)
RP Soh, BS; Ng, SY (corresponding author), A STAR Res Ent, Inst Mol & Cell Biol, Singapore 138673, Singapore.; Soh, BS (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.; Soh, BS; Fan, Y; Ng, SY (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou 510150, Peoples R China.; Ng, SY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med Physiol, Singapore 117456, Singapore.; Ng, SY (corresponding author), Natl Neurosci Inst, Singapore 308433, Singapore.
EM bssoh@imcb.a-star.edu.sg; yongfan011@gzmh.edu.cn; syng@imcb.a-star.edu.sg
FU Institute of Molecular and Cell Biology; National Medical Research Council, Singapore [NMRC/OFYIRG/0011/2016]; National Natural Science Foundation of China [81871162]; National Research Foundation Singapore [NRF-NRFF2018-03]
CR Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8
   Chang JC, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-10870-5
   Chen L, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-018-1083-y
   Du ZW, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7626
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202
   Hor JH, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-018-1081-0
   Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Levy OA, 2002, DEV NEUROSCI-BASEL, V24, P79, DOI 10.1159/000064948
   Perumalsamy LR, 2010, P NATL ACAD SCI USA, V107, P6882, DOI 10.1073/pnas.0910060107
   Shi M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0014570
   Tan GC, 2016, CELL REP, V16, P907, DOI 10.1016/j.celrep.2016.06.067
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
NR 16
TC 28
Z9 28
U1 3
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
EI 
J9 CELL DEATH DIS
JI Cell Death Dis.
PD MAR 13
PY 2020
VL 11
IS 3
BP 
EP 
DI 10.1038/s41419-020-2383-6
PG 8
WC Cell Biology
SC Cell Biology
GA KW2AA
UT WOS:000520970900005
PM 32170107
DA 2024-11-01
ER

PT J
AU Rodríguez-López, C
   García-Cárdaba, LM
   Blázquez, A
   Serrano-Lorenzo, P
   Gutiérrez-Gutiérrez, G
   San Millán-Tejado, B
   Muelas, N
   Hernández-Laín, A
   Vílchez, JJ
   Gutiérrez-Rivas, E
   Arenas, J
   Martín, MA
   Domínguez-González, C
AF Rodriguez-Lopez, Claudia
   Garcia-Cardaba, Luis M.
   Blazquez, Alberto
   Serrano-Lorenzo, Pablo
   Gutierrez-Gutierrez, Gerardo
   San Millan-Tejado, Beatriz
   Muelas, Nuria
   Hernandez-Lain, Aurelio
   Vilchez, Juan J.
   Gutierrez-Rivas, Eduardo
   Arenas, Joaquin
   Martin, Miguel A.
   Dominguez-Gonzalez, Cristina
TI Clinical, pathological and genetic spectrum in 89 cases of mitochondrial progressive external ophthalmoplegia
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE clinical genetics; diagnostics; muscle disease; molecular genetics; neuromuscular disease
ID mutation; polg
AB Background Mitochondrial progressive external ophthalmoplegia (PEO) encompasses a broad spectrum of clinical and genetic disorders. We describe the phenotypic subtypes of PEO and its correlation with molecular defects and propose a diagnostic algorithm. Methods Retrospective analysis of the clinical, pathological and genetic features of 89 cases. Results Three main phenotypes were found: 'pure PEO' (42%), consisting of isolated palpebral ptosis with ophthalmoparesis; Kearns-Sayre syndrome (10%); and 'PEO plus', which associates extraocular symptoms, distinguishing the following subtypes: : myopathic (33%), bulbar (12%) and others (3%). Muscle biopsy was the most accurate test, showing mitochondrial changes in 95%. Genetic diagnosis was achieved in 96% of the patients. Single large-scale mitochondrial DNA (mtDNA) deletion was the most frequent finding (63%), followed by multiple mtDNA deletions (26%) due to mutations inTWNK(n=8),POLG(n=7),TK2(n=6) orRRM2B(n=2) genes, and point mtDNA mutations (7%). Three new likely pathogenic mutations were identified in theTWNKandMT-TNgenes. Conclusions Phenotype-genotype correlations cannot be brought in mitochondrial PEO. Muscle biopsy should be the first step in the diagnostic flow of PEO when mitochondrial aetiology is suspected since it also enables the study of mtDNA rearrangements. If no mtDNA deletions are identified, whole mtDNA sequencing should be performed.
C1 [Rodriguez-Lopez, Claudia; Garcia-Cardaba, Luis M.; Gutierrez-Rivas, Eduardo] Hosp Univ 12 Octubre, Neurol, Madrid, Comunidad De Ma, Spain.
   [Blazquez, Alberto; Arenas, Joaquin; Martin, Miguel A.] Hosp Univ 12 Octubre, Inst Invest Sanitaria Hosp 12 Octubre Imas12, Clin Biochem Dept, Mitochondrial Disorders Lab, Madrid, Spain.
   [Blazquez, Alberto; Muelas, Nuria; Vilchez, Juan J.; Arenas, Joaquin; Martin, Miguel A.; Dominguez-Gonzalez, Cristina] Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain.
   [Serrano-Lorenzo, Pablo; Dominguez-Gonzalez, Cristina] Inst Invest Sanitaria Hosp 12 Octubre Imas12, Mitochondrial Disorders Res Grp, Madrid, Comunidad De Ma, Spain.
   [Gutierrez-Gutierrez, Gerardo] Hosp Univ Infanta Sofia, Neurol, Madrid, Spain.
   [San Millan-Tejado, Beatriz] Complejo Hosp Vigo Hosp Xeral, Pathol, Vigo, Spain.
   [Muelas, Nuria] Hosp Univ & Politecn La Fe, Neurol, Valencia, Valenciana, Spain.
   [Hernandez-Lain, Aurelio] Hosp Univ 12 Octubre, Neuropathol Sect, Pathol, Madrid, Comunidad De Ma, Spain.
   [Vilchez, Juan J.] Hosp Univ & Politecn La Fe, Neurol Dept, Neuromuscular Dis Unit, Valencia, Valenciana, Spain.
   [Vilchez, Juan J.] Inst Invest Sanitaria La Fe, Neuromuscular & Ataxias Res Grp, Valencia, Spain.
   [Dominguez-Gonzalez, Cristina] Hosp Univ 12 Octubre, Neuromuscular Unit, Madrid, Comunidad De Ma, Spain.
C3 Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario Infanta Sofia; Hospital Universitari i Politecnic La Fe; Hospital Universitario 12 de Octubre; Hospital Universitari i Politecnic La Fe; Hospital Universitario 12 de Octubre
RP Martín, MA (corresponding author), Hosp Univ 12 Octubre, Mitochondrial Disorders Lab, Madrid 28041, Spain.
EM mamcasanueva.imas12@h12o.es
FU Spanish Instituto de Salud Carlos III (ISCIII); European Regional Development Fund (ERDF); (FEDER) [PI18/01374, PI15/00431]
CR Arredondo JJ, 2012, MITOCHONDRION, V12, P357, DOI 10.1016/j.mito.2011.09.010
   Blázquez-Bermejo C, 2019, FASEB J, V33, P7168, DOI 10.1096/fj.201801591R
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Coelho MP, 2019, EUR J PEDIATR, V178, P21, DOI 10.1007/s00431-018-3292-x
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Gorman GS, 2014, GENEREVIEWS, V0, P1993
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Nurminen A, 2017, BBA CLIN, V7, P147, DOI 10.1016/j.bbacli.2017.04.001
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Zhu JF, 2016, MITOCHONDRIAL DNA A, V27, P1340, DOI 10.3109/19401736.2014.945580
NR 19
TC 17
Z9 18
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD SEP 15
PY 2020
VL 57
IS 9
BP 643
EP 646
DI 10.1136/jmedgenet-2019-106649
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA NK8VQ
UT WOS:000567008800009
PM 32161153
DA 2024-11-01
ER

PT J
AU Chinopoulos, C
AF Chinopoulos, Christos
TI Quantification of mitochondrial DNA from peripheral tissues: Limitations in predicting the severity of neurometabolic disorders and proposal of a novel diagnostic test
SO MOLECULAR ASPECTS OF MEDICINE
LA English
DT Review
DE Fibroblast; Blood; Lymphocyte; Oxidative phosphorylation; Neuropathology; Ragged-blue fibers
ID respiratory-chain deficiency; mtdna depletion; copy number; mutations; succinate; muscle; encephalomyopathy; deletions; maintenance; dysfunction
AB Neurometabolic disorders stem from errors in metabolic processes yielding a neurological phenotype. A subset of those disorders encompasses mitochondrial abnormalities partially due to mitochondrial DNA (mtDNA) depletion. mtDNA depletion can be attributed to inheritance, spontaneous mutations or acquired from drug-related toxicities. In the armamentarium of diagnostic procedures, mtDNA quantification is a standard for disease classification. However, alterations in mtDNA obtained from peripheral tissues such as skin fibroblasts and blood cells do not often reflect the severity of the affected organ, in this case, the brain. The purpose of this review is to highlight the pitfalls of quantitating mtDNA from peripheral -and not limited to-tissues for diagnosing patients suffering from a variety of mtDNA depletion syndromes exhibiting neurologic abnormalities. In lieu, a qualitative test of mitochondrial substrate-level phosphorylation -even from peripheral tissues-reflecting the ability of mitochondria to rely on glutaminolysis in the presence of respiratory chain defects is proposed as a novel diagnostic assessment of mitochondrial functionality.
C1 [Chinopoulos, Christos] Semmelweis Univ, Dept Med Biochem, Tuzolto St 37-47, H-1094 Budapest, Hungary.
C3 Semmelweis University
RP Chinopoulos, C (corresponding author), Semmelweis Univ, Dept Med Biochem, Tuzolto St 37-47, H-1094 Budapest, Hungary.
EM chinopoulos.christos@eok.sote.hu
FU NKFIH [FIKP-6182264888-EATV, VEKOP 2.3.3-15-2016-00012, 2017-2.3.4-TET-RU2017-00003, KH129567]
CR ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Balciuniene J, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00518
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Casula M, 2007, J INFECT DIS, V196, P371, DOI 10.1086/519284
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chinopoulos C, 2019, INT J BIOCHEM CELL B, V115, P0, DOI 10.1016/j.biocel.2019.105580
   Chinopoulos C, 2018, ASN NEURO, V10, P0, DOI 10.1177/1759091418818261
   Chinopoulos C, 2019, MOL GENET METAB, V126, P43, DOI 10.1016/j.ymgme.2018.11.009
   Chinopoulos C, 2011, J NEUROSCI RES, V89, P1897, DOI 10.1002/jnr.22659
   Chinopoulos C, 2011, FEBS LETT, V585, P1255, DOI 10.1016/j.febslet.2011.04.004
   Chinopoulos C, 2010, FASEB J, V24, P2405, DOI 10.1096/fj.09-149898
   Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Dagan T, 2002, MITOCHONDRION, V1, P397, DOI 10.1016/S1567-7249(02)00003-X
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166
   DiMauro S, 1999, J CHILD NEUROL, V14, PS23, DOI 10.1177/0883073899014001051
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Gauthier-Villars M, 2001, NEUROPEDIATRICS, V32, P150, DOI 10.1055/s-2001-16614
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Gourlain K, 2003, HIV MED, V4, P287, DOI 10.1046/j.1468-1293.2003.00158.x
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580
   Johnston IG, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.07464
   Kacso G, 2016, BIOCHEM J, V473, P3463, DOI 10.1042/BCJ20160594
   Kiss G, 2013, FASEB J, V27, P2392, DOI 10.1096/fj.12-220202
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Lacombe ML, 2018, LAB INVEST, V98, P582, DOI 10.1038/s41374-017-0004-5
   Lewis W, 2001, LAB INVEST, V81, P777, DOI 10.1038/labinvest.3780288
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Lutz-Bonengel S, 2019, P NATL ACAD SCI USA, V116, P1821, DOI 10.1073/pnas.1820533116
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Montaner JSG, 2004, CLIN INFECT DIS, V38, PS73, DOI 10.1086/381449
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Morse CG, 2012, J INFECT DIS, V205, P1778, DOI 10.1093/infdis/jis101
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Nogueira C, 2014, ITAL J PEDIATR, V40, P0, DOI 10.1186/1824-7288-40-34
   Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003
   Ostergaard E, 2008, J INHERIT METAB DIS, V31, P226, DOI 10.1007/s10545-008-0828-7
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Persson Ö, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Poulton Joanna, 2009, NEUROMUSCUL DISORD, V19, P439, DOI 10.1016/j.nmd.2009.04.009
   Pyle A, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005040
   Ravasz D, 2018, BBA-BIOENERGETICS, V1859, P909, DOI 10.1016/j.bbabio.2018.05.002
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Rodenburg RJT, 2013, MITOCHONDRION, V13, P36, DOI 10.1016/j.mito.2012.11.004
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2011, J INHERIT METAB DIS, V34, P277, DOI 10.1007/s10545-010-9222-3
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012
   Tucker EJ, 2011, IUBMB LIFE, V63, P669, DOI 10.1002/iub.495
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Willemsen MA, 2016, NEUROL-CLIN PRACT, V6, P348, DOI 10.1212/CPJ.0000000000000266
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Young MJ, 2017, FRONT MOL BIOSCI, V4, P0, DOI 10.3389/fmolb.2017.00074
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
NR 99
TC 2
Z9 2
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0098-2997
EI 1872-9452
J9 MOL ASPECTS MED
JI Mol. Asp. Med.
PD FEB 15
PY 2020
VL 71
IS 
BP 
EP 
DI 10.1016/j.mam.2019.11.004
PG 8
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA KN1YC
UT WOS:000514635900003
PM 31740079
DA 2024-11-01
ER

PT J
AU Dhar, R
AF Dhar, Riddhiman
TI Role of Mitochondria in Generation of Phenotypic Heterogeneity in Yeast
SO JOURNAL OF THE INDIAN INSTITUTE OF SCIENCE
LA English
DT Review
ID dna copy number; intra-tumor heterogeneity; toxin-antitoxin systems; human skeletal-muscle; gene-expression; nongenetic heterogeneity; drug-resistance; bacterial persistence; antibiotic tolerance; multidrug-resistance
AB A cell's phenotype is determined by its genome sequence and epigenetic state which translate into the biochemical reactions occurring inside the cells. As these biochemical processes are driven by small biological molecules, stochastic fluctuations may arise in the number of these biological molecules inside the cell and in the interactions between these molecules. These fluctuations can cause temporal variations in the cellular processes leading to variations in phenotype between two cells present in a population under identical environmental condition. Phenotypic variations in a population can enable a small fraction of cells to survive sudden changes in the environmental condition, as some of the cells are always prepared for such a change. Phenotypic variations can thus have very important implications for survival of a cell population and have been shown to affect our ability to treat human diseases-from eradication of a bacterial infection to treatment of cancer. In this review, I discuss the role of mitochondria, an important organelle in all eukaryotic cells, in generation of phenotypic heterogeneity. Mitochondria contains its own genome in multiple copies per cell and many proteins and RNA molecules required for proper functioning of mitochondria are present on the mitochondrial genome. Variations in number of copies of the mitochondrial genomes can thus lead to variations in mitochondrial functional state. As mitochondria have important roles in several cellular process, this can lead to variations in several cellular phenotypes including drug resistance. In this context, I also discuss the role of mitochondria in human diseases where mitochondrial heterogeneity could have important implications for disease progression and therapy. Thus, understanding the role of mitochondria in generation of phenotypic variation assumes significant importance in the context of human diseases as well as emergence of drug resistance.
C1 [Dhar, Riddhiman] IIT Kharagpur, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
C3 Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur
RP Dhar, R (corresponding author), IIT Kharagpur, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM riddhiman.dhar@iitkgp.ac.in
FU ISIRD Grant from IIT Kharagpur; ECR from Science and Engineering Research Board (SERB), India [ECR/2017/002328]
CR Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110
   Ackermann M, 2015, NAT REV MICROBIOL, V13, P497, DOI 10.1038/nrmicro3491
   Alberts B, 2002, MOLECULAR BIOLOGY OF THE CELL IN CELL, V4th, P0
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arnoldini M, 2014, PLOS BIOL, V12, P0, DOI 10.1371/journal.pbio.1001928
   Assenov Y, 2018, SEMIN CANCER BIOL, V51, P12, DOI 10.1016/j.semcancer.2018.01.010
   Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460
   Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390
   Battich N, 2015, CELL, V163, P1596, DOI 10.1016/j.cell.2015.11.018
   Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575
   Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625
   Berg JM, 2002, BIOCHEMISTRY, V5, P0
   BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0
   Bertram R, 2006, J THEOR BIOL, V243, P575, DOI 10.1016/j.jtbi.2006.07.019
   Bettenworth V, 2019, J MOL BIOL, V431, P4530, DOI 10.1016/j.jmb.2019.04.036
   Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x
   Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546
   Böckler S, 2017, J CELL BIOL, V216, P2481, DOI 10.1083/jcb.201611197
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bohacek J, 2015, NAT REV GENET, V16, P641, DOI 10.1038/nrg3964
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brauner A, 2016, NAT REV MICROBIOL, V14, P320, DOI 10.1038/nrmicro.2016.34
   Brbic M, 2016, NUCLEIC ACIDS RES, V44, P10074, DOI 10.1093/nar/gkw964
   Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556
   Burga A, 2013, CURR OPIN BIOTECH, V24, P803, DOI 10.1016/j.copbio.2013.03.004
   Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Cardamone MD, 2018, MOL CELL, V69, P757, DOI 10.1016/j.molcel.2018.01.037
   Carja O, 2019, GENETICS, V211, P977, DOI 10.1534/genetics.118.301758
   Carja O, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-05214-2
   Casacuberta JM, 2016, G3-GENES GENOM GENET, V6, P775, DOI 10.1534/g3.115.025502
   Casadesús J, 2016, ADV EXP MED BIOL, V945, P35, DOI 10.1007/978-3-319-43624-1_3
   Casadesús J, 2013, J BIOL CHEM, V288, P13929, DOI 10.1074/jbc.R113.472274
   Chen HC, 2017, CELL METAB, V26, P39, DOI 10.1016/j.cmet.2017.05.016
   Chen XS, 2016, CELL SYST, V2, P347, DOI 10.1016/j.cels.2016.03.009
   Cheung P, 2018, CELL, V173, P1385, DOI 10.1016/j.cell.2018.03.079
   Chevin LM, 2013, PHILOS T R SOC B, V368, P0, DOI 10.1098/rstb.2012.0089
   das Neves RP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000560
   Dewachter L, 2019, MOL CELL, V76, P255, DOI 10.1016/j.molcel.2019.09.028
   Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007
   Dhar R, 2019, ELIFE, V8, P0, DOI 10.7554/eLife.38904
   Domingo J, 2019, ANNU REV GENOM HUM G, V20, P433, DOI 10.1146/annurev-genom-083118-014857
   Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115
   Drouin A, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-40561-2
   Truong DT, 2017, GENOME RES, V27, P626, DOI 10.1101/gr.216242.116
   Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015
   Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919
   ERNSTER L, 1959, NATURE, V184, P1851, DOI 10.1038/1841851a0
   Farquhar KS, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-10330-w
   Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581
   Freel KC, 2015, FEMS YEAST RES, V15, P0, DOI 10.1093/femsyr/fov023
   Fridman O, 2014, NATURE, V513, P418, DOI 10.1038/nature13469
   Furlan-Magaril M, 2015, CURR OPIN GENET DEV, V31, P36, DOI 10.1016/j.gde.2015.04.004
   Gallion J, 2017, HUM MUTAT, V38, P569, DOI 10.1002/humu.23193
   Gawad C, 2016, NAT REV GENET, V17, P175, DOI 10.1038/nrg.2015.16
   Gilkerson R, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011080
   Gnoni GV, 2009, IUBMB LIFE, V61, P987, DOI 10.1002/iub.249
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Guantes R, 2015, GENOME RES, V25, P633, DOI 10.1101/gr.178426.114
   Guo RY, 2018, BIOMED J, V41, P9, DOI 10.1016/j.bj.2017.12.001
   Gupta PB, 2019, CELL STEM CELL, V24, P65, DOI 10.1016/j.stem.2018.11.011
   Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026
   Hallstrom TC, 2000, J BIOL CHEM, V275, P37347, DOI 10.1074/jbc.M007338200
   Hammerlindl H, 2018, J CELL COMMUN SIGNAL, V12, P133, DOI 10.1007/s12079-017-0435-1
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   Holland SL, 2014, ENVIRON MICROBIOL, V16, P1729, DOI 10.1111/1462-2920.12243
   Hornung G, 2012, GENOME RES, V22, P2409, DOI 10.1101/gr.139378.112
   Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769
   Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139
   Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729
   Ichikawa Y, 2012, P NATL ACAD SCI USA, V109, P4152, DOI 10.1073/pnas.1119338109
   Inde Z, 2018, CRIT REV BIOCHEM MOL, V53, P99, DOI 10.1080/10409238.2017.1412395
   Jamal-Hanjani M, 2015, CLIN CANCER RES, V21, P1258, DOI 10.1158/1078-0432.CCR-14-1429
   Jelier R, 2011, NAT GENET, V43, P1270, DOI 10.1038/ng.1007
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kaspy I, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms4001
   Kelsey G, 2017, SCIENCE, V358, P69, DOI 10.1126/science.aan6826
   Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5
   Kiviet DJ, 2014, NATURE, V514, P376, DOI 10.1038/nature13582
   Koch L, 2019, NAT REV GENET, V20, P565, DOI 10.1038/s41576-019-0164-9
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kulkarni A, 2019, CURR OPIN BIOTECH, V58, P129, DOI 10.1016/j.copbio.2019.03.001
   Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352
   Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383
   Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311
   Lehner B, 2013, NAT REV GENET, V14, P168, DOI 10.1038/nrg3404
   Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445
   Levin-Reisman I, 2017, SCIENCE, V355, P826, DOI 10.1126/science.aaj2191
   Levy SF, 2012, PLOS BIOL, V10, P0, DOI 10.1371/journal.pbio.1001325
   Li S, 2018, PLOS GENET, V14, P0, DOI 10.1371/journal.pgen.1007744
   Li X, 2018, P NATL ACAD SCI USA, V115, P6679, DOI 10.1073/pnas.1718326115
   Libby E, 2019, AM NAT, V193, P409, DOI 10.1086/701786
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   LITI G, 2017, COLD SPRING HARB PRO, V2017, P606
   Lo Pang-Kuo, 2018, J CLIN GENOM, V1, P0, DOI 10.4172/JCG.1000103
   Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818
   Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261
   Maughan H, 2004, J BACTERIOL, V186, P2212, DOI 10.1128/JB.186.7.2212-2214.2004
   McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814
   McBride HM, 2006, CURR BIOL, V16, PR551, DOI 10.1016/j.cub.2006.06.054
   Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624
   Mena NP, 2015, MITOCHONDRION, V21, P92, DOI 10.1016/j.mito.2015.02.001
   Meziti A, 2019, ISME J, V13, P767, DOI 10.1038/s41396-018-0307-6
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Mitchell S, 2018, P NATL ACAD SCI USA, V115, PE2888, DOI 10.1073/pnas.1715639115
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moye-Rowley WS, 2005, GENE, V354, P15, DOI 10.1016/j.gene.2005.03.019
   Munro D, 2017, J EXP BIOL, V220, P1170, DOI 10.1242/jeb.132142
   NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064
   Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785
   Nguyen A, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms11246
   Nichol D, 2016, GENETICS, V204, P1523, DOI 10.1534/genetics.116.193474
   Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923
   Nuzhdin SV, 2012, TRENDS GENET, V28, P421, DOI 10.1016/j.tig.2012.06.003
   Page R, 2016, NAT CHEM BIOL, V12, P208, DOI 10.1038/NCHEMBIO.2044
   Panel M, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12793
   Patange O, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-07702-z
   Pavlicev M, 2011, J EXP ZOOL PART B, V316B, P371, DOI 10.1002/jez.b.21410
   PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9
   Pisco AO, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3467
   Polster R, 2016, MOL BIOL EVOL, V33, P3213, DOI 10.1093/molbev/msw206
   Porto A, 2016, GENETICS, V204, P1601, DOI 10.1534/genetics.116.189431
   Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372
   Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032
   Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3
   Rossolini GM, 2014, CURR OPIN PHARMACOL, V18, P56, DOI 10.1016/j.coph.2014.09.006
   Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107
   Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8
   Ryzhkova AI, 2018, THER CLIN RISK MANAG, V14, P1933, DOI 10.2147/TCRM.S154863
   Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002
   Sánchez-Romero MA, 2015, CURR OPIN MICROBIOL, V25, P9, DOI 10.1016/j.mib.2015.03.004
   Sanglard D, 2016, FRONT MED-LAUSANNE, V3, P0, DOI 10.3389/fmed.2016.00011
   SCHANTZ PG, 1986, ACTA PHYSIOL SCAND, V128, P397, DOI 10.1111/j.1748-1716.1986.tb07993.x
   Schuster CF, 2016, TOXINS, V8, P0, DOI 10.3390/toxins8050140
   Scott I, 2010, ESSAYS BIOCHEM, V47, P85, DOI 10.1042/BSE0470085
   Sharma A, 2019, CELL REP, V29, P2164, DOI 10.1016/j.celrep.2019.10.045
   Sheng S, 2018, CANCER METAST REV, V37, P655, DOI 10.1007/s10555-018-9767-4
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Silander OK, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002443
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0
   SPURLOCK B, 2019, J CELL SCI, V132, P0
   Stanta G, 2018, FRONT MED-LAUSANNE, V5, P0, DOI 10.3389/fmed.2018.00085
   Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015
   Starrfelt J, 2012, BIOL REV, V87, P742, DOI 10.1111/j.1469-185X.2012.00225.x
   Stefano GB, 2017, ADV EXP MED BIOL, V982, P577, DOI 10.1007/978-3-319-55330-6_30
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stuart T, 2019, NAT REV GENET, V20, P257, DOI 10.1038/s41576-019-0093-7
   Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thomas P, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06912-9
   Trujillano D, 2017, MOL GENET GENOM MED, V5, P66, DOI 10.1002/mgg3.262
   Turajlic S, 2019, NAT REV GENET, V20, P404, DOI 10.1038/s41576-019-0114-6
   Turner NC, 2012, LANCET ONCOL, V13, PE178, DOI 10.1016/S1470-2045(11)70335-7
   van Boxtel C, 2017, J R SOC INTERFACE, V14, P0, DOI 10.1098/rsif.2017.0141
   van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011072
   van Dijk D, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8972
   Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014
   Verma A, 2019, AM J HUM GENET, V104, P55, DOI 10.1016/j.ajhg.2018.11.006
   Virdi JS, 2005, CURR SCI INDIA, V89, P113
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wang YM, 2007, J BIOL CHEM, V282, P8228, DOI 10.1074/jbc.M609635200
   WHITTAKER PA, 1972, NATURE-NEW BIOL, V238, P266, DOI 10.1038/newbio238266a0
   Willbanks A, 2016, GENET EPIGENETICS, V8, P25, DOI 10.4137/GEG.S31863
   Williams JJ, 2011, FEMS MICROBIOL LETT, V322, P41, DOI 10.1111/j.1574-6968.2011.02330.x
   Williamson D H, 1979, METHODS ENZYMOL, V56, P728
   Winkler LR, 2016, FRONT PLANT SCI, V7, P0, DOI 10.3389/fpls.2016.01077
   Woods DC, 2017, STEM CELLS INT, V2017, P0, DOI 10.1155/2017/7068567
   Xue BK, 2018, P NATL ACAD SCI USA, V115, P12745, DOI 10.1073/pnas.1813447115
   Yaakov G, 2017, NAT ECOL EVOL, V1, P0, DOI 10.1038/s41559-016-0016
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838
   Zhang WL, 2019, BRIEF BIOINFORM, V20, P2098, DOI 10.1093/bib/bby071
   Ziv N, 2013, MOL BIOL EVOL, V30, P2568, DOI 10.1093/molbev/mst138
NR 181
TC 0
Z9 1
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0970-4140
EI 0019-4964
J9 J INDIAN I SCI
JI J. Indian Inst. Sci.
PD JUL 15
PY 2020
VL 100
IS 3
BP 497
EP 514
DI 10.1007/s41745-020-00176-3
EA MAY 2020
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA MF9KH
UT WOS:000536420800001
DA 2024-11-01
ER

PT J
AU Chang, XL
   Wu, YX
   Zhou, J
   Meng, HX
   Zhang, W
   Guo, JH
AF Chang, Xueli
   Wu, Yaxin
   Zhou, Jie
   Meng, Huaxing
   Zhang, Wei
   Guo, Junhong
TI A meta-analysis and systematic review of Leigh syndrome: clinical manifestations, respiratory chain enzyme complex deficiency, and gene mutations
SO MEDICINE
LA English
DT Article
DE clinical features; gene mutations; Leigh syndrome; mitochondrial respiratory chain enzyme complex
ID mitochondrial disorders; diagnosis; children
AB Leigh syndrome (also called Leigh disease or subacute necrotizing encephalomyelopathy) is a rare inherited neurometabolic disorder, which affects the central nervous system. This meta-study systematically analyzed clinical manifestations, respiratory chain enzyme complex deficiency, and gene mutations.Literature was searched for publications in MEDLINE, EMBASE, and the China National Knowledge Infrastructure database for meta-analyses of the incidence of clinical symptoms, laboratory assessments, imaging data, muscle biopsy histochemical staining, activity of the mitochondrial respiratory chain enzyme complex, gene mutations, and the association between age at disease onset and type of gene mutations.This study included 5 studies with 385 Leigh syndrome patients. The most common clinical features of Leigh syndrome included elevated blood and/or cerebrospinal fluid (CSF) levels of lactate (72%), developmental retardation (57%), hypotonia (42%), followed by respiratory dysfunction (34%), epileptic seizures (33%), poor feeding (29%), and weakness (27%). Approximately 80% of the patients had deficiencies of the respiratory chain enzyme complex or isolated complex I deficiency (35%), 32% had mitochondrial DNA (mtDNA) mutations, and 38% had nuclear DNA (nDNA) mutations. Patients with nDNA mutations were younger than those with mtDNA mutations (8.82 13.88 vs 26.20 +/- 41.11 years, P=.007).The data from the current meta-analysis demonstrated a variety of clinical and molecular manifestations of Leigh syndrome, with upregulated lactate levels in the blood or CSF being the most common feature. Diagnosis of Leigh syndrome could be confirmed using combined enzymatic and genetic analyses.
C1 [Chang, Xueli; Zhou, Jie; Meng, Huaxing; Zhang, Wei; Guo, Junhong] Shanxi Med Univ, Hosp 1, Dept Neurol, 85 Jiefang South Rd, Taiyuan 030001, Shanxi, Peoples R China.
   [Wu, Yaxin] First Peoples Hosp Xianyang, Xianyang, Shaanxi, Peoples R China.
C3 Shanxi Medical University
RP Guo, JH (corresponding author), Shanxi Med Univ, Hosp 1, Dept Neurol, 85 Jiefang South Rd, Taiyuan 030001, Shanxi, Peoples R China.
EM neuroguo@163.com
CR Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169
   Fang F, 2017, ZHONGHUA ER KE ZA ZHI, V55, P205, DOI 10.3760/cma.j.issn.0578-1310.2017.03.008
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Gerards M, 2016, MOL GENET METAB, V117, P300, DOI 10.1016/j.ymgme.2015.12.004
   Goldenberg PC, 2003, NEUROLOGY, V60, P865, DOI 10.1212/01.WNL.0000049460.72439.7F
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Jin TR, 2014, J CHILD NEUROL, V29, PNP143, DOI 10.1177/0883073813512524
   Jüni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   Lee JS, 2016, J CLIN NEUROL, V12, P181, DOI 10.3988/jcn.2016.12.2.181
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Loney P L, 1998, CHRONIC DIS CAN, V19, P170
   Ma YY, 2013, J CLIN NEUROSCI, V20, P1591, DOI 10.1016/j.jocn.2013.03.034
   Mak SC, 1998, J CHILD NEUROL, V13, P349, DOI 10.1177/088307389801300709
   MONTPETIT VJ, 1971, BRAIN, V94, P1, DOI 10.1093/brain/94.1.1
   Ogawa E, 2017, J INHERIT METAB DIS, V40, P685, DOI 10.1007/s10545-017-0042-6
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Richardson WS, 2003, J GEN INTERN MED, V18, P203, DOI 10.1046/j.1525-1497.2003.20215.x
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Sobreira C, 2009, J NEUROL SCI, V278, P132, DOI 10.1016/j.jns.2008.11.023
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   Sofou K, 2013, MITOCHONDRION, V13, P364, DOI 10.1016/j.mito.2013.04.008
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Yang YL, 2006, CHINESE MED J-PEKING, V119, P373, DOI 10.1097/00029330-200603010-00004
NR 27
TC 37
Z9 41
U1 0
U2 24
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD JAN 15
PY 2020
VL 99
IS 5
BP 
EP 
DI 10.1097/MD.0000000000018634
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA LD1BP
UT WOS:000525767500014
PM 32000367
DA 2024-11-01
ER

PT J
AU O'Donnell, L
   Blakely, EL
   Baty, K
   Alexander, M
   Bogdanova-Mihaylova, P
   Craig, J
   Walsh, R
   Brett, F
   Taylor, RW
   Murphy, SM
AF O'Donnell, Luke
   Blakely, Emma L.
   Baty, Karen
   Alexander, Michael
   Bogdanova-Mihaylova, Petya
   Craig, John
   Walsh, Ronan
   Brett, Francesca
   Taylor, Robert W.
   Murphy, Sinead M.
TI Chronic Progressive External Ophthalmoplegia due to a Rare <i>de novo</i> m.12334G&gt;A MT-TL2 Mitochondrial DNA Variant
SO JOURNAL OF NEUROMUSCULAR DISEASES
LA English
DT Article
DE Chronic progressive external ophthalmoplegia; CPEO; mitochondrial DNA; cytochrome c oxidase
ID mutation
AB We describe a patient with chronic progressive external ophthalmoplegia (CPEO) due to a rare mitochondrial genetic variant. Muscle biopsy revealed numerous cytochrome c oxidase (COX)-deficient fibres, prompting sequencing of the entire mitochondrial genome in muscle which revealed a rare m.12334G>A variant in the mitochondrial (mt-) tRNA(Leu(CUN))(MT-TL2) gene. Analysis of several tissues showed this to be a de novo mutational event. Single fibre studies confirmed the segregation of high m.12334G>A heteroplasmy levels with the COX histochemical defect, confirming pathogenicity of the m.12334G>A MT-TL2 variant. This case illustrates the importance of pursuing molecular genetic analysis in clinically-affected tissues when mitochondrial disease is suspected.
C1 [O'Donnell, Luke; Bogdanova-Mihaylova, Petya; Murphy, Sinead M.] Tallaght Univ Hosp, Dept Neurol, Dublin 24, Ireland.
   [Blakely, Emma L.; Baty, Karen; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England.
   [Blakely, Emma L.; Baty, Karen; Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
   [Alexander, Michael] Tallaght Univ Hosp, Dept Neurophysiol, Dublin, Ireland.
   [Alexander, Michael; Murphy, Sinead M.] Univ Dublin, Acad Unit Neurol, Trinity Coll Dublin, Dublin, Ireland.
   [Craig, John] Belfast Hlth & Social Care Trust, Dept Neurol, Belfast, Antrim, North Ireland.
   [Walsh, Ronan] Hermitage Med Clin, Dept Neurol, Dublin, Ireland.
   [Brett, Francesca] Beaumont Hosp, Dept Neuropathol, Dublin, Ireland.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Trinity College Dublin
RP O'Donnell, L (corresponding author), Tallaght Univ Hosp, Dept Neurol, Dublin 24, Ireland.
EM odonnell4ie@hotmail.com
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease; MRC Mitochondrial Disease Patient Cohort: A Natural History Study and Patient Registry [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre for Ageing; Newcastle upon Tyne Foundation Hospitals NHS Trust; MRC/EPSRC Molecular Pathology Node; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Edgar R, 2013, PLOS ONE, V8, P0
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Kirches E, 2001, J MED GENET, V38, P312, DOI 10.1136/jmg.38.5.312
   Lott MT, 2013, CURR PROTOC BIOINF, V44, P1231, DOI 10.1002/0471250953.BI0123S44
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pinós T, 2011, MITOCHONDRION, V11, P228, DOI 10.1016/j.mito.2010.08.008
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Soldath P, 2017, BMC MUSCULOSKEL DIS, V18, P0, DOI 10.1186/s12891-017-1781-0
   USDepartment of Health & Human Services, 2016, PROGR EXT OPHTH, V0, P0
   Vives-Bauza C, 2001, ANN MED, V33, P493, DOI 10.3109/07853890109002099
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 16
TC 1
Z9 1
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 2214-3599
EI 2214-3602
J9 J NEUROMUSCULAR DIS
JI J. Neuromusc. Dis.
PD JUN 15
PY 2020
VL 7
IS 3
BP 355
EP 360
DI 10.3233/JND-200486
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA UA4BQ
UT WOS:000685106600016
PM 32310184
DA 2024-11-01
ER

PT J
AU Arbeithuber, B
   Hester, J
   Cremona, MA
   Stoler, N
   Zaidi, A
   Higgins, B
   Anthony, K
   Chiaromonte, F
   Diaz, FJ
   Makova, KD
AF Arbeithuber, Barbara
   Hester, James
   Cremona, Marzia A.
   Stoler, Nicholas
   Zaidi, Arslan
   Higgins, Bonnie
   Anthony, Kate
   Chiaromonte, Francesca
   Diaz, Francisco J.
   Makova, Kateryna D.
TI Age-related accumulation of de novo mitochondrial mutations in mammalian oocytes and somatic tissues
SO PLOS BIOLOGY
LA English
DT Article
ID base excision-repair; random genetic drift; point mutations; dna mutations; mtdna heteroplasmy; sequence; rates; methylation; muscle; mice
AB Mutations create genetic variation for other evolutionary forces to operate on and cause numerous genetic diseases. Nevertheless, how de novo mutations arise remains poorly understood. Progress in the area is hindered by the fact that error rates of conventional sequencing technologies (1 in 100 or 1,000 base pairs) are several orders of magnitude higher than de novo mutation rates (1 in 10,000,000 or 100,000,000 base pairs per generation). Moreover, previous analyses of germline de novo mutations examined pedigrees (and not germ cells) and thus were likely affected by selection. Here, we applied highly accurate duplex sequencing to detect low-frequency, de novo mutations in mitochondrial DNA (mtDNA) directly from oocytes and from somatic tissues (brain and muscle) of 36 mice from two independent pedigrees. We found mtDNA mutation frequencies 2- to 3-fold higher in 10-month-old than in 1-month-old mice, demonstrating mutation accumulation during the period of only 9 mo. Mutation frequencies and patterns differed between germline and somatic tissues and among mtDNA regions, suggestive of distinct mutagenesis mechanisms. Additionally, we discovered a more pronounced genetic drift of mitochondrial genetic variants in the germline of older versus younger mice, arguing for mtDNA turnover during oocyte meiotic arrest. Our study deciphered for the first time the intricacies of germline de novo mutagenesis using duplex sequencing directly in oocytes, which provided unprecedented resolution and minimized selection effects present in pedigree studies. Moreover, our work provides important information about the origins and accumulation of mutations with aging/maturation and has implications for delayed reproduction in modern human societies. Furthermore, the duplex sequencing method we optimized for single cells opens avenues for investigating low-frequency mutations in other studies.
C1 [Arbeithuber, Barbara; Zaidi, Arslan; Higgins, Bonnie; Anthony, Kate; Makova, Kateryna D.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA.
   [Hester, James; Chiaromonte, Francesca; Diaz, Francisco J.] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA.
   [Cremona, Marzia A.] Penn State Univ, Dept Stat, University Pk, PA 16802 USA.
   [Stoler, Nicholas] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.
   [Chiaromonte, Francesca] St Anna Sch Adv Studies, EMbeDS, Pisa, Italy.
   [Cremona, Marzia A.] Univ Laval, Dept Operat & Decis Syst, Quebec City, PQ, Canada.
   [Zaidi, Arslan] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Scuola Superiore Sant'Anna; Laval University; University of Pennsylvania
RP Makova, KD (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.
EM kdm16@psu.edu
FU NIH [R01GM116044]; Austrian Science Fund (FWF) [J-4096]; Office of Science Engagement at Penn State; Huck Institute of Life Sciences at Penn State; Institute for Computational and Data Sciences at Penn State; Pennsylvania Department of Health; Eberly College of Sciences at Penn State; Austrian Science Fund (FWF) [J4096] Funding Source: Austrian Science Fund (FWF)
CR Afgan E, 2018, NUCLEIC ACIDS RES, V46, PW537, DOI 10.1093/nar/gky379
   Ahn EH, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0136216
   Alseth I, 2014, CURR OPIN GENET DEV, V26, P116, DOI 10.1016/j.gde.2014.07.008
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   Ancora M, 2017, MITOCHONDRIAL DNA A, V28, P180, DOI 10.3109/19401736.2015.1115499
   Anderson AP, 2020, NUCLEIC ACIDS RES, V48, P817, DOI 10.1093/nar/gkz1018
   [Anonymous], 2014, DIABETOL KLIN SA, V3, P0
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174
   Barrett A, 2019, PHILOS T R SOC B, V0, P0, DOI DOI 10.1098/rstb.2019-0175
   Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Blankenberg D, 2014, GENOME BIOL, V15, P0, DOI 10.1186/gb4161
   Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Boucret L, 2017, HUM REPROD, V32, P2101, DOI 10.1093/humrep/dex268
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Bujak AL, 2015, CELL METAB, V21, P883, DOI 10.1016/j.cmet.2015.05.016
   Burgstaller JP, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04797-2
   Calabrese FM, 2012, BMC BIOINFORMATICS, V13, P0, DOI 10.1186/1471-2105-13-S4-S15
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862
   Dianov GL, 2001, PROG NUCLEIC ACID RE, V68, P285
   DIMONTE DA, 1991, NEUROLOGY, V41, P38, DOI 10.1212/WNL.41.5_Suppl_2.38
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   Fan LH, 2019, BIOCHEM BIOPH RES CO, V513, P912, DOI 10.1016/j.bbrc.2019.04.100
   Fox Edward J, 2014, NEXT GENER SEQ APPL, V1, P0
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Gianoarli L, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0102182
   Gigarel N, 2011, AM J HUM GENET, V88, P494, DOI 10.1016/j.ajhg.2011.03.010
   Goldmann JM, 2016, NAT GENET, V48, P935, DOI 10.1038/ng.3597
   Grazina M, 2006, GENES BRAIN BEHAV, V5, P92, DOI 10.1111/j.1601-183X.2006.00225.x
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Halldorsson BV, 2019, SCIENCE, V363, P364, DOI 10.1126/science.aau1043
   Hazkani-Covo E, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1000834
   Hendy MD, 2009, BIOL LETTERS, V5, P397, DOI 10.1098/rsbl.2009.0104
   Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098
   Hoekstra JG, 2016, ANN NEUROL, V80, P301, DOI 10.1002/ana.24709
   Itsara LS, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1003974
   Jacobs L, 2007, MOL HUM REPROD, V13, P149, DOI 10.1093/molehr/gal112
   Jayaprakash AD, 2015, NUCLEIC ACIDS RES, V43, P2177, DOI 10.1093/nar/gkv052
   Jee J, 2016, NATURE, V534, P693, DOI 10.1038/nature18313
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jónsson H, 2017, NATURE, V549, P519, DOI 10.1038/nature24018
   Jun G, 2015, GENOME RES, V25, P918, DOI 10.1101/gr.176552.114
   Katju V, 2019, GENOME BIOL EVOL, V11, P136, DOI 10.1093/gbe/evy252
   Kauppila JHK, 2018, NUCLEIC ACIDS RES, V46, P6642, DOI 10.1093/nar/gky456
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Kessler MD, 2020, P NATL ACAD SCI USA, V117, P2560, DOI 10.1073/pnas.1902766117
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396
   Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Lei L, 2016, SCIENCE, V352, P95, DOI 10.1126/science.aad2156
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lindsay SJ, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12023-w
   Liu BJ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep23421
   Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003
   Ma H, 2020, BIOL REPROD, V102, P607, DOI 10.1093/biolre/ioz202
   Ma H, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0201304
   Maclaine KD, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0226860
   Marchington DR, 1997, AM J HUM GENET, V60, P408
   Mason PA, 2003, FEBS LETT, V554, P6, DOI 10.1016/S0014-5793(03)01169-4
   Mechta M, 2017, FRONT GENET, V8, P0, DOI 10.3389/fgene.2017.00166
   Millar CD, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000209
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Morris J, 2017, CELL REP, V21, P2706, DOI 10.1016/j.celrep.2017.11.031
   Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   Patil V, 2019, NUCLEIC ACIDS RES, V47, P10072, DOI 10.1093/nar/gkz762
   POLLACK Y, 1984, NUCLEIC ACIDS RES, V12, P4811, DOI 10.1093/nar/12.12.4811
   Poulton J, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001066
   Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Santibanez-Koref M, 2019, MITOCHONDRION, V46, P302, DOI 10.1016/j.mito.2018.08.003
   Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Shtolz N, 2019, FRONT ECOL EVOL, V7, P0, DOI 10.3389/fevo.2019.00342
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stoler N, 2020, BMC BIOINFORMATICS, V21, P0, DOI 10.1186/s12859-020-3419-8
   Stoler N, 2016, GENOME BIOL, V17, P0, DOI 10.1186/s13059-016-1039-4
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thrash A, 2018, ANAL BIOCHEM, V548, P38, DOI 10.1016/j.ab.2018.01.028
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Uchimura A, 2015, GENOME RES, V25, P1125, DOI 10.1101/gr.186148.114
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Williams SL, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003990
   Wong WSW, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms10486
   Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P25172, DOI 10.1073/pnas.1906331116
   Zambelli F, 2018, STEM CELL REP, V11, P102, DOI 10.1016/j.stemcr.2018.05.007
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 106
TC 48
Z9 56
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD JUL 15
PY 2020
VL 18
IS 7
BP 
EP 
DI 10.1371/journal.pbio.3000745
PG 37
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics
GA MQ6ZX
UT WOS:000553044200001
PM 32667908
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Stöllberger, C
AF Finsterer, Josef
   Stoellberger, Claudia
TI Left Ventricular Noncompaction Syndrome: Genetic Insights and Therapeutic Perspectives
SO CURRENT CARDIOLOGY REPORTS
LA English
DT Review
DE Noncompaction; Hypertrabeculation; Genetics; Neuromuscular; Myopathy; Chromosomal; Hereditary
ID non-compaction cardiomyopathy; wearable cardioverter-defibrillator; de-novo mutation; patient; hypertrabeculation/noncompaction; deficiency; diagnosis; risk; variants; disease
AB Purpose of Review To discuss the association of left ventricular hypertrabeculation/noncompaction (LVHT/LVNC/NCCM) with genetic disease and to outline the therapeutic options for non-symptomatic and symptomatic LVHT. Recent Findings A number of new mutated genes have been recently detected being associated with LVHT. There are indications that microtubules changing cell polarity, the transcription factor Nkx2-5, and NOTCH-1 signaling are involved in the pathogenesis of LVHT. There are also indications that the PKC signaling pathway, which is involved in the regulation of gap junction intercellular communication, is disturbed in LVHT. LVHT is the same as LVNC and is associated with pathogenic variants in > 110 mtDNA or nDNA genes. LVHT has been also reported in > 15 chromosomal defects. However, a causal relation between any of these variants and LVHT has not been proven. There is no general agreement on the treatment of LVHT. According to expert opinions, LVHT patients require anticoagulation if they meet the criteria for anticoagulation or an ICD if they meet the appropriate criteria. Heart failure therapy is equal to patients with other causes of heart failure.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Messerli Inst, Postfach 20, A-1180 Vienna, Austria.
   [Stoellberger, Claudia] Krankenanstalt Rudolfstiftung Wien, Med Dept Cardiol & Intens Care Med 2, Vienna, Austria.
C3 Rudolfstiftung Hospital; Rudolfstiftung Hospital
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Messerli Inst, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de; Claudia.stoellberger@chello.at
CR Abdullah S, 2017, AM J MED GENET A, V173, P3082, DOI 10.1002/ajmg.a.38394
   Ader F, 2019, CLIN GENET, V96, P317, DOI 10.1111/cge.13594
   Al Senaidi K, 2019, AM J MED GENET A, V179, P1235, DOI 10.1002/ajmg.a.61176
   Al-Kindi SG, 2015, J HEART LUNG TRANSPL, V34, P761, DOI 10.1016/j.healun.2014.11.005
   Altenberger J, 2012, AM J CARDIOL, V110, P314, DOI 10.1016/j.amjcard.2012.02.070
   Amiya E, 2016, INT J CARDIOL, V222, P727, DOI 10.1016/j.ijcard.2016.08.011
   Bai XH, 2019, FRONT PEDIATR, V7, P0, DOI 10.3389/fped.2019.00247
   Bainbridge MN, 2015, CIRC-CARDIOVASC GENE, V8, P544, DOI 10.1161/CIRCGENETICS.115.001026
   Basu R, 2014, CIRC-HEART FAIL, V7, P1059, DOI 10.1161/CIRCHEARTFAILURE.114.001666
   Bavishi A, 2018, J RADIOL CASE REP, V12, P10, DOI 10.3941/jrcr.v12i7.3351
   Bertini M, 2018, J CARDIOVASC MED, V19, P324, DOI 10.2459/JCM.0000000000000657
   Boban M, 2018, YONSEI MED J, V59, P63, DOI 10.3349/ymj.2018.59.1.63
   Bohrer Thomas, 2006, HEART LUNG CIRC, V15, P269, DOI 10.1016/j.hlc.2006.02.007
   Brndiarova M, 2020, J NEPHROL, V33, P183, DOI 10.1007/s40620-019-00651-w
   Cerar A, 2018, CELL TRANSPLANT, V27, P1027, DOI 10.1177/0963689718779349
   CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507
   Choquet C, 2018, PLOS GENET, V14, P0, DOI 10.1371/journal.pgen.1007502
   Ciolli A, 2015, J CARDIOVASC ECHOGR, V25, P26, DOI 10.4103/2211-4122.158421
   Codron P, 2019, REV NEUROL-FRANCE, V175, P201, DOI 10.1016/j.neurol.2018.04.012
   Cojan-Minzat BO, 2019, MEDICINE, V98, P0, DOI 10.1097/MD.0000000000014267
   del Monte-Nieto G, 2018, NATURE, V557, P439, DOI 10.1038/s41586-018-0110-6
   Delplancq G, 2020, AM J MED GENET C, V184, P129, DOI 10.1002/ajmg.c.31766
   Dreisbach JG, 2020, J CARDIOVASC MAGN R, V22, P0, DOI 10.1186/s12968-020-0599-3
   Eldomery MK, 2016, GENOME MED, V8, P0, DOI 10.1186/s13073-016-0360-6
   Epstein AE, 2013, J AM COLL CARDIOL, V62, P2000, DOI 10.1016/j.jacc.2013.05.086
   Fan P, 2019, CHINESE MED J-PEKING, V132, P127, DOI 10.1097/CM9.0000000000000001
   Finsterer J, 2006, INT J CARDIOL, V106, P420, DOI 10.1016/j.ijcard.2005.01.018
   Finsterer J, 2004, CARDIOLOGY, V102, P228, DOI 10.1159/000081015
   Finsterer J, 2009, INT J CARDIOL, V137, P310, DOI 10.1016/j.ijcard.2008.05.066
   Finsterer J, 2008, SCAND CARDIOVASC J, V42, P25, DOI 10.1080/14017430701744451
   Finsterer J, 2017, NAT REV CARDIOL, V14, P224, DOI 10.1038/nrcardio.2016.207
   Finsterer J, 2013, CARDIOLOGY, V125, P146, DOI 10.1159/000350411
   Finsterer J, 2010, CURR PHARM DESIGN, V16, P2895, DOI 10.2174/138161210793176437
   Finsterer J, 2009, PEDIATR CARDIOL, V30, P659, DOI 10.1007/s00246-008-9359-0
   Fujino Mitsuhiro, 2018, J CARDIOL CASES, V18, P33, DOI 10.1016/j.jccase.2018.04.001
   Gan CP, 2014, J CARDIAC SURG, V29, P827, DOI 10.1111/jocs.12339
   García-García J, 2018, NEUROMUSCULAR DISORD, V28, P952, DOI 10.1016/j.nmd.2018.08.003
   Gati S, 2014, CIRCULATION, V130, P475, DOI 10.1161/CIRCULATIONAHA.114.008554
   Gati S, 2013, HEART, V99, P401, DOI 10.1136/heartjnl-2012-303418
   Gleva MJ, 2017, AM J CARDIOL, V120, P1891, DOI 10.1016/j.amjcard.2017.07.103
   Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011
   Grigoratos C, 2019, JACC-CARDIOVASC IMAG, V12, P2141, DOI 10.1016/j.jcmg.2018.12.029
   Grothoff M, 2012, EUR RADIOL, V22, P2699, DOI 10.1007/s00330-012-2554-7
   Hachiya A, 2016, PEDIATR INT, V58, P797, DOI 10.1111/ped.12983
   Hastings R, 2016, CIRC-CARDIOVASC GENE, V9, P426, DOI 10.1161/CIRCGENETICS.116.001431
   Hirono K, 2019, CIRC J, V83, P1737, DOI 10.1253/circj.CJ-19-0116
   Hirono K, 2019, CLIN CASE REP, V7, P553, DOI 10.1002/ccr3.2050
   Hirono K, 2014, J THORAC CARDIOV SUR, V148, PE223, DOI 10.1016/j.jtcvs.2014.08.049
   Howard TS, 2019, J CARD FAIL, V25, P1004, DOI 10.1016/j.cardfail.2019.09.014
   Jacquier A, 2010, EUR HEART J, V31, P1098, DOI 10.1093/eurheartj/ehp595
   Jahnke C, 2017, EUR HEART J, V38, P2633, DOI 10.1093/eurheartj/ehx360
   Jain-Ghai S, 2013, AM J MED GENET A, V161A, P285, DOI 10.1002/ajmg.a.35714
   Kayvanpour E, 2019, CLIN RES CARDIOL, V108, P1297, DOI 10.1007/s00392-019-01465-3
   Kido K, 2019, J CARDIOVASC PHARM T, V24, P31, DOI 10.1177/1074248418783745
   Kornberger A, 2016, J CARDIOTHORAC SURG, V11, P0, DOI 10.1186/s13019-016-0503-2
   Lai D, 2010, CIRC RES, V107, P715, DOI 10.1161/CIRCRESAHA.110.218693
   Lan NSR, 2018, CARDIOVASC PATHOL, V35, P48, DOI 10.1016/j.carpath.2018.04.006
   Li J, 2015, CLIN RES CARDIOL, V104, P241, DOI 10.1007/s00392-014-0778-z
   Liu Y, 2018, PEDIATR CARDIOL, V39, P1099, DOI 10.1007/s00246-018-1882-z
   Lubrano R, 2009, NEPHROL DIAL TRANSPL, V24, P3884, DOI 10.1093/ndt/gfp499
   Luxán G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046
   McMillan HJ, 2014, BMC MED GENET, V15, P0, DOI 10.1186/1471-2350-15-36
   Minamisawa M, 2016, J CARDIOL, V68, P431, DOI 10.1016/j.jjcc.2015.11.008
   Miszalski-Jamka K, 2017, CIRC-CARDIOVASC GENE, V10, P0, DOI 10.1161/CIRCGENETICS.117.001763
   Moller DV, 2009, EUR J HUM GENET, V17, P1241, DOI 10.1038/ejhg.2009.34
   Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003
   Muser D, 2017, HEART RHYTHM, V14, P166, DOI 10.1016/j.hrthm.2016.11.014
   Musmar A, 2019, CUREUS J MED SCIENCE, V11, P0, DOI 10.7759/cureus.5107
   Navarrete G, 2017, CIRC-HEART FAIL, V10, P0, DOI 10.1161/CIRCHEARTFAILURE.116.003718
   Nozaki Y, 2020, CIRC J, V84, P226, DOI 10.1253/circj.CJ-19-0720
   Oechslin E, 2018, J AM COLL CARDIOL, V71, P723, DOI 10.1016/j.jacc.2017.12.031
   Ojala T, 2015, EUR J PEDIATR, V174, P1689, DOI 10.1007/s00431-015-2574-9
   Olgac A, 2020, J PEDIATR ENDOCR MET, V33, P165, DOI 10.1515/jpem-2019-0245
   Petersen SE, 2005, J AM COLL CARDIOL, V46, P101, DOI 10.1016/j.jacc.2005.03.045
   Piccolo P, 2017, HUM MOL GENET, V26, P33, DOI 10.1093/hmg/ddw365
   Ping OY, 2011, CLIN CHIM ACTA, V412, P170, DOI 10.1016/j.cca.2010.09.035
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Prada CE, 2012, PEDIATRICS, V130, PE456, DOI 10.1542/peds.2011-2927
   Ramond F, 2017, CLIN GENET, V91, P126, DOI 10.1111/cge.12780
   Rea G, 2017, CSH MOL CASE STUD, V3, P0, DOI 10.1101/mcs.a001271
   Reuschel E, 2016, INT J CARDIOL, V223, P154, DOI 10.1016/j.ijcard.2016.08.097
   Robinson AA, 2020, JAMA CARDIOL, V5, P685, DOI 10.1001/jamacardio.2020.0652
   Rowland TJ, 2016, J AM COLL CARDIOL, V68, P2237, DOI 10.1016/j.jacc.2016.08.052
   Sakai Yoshitaka, 2007, INT J CARDIOL, V117, Pe104, DOI 10.1016/j.ijcard.2006.11.223
   Smith JGW, 2018, STEM CELL REP, V11, P1226, DOI 10.1016/j.stemcr.2018.10.006
   Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018
   Stöllberger C, 2007, J CARD FAIL, V13, P211, DOI 10.1016/j.cardfail.2006.11.007
   Stöllberger C, 2015, HERZ, V40, P906, DOI 10.1007/s00059-015-4310-7
   Stöllberger C, 2015, ANN NONINVAS ELECTRO, V20, P79, DOI 10.1111/anec.12155
   Stöllberger C, 2013, INT J CARDIOL, V168, P2910, DOI 10.1016/j.ijcard.2013.03.111
   Stöllberger C, 2013, J STROKE CEREBROVASC, V22, P709, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.014
   Stöllberger C, 2013, INT J CARDIOL, V165, P463, DOI 10.1016/j.ijcard.2011.08.845
   Takasaki A, 2018, PEDIATR RES, V84, P733, DOI 10.1038/s41390-018-0162-1
   Thakur V, 2016, CARDIOL YOUNG, V26, P368, DOI 10.1017/S1047951115000773
   Tian T, 2015, HEART VESSELS, V30, P258, DOI 10.1007/s00380-014-0503-x
   Uribarri A, 2015, INT J CARDIOL, V197, P128, DOI 10.1016/j.ijcard.2015.04.046
   Van der Starre P, 2013, MUSCLE NERVE, V47, P135, DOI 10.1002/mus.23517
   van Waning JI, 2019, J AM HEART ASSOC, V8, P0, DOI 10.1161/JAHA.119.012993
   Villa CR, 2015, NEUROMUSCULAR DISORD, V25, P165, DOI 10.1016/j.nmd.2014.09.011
   Vinardell JM, 2016, REV CARDIOVASC MED, V17, P80, DOI 10.3909/riu0817
   Wenger TL, 2017, AM J MED GENET A, V173, P414, DOI 10.1002/ajmg.a.38030
   Williams T, 2011, CLIN RES CARDIOL, V100, P1087, DOI 10.1007/s00392-011-0345-9
   Xie YY, 2017, CELL PHYSIOL BIOCHEM, V44, P828, DOI 10.1159/000485348
   Yilmaz S, 2016, BRAIN DEV-JPN, V38, P124, DOI 10.1016/j.braindev.2015.06.004
   Yokoyama R, 2018, HEART VESSELS, V33, P802, DOI 10.1007/s00380-018-1116-6
   Zhou HM, 2017, INT J CARDIOVAS IMAG, V33, P2013, DOI 10.1007/s10554-017-1209-9
NR 106
TC 17
Z9 18
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1523-3782
EI 1534-3170
J9 CURR CARDIOL REP
JI Curr. Cardiol. Rep.
PD JUL 9
PY 2020
VL 22
IS 9
BP 
EP 
DI 10.1007/s11886-020-01339-5
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MP1LG
UT WOS:000551972300015
PM 32648009
DA 2024-11-01
ER

PT J
AU Varhaug, KN
   Nido, GS
   de Coo, I
   Isohanni, P
   Suomalainen, A
   Tzoulis, C
   Knappskog, P
   Bindoff, LA
AF Varhaug, Kristin N.
   Nido, Gonzalo S.
   de Coo, Irenaeus
   Isohanni, Pirjo
   Suomalainen, Anu
   Tzoulis, Charalampos
   Knappskog, Per
   Bindoff, Laurence A.
TI Using urine to diagnose large-scale mtDNA deletions in adult patients
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID mitochondrial-dna; read alignment; single; phenotypes; disorders; detect
AB Objective: The aim of this study was to evaluate if urinary sediment cells offered a robust alternative to muscle biopsy for the diagnosis of single mtDNA deletions. Methods: Eleven adult patients with progressive external ophthalmoplegia and a known single mtDNA deletion were investigated. Urinary sediment cells were used to isolate DNA, which was then subjected to long-range polymerase chain reaction. Where available, the patient's muscle DNA was studied in parallel. Breakpoint and thus deletion size were identified using both Sanger sequencing and next generation sequencing. The level of heteroplasmy was determined using quantitative polymerase chain reaction. Results: We identified the deletion in urine in 9 of 11 cases giving a sensitivity of 80%. Breakpoints and deletion size were readily detectable in DNA extracted from urine. Mean heteroplasmy level in urine was 38% +/- 26 (range 8 - 84%), and 57% +/- 28 (range 12 - 94%) in muscle. While the heteroplasmy level in urinary sediment cells differed from that in muscle, we did find a statistically significant correlation between these two levels (R = 0.714, P = 0.031(Pearson correlation)). Interpretation: Our findings suggest that urine can be used to screen patients suspected clinically of having a single mtDNA deletion. Based on our data, the use of urine could considerably reduce the need for muscle biopsy in this patient group.
C1 [Varhaug, Kristin N.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Varhaug, Kristin N.; Nido, Gonzalo S.; Tzoulis, Charalampos; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med K1, Bergen, Norway.
   [Nido, Gonzalo S.; Tzoulis, Charalampos; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, NeurosysMed, Bergen, Norway.
   [de Coo, Irenaeus] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands.
   [de Coo, Irenaeus] Univ Maastricht, Dept Genet & Cell Biol, Maastricht, Netherlands.
   [Isohanni, Pirjo; Suomalainen, Anu] Univ Helsinki, Fac Med, Stem Cells & Metab, Res Programs Unit, Helsinki, Finland.
   [Isohanni, Pirjo] Univ Helsinki, Childrens Hosp, Helsinki, Finland.
   [Isohanni, Pirjo] Helsinki Univ Hosp, Helsinki, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, HUSlab, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Neurosci Ctr, Helsinki, Finland.
   [Knappskog, Per] Haukeland Hosp, Ctr Med Genet & Mol Med, Bergen, Norway.
   [Knappskog, Per] Univ Bergen, Dept Clin Sci, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; Medical Spectrum Twente; Maastricht University; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Bergen; Haukeland University Hospital; University of Bergen
RP Varhaug, KN (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM Kristin.nielsen.varhaug@helse-bergen.no
CR [Anonymous], 2007, MITOMAP HUMAN MITOCH, V0, P0
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Blackwood JK, 2010, BIOCHEM BIOPH RES CO, V393, P740, DOI 10.1016/j.bbrc.2010.02.072
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   POULTON J, 1994, HUM MOL GENET, V3, P947, DOI 10.1093/hmg/3.6.947
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 25
TC 11
Z9 11
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
EI 
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD AUG 15
PY 2020
VL 7
IS 8
BP 1318
EP 1326
DI 10.1002/acn3.51119
EA JUL 2020
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA NE2SX
UT WOS:000545793900001
PM 32634300
DA 2024-11-01
ER

PT J
AU Oexner, RR
   Pla-Martín, D
   Pass, T
   Wiesen, MHJ
   Zentis, P
   Schauss, A
   Baris, OR
   Kimoloi, S
   Wiesner, RJ
AF Oexner, Rafael R.
   Pla-Martin, David
   Pass, Thomas
   Wiesen, Martin H. J.
   Zentis, Peter
   Schauss, Astrid
   Baris, Olivier R.
   Kimoloi, Sammy
   Wiesner, Rudolf J.
TI Extraocular Muscle Reveals Selective Vulnerability of Type IIB Fibers to Respiratory Chain Defects Induced by Mitochondrial DNA Alterations
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
DE mtDNA deletions; extraocular muscle; type IIB fibers; cytochrome C oxidase; selective vulnerability
ID progressive external ophthalmoplegia; layer-specific differences; skeletal-muscle; deletion mutations; abnormality; expression; cells
AB PURPOSE. The purpose of this study was to gain insights on the pathogenesis of chronic progressive external ophthalmoplegia, thus we investigated the vulnerability of five extra ocular muscles (EOMs) fiber types to pathogenic mitochondrial DNA deletions in a mouse model expressing a mutated mitochondrial helicase TWINKLE. METHODS. Consecutive pairs of EOM sections were analyzed by cytochrome C oxidase (COX)/succinate dehydrogenase (SDH) assay and fiber type specific immunohistochemistry (type I, IIA, IIB, embryonic, and EOM-specific staining). RESULTS. The mean average of COX deficient fibers (COX-) in the recti muscles of mutant mice was 1.04 +/- 0.52% at 12 months and increased with age (7.01 +/- 1.53% at 24 months). A significant proportion of these COX-fibers were of the fast-twitch, glycolytic type IIB (> 50% and > 35% total COX-fibers at 12 and 24 months, respectively), whereas embryonic myosin heavy chain-expressing fibers were almost completely spared. Furthermore, the proportion of COX-fibers in the type IIB-rich retractor bulbi muscle was > 2-fold higher compared to the M. recti at both 12 (2.6 +/- 0.78%) and 24 months (20.85 +/- 2.69%). Collectively, these results demonstrate a selective vulnerability of type IIB fibers to mitochondrial DNA (mtDNA) deletions in EOMs and retractor bulbi muscle. We also show that EOMs of mutant mice display histopathological abnormalities, including altered fiber type composition, increased fibrosis, ragged red fibers, and infiltration of mononucleated nonmuscle cells. CONCLUSIONS. Our results point to the existence of fiber type IIB-intrinsic factors and/or molecular mechanisms that predispose them to increased generation, clonal expansion, and detrimental effects of mtDNA deletions.
C1 [Oexner, Rafael R.; Pla-Martin, David; Pass, Thomas; Baris, Olivier R.; Kimoloi, Sammy; Wiesner, Rudolf J.] Univ Cologne, Ctr Physiol & Pathophysiol, Inst Vegetat Physiol, Cologne, Germany.
   [Kimoloi, Sammy] Masinde Muliro Univ Sci & Technol, Dept Med Lab Sci, POB 190-50100, Kakamega, Kenya.
   [Wiesen, Martin H. J.] Univ Hosp Koln, Med Fac, Ctr Pharmacol, Therapeut Drug Monitoring Unit, Cologne, Germany.
   [Pla-Martin, David; Zentis, Peter; Schauss, Astrid; Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.
   [Wiesner, Rudolf J.] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany.
   [Baris, Olivier R.] Univ Angers, Inst MitoVasc, INSERM U1083, Equipe MitoLab,UMR CNRS 6015, Angers, France.
C3 University of Cologne; University of Cologne; University of Cologne; University of Cologne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers
RP Kimoloi, S (corresponding author), Masinde Muliro Univ Sci & Technol, Dept Med Lab Sci, POB 190-50100, Kakamega, Kenya.
EM kimoloi@mmust.ac.ke
FU Deutscher Akademischer Austauschdienst (DAAD); Deutsche Forschungsgemeinschaft (DFG, German Research Fundation) [269925409, SFB1218]; Cologne Excellence cluster on Cellular stress responses in Aging associated diseases - CECAD; CECAD
CR Arganda-Carreras Ignacio, 2006, CONSISTENT AND ELASTIC REGISTRATION OF HISTOLOGICAL SECTIONS USING VECTOR-SPLINE REGULARIZATION, V0, P0
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F
   Briggs MM, 2002, J EXP BIOL, V205, P3133
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Budak MT, 2004, PHYSIOL GENOMICS, V20, P55, DOI 10.1152/physiolgenomics.00191.2004
   CARRY MR, 1986, ANAT RECORD, V214, P8, DOI 10.1002/ar.1092140103
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   JA B-E, 1988, STRUCTURAL ORG EXTRA, V2, P0
   Caballero PEJ, 2007, NEUROLOGIST, V13, P33, DOI 10.1097/01.nrl.0000252953.49721.f5
   Jones TR, 2008, BMC BIOINFORMATICS, V9, P0, DOI 10.1186/1471-2105-9-482
   Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   KOERNER F, 1972, ARCH OPHTHALMOL-CHIC, V88, P155, DOI 10.1001/archopht.1972.01000030157005
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lopez ME, 2000, MUTAT RES-FUND MOL M, V452, P123, DOI 10.1016/S0027-5107(00)00059-2
   McBride HM, 2006, CURR BIOL, V16, PR551, DOI 10.1016/j.cub.2006.06.054
   Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Neuhaus JFG, 2014, BRAIN, V137, P354, DOI 10.1093/brain/awt291
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   Porter JD, 1998, CELL TISSUE RES, V292, P495, DOI 10.1007/s004410051078
   Remington LA, 2011, CLINICAL ANATOMY AND PHYSIOLOGY OF THE VISUAL SYSTEM, V3rd, P0
   Ross JM, 2011, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/3266
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI 10.1038/nmeth.2019
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Spencer RF, 2006, PROG BRAIN RES, V151, P43, DOI 10.1016/S0079-6123(05)51002-1
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Treuting PM, 2012, COMP ANATOMY HISTOLO, V0, P0
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wasicky R, 2000, INVEST OPHTH VIS SCI, V41, P980
   Wiesen MHJ, 2007, INVEST OPHTH VIS SCI, V48, P1119, DOI 10.1167/iovs.06-0701
   WOOTEN GF, 1972, ARCH NEUROL-CHICAGO, V26, P350, DOI 10.1001/archneur.1972.00490100080008
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
NR 45
TC 6
Z9 6
U1 1
U2 3
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD OCT 15
PY 2020
VL 61
IS 12
BP 
EP 
DI 10.1167/iovs.61.12.14
PG 13
WC Ophthalmology
SC Ophthalmology
GA OR2IJ
UT WOS:000589298400006
PM 33057669
DA 2024-11-01
ER

PT J
AU Liu, MC
   Yu, ST
   Wang, JW
   Qiao, JH
   Liu, Y
   Wang, SM
   Zhao, Y
AF Liu, Meichen
   Yu, Shiting
   Wang, Jiawen
   Qiao, Juhui
   Liu, Ying
   Wang, Siming
   Zhao, Yu
TI Ginseng protein protects against mitochondrial dysfunction and neurodegeneration by inducing mitochondrial unfolded protein response in <i>Drosophila melanogaster</i> PINK1 model of Parkinson's disease
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Parkinson's disease; Drosophila melanogaster; Ginseng protein; Mitochondria; Oxidative stress
ID degeneration; mutations; pathway
AB Ethnopharmacological relevance: Historical literature and pharmacological studies demonstrate that ginseng, one of the most popular herbal medicines in China, holds potential benefits for Parkinson's disease (PD). Aim of the study: Studies in Drosophila melanogaster (Dm) have highlighted mitochondria] dysfunction upon loss of PTEN-induced putative kinase 1 (PINK1) as a central mechanism of PD pathogenesis. Using PINK1(B9) mutant Dm, we aimed to explore the therapeutic action of ginseng total protein (GTP) on PD and provide in-depth scientific interpretation about the traditional efficacy of ginseng. Materials and methods: We first used gel chromatography to purify GTP and confirmed its molecular weight by SDS-PAGE. Effects of GTP on PINK1(B9) mutants, which were supplied with standard diet from larvae to adult stages, were assayed in flies aged 3-6 (I), 10-15 (II), and 20-25 (III) days. Parkinson-like phenotypes were analyzed by evaluating lifespan, dopaminergic neurons, dopamine levels, and locomotor ability. Mitochondrial function was assessed by evaluating ATP production, respirometry, and mitochondrial DNA. In addition, reactive oxygen species were measured using dihydroethidium and 2',7'-dichlorodihydrofluorescein diacetate staining. PD-related oxidative stress was simulated by paraquat and rotenone, and mitochondrial membrane potential was measured using JC-10 reagent. Protein and mRNA expression was detected by Western blot and real-time quantitative reverse transcription polymerase chain reaction, respectively. Results: This study demonstrates for the first time that GTP treatment delays the onset of a Parkinson-like phenotype in PINK1(B9) Dm, including prolongation of lifespan and rescue of climbing ability, as well as rescue of the progressive loss of a cluster of dopaminergic neurons in the protocerebral posterior lateral 1 region, which was accompanied by a significant increase of dopamine content in the brain. In addition, GTP notably reduced the penetrance of abnormal wing position, indicating a strong inhibitory effect on indirect flight muscle degeneration. We further showed that GTP could promote maintenance of mitochondrial function and protect mitochondria from PD-associated oxidative stress by activating the mitochondrial unfolded protein response (UPRmt). Conclusions: GTP protected against mitochondrial dysfunction and neurodegeneration by inducing UPRmt in the Dm PINK1(B9) model of PD. Our results suggest that GTP is a promising candidate for PD, and reveal a new mechanism by which ginseng is neuroprotective.
C1 [Liu, Meichen; Yu, Shiting; Wang, Jiawen; Qiao, Juhui; Liu, Ying; Wang, Siming; Zhao, Yu] Changchun Univ Chinese Med, Jilin Ginseng Acad, Changchun 130117, Jilin, Peoples R China.
C3 Changchun University of Chinese Medicine
RP Wang, SM; Zhao, Y (corresponding author), Changchun Univ Chinese Med, Jilin Ginseng Acad, Changchun 130117, Jilin, Peoples R China.
EM liumc0367@163.com; 18843196008@163.com; wangjiawen1229@163.com; 3022336742@qq.com; 2362943206@qq.com; lwsm126030@126.com; cnzhaoyu1972@126.com
FU Edanz Group China; National Natural Foundation of China [81703663]; National Key Research and Development Program of China [2017YFC1702104]
CR Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004
   Basil AH, 2017, FRONT CELL NEUROSCI, V11, P0, DOI 10.3389/fncel.2017.00241
   Broadley SA, 2008, TRENDS CELL BIOL, V18, P1, DOI 10.1016/j.tcb.2007.11.003
   Brooks David J, 2008, NEUROPSYCHIATR DIS TREAT, V4, P39
   Chen Liang-Wei, 2007, CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, V6, P273
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Cooper JF, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-16637-2
   de Castro IP, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.394
   de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5
   Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03
   González-Burgos E, 2015, J NEUROIMMUNE PHARM, V10, P14, DOI 10.1007/s11481-014-9569-6
   Hwang Onyou, 2013, EXP NEUROBIOL, V22, P11, DOI 10.5607/en.2013.22.1.11
   Lehmann S, 2016, CELL DEATH DIS, V7, P0, DOI 10.1038/cddis.2016.72
   Li HY, 2016, J ETHNOPHARMACOL, V179, P162, DOI 10.1016/j.jep.2015.12.020
   Liu ZY, 2008, GEN COMP ENDOCR, V156, P164, DOI 10.1016/j.ygcen.2008.01.006
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu BW, 2009, ANNU REV PATHOL-MECH, V4, P315, DOI 10.1146/annurev.pathol.3.121806.151529
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Ong WY, 2015, FRONT AGING NEUROSCI, V7, P0, DOI 10.3389/fnagi.2015.00129
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Rascol O, 2011, MOVEMENT DISORD, V26, P1072, DOI 10.1002/mds.23714
   Straka I, 2018, MEDICINE, V97, P0, DOI 10.1097/MD.0000000000010962
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256
   Wang Y, 2019, CNS NEUROSCI THER, V25, P816, DOI 10.1111/cns.13116
   Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102
   Wu K, 2014, FASEB J, V28, P5111, DOI 10.1096/fj.14-255802
   Wu ZH, 2018, EXP GERONTOL, V113, P10, DOI 10.1016/j.exger.2018.09.014
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Yang YF, 2009, J NEUROPATH EXP NEUR, V68, P953, DOI 10.1097/NEN.0b013e3181b2048c
NR 30
TC 54
Z9 59
U1 2
U2 98
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD JAN 30
PY 2020
VL 247
IS 
BP 
EP 
DI 10.1016/j.jep.2019.112213
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine
GA JO0BT
UT WOS:000497253400005
PM 31562951
DA 2024-11-01
ER

PT J
AU Mojbafan, M
   Nojehdeh, ST
   Rahiminejad, F
   Nilipour, Y
   Tonekaboni, SH
   Zeinali, S
AF Mojbafan, Marzieh
   Nojehdeh, Somayeh Takrim
   Rahiminejad, Faezeh
   Nilipour, Yalda
   Tonekaboni, Seyed Hasan
   Zeinali, Sirous
TI Reporting a rare form of myopathy, myopathy with extrapyramidal signs, in an Iranian family using next generation sequencing: a case report
SO BMC MEDICAL GENETICS
LA English
DT Article
DE Myopathy with extrapyramidal signs; MICU1 gene; Next generation sequencing; Autozygosity mapping
ID mitochondrial ca2+ uptake; micu1; gatekeeper; binding; gene
AB Background Myopathy with extrapyramidal signs (MPXPS) is an autosomal recessive mitochondrial disorder which is caused by mutation in mitochondrial calcium uptake 1 (MICU1) gene located on chromosome 10q22.1. Next Generation Sequencing (NGS) technology is the most effective method for identification of pathogenic variants with the ability to overcome some limitations which Sanger sequencing may encountered. There are few reports on this rare disease around the world and here in this study we first revealed genetic identification of two affected individuals in an Iranian family with a novel mutation. Case presentation The proband was a 5-year-old girl from consanguenous parents. She was first clinically suspicious of affected with limb-girdle muscular dystrophy (LGMD). Muscle biopsy studies and autozygosity mapping, using four short tandem repeat (STR) markers linked to 6 genes of the most prevalent forms of LGMD, ruled out calpainopathy, dysferlinopathy, and sarcoglycanopathis. DNA sample of the proband was sent for NGS. Whole exome sequencing (WES) revealed a novel mutation c.1295delA in exon 13 of MICU1 gene. This homozygous deletion creates a frameshift and a premature stop codon downstream of canonical EF4 calcium binding motif of MICU1. According to the American College of Medical Genetics and Genomics (ACMG) guidline for sequence interpretation, this variant was a pathogenic one. Sanger sequencing in all family members confirmed the results of the WES. Conclusions This study was the first report of MPXPS in Iranian population which also revealed a novel mutation in the MICU1 gene.
C1 [Mojbafan, Marzieh] Iran Univ Med Sci, Fac Med, Dept Med Genet & Mol Biol, Shahid Hemmat Highway, Tehran, Iran.
   [Mojbafan, Marzieh] Ali Asghar Childrens Hosp, Dept Med Genet, Zafar St,Shahid Modarres Highway, Tehran, Iran.
   [Nojehdeh, Somayeh Takrim; Rahiminejad, Faezeh; Zeinali, Sirous] Kawsar Human Genet Res Ctr, Med Genet Lab, 41 Majlesi St,Valieasr Ave, Tehran, Iran.
   [Nilipour, Yalda] Shahid Beheshti Univ Med Sci, Res Inst Children Hlth, Pediat Pathol Res Ctr, Mofid Hosp,Pathol Dept, Tehran, Iran.
   [Tonekaboni, Seyed Hasan] Shahid Beheshti Med Univ, Dept Pediat Neurol, Pediat Neurol Ctr Excellence, Mofid Children Hosp,Fac Med, Tehran, Iran.
   [Zeinali, Sirous] Pasteur Inst Iran, Dept Mol Med, Biotechnol Res Ctr, 69 Pasteur Ave, Tehran, Iran.
C3 Iran University of Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Pasteur Network; Pasteur Institute of Iran
RP Zeinali, S (corresponding author), Kawsar Human Genet Res Ctr, Med Genet Lab, 41 Majlesi St,Valieasr Ave, Tehran, Iran.; Zeinali, S (corresponding author), Pasteur Inst Iran, Dept Mol Med, Biotechnol Res Ctr, 69 Pasteur Ave, Tehran, Iran.
EM zeinalipasteur@yahoo.com
CR Dubowitz V, 1973, HISTOLOGICAL HISTOCH, V0, P0
   Hoffman NE, 2013, CELL REP, V5, P1576, DOI 10.1016/j.celrep.2013.11.026
   Kamer KJ, 2014, EMBO REP, V15, P299, DOI 10.1002/embr.201337946
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Lewis-Smith D, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000059
   Liu JC, 2016, CELL REP, V16, P1561, DOI 10.1016/j.celrep.2016.07.011
   Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851
   MAngale PG, 2017, GENET MOL RES, V16, P0, DOI 10.4238/gmr16019436
   Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011
   Marchi S, 2014, J PHYSIOL-LONDON, V592, P829, DOI 10.1113/jphysiol.2013.268235
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Mojbafan M, 2018, GENE, V677, P259, DOI 10.1016/j.gene.2018.07.067
   Mojbafan M, 2016, J MOL NEUROSCI, V59, P392, DOI 10.1007/s12031-016-0772-1
   Mojbafan M, 2016, J NEUROGENET, V30, P1, DOI 10.3109/01677063.2016.1141208
   Musa S, 2018, MIDDLE E FOUNDER MUT, V0, P0
   Nigro Vincenzo, 2014, ACTA MYOL, V33, P1
   Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358
   Petrungaro C, 2015, CELL METAB, V22, P721, DOI 10.1016/j.cmet.2015.08.019
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Safari R, 2016, J INTEGR NEUROSCI, V15, P163, DOI 10.1142/S0219635216500096
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Thompson R, 2016, NAT REV NEUROL, V12, P294, DOI 10.1038/nrneurol.2016.35
   Truong AH, 2016, VASCULAR ION CHANNEL, V0, P0
   Wang LL, 2014, EMBO J, V33, P594, DOI 10.1002/embj.201386523
   Woods CG, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.016873
NR 25
TC 12
Z9 12
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2350
J9 BMC MED GENET
JI BMC Med. Genet.
PD APR 15
PY 2020
VL 21
IS 1
BP 
EP 
DI 10.1186/s12881-020-01016-y
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA LH3ZQ
UT WOS:000528726000003
PM 32293312
DA 2024-11-01
ER

PT J
AU Zhang, XN
   Zheng, YR
   Chen, Z
AF Zhang, Xiangnan
   Zheng, Yanrong
   Chen, Zhong
TI Autophagy and Mitochondrial Encephalomyopathies
SO AUTOPHAGY: BIOLOGY AND DISEASES: CLINICAL SCIENCE
LA English
DT Article; Book Chapter
DE Encephalomyopathy; Autophagy; Mitochondria; Mitophagy
ID complex i; mutation; dna; melas; fibroblasts; deletions; myopathy
AB Mitochondrial encephalomyopathies are a group of disorders affecting skeletal muscles and brain. Although the symptoms vary among these disorders, mitochondrial DNA mutation or loss is the common characteristic. The abnormality of mitochondrial genome usually causes the dysfunction of mitochondrial respiratory and even mitochondrial damage. As a critical way of degradation, attention has been paid to the involvement of autophagy in encephalomyopathies. Autophagy is found activated in these encephalomyopathies-relevant cells as a compensatory manner to eliminate these damaged and dysfunctional mitochondria. However, accumulating evidences indicate that autophagy is incompetent to clear them. The insufficient mitophagy may ultimately accelerate cell death. Here we discuss the involvement of autophagy in encephalomyopathies based on the current evidence. We further look into the future to rescue encephalomyopathies by regulating autophagy. Only five encephalomyopathies are included in this chapter due to the availability of evidence. Nevertheless, these encephalomyopathies share a variety of common features and autophagy may also be regulated in the other encephalomyopathies.
C1 [Zhang, Xiangnan; Zheng, Yanrong; Chen, Zhong] Zhejiang Univ, Coll Pharmaceut Sci, NHC & CAMS Key Lab Med Neurobiol, Inst Pharmacol & Toxicol, Hangzhou 310058, Peoples R China.
C3 Zhejiang University
RP Chen, Z (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, NHC & CAMS Key Lab Med Neurobiol, Inst Pharmacol & Toxicol, Hangzhou 310058, Peoples R China.
EM chenzhong@zju.edu.cn
CR Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   Bacalhau M, 2018, NEUROMUSCULAR DISORD, V28, P350, DOI 10.1016/j.nmd.2017.11.006
   Bernardi P, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011387
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Chen CY, 2011, MITOCHONDRION, V11, P739, DOI 10.1016/j.mito.2011.05.014
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   De la Mata M, 2012, NEUROTHERAPEUTICS, V9, P446, DOI 10.1007/s13311-012-0103-3
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Houshmand M, 2006, NEUROL INDIA, V54, P182
   HUOPONEN K, 1991, AM J HUM GENET, V48, P1147
   Ikeda T, 2018, HUM GENOME VAR, V5, P0, DOI 10.1038/s41439-018-0026-6
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Lin DS, 2017, ONCOTARGET, V8, P73627, DOI 10.18632/oncotarget.20617
   López LC, 2014, MOL SYNDROMOL, V5, P163, DOI 10.1159/000360494
   Ogle RF, 1997, J PEDIATR-US, V130, P138, DOI 10.1016/S0022-3476(97)70323-8
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rodríguez-Hernández A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174
   Sharma LK, 2019, HUM MOL GENET, V28, P422, DOI 10.1093/hmg/ddy354
   Wang TK, 2014, BIOCHEM J, V459, P149, DOI 10.1042/BJ20131235
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Yuan JH, 2013, J CLIN PATHOL, V66, P659, DOI 10.1136/jclinpath-2012-201431
   Zeviani Massimo, 1993, EUROPEAN JOURNAL OF HUMAN GENETICS, V1, P80
   Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107
NR 27
TC 8
Z9 8
U1 1
U2 6
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PD JUN 15
PY 2020
VL 1207
IS 
BP 103
EP 110
DI 10.1007/978-981-15-4272-5_6
PG 8
WC Medicine, Research & Experimental; Clinical Neurology
SC Research & Experimental Medicine; Neurosciences & Neurology
GA BP5KY
UT WOS:000556133800007
PM 32671741
DA 2024-11-01
ER

PT J
AU Sommerville, EW
   Dalla Rosa, I
   Rosenberg, MM
   Bruni, F
   Thompson, K
   Rocha, M
   Blakely, EL
   He, LP
   Falkous, G
   Schaefer, AM
   Yu-Wai-Man, P
   Chinnery, PF
   Hedstrom, L
   Spinazzola, A
   Taylor, RW
   Gorman, GS
AF Sommerville, Ewen W.
   Dalla Rosa, Ilaria
   Rosenberg, Masha M.
   Bruni, Francesco
   Thompson, Kyle
   Rocha, Mariana
   Blakely, Emma L.
   He, Langping
   Falkous, Gavin
   Schaefer, Andrew M.
   Yu-Wai-Man, Patrick
   Chinnery, Patrick F.
   Hedstrom, Lizbeth
   Spinazzola, Antonella
   Taylor, Robert W.
   Gorman, Grainne S.
TI Identification of a novel heterozygous guanosine monophosphate reductase (<i>GMPR</i>) variant in a patient with a late-onset disorder of mitochondrial DNA maintenance
SO CLINICAL GENETICS
LA English
DT Article
DE GMPR; mitochondrial DNA maintenance; multiple mtDNA deletions; PEO; whole exome sequencing
ID human-equilibrative-nucleoside-transporter-1 hent1; ribonucleotide reduction; deficiency; deletions; gene; replication; expression; mutations; toxicity; subunit
AB Autosomal dominant progressive external ophthalmoplegia (adPEO) is a late-onset, Mendelian mitochondrial disorder characterised by paresis of the extraocular muscles, ptosis, and skeletal-muscle restricted multiple mitochondrial DNA (mtDNA) deletions. Although dominantly inherited, pathogenic variants in POLG, TWNK and RRM2B are among the most common genetic defects of adPEO, identification of novel candidate genes and the underlying pathomechanisms remains challenging. We report the clinical, genetic and molecular investigations of a patient who presented in the seventh decade of life with PEO. Oxidative histochemistry revealed cytochrome c oxidase-deficient fibres and occasional ragged red fibres showing subsarcolemmal mitochondrial accumulation in skeletal muscle, while molecular studies identified the presence of multiple mtDNA deletions. Negative candidate screening of known nuclear genes associated with PEO prompted diagnostic exome sequencing, leading to the prioritisation of a novel heterozygous c.547G>C variant in GMPR (NM_006877.3) encoding guanosine monophosphate reductase, a cytosolic enzyme required for maintaining the cellular balance of adenine and guanine nucleotides. We show that the novel c.547G>C variant causes aberrant splicing, decreased GMPR protein levels in patient skeletal muscle, proliferating and quiescent cells, and is associated with subtle changes in nucleotide homeostasis protein levels and evidence of disturbed mtDNA maintenance in skeletal muscle. Despite confirmation of GMPR deficiency, demonstrating marked defects of mtDNA replication or nucleotide homeostasis in patient cells proved challenging. Our study proposes that GMPR is the 19th locus for PEO and highlights the complexities of uncovering disease mechanisms in late-onset PEO phenotypes.
C1 [Sommerville, Ewen W.; Bruni, Francesco; Thompson, Kyle; Rocha, Mariana; Blakely, Emma L.; He, Langping; Falkous, Gavin; Schaefer, Andrew M.; Taylor, Robert W.; Gorman, Grainne S.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Dalla Rosa, Ilaria; Spinazzola, Antonella] UCL, Dept Clin & Movement Neurosci, UCL Queens Sq Inst Neurol, Royal Free Campus, London, England.
   [Rosenberg, Masha M.; Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.
   [Bruni, Francesco] Univ Bari Ldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.
   [Yu-Wai-Man, Patrick] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England.
   [Yu-Wai-Man, Patrick] UCL Inst Ophthalmol, London, England.
   [Yu-Wai-Man, Patrick] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.
   [Yu-Wai-Man, Patrick] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England.
   [Chinnery, Patrick F.] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
   [Chinnery, Patrick F.] Univ Cambridge, Sch Clin Med, Med Res Council Mitochondria Biol Unit, Cambridge, England.
   [Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, 415 South St, Waltham, MA 02254 USA.
   [Spinazzola, Antonella] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England.
   [Spinazzola, Antonella] Natl Hosp Neurol & Neurosurg, London, England.
C3 Newcastle University - UK; University of London; University College London; Brandeis University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Brandeis University; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust
RP Taylor, RW (corresponding author), Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU Evelyn Trust; Fight for Sight UK; Isaac Newton Trust; Medical Research Council UK [G1002570, MC_PC_13029, MC_UP_1501/2]; MRC Centre for Neuromuscular Diseases [G0601943]; MRC/ESPRC Newcastle Molecular Pathology Node; National Institute for Health Research (NIHR) Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust; Newcastle University Centre for Ageing and Vitality [G016354/1]; NIHR Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; Lily Foundation; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders; UK NIHR Biomedical Research Centre in Age and Age Related Diseases; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Wellcome Trust [212219/Z/18/Z]; MRC [G0701386, MC_PC_13029/2, MC_UU_00015/8, G1002570, G0601943, MC_UU_00015/9] Funding Source: UKRI
CR Berglund AK, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1006628
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bruni F, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064670
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Dalla Rosa I, 2014, NUCLEIC ACIDS RES, V42, P8500, DOI 10.1093/nar/gku513
   Deng YF, 2002, INT J BIOCHEM CELL B, V34, P1035, DOI 10.1016/S1357-2725(02)00024-9
   Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Franzolin E, 2012, EXP CELL RES, V318, P2226, DOI 10.1016/j.yexcr.2012.05.028
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Gasteiger E, 2005, THE PROTEOMICS PROTOCOLS HANDBOOK, V0, PP571, DOI 10.1385/1592598900
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Håkansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Johnson MA, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0093597
   Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200
   Lee EW, 2006, J BIOL CHEM, V281, P16700, DOI 10.1074/jbc.M513825200
   Li JX, 2006, J MOL BIOL, V355, P980, DOI 10.1016/j.jmb.2005.11.047
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Moss CF, 2017, NUCLEIC ACIDS RES, V45, P0, DOI 10.1093/nar/gkx1009
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Oláhová M, 2017, J INHERIT METAB DIS, V40, P121, DOI 10.1007/s10545-016-9977-2
   Oliveira R, 2017, JIMD REP, V33, P61, DOI 10.1007/8904_2016_581
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Rosenberg MM, 2016, J BIOL CHEM, V291, P22988, DOI 10.1074/jbc.M116.739516
   Sommerville Ewen W, 2014, J NEUROMUSCUL DIS, V1, P119
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   SPECTOR T, 1979, J BIOL CHEM, V254, P2308
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 46
TC 7
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9163
EI 1399-0004
J9 CLIN GENET
JI Clin. Genet.
PD FEB 15
PY 2020
VL 97
IS 2
BP 276
EP 286
DI 10.1111/cge.13652
EA NOV 2019
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA KE5QB
UT WOS:000496413600001
PM 31600844
DA 2024-11-01
ER

PT J
AU Lombardi, M
   Lazzeroni, D
   Pisano, A
   Girolami, F
   Alfieri, O
   La Canna, G
   d'Amati, G
   Olivotto, I
   Rimoldi, OE
   Foglieni, C
   Camici, PG
AF Lombardi, Maria
   Lazzeroni, Davide
   Pisano, Annalinda
   Girolami, Francesca
   Alfieri, Ottavio
   La Canna, Giovanni
   d'Amati, Giulia
   Olivotto, Iacopo
   Rimoldi, Ornella E.
   Foglieni, Chiara
   Camici, Paolo G.
TI Mitochondrial Energetics and Ca<SUP>2+</SUP>-Activated ATPase in Obstructive Hypertrophic Cardiomyopathy
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE obstructive hypertrophic cardiomyopathy (HCM); mitochondrial energetics; mitochondrial Complex I (NADH dehydrogenase); mitochondrial Complex V (ATP synthase); reactive oxygen species (ROS) scavenger enzymes; Ca2+-activated ATPase
ID oxidative stress; antioxidative enzymes; phosphate metabolites; systolic dysfunction; skeletal-muscle; myosin atpase; human heart; guidelines; reticulum; aconitase
AB Hypertrophic cardiomyopathy (HCM) is the most common genetic disease of the myocardium associated to mutations in sarcomeric genes, but the link between genotype and phenotype remains poorly understood. Magnetic resonance spectroscopy studies have demonstrated impaired cardiac energetics in patients with HCM, and altered mitochondria were described in biopsies, but little is known about possible perturbations of mitochondrial function and adenosine triphosphate (ATP) production/consumption. The aim of this study was to investigate possible abnormalities in mitochondrial enzymes generating/scavenging reactive oxygen species, and changes in the Ca2+-activated ATPases in myocardial tissue from patients with obstructive HCM undergoing surgical myectomy compared to unused donor hearts (CTRL). Methods and Results: Both the amount and activity of mitochondrial Complex I (nicotinamide adenine dinucleotide -reduced form, NADH, dehydrogenase) were upregulated in HCM vs. CTRL, whilst the activity of Complex V (ATP synthase) was not reduced and ATP levels were significantly higher in HCM vs. CTRL. Antioxidant Mn-activated superoxide dismutase (SOD2) and (m)-aconitase activities were increased in HCM vs. CTRL. The Cu/Zn-activated superoxide dismutase (SOD1) amount and mtDNA copy number were unaltered in HCM. Total Ca2+-activated ATPase activity and absolute amount were not different HCM vs. CTRL, but the ratio between ATPase sarcoplasmic/endoplasmic reticulum Ca(2+)transporting type 2 (ATP2A2) and type 1 (ATP2A1), ATP2A2/ATP2A1, was increased in HCM in favor of the slow isoform (ATP2A2). Conclusion: HCM is characterized by mitochondrial Complex I hyperactivity and preserved Ca2+-activated ATPase activity with a partial switch towards slow ATP2A2. This data may give insight into the abnormal cellular energetics observed in HCM cardiomyopathy but other studies would need to be performed to confirm the observations described here.
C1 [Lombardi, Maria; Lazzeroni, Davide; Foglieni, Chiara; Camici, Paolo G.] IRCCS San Raffaele Sci Inst, Cardiovasc Res Ctr, I-20132 Milan, Italy.
   [Pisano, Annalinda; d'Amati, Giulia] Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, I-00161 Rome, Italy.
   [Pisano, Annalinda; d'Amati, Giulia] Policlin Umberto 1, I-00161 Rome, Italy.
   [Girolami, Francesca] Meyer Childrens Hosp, Cardiol Unit, I-50139 Florence, Italy.
   [Alfieri, Ottavio] IRCCS San Raffaele Sci Inst, Cardiac Surg Unit, I-20132 Milan, Italy.
   [La Canna, Giovanni] Humanitas Clin & Res Hosp, Cardiovasc Dept, Appl Diagnost Echocardiog Unit, I-20089 Rozzano Milan, Italy.
   [Olivotto, Iacopo] Careggi Univ Hosp, Cardiomyopathy Unit, I-50139 Florence, Italy.
   [Rimoldi, Ornella E.] Natl Res Council IBFM CNR, Inst Mol Bioimaging & Physiol, I-20090 Segrate, Italy.
   [Camici, Paolo G.] Univ Vita Salute San Raffaele, Fac Med & Surg, I-20132 Milan, Italy.
C3 Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sapienza University Rome; Sapienza University Rome; University Hospital Sapienza Rome; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Florence; Azienda Ospedaliero Universitaria Careggi; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Vita-Salute San Raffaele University
RP Foglieni, C (corresponding author), IRCCS San Raffaele Sci Inst, Cardiovasc Res Ctr, I-20132 Milan, Italy.
EM lombardi.maria@hsr.it; lazzeroni.davide@hsr.it; annalinda.pisano@uniroma1.it; girolami.fra@gmail.com; alfieri.ottavio@hsr.it; lacannagiovanni.cardio@gmail.com; giulia.damati@uniroma1.it; rimoldi.ornella@hsr.it; foglieni.chiara@hsr.it; camici.paolo@hsr.it
FU Italian Ministry of Health [NET-2011-02347173]
CR Abraham MR, 2013, AM J CARDIOL, V112, P861, DOI 10.1016/j.amjcard.2013.05.017
   Agbulut O, 1996, BIOL CELL, V88, P131, DOI 10.1016/S0248-4900(97)83528-9
   Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7
   Bäumer AT, 2000, J MOL CELL CARDIOL, V32, P121, DOI 10.1006/jmcc.1999.1061
   Beer M, 2002, J AM COLL CARDIOL, V40, P1267, DOI 10.1016/S0735-1097(02)02160-5
   Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559
   Christiansen LB, 2015, AM J PHYSIOL-HEART C, V308, PH1237, DOI 10.1152/ajpheart.00727.2014
   Coppini R, 2013, CIRCULATION, V127, P575, DOI 10.1161/CIRCULATIONAHA.112.134932
   Crilley JG, 2003, J AM COLL CARDIOL, V41, P1776, DOI 10.1016/S0735-1097(02)03009-7
   Dass S, 2015, EUR HEART J, V36, P1547, DOI 10.1093/eurheartj/ehv120
   del Monte F, 2004, P NATL ACAD SCI USA, V101, P5622, DOI 10.1073/pnas.0305778101
   Dieterich S, 2000, CIRCULATION, V101, P33, DOI 10.1161/01.CIR.101.1.33
   Eisner V, 2013, J CELL SCI, V126, P2965, DOI 10.1242/jcs.093609
   Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284
   Foglieni C, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-77
   Hayashi T, 2020, KEIJO J MED, V69, P77, DOI 10.2302/kjm.2019-0012-OA
   Ho CY, 2015, CARDIOVASC RES, V105, P397, DOI 10.1093/cvr/cvv025
   Hughes SE, 2004, HISTOPATHOLOGY, V44, P412, DOI 10.1111/j.1365-2559.2004.01835.x
   Jung WI, 1998, CIRCULATION, V97, P2536, DOI 10.1161/01.CIR.97.25.2536
   Kaasik A, 2001, CIRC RES, V89, P153, DOI 10.1161/hh1401.093440
   KATZ AM, 1966, CIRC RES, V19, P611, DOI 10.1161/01.RES.19.3.611
   KATZ LA, 1989, AM J PHYSIOL, V256, PH265, DOI 10.1152/ajpheart.1989.256.1.H265
   KHAN MA, 1974, HISTOCHEMISTRY, V38, P181, DOI 10.1007/BF00499665
   Caldas FRL, 2015, J CARDIOVASC PHARM, V65, P393, DOI 10.1097/FJC.0000000000000210
   Li Q, 2017, AM J HUM GENET, V100, P267, DOI 10.1016/j.ajhg.2017.01.004
   Lipskaia L, 2010, EXPERT OPIN BIOL TH, V10, P29, DOI 10.1517/14712590903321462
   Lombardi M, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-05137-y
   Lu TM, 2014, J BIOMED SCI, V21, P0, DOI 10.1186/1423-0127-21-57
   Lucas DT, 2003, AM J PHYSIOL-HEART C, V284, PH575, DOI 10.1152/ajpheart.00619.2002
   Marian AJ, 2017, CIRC RES, V121, P749, DOI 10.1161/CIRCRESAHA.117.311059
   Maron BJ, 2018, JACC-HEART FAIL, V6, P353, DOI 10.1016/j.jchf.2017.09.011
   Maron MS, 2006, CIRCULATION, V114, P2232, DOI 10.1161/CIRCULATIONAHA.106.644682
   MORKIN E, 1977, FEBS LETT, V79, P357, DOI 10.1016/0014-5793(77)80820-X
   Nakamura K, 2005, J CARD FAIL, V11, P117, DOI 10.1016/j.cardfail.2004.05.005
   Ormerod JOM, 2016, NAT REV CARDIOL, V13, P677, DOI 10.1038/nrcardio.2016.98
   Pisano A, 2016, CARDIOVASC PATHOL, V25, P103, DOI 10.1016/j.carpath.2015.09.009
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Saha B, 2017, P 65 CARD SOC AUSTR, V0, PS104
   Sam F, 2005, J CARD FAIL, V11, P473, DOI 10.1016/j.cardfail.2005.01.007
   Sharov VG, 2000, J MOL CELL CARDIOL, V32, P2361, DOI 10.1006/jmcc.2000.1266
   Sheeran FL, 2016, AM J PHYSIOL-ENDOC M, V311, PE449, DOI 10.1152/ajpendo.00127.2016
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   TAUSSKY HH, 1953, J BIOL CHEM, V202, P675
   Timmer SAJ, 2013, EUR HEART J-CARD IMG, V14, P95, DOI 10.1093/ehjci/jes242
   Unno K, 2009, EUR HEART J, V30, P1853, DOI 10.1093/eurheartj/ehp184
   Vakrou S, 2018, JCI INSIGHT, V3, P0, DOI 10.1172/jci.insight.94493
   Vakrou S, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00309
   van der Velden J, 2018, CARDIOVASC RES, V114, P1273, DOI 10.1093/cvr/cvy147
   Vásquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064
   Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923
   WEISBERG A, 1982, CIRC RES, V51, P802, DOI 10.1161/01.RES.51.6.802
   Whiffin N, 2018, GENET MED, V20, P1246, DOI 10.1038/gim.2017.258
   Wilder T, 2015, AM J PHYSIOL-HEART C, V309, PH1720, DOI 10.1152/ajpheart.00339.2015
   Williams B, 2018, J HYPERTENS, V36, P2284, DOI 10.1097/HJH.0000000000001961
NR 56
TC 6
Z9 6
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD JUN 15
PY 2020
VL 9
IS 6
BP 
EP 
DI 10.3390/jcm9061799
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA ML2RJ
UT WOS:000549319300001
PM 32527005
DA 2024-11-01
ER

PT J
AU Cho, HY
   Kleeberger, SR
AF Cho, Hye-Youn
   Kleeberger, Steven R.
TI Mitochondrial biology in airway pathogenesis and the role of NRF2
SO ARCHIVES OF PHARMACAL RESEARCH
LA English
DT Review
DE NRF2; Mitochondria; Lung; Antioxidant response element; Metabolism; Sulforaphane
ID obstructive pulmonary-disease; transcription factor nrf2; factor e2-related factor-2; positive feedback loop; oxidative stress; lung injury; antioxidant response; epithelial-cells; gene-expression; hepatocellular-carcinoma
AB A constant improvement in understanding of mitochondrial biology has provided new insights into mitochondrial dysfunction in human disease pathogenesis. Impaired mitochondrial dynamics caused by various stressors are characterized by structural abnormalities and leakage, compromised turnover, and reactive oxygen species overproduction in mitochondria as well as increased mitochondrial DNA mutation frequency, which leads to modified energy production and mitochondria-derived cell signaling. The mitochondrial dysfunction in airway epithelial, smooth muscle, and endothelial cells has been implicated in diseases including chronic obstructive lung diseases and acute lung injury. Increasing evidence indicates that the NRF2-antioxidant response element (ARE) pathway not only enhances redox defense but also facilitates mitochondrial homeostasis and bioenergetics. Identification of functional or potential AREs further supports the role for Nrf2 in mitochondrial dysfunction-associated airway disorders. While clinical reports indicate mixed efficacy, NRF2 agonists acting on respiratory mitochondrial dynamics are potentially beneficial. In lung cancer, growth advantage provided by sustained NRF2 activation is suggested to be through increased cellular antioxidant defense as well as mitochondria reinforcement and metabolic reprogramming to the preferred pathways to meet the increased energy demands of uncontrolled cell proliferation. Further studies are warranted to better understand NRF2 regulation of mitochondrial functions as therapeutic targets in airway disorders.
C1 [Cho, Hye-Youn; Kleeberger, Steven R.] NIEHS, Immun Inflammat & Dis Lab, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Cho, HY (corresponding author), NIEHS, Immun Inflammat & Dis Lab, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.
EM cho2@niehs.nih.gov
FU Intramural NIH HHS [Z01 ES100513] Funding Source: Medline
CR Abdullah A, 2012, PHARMACOL REP, V64, P680, DOI 10.1016/S1734-1140(12)70863-0
   Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006
   Afolayan AJ, 2012, AM J PHYSIOL-LUNG C, V303, PL870, DOI 10.1152/ajplung.00098.2012
   Alexeyev M, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012641
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Ariga H, 2015, BIOL PHARM BULL, V38, P795, DOI 10.1248/bpb.b15-00125
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Athale J, 2012, FREE RADICAL BIO MED, V53, P1584, DOI 10.1016/j.freeradbiomed.2012.08.009
   Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662
   Banoth B, 2018, TRANSL RES, V202, P52, DOI 10.1016/j.trsl.2018.07.014
   Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703
   Berkelhamer SK, 2013, FREE RADICAL BIO MED, V61, P51, DOI 10.1016/j.freeradbiomed.2013.03.003
   Bernard K, 2017, J BIOL CHEM, V292, P3029, DOI 10.1074/jbc.M116.752261
   Bertrand HC, 2015, J MED CHEM, V58, P7186, DOI 10.1021/acs.jmedchem.5b00602
   Bewley MA, 2017, AM J RESP CRIT CARE, V196, P845, DOI 10.1164/rccm.201608-1714OC
   Boelens MC, 2011, LUNG CANCER, V72, P177, DOI 10.1016/j.lungcan.2010.08.014
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942
   Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101
   Canet-Avilés RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Carraway MS, 2008, ANTIOXID REDOX SIGN, V10, P269, DOI 10.1089/ars.2007.1910
   Chalker J, 2018, REDOX BIOL, V15, P216, DOI 10.1016/j.redox.2017.12.006
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chang AL, 2015, FREE RADICAL BIO MED, V78, P179, DOI 10.1016/j.freeradbiomed.2014.10.582
   Chartoumpekis DV, 2015, BIOCHEM SOC T, V43, P639, DOI 10.1042/BST20150049
   Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112
   Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107
   Cho HY, 2004, FASEB J, V18, P1258, DOI 10.1096/fj.03-1127fje
   Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013
   Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501
   Cho HY, 2019, TOXICOL APPL PHARM, V364, P29, DOI 10.1016/j.taap.2018.12.004
   Cho HY, 2015, ARCH TOXICOL, V89, P1931, DOI 10.1007/s00204-015-1557-y
   Cho HY, 2015, FREE RADICAL BIO MED, V88, P362, DOI 10.1016/j.freeradbiomed.2015.06.012
   Cho HY, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/286524
   Cho HY, 2012, ANTIOXID REDOX SIGN, V17, P1066, DOI 10.1089/ars.2011.4288
   Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC
   Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409
   Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103
   Cloonan SM, 2016, NAT MED, V22, P163, DOI 10.1038/nm.4021
   Conti V, 2015, ANAL CELL PATHOL, V2015, P1, DOI 10.1155/2015/897327
   Das KC, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0073358
   Dasgupta S, 2012, J CELL PHYSIOL, V227, P2451, DOI 10.1002/jcp.22980
   de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490
   Delmotte P, 2015, CAN J PHYSIOL PHARM, V93, P97, DOI 10.1139/cjpp-2014-0361
   Demeo DL, 2009, AM J HUM GENET, V85, P493, DOI 10.1016/j.ajhg.2009.09.004
   Denzer I, 2016, PHARMACOL RES, V103, P80, DOI 10.1016/j.phrs.2015.11.019
   Ding CM, 2012, EXP THER MED, V3, P861, DOI 10.3892/etm.2012.490
   Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036
   Dittrich AM, 2010, EUR RESPIR J, V35, P1148, DOI 10.1183/09031936.00026108
   Egner PA, 2014, CANCER PREV RES, V7, P813, DOI 10.1158/1940-6207.CAPR-14-0103
   Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367
   Fang HY, 2012, HUM PATHOL, V43, P105, DOI 10.1016/j.humpath.2011.04.012
   Gamet-Payrastre L, 2000, CANCER RES, V60, P1426
   Gebb SA, 2013, NEONATOLOGY, V103, P91, DOI 10.1159/000342632
   Hancock DB, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003098
   Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002
   Heo JY, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032629
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Holmström KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853
   Hota KB, 2012, HIPPOCAMPUS, V22, P723, DOI 10.1002/hipo.20934
   Huang KP, 2017, EXP CELL RES, V361, P63, DOI 10.1016/j.yexcr.2017.09.042
   Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617
   Im JY, 2012, HUM MOL GENET, V21, P3013, DOI 10.1093/hmg/dds131
   Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419
   Ivankovic D, 2016, J NEUROCHEM, V136, P388, DOI 10.1111/jnc.13412
   Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976
   Jiang ZQ, 2017, AM J RESP CELL MOL, V56, P738, DOI 10.1165/rcmb.2016-0282OC
   Johri A, 2013, FREE RADICAL BIO MED, V62, P37, DOI 10.1016/j.freeradbiomed.2013.04.016
   Jung KA, 2017, ANTIOXID REDOX SIGN, V27, P945, DOI 10.1089/ars.2016.6797
   Kageyama S, 2018, MOL CELL BIOL, V38, P0, DOI 10.1128/MCB.00642-17
   Kay HY, 2011, ANTIOXID REDOX SIGN, V15, P2135, DOI 10.1089/ars.2010.3834
   Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339
   Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246
   Kobayashi K, 2016, J IMMUNOL, V197, P504, DOI 10.4049/jimmunol.1600265
   Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020
   Kovac S, 2015, BBA-GEN SUBJECTS, V1850, P794, DOI 10.1016/j.bbagen.2014.11.021
   Krebiehl G, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0009367
   Kulkarni SR, 2014, ANTIOXID REDOX SIGN, V20, P15, DOI 10.1089/ars.2012.5082
   Kulkarni SR, 2013, PHARM RES-DORDR, V30, P2221, DOI 10.1007/s11095-013-1138-9
   Kung CT, 2012, J TRANSL MED, V10, P0, DOI 10.1186/1479-5876-10-130
   Kwon HS, 2012, LIFE SCI, V90, P502, DOI 10.1016/j.lfs.2012.01.003
   Lam HC, 2013, J CLIN INVEST, V123, P5212, DOI 10.1172/JCI69636
   Lazarowski ER, 2009, CURR OPIN PHARMACOL, V9, P262, DOI 10.1016/j.coph.2009.02.004
   Leclercq B, 2018, ENVIRON POLLUT, V243, P1434, DOI 10.1016/j.envpol.2018.09.062
   Li X, 2018, J ALLERGY CLIN IMMUN, V141, P1634, DOI 10.1016/j.jaci.2017.08.017
   Lin K, 2017, CELL DEATH DISCOV, V3, P0, DOI 10.1038/cddiscovery.2017.25
   Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014
   Ludtmann MHR, 2014, BIOCHEM J, V457, P415, DOI 10.1042/BJ20130863
   MacGarvey NC, 2012, AM J RESP CRIT CARE, V185, P851, DOI 10.1164/rccm.201106-1152OC
   Mailloux RJ, 2014, FRONT CELL DEV BIOL, V2, P0, DOI 10.3389/fcell.2014.00068
   Mailloux RJ, 2014, J BIOL CHEM, V289, P14812, DOI 10.1074/jbc.M114.550574
   Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515
   Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com
   Merry TL, 2016, J PHYSIOL-LONDON, V594, P5195, DOI 10.1113/JP271957
   Michaeloudes C, 2011, AM J RESP CRIT CARE, V184, P894, DOI 10.1164/rccm.201011-1780OC
   Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036
   Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016
   Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moorman Jeanne E, 2012, VITAL HEALTH STAT 3, V0, P1
   Murata H, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0142438
   Myzak MC, 2006, CANCER LETT, V233, P208, DOI 10.1016/j.canlet.2005.02.033
   Nakahira K, 2015, ANTIOXID REDOX SIGN, V23, P1329, DOI 10.1089/ars.2015.6407
   Nam HS, 2017, BIOMARK MED, V11, P475, DOI 10.2217/bmm-2016-0373
   Negrette-Guzmán M, 2013, FREE RADICAL BIO MED, V65, P1078, DOI 10.1016/j.freeradbiomed.2013.08.182
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Nishinaka T, 2005, J PHARMACOL SCI, V97, P43, DOI 10.1254/jphs.FP0040404
   OBrien M, 2017, FREE RADICAL BIO MED, V106, P302, DOI 10.1016/j.freeradbiomed.2017.02.046
   OMealey GB, 2017, J CELL SCI, V130, P3467, DOI 10.1242/jcs.203216
   Orsucci D, 2018, EBIOMEDICINE, V30, P3, DOI 10.1016/j.ebiom.2018.03.007
   Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107
   Park SH, 2018, FASEB J, V32, P5862, DOI 10.1096/fj.201800011R
   Patel AS, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0121246
   Peng H, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082739
   Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Pouwels SD, 2017, AM J PHYSIOL-LUNG C, V313, PL559, DOI 10.1152/ajplung.00466.2016
   Priya DKD, 2011, ASIAN PAC J CANCER P, V12, P103
   Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC
   Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538
   Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146
   Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091
   Ratner V, 2009, AM J RESP CELL MOL, V40, P511, DOI 10.1165/rcmb.2008-0341RC
   Ray NB, 2010, NAT MED, V16, P1120, DOI 10.1038/nm.2213
   Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543
   Remels AH, 2007, EUR RESPIR J, V30, P245, DOI 10.1183/09031936.00144106
   Ribas V, 2014, FRONT PHARMACOL, V5, P0, DOI 10.3389/fphar.2014.00151
   Rimessi A, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7201
   Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC
   Ryan JJ, 2013, AM J RESP CRIT CARE, V187, P865, DOI 10.1164/rccm.201209-1687OC
   Ryoo IG, 2018, TOXICOL APPL PHARM, V359, P24, DOI 10.1016/j.taap.2018.09.014
   Ryter SW, 2018, ANN AM THORAC SOC, V15, PS266, DOI 10.1513/AnnalsATS.201808-585MG
   Ryu CW, 2017, AM J RESP CRIT CARE, V196, P1571, DOI 10.1164/rccm.201612-2480OC
   Sabouny R, 2017, ANTIOXID REDOX SIGN, V27, P1447, DOI 10.1089/ars.2016.6855
   Saito T, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms12030
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Schumacker PT, 2014, AM J PHYSIOL-LUNG C, V306, PL962, DOI 10.1152/ajplung.00073.2014
   Selman M, 2010, SEMIN RESP CRIT CARE, V31, P607, DOI 10.1055/s-0030-1265901
   Simmons JD, 2013, ANN SURG, V258, P591, DOI 10.1097/SLA.0b013e3182a4ea46
   Soundararajan R, 2016, AGING-US, V8, P2232, DOI 10.18632/aging.101056
   Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, P0, DOI 10.1186/gb-2012-13-8-418
   Strom J, 2016, FASEB J, V30, P66, DOI 10.1096/fj.14-268904
   Suliman HB, 2017, AM J PHYSIOL-LUNG C, V313, PL699, DOI 10.1152/ajplung.00197.2017
   Sureshbabu A, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00384
   Sutcliffe A, 2012, AM J RESP CRIT CARE, V185, P267, DOI 10.1164/rccm.201107-1281OC
   Sutendra G, 2014, CELL METAB, V19, P558, DOI 10.1016/j.cmet.2014.01.004
   Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x
   Talati M, 2015, PULM CIRC, V5, P269, DOI 10.1086/681227
   Tan XL, 2009, CANCER DETECT PREV, V32, P403, DOI 10.1016/j.cdp.2009.02.004
   Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102
   Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430
   Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849
   Traver G, 2017, FREE RADICAL BIO MED, V112, P578, DOI 10.1016/j.freeradbiomed.2017.08.026
   Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956
   Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13
   Vénéreau E, 2015, FRONT IMMUNOL, V6, P0, DOI 10.3389/fimmu.2015.00422
   Vollrath V, 2006, BIOCHEM J, V395, P599, DOI 10.1042/BJ20051518
   Wang AS, 2017, FOOD FUNCT, V8, P4555, DOI 10.1039/c7fo00969k
   Wang JJ, 2017, J CHROMATOGR B, V1053, P16, DOI 10.1016/j.jchromb.2017.04.013
   Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066
   WARBURG O, 1956, SCIENCE, V124, P269
   Wise RA, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0163716
   Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104
   Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132
   Young A, 2019, CHEM-BIOL INTERACT, V299, P151, DOI 10.1016/j.cbi.2018.12.003
   Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992
   Yue P, 2018, TALANTA, V178, P24, DOI 10.1016/j.talanta.2017.08.085
   Yun JH, 2017, AM J RESP CELL MOL, V57, P47, DOI 10.1165/rcmb.2016-0328OC
   Zhang ZL, 2015, AM J RESP CELL MOL, V52, P387, DOI 10.1165/rcmb.2014-0263OC
   Zhao C, 2018, J PHYSIOL PHARMACOL, V69, P0, DOI 10.26402/jpp.2018.2.01
   Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200
NR 175
TC 23
Z9 24
U1 0
U2 11
PU PHARMACEUTICAL SOC KOREA
PI SEOUL
PA 1489-3 SUHCHO-DONG, SUHCHO-KU, SEOUL 137-071, SOUTH KOREA
SN 0253-6269
EI 1976-3786
J9 ARCH PHARM RES
JI Arch. Pharm. Res.
PD MAR 15
PY 2020
VL 43
IS 3
BP 297
EP 320
DI 10.1007/s12272-019-01182-5
PG 24
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KX2VV
UT WOS:000521740600003
PM 31486024
DA 2024-11-01
ER

PT J
AU Montano, V
   Gruosso, F
   Carelli, V
   Comi, GP
   Filosto, M
   Lamperti, C
   Mongini, T
   Musumeci, O
   Servidei, S
   Tonin, P
   Toscano, A
   Modenese, A
   Primiano, G
   Valentino, ML
   Bortolani, S
   Marchet, S
   Meneri, M
   Tavilla, G
   Siciliano, G
   Mancuso, M
AF Montano, Vincenzo
   Gruosso, Francesco
   Carelli, Valerio
   Comi, Giacomo Pietro
   Filosto, Massimiliano
   Lamperti, Costanza
   Mongini, Tiziana
   Musumeci, Olimpia
   Servidei, Serenella
   Tonin, Paola
   Toscano, Antonio
   Modenese, Angela
   Primiano, Guido
   Valentino, Maria Lucia
   Bortolani, Sara
   Marchet, Silvia
   Meneri, Megi
   Tavilla, Graziana
   Siciliano, Gabriele
   Mancuso, Michelangelo
TI Primary mitochondrial myopathy: Clinical features and outcome measures in 118 cases from Italy
SO NEUROLOGY-GENETICS
LA English
DT Article
AB Objective To determine whether a set of functional tests, clinical scales, patient-reported questionnaires, and specific biomarkers can be considered reliable outcome measures in patients with primary mitochondrial myopathy (PMM), we analyzed a cohort of Italian patients. Methods Baseline data were collected from 118 patients with PMM, followed by centers of the Italian network for mitochondrial diseases. We used the 6-Minute Walk Test (6MWT), Timed Up-and-Go Test (x3) (3TUG), Five-Times Sit-To-Stand Test (5XSST), Timed Water Swallow Test (TWST), and Test of Masticating and Swallowing Solids (TOMASS) as functional outcome measures; the Fatigue Severity Scale and West Haven-Yale Multidimensional Pain Inventory as patient-reported outcome measures; and FGF21, GDF15, lactate, and creatine kinase (CK) as biomarkers. Results A total of 118 PMM cases were included. Functional outcome measures (6MWT, 3TUG, 5XSST, TWST, and TOMASS) and biomarkers significantly differed from healthy reference values and controls. Moreover, functional measures correlated with patients' perceived fatigue and pain severity. Patients with either mitochondrial or nuclear DNA point mutations performed worse in functional measures than patients harboring single deletion, even if the latter had an earlier age at onset but similar disease duration. Both the biomarkers FGF21 and GDF15 were significantly higher in the patients compared with a matched control population; however, there was no relation with severity of disease. Conclusions We characterized a large cohort of PMM by evaluating baseline mitochondrial biomarkers and functional scales that represent potential outcome measures to monitor the efficacy of treatment in clinical trials; these outcome measures will be further reinvestigated longitudinally to define the natural history of PMM.
C1 [Montano, Vincenzo; Gruosso, Francesco; Meneri, Megi; Siciliano, Gabriele] Univ Pisa, Neurol Clin, Dept Clin & Expt Med, Pisa, Italy.
   [Carelli, Valerio; Valentino, Maria Lucia] IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, Bologna, Italy.
   [Carelli, Valerio; Valentino, Maria Lucia] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Bologna, Italy.
   [Comi, Giacomo Pietro] Univ Milan, Dept Pathophysiol & Transplantat DEPT, Dino Ferrari Ctr, Milan, Italy.
   [Comi, Giacomo Pietro; Mancuso, Michelangelo] ASST Spedali Civili, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuromuscular & Rare Dis Unit, Brescia, Italy.
   [Filosto, Massimiliano] ASST Spedali Civili, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Unit Neurol, Brescia, Italy.
   [Filosto, Massimiliano] Univ Brescia, Brescia, Italy.
   [Lamperti, Costanza; Marchet, Silvia] Fdn IRCCS Ist Neurol C Besta, UO Med Genet & Neurogenet, Milan, Italy.
   [Mongini, Tiziana; Bortolani, Sara] Univ Torino, Dept Neurosci, Neuromuscular Unit, Turin, Italy.
   [Musumeci, Olimpia; Toscano, Antonio; Tavilla, Graziana] Univ Messina, UOC Neurol & Malattie Neuromuscolari, Dept Clin & Expt Med, Messina, Italy.
   [Servidei, Serenella; Primiano, Guido] Fdn Policlin Univ A Gemelli IRCCS, UOC Neurofisiopatol, Rome, Italy.
   [Servidei, Serenella; Primiano, Guido] Univ Cattolica Sacro Cuore, Dipartimento Univ Neurosci, Rome, Italy.
   [Tonin, Paola] Univ Verona, Sect Clin Neurol, Biomed & Movement Sci, Dept Neurosci, Verona, Italy.
   [Modenese, Angela] Univ Hosp Verona, Dept Neurosci, Neurorehabil Unit, Verona, Italy.
C3 University of Pisa; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Milan; Hospital Spedali Civili Brescia; IRCCS Ca Granda Ospedale Maggiore Policlinico; Hospital Spedali Civili Brescia; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Brescia; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Turin; University of Messina; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, Dept Clin & Expt Med, Pisa, Italy.
EM michelangelo.mancuso@unipi.it
FU Telethon Grant [GUP09004]; Telethon-MITOCON Grant [GSP16001]; GENOMIT;  [RF-2016-02361495]
CR Bohannon RW, 2006, PERCEPT MOTOR SKILL, V103, P215, DOI 10.2466/PMS.103.1.215-222
   Brewster LM, 2007, AM HEART J, V154, P655, DOI 10.1016/j.ahj.2007.06.008
   Chetta A, 2006, RESP MED, V100, P1573, DOI 10.1016/j.rmed.2006.01.001
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Harboe E, 2008, J NEUROL NEUROSUR PS, V79, P199, DOI 10.1136/jnnp.2007.120626
   Hedermann G, 2017, MITOCHONDRION, V32, P27, DOI 10.1016/j.mito.2016.11.007
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Huckabee ML, 2018, INT J LANG COMM DIS, V53, P144, DOI 10.1111/1460-6984.12332
   Karaa A, 2018, NEUROLOGY, V90, PE1212, DOI 10.1212/WNL.0000000000005255
   KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1
   Kyriakides T, 2010, EUR J NEUROL, V17, P767, DOI 10.1111/j.1468-1331.2010.03012.x
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Madsen KL, 2020, NEUROLOGY, V94, PE687, DOI 10.1212/WNL.0000000000008861
   Mancuso M, 2012, NEUROMUSCULAR DISORD, V22, PS226, DOI 10.1016/j.nmd.2012.10.012
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902
   Morovat A, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6080080
   NATHADWARAWALA KM, 1992, J NEUROL NEUROSUR PS, V55, P822, DOI 10.1136/jnnp.55.9.822
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126
   Sanders DB, 2018, MUSCLE NERVE, V57, P561, DOI 10.1002/mus.26052
   Sanders DB, 2018, MUSCLE NERVE, V57, P136, DOI 10.1002/mus.25700
   Smits BW, 2011, J NEUROL, V258, P2020, DOI 10.1007/s00415-011-6060-7
   Takeuchi Y, 2008, MUSCLE NERVE, V38, P964, DOI 10.1002/mus.21077
   van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859
   Vincent Katy, 2008, REV PAIN, V2, P20, DOI 10.1177/204946370800200206
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
NR 31
TC 7
Z9 7
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
EI 
J9 NEUROL-GENET
JI Neurol.-Genet.
PD DEC 15
PY 2020
VL 6
IS 6
BP 
EP 
DI 10.1212/NXG.0000000000000519
PG 10
WC Genetics & Heredity; Clinical Neurology
SC Genetics & Heredity; Neurosciences & Neurology
GA PS3GO
UT WOS:000607814300003
PM 33209982
DA 2024-11-01
ER

PT J
AU Compagnoni, GM
   Di Fonzo, A
   Corti, S
   Comi, GP
   Bresolin, N
   Masliah, E
AF Compagnoni, Giacomo Monzio
   Di Fonzo, Alessio
   Corti, Stefania
   Comi, Giacomo P.
   Bresolin, Nereo
   Masliah, Eliezer
TI The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Neurodegeneration; Mitochondria; Alzheimer's disease; Parkinson's disease; Pathogenesis
ID progressive external ophthalmoplegia; multiple system atrophy; dna-polymerase-gamma; amyloid precursor protein; cytochrome-c-oxidase; positron emission tomography; respiratory-chain activity; electron-transport chain; maternal family-history; complex-i deficiency
AB Although the pathogenesis of neurodegenerative diseases is still widely unclear, various mechanisms have been proposed and several pieces of evidence are supportive for an important role of mitochondrial dysfunction. The present review provides a comprehensive and up-to-date overview about the role of mitochondria in the two most common neurodegenerative disorders: Alzheimer's disease (AD) and Parkinson's disease (PD). Mitochondrial involvement in AD is supported by clinical features like reduced glucose and oxygen brain metabolism and by numerous microscopic and molecular findings, including altered mitochondrial morphology, impaired respiratory chain function, and altered mitochondrial DNA. Furthermore, amyloid pathology and mitochondrial dysfunction seem to be bi-directionally correlated. Mitochondria have an even more remarkable role in PD. Several hints show that respiratory chain activity, in particular complex I, is impaired in the disease. Mitochondrial DNA alterations, involving deletions, point mutations, depletion, and altered maintenance, have been described. Mutations in genes directly implicated in mitochondrial functioning (like Parkin and PINK1) are responsible for rare genetic forms of the disease. A close connection between alpha-synuclein accumulation and mitochondrial dysfunction has been observed. Finally, mitochondria are involved also in atypical parkinsonisms, in particular multiple system atrophy. The available knowledge is still not sufficient to clearly state whether mitochondrial dysfunction plays a primary role in the very initial stages of these diseases or is secondary to other phenomena. However, the presented data strongly support the hypothesis that whatever the initial cause of neurodegeneration is, mitochondrial impairment has a critical role in maintaining and fostering the neurodegenerative process.
C1 [Compagnoni, Giacomo Monzio; Di Fonzo, Alessio; Corti, Stefania; Comi, Giacomo P.; Bresolin, Nereo] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Milan, Italy.
   [Compagnoni, Giacomo Monzio] Univ Milano Bicocca, Sch Med & Surg, Dept Neurol, Monza, Italy.
   [Compagnoni, Giacomo Monzio] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Khurana Lab, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.
   [Compagnoni, Giacomo Monzio] Harvard Med Sch, Boston, MA 02115 USA.
   [Corti, Stefania; Comi, Giacomo P.; Bresolin, Nereo] Univ Milan, Dino Ferrari Ctr, Neurosci Sect, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Masliah, Eliezer] NIA, Div Neurosci, NIH, Bethesda, MD 20892 USA.
   [Masliah, Eliezer] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milano-Bicocca; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Milan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)
RP Compagnoni, GM (corresponding author), IRCCS Fdn Ca Granda Osped Maggiore Policlin, Milan, Italy.; Compagnoni, GM (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Dept Neurol, Monza, Italy.; Compagnoni, GM (corresponding author), Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Khurana Lab, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.; Compagnoni, GM (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.
EM gmonziocompagnoni@bwh.harvard.edu
FU Fresco Institute for Parkinson's and Movement Disorders; National Institute on Aging [ZIAAG000936] Funding Source: NIH RePORTER
CR Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Baloyannis SJ, 2006, J ALZHEIMERS DIS, V9, P119
   Banerjee K, 2010, FEBS LETT, V584, P1571, DOI 10.1016/j.febslet.2010.03.012
   Barca E, 2016, J NEUROPATH EXP NEUR, V75, P663, DOI 10.1093/jnen/nlw037
   Beal MF, 2014, JAMA NEUROL, V71, P543, DOI 10.1001/jamaneurol.2014.131
   Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550
   Beck JS, 2016, CURR ALZHEIMER RES, V13, P610, DOI 10.2174/1567205013666151221145445
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0062277
   Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004
   Bentley SR, 2014, MITOCHONDRION, V15, P65, DOI 10.1016/j.mito.2014.01.004
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546
   Canevari L, 1999, FEBS LETT, V457, P131, DOI 10.1016/S0014-5793(99)01028-5
   Cannon JR, 2013, EXP NEUROL, V240, P44, DOI 10.1016/j.expneurol.2012.11.007
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2
   Cardoso SM, 2001, FASEB J, V15, P1439, DOI 10.1096/fj.00-0561fje
   Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje
   Cenini G, 2019, FRONT PHARMACOL, V10, P0, DOI 10.3389/fphar.2019.00902
   Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K
   Champy P, 2004, J NEUROCHEM, V88, P63, DOI 10.1046/j.1471-4159.2003.02138.x
   Chang SW, 2000, BIOCHEM BIOPH RES CO, V273, P203, DOI 10.1006/bbrc.2000.2885
   Charan RA, 2015, MOL CELL NEUROSCI, V66, P62, DOI 10.1016/j.mcn.2015.02.008
   Chen JX, 2010, J ALZHEIMERS DIS, V20, PS569, DOI 10.3233/JAD-2010-100357
   Cheng Y, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00163
   Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061
   Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Collier TJ, 2011, NAT REV NEUROSCI, V12, P359, DOI 10.1038/nrn3039
   Compagnoni GM, 2019, ACTA NEUROPATHOL COM, V7, P0, DOI 10.1186/s40478-019-0730-6
   Compagnoni GM, 2018, STEM CELL REP, V11, P1185, DOI 10.1016/j.stemcr.2018.09.007
   Compagnoni GM, 2018, BBA-MOL BASIS DIS, V1864, P3588, DOI 10.1016/j.bbadis.2018.09.018
   Compta Y, 2018, PARKINSONISM RELAT D, V46, P16, DOI 10.1016/j.parkreldis.2017.10.010
   Cooper O, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003985
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coskun PE, 2010, J ALZHEIMERS DIS, V20, PS293, DOI 10.3233/JAD-2010-100351
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005
   Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599
   David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4
   DELEON MJ, 1983, AM J NEURORADIOL, V4, P568
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006
   Di Maio R, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aaf3634
   DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Dolhun R, 2013, BMC NEUROL, V13, P0, DOI 10.1186/1471-2377-13-92
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868
   Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777
   Eckert A, 2014, BBA-MOL BASIS DIS, V1842, P1258, DOI 10.1016/j.bbadis.2013.08.013
   Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Egensperger R, 1997, NEUROPATH APPL NEURO, V23, P315, DOI 10.1046/j.1365-2990.1997.4098040.x
   Elfawy HA, 2019, LIFE SCI, V218, P165, DOI 10.1016/j.lfs.2018.12.029
   Elson JL, 2006, HUM GENET, V119, P241, DOI 10.1007/s00439-005-0123-8
   Erkkinen MG, 2018, CSH PERSPECT BIOL, V10, P0, DOI 10.1101/cshperspect.a033118
   Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007
   Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9
   FERRIS SH, 1980, NEUROBIOL AGING, V1, P127, DOI 10.1016/0197-4580(80)90005-6
   Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102
   FOSTER NL, 1983, NEUROLOGY, V33, P961, DOI 10.1212/WNL.33.8.961
   Fountaine TM, 2007, J NEUROSCI RES, V85, P351, DOI 10.1002/jnr.21125
   FRACKOWIAK RSJ, 1981, BRAIN, V104, P753, DOI 10.1093/brain/104.4.753
   FRIEDLAND RP, 1983, J COMPUT ASSIST TOMO, V7, P590, DOI 10.1097/00004728-198308000-00003
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104
   FUKUYAMA H, 1994, J NUCL MED, V35, P1
   GABUZDA D, 1994, J BIOL CHEM, V269, P13623
   García-Lozano JR, 2002, EUR NEUROL, V48, P34, DOI 10.1159/000064955
   Gasparini L, 1997, NEUROSCI LETT, V231, P113, DOI 10.1016/S0304-3940(97)00536-3
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   GIBSON GE, 1988, ARCH NEUROL-CHICAGO, V45, P836, DOI 10.1001/archneur.1988.00520320022009
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Gu M, 1997, MOVEMENT DISORD, V12, P418, DOI 10.1002/mds.870120323
   Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014
   Guardia-Laguarta C, 2015, MOVEMENT DISORD, V30, P1026, DOI 10.1002/mds.26239
   Gui YX, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050086
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Hamblet NS, 1997, MUTAT RES-FUND MOL M, V379, P253, DOI 10.1016/S0027-5107(97)00158-9
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409
   HEIKKILA RE, 1984, SCIENCE, V224, P1451, DOI 10.1126/science.6610213
   Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001
   Höglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x
   Höglinger GU, 2003, J NEUROCHEM, V84, P491, DOI 10.1046/j.1471-4159.2003.01533.x
   Honea RA, 2010, NEUROLOGY, V74, P113, DOI 10.1212/WNL.0b013e3181c918cb
   Hudson G, 2012, NEUROLOGY, V78, P1038, DOI 10.1212/WNL.0b013e31824e8f1d
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Imaizumi Y, 2012, MOL BRAIN, V5, P0, DOI 10.1186/1756-6606-5-35
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Ishii K, 1996, J NUCL MED, V37, P1159
   JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173
   Jenner P, 2001, TRENDS NEUROSCI, V24, P245, DOI 10.1016/S0166-2236(00)01789-6
   Jeon BS, 2014, NEW ENGL J MED, V371, P80, DOI 10.1056/NEJMc1311763
   Jiang HB, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms1669
   Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223
   Kapsa RMI, 1996, J NEUROL SCI, V144, P204, DOI 10.1016/S0022-510X(96)00247-X
   Kasai T, 2016, PLOS ONE, V11, P1
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kerr JS, 2017, TRENDS NEUROSCI, V40, P151, DOI 10.1016/j.tins.2017.01.002
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khan SM, 2000, ANN NEUROL, V48, P148, DOI 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018
   Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   Kösel S, 2000, NEUROGENETICS, V2, P227
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   Krüger J, 2010, MOL NEURODEGENER, V5, P0, DOI 10.1186/1750-1326-5-8
   Krüger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukreja L, 2014, MOL NEURODEGENER, V9, P0, DOI 10.1186/1750-1326-9-16
   Lakatos A, 2010, NEUROBIOL AGING, V31, P1355, DOI 10.1016/j.neurobiolaging.2010.04.031
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406
   LESTIENNE P, 1990, J NEUROCHEM, V55, P1810, DOI 10.1111/j.1471-4159.1990.tb04973.x
   Li L, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0085815
   Li XC, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep24756
   Lin CH, 2015, MOVEMENT DISORD, V30, P436, DOI 10.1002/mds.26138
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056
   Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051
   Ludtmann MHR, 2016, J NEUROSCI, V36, P10510, DOI 10.1523/JNEUROSCI.1659-16.2016
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749
   Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774
   Mancuso M, 2007, NEUROL SCI, V28, P142, DOI 10.1007/s10072-007-0807-z
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Manczak M, 2012, HUM MOL GENET, V21, P2538, DOI 10.1093/hmg/dds072
   Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   MANN VM, 1994, ANN NEUROL, V36, P876, DOI 10.1002/ana.410360612
   MANN VM, 1992, FEBS LETT, V299, P218, DOI 10.1016/0014-5793(92)80118-Z
   Martin MA, 1996, NEUROLOGY, V46, P1343, DOI 10.1212/WNL.46.5.1343
   Martín-Maestro P, 2017, FRONT MOL NEUROSCI, V10, P0, DOI 10.3389/fnmol.2017.00291
   Maruszak A, 2009, NEUROBIOL AGING, V30, P1749, DOI 10.1016/j.neurobiolaging.2008.01.004
   Masters CL, 2015, NAT REV DIS PRIMERS, V1, P0, DOI 10.1038/nrdp.2015.56
   Mawrin C, 2004, NEUROSCI LETT, V357, P111, DOI 10.1016/j.neulet.2003.11.073
   Melberg A, 2005, ACTA NEUROPATHOL, V110, P315, DOI 10.1007/s00401-005-1047-z
   Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Mitsui J, 2016, JAMA NEUROL, V73, P977, DOI 10.1001/jamaneurol.2016.1325
   Mitsui J, 2013, NEW ENGL J MED, V369, P233, DOI 10.1056/NEJMoa1212115
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   Mosconi L, 2007, P NATL ACAD SCI USA, V104, P19067, DOI 10.1073/pnas.0705036104
   Mosconi L, 2010, P NATL ACAD SCI USA, V107, P5949, DOI 10.1073/pnas.0914141107
   Müftüoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   Nakamoto FK, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-32573-1
   Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538
   Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008
   NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8
   Nieto M, 2006, NEUROBIOL AGING, V27, P848, DOI 10.1016/j.neurobiolaging.2005.04.010
   Ogaki K, 2014, MOL NEURODEGENER, V9, P0, DOI 10.1186/1750-1326-9-44
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Ordonez DG, 2018, NEURON, V97, P108, DOI 10.1016/j.neuron.2017.11.036
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050
   Pagani MR, 2011, NEUROL RES INT, V2011, P0, DOI 10.1155/2011/497080
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   Pereira C, 1998, NEUROREPORT, V9, P1749, DOI 10.1097/00001756-199806010-00015
   PERRY EK, 1980, NEUROSCI LETT, V18, P105, DOI 10.1016/0304-3940(80)90220-7
   Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955
   Poewe W, 2017, NAT REV DIS PRIMERS, V3, P0, DOI 10.1038/nrdp.2017.13
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Porras G, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a009308
   Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010
   Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2011, BIOFACTORS, V37, P361, DOI 10.1002/biof.155
   Rango M, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9050250
   Rappold PM, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6244
   Reeve AK, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.166
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   Ridge PG, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0045134
   Ronchi D, 2016, NEUROBIOL AGING, V45, P0, DOI 10.1016/j.neurobiolaging.2016.05.022
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Santoro A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012037
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   SCHAPIRA AHV, 1990, MOVEMENT DISORD, V5, P294, DOI 10.1002/mds.870050406
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1
   Schon EA, 1998, NEUROLOGY, V51, P326, DOI 10.1212/WNL.51.1.326
   Schottlaender LV, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0149557
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741
   Shaltouki A, 2015, STEM CELL REP, V4, P847, DOI 10.1016/j.stemcr.2015.02.019
   Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005
   Sheehan JP, 1997, J NEUROSCI, V17, P4612
   Sherer TB, 2002, J NEUROSCI, V22, P7006
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Shokouhi S, 2014, J ALZHEIMERS DIS PAR, V4, P2, DOI 10.4172/2161-0460.1000143
   Silva DF, 2013, HUM MOL GENET, V22, P3931, DOI 10.1093/hmg/ddt247
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278
   Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X
   Song LK, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0131281
   SORBI S, 1983, ANN NEUROL, V13, P72, DOI 10.1002/ana.410130116
   Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Stefanova N, 2005, AM J PATHOL, V166, P869, DOI 10.1016/S0002-9440(10)62307-3
   Subramaniam SR, 2014, NEUROBIOL DIS, V70, P204, DOI 10.1016/j.nbd.2014.06.017
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Supnet C, 2010, J ALZHEIMERS DIS, V20, PS487, DOI 10.3233/JAD-2010-100306
   Suzuki S, 2017, BIOCHEM BIOPH RES CO, V483, P88, DOI 10.1016/j.bbrc.2016.12.188
   Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Swerdlow RH, 2018, J ALZHEIMERS DIS, V62, P1403, DOI 10.3233/JAD-170585
   Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, PS265, DOI 10.3233/JAD-2010-100339
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Szabados T, 2004, BEHAV BRAIN RES, V154, P31, DOI 10.1016/j.bbr.2004.01.016
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Tabata Y, 2018, STEM CELL REP, V11, P1171, DOI 10.1016/j.stemcr.2018.09.006
   Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515
   Tapias V, 2017, CELL MOL LIFE SCI, V74, P2851, DOI 10.1007/s00018-017-2541-x
   Theurey P, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9010022
   Thomas B, 2010, MOVEMENT DISORD, V25, PS155, DOI 10.1002/mds.22781
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Tohgi H, 1998, NEURORADIOLOGY, V40, P131, DOI 10.1007/s002340050553
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Ubhi K, 2011, TRENDS NEUROSCI, V34, P581, DOI 10.1016/j.tins.2011.08.003
   Ubhi K, 2009, J NEUROSCI RES, V87, P2728, DOI 10.1002/jnr.22089
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang J, 2016, GENES DIS, V3, P3, DOI 10.1016/j.gendis.2016.01.002
   Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208
   Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009
   Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-016-0404-6
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
   Wragg MA, 1995, NEUROSCI LETT, V201, P107, DOI 10.1016/0304-3940(95)12146-3
   Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105
   Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106
   Ye X, 2015, HUM MOL GENET, V24, P2938, DOI 10.1093/hmg/ddv056
   Ylönen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795
   Zhang L, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep18725
   Zhao QZ, 2016, NEUROL SCI, V37, P423, DOI 10.1007/s10072-015-2414-8
   Zharikov AD, 2015, J CLIN INVEST, V125, P2721, DOI 10.1172/JCI64502
NR 302
TC 194
Z9 206
U1 13
U2 73
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD JUL 15
PY 2020
VL 57
IS 7
BP 2959
EP 2980
DI 10.1007/s12035-020-01926-1
EA MAY 2020
PG 22
WC Neurosciences
SC Neurosciences & Neurology
GA MC7MN
UT WOS:000534844900001
PM 32445085
DA 2024-11-01
ER

PT J
AU Kazuhito, T
   Wei, FY
AF Kazuhito, Tomizawa
   Wei, Fan-Yan
TI Posttranscriptional modifications in mitochondria! tRNA and its implication in mitochondria! translation and disease
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Review
ID anticodon wobble nucleotide; transfer rnaleu(uur) gene; lactic-acidosis; hypertrophic cardiomyopathy; strokelike episodes; modification defect; mto1; mutations; myopathy; dna
AB A fundamental aspect of mitochondria is that they possess DNA and protein translation machinery. Mitochondrial DNA encodes 22 tRNAs that translate mitochondrial mRNAs to 13 polypeptides of respiratory complexes. Various chemical modifications have been identified in mitochondrial tRNAs via complex enzymatic processes. A growing body of evidence has demonstrated that these modifications are essential for translation by regulating tRNA stability, structure and mRNA binding, and can be dynamically regulated by the metabolic environment. Importantly, the hypomodification of mitochondrial tRNA due to pathogenic mutations in mitochondrial tRNA genes or nuclear genes encoding modifying enzymes can result in lifethreatening mitochondrial diseases in humans. Thus, the mitochondrial tRNA modification is a fundamental mechanism underlying the tight regulation of mitochondrial translation and is essential for life. In this review, we focus on recent findings on the physiological roles of 5-taurinomethyl modification (herein referred as taurine modification) in mitochondrial tRNAs. We summarize the findings in human patients and animal models with a deficiency of taurine modifications and provide pathogenic links to mitochondrial diseases. We anticipate that this review will help understand the complexity of mitochondrial biology and disease. [GRAPHICS] .
C1 [Kazuhito, Tomizawa; Wei, Fan-Yan] Kumamoto Univ, Fac Life Sci, Dept Mol Physiol, Chuo Ku, Honjo 1-1-1, Kumamoto, Kumamoto 8608556, Japan.
   [Wei, Fan-Yan] Tohoku Univ, Inst Dev Aging & Canc, Dept Mod Biol & Med, Aoba Ku, Seriyo Machi 4-1, Sendai, Miyagi 9808575, Japan.
C3 Kumamoto University; Tohoku University
RP Wei, FY (corresponding author), Seiryo Machi 4-1,Aoba Ku, Sendai, Miyagi 9808575, Japan.
EM fanyan.wei.d3@tohoku.ac.jp
CR Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363
   Abbott JA, 2014, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00158
   Agris Paul F, 2017, ENZYMES, V41, P1, DOI 10.1016/bs.enz.2017.03.005
   Alexeyev M, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012641
   [Anonymous], 2014, PRION, V0, P0
   Asano K, 2018, NUCLEIC ACIDS RES, V46, P1565, DOI 10.1093/nar/gky068
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bar-Yaacov D, 2016, PLOS BIOL, V14, P0, DOI 10.1371/journal.pbio.1002557
   Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393
   Becker L, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114918
   Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6
   Carter JM, 2019, NUCLEIC ACIDS RES, V47, PE113, DOI 10.1093/nar/gkz658
   Charif M, 2015, AM J MED GENET A, V167, P2366, DOI 10.1002/ajmg.a.37188
   Chen DN, 2019, NUCLEIC ACIDS RES, V47, P5341, DOI 10.1093/nar/gkz218
   Chujo T, 2012, RNA, V18, P2269, DOI 10.1261/rna.035600.112
   Clark WC, 2016, RNA, V22, P1771, DOI 10.1261/rna.056531.116
   Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945
   Fakruddin M, 2018, CELL REP, V22, P482, DOI 10.1016/j.celrep.2017.12.051
   FUKUHARA N, 1985, ANN NEUROL, V18, P368, DOI 10.1002/ana.410180323
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haag S, 2016, EMBO J, V35, P2104, DOI 10.15252/embj.201694885
   Hawkins PN, 2015, ANN MED, V47, P625, DOI 10.3109/07853890.2015.1068949
   Hino N, 2004, GENES CELLS, V9, P243, DOI 10.1111/j.1356-9597.2004.00718.x
   Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308
   Kawarada L, 2017, NUCLEIC ACIDS RES, V45, P7401, DOI 10.1093/nar/gkx354
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017
   Kurata Shinya, 2003, NUCLEIC ACIDS RES SUPPL, V0, P245
   Li XY, 2017, MOL CELL, V68, P993, DOI 10.1016/j.molcel.2017.10.019
   Liu FG, 2016, CELL, V167, P816, DOI 10.1016/j.cell.2016.09.038
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Marchand V, 2017, BIOMOLECULES, V7, P0, DOI 10.3390/biom7010013
   Martín MA, 2017, CLIN GENET, V91, P46, DOI 10.1111/cge.12815
   Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003
   Morscher RJ, 2018, NATURE, V554, P128, DOI 10.1038/nature25460
   Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762
   Nachtergaele S, 2017, RNA BIOL, V14, P156, DOI 10.1080/15476286.2016.1267096
   Navarro-González C, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1006921
   OByrne JJ, 2018, MOL GENET METAB, V123, P28, DOI 10.1016/j.ymgme.2017.11.003
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003
   Priesnitz C, 2018, GENE DEV, V32, P1285, DOI 10.1101/gad.316547.118
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Rikimaru M, 2012, INTERNAL MED, V51, P3351, DOI 10.2169/internalmedicine.51.7529
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Suzuki T, 2001, NUCLEIC ACIDS RES SUPPL, V0, P257
   Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390
   Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8
   Tani H, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-52372-6
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743
   Tuorto F, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201899777
   Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
   Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Yasukawa T, 2018, J BIOCHEM, V164, P183, DOI 10.1093/jb/mvy058
   YONEDA M, 1990, BIOCHEM INT, V21, P789
NR 66
TC 16
Z9 17
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0021-924X
EI 1756-2651
J9 J BIOCHEM
JI J. Biochem.
PD NOV 15
PY 2020
VL 168
IS 5
BP 435
EP 444
DI 10.1093/jb/mvaa098
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA OX2LA
UT WOS:000593401600001
PM 32818253
DA 2024-11-01
ER

PT J
AU Keshavan, N
   Abdenur, J
   Anderson, G
   Assouline, Z
   Barcia, G
   Bouhikbar, L
   Chakrapani, A
   Cleary, M
   Cohen, MC
   Feillet, F
   Fratter, C
   Hauser, N
   Jacques, T
   Lam, A
   McCullagh, H
   Phadke, R
   Rötig, A
   Sharrard, M
   Simon, M
   Smith, C
   Sommerville, EW
   Taylor, RW
   Yue, WW
   Rahman, S
AF Keshavan, Nandaki
   Abdenur, Jose
   Anderson, Glenn
   Assouline, Zahra
   Barcia, Giulia
   Bouhikbar, Lamia
   Chakrapani, Anupam
   Cleary, Maureen
   Cohen, Marta C.
   Feillet, Francois
   Fratter, Carl
   Hauser, Natalie
   Jacques, Tom
   Lam, Amanda
   McCullagh, Helen
   Phadke, Rahul
   Rotig, Agnes
   Sharrard, Mark
   Simon, Mariella
   Smith, Conrad
   Sommerville, Ewen W.
   Taylor, Robert W.
   Yue, Wyatt W.
   Rahman, Shamima
TI The natural history of infantile mitochondrial DNA depletion syndrome due to RRM2B deficiency
SO GENETICS IN MEDICINE
LA English
DT Article
DE mitochondrial disease; mtDNA depletion; ribonucleotide reductase; treatment; outcomes
ID mutations; mtdna; p53r2
AB Purpose Mitochondrial DNA (mtDNA) depletion syndrome (MDDS) encompasses a group of genetic disorders of mtDNA maintenance. Mutation of RRM2B is an uncommon cause of infantile-onset encephalomyopathic MDDS. Here we describe the natural history of this disease. Methods Multinational series of new genetically confirmed cases from six pediatric centers. Results Nine new cases of infantile-onset RRM2B deficiency, and 22 previously published cases comprised a total cohort of 31 patients. Infants presented at a mean of 1.95 months with truncal hypotonia, generalized weakness, and faltering growth. Seizures evolved in 39% at a mean of 3.1 months. Non-neurological manifestations included respiratory distress/failure (58%), renal tubulopathy (55%), sensorineural hearing loss (36%), gastrointestinal disturbance (32%), eye abnormalities (13%), and anemia (13%). Laboratory features included elevated lactate (blood, cerebrospinal fluid (CSF), urine, magnetic resonance (MR), spectroscopy), ragged-red and cytochrome c oxidase-deficient fibers, lipid myopathy, and multiple oxidative phosphorylation enzyme deficiencies in skeletal muscle. Eight new RRM2B variants were identified. Patients with biallelic truncating variants had the worst survival. Overall survival was 29% at 6 months and 16% at 1 year. Conclusions Infantile-onset MDDS due to RRM2B deficiency is a severe disorder with characteristic clinical features and extremely poor prognosis. Presently management is supportive as there is no effective treatment. Novel treatments are urgently needed.
C1 [Keshavan, Nandaki; Chakrapani, Anupam; Cleary, Maureen; Rahman, Shamima] Great Ormond St Hosp Children NHS Fdn Trust, Metab Unit, London, England.
   [Keshavan, Nandaki; Rahman, Shamima] UCL Great Ormond St Inst Child Hlth, Mitochondrial Res Grp, London, England.
   [Abdenur, Jose; Simon, Mariella] Childrens Hosp Orange Cty, Div Metab Disorders, Orange, CA 92668 USA.
   [Anderson, Glenn; Jacques, Tom] Great Ormond St Hosp Children NHS Fdn Trust, Dept Histopathol, London, England.
   [Assouline, Zahra; Barcia, Giulia] Necker Hosp Sick Children, Dept Genet, Paris, France.
   [Bouhikbar, Lamia] UCL Great Ormond St Inst Child Hlth, GOSgene Ctr Translat Omics, London, England.
   [Bouhikbar, Lamia] NIHR GOSH Biomed Res Ctr, London, England.
   [Cohen, Marta C.; Sharrard, Mark] Sheffield Childrens NHS Fdn Trust, Sheffield, S Yorkshire, England.
   [Feillet, Francois] Reference Ctr Inherited Metab Dis, Nancy, France.
   [Fratter, Carl; Smith, Conrad] Oxford Univ Hosp NHS Fdn Trust, Oxford Med Genet Labs, Oxford, England.
   [Hauser, Natalie] Inova Translat Med Inst, Falls Church, VA USA.
   [Lam, Amanda] Natl Hosp Neurol & Neurosurg, Neurometabol Unit, London, England.
   [Lam, Amanda; Phadke, Rahul] UCL Queen Sq Inst Neurol, London, England.
   [McCullagh, Helen] Leeds Childrens Hosp, Dept Paediat Neurol, Leeds, W Yorkshire, England.
   [Rotig, Agnes] Imagine Inst, Paris, France.
   [Sommerville, Ewen W.; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Sommerville, Ewen W.] Cardiff Univ, Div Psychol Med & Clin Neurosci, Cardiff, Wales.
   [Yue, Wyatt W.] Univ Oxford, Nuffield Dept Med, Struct Genom Consortium, Oxford, England.
C3 University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Childrens Hospital of Orange County; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; University of London; University College London; Sheffield Children's NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Universite Paris Cite; Newcastle University - UK; Cardiff University; University of Oxford
RP Rahman, S (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, Metab Unit, London, England.; Rahman, S (corresponding author), UCL Great Ormond St Inst Child Hlth, Mitochondrial Res Grp, London, England.
EM shamima.rahman@ucl.ac.uk
FU Great Ormond Street Hospital Children's Charity Research Leadership Award [V1260]; National Institute for Health Research (NIHR) Great Ormond Street Hospital Biomedical Research Center; Lily Foundation; Wellcome Center for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) Center for Translational Research in Neuromuscular Disease, Mitochondrial Disease Patient Cohort (UK) [G0800674]; UK NIHR Biomedical Research Center for Ageing and Age-related disease award; MRC/Engineering and Physical Sciences Research Council (EPSRC) Molecular Pathology Node; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; Medical Research Council (MRC); MRC [G0800674] Funding Source: UKRI
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Gorman GS, 1993, GENEREVIEWS, V0, P0
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Keshavan N, 2018, ESSAYS BIOCHEM, V62, P423, DOI 10.1042/EBC20170108
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Kropach N, 2017, NEUROPEDIATRICS, V48, P456, DOI 10.1055/s-0037-1601867
   Larcher V, 2015, ARCH DIS CHILD, V100, PS3, DOI 10.1136/archdischild-2014-306666
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   McCormack Shana E, 2016, MITOCHONDRIAL CASE S, V0, P187
   Mestek-Boukhibar L, 2018, J MED GENET, V55, P721, DOI 10.1136/jmedgenet-2018-105396
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Pontarin G, 2012, CELL CYCLE, V11, P4099, DOI 10.4161/cc.22324
   Pontarin G, 2011, J BIOL CHEM, V286, P11132, DOI 10.1074/jbc.M110.202283
   Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105
   POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Ray S, 2018, ARCH DIS CHILD, V103, P1080, DOI 10.1136/archdischild-2018-314997
   Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, PW382, DOI 10.1093/nar/gki387
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Smith P, 2009, BIOCHEMISTRY-US, V48, P11134, DOI 10.1021/bi9001425
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stojanovic V, 2013, CROAT MED J, V54, P579, DOI 10.3325/cmj.2013.54.579
   Takata A, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-9-r92
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valencia CA, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0156738
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
NR 40
TC 15
Z9 16
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1098-3600
EI 1530-0366
J9 GENET MED
JI Genet. Med.
PD JAN 15
PY 2020
VL 22
IS 1
BP 199
EP 209
DI 10.1038/s41436-019-0613-z
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA KH9BF
UT WOS:000510943400024
PM 31462754
DA 2024-11-01
ER

PT J
AU Pirinen, E
   Auranen, M
   Khan, NA
   Brilhante, V
   Urho, N
   Pessia, A
   Hakkarainen, A
   Kuula, J
   Heinonen, U
   Schmidt, MS
   Haimilahti, K
   Piirilä, P
   Lundbom, N
   Taskinen, MR
   Brenner, C
   Velagapudi, V
   Pietiläinen, KH
   Suomalainen, A
AF Pirinen, Eija
   Auranen, Mari
   Khan, Nahid A.
   Brilhante, Virginia
   Urho, Niina
   Pessia, Alberto
   Hakkarainen, Antti
   Kuula, Juho
   Heinonen, Ulla
   Schmidt, Mark S.
   Haimilahti, Kimmo
   Piirila, Paivi
   Lundbom, Nina
   Taskinen, Marja-Riitta
   Brenner, Charles
   Velagapudi, Vidya
   Pietilainen, Kirsi H.
   Suomalainen, Anu
TI Niacin Cures Systemic NAD<SUP>+</SUP> Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy
SO CELL METABOLISM
LA English
DT Article
ID fatty liver-disease; nicotinamide riboside; multiple deletions; life-span; dna; spectroscopy; adiponectin; metabolism; mutations; biomarker
AB NAD(+) is a redox-active metabolite, the depletion of which has been proposed to promote aging and degenerative diseases in rodents. However, whether NAD(+) depletion occurs in patients with degenerative disorders and whether NAD(+) repletion improves their symptoms has remained open. Here, we report systemic NAD(+) deficiency in adult-onset mitochondrial myopathy patients. We administered an increasing dose of NAD(+) booster niacin, a vitamin B3 form (to 750-1,000 mg/day; clinicaltrials.gov NCT03973203) for patients and their matched controls for 10 or 4 months, respectively. Blood NAD(+) increased in all subjects, up to 8-fold, and muscle-NAD(+) of patients reached the level of their controls. Some patients showed anemia tendency, while muscle strength and mitochondrial biogenesis increased in all subjects. In patients, muscle metabolome shifted toward controls and liver fat decreased even 50%. Our evidence indicates that blood analysis is useful in identifying NAD(+) deficiency and points niacin to be an efficient NAD(+) booster for treating mitochondrial myopathy.
C1 [Pirinen, Eija; Haimilahti, Kimmo; Taskinen, Marja-Riitta] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki 00290, Finland.
   [Auranen, Mari; Khan, Nahid A.; Brilhante, Virginia; Suomalainen, Anu] Univ Helsinki, Fac Med, Res Program Stem Cells & Metab, Helsinki 00290, Finland.
   [Auranen, Mari; Urho, Niina; Heinonen, Ulla] Helsinki Univ Hosp, Dept Neurosci, Helsinki, Finland.
   [Pessia, Alberto; Velagapudi, Vidya] Inst Mol Med Finland FIMM, Metabol Unit, Helsinki 00290, Finland.
   [Hakkarainen, Antti; Kuula, Juho; Lundbom, Nina] Univ Helsinki, Med Imaging Ctr, Dept Radiol, Helsinki, Finland.
   [Hakkarainen, Antti; Kuula, Juho; Lundbom, Nina] Helsinki Univ Hosp, Helsinki, Finland.
   [Hakkarainen, Antti] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Espoo 12200, Finland.
   [Schmidt, Mark S.; Brenner, Charles] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.
   [Piirila, Paivi] Helsinki Univ Hosp, Unit Clin Physiol, Helsinki, Finland.
   [Piirila, Paivi; Pietilainen, Kirsi H.] Univ Helsinki, Helsinki, Finland.
   [Pietilainen, Kirsi H.] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Obes Res Unit, Helsinki 00290, Finland.
   [Pietilainen, Kirsi H.] Helsinki Univ Hosp, Endocrinol, Abdominal Ctr, Obes Ctr, Helsinki, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, HUSlab, Helsinki 00290, Finland.
   [Suomalainen, Anu] Univ Helsinki, HiLife, Neurosci Ctr, Helsinki 00290, Finland.
   [Velagapudi, Vidya] Astra Zeneca, Biopharmaceut R&D, Discovery Sci, Gothenburg, Sweden.
C3 University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Aalto University; University of Iowa; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; AstraZeneca
RP Pirinen, E (corresponding author), Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki 00290, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Fac Med, Res Program Stem Cells & Metab, Helsinki 00290, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, HUSlab, Helsinki 00290, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, HiLife, Neurosci Ctr, Helsinki 00290, Finland.
EM eija.pirinen@helsinki.fi; anu.wartiovaara@helsinki.fi
FU Centre of Excellence from Academy of Finland [307431]; academy grants [307592, 303349, 286359, 272376, 314383, 266286]; Sigrid Juselius Foundation; United Mitochondrial Disease Foundation; Finnish Medical Foundation; Novo Nordisk Foundation; Gyllenberg Foundation; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; HiLife/University of Helsinki; Government Research Funds (Helsinki University Hospital); Academy of Finland (AKA) [307592, 303349, 307431] Funding Source: Academy of Finland (AKA)
CR Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Airhart SE, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0186459
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bachorik P S, 1986, METHODS ENZYMOL, V129, P78
   Bao XR, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10575
   Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006
   Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024
   Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7
   BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8
   Brosnan JT, 2007, ANNU REV NUTR, V27, P241, DOI 10.1146/annurev.nutr.27.061406.093621
   Bruckert E, 2010, ATHEROSCLEROSIS, V210, P353, DOI 10.1016/j.atherosclerosis.2009.12.023
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chong J, 2018, NUCLEIC ACIDS RES, V46, PW486, DOI 10.1093/nar/gky310
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Elhassan YS, 2019, CELL REP, V28, P1717, DOI 10.1016/j.celrep.2019.07.043
   ERA P, 1992, EUR J APPL PHYSIOL O, V64, P84, DOI 10.1007/BF00376446
   Forsström S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   Ganji SH, 2014, AM J PHYSIOL-GASTR L, V306, PG320, DOI 10.1152/ajpgi.00181.2013
   Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245
   Giby VG, 2014, WORLD J HEPATOL, V6, P570, DOI 10.4254/wjh.v6.i8.570
   Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051
   Guyton JR, 2007, AM J CARDIOL, V99, P22C, DOI 10.1016/j.amjcard.2006.11.018
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HARDIN CD, 1994, J MOL CELL CARDIOL, V26, P1197, DOI 10.1006/jmcc.1994.1138
   HOLT IJ, 1988, LANCET, V1, P1462
   Hu M, 2012, J LIPID RES, V53, P802, DOI 10.1194/jlr.P023614
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005
   Kühl I, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.30952
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018
   LONGO R, 1995, JMRI-J MAGN RESON IM, V5, P281, DOI 10.1002/jmri.1880050311
   Love MI, 2014, GENOME BIOL, V15, P0, DOI 10.1186/s13059-014-0550-8
   Migliavacca E, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-13694-1
   Mudd SH, 2007, AM J CLIN NUTR, V85, P19, DOI 10.1093/ajcn/85.1.19
   Nandania J, 2018, METABOLITES, V8, P0, DOI 10.3390/metabo8030044
   Nandania J, 2018, J CHROMATOGR B, V1092, P168, DOI 10.1016/j.jchromb.2018.06.008
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ollila L, 2017, CLIN PHYSIOL FUNCT I, V37, P8, DOI 10.1111/cpf.12260
   Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002
   Plaisance EP, 2009, AM J PHYSIOL-ENDOC M, V296, PE549, DOI 10.1152/ajpendo.91004.2008
   Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011
   Ryu D, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aaf5504
   Shi HJ, 2017, NEW ENGL J MED, V377, P544, DOI 10.1056/NEJMoa1616361
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spriet LL, 2015, CURR OPIN CLIN NUTR, V18, P96, DOI 10.1097/MCO.0000000000000135
   Stefan D, 2009, MEAS SCI TECHNOL, V20, P0, DOI 10.1088/0957-0233/20/10/104035
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, PE977, DOI 10.1152/ajpendo.1999.276.5.E977
   Trammell SAJ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep26933
   Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, P0, DOI 10.5936/csbj.201301012
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Van Bergen NJ, 2019, BRAIN, V142, P50, DOI 10.1093/brain/awy310
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244
   Vosper H, 2009, BRIT J PHARMACOL, V158, P429, DOI 10.1111/j.1476-5381.2009.00349.x
   Westphal S, 2007, ATHEROSCLEROSIS, V193, P361, DOI 10.1016/j.atherosclerosis.2006.06.028
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
NR 68
TC 140
Z9 146
U1 5
U2 25
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD JUN 2
PY 2020
VL 31
IS 6
BP 1078
EP +
DI 10.1016/j.cmet.2020.04.008
PG 18
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA MC6LR
UT WOS:000543396400010
PM 32386566
DA 2024-11-01
ER

PT J
AU Yokota, Y
   Hara, M
   Akimoto, T
   Mizoguchi, T
   Goto, Y
   Nishino, I
   Kamei, S
   Nakajima, H
AF Yokota, Yuki
   Hara, Makoto
   Akimoto, Takayoshi
   Mizoguchi, Tomotaka
   Goto, Yu-ichi
   Nishino, Ichizo
   Kamei, Satoshi
   Nakajima, Hideto
TI Late-onset MELAS syndrome with mtDNA 14453G→A mutation masquerading as an acute encephalitis: a case report
SO BMC NEUROLOGY
LA English
DT Article
DE MELAS; Late-onset; ND6 gene; Encephalitis
ID hereditary optic neuropathy; mitochondrial-dna mutation; nd6 gene; lactic-acidosis; clinical-features; sequence-analysis; episodes melas; encephalopathy; myopathy; family
AB Background A unique patient with MELAS syndrome, who initially masqueraded as having acute encephalitis and was eventually diagnosed with MELAS syndrome harboring a mtDNA 14453G -> A mutation, is described. Case presentation A 74-year-old Japanese man was admitted to another hospital due to acute onset of cognitive impairment and psychosis. After 7 days he was transferred to our hospital with seizures and deteriorating psychosis. The results of primary ancillary tests that included EEG, CSF findings, and brain MRI supported the diagnosis of an acute encephalitis. HSV-DNA and antibodies against neuronal surface antigens in the CSF were all negative. With the assistance of the lactate peak on the brain lesions in the magnetic resonance spectroscopy image and genetic analysis of the biopsied muscle, he was eventually diagnosed with MELAS syndrome harboring mtDNA 14453G -> A mutation in the ND6 gene. Conclusions This case provides a caveat that MELAS syndrome can manifest in the symptoms and ancillary tests masquerading as an acute encephalitis caused by infection or autoimmunity. This is the first adult patient seen to harbor the mtDNA14453G -> A with a unique onset, which broadens the phenotypic spectrum of MELAS syndrome associated with ND6 gene mutation.
C1 [Yokota, Yuki; Hara, Makoto; Akimoto, Takayoshi; Mizoguchi, Tomotaka; Kamei, Satoshi; Nakajima, Hideto] Nihon Univ, Dept Med, Div Neurol, Sch Med,Itabashi Ku, 30-1 Oyaguchi Kamicyo, Tokyo 1738610, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Tokyo, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan.
   [Kamei, Satoshi] Ageo Cent Gen Hosp, Ctr Neuroinfect, Dept Neurol, Saitama, Japan.
C3 Nihon University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan
RP Hara, M (corresponding author), Nihon Univ, Dept Med, Div Neurol, Sch Med,Itabashi Ku, 30-1 Oyaguchi Kamicyo, Tokyo 1738610, Japan.
EM hara.makoto@nihon-u.ac.jp
FU Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [29-4]; Takeda Science Foundation
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Caporali L, 2018, PLOS GENET, V14, P0, DOI 10.1371/journal.pgen.1007210
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   DeVries DD, 1996, AM J HUM GENET, V58, P703
   Fassone E, 2012, J MED GENET, V49, P668, DOI 10.1136/jmedgenet-2012-101159corr1
   Gieraerts C, 2013, J COMPUT ASSIST TOMO, V37, P279, DOI 10.1097/RCT.0b013e3182811170
   Gooriah R, 2015, ACTA NEUROL BELG, V115, P789, DOI 10.1007/s13760-014-0416-6
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9
   Howell N, 1998, AM J HUM GENET, V62, P196, DOI 10.1086/301675
   Howell N, 2003, AM J HUM GENET, V72, P1460, DOI 10.1086/375537
   Hsu Yu-Chuan, 2012, J EMERG MED, V43, Pe163, DOI 10.1016/j.jemermed.2009.10.021
   Ienco EC, 2016, MITOCHONDRION, V30, P148, DOI 10.1016/j.mito.2016.07.008
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   JOHNS DR, 1993, NEUROLOGY, V43, P2471, DOI 10.1212/WNL.43.12.2471
   Jun AS, 1996, MOL CELL BIOL, V16, P771
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   LeoKottler B, 1996, GER J OPHTHALMOL, V5, P233
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Lukyanova LD, 2015, FRONT NEUROSCI-SWITZ, V9, P0, DOI 10.3389/fnins.2015.00320
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   MIYABAYASHI S, 1992, J INHERIT METAB DIS, V15, P797, DOI 10.1007/BF01800024
   Ng YS, 2018, EBIOMEDICINE, V30, P86, DOI 10.1016/j.ebiom.2018.02.010
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Qian YP, 2005, BIOCHEM BIOPH RES CO, V332, P614, DOI 10.1016/j.bbrc.2005.05.003
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Sharfstein SR, 1999, ARCH NEUROL-CHICAGO, V56, P241, DOI 10.1001/archneur.56.2.241
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Wang QX, 2004, AM J MED GENET A, V131A, P50, DOI 10.1002/ajmg.a.30323
   Wissinger B, 1997, BIOCHEM BIOPH RES CO, V234, P511, DOI 10.1006/bbrc.1997.6660
   Yokota M, 2015, HUM MOL GENET, V24, P4698, DOI 10.1093/hmg/ddv201
   Zhadanov SI, 2005, BIOCHEM BIOPH RES CO, V332, P1115, DOI 10.1016/j.bbrc.2005.05.059
NR 40
TC 13
Z9 17
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2377
J9 BMC NEUROL
JI BMC Neurol.
PD JUN 17
PY 2020
VL 20
IS 1
BP 
EP 
DI 10.1186/s12883-020-01818-w
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA MB6DP
UT WOS:000542692100001
PM 32552696
DA 2024-11-01
ER

PT J
AU Yang, SL
   Huo, YY
   Wang, HJ
   Ji, JF
   Chen, W
   Huang, YQ
AF Yang, Suliang
   Huo, Yangyang
   Wang, Huanjie
   Ji, Jiefei
   Chen, Wen
   Huang, Yanqun
TI The spatio-temporal features of chicken mitochondrial ND2 gene heteroplasmy and the effects of nutrition factors on this gene
SO SCIENTIFIC REPORTS
LA English
DT Article
ID dna-sequence variation; mtdna heteroplasmy; energy restriction; adipose-tissue; health; dysfunction; expression; omega-6; damage
AB Mitochondrial heterogeneity is the presence of two or more types of mitochondrial (mt)DNA in the same individual/tissue/cell. It is closely related to animal health and disease. ND2 is a protein-coding gene in mtDNA, which participates in mitochondrial respiratory chain and oxidative phosphorylation. In previous studies, we observed that the mt.A5703T and mt.T5727G sites in the ND2 gene were the heteroplasmic variation sites. We used pyrophosphate sequencing technology to examine chicken mt.A5703T and mt.T5727G heteroplasmic sites in the ND2 gene, in different tissues and at different development stages in chickens. We also investigated whether nutritional factors could affect the mt.A5703T and mt.T5727G heteroplasmy. Our results showed that chicken mt.A5703T and mt.T5727G heteroplasmy had clear spatio-temporal specificities, which varied between tissues/development stages. The mtDNA heterogeneity was relatively stable upon nutrition intervention, 30% dietary energy restriction (from 18 to 48 days old) and different types of dietary fats (at 5% concentration, from 1 to 42 days old) did not change the breast muscle heteroplasmy of broilers at the mt.A5703T and mt.T5727G sites. In addition, multiple potential heteroplasmic sites were detected by clone sequencing in the ND2 region, which potentially reflected abundant heteroplasmy in the chicken mitochondrial genome. These results provide an important reference for further research on heteroplasmy in chicken mitochondria.
C1 [Yang, Suliang; Huo, Yangyang; Wang, Huanjie; Ji, Jiefei; Chen, Wen; Huang, Yanqun] Henan Agr Univ, Coll Livestock Husb & Vet Engn, 15 Longzi Lake Univ Campus, Zhengzhou 450046, Peoples R China.
C3 Henan Agricultural University
RP Huang, YQ (corresponding author), Henan Agr Univ, Coll Livestock Husb & Vet Engn, 15 Longzi Lake Univ Campus, Zhengzhou 450046, Peoples R China.
EM hyanqun@aliyun.com
FU National Natural Science Foundation of China [31272434]; National infrastructure of domestic animal resource of China
CR [Anonymous], 1994, NUTRIENT REQUIREMENT, V0, P0
   BAUMER A, 1994, AM J HUM GENET, V54, P618
   Blass JP, 2002, J ALZHEIMERS DIS, V4, P225, DOI 10.3233/JAD-2002-4312
   BROWN JR, 1993, MOL BIOL EVOL, V10, P326
   BROWN JR, 1992, GENETICS, V132, P221
   Duchen MR, 2004, DIABETES, V53, PS96, DOI 10.2337/diabetes.53.2007.S96
   Eckert A, 2003, BIOCHEM PHARMACOL, V66, P1627, DOI 10.1016/S0006-2952(03)00534-3
   Enriquez JA, 2014, MOL SYNDROMOL, V5, P119, DOI 10.1159/000363364
   Ghosh S, 2006, FREE RADICAL BIO MED, V41, P1413, DOI 10.1016/j.freeradbiomed.2006.07.021
   Grazina M, 2006, GENES BRAIN BEHAV, V5, P92, DOI 10.1111/j.1601-183X.2006.00225.x
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Houstek J, 2012, PHYSIOL GENOMICS, V44, P487, DOI 10.1152/physiolgenomics.00156.2011
   Huang YQ, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0224677
   Hynes GR, 2003, J LIPID RES, V44, P893, DOI 10.1194/jlr.M200318-JLR200
   Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Lu WW, 2016, MITOCHONDRIAL DNA A, V27, P2303, DOI 10.3109/19401736.2014.971022
   Marom S, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep43449
   MCCLELLAN J, 2012, PLOS ONE, V7, P0, DOI 10.1371/JOURNAL.PONE.00464032012PLOSO...746403B
   McLeod BA, 2010, J HERED, V101, P235, DOI 10.1093/jhered/esp098
   Ministry of Agriculture of the Peoples Republic of China, 2004, 332004 GB NT MIN AGR, V0, P0
   MITCHELL P, 1967, NATURE, V213, P137, DOI 10.1038/213137a0
   Near TJ, 2003, MOL PHYLOGENET EVOL, V28, P87, DOI 10.1016/S1055-7903(03)00029-0
   Pepe S, 1999, AM J PHYSIOL-HEART C, V276, PH149, DOI 10.1152/ajpheart.1999.276.1.H149
   Pereira SL, 2004, BMC EVOL BIOL, V4, P0, DOI 10.1186/1471-2148-4-17
   Rodríguez VM, 2002, BRIT J NUTR, V87, P427, DOI 10.1079/BJN2002570
   Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x
   Sealls W, 2008, BBA-MOL CELL BIOL L, V1781, P406, DOI 10.1016/j.bbalip.2008.06.010
   Shao L, 2008, ANN MED, V40, P281, DOI 10.1080/07853890801923753
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Shi Y, 2018, MITOCHONDRIAL DNA A, V29, P485, DOI 10.1080/24701394.2017.1307976
   Sondheimer N, 2011, HUM MOL GENET, V11, P654, DOI 10.1016/j.mito.2011.03.059
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tranah GJ, 2012, J ALZHEIMERS DIS, V32, P357, DOI 10.3233/JAD-2012-120466
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Vollmer NL, 2011, CURR GENET, V57, P115, DOI 10.1007/s00294-010-0331-1
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wang JW, 2012, POULTRY SCI, V91, P972, DOI 10.3382/ps.2011-01949
   Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168
   Wilton PR, 2018, GENETICS, V208, P1261, DOI 10.1534/genetics.118.300711
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
   Yao YG, 2013, MUTAT RES-FUND MOL M, V751, P36, DOI 10.1016/j.mrfmmm.2013.09.001
   Zhang WW, 2016, MITOCHONDRIAL DNA A, V27, P3787, DOI 10.3109/19401736.2015.1079904
NR 46
TC 3
Z9 5
U1 0
U2 7
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD FEB 19
PY 2020
VL 10
IS 1
BP 
EP 
DI 10.1038/s41598-020-59703-y
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NB2ZC
UT WOS:000560380700001
PM 32075998
DA 2024-11-01
ER

PT J
AU Li, HM
   Hu, BW
   Luo, QB
   Hu, S
   Luo, YB
   Zhao, BJ
   Gan, YM
   Li, Y
   Shi, MQ
   Nie, QH
   Zhang, DX
   Zhang, XQ
AF Li, Hongmei
   Hu, Bowen
   Luo, Qingbin
   Hu, Shuang
   Luo, Yabiao
   Zhao, Bojing
   Gan, Yanmin
   Li, Ying
   Shi, Meiqing
   Nie, Qinghua
   Zhang, Dexiang
   Zhang, Xiquan
TI Runting and Stunting Syndrome Is Associated With Mitochondrial Dysfunction in Sex-Linked Dwarf Chicken
SO FRONTIERS IN GENETICS
LA English
DT Article
DE runting and stunting syndrome; chicken; mitochondrial dysfunction; oxidative phosphorylation; ATP synthesis; vacuoles
ID succinate-dehydrogenase; gene; inhibition; expression; activation; generation; mutations; depletion; enzymes; muscle
AB Runting and stunting syndrome (RSS) in chicken are commonly known as "frozen chicken." The disease is characterized by lower body weight and slow growth and the incidence rate is widely 5%-20% in sex-linked dwarf (SLD) chickens. However, the etiology of RSS in chickens has plagued researchers for several decades. In this study, histopathology studies demonstrated that the hepatocytes of the RSS chickens contain many mitochondria with damaged and outer and inner membrane along with vacuolar hydropic degeneration. No mtDNA mutation was detected, but our microarray data showed that RSS chickens exhibited abnormal expression of genes, many of which are involved in oxidative phosphorylation (OXPHOS) and fatty acid metabolism. In particular, nuclear gene IGF2BP3 was upregulated in RSS chickens' liver cells. The abnormal expression of these genes is likely to impair the OXPHOS, resulting in reduced ATP synthesis in the hepatocytes of the RSS chickens, which may in turn leads to poor weight gain and retarded growth or stunting of chicks. Our findings suggest that mitochondria dysfunction rather than chronic inflammation is responsible for the reduced growth and RSS in SLD chickens. Mutations in GHR have been shown to compromise mitochondrial function in SLD chickens. Since the mitochondrial damage in the RSS chicken is more severe, we suggest that extra genes are likely to be affected to exacerbate the phenotype.
C1 [Li, Hongmei; Hu, Bowen; Luo, Qingbin; Hu, Shuang; Luo, Yabiao; Zhao, Bojing; Gan, Yanmin; Nie, Qinghua; Zhang, Dexiang; Zhang, Xiquan] South China Agr Univ, Coll Anim Sci, Dept Anim Genet Breeding & Reprod, Guangzhou, Peoples R China.
   [Li, Hongmei; Hu, Bowen; Luo, Qingbin; Hu, Shuang; Luo, Yabiao; Zhao, Bojing; Gan, Yanmin; Nie, Qinghua; Zhang, Dexiang; Zhang, Xiquan] South China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Minist Agr, Guangzhou, Peoples R China.
   [Li, Hongmei; Hu, Bowen; Luo, Qingbin; Hu, Shuang; Luo, Yabiao; Zhao, Bojing; Gan, Yanmin; Nie, Qinghua; Zhang, Dexiang; Zhang, Xiquan] South China Agr Univ, Coll Anim Sci, Key Lab Chicken Genet Breeding & Reprod, Minist Agr, Guangzhou, Peoples R China.
   [Li, Ying] Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Peoples R China.
   [Shi, Meiqing] Univ Maryland, Virginia Maryland Reg Coll Vet Med, Div Immunol, College Pk, MD 20742 USA.
C3 South China Agricultural University; South China Agricultural University; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; South China Agricultural University; Guangdong Academy of Agricultural Sciences; University System of Maryland; University of Maryland College Park
RP Zhang, DX; Zhang, XQ (corresponding author), South China Agr Univ, Coll Anim Sci, Dept Anim Genet Breeding & Reprod, Guangzhou, Peoples R China.; Zhang, DX; Zhang, XQ (corresponding author), South China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Minist Agr, Guangzhou, Peoples R China.; Zhang, DX; Zhang, XQ (corresponding author), South China Agr Univ, Coll Anim Sci, Key Lab Chicken Genet Breeding & Reprod, Minist Agr, Guangzhou, Peoples R China.
EM zhangdexiang0001@sina.com; xqzhang@scau.edu.cn
FU National Natural Science Fund Committee National Youth Project [31401046]; Guangdong Provincial Promotion Project on Preservation and Utilization of Local Breed of Livestock and Poultry and Guangdong Youth Talent Project
CR Barrientos Antoni, 2009, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1903s63
   Booth DM, 2016, MOL CELL, V63, P240, DOI 10.1016/j.molcel.2016.05.040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   BRACEWELL CD, 1981, VET REC, V109, P64, DOI 10.1136/vr.109.3.64-b
   Brown-Borg HM, 2012, AGE, V34, P43, DOI 10.1007/s11357-011-9212-x
   DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elagib KE, 2017, J CLIN INVEST, V127, P2365, DOI 10.1172/JCI88936
   Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07
   Hirst J, 2005, BIOCHEM SOC T, V33, P525, DOI 10.1042/BST0330525
   Hu BW, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20071608
   Javadov S, 2006, J PHARMACOL EXP THER, V317, P1036, DOI 10.1124/jpet.105.100107
   Kang KI, 2018, J GEN VIROL, V99, P512, DOI 10.1099/jgv.0.001025
   Kim TS, 2003, BIOCHEM PHARMACOL, V66, P2301, DOI 10.1016/j.bcp.2003.08.021
   Konieczna A, 2015, BMC CELL BIOL, V16, P0, DOI 10.1186/s12860-015-0062-8
   KOUWENHOVEN B, 1978, AVIAN PATHOL, V7, P183, DOI 10.1080/03079457808418269
   Lancaster CRD, 2002, BBA-BIOENERGETICS, V1553, P84, DOI 10.1016/S0005-2728(01)00230-4
   Luo W, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17030276
   Meldau S, 2018, CLIN GENET, V93, P1093, DOI 10.1111/cge.13208
   Minchenko D O, 2015, ENDOCR REGUL, V49, P73
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Ouyang JH, 2012, J INTEGR AGR, V11, P1500, DOI 10.1016/S2095-3119(12)60150-6
   Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107
   Palanichamy JK, 2016, J CLIN INVEST, V126, P1495, DOI 10.1172/JCI80046
   Perret-Vivancos C, 2006, EXP CELL RES, V312, P215, DOI 10.1016/j.yexcr.2005.10.027
   Rebel JMJ, 2006, WORLD POULTRY SCI J, V62, P17, DOI 10.1079/WPS200481
   ROBINSON KM, 1994, EUR J BIOCHEM, V222, P983, DOI 10.1111/j.1432-1033.1994.tb18949.x
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Su Y, 2016, THERANOSTICS, V6, P1244, DOI 10.7150/thno.13804
   Sudheesh NP, 2013, INT J CARDIOL, V165, P117, DOI 10.1016/j.ijcard.2011.07.103
   Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112
   Zavala G, 2006, IN VIVO STUD, V0, P0
   ZEVIANI M, 1989, NEUROL CLIN, V7, P123, DOI 10.1016/S0733-8619(18)30832-6
   Zhang L, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0127342
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 40
TC 6
Z9 6
U1 1
U2 14
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JAN 17
PY 2020
VL 10
IS 
BP 
EP 
DI 10.3389/fgene.2019.01337
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA KH8MQ
UT WOS:000510905200001
PM 32010193
DA 2024-11-01
ER

PT J
AU Yamada, Y
   Fujishita, N
   Harashima, H
AF Yamada, Yuma
   Fujishita, Naoki
   Harashima, Hideyoshi
TI A nanocarrier for the mitochondrial delivery of nucleic acids to cardiomyocytes
SO NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
LA English
DT Article
DE Cardiac myoblasts; mitochondria; nucleic acids delivery; liposomes; mitochondrial delivery; multifunctional envelope-type nano device (MEND)
ID mito-porter; dna vector; system; cells; rna; macromolecule; validation; peptides
AB Cardiomyopathy caused by mitochondrial dysfunction associated with the mutation/deletion of mitochondrial DNA has been reported, and nucleic acid therapy targeting cardiac mitochondria represents a possible therapy for treating these diseases. Such a treatment, however, has not yet been achieved because delivering nucleic acids to mitochondria of cardiac muscle is difficult. In this study, H9c2 cells a type of rat cardiac myoblasts, were used as model cardiac muscle cells. The use of a lipid composition used to prepare the ?-MEND (where MEND denotes multifunctional envelope-type nano device) permitted the particles to be efficiently internalized by H9c2 cells, as evidenced by flow cytometry analyses. Intracellular observations by confocal laser scanning microscopy showed that the ?-MEND efficiently accumulated in mitochondria of H9c2 cells. We also constructed an RP/?-MEND that contained a mitochondrial RNA aptamer to achieve mitochondrial delivery in H9c2 cells. The successful direct mitochondrial transfection of exogenous RNA was confirmed using these carrier systems, based on PCR experiments after reverse transcription. Thus, the ?-MEND holds promise as a direct mitochondrial transfection system for delivering nucleic acids targeted to H9c2 cells.
C1 [Yamada, Yuma; Fujishita, Naoki; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan.
C3 Hokkaido University
RP Yamada, Y; Harashima, H (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.
EM u-ma@pharm.hokudai.ac.jp; harasima@pharm.hokudai.ac.jp
FU Japan Agency for Medical Research and Development; Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation
CR Abe J, 2018, J CONTROL RELEASE, V269, P177, DOI 10.1016/j.jconrel.2017.11.024
   Bertero E, 2018, J CLIN INVEST, V128, P5191, DOI 10.1172/JCI124944
   Biswas S, 2014, ADV DRUG DELIVER REV, V66, P26, DOI 10.1016/j.addr.2013.11.004
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Furukawa R, 2015, BIOMATERIALS, V57, P107, DOI 10.1016/j.biomaterials.2015.04.022
   Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l
   Ishikawa T, 2018, J CONTROL RELEASE, V274, P109, DOI 10.1016/j.jconrel.2018.02.005
   Katayama T, 2019, MITOCHONDRION, V49, P66, DOI 10.1016/j.mito.2019.07.005
   Kawamura E, 2013, MITOCHONDRION, V13, P610, DOI 10.1016/j.mito.2013.08.010
   Kusumoto K, 2013, ACS NANO, V7, P7534, DOI 10.1021/nn401317t
   Lee SR, 2017, ADV EXP MED BIOL, V982, P81, DOI 10.1007/978-3-319-55330-6_5
   McCully JD, 2016, CLIN TRANSL MED, V5, P0, DOI 10.1186/s40169-016-0095-4
   Milane L, 2015, J CONTROL RELEASE, V207, P40, DOI 10.1016/j.jconrel.2015.03.036
   Nakamura T, 2019, BIOMATERIALS, V218, P0, DOI 10.1016/j.biomaterials.2019.119329
   Sato Y, 2017, MACROMOL BIOSCI, V17, P0, DOI 10.1002/mabi.201600179
   Takano Y, 2017, NANOSCALE, V9, P18690, DOI 10.1039/c7nr06310e
   Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035
   Wen R, 2016, ADV DRUG DELIVER REV, V99, P52, DOI 10.1016/j.addr.2015.12.024
   Yamada Y, 2008, ADV DRUG DELIVER REV, V60, P1439, DOI 10.1016/j.addr.2008.04.016
   Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002
   Yamada Y, 2019, CHEM COMMUN, V55, P7203, DOI 10.1039/c9cc03272j
   Yamada Y, 2017, BIOMATERIALS, V136, P56, DOI 10.1016/j.biomaterials.2017.05.016
   Yamada Y, 2016, J PHARM SCI-US, V105, P1705, DOI 10.1016/j.xphs.2016.03.002
   Yamada Y, 2015, J CONTROL RELEASE, V213, P86, DOI 10.1016/j.jconrel.2015.06.037
   Yamada Y, 2014, BIOMATERIALS, V35, P6430, DOI 10.1016/j.biomaterials.2014.04.017
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Yasuzaki Y, 2015, MOL PHARMACEUT, V12, P4311, DOI 10.1021/acs.molpharmaceut.5b00511
NR 27
TC 13
Z9 14
U1 1
U2 17
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1525-7770
EI 1532-2335
J9 NUCLEOS NUCLEOT NUCL
JI Nucleosides Nucleotides Nucleic Acids
PD FEB 20
PY 2020
VL 39
IS 1-3
BP 141
EP 155
DI 10.1080/15257770.2019.1675167
EA OCT 2019
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA LF1XH
UT WOS:000492243500001
PM 31595823
DA 2024-11-01
ER

PT J
AU Toncheva, D
   Serbezov, D
   Karachanak-Yankova, S
   Nesheva, D
AF Toncheva, Draga
   Serbezov, Dimitar
   Karachanak-Yankova, Sena
   Nesheva, Desislava
TI Ancient mitochondrial DNA pathogenic variants putatively associated with mitochondrial disease
SO PLOS ONE
LA English
DT Article
ID progressive external ophthalmoplegia; respiratory-chain deficiency; point mutation; myoclonic epilepsy; sequence variation; diabetes-mellitus; trna(asn) gene; trna(lys); myopathy; prevalence
AB Mitochondrial DNA variants associated with diseases are widely studied in contemporary populations, but their prevalence has not yet been investigated in ancient populations. The publicly available AmtDB database contains 1443 ancient mtDNA Eurasian genomes from different periods. The objective of this study was to use this data to establish the presence of pathogenic mtDNA variants putatively associated with mitochondrial diseases in ancient populations. The clinical significance, pathogenicity prediction and contemporary frequency of mtDNA variants were determined using online platforms. The analyzed ancient mtDNAs contain six variants designated as being "confirmed pathogenic" in modern patients. The oldest of these, m.7510T>C in theMT-TS1gene, was found in a sample from the Neolithic period, dated 5800-5400 BCE. All six have well established clinical association, and their pathogenic effect is corroborated by very low population frequencies in contemporary populations. Analysis of the geographic location of the ancient samples, contemporary epidemiological trends and probable haplogroup association indicate diverse spatiotemporal dynamics of these variants. The dynamics in the prevalence and distribution is conceivably result ofde novomutations or human migrations and subsequent evolutionary processes. In addition, ten variants designated as possibly or likely pathogenic were found, but the clinical effect of these is not yet well established and further research is warranted. All detected mutations putatively associated with mitochondrial disease in ancient mtDNA samples are in tRNA coding genes. Most of these mutations are in a mt-tRNA type (Model 2) that is characterized by loss of D-loop/T-loop interaction. Exposing pathogenic variants in ancient human populations expands our understanding of their origin and prevalence dynamics.
C1 [Toncheva, Draga; Serbezov, Dimitar; Karachanak-Yankova, Sena; Nesheva, Desislava] Med Univ Sofia, Bulgarian Acad Sci, Dept Med Genet, Sofia, Bulgaria.
   [Toncheva, Draga] Bulgarian Acad Sci BAS, Sofia, Bulgaria.
   [Karachanak-Yankova, Sena] Sofia Univ St Kliment Ohridski, Dept Genet, Fac Biol, Sofia, Bulgaria.
C3 Bulgarian Academy of Sciences; Medical University Sofia; Bulgarian Academy of Sciences; University of Sofia
RP Toncheva, D (corresponding author), Med Univ Sofia, Bulgarian Acad Sci, Dept Med Genet, Sofia, Bulgaria.; Toncheva, D (corresponding author), Bulgarian Acad Sci BAS, Sofia, Bulgaria.
EM dragatoncheva@gmail.com
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   [Anonymous], 2013, J SOC PHILOS, V44, P1
   [Anonymous], 2007, ORAL SURG ORAL MED O, V0, P0
   Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002
   Berens AJ, 2017, HUM BIOL, V89, P7, DOI 10.13110/humanbiology.89.1.01
   Binder M, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0090924
   Blakely EL, 2007, J NEUROL, V254, P1283, DOI 10.1007/s00415-006-0490-7
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801
   Broushaki F, 2016, SCIENCE, V353, P499, DOI 10.1126/science.aaf7943
   Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004
   Clark K, 2016, NUCLEIC ACIDS RES, V44, PD67, DOI 10.1093/nar/gkv1276
   Damgaard PD, 2018, NATURE, V557, P369, DOI 10.1038/s41586-018-0094-2
   de Laat P, 2016, BBA CLIN, V6, P19, DOI 10.1016/j.bbacli.2016.04.007
   del Castillo F J, 2002, J MED GENET, V39, Pe82, DOI 10.1136/jmg.39.12.e82
   Derenko M, 2014, BMC EVOL BIOL, V14, P0, DOI 10.1186/s12862-014-0217-9
   Diroma MA, 2016, BMC BIOINFORMATICS, V17, P0, DOI 10.1186/s12859-016-1193-4
   Edward JO, 2016, S AFRICAN J SCI, V112, P0
   Entezami P, 2011, HAND CLIN, V27, P1, DOI 10.1016/j.hcl.2010.09.006
   Finnilä S, 2001, J MOL MED, V79, P641, DOI 10.1007/s001090100268
   Finsterer J, 2019, CHINESE MED J-PEKING, V132, P1752, DOI 10.1097/CM9.0000000000000337
   Fu J, 2019, CHINESE MED J-PEKING, V132, P865, DOI 10.1097/CM9.0000000000000151
   Gamba J, 2012, J NEUROL SCI, V320, P131, DOI 10.1016/j.jns.2012.05.037
   Ghelli A, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0007922
   Gilbert MTP, 2006, NUCL ACID M, V18, P91
   Gill JS, 2017, BRIT J OPHTHALMOL, V101, P1298, DOI 10.1136/bjophthalmol-2017-310370
   González-Vioque E, 2014, MOL GENET GENOM MED, V2, P107, DOI 10.1002/mgg3.47
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Horváth R, 2003, J MED GENET, V40, P752, DOI 10.1136/jmg.40.10.752
   Horvath R, 2010, NEUROMUSCULAR DISORD, V20, PS25, DOI 10.1016/S0960-8966(10)70090-0
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2014, NEUROMUSCULAR DISORD, V24, P162, DOI 10.1016/j.nmd.2013.08.004
   Juras A, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep43950
   Kameoka K, 1998, BIOCHEM BIOPH RES CO, V245, P523, DOI 10.1006/bbrc.1998.8437
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Knipper C, 2017, P NATL ACAD SCI, V0, P0
   Komlosi K, 2012, JIMD REPORTS CASE RE, V0, P105
   Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718
   Kytövuori L, 2017, BRAIN BEHAV, V7, P0, DOI 10.1002/brb3.859
   Labay V, 2008, CLIN GENET, V73, P50, DOI 10.1111/j.1399-0004.2007.00925.x
   Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, PD980, DOI 10.1093/nar/gkt1113
   Langdahl JH, 2018, CLIN GENET, V93, P925, DOI 10.1111/cge.13201
   Lehmann D, 2015, EUR J HUM GENET, V23, P1735, DOI 10.1038/ejhg.2015.73
   Lehmann D, 2015, NEUROMUSCULAR DISORD, V25, P81, DOI 10.1016/j.nmd.2014.09.008
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Martín-Jiménez R, 2012, MITOCHONDRION, V12, P288, DOI 10.1016/j.mito.2011.10.004
   Mathieson I, 2018, NATURE, V555, P197, DOI 10.1038/nature25778
   McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007
   Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   Modi A, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-41945-0
   Monge J, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064539
   MONTAGNA P, 1988, HEADACHE, V28, P477, DOI 10.1111/j.1526-4610.1988.hed2807477.x
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Murphy WA, 2003, RADIOLOGY, V226, P614, DOI 10.1148/radiol.2263020338
   Niedermayr K, 2018, CONGENIT HEART DIS, V13, P671, DOI 10.1111/chd.12634
   Nishino I, 1996, BIOCHEM BIOPH RES CO, V225, P180, DOI 10.1006/bbrc.1996.1150
   Odes EJ, 2016, S AFR J SCI, V112, P100
   Olivieri A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0070492
   Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Sangatsuda Y, 2012, MITOCHONDRION, V12, P617, DOI 10.1016/j.mito.2012.10.002
   Scarpelli M, 2018, NEUROMUSCULAR DISORD, V28, P137, DOI 10.1016/j.nmd.2017.10.006
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schroeder H, 2019, P NATL ACAD SCI USA, V116, P10705, DOI 10.1073/pnas.1820210116
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Souilem S, 2011, J NEUROL SCI, V300, P187, DOI 10.1016/j.jns.2010.08.065
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Stolarek I, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-20705-6
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Tarnopolsky MA, 2019, MITOCHONDRION, V46, P69, DOI 10.1016/j.mito.2018.02.008
   The UniProt C, 2018, NUCLEIC ACIDS RES, V47, P0
   The UniProt C, 2018, NUCLEIC ACIDS RES, V47, P0
   Tiranti V, 1999, NEUROMUSCULAR DISORD, V9, P66, DOI 10.1016/S0960-8966(98)00103-5
   Tranah GJ, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-30255-6
   Usami S, 1993, GENEREVIEWS, V0, P0
   Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Vives-Bauza C, 2003, J INHERIT METAB DIS, V26, P507, DOI 10.1023/A:1025133629685
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wei W, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1007126
   Wibrand F, 2010, MUSCLE NERVE, V41, P607, DOI 10.1002/mus.21541
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 94
TC 5
Z9 6
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD SEP 24
PY 2020
VL 15
IS 9
BP 
EP 
DI 10.1371/journal.pone.0233666
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NY2ZZ
UT WOS:000576265600050
PM 32970680
DA 2024-11-01
ER

PT J
AU Hathazi, D
   Griffin, H
   Jennings, MJ
   Giunta, M
   Powell, C
   Pearce, SF
   Munro, B
   Wei, W
   Boczonadi, V
   Poulton, J
   Pyle, A
   Calabrese, C
   Gomez-Duran, A
   Schara, U
   Pitceathly, RD
   Hanna, MG
   Joost, K
   Cotta, A
   Paim, JF
   Navarro, MM
   Duff, J
   Mattmann, A
   Chapman, K
   Servidei, S
   Della Marina, A
   Uusimaa, J
   Roos, A
   Mootha, V
   Hirano, M
   Tulinius, M
   Giri, M
   Hoffmann, EP
   Lochmuller, H
   DiMauro, S
   Minczuk, M
   Chinnery, PF
   Muller, JS
   Horvath, R
AF Hathazi, Denisa
   Griffin, Helen
   Jennings, Matthew J.
   Giunta, Michele
   Powell, Christopher
   Pearce, Sarah F.
   Munro, Benjamin
   Wei, Wei
   Boczonadi, Veronika
   Poulton, Joanna
   Pyle, Angela
   Calabrese, Claudia
   Gomez-Duran, Aurora
   Schara, Ulrike
   Pitceathly, Robert D. S.
   Hanna, Michael G.
   Joost, Kairit
   Cotta, Ana
   Paim, Julia Filardi
   Navarro, Monica Machado
   Duff, Jennifer
   Mattmann, Andre
   Chapman, Kristine
   Servidei, Serenella
   Della Marina, Adela
   Uusimaa, Johanna
   Roos, Andreas
   Mootha, Vamsi
   Hirano, Michio
   Tulinius, Mar
   Giri, Manta
   Hoffmann, Eric P.
   Lochmuller, Hanns
   DiMauro, Salvatore
   Minczuk, Michal
   Chinnery, Patrick F.
   Muller, Juliane S.
   Horvath, Rita
TI Metabolic shift underlies recovery in reversible infantile respiratory chain deficiency
SO EMBO JOURNAL
LA English
DT Article
DE digenic inheritance; homoplasmic tRNA mutation; mitochondrial myopathy; reversible infantile respiratory chain deficiency
ID citric-acid cycle; stress-response; mitochondrial translation; reaction-mechanism; fatty-acid; key role; rna; glutaminase; regulator; oxidation
AB Reversible infantile respiratory chain deficiency (RIRCD) is a rare mitochondrial myopathy leading to severe metabolic disturbances in infants, which recover spontaneously after 6-months of age. RIRCD is associated with the homoplasmic m.14674T>C mitochondrial DNA mutation; however, only similar to 1/100 carriers develop the disease. We studied 27 affected and 15 unaffected individuals from 19 families and found additional heterozygous mutations in nuclear genes interacting with mt-tRNAGlu including EARS2 and TRMU in the majority of affected individuals, but not in healthy carriers of m.14674T>C, supporting a digenic inheritance. Our transcriptomic and proteomic analysis of patient muscle suggests a stepwise mechanism where first, the integrated stress response associated with increased FGF21 and GDF15 expression enhances the metabolism modulated by serine biosynthesis, one carbon metabolism, TCA lipid oxidation and amino acid availability, while in the second step mTOR activation leads to increased mitochondrial biogenesis. Our data suggest that the spontaneous recovery in infants with digenic mutations may be modulated by the above described changes. Similar mechanisms may explain the variable penetrance and tissue specificity of other mtDNA mutations and highlight the potential role of amino acids in improving mitochondrial disease.
C1 [Hathazi, Denisa; Jennings, Matthew J.; Munro, Benjamin; Wei, Wei; Calabrese, Claudia; Gomez-Duran, Aurora; Chinnery, Patrick F.; Muller, Juliane S.; Horvath, Rita] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
   [Griffin, Helen; Giunta, Michele; Boczonadi, Veronika; Pyle, Angela; Duff, Jennifer] Newcastle Univ, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Powell, Christopher; Pearce, Sarah F.; Wei, Wei; Calabrese, Claudia; Gomez-Duran, Aurora; Minczuk, Michal; Chinnery, Patrick F.] MRC Mitochondrial Biol Unit, Cambridge, England.
   [Pearce, Sarah F.] Univ Stockholm, Karolinska Inst, Stockholm, Sweden.
   [Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.
   [Schara, Ulrike; Della Marina, Adela; Roos, Andreas] Univ Essen Gesamthsch, Pediat Neurol, Essen, Germany.
   [Pitceathly, Robert D. S.; Hanna, Michael G.] UCL Queen Sq Inst Neurol, Dept Neuromuscular Dis, London, England.
   [Pitceathly, Robert D. S.; Hanna, Michael G.] Natl Hosp Neurol & Neurosurg, London, England.
   [Joost, Kairit] East Tallinn Cent Hosp, Ctr Allergol & Immunol, Tallinn, Estonia.
   [Cotta, Ana; Paim, Julia Filardi] SARAH Network Rehabil Hosp, Neuromuscular Unit, Dept Pathol, Belo Horizonte, MG, Brazil.
   [Navarro, Monica Machado] SARAH Network Rehabil Hosp, Neuromuscular Unit, Dept Pediat, Belo Horizonte, MG, Brazil.
   [Mattmann, Andre; Chapman, Kristine] St Pauls Hosp, Dept Pathol & Lab Med SPH, Vancouver, BC, Canada.
   [Servidei, Serenella] Univ Cattolica Sacro Cuore, Dept Neurol, Rome, Italy.
   [Uusimaa, Johanna] Oulu Univ Hosp, Med Res Ctr Oulu, PEDEGO Res Unit Pediat Neurol, Oulu, Finland.
   [Uusimaa, Johanna] Univ Oulu, Oulu, Finland.
   [Roos, Andreas] Leibniz Inst Analyt Sci ISAS, Dortmund, Germany.
   [Mootha, Vamsi] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.
   [Hirano, Michio; DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
   [Tulinius, Mar] Univ Gothenburg, Sahlgrenska Acad, Dept Pediat, Gothenburg, Sweden.
   [Giri, Manta; Hoffmann, Eric P.] Binghampton Univ, Sch Pharm & Pharmaceut Sci, New York, NY USA.
   [Lochmuller, Hanns] Univ Freiburg, Med Ctr, Fac Med, Dept Neuropediat & Muscle Disorders, Freiburg, Germany.
   [Lochmuller, Hanns] Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat, Ctr Nacl Anal Genom CNAG CRG, Barcelona, Spain.
   [Lochmuller, Hanns] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada.
   [Lochmuller, Hanns] Ottawa Hosp, Div Neurol, Dept Med, Ottawa, ON, Canada.
C3 University of Cambridge; Newcastle University - UK; Stockholm University; Karolinska Institutet; University of Oxford; University of Duisburg Essen; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; St. Paul's Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Oulu; University of Oulu; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Columbia University; University of Gothenburg; University of Freiburg; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa Hospital Research Institute
RP Horvath, R (corresponding author), Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
EM rh732@medschl.cam.ac.uk
FU European Research Council [309548]; Wellcome Investigator Award [109915/Z/15/Z]; Medical Research Council (UK) [MR/N025431/1]; Wellcome Trust Pathfinder Scheme [201064/Z/16/Z]; Newton Fund [UK/Turkey] [MR/N027302/1]; Lily Foundation; Evelyn Trust; Medical Research Council Mitochondrial Biology Unit [MC_UU_00015/9]; Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease; National Institute for Health Research (NIHR) Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge; Bundesministerium fur Bildung und Forschung; French Muscular Dystrophy Association (AFMTelethon) [21466]; Canadian Institute of Health and Research [CIHR FDN-167281]; Medical Research Council Clinician Scientist Fellowship [MR/S002065/1]; Department of Health's NIHR BRC funding scheme; UK NHS; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; MRC [MC_UU_00015/4, MR/N025431/2, MR/J010448/1, MR/N025431/1, MR/N010035/1, G0800674, G1000848] Funding Source: UKRI; Newton Fund [MR/N027302/2, MR/N027302/1] Funding Source: UKRI
CR Aljohani A, 2019, J BIOL CHEM, V294, P19475, DOI 10.1074/jbc.RA119.009868
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bareth B, 2016, MOL BIOL CELL, V27, P1570, DOI 10.1091/mbc.E15-12-0811
   Bartsakoulia Marina, 2016, J NEUROMUSCUL DIS, V3, P363
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Boczonadi V, 2013, HUM MOL GENET, V22, P4602, DOI 10.1093/hmg/ddt309
   Burns DT, 2018, AM J HUM GENET, V102, P858, DOI 10.1016/j.ajhg.2018.03.011
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Duggan AT, 2014, AM J HUM GENET, V94, P721, DOI 10.1016/j.ajhg.2014.03.014
   Ferreira N, 2019, EMBO J, V38, P0, DOI 10.15252/embj.2019102155
   Forsström S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   FORSTER MEC, 1992, INT J BIOCHEM, V24, P1111, DOI 10.1016/0020-711X(92)90381-A
   Friederich MW, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06250-w
   García-Villegas R, 2017, J BIOL CHEM, V292, P10912, DOI 10.1074/jbc.M116.773077
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Griffin HR, 2014, GENET MED, V16, P962, DOI 10.1038/gim.2014.66
   Haapalainen AM, 2007, BIOCHEMISTRY-US, V46, P4305, DOI 10.1021/bi6026192
   Han Q, 2011, BIOSCIENCE REP, V31, P323, DOI 10.1042/BSR20100117
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   HOUSHMAND M, 1994, BBA-MOL BASIS DIS, V1226, P49, DOI 10.1016/0925-4439(94)90058-2
   Joost K, 2012, MOL SYNDROMOL, V3, P113, DOI 10.1159/000341375
   Kandasamy P, 2018, TRENDS BIOCHEM SCI, V43, P752, DOI 10.1016/j.tibs.2018.05.003
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kiema TR, 2014, ACTA CRYSTALLOGR D, V70, P3212, DOI 10.1107/S1399004714023827
   Koletzko B, 2018, ANN NUTR METAB, V73, P29, DOI 10.1159/000494780
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   LI S, 2000, EUR J HUM GENET, V22, P1040
   LIAW SH, 1994, BIOCHEMISTRY-US, V33, P675, DOI 10.1021/bi00169a007
   Love MI, 2014, GENOME BIOL, V15, P0, DOI 10.1186/s13059-014-0550-8
   Majer M, 1998, MOL GENET METAB, V65, P181, DOI 10.1006/mgme.1998.2748
   Masson GR, 2019, BIOCHEM SOC T, V47, P1481, DOI 10.1042/BST20190331
   Melber A, 2018, CELL RES, V28, P281, DOI 10.1038/cr.2018.16
   Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Moulinier L, 2017, HUM MUTAT, V38, P1316, DOI 10.1002/humu.23277
   Moyer Adam L, 2015, J NEUROMUSCUL DIS, V2, P371
   Nagara M, 2018, EUR J MED GENET, V61, P1, DOI 10.1016/j.ejmg.2017.10.002
   Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896
   Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200
   Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200
   Pabarcus MK, 2002, BBA-PROTEIN STRUCT M, V1596, P201, DOI 10.1016/S0167-4838(02)00232-7
   Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195
   Park S, 2018, DIABETES METAB J, V42, P270
   Pearce SF, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.27596
   Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, PD442, DOI 10.1093/nar/gky1106
   Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Reza M, 2017, NEUROMUSCULAR DISORD, V27, P1054, DOI 10.1016/j.nmd.2017.07.001
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784
   Roos A, 2019, FRONT IMMUNOL, V10, P0, DOI 10.3389/fimmu.2019.01040
   Sauer SW, 2007, J INHERIT METAB DIS, V30, P673, DOI 10.1007/s10545-007-0678-8
   Steele H, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911589
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   STURMAN JA, 1970, SCIENCE, V169, P74, DOI 10.1126/science.169.3940.74
   Talim B, 2013, BRAIN, V136, P0, DOI 10.1093/brain/aws197
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tillander V, 2014, CELL MOL LIFE SCI, V71, P933, DOI 10.1007/s00018-013-1422-1
   Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995
   van Karnebeek CDM, 2019, AM J HUM GENET, V105, P534, DOI 10.1016/j.ajhg.2019.07.015
   van Kuilenburg ABP, 2019, NEW ENGL J MED, V380, P1433, DOI 10.1056/NEJMoa1806627
   Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595
   von Holstein-Rathlou S, 2016, CELL METAB, V23, P335, DOI 10.1016/j.cmet.2015.12.003
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   Xia XJ, 2018, CELL DEATH DISCOV, V4, P0, DOI 10.1038/s41420-017-0022-5
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
   Zhang SH, 2017, J ANIM SCI BIOTECHNO, V8, P0, DOI 10.1186/s40104-016-0139-z
NR 71
TC 27
Z9 27
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD DEC 1
PY 2020
VL 39
IS 23
BP 
EP 
DI 10.15252/embj.2020105364
EA OCT 2020
PG 19
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA PB0KH
UT WOS:000582980600001
PM 33128823
DA 2024-11-01
ER

PT J
AU Farnezi, HCM
   Goulart, ACX
   dos Santos, A
   Ramos, MG
   Penna, MLF
AF Moreira Farnezi, Hana Carolina
   Xavier Goulart, Ana Carolina
   dos Santos, Adriana
   Ramos, Mariana Gontijo
   Firpe Penna, Maria Lecticia
TI Three-parent babies: Mitochondrial replacement therapies
SO JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA
LA English
DT Review
DE mitochondrial; mtDNA; mitochondrial mutations; mitochondrial donation; mitochondrial replacement; reproductive technology
ID assisted reproductive technology; preimplantation genetic diagnosis; pronuclear transfer; prevent transmission; genome transfer; disease; inheritance; embryos; birth
AB y The mitochondria are intracellular organelles, and just like the cell nucleus they have their own genome. They are extremely important for normal body functioning and are responsible for ATP production - the main energy source for the cell. Mitochondrial diseases are associated with mutations in mitochondrial DNA and are inherited exclusively from the mother. They can affect organs that depend on energy metabolism, such as skeletal muscles, the cardiac system, the central nervous system, the endocrine system, the retina and liver, causing various incurable diseases. Mitochondrial replacement techniques provide women with mitochondrial defects a chance to have normal biological children. The goal of such treatment is to reconstruct functional oocytes and zygotes, in order to avoid the inheritance of mutated genes; for this the nuclear genome is withdrawn from an oocyte or zygotes, which carries mitochondrial mutations, and is implanted in a normal anucleated cell donor. Currently, the options of a couple to prevent the transmission of mitochondrial diseases are limited, and mitochondrial donation techniques provide women with mitochondrial defects a chance to have normal children. The nuclear genome can be transferred from oocytes or zygotes using techniques such as pronuclear transfer, spindle transfer, polar body transfer and germinal vesicle transfer. This study presents a review of developed mitochondrial substitution techniques, and its ability to prevent hereditary diseases.
C1 [Moreira Farnezi, Hana Carolina; Xavier Goulart, Ana Carolina; dos Santos, Adriana; Ramos, Mariana Gontijo; Firpe Penna, Maria Lecticia] Univ FUMEC, Fac Ciencias Humanas, Belo Horizonte, MG, Brazil.
RP Penna, MLF (corresponding author), Univ FUMEC, Fac Ciencias Humanas, Belo Horizonte, MG, Brazil.
EM mlpenna@fumec.br
CR Adashi EY, 2018, TRENDS MOL MED, V24, P449, DOI 10.1016/j.molmed.2018.03.002
   Amato P, 2014, FERTIL STERIL, V101, P31, DOI 10.1016/j.fertnstert.2013.11.030
   Baylis F, 2017, BIOETHICS, V31, P7, DOI 10.1111/bioe.12309
   Bianco B, 2016, EINSTEIN-SAO PAULO, V14, P291, DOI 10.1590/S1679-45082016MD3561
   Chiaratti MR, 2018, CELL BIOL INT, V42, P711, DOI 10.1002/cbin.10947
   Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7
   Costa CM, 2016, REV SA DE FOCO, V3, P107
   Craven L, 2017, HUM REPROD UPDATE, V23, P501, DOI 10.1093/humupd/dmx018
   Craven L, 2011, HUM MOL GENET, V20, PR168, DOI 10.1093/hmg/ddr373
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Cree L, 2015, MOL HUM REPROD, V21, P3, DOI 10.1093/molehr/gau082
   Eyre-Walker A, 2017, GENETICS, V205, P1365, DOI 10.1534/genetics.116.196436
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Fragouli E, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005241
   Greenfield A, 2017, NAT BIOTECHNOL, V35, P1059, DOI 10.1038/nbt.3997
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Kasahara T, 2018, BIOL PSYCHIAT, V83, P731, DOI 10.1016/j.biopsych.2017.09.010
   Klopstock T, 2016, GENOME MED, V8, P0, DOI 10.1186/s13073-016-0380-2
   Laureano JFM, 2015, THESIS, V0, P0
   Ma H, 2017, CELL STEM CELL, V20, P112, DOI 10.1016/j.stem.2016.10.001
   MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250
   Mitalipov S, 2014, CELL REP, V7, P935, DOI 10.1016/j.celrep.2014.05.004
   Nogueira Célia, 2015, ARQ MED, V29, P11
   Richardson J, 2015, STEM CELLS, V33, P639, DOI 10.1002/stem.1887
   Schon EA, 2003, CURR MED CHEM, V10, P2523, DOI 10.2174/0929867033456503
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tanaka A, 2009, FERTIL STERIL, V92, P0
   Treff NR, 2012, FERTIL STERIL, V98, P1236, DOI 10.1016/j.fertnstert.2012.07.1119
   Volobueva AS, 2018, THER CLIN RISK MANAG, V14, P237, DOI 10.2147/TCRM.S153895
   Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042
   Wolf DP, 2017, EMBO J, V36, P2177, DOI 10.15252/embj.201797606
   Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001
   Wolf DP, 2014, CELL METAB, V20, P6, DOI 10.1016/j.cmet.2014.06.012
   Xu L, 2016, HUM FERTIL, V19, P222, DOI 10.1080/14647273.2016.1230234
   Yabuuchi A, 2012, BBA-GEN SUBJECTS, V1820, P637, DOI 10.1016/j.bbagen.2011.10.014
   Zhang J, 2017, REPROD BIOMED ONLINE, V34, P361, DOI 10.1016/j.rbmo.2017.01.013
   Zhang J, 2016, REPROD BIOMED ONLINE, V33, P529, DOI 10.1016/j.rbmo.2016.07.008
NR 39
TC 14
Z9 18
U1 3
U2 40
PU SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA
PI RIBEIRAO
PA SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA, RIBEIRAO, 00000, BRAZIL
SN 1517-5693
EI 1518-0557
J9 J BRAS REPROD ASSIST
JI J. Bras. Reprod. Assist.
PD APR-JUN 15
PY 2020
VL 24
IS 2
BP 189
EP 196
DI 10.5935/1518-0557.20190086
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA LD0XA
UT WOS:000525755600017
PM 32073245
DA 2024-11-01
ER

PT J
AU Schneider, AM
   ÖOzsoy, M
   Zimmermann, FA
   Feichtinger, RG
   Mayr, JA
   Kofler, B
   Sperl, W
   Weghuber, D
   Mörwald, K
AF Schneider, Anna M.
   Ozsoy, Mihriban
   Zimmermann, Franz A.
   Feichtinger, Rene G.
   Mayr, Johannes A.
   Kofler, Barbara
   Sperl, Wolfgang
   Weghuber, Daniel
   Moerwald, Katharina
TI Age-Related Deterioration of Mitochondrial Function in the Intestine
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Review
ID cytochrome-c-oxidase; respiratory-chain function; oxidative stress; skeletal-muscle; dna mutations; frailty syndrome; point mutations; stem-cells; complex-i; deletions
AB Aging is an important and inevitable biological process in human life, associated with the onset of chronic disease and death. The mechanisms behind aging remain unclear. However, changes in mitochondrial function and structure, including reduced activity of the mitochondrial respiratory chain and increased production of reactive oxygen species-thus oxidative damage-are believed to play a major role. Mitochondria are the main source of cellular energy, producing adenosine triphosphate (ATP) via oxidative phosphorylation. Accumulation of damaged cellular components reduces a body's capacity to preserve tissue homeostasis and affects biological aging and all age-related chronic conditions. This includes the onset and progression of classic degenerative diseases such as cardiovascular disease, kidney failure, neurodegenerative diseases, and cancer. Clinical manifestations of intestinal disorders, such as mucosal barrier dysfunction, intestinal dysmotility, and chronic obstipation, are highly prevalent in the elderly population and have been shown to be associated with an age-dependent decline of mitochondrial function. This review summarizes our current understanding of the role of mitochondrial dysfunction in intestinal aging.
C1 [Schneider, Anna M.; Ozsoy, Mihriban; Zimmermann, Franz A.; Feichtinger, Rene G.; Mayr, Johannes A.; Kofler, Barbara; Sperl, Wolfgang; Weghuber, Daniel; Moerwald, Katharina] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria.
   [Zimmermann, Franz A.; Feichtinger, Rene G.; Kofler, Barbara] Paracelsus Med Univ, Dept Pediat, Res Program Receptor Biochem & Tumor Metab, Salzburg, Austria.
C3 Paracelsus Private Medical University; Paracelsus Private Medical University
RP Weghuber, D (corresponding author), Paracelsus Med Univ, Dept Pediat, Salzburg, Austria.
EM d.weghuber@salk.at
FU "Association for Pediatric Research and Education," University Hospital of Pediatrics, Paracelsus Medical University, Salzburg, Austria
CR Acín-Pérez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   Acín-Pérez R, 2020, METHOD CELL BIOL, V155, P181, DOI 10.1016/bs.mcb.2019.12.002
   Acin-Pérez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x
   ANTONERXLEBEN F, 1983, MECH AGEING DEV, V23, P265, DOI 10.1016/0047-6374(83)90027-1
   Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8
   Beltrán B, 2010, INFLAMM BOWEL DIS, V16, P76, DOI 10.1002/ibd.21027
   Bertram R, 2006, J THEOR BIOL, V243, P575, DOI 10.1016/j.jtbi.2006.07.019
   Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Canugovi C, 2019, REDOX BIOL, V26, P0, DOI 10.1016/j.redox.2019.101288
   Chalmers S, 2016, J PHYSIOL-LONDON, V594, P4283, DOI 10.1113/JP271942
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   Chistiakov DA, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/238463
   Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   da Costa JP, 2016, AGEING RES REV, V29, P90, DOI 10.1016/j.arr.2016.06.005
   Dakubo GD, 2010, MITOCHONDRIAL GENETICS AND CANCER, V0, PP321, DOI 10.1007/978-3-642-11416-8_14
   Deepa SS, 2017, GEROSCIENCE, V39, P187, DOI 10.1007/s11357-017-9975-9
   Di Sabatino A, 2018, DIGEST LIVER DIS, V50, P533, DOI 10.1016/j.dld.2018.03.010
   Din S, 2014, CIRC RES, V115, P376, DOI 10.1161/CIRCRESAHA.115.304441
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   England K, 2017, EUR J PUBLIC HEALTH, V27, P9, DOI 10.1093/eurpub/ckx159
   Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, PG914, DOI 10.1152/ajpgi.00402.2011
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gidwaney NG, 2016, J CLIN GASTROENTEROL, V50, P819, DOI 10.1097/MCG.0000000000000650
   Greaves LC, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003082
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174
   Guha M, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0206897
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   HSIEH RH, 1994, BIOCHEM MOL BIOL INT, V32, P1009
   Inglés M, 2014, J AM GERIATR SOC, V62, P1324, DOI 10.1111/jgs.12876
   Kim MJ, 2019, EXP GERONTOL, V125, P0, DOI 10.1016/j.exger.2019.110675
   Kozlov AV, 2005, BBA-MOL BASIS DIS, V1740, P382, DOI 10.1016/j.bbadis.2004.11.004
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14
   Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106
   Lefai E, 1997, BBA-BIOENERGETICS, V1318, P191, DOI 10.1016/S0005-2728(96)00136-3
   Letts JA, 2019, MOL CELL, V75, P1131, DOI 10.1016/j.molcel.2019.07.022
   Letts JA, 2017, NAT STRUCT MOL BIOL, V24, P800, DOI 10.1038/nsmb.3460
   Lobo-Jarne T, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2019103912
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lowes DA, 2013, BRIT J ANAESTH, V110, P472, DOI 10.1093/bja/aes577
   Man AL, 2015, CLIN SCI, V129, P515, DOI 10.1042/CS20150046
   McQuade RM, 2016, BRIT J PHARMACOL, V173, P3502, DOI 10.1111/bph.13646
   Mellem D, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0174469
   Michielan A, 2015, MEDIAT INFLAMM, V2015, P0, DOI 10.1155/2015/628157
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mitchell EL, 2017, J NUTR HEALTH AGING, V21, P354, DOI 10.1007/s12603-016-0725-y
   Moher D, 2015, SYST REV-LONDON, V4, P0, DOI 10.1371/journal.pmed.1000097
   Mohler MJ, 2014, EXP GERONTOL, V54, P6, DOI 10.1016/j.exger.2014.01.024
   Moore AZ, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011069
   Moorefield EC, 2017, AGING-US, V9, P1898, DOI 10.18632/aging.101279
   Mora AL, 2017, J CLIN INVEST, V127, P405, DOI 10.1172/JCI87440
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Nagarajan P, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.12992
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, PC670, DOI 10.1152/ajpcell.00213.2006
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nooteboom M, 2010, AGING CELL, V9, P96, DOI 10.1111/j.1474-9726.2009.00531.x
   OMahoney D, 2002, DRUG AGING, V19, P515, DOI 10.2165/00002512-200219070-00005
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Olgar Y, 2018, EXP GERONTOL, V110, P172, DOI 10.1016/j.exger.2018.06.012
   Özsoy M, 2020, EXP GERONTOL, V135, P0, DOI 10.1016/j.exger.2020.110924
   Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200
   Regmi SG, 2014, AGING-US, V6, P118, DOI 10.18632/aging.100639
   Reichart G, 2019, ACTA PHYSIOL, V225, P0, DOI 10.1111/apha.13214
   Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008
   Rybka V, 2019, ANTIOXIDANTS-BASEL, V8, P0, DOI 10.3390/antiox8060171
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Savitha S, 2006, MECH AGEING DEV, V127, P349, DOI 10.1016/j.mad.2005.12.004
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Schiavi A, 2014, EXP GERONTOL, V56, P147, DOI 10.1016/j.exger.2014.02.015
   Sedelnikova OA, 2010, MUTAT RES-REV MUTAT, V704, P152, DOI 10.1016/j.mrrev.2009.12.005
   Serviddio G, 2009, INT J IMMUNOPATH PH, V22, P819, DOI 10.1177/039463200902200328
   Sifroni KG, 2010, MOL CELL BIOCHEM, V342, P111, DOI 10.1007/s11010-010-0474-x
   Stahon KE, 2016, J NEUROSCI, V36, P9990, DOI 10.1523/JNEUROSCI.1316-16.2016
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Szeto HH, 2018, ARCH BIOCHEM BIOPHYS, V660, P137, DOI 10.1016/j.abb.2018.10.013
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Troen BR, 2003, MT SINAI J MED, V70, P3
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tsurudome Y, 2001, J GERONTOL A-BIOL, V56, PB483, DOI 10.1093/gerona/56.11.B483
   Tuo BG, 2012, AM J PHYSIOL-GASTR L, V303, PG1312, DOI 10.1152/ajpgi.00035.2012
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Vasileiou PVS, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18081821
   Vásquez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Viña J, 2018, FREE RADICAL BIO MED, V124, P358, DOI 10.1016/j.freeradbiomed.2018.06.028
   Vissing J, 2002, NEUROLOGY, V59, P926, DOI 10.1212/WNL.59.6.926
   Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Walston J, 2008, J GERONTOL A-BIOL, V63, P391, DOI 10.1093/gerona/63.4.391
   Wu IC, 2009, J AM GERIATR SOC, V57, P1666, DOI 10.1111/j.1532-5415.2009.02392.x
   Xue X, 2017, P NATL ACAD SCI USA, V114, PE9608, DOI 10.1073/pnas.1712946114
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   Zeki SS, 2011, NAT REV GASTRO HEPAT, V8, P90, DOI 10.1038/nrgastro.2010.211
   Zhang XY, 2010, HEPATOLOGY, V52, P2137, DOI 10.1002/hep.23909
   ZsNagy I, 1997, J MOL MED, V75, P703
NR 117
TC 11
Z9 11
U1 0
U2 13
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD AUG 19
PY 2020
VL 2020
IS 
BP 
EP 
DI 10.1155/2020/4898217
PG 12
WC Cell Biology
SC Cell Biology
GA NL0QN
UT WOS:000567130800001
PM 32922652
DA 2024-11-01
ER

PT J
AU Kamal, NZM
   Dangnga, MS
   Irmayani
   Naim, DM
AF Kamal, Nur Zawani Mustafa
   Dangnga, Muhammad Siri
   Irmayani
   Naim, Darlina Md
TI Species identification and genetic diversity of <i>Aedes</i> in Penang (Malaysia) based on Cytochrome Oxidase Subunit I
SO NUSANTARA BIOSCIENCE
LA English
DT Article
DE Aedes; COI; dengue; mtDNA; phylogenetics
ID nucleotide substitutions; mitochondrial; populations; dna
AB Cases of dengue fever are expanding globally and recently it was identified as being notable in remote/rural regions in South-East Asia in spite of the previous belief that it is outbreak to urban areas, especially in Malaysia. In an effort to constraint, the extent of the virus, the most important thing is to know the distribution of the vector that causes the disease. This research aims to recognize all species of mosquitoes distributed in Penang utilizing DNA barcode method in which the mtDNA cytochrome oxidase subunit 1 (COI) as a gene marker. Approximately 497 larvae of mosquitoes were obtained from four regions in Penang, Malaysia namely Central Seberang Perai, North Seberang Perai, North East, and South West of Penang. All samples were extracted and PCR amplified. Sequences were employed in BLAST of GenBank and aligned with MUSCLE. The ABGD analysis was performed to partition all the samples and substitution saturation analysis was employed in DAMBE. Phylogenetic relationships among nucleotides were reconstructed utilizing Maximum Likelihood (ML) and Neighbor-Joining (NJ) calculated following Kimura 2-parameter. Tatra and interspecific genetic variation among population were also conducted based on Tamura-Nei parameter and all analyses were employed in MEGA version 6.0. As a result, COI gene has successfully recognized all larvae obtained in this study. We found a total of six species (including outgroup sequence) as revealed by BLASTn, ABGD and phylogenetic analysis. Genetic distance test has further supported the results. This study revealed that there is no visible population structure and all species have a uniform distribution throughout all sampling locations in Penang. We also found that Ae. albopictus has occupied most areas in Penang, and this includes urban locations, hence, suggest that Ae. albopictus probably succeed Ae. aegypti as the main vector for dengue virus in Penang.
C1 [Kamal, Nur Zawani Mustafa; Naim, Darlina Md] Univ Sains Malaysia, Sch Biol Sci, P Pinang 11800, Malaysia.
   [Dangnga, Muhammad Siri] Univ Muhammadiyah Parepare, Postgrad Program, Parepare 91112, South Sulawesi, Indonesia.
   [Irmayani] Univ Muhammadiyah Parepare, Fac Agr Anim Husb & Fisheries, Parepare 91112, South Sulawesi, Indonesia.
C3 Universiti Sains Malaysia; Universitas Muhammadiyah Parepare; Universitas Muhammadiyah Parepare
RP Naim, DM (corresponding author), Univ Sains Malaysia, Sch Biol Sci, P Pinang 11800, Malaysia.
EM darlinamdn@usm.my
FU Ministry of Education Malaysia [304/PBIO/650576]; Universiti Sains Malaysia, Penang, Malaysia [1001/PBIOLOGI/8011068]
CR Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692
   Alshehri MSA, 2013, WORLD APPLIED SCIENCES JOURNAL, V22, P506
   [Anonymous], 1988, THE NATURAL HISTORY OF LARVAL MOSQUITO HABITATS, V0, P0
   [Anonymous], 1993, MOSQUITO ECOLOGY - FIELD SAMPLING METHODS, V0, P0
   Barbosa NCCP, 2014, REV BRAS ENTOMOL, V58, P203, DOI 10.1590/S0085-56262014000200012
   Barry GH, 1942, PHYLOGENETIC TREES M, V0, P0
   Bonacum J, 2001, DROSOPHILA INFORMATION SERVICE, V84, P201
   Brelsfoard CL, 2012, PARASITE VECTOR, V5, P0, DOI 10.1186/1756-3305-5-80
   Chung Chao-Lin, 1997, CHINESE JOURNAL OF ENTOMOLOGY, V17, P86
   Gutiérrez MAC, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0085496
   Delatte H, 2013, PLOS NEGLECT TROP D, V7, P0, DOI 10.1371/journal.pntd.0002111
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Engdahl C, 2014, MOL ECOL RESOUR, V14, P478, DOI 10.1111/1755-0998.12202
   Feng XR, 2003, P NATL ACAD SCI USA, V100, P8502, DOI 10.1073/pnas.1232502100
   Goswami RP, 2012, J INFECT DEV COUNTR, V6, P208, DOI 10.3855/jidc.2241
   Graur D, 2000, FUNDAMENTALS OF MOLECULAR EVOLUTION, V2nd, P0
   Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, P0, DOI 10.1186/1742-7622-2-1
   Harbach R, 2008, FAMILY CULICIDAE MEI, V0, P0
   Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008
   JUKES T H, 1969, P21, V0, P0
   JUKES TH, 1986, J MOL EVOL, V24, P39, DOI 10.1007/BF02099949
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Minakawa N, 2002, AM J TROP MED HYG, V67, P32, DOI 10.4269/ajtmh.2002.67.32
   Ministry of Health Malaysia, 2014, KEN AKHB SIT SEM DEM, V0, P0
   Novak R, 1992, AEDES ALBOPICTUS WIN, V3, P5
   Provan J, 2005, MOL ECOL, V14, P793, DOI 10.1111/j.1365-294X.2005.02447.x
   Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x
   Talbalaghi A, 2011, EUR J ENTOMOL, V108, P35, DOI 10.14411/eje.2011.004
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tolle Michael A, 2009, CURR PROBL PEDIATR ADOLESC HEALTH CARE, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4
   World Health Organization, 2005, DENG SEV DENG, V0, P0
   Xia X, 2008, DAMBE DATA ANAL MOLE, V0, P0
   Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064
NR 36
TC 1
Z9 2
U1 0
U2 1
PU UNIV SEBELAS MARET
PI SURAKARTA
PA IR SUTAMI 36 A, SURAKARTA, 57126, INDONESIA
SN 2087-3948
EI 2087-3956
J9 NUSANT BIOSCI
JI Nusant. Biosci.
PD MAY 15
PY 2020
VL 12
IS 1
BP 6
EP 12
DI 10.13057/nusbiosci/n120102
PG 7
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA NB6ZI
UT WOS:000560662800002
DA 2024-11-01
ER

PT J
AU Gervasoni, J
   Primiano, A
   Marini, F
   Sabino, A
   Biancolillo, A
   Calvani, R
   Picca, A
   Marzetti, E
   Persichilli, S
   Urbani, A
   Servidei, S
   Primiano, G
AF Gervasoni, Jacopo
   Primiano, Aniello
   Marini, Federico
   Sabino, Andrea
   Biancolillo, Alessandra
   Calvani, Riccardo
   Picca, Anna
   Marzetti, Emanuele
   Persichilli, Silvia
   Urbani, Andrea
   Servidei, Serenella
   Primiano, Guido
TI Fourier-Transform Infrared Spectroscopy of Skeletal Muscle Tissue: Expanding Biomarkers in Primary Mitochondrial Myopathies
SO GENES
LA English
DT Article
DE mitochondrial diseases; FTIR; biomarkers; metabolomics; differential diagnosis; mtDNA; oculopharyngeal muscular dystrophy (OPMD); progressive external ophthalmoplegia (PEO); personalized medicine
ID dna; deletions; disease; tool
AB Primary mitochondrial myopathies (PMM) are a group of mitochondrial disorders characterized by a predominant skeletal muscle involvement. The aim of this study was to evaluate whether the biochemical profile determined by Fourier-transform infrared (FTIR) spectroscopic technique would allow to distinguish among patients affected by progressive external ophthalmoplegia (PEO), the most common PMM presentation, oculopharyngeal muscular dystrophy (OPMD), and healthy controls. Thirty-four participants were enrolled in the study. FTIR spectroscopy was found to be a sensitive and specific diagnostic marker for PEO. In particular, FTIR spectroscopy was able to distinguish PEO patients from those affected by OPMD, even in the presence of histological findings similar to mitochondrial myopathy. At the same time, FTIR spectroscopy differentiated single mtDNA deletion and mutations in POLG, the most common nuclear gene associated with mitochondrial diseases, with high sensitivity and specificity. In conclusion, our data suggest that FTIR spectroscopy is a valuable biodiagnostic tool for the differential diagnosis of PEO with a high ability to also distinguish between single mtDNA deletion and mutations in POLG gene based on specific metabolic transitions.
C1 [Gervasoni, Jacopo; Primiano, Aniello; Calvani, Riccardo; Picca, Anna; Marzetti, Emanuele; Persichilli, Silvia; Urbani, Andrea; Servidei, Serenella; Primiano, Guido] Fdn Policlin Univ A Gemelli IRCCS, I-00168 Rome, Italy.
   [Primiano, Aniello; Sabino, Andrea; Marzetti, Emanuele; Persichilli, Silvia; Urbani, Andrea; Servidei, Serenella; Primiano, Guido] Univ Cattolica Sacro Cuore, I-00168 Rome, Italy.
   [Marini, Federico] Sapienza Univ Roma, Dept Chem, I-00185 Rome, Italy.
   [Biancolillo, Alessandra] Univ Aquila, Dept Phys & Chem Sci, I-67100 Laquila, Italy.
   [Calvani, Riccardo; Picca, Anna] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, S-17177 Stockholm, Sweden.
   [Calvani, Riccardo; Picca, Anna] Stockholm Univ, S-17177 Stockholm, Sweden.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; University of L'Aquila; Karolinska Institutet; Stockholm University
RP Primiano, G (corresponding author), Fdn Policlin Univ A Gemelli IRCCS, I-00168 Rome, Italy.; Primiano, G (corresponding author), Univ Cattolica Sacro Cuore, I-00168 Rome, Italy.
EM jacopo.gervasoni@policlinicogemelli.it; aniello.primiano@unicatt.it; federico.marini@uniroma1.it; andrea.sabino@unicatt.it; alessandra.biancolilllo@univaq.it; riccardo.calvani@guest.policlinicogemelli.it; anna.picca@guest.policlinicogemelli.it; emanuele.marzetti@policlinicogemelli.it; silvia.persichilli@policlinicogemelli.it; andrea.urbani@policlinicogemelli.it; serenella.servidei@unicatt.it; guidoalessandro.primiano@policlinicogemelli.it
FU [870177]
CR [Anonymous], 2020, J INHERIT METAB 1118, V0, P0
   Cocchi M, 2018, COMPR. ANAL. CHEM, V82, P265, DOI 10.1016/bs.coac.2018.08.006
   De Vries MC, 2020, J INHERIT METAB DIS, V43, P800, DOI 10.1002/jimd.12196
   Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Primiano A, 2014, DIS MARKERS, V2014, P0, DOI 10.1155/2014/176165
   Roger JM, 2011, CHEMOMETR INTELL LAB, V106, P216, DOI 10.1016/j.chemolab.2010.10.003
   Romanò S, 2020, ANAL CHIM ACTA, V1140, P219, DOI 10.1016/j.aca.2020.09.037
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Sjostrom M, 1986, PATTERN RECOGN, V0, P461
   Smit S, 2007, ANAL CHIM ACTA, V592, P210, DOI 10.1016/j.aca.2007.04.043
   Szymanska E, 2012, METABOLOMICS, V8, PS3, DOI 10.1007/s11306-011-0330-3
   Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 22
TC 7
Z9 7
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD DEC 15
PY 2020
VL 11
IS 12
BP 
EP 
DI 10.3390/genes11121522
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA PJ8HC
UT WOS:000602000400001
PM 33352713
DA 2024-11-01
ER

PT J
AU Smolina, N
   Khudiakov, A
   Knyazeva, A
   Zlotina, A
   Sukhareva, K
   Kondratov, K
   Gogvadze, V
   Zhivotovsky, B
   Sejersen, T
   Kostareva, A
AF Smolina, Natalia
   Khudiakov, Aleksandr
   Knyazeva, Anastasiya
   Zlotina, Anna
   Sukhareva, Kseniya
   Kondratov, Kirill
   Gogvadze, Vladimir
   Zhivotovsky, Boris
   Sejersen, Thomas
   Kostareva, Anna
TI Desmin mutations result in mitochondrial dysfunction regardless of their aggregation properties
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Desmin; Extracellular vesicles; Mitochondria; mtDNA; Satellite cells; Skeletal myopathy
ID intermediate-filaments; energy-metabolism; skeletal-muscle; cytoskeleton; respiration; myopathy; desminopathy; release; plectin; cells
AB Desmin, being a major intermediate filament of muscle cells, contributes to stabilization and positioning of mitochondria. Desmin mutations have been reported in conjunction with skeletal myopathies accompanied by mitochondrial dysfunction. Depending on the ability to promote intracellular aggregates formation, mutations can be considered aggregate-prone or non-aggregate-prone. The aim of the present study was to describe how expression of different desmin mutant isoforms effects mitochondria and contributes to the development of myocyte dysfunction. To achieve this goal, two non-aggregate-prone (Des S12F and Des A213V) and four aggregate-prone (Des L345P, Des A357P, Des L370P, Des D399Y) desmin mutations were expressed in skeletal muscle cells. We showed that all evaluated mutations affected the morphology of mitochondrial network, suppressed parameters of mitochondrial respiration, diminished mitochondrial membrane potential, increased ADP/ATP ratio, and enhanced mitochondrial DNA (mtDNA) release. mtDNA was partially secreted through exosomes as demonstrated by GW4869 treatment. Dysfunction of mitochondria was observed regardless the type of mutation: aggregate-prone or non-aggregate-prone. However, expression of aggregate-prone mutations resulted in more prominent phenotype. Thus, in this comparative study of six pathogenic desmin mutations that cause skeletal myopathy development, we confirmed a role of mitochondrial dysfunction and mtDNA release in the pathogenesis of desmin myopathies, regardless of the aggregation capacity of the mutated desmin.
C1 [Smolina, Natalia; Khudiakov, Aleksandr; Knyazeva, Anastasiya; Zlotina, Anna; Sukhareva, Kseniya; Kondratov, Kirill; Kostareva, Anna] Almazov Natl Med Res Ctr, St Petersburg, Russia.
   [Smolina, Natalia; Sejersen, Thomas; Kostareva, Anna] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.
   [Sukhareva, Kseniya] Univ Verona, Verona, Italy.
   [Gogvadze, Vladimir; Zhivotovsky, Boris] Lomonosov Moscow State Univ, Fac Med, Moscow, Russia.
   [Gogvadze, Vladimir; Zhivotovsky, Boris] Karolinska Inst, Inst Environm Med, Stockholm, Sweden.
C3 Almazov National Medical Research Centre; Karolinska Institutet; University of Verona; Lomonosov Moscow State University; Karolinska Institutet
RP Smolina, N (corresponding author), Almazov Natl Med Res Ctr, St Petersburg, Russia.
EM natalia.smolina@ki.se
FU Russian Science Foundation [19-14-00122, 14-16-00745]; Swedish Institute [25932/2018]; Swedish Cancer Societies [190345]; Stockholm County Council [20170831]; Stiftelsen Frimurare Foundation [190528]; Promobilia [19039];  [181301]; Russian Science Foundation [19-14-00122] Funding Source: Russian Science Foundation
CR Alam S, 2018, J AM HEART ASSOC, V7, P0, DOI 10.1161/JAHA.118.009289
   Appaix F, 2003, EXP PHYSIOL, V88, P175, DOI 10.1113/eph8802511
   Arias M, 2006, NEUROMUSCULAR DISORD, V16, P498, DOI 10.1016/j.nmd.2006.05.011
   Bär H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068
   Balaban RS, 2009, J MOL CELL CARDIOL, V46, P832, DOI 10.1016/j.yjmcc.2009.02.018
   Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082
   Brodehl Andreas, 2018, BIOPHYS REV, V10, P983, DOI 10.1007/s12551-018-0429-0
   Cabet E, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0137009
   Chernoivanenko IS, 2015, FASEB J, V29, P820, DOI 10.1096/fj.14-259903
   Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6
   Cudré-Mauroux C, 2003, HUM GENE THER, V14, P1525, DOI 10.1089/104303403322495034
   Dalakas MC, 2003, NEUROMUSCULAR DISORD, V13, P252, DOI 10.1016/S0960-8966(02)00271-7
   Dedkova EN, 2008, CELL CALCIUM, V44, P77, DOI 10.1016/j.ceca.2007.11.002
   Dold T, 2012, NEUROMUSCULAR DISORD, V22, P822, DOI 10.1016/j.nmd.2012.06.070
   Fearon U, 2016, NAT REV RHEUMATOL, V12, P385, DOI 10.1038/nrrheum.2016.69
   Fidzianska A, 2005, NEUROMUSCULAR DISORD, V15, P525, DOI 10.1016/j.nmd.2005.05.006
   Forterre A, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0084153
   Fountoulakis M, 2005, J MOL CELL CARDIOL, V38, P461, DOI 10.1016/j.yjmcc.2004.12.008
   Goldfarb LG, 2008, ADV EXP MED BIOL, V642, P131
   Gonzalez-Hunt Claudia P, 2016, CURR PROTOC TOXICOL, V67, P0, DOI 10.1002/0471140856.tx2011s67
   Goudeau B, 2006, HUM MUTAT, V27, P906, DOI 10.1002/humu.20351
   Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006
   Jackson S, 2015, EUR J NEUROL, V22, P1429, DOI 10.1111/ene.12814
   Kay L, 1997, BBA-BIOENERGETICS, V1322, P41, DOI 10.1016/S0005-2728(97)00071-6
   Kostareva A, 2006, ACTA MYOL, V25, P109
   Kreplak L, 2009, J MOL BIOL, V385, P1043, DOI 10.1016/j.jmb.2008.10.095
   LAZARIDES E, 1976, P NATL ACAD SCI USA, V73, P4344, DOI 10.1073/pnas.73.12.4344
   Lowery J, 2015, J BIOL CHEM, V290, P17145, DOI 10.1074/jbc.R115.640359
   Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516
   MCCORMACK JG, 1990, P NUTR SOC, V49, P57, DOI 10.1079/PNS19900009
   McCormick EM, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00199
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Nakahira K, 2015, ANTIOXID REDOX SIGN, V23, P1329, DOI 10.1089/ars.2015.6407
   Patrushev M, 2004, CELL MOL LIFE SCI, V61, P3100, DOI 10.1007/s00018-004-4424-1
   Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Reipert S, 1999, EXP CELL RES, V252, P479, DOI 10.1006/excr.1999.4626
   Schröder R, 2003, HUM MOL GENET, V12, P657, DOI 10.1093/hmg/ddg060
   Segard BD, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0076361
   Sjöberg G, 1999, HUM MOL GENET, V8, P2191, DOI 10.1093/hmg/8.12.2191
   Smolina N, 2017, METHODS MOL BIOL, V1601, P79, DOI 10.1007/978-1-4939-6960-9_7
   Smolina N, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/594751
   Smolina N, 2014, CELL CALCIUM, V56, P269, DOI 10.1016/j.ceca.2014.08.001
   Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991
   THORNELL LE, 1980, J NEUROL SCI, V47, P153, DOI 10.1016/0022-510X(80)90001-5
   Tsikitis Mary, 2018, BIOPHYS REV, V10, P1007, DOI 10.1007/s12551-018-0443-2
   Varhaug KN, 2017, MITOCHONDRION, V34, P32, DOI 10.1016/j.mito.2016.12.003
   Varikmaa M, 2014, BBA-BIOENERGETICS, V1837, P232, DOI 10.1016/j.bbabio.2013.10.011
   Vernengo L, 2010, NEUROMUSCULAR DISORD, V20, P178, DOI 10.1016/j.nmd.2010.01.001
   Vincent AE, 2016, NEUROMUSCULAR DISORD, V26, P691, DOI 10.1016/j.nmd.2016.08.004
   Vrabie A, 2005, ACTA NEUROPATHOL, V109, P411, DOI 10.1007/s00401-005-0980-1
   WEBER K, 1985, ANN NY ACAD SCI, V455, P126, DOI 10.1111/j.1749-6632.1985.tb50408.x
   Winter L, 2019, NEUROPATH APPL NEURO, V45, P476, DOI 10.1111/nan.12516
   Winter L, 2016, ACTA NEUROPATHOL, V132, P453, DOI 10.1007/s00401-016-1592-7
NR 54
TC 23
Z9 23
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JUN 1
PY 2020
VL 1866
IS 6
BP 
EP 
DI 10.1016/j.bbadis.2020.165745
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA LG2PT
UT WOS:000527950000009
PM 32105824
DA 2024-11-01
ER

PT J
AU Gao, J
   Collyer, J
   Wang, MC
   Sun, FP
   Xu, FY
AF Gao, Jun
   Collyer, John
   Wang, Maochun
   Sun, Fengping
   Xu, Fuyi
TI Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE hypertrophic cardiomyopathy; RNA-seq; pathogenic variants; differential gene expression; gene network
ID genotype-phenotype associations; delta-sarcoglycan gene; muscle lim protein; dilated cardiomyopathy; mitochondrial-dna; mutations; titin; powerful; children; fibrosis
AB Hypertrophic cardiomyopathy (HCM) is an inherited disorder of the myocardium, and pathogenic mutations in the sarcomere genes myosin heavy chain 7 (MYH7) and myosin-binding protein C (MYBPC3) explain 60%-70% of observed clinical cases. The heterogeneity of phenotypes observed in HCM patients, however, suggests that novel causative genes or genetic modifiers likely exist. Here, we systemically evaluated RNA-seq data from 28 HCM patients and 9 healthy controls with pathogenic variant identification, differential expression analysis, and gene co-expression and protein-protein interaction network analyses. We identified 43 potential pathogenic variants in 19 genes in 24 HCM patients. Genes with more than one variant included the following: MYBPC3, TTN, MYH7, PSEN2, and LDB3. A total of 2538 protein-coding genes, six microRNAs (miRNAs), and 1617 long noncoding RNAs (lncRNAs) were identified differentially expressed between the groups, including several well-characterized cardiomyopathy-related genes (ANKRD1, FHL2, TGFB3, miR-30d, and miR-154). Gene enrichment analysis revealed that those genes are significantly involved in heart development and physiology. Furthermore, we highlighted four subnetworks: mtDNA-subnetwork, DSP-subnetwork, MYH7-subnetwork, and MYBPC3-subnetwork, which could play significant roles in the progression of HCM. Our findings further illustrate that HCM is a complex disease, which results from mutations in multiple protein-coding genes, modulation by non-coding RNAs and perturbations in gene networks.
C1 [Gao, Jun; Xu, Fuyi] Univ Tennessee, Ctr Hlth Sci, Dept Genet Genom & Informat, Memphis, TN 38163 USA.
   [Gao, Jun; Sun, Fengping] Shanghai Acad Agr Sci, Inst Anim Husb & Vet Sci, Shanghai 201106, Peoples R China.
   [Collyer, John] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA.
   [Wang, Maochun] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
C3 University of Tennessee System; University of Tennessee Health Science Center; Shanghai Academy of Agricultural Sciences; University of Tennessee System; University of Tennessee Health Science Center; Donghua University
RP Xu, FY (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Genet Genom & Informat, Memphis, TN 38163 USA.; Sun, FP (corresponding author), Shanghai Acad Agr Sci, Inst Anim Husb & Vet Sci, Shanghai 201106, Peoples R China.
EM jgao21@uthsc.edu; jcollyer@uthsc.edu; wangmaochun0815@163.com; sfp_hot@163.com; fxu10@uthsc.edu
CR Akhtar M, 2018, GLOB CARDIOL SCI PRA, V36, P1
   Alila-Fersi O, 2017, BIOCHEM BIOPH RES CO, V484, P71, DOI 10.1016/j.bbrc.2017.01.070
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Arimura T, 2000, HUM GENET, V107, P440, DOI 10.1007/s004390000389
   Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bernardo BC, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep22442
   Bhandary B, 2018, J AM HEART ASSOC, V7, P0, DOI 10.1161/JAHA.118.010013
   Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329
   Bonne G, 1998, CIRC RES, V83, P580, DOI 10.1161/01.RES.83.6.580
   Bos JM, 2006, MOL GENET METAB, V88, P78, DOI 10.1016/j.ymgme.2005.10.008
   Bukauskas T, 2019, MED SCI MONITOR, V25, P3925, DOI 10.12659/MSM.913743
   Burns C, 2017, CIRC-CARDIOVASC GENE, V10, P0, DOI 10.1161/CIRCGENETICS.116.001666
   Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699
   Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560
   Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4
   De Bortoli M, 2017, EUR J HUM GENET, V25, P1165, DOI 10.1038/ejhg.2017.109
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dong P, 2018, EUR REV MED PHARMACO, V22, P2052, DOI 10.26355/eurrev_201804_14735
   Duggan DJ, 1997, NEUROGENETICS, V1, P49, DOI 10.1007/s100480050008
   Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002
   Fang L, 2015, J TRANSL MED, V13, P0, DOI 10.1186/s12967-015-0672-0
   Forleo C, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0181842
   Friedrich FW, 2014, BASIC RES CARDIOL, V109, P0, DOI 10.1007/s00395-014-0451-8
   FUJII J, 1991, J BIOL CHEM, V266, P11669
   Geier C, 2008, HUM MOL GENET, V17, P2753, DOI 10.1093/hmg/ddn160
   Gupte TM, 2015, J BIOL CHEM, V290, P7003, DOI 10.1074/jbc.M114.596676
   Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108
   Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065
   Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058
   He Y, 2010, J CARDIOVASC MAGN R, V12, P0, DOI 10.1186/1532-429X-12-68
   Hobuss L, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00030
   Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6
   Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448
   Jacoby D, 2012, EUR HEART J, V33, P296, DOI 10.1093/eurheartj/ehr260
   Jensen MK, 2013, CIRCULATION, V127, P48, DOI 10.1161/CIRCULATIONAHA.111.090514
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, P0, DOI 10.1186/1471-2105-9-559
   Li DX, 2006, AM J HUM GENET, V79, P1030, DOI 10.1086/509900
   Li YY, 1997, J MOL CELL CARDIOL, V29, P2699, DOI 10.1006/jmcc.1997.0501
   Liu XY, 2019, SCI DATA, V6, P0, DOI 10.1038/s41597-019-0094-6
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Lopes LR, 2015, HEART, V101, P294, DOI 10.1136/heartjnl-2014-306387
   Lopes LR, 2013, HEART, V99, P1800, DOI 10.1136/heartjnl-2013-303939
   Love MI, 2014, GENOME BIOL, V15, P0, DOI 10.1186/s13059-014-0550-8
   Marchese FP, 2017, GENOME BIOL, V18, P0, DOI 10.1186/s13059-017-1348-2
   Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3
   Maron MS, 2012, J CARDIOVASC MAGN R, V14, P0, DOI 10.1186/1532-429X-14-13
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005
   Minamisawa S, 2003, BIOCHEM BIOPH RES CO, V304, P1, DOI 10.1016/S0006-291X(03)00526-6
   Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2
   Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463
   Ono H, 2010, INTERNAL MED, V49, P2039, DOI 10.2169/internalmedicine.49.3710
   Pacheu-Grau D, 2015, CELL METAB, V21, P823, DOI 10.1016/j.cmet.2015.04.012
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Rader EP, 2016, P NATL ACAD SCI USA, V113, P10992, DOI 10.1073/pnas.1605265113
   Rajewsky N, 2006, NAT GENET, V38, PS8, DOI 10.1038/ng1798
   Ramírez Carlos Darío, 2004, INVEST. CLÍN, V45, P69
   Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208
   Ransohoff JD, 2018, NAT REV MOL CELL BIO, V19, P143, DOI 10.1038/nrm.2017.104
   Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54
   Sabater-Molina M, 2018, CLIN GENET, V93, P3, DOI 10.1111/cge.13027
   Schmitz SU, 2016, CELL MOL LIFE SCI, V73, P2491, DOI 10.1007/s00018-016-2174-5
   Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019
   Song Y, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050436
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, PD607, DOI 10.1093/nar/gky1131
   Templin C, 2011, EUR HEART J, V32, P1077, DOI 10.1093/eurheartj/ehr076
   Toepfer CN, 2019, SCI TRANSL MED, V11, P0, DOI 10.1126/scitranslmed.aat1199
   Tomita Y, 1997, AM HEART J, V134, P779, DOI 10.1016/S0002-8703(97)70064-4
   Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224
   Uchida S, 2015, CIRC RES, V116, P737, DOI 10.1161/CIRCRESAHA.116.302521
   Verdonschot JAJ, 2018, EUR HEART J, V39, P864, DOI 10.1093/eurheartj/ehx808
   Vite A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075082
   Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013
   Wang J, 2017, NUCLEIC ACIDS RES, V45, PW130, DOI 10.1093/nar/gkx356
   Xiao JJ, 2017, CELL PHYSIOL BIOCHEM, V41, P865, DOI 10.1159/000459899
   Xu TH, 2010, J AM COLL CARDIOL, V55, P587, DOI 10.1016/j.jacc.2009.11.020
   Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105
NR 78
TC 25
Z9 26
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY 15
PY 2020
VL 21
IS 9
BP 
EP 
DI 10.3390/ijms21093040
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA LR3GK
UT WOS:000535581700011
PM 32344918
DA 2024-11-01
ER

PT J
AU Villanueva-Paz, M
   Povea-Cabello, S
   Villalón-García, I
   Alvarez-Córdoba, M
   Suárez-Rivero, JM
   Talaverón-Rey, M
   Jackson, S
   Falcón-Moya, R
   Rodríguez-Moreno, A
   Sánchez-Alcázar, JA
AF Villanueva-Paz, Marina
   Povea-Cabello, Suleva
   Villalon-Garcia, Irene
   Alvarez-Cordoba, Monica
   Suarez-Rivero, Juan M.
   Talaveron-Rey, Marta
   Jackson, Sandra
   Falcon-Moya, Rafael
   Rodriguez-Moreno, Antonio
   Sanchez-Alcazar, Jose A.
TI Parkin-mediated mitophagy and autophagy flux disruption in cellular models of MERRF syndrome
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Mitochondria; Mitochondrial diseases; Autophagy; Mitophagy; Coenzyme Q(10)
ID activated protein-kinase; ragged-red fibers; mitochondrial-dna mutations; oxidative stress; coenzyme q(10); myoclonic epilepsy; human fibroblasts; skeletal-muscle; mtdna mutation; double-blind
AB Mitochondrial diseases are considered rare genetic disorders characterized by defects in oxidative phosphorylation (OXPHOS). They can be provoked by mutations in nuclear DNA (nDNA) or mitochondrial DNA (mtDNA). MERRF (Myoclonic Epilepsy with Ragged-Red Fibers) syndrome is one of the most frequent mitochondrial diseases, principally caused by the m.8344A> G mutation in mtDNA, which affects the translation of all mtDNA-encoded proteins and therefore impairs mitochondrial function. In the present work, we evaluated autophagy and mitophagy flux in transmitochondrial cybrids and fibroblasts derived from a MERRF patient, reporting that Parkin-mediated mitophagy is increased in MERRF cell cultures. Our results suggest that supplementation with coenzyme Q(10) (CoQ), a component of the electron transport chain (ETC) and lipid antioxidant, prevents Parkin translocation to the mitochondria. In addition, CoQ acts as an enhancer of autophagy and mitophagy flux, which partially improves cell pathophysiology. The significance of Parkin-mediated mitophagy in cell survival was evaluated by silencing the expression of Parkin in MERRF cybrids. Our results show that mitophagy acts as a cell survival mechanism in mutant cells. To confirm these results in one of the main affected cell types in MERRF syndrome, mutant induced neurons (iNs) were generated by direct reprogramming of patients-derived skin fibroblasts. The treatment of MERRF iNs with Guttaquinon CoQ(10) (GuttaQ), a water-soluble derivative of CoQ, revealed a significant improvement in cell bioenergetics. These results indicate that iNs, along with fibroblasts and cybrids, can be utilized as reliable cellular models to shed light on disease pathomechanisms as well as for drug screening.
C1 [Villanueva-Paz, Marina; Povea-Cabello, Suleva; Villalon-Garcia, Irene; Alvarez-Cordoba, Monica; Suarez-Rivero, Juan M.; Talaveron-Rey, Marta; Sanchez-Alcazar, Jose A.] Univ Pablo de Olavide, CSIC, CABD, Carretera Utrera Km 1, Seville 41013, Spain.
   [Villanueva-Paz, Marina; Povea-Cabello, Suleva; Villalon-Garcia, Irene; Alvarez-Cordoba, Monica; Suarez-Rivero, Juan M.; Talaveron-Rey, Marta; Sanchez-Alcazar, Jose A.] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain.
   [Jackson, Sandra] Uniklinikum CG Carus, Dept Neurol, Dresden, Germany.
   [Falcon-Moya, Rafael; Rodriguez-Moreno, Antonio] Univ Pablo de Olavide, Dept Fisiol Anat & Biol Celular, Lab Neurociencia Celular & Plasticidad, Seville 41013, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Technische Universitat Dresden; Universidad Pablo de Olavide
RP Sánchez-Alcázar, JA (corresponding author), Univ Pablo de Olavide, CSIC, CABD, Carretera Utrera Km 1, Seville 41013, Spain.
EM jasanalc@upo.es
FU FIS [PI16/00786]; Ministerio de Sanidad, Spain; Fondo Europeo de Desarrollo Regional (FEDERUnion Europea); Spanish Ministry of Education, Culture and Sports; "Ayudas para la Formacion de Profesorado Universitario" (FPU); AEPMI (Asociacion de Enfermos de Patologia Mitocondrial); ENACH (Asociacion de enfermos de Neurodegeneracion con Acumulacion Cerebral de Hierro); EMBO
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   BOWMAN PD, 1975, EXP CELL RES, V93, P184, DOI 10.1016/0014-4827(75)90438-3
   Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082
   BRESOLIN N, 1990, J NEUROL SCI, V100, P70, DOI 10.1016/0022-510X(90)90015-F
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Chuang YC, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/5691215
   Cloonan SM, 2016, J CLIN INVEST, V126, P809, DOI 10.1172/JCI81113
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Cronin-Furman EN, 2013, MOL NEURODEGENER, V8, P0, DOI 10.1186/1750-1326-8-6
   De la Mata M, 2012, NEUROTHERAPEUTICS, V9, P446, DOI 10.1007/s13311-012-0103-3
   Decleer M, 2018, TOXINS, V10, P0, DOI 10.3390/toxins10070266
   DiMauro S, 2003, GENEREVIEWS R, V0, P0
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Drouin-Ouellet J, 2017, EMBO MOL MED, V9, P1117, DOI 10.15252/emmm.201607471
   Duberley KEC, 2013, J INHERIT METAB DIS, V36, P63, DOI 10.1007/s10545-012-9511-0
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   ESTORNELL E, 1992, FEBS LETT, V311, P107, DOI 10.1016/0014-5793(92)81378-Y
   Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108
   Fukuda T, 2006, MOL THER, V14, P831, DOI 10.1016/j.ymthe.2006.08.009
   Garrido-Maraver J, 2015, BBA-MOL BASIS DIS, V1852, P2535, DOI 10.1016/j.bbadis.2015.08.027
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Glover EI, 2010, MUSCLE NERVE, V42, P739, DOI 10.1002/mus.21758
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074
   Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879
   Iommarini L, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19030764
   Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Jing L, 2015, INT J BIOL SCI, V11, P59, DOI 10.7150/ijbs.10174
   Khandelwal PJ, 2011, HUM MOL GENET, V20, P2091, DOI 10.1093/hmg/ddr091
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Le Boedec K, 2016, VET CLIN PATH, V45, P648, DOI 10.1111/vcp.12390
   Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451
   Lee SK, 2012, CELL SIGNAL, V24, P2329, DOI 10.1016/j.cellsig.2012.07.022
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lin DS, 2017, ONCOTARGET, V8, P73627, DOI 10.18632/oncotarget.20617
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Malicdan MCV, 2012, BRAIN PATHOL, V22, P82, DOI 10.1111/j.1750-3639.2011.00543.x
   Marco-Brualla J, 2019, CANCERS, V11, P0, DOI 10.3390/cancers11071027
   Martín-Maestro P, 2016, HUM MOL GENET, V25, P792, DOI 10.1093/hmg/ddv616
   Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528
   Mastroeni D, 2018, ALZHEIMERS DEMENT, V14, P775, DOI 10.1016/j.jalz.2017.12.005
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Mauro-Lizcano M, 2015, AUTOPHAGY, V11, P833, DOI 10.1080/15548627.2015.1034403
   Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985
   Morán M, 2014, BBA-MOL BASIS DIS, V1842, P1059, DOI 10.1016/j.bbadis.2014.03.013
   Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Nicholls David G, 2010, J VIS EXP, V0, P0, DOI DOI 10.3791/2511
   Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604
   Oropesa-Avila M, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.58
   OZAWA M, 1995, NEUROMUSCULAR DISORD, V5, P483, DOI 10.1016/0960-8966(95)00009-C
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639
   Parikh SM, 2015, SEMIN NEPHROL, V35, P108, DOI 10.1016/j.semnephrol.2015.01.011
   Paz MV, 2016, EXPERT OPIN THER TAR, V20, P487, DOI 10.1517/14728222.2016.1101068
   Pereira CV, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708084
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680
   Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108
   Rodríguez-Hernández A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174
   Sánchez-Alcázar JA, 2007, APOPTOSIS, V12, P1195, DOI 10.1007/s10495-006-0044-6
   Shepherd RK, 2006, J INHERIT METAB DIS, V29, P86, DOI 10.1007/s10545-006-0148-8
   Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shrigley S, 2018, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/56904
   Sinha RA, 2016, CELL BIOSCI, V6, P0, DOI 10.1186/s13578-016-0113-7
   Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, PE730, DOI 10.1152/ajpendo.00225.2016
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Tsai HY, 2016, J DIABETES RES, V2016, P0, DOI 10.1155/2016/6384759
   Tsai KL, 2011, MOL NUTR FOOD RES, V55, PS227, DOI 10.1002/mnfr.201100147
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X
   Villanueva-Paz M, 2019, BBA-MOL CELL RES, V1866, P861, DOI 10.1016/j.bbamcr.2019.02.010
   Villanueva-Paz M, 2016, EXPERIENTIA SUPPL, V107, P45, DOI 10.1007/978-3-319-43589-3_3
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Wang L, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0150441
   Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018
   Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003
   Wong YC, 2014, J NEUROSCI, V34, P1293, DOI 10.1523/JNEUROSCI.1870-13.2014
   Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Xu Z, 2017, SCI REP, V7, P0
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Ye X, 2015, HUM MOL GENET, V24, P2938, DOI 10.1093/hmg/ddv056
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Yuan JH, 2013, J CLIN PATHOL, V66, P659, DOI 10.1136/jclinpath-2012-201431
   Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200
   Zhang XJ, 2013, ACTA PHARMACOL SIN, V34, P595, DOI 10.1038/aps.2012.184
   Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797
   Zhao BZ, 2016, GENES DIS, V3, P82, DOI 10.1016/j.gendis.2015.12.002
   Zhao CY, 2017, ONCOTARGET, V8, P20988, DOI 10.18632/oncotarget.15470
   Zhu YS, 2014, METHOD ENZYMOL, V547, P39, DOI 10.1016/B978-0-12-801415-8.00003-5
   Zsurka G, 2007, AM J HUM GENET, V80, P298, DOI 10.1086/511282
   Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871
NR 118
TC 26
Z9 26
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JUN 1
PY 2020
VL 1866
IS 6
BP 
EP 
DI 10.1016/j.bbadis.2020.165726
PG 25
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA LG2PT
UT WOS:000527950000023
PM 32061767
DA 2024-11-01
ER

PT J
AU Nguyen, NNY
   Kim, SS
   Jo, YH
AF Ngoc Ngo Yen Nguyen
   Kim, Sung Soo
   Jo, Yong Hwa
TI Deregulated Mitochondrial DNA in Diseases
SO DNA AND CELL BIOLOGY
LA English
DT Article
DE mitochondrial DNA; mutation; cancer; predictor; oxidative stress
ID progressive external ophthalmoplegia; hereditary optic neuropathy; copy number; breast-cancer; colorectal-cancer; mtdna mutation; oxidative stress; leigh-syndrome; cardiac involvement; myoclonic epilepsy
AB Mitochondria play various important roles in energy production, metabolism, and apoptosis. Mitochondrial dysfunction caused by alterations in mitochondrial DNA (mtDNA) can lead to the initiation and progression of cancers and other diseases. These alterations include mutations and copy number variations. Especially, the mutations in D-loop, MT-ND1, and MT-ND5 affect mitochondrial functions and are widely detected in various cancers. Meanwhile, several other mutations have been correlated with muscular and neuronal diseases, especially MT-TL1 is deeply related. These pieces of evidence indicated mtDNA alterations in diseases show potential as a novel therapeutic target. mtDNA repair enzymes are the target for delaying or stalling the mtDNA damage-induced cancer progression and metastasis. Moreover, some mutations reveal a prognosis ability of the drug resistance. Current efforts aim to develop mitochondrial transplantation technique as a direct cure for deregulated mitochondria-associated diseases. This review summarizes the implications of mitochondrial dysfunction in cancers and other pathologies; and discusses the relevance of mitochondria-targeted therapies, along with their contribution as potential biomarkers.
C1 [Ngoc Ngo Yen Nguyen] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea.
   [Ngoc Ngo Yen Nguyen; Kim, Sung Soo; Jo, Yong Hwa] Kyung Hee Univ, Biomed Sci Inst, Seoul, South Korea.
   [Kim, Sung Soo; Jo, Yong Hwa] Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, 26 Kyungheedae Ro, Seoul 02447, South Korea.
C3 Kyung Hee University; Kyung Hee University; Kyung Hee University
RP Kim, SS; Jo, YH (corresponding author), Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, 26 Kyungheedae Ro, Seoul 02447, South Korea.
EM sgskim@khu.ac.kr; yonghwa.jo@gmail.com
FU Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean government [NRF-2017R1A6A3A11028420, NRF-2018R1A6A 1A03025124, NRF-2017R1A2B2007870]
CR Akbari M, 2014, DNA REPAIR, V16, P44, DOI 10.1016/j.dnarep.2014.01.015
   Akouchekian M, 2011, J RES MED SCI, V16, P50
   Akouchekian M, 2009, DIS COLON RECTUM, V52, P526, DOI 10.1007/DCR.0b013e31819acb99
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   [Anonymous], 2019, HOM SAP MIT COMPL GE, V0, P0
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Babenko VA, 2015, STEM CELL TRANSL MED, V4, P1011, DOI 10.5966/sctm.2015-0010
   Bakhoum MF, 2018, GRAEF ARCH CLIN EXP, V256, P583, DOI 10.1007/s00417-018-3914-z
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Bianco A, 2018, INVEST OPHTH VIS SCI, V59, P331, DOI 10.1167/iovs.17-22822
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Bodzioch M, 2009, GENOMICS, V94, P247, DOI 10.1016/j.ygeno.2009.05.006
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Chang CY, 2019, TRANSL NEURODEGENER, V8, P0, DOI 10.1186/s40035-019-0158-8
   Choi Y, 2016, CIRCULATION, V133, P1297, DOI 10.1161/CIRCULATIONAHA.115.020463
   Cloos CR, 2009, RADIAT RES, V171, P581, DOI 10.1667/RR1395.1
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617
   Dang SW, 2014, DIAGN PATHOL, V9, P0, DOI 10.1186/1746-1596-9-28
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   Delsite Robert, 2002, MOL CANCER, V1, P6, DOI 10.1186/1476-4598-1-6
   Desler C, 2007, MUTAT RES-FUND MOL M, V625, P112, DOI 10.1016/j.mrfmmm.2007.06.002
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Dianov GL, 2001, PROG NUCLEIC ACID RE, V68, P285
   Dionisi-Vici C, 1998, J INHERIT METAB DIS, V21, P2, DOI 10.1023/A:1005397227996
   Dylag AM, 2019, AM J PHYSIOL-LUNG C, V317, PL737, DOI 10.1152/ajplung.00395.2019
   El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   Falk MJ, 2010, CURR OPIN PEDIATR, V22, P711, DOI 10.1097/MOP.0b013e3283402e21
   Fan AXC, 2009, J CANCER RES CLIN, V135, P983, DOI 10.1007/s00432-008-0533-9
   Fendt SM, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3236
   Feng S, 2011, ONCOL LETT, V2, P899, DOI 10.3892/ol.2011.322
   Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267
   Fu AL, 2017, FRONT PHARMACOL, V8, P0, DOI 10.3389/fphar.2017.00241
   Gao JH, 2015, MOL MED REP, V12, P7033, DOI 10.3892/mmr.2015.4256
   Ghaffarpour M, 2014, CANCER CELL INT, V14, P0, DOI 10.1186/1475-2867-14-21
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guerra F, 2012, J CLIN ONCOL, V30, PE373, DOI 10.1200/JCO.2012.43.5933
   Hahn A, 2011, NEUROPEDIATRICS, V42, P148, DOI 10.1055/s-0031-1283167
   Han H, 2016, MOL MED REP, V13, P1517, DOI 10.3892/mmr.2015.4726
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Harrington JS, 2019, CHEST, V156, P1120, DOI 10.1016/j.chest.2019.07.014
   Hashizume M, 2013, AM J PHYSIOL-LUNG C, V304, PL287, DOI 10.1152/ajplung.00071.2012
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Hofmann JN, 2014, CARCINOGENESIS, V35, P1028, DOI 10.1093/carcin/bgt495
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hopkins JF, 2018, GASTROENTEROLOGY, V154, P1620, DOI 10.1053/j.gastro.2018.01.029
   HOWELL N, 1991, AM J HUM GENET, V49, P939
   Hsu CW, 2010, BREAST J, V16, P264, DOI 10.1111/j.1524-4741.2010.00908.x
   Huang B, 2014, CANCER EPIDEM BIOMAR, V23, P2357, DOI 10.1158/1055-9965.EPI-14-0297
   Hwang J M, 2000, KOREAN J OPHTHALMOL, V14, P45
   Iommarini L, 2017, BBA-BIOENERGETICS, V1858, P582, DOI 10.1016/j.bbabio.2017.02.006
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Ivanova R, 1998, INT J CANCER, V76, P495, DOI 10.1002/(SICI)1097-0215(19980518)76:4<495::AID-IJC9>3.3.CO;2-3
   Jerónimo C, 2001, ONCOGENE, V20, P5195, DOI 10.1038/sj.onc.1204646
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   Jones JB, 2001, CANCER RES, V61, P1299
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kang KA, 2012, TUMOR BIOL, V33, P403, DOI 10.1007/s13277-012-0322-6
   Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546
   Kassauei K, 2006, J GASTROINTEST CANC, V37, P57, DOI 10.1007/s12029-007-0008-2
   Kim H, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17122049
   Kim HR, 2015, ANN LAB MED, V35, P1, DOI 10.3343/alm.2015.35.1.1
   Kim MM, 2004, CLIN CANCER RES, V10, P8512, DOI 10.1158/1078-0432.CCR-04-0734
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Koshikawa N, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-15592-2
   Kuo SJ, 2010, CANCER GENET CYTOGEN, V201, P94, DOI 10.1016/j.cancergencyto.2010.05.013
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   Li X, 2017, TUMOUR BIOL, V39, P1010428317713671
   Lin CS, 2010, J THORAC CARDIOV SUR, V139, P189, DOI 10.1016/j.jtcvs.2009.04.007
   Lin Chen-Sung, 2008, INTERACT CARDIOVASC THORAC SURG, V7, P954, DOI 10.1510/icvts.2008.177006
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   Liu VWS, 2001, CANCER RES, V61, P5998
   Loureiro R, 2017, SEMIN CANCER BIOL, V47, P18, DOI 10.1016/j.semcancer.2017.06.012
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002
   Maceluch Jaros Aw, 2006, PEDIATR ENDOCRINOL REV, V4, P117
   Macmillan CJ, 1996, PEDIATR NEUROL, V14, P203, DOI 10.1016/0887-8994(96)00018-5
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Majamaa-Voltti Kirsi, 2002, BMC CARDIOVASC DISORD, V2, P12
   Makino M, 1998, NEUROMUSCULAR DISORD, V8, P149, DOI 10.1016/S0960-8966(98)00017-0
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Manfredi G, 1996, HUM MUTAT, V7, P158
   Máximo V, 2002, AM J PATHOL, V160, P1857, DOI 10.1016/S0002-9440(10)61132-7
   Máximo V, 2001, GENE CHROMOSOME CANC, V32, P136, DOI 10.1002/gcc.1175
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MERANTE F, 1994, AM J HUM GENET, V55, P437
   Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.0.CO;2-7
   Miyazono F, 2002, ONCOGENE, V21, P3780, DOI 10.1038/sj.onc.1205532
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Naito A, 2008, INT J CANCER, V122, P1506, DOI 10.1002/ijc.23235
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nishino I, 1996, MUSCLE NERVE, V19, P1603, DOI 10.1002/(SICI)1097-4598(199612)19:12<1603::AID-MUS10>3.0.CO;2-S
   NOER AS, 1991, AM J HUM GENET, V49, P715
   Parrella P, 2001, CANCER RES, V61, P7623
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Qu FL, 2015, CARCINOGENESIS, V36, P543, DOI 10.1093/carcin/bgv042
   Rachek LI, 2006, DIABETES, V55, P1022, DOI 10.2337/diabetes.55.04.06.db05-0865
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahmani Babak, 2012, ACTA MED IRAN, V50, P447
   Reddy PL, 2002, BRIT J HAEMATOL, V116, P564, DOI 10.1046/j.0007-1048.2001.03323.x
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Ronchi D, 2011, BMC NEUROL, V11, P0, DOI 10.1186/1471-2377-11-85
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Sanchez-Cespedes M, 2001, CANCER RES, V61, P7015
   Sano M, 1996, J NEUROL, V243, P441, DOI 10.1007/BF00900496
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Santorelli FM, 1999, AM J HUM GENET, V64, P295, DOI 10.1086/302188
   Santorelli FM, 1997, NEUROMUSCULAR DISORD, V7, P156, DOI 10.1016/S0960-8966(97)00444-6
   SATO W, 1994, BIOCHEM MOL BIOL INT, V33, P1055
   SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schrijver I, 2009, GENET MED, V11, P118, DOI 10.1097/GIM.0b013e318190356b
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Shen J, 2015, CARCINOGENESIS, V36, P1307, DOI 10.1093/carcin/bgv130
   Shi XX, 2017, MITOCHONDRION, V34, P91, DOI 10.1016/j.mito.2017.02.005
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Singh KK, 2005, GENE, V354, P140, DOI 10.1016/j.gene.2005.03.027
   Singh RK, 2017, MITOCHONDRION, V35, P35, DOI 10.1016/j.mito.2017.05.001
   Smiraglia DJ, 2008, CANCER BIOL THER, V7, P1182, DOI 10.4161/cbt.7.8.6215
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Suzuki M, 2003, CLIN CANCER RES, V9, P5636
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tabebi M, 2017, J DIABETES COMPLICAT, V31, P253, DOI 10.1016/j.jdiacomp.2016.06.028
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tamura G, 1999, EUR J CANCER, V35, P316, DOI 10.1016/S0959-8049(98)00360-8
   Tan DJ, 2002, CANCER RES, V62, P972
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T
   Tranah GJ, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-30255-6
   Tranah GJ, 2015, J GERONTOL A-BIOL, V70, P1418, DOI 10.1093/gerona/glv097
   Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326
   Tuchalska-Czurón J, 2019, PANCREATOLOGY, V19, P73, DOI 10.1016/j.pan.2018.11.009
   van Osch FHM, 2015, CARCINOGENESIS, V36, P1502, DOI 10.1093/carcin/bgv151
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Verma A, 1996, NEUROLOGY, V46, P1334, DOI 10.1212/WNL.46.5.1334
   Voets AM, 2012, BBA-BIOENERGETICS, V1817, P1971, DOI 10.1016/j.bbabio.2012.07.001
   Voets AM, 2012, BBA-MOL BASIS DIS, V1822, P1161, DOI 10.1016/j.bbadis.2011.10.009
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211
   Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Webb E, 2008, BRIT J CANCER, V99, P2088, DOI 10.1038/sj.bjc.6604805
   Weerts MJA, 2017, CLIN CANCER RES, V23, P4735, DOI 10.1158/1078-0432.CCR-17-0032
   Wen SL, 2013, ONCOL LETT, V6, P1098, DOI 10.3892/ol.2013.1492
   Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108
   Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213
   Xia P, 2009, BMC CANCER, V9, P0, DOI 10.1186/1471-2407-9-454
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Xu JF, 2020, CARCINOGENESIS, V41, P267, DOI 10.1093/carcin/bgz139
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yamada S, 2006, EJSO-EUR J SURG ONC, V32, P303, DOI 10.1016/j.ejso.2006.01.002
   Yeh JJ, 2000, ONCOGENE, V19, P2060, DOI 10.1038/sj.onc.1203537
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   Yu EPK, 2016, FREE RADICAL BIO MED, V100, P223, DOI 10.1016/j.freeradbiomed.2016.06.011
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Yu M, 2009, EUR J CANCER PREV, V18, P445, DOI 10.1097/CEJ.0b013e32832f9bd6
   Yu Y, 2015, GENET MOL RES, V14, P17426, DOI 10.4238/2015.December.21.12
   Yuzefovych LV, 2016, CANCER RES, V76, P30, DOI 10.1158/0008-5472.CAN-15-0692
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhu X, 2017, MOL CARCINOGEN, V56, P2593, DOI 10.1002/mc.22703
NR 195
TC 17
Z9 19
U1 1
U2 13
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD AUG 1
PY 2020
VL 39
IS 8
BP 1385
EP 1400
DI 10.1089/dna.2019.5220
EA JAN 2020
PG 16
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA MU1AS
UT WOS:000507621000001
PM 31944832
DA 2024-11-01
ER

PT J
AU Bulduk, BK
   Kilic, HB
   Bekircan-Kurt, CE
   Haliloglu, G
   Ozdamar, SE
   Topaloglu, H
   Kocaefe, YC
AF Bulduk, Bengisu Kevser
   Kilic, Hasan Basri
   Bekircan-Kurt, Can Ebru
   Haliloglu, Goknur
   Ozdamar, Sevim Erdem
   Topaloglu, Haluk
   Kocaefe, Y. Cetin
TI A Novel Amplification-Refractory Mutation System-PCR Strategy to Screen <i>MT-TL1</i> Pathogenic Variants in Patient Repositories
SO GENETIC TESTING AND MOLECULAR BIOMARKERS
LA English
DT Article
DE mitochondrial cytopathies; ARMS-PCR; HRM; mtDNA; mt-tRNA mutations
ID transfer rnaleu(uur) gene; mitochondrial transcription termination; stroke-like episodes; point mutation; lactic-acidosis; melas subgroup; dna; myopathy; mtdna; cardiomyopathy
AB Aim: Pathogenic variants within mitochondrial tRNA and rRNA genes negatively affect protein synthesis function and cause oxidative phosphorylation defects. The majority of mitochondrial cytopathies are caused by pathogenic point variants within the mitochondrial tRNA gene for leucine (MT-TL1). This study was designed to evaluate a novel amplification-refractory mutation system (ARMS)-PCR based assay to screen patient samples with a clinical diagnosis of mitochondrial cytopathies. Methods: Tissue DNA samples from 219 affected individuals were screened for the pathogenic variants m.3271T>C, m.3291Ty >C, m.3303C>T, m.3256C>T, and m.3260A>G along with the most frequent m.3243A>G mutation in the MT-TL1 gene. The assay included a "High Resolution Melt curve analysis" to enhance detection limits. The precision of the assay was verified using synthetic controls with variant heteroplasmy ratios. Results: The screening identified the second reported m.3303C>T case as well as two patients with m.3243A>G variants and a rare variant exhibiting m.3290T>C. Conclusion: ARMS-PCR is superior to Sanger sequencing for the detection of variations exhibiting low heteroplasmy. These results provide "proof of concepts" for the implementation of this application for future screening of rare mtDNA variations in sample repositories.
C1 [Bulduk, Bengisu Kevser; Kilic, Hasan Basri; Kocaefe, Y. Cetin] Hacettepe Univ, Sch Med, Dept Med Biol, TR-06100 Ankara, Turkey.
   [Bekircan-Kurt, Can Ebru; Ozdamar, Sevim Erdem] Hacettepe Univ, Sch Med, Dept Neurol, Ankara, Turkey.
   [Haliloglu, Goknur; Topaloglu, Haluk] Hacettepe Univ, Dept Pediat Neurol, Sch Med, Ankara, Turkey.
C3 Hacettepe University; Hacettepe University; Hacettepe University
RP Kocaefe, YC (corresponding author), Hacettepe Univ, Sch Med, Dept Med Biol, TR-06100 Ankara, Turkey.
EM kocaefe@hacettepe.edu.tr
CR Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Brisca G, 2015, BIOCHEM BIOPH RES CO, V458, P601, DOI 10.1016/j.bbrc.2015.01.157
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Collins A, 2012, OPEN BIOINFORMAT. J., V6, P55, DOI 10.2174/1875036201206010055
   Druml B, 2014, FOOD CHEM, V158, P245, DOI 10.1016/j.foodchem.2014.02.111
   GOTO Y, 1992, ANN NEUROL, V31, P672, DOI 10.1002/ana.410310617
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, V0, PS107
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Kelland E, 2016, MOL GENET METAB REP, V6, P64, DOI 10.1016/j.ymgmr.2016.02.003
   Kiliç HB, 2019, TURK J BIOCHEM, V44, P769, DOI 10.1515/tjb-2018-0372
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Li M, 2014, CLIN CHEM, V60, P864, DOI 10.1373/clinchem.2013.220160
   Palecek T, 2012, INT HEART J, V53, P383, DOI 10.1536/ihj.53.383
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Ryan SE, 2016, MOL VIS, V22, P1169
   SAKUTA R, 1993, J NEUROL SCI, V115, P158, DOI 10.1016/0022-510X(93)90219-O
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Suomalainen A, 2015, EMBO MOL MED, V7, P1245, DOI 10.15252/emmm.201505350
   SWEENEY MG, 1993, Q J MED, V86, P435
   Medrano RFV, 2014, MOL BIOTECHNOL, V56, P599, DOI 10.1007/s12033-014-9734-4
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
NR 29
TC 2
Z9 2
U1 2
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1945-0265
EI 1945-0257
J9 GENET TEST MOL BIOMA
JI Genet. Test. Mol. Biomark.
PD MAR 1
PY 2020
VL 24
IS 3
BP 165
EP 170
DI 10.1089/gtmb.2019.0079
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA LB8QP
UT WOS:000524895300008
PM 32167396
DA 2024-11-01
ER

PT J
AU Al-Shahoumi, R
   Brady, LI
   Tarnopolsky, MA
AF Al-Shahoumi, Rashid
   Brady, Lauren I.
   Tarnopolsky, Mark A.
TI A mitochondrial disorder with ptosis and exercise intolerance without ophthalmoparesis secondary to m.5865 T &gt; C variant
SO MITOCHONDRION
LA English
DT Article
ID dna mutations; genetics; genome
AB We describe a novel mitochondrial variant (m.5865 T > C) in a patient with decreased exercise endurance and juvenile onset slowly progressive bilateral ptosis without ophthamloparesis. The m.5865 T > C variant was seen in 82.9% of mtDNA molecules in skeletal muscle tissue and similar to 8% of mtDNA molecules in urine epithelium, but was not detected in blood leukocytes. The proband does not demonstrate any additional features often seen in individuals with a mitochondrial disorder (i.e., sensorineural hearing loss, type 2 diabetes, stroke-like episodes, muscle weakness, ophthalmoparesis, cardiomyopathy or cardiac arrhythmias). This case suggests that ptosis and exercise intolerance, without ophthalmoparesis, are the primary clinical features of the m.5865 T > C. mtDNA variant.
C1 [Al-Shahoumi, Rashid; Brady, Lauren I.; Tarnopolsky, Mark A.] McMaster Univ, Dept Paediat, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.
C3 McMaster University
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Paediat, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
FU CIHR Foundation [143325]; Warren Lammert and Family; Dan Wright and family
CR El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Heighton JN, 2019, MITOCHONDRION, V49, P227, DOI 10.1016/j.mito.2019.09.002
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Kerkhof J, 2017, J MOL DIAGN, V19, P905, DOI 10.1016/j.jmoldx.2017.07.004
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, PD1062, DOI 10.1093/nar/gkx1153
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wong LJC, 2020, GENET MED, V0, P0, DOI DOI 10.1038/s41436-019-0746-0
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zsurka G, 2009, MITOWHEEL VISUALIZIN, V0, P0
NR 17
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2020
VL 53
IS 
BP 150
EP 153
DI 10.1016/j.mito.2020.05.006
PG 4
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA MO6RS
UT WOS:000551651100016
PM 32485333
DA 2024-11-01
ER

PT J
AU Peter, B
   Falkenberg, M
AF Peter, Bradley
   Falkenberg, Maria
TI TWINKLE and Other Human Mitochondrial DNA Helicases: Structure, Function and Disease
SO GENES
LA English
DT Review
DE mitochondria; mtDNA; replication; PEO; TWINKLE
ID progressive external ophthalmoplegia; human pif1 helicase; n-terminal domain; onset spinocerebellar ataxia; structure-function defects; g-quadruplex dna; binding-protein; crystal-structure; linker region; multiple deletions
AB Mammalian mitochondria contain a circular genome (mtDNA) which encodes subunits of the oxidative phosphorylation machinery. The replication and maintenance of mtDNA is carried out by a set of nuclear-encoded factors-of which, helicases form an important group. The TWINKLE helicase is the main helicase in mitochondria and is the only helicase required for mtDNA replication. Mutations in TWINKLE cause a number of human disorders associated with mitochondrial dysfunction, neurodegeneration and premature ageing. In addition, a number of other helicases with a putative role in mitochondria have been identified. In this review, we discuss our current knowledge of TWINKLE structure and function and its role in diseases of mtDNA maintenance. We also briefly discuss other potential mitochondrial helicases and postulate on their role(s) in mitochondria.
C1 [Peter, Bradley; Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.
C3 University of Gothenburg
RP Peter, B; Falkenberg, M (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.
EM peter.bradley@gu.se; maria.falkenberg@medkem.gu.se
FU Swedish Research Council [2018-02439]; Swedish Cancer Foundation [2019-816]; Knut and AliceWallenberg Foundation [KAW2017.0080]; European Research Council [683191]; Swedish government [ALFGBG-727491]; county councils, the ALF agreement [ALFGBG-727491]; European Research Council (ERC) [683191] Funding Source: European Research Council (ERC); Formas [2018-02439] Funding Source: Formas; Swedish Research Council [2018-02439] Funding Source: Swedish Research Council
CR Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267
   ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030
   Ariza A, 2005, NUCLEIC ACIDS RES, V33, P1465, DOI 10.1093/nar/gki288
   Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200
   Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353
   Bannwarth S, 2016, MITOCHONDRION, V30, P126, DOI 10.1016/j.mito.2016.02.005
   Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008
   BOGENHAGEN D, 1978, J MOL BIOL, V119, P69, DOI 10.1016/0022-2836(78)90270-X
   Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003
   Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130
   Boulé JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199
   BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766
   Butler TJ, 2020, HUM MOL GENET, V29, P1292, DOI 10.1093/hmg/ddaa043
   Byrd AK, 2017, BIOCHEM SOC T, V45, P1159, DOI 10.1042/BST20170096
   Chen H, 2010, ANN NY ACAD SCI, V1201, P21, DOI 10.1111/j.1749-6632.2010.05615.x
   Chen PL, 2013, ONCOGENE, V32, P1193, DOI 10.1038/onc.2012.120
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   Chi ZF, 2012, INT J BIOCHEM CELL B, V44, P1942, DOI 10.1016/j.biocel.2012.07.016
   Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101
   Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037
   Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x
   De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501
   de Souza-Pinto NC, 2010, MECH AGEING DEV, V131, P503, DOI 10.1016/j.mad.2010.04.009
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l
   Dmochowska A, 1999, ACTA BIOCHIM POL, V46, P155, DOI 10.18388/abp.1999_4193
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011
   Falkenberg M, 1997, J BIOL CHEM, V272, P22766, DOI 10.1074/jbc.272.36.22766
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Fekete B, 2019, BMC MED GENET, V20, P0, DOI 10.1186/s12881-019-0934-4
   Fernández-Millán P, 2015, NUCLEIC ACIDS RES, V43, P4284, DOI 10.1093/nar/gkv189
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39
   Fusté JM, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004832
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Futami K, 2007, BIOL PHARM BULL, V30, P1685, DOI 10.1248/bpb.30.1685
   Gao Y, 2019, SCIENCE, V363, P835, DOI 10.1126/science.aav7003
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   George T, 2009, NUCLEIC ACIDS RES, V37, P6491, DOI 10.1093/nar/gkp671
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gottschalk ME, 1996, AM J MED GENET, V65, P274, DOI 10.1002/(SICI)1096-8628(19961111)65:4<274::AID-AJMG5>3.0.CO;2-P
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303
   Hagström E, 2014, NUCLEIC ACIDS RES, V42, P1111, DOI 10.1093/nar/gkt969
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Howell N, 1996, AM J HUM GENET, V59, P749
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Jia PP, 2017, DNA REPAIR, V59, P9, DOI 10.1016/j.dnarep.2017.09.001
   Kaur P, 2020, J BIOL CHEM, V295, P5564, DOI 10.1074/jbc.RA120.012795
   Kazak L, 2013, NUCLEIC ACIDS RES, V41, P2354, DOI 10.1093/nar/gks1347
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Keller H, 2014, NUCLEIC ACIDS RES, V42, P12614, DOI 10.1093/nar/gku993
   Khan I, 2016, J BIOL CHEM, V291, P14324, DOI 10.1074/jbc.M115.712026
   Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200
   Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595
   Kong DC, 1996, EMBO J, V15, P2010, DOI 10.1002/j.1460-2075.1996.tb00552.x
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kulczyk AW, 2017, P NATL ACAD SCI USA, V114, PE1848, DOI 10.1073/pnas.1701252114
   Kusakabe T, 1996, J BIOL CHEM, V271, P19563, DOI 10.1074/jbc.271.32.19563
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873
   Lee SJ, 2006, J BIOL CHEM, V281, P25841, DOI 10.1074/jbc.M604602200
   Lee SJ, 2012, J BIOL CHEM, V287, P39030, DOI 10.1074/jbc.M112.414151
   Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200
   Lee SR, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/8060949
   LeGac NT, 1996, J BIOL CHEM, V271, P21645
   Lin WQ, 2013, EMBO J, V32, P1425, DOI 10.1038/emboj.2013.88
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Loparo JJ, 2011, P NATL ACAD SCI USA, V108, P3584, DOI 10.1073/pnas.1018824108
   Marino F, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep21501
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Matsushima Y, 2009, BBA-BIOENERGETICS, V1787, P290, DOI 10.1016/j.bbabio.2008.11.005
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Minczuk M, 2002, YEAST, V19, P1285, DOI 10.1002/yea.906
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Muftuoglu M, 2014, MITOCHONDRION, V17, P164, DOI 10.1016/j.mito.2014.03.007
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811
   Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   OShea VL, 2014, CURR OPIN STRUC BIOL, V25, P16, DOI 10.1016/j.sbi.2013.11.006
   Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983
   Patel SS, 2011, CURR OPIN CHEM BIOL, V15, P595, DOI 10.1016/j.cbpa.2011.08.003
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   PERRAULT M, 1951, BULL MEM SOC MED HOP PARIS, V67, P79
   Peter B, 2019, HUM MOL GENET, V28, P1090, DOI 10.1093/hmg/ddy415
   Picha KM, 2000, BIOCHEMISTRY-US, V39, P6401, DOI 10.1021/bi992857i
   Pierce SB, 2016, CSH MOL CASE STUD, V2, P0, DOI 10.1101/mcs.a001107
   Piro-Mégy C, 2020, J CLIN INVEST, V130, P143, DOI 10.1172/JCI128513
   Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908
   Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988
   Ramanagoudr-Bhojappa R, 2013, NUCLEIC ACIDS RES, V41, P1029, DOI 10.1093/nar/gks1088
   Ramos ES, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1008085
   Remtulla S, 2019, PEDIATR NEUROL, V90, P61, DOI 10.1016/j.pediatrneurol.2018.08.007
   ROBBERSODL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7
   Sedlackova H, 2015, DNA REPAIR, V30, P80, DOI 10.1016/j.dnarep.2015.02.020
   Sen D, 2016, NUCLEIC ACIDS RES, V44, P4200, DOI 10.1093/nar/gkw098
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5
   Snow BE, 2007, MOL CELL BIOL, V27, P1017, DOI 10.1128/MCB.01866-06
   Sparks MA, 2019, NUCLEIC ACIDS RES, V47, P8595, DOI 10.1093/nar/gkz608
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suzuki T, 2009, J BIOCHEM, V146, P327, DOI 10.1093/jb/mvp074
   Szczesny RJ, 2007, BIOL CELL, V99, P323, DOI 10.1042/BC20060108
   Szczesny RJ, 2013, BBA-GENE REGUL MECH, V1829, P842, DOI 10.1016/j.bbagrm.2013.02.009
   Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Taylor RW, 2007, CELL, V130, P211, DOI 10.1016/j.cell.2007.07.002
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TSURUMI C, 1990, BIOCHEM BIOPH RES CO, V169, P136, DOI 10.1016/0006-291X(90)91444-W
   Tu YT, 2015, CELL REP, V10, P854, DOI 10.1016/j.celrep.2015.01.033
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Valgardsdottir R, 2001, J BIOL CHEM, V276, P32056, DOI 10.1074/jbc.M011629200
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Wallen JR, 2017, STRUCTURE, V25, P157, DOI 10.1016/j.str.2016.11.019
   Wang JT, 2014, CELL REP, V7, P848, DOI 10.1016/j.celrep.2014.03.037
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825
   Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061
   Wu JH, 2008, DEV BIOL, V323, P130, DOI 10.1016/j.ydbio.2008.08.006
   Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029
   Zhang Y, 2013, J PHYS-CONDENS MAT, V25, P0, DOI 10.1088/0953-8984/25/37/374101
   Zheng HJ, 2015, STEM CELLS DEV, V24, P372, DOI 10.1089/scd.2014.0077
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
NR 168
TC 35
Z9 37
U1 1
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD APR 15
PY 2020
VL 11
IS 4
BP 
EP 
DI 10.3390/genes11040408
PG 21
WC Genetics & Heredity
SC Genetics & Heredity
GA LT7CM
UT WOS:000537224600102
PM 32283748
DA 2024-11-01
ER

PT J
AU Basu, S
   Xie, X
   Uhler, JP
   Hedberg-Oldfors, C
   Milenkovic, D
   Baris, OR
   Kimoloi, S
   Matic, S
   Stewart, JB
   Larsson, NG
   Wiesner, RJ
   Oldfors, A
   Gustafsson, CM
   Falkenberg, M
   Larsson, E
AF Basu, Swaraj
   Xie, Xie
   Uhler, Jay P.
   Hedberg-Oldfors, Carola
   Milenkovic, Dusanka
   Baris, Olivier R.
   Kimoloi, Sammy
   Matic, Stanka
   Stewart, James B.
   Larsson, Nils-Goran
   Wiesner, Rudolf J.
   Oldfors, Anders
   Gustafsson, Claes M.
   Falkenberg, Maria
   Larsson, Erik
TI Accurate mapping of mitochondrial DNA deletions and duplications using deep sequencing
SO PLOS GENETICS
LA English
DT Article
ID progressive external ophthalmoplegia; mtdna replication; mutations; genome; deficiency; increase; twinkle; disease; hisat; polg
AB Deletions and duplications in mitochondrial DNA (mtDNA) cause mitochondrial disease and accumulate in conditions such as cancer and age-related disorders, but validated high-throughput methodology that can readily detect and discriminate between these two types of events is lacking. Here we establish a computational method, MitoSAlt, for accurate identification, quantification and visualization of mtDNA deletions and duplications from genomic sequencing data. Our method was tested on simulated sequencing reads and human patient samples with single deletions and duplications to verify its accuracy. Application to mouse models of mtDNA maintenance disease demonstrated the ability to detect deletions and duplications even at low levels of heteroplasmy. Author summary Deletions in the mitochondrial genome cause a wide variety of rare disorders, but are also linked to more common conditions such as neurodegeneration, diabetes type 2, and the normal ageing process. There is also a growing awareness that mtDNA duplications, which are also relevant for human disease, may be more common than previously thought. Despite their clinical importance, our current knowledge about the abundance, characteristics and diversity of mtDNA deletions and duplications is fragmented, and based to large extent on a limited view provided by traditional low-throughput analyses. Here, we describe a bioinformatics method, MitoSAlt, that can accurately map and classify mtDNA deletions and duplications using high-throughput sequencing. Application of this methodology to mouse models of mitochondrial deficiencies revealed a large number of duplications, suggesting that these may previously have been underestimated.
C1 [Basu, Swaraj; Xie, Xie; Uhler, Jay P.; Gustafsson, Claes M.; Falkenberg, Maria; Larsson, Erik] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
   [Hedberg-Oldfors, Carola; Oldfors, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Lab Med, Gothenburg, Sweden.
   [Milenkovic, Dusanka; Matic, Stanka; Stewart, James B.] Max Planck Inst Biol Ageing, Cologne, Germany.
   [Baris, Olivier R.; Kimoloi, Sammy; Wiesner, Rudolf J.] Univ Cologne, Ctr Physiol & Pathophysiol, Inst Vegetat Physiol, Cologne, Germany.
   [Baris, Olivier R.] Univ Angers, Inst MitoVasc, Equipe MitoLab, INSERM U1083,UMR CNRS 6015,SFRICAT 4208, Angers, France.
   [Stewart, James B.] Newcastle Univ, Biosci Inst, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Larsson, Nils-Goran] Karolinska Inst, Dept Med Biochem & Biophys MBB, Div Mol Metab, Stockholm, Sweden.
   [Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.
C3 University of Gothenburg; University of Gothenburg; Max Planck Society; University of Cologne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Newcastle University - UK; Karolinska Institutet; University of Cologne
RP Falkenberg, M; Larsson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
EM maria.falkenberg@medkem.gu.se; erik.larsson@gu.se
FU Swedish Research Council [2018-02439, 2017-01257, 2018-02852]; Swedish Cancer Foundation [2019-816, 2017-631, 2018-747]; Knut and Alice Wallenberg Foundation [KAW 2017.0080, KAW 2015.0144]; European Research Council [683191]; Swedish government; county councils, the ALF agreement [ALFGBG-727491, ALFGBG-728151]; Vinnova [2018-02852] Funding Source: Vinnova; Swedish Research Council [2018-02439, 2018-02852, 2017-01257] Funding Source: Swedish Research Council; European Research Council (ERC) [683191] Funding Source: European Research Council (ERC); Formas [2018-02852, 2018-02439] Funding Source: Formas
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   [Anonymous], 1996, J DONNE J, V15, P95
   [Anonymous], 2019, CIRCULATION, V2019, P0
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1821-7
   Calabrese FM, 2012, BMC BIOINFORMATICS, V13, P0, DOI 10.1186/1471-2105-13-S4-S15
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Durham SE, 2003, BRIT J CANCER, V88, P90, DOI 10.1038/sj.bjc.6600773
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Gourlé H, 2019, BIOINFORMATICS, V35, P521, DOI 10.1093/bioinformatics/bty630
   Hedberg-Oldfors C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000391
   Hjelm BE, 2019, NUCLEIC ACIDS RES, V47, P0, DOI 10.1093/nar/gkz164
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HORTON TM, 1995, NEUROLOGY, V45, P1879, DOI 10.1212/WNL.45.10.1879
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110
   Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4
   Kim D, 2015, NAT METHODS, V12, P357, DOI 10.1038/NMETH.3317
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kosugi S, 2019, GENOME BIOL, V20, P0, DOI 10.1186/s13059-019-1720-5
   Macao B, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8303
   Matic S, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03552-x
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Persson Ö, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   POULTON J, 1989, LANCET, V1, P236
   POULTON J, 1991, CLIN GENET, V39, P33
   POULTON J, 1995, MUSCLE NERVE, V0, PS154
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   SAVRETRAIN I, 1992, HUM MOL GENET, V1, P203, DOI 10.1093/hmg/1.3.203
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Torregrosa-Muñumer R, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-45244-6
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wendt A, 2000, REV INT STUD, V26, P165, DOI 10.1017/S0260210500001650
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zambelli F, 2017, EUR J HUM GENET, V25, P1229, DOI 10.1038/ejhg.2017.129
   1992, 1900, V1, V0, P11
NR 47
TC 40
Z9 42
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
EI 
J9 PLOS GENET
JI PLoS Genet.
PD DEC 15
PY 2020
VL 16
IS 12
BP 
EP 
DI 10.1371/journal.pgen.1009242
PG 15
WC Genetics & Heredity
SC Genetics & Heredity
GA PG9KP
UT WOS:000600045600004
PM 33315859
DA 2024-11-01
ER

PT J
AU Urban, DL
   Scholle, LM
   Alt, K
   Ludolph, AC
   Rosenbohm, A
AF Urban, Diana Lehmann
   Scholle, Leila Motlagh
   Alt, Kerstin
   Ludolph, Albert C.
   Rosenbohm, Angela
TI Camptocormia as a Novel Phenotype in a Heterozygous <i>POLG2</i> Mutation
SO DIAGNOSTICS
LA English
DT Article
DE mitochondrial myopathy; polymerase gamma 2 (POLG2); camptocormia; mutations of nuclear origin
ID mitochondrial; myopathy; spectrum; mtdna
AB Mitochondrial dysfunction is known to play a key role in the pathophysiological pathway of neurodegenerative disorders. Nuclear-encoded proteins are involved in mtDNA replication, including DNA polymerase gamma, which is the only known replicative mtDNA polymerase, encoded by nuclear genes Polymerase gamma 1 (POLG) and Polymerase gamma 2 (POLG2). POLG mutations are well-known as a frequent cause of mitochondrial myopathies of nuclear origin. However, only rare descriptions of POLG2 mutations leading to mitochondriopathies exist. Here we describe a 68-year-old woman presenting with a 20-year history of camptocormia, mild proximal weakness, and moderate CK increase. Muscle histology showed COX-negative fibres. Genetic analysis by next generation sequencing revealed an already reported heterozygous c.1192-8_1207dup24 mutation in the POLG2 gene. This is the first report on a POLG2 mutation leading to camptocormia as the main clinical phenotype, extending the phenotypic spectrum of POLG2 associated diseases. This underlines the broad phenotypic spectrum found in mitochondrial diseases, especially in mitochondrial disorders of nuclear origin.
C1 [Urban, Diana Lehmann; Ludolph, Albert C.; Rosenbohm, Angela] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany.
   [Scholle, Leila Motlagh] Univ Halle S, Dept Neurol, D-06120 Halle, Germany.
   [Alt, Kerstin] Genetikum, D-89231 Neu, Germany.
C3 Ulm University; Martin Luther University Halle Wittenberg
RP Urban, DL (corresponding author), Univ Ulm, Dept Neurol, D-89081 Ulm, Germany.
EM diana.lehmann@rku.de
FU Hertha-Nathorff-Programm (HNP) of the Ulm Medical University, Germany - German Ministry of Education and Research
CR Ali F, 2018, NEUROL-CLIN PRACT, V8, P240, DOI 10.1212/CPJ.0000000000000453
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393
   Béreau M, 2016, J NEUROL SCI, V368, P70, DOI 10.1016/j.jns.2016.06.062
   Chanson JB, 2016, EUR J NEUROL, V23, P1086, DOI 10.1111/ene.12989
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380
   Da Pozzo P, 2017, NEUROL SCI, V38, P563, DOI 10.1007/s10072-016-2734-3
   Delcey V, 2002, REV MED INTERNE, V23, P144, DOI 10.1016/S0248-8663(01)00530-6
   den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Garrison E, 2012, ARXIV12073907, V0, P0
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   Gómez-Puerta JA, 2007, CLIN RHEUMATOL, V26, P1017, DOI 10.1007/s10067-006-0259-5
   Jungbluth H, 2007, ORPHANET J RARE DIS, V2, P0, DOI 10.1186/1750-1172-2-25
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, PD1062, DOI 10.1093/nar/gkx1153
   Lehmann D, 2015, NEUROMUSCULAR DISORD, V25, P81, DOI 10.1016/j.nmd.2014.09.008
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Li Heng, 2013, PREPRINT, V0, P0, DOI DOI 10.48550/ARXIV.1303.3997
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mose LE, 2014, BIOINFORMATICS, V30, P2813, DOI 10.1093/bioinformatics/btu376
   Paolini C, 2015, SKELET MUSCLE, V5, P0, DOI 10.1186/s13395-015-0035-9
   POULLIN P, 1993, REV RHUM, V60, P159
   Reichmann H, 1996, EUR NEUROL, V36, P98, DOI 10.1159/000117217
   Reimann J, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000147
   Sakiyama Y, 2011, ACTA NEUROPATHOL, V121, P775, DOI 10.1007/s00401-011-0818-y
   Schäbitz WR, 2003, MOVEMENT DISORD, V18, P408, DOI 10.1002/mds.10385
   Serratrice G, 1996, J NEUROL NEUROSUR PS, V60, P51, DOI 10.1136/jnnp.60.1.51
   Sewry CA, 2002, NEUROMUSCULAR DISORD, V12, P930, DOI 10.1016/S0960-8966(02)00135-9
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Sturm M, 2016, BMC BIOINFORMATICS, V17, P0, DOI 10.1186/s12859-016-1069-7
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Maldergem L, 2017, ANN CLIN TRANSL NEUR, V4, P4, DOI 10.1002/acn3.361
   Varma H, 2016, EUR J MED GENET, V59, P540, DOI 10.1016/j.ejmg.2016.08.012
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Zierz CM, 2015, NEUROPATHOLOGY, V35, P130, DOI 10.1111/neup.12173
NR 36
TC 3
Z9 3
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2075-4418
J9 DIAGNOSTICS
JI Diagnostics
PD FEB 15
PY 2020
VL 10
IS 2
BP 
EP 
DI 10.3390/diagnostics10020068
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA KU2LZ
UT WOS:000519541300043
PM 31991853
DA 2024-11-01
ER

PT J
AU Bornstein, R
   Gonzalez, B
   Johnson, SC
AF Bornstein, Rebecca
   Gonzalez, Brenda
   Johnson, Simon C.
TI Mitochondrial pathways in human health and aging
SO MITOCHONDRION
LA English
DT Review
ID unfolded protein response; life-span extension; free-radical theory; dna mutations; oxidative stress; skeletal-muscle; quality-control; molecular-mechanisms; uncoupling protein-3; retrograde response
AB Mitochondria are eukaryotic organelles known best for their roles in energy production and metabolism. While often thought of as simply the 'powerhouse of the cell,' these organelles participate in a variety of critical cellular processes including reactive oxygen species (ROS) production, regulation of programmed cell death, modulation of inter- and intracellular nutrient signaling pathways, and maintenance of cellular proteostasis. Disrupted mitochondrial function is a hallmark of eukaryotic aging, and mitochondrial dysfunction has been reported to play a role in many aging-related diseases. While mitochondria are major players in human diseases, significant questions remain regarding their precise mechanistic role. In this review, we detail mechanisms by which mitochondrial dysfunction participate in disease and aging based on findings from model organisms and human genetics studies.
C1 [Bornstein, Rebecca] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   [Gonzalez, Brenda] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.
   [Johnson, Simon C.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA.
   [Johnson, Simon C.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.
   [Johnson, Simon C.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA.
C3 University of Washington; University of Washington Seattle; Yeshiva University; Montefiore Medical Center; Albert Einstein College of Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital
RP Johnson, SC (corresponding author), Univ Washington, Dept Neurol, Ctr Integrat Brain Res, Seattle Childrens Res Inst, 1900 9th Ave,JMB 10, Seattle, WA 98195 USA.
EM simoncj@tuw.edu
FU NIH [GM126147, T32GM095421]
CR Al-Furoukh N, 2015, BBA-MOL CELL RES, V1853, P2580, DOI 10.1016/j.bbamcr.2015.06.016
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x
   Arnould T, 2015, INT J MOL SCI, V16, P18224, DOI 10.3390/ijms160818224
   Aryaman J, 2019, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00718
   Baertling F, 2018, J PEDIATR-US, V196, P309, DOI 10.1016/j.jpeds.2017.12.043
   Bennett CF, 2014, EXP GERONTOL, V56, P142, DOI 10.1016/j.exger.2014.02.002
   Bennett CF, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4483
   Bingol B, 2016, FREE RADICAL BIO MED, V100, P210, DOI 10.1016/j.freeradbiomed.2016.04.015
   Bock R, 2017, ANNU REV GENET, V51, P1, DOI 10.1146/annurev-genet-120215-035329
   Boggan RM, 2019, MOL GENET METAB, V128, P19, DOI 10.1016/j.ymgme.2019.09.003
   Bris C, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00632
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Busiello RA, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00036
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Cai HH, 2017, J GERONTOL A-BIOL, V72, P1311, DOI 10.1093/gerona/glx013
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Cardamone MD, 2018, MOL CELL, V69, P757, DOI 10.1016/j.molcel.2018.01.037
   Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043
   Catania A, 2018, J HUM GENET, V63, P563, DOI 10.1038/s10038-018-0423-1
   Chang HW, 2015, FREE RADICAL BIO MED, V78, P168, DOI 10.1016/j.freeradbiomed.2014.10.576
   Chathoth S, 2018, BMC MED GENET, V19, P0, DOI 10.1186/s12881-018-0715-5
   Chauhan A, 2014, BIOGERONTOLOGY, V15, P1, DOI 10.1007/s10522-013-9474-z
   Chen JJ, 2017, J CELL PHYSIOL, V232, P2308, DOI 10.1002/jcp.25669
   Childress ES, 2018, J MED CHEM, V61, P4641, DOI 10.1021/acs.jmedchem.7b01182
   Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579
   Clancy DJ, 2008, AGING CELL, V7, P795, DOI 10.1111/j.1474-9726.2008.00428.x
   Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082
   Coppieters N, 2014, NEUROBIOL AGING, V35, P1334, DOI 10.1016/j.neurobiolaging.2013.11.031
   Zárate SC, 2019, FRONT AGING NEUROSCI, V11, P0, DOI 10.3389/fnagi.2019.00123
   da Cunha FM, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/482582
   da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x
   Dai Dao-Fu, 2014, LONGEV HEALTHSPAN, V3, P6, DOI 10.1186/2046-2395-3-6
   Dai DF, 2012, ANTIOXID REDOX SIGN, V16, P1492, DOI 10.1089/ars.2011.4179
   Dancy BM, 2014, EXP GERONTOL, V56, P245, DOI 10.1016/j.exger.2014.03.028
   de Souza BM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054259
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   DellAgnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Dues DJ, 2017, FREE RADICAL BIO MED, V108, P362, DOI 10.1016/j.freeradbiomed.2017.04.004
   Egea J, 2017, REDOX BIOL, V13, P94, DOI 10.1016/j.redox.2017.05.007
   Filograna R, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav9824
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Geisler JG, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8030280
   Gorini S, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/7582730
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Guigni BA, 2018, AM J PHYSIOL-CELL PH, V315, PC744, DOI 10.1152/ajpcell.00002.2018
   Hahn A, 2019, TRENDS CELL BIOL, V29, P227, DOI 10.1016/j.tcb.2018.11.004
   Hahn T, 2019, TANZ, V0, P8
   Hamilton RT, 2012, J CLIN EXP PATHOL, V0, P0, DOI DOI 10.4172/2161-0681.S4-005
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x
   Herrmann JM, 2010, ANTIOXID REDOX SIGN, V13, P1341, DOI 10.1089/ars.2009.3063
   Holmbeck MA, 2015, DIS MODEL MECH, V8, P843, DOI 10.1242/dmm.019323
   Hood WR, 2018, INTEGR COMP BIOL, V58, P567, DOI 10.1093/icb/icy073
   Hunt RJ, 2018, FEBS LETT, V592, P663, DOI 10.1002/1873-3468.12890
   Hwang AB, 2014, P NATL ACAD SCI USA, V111, PE4458, DOI 10.1073/pnas.1411199111
   Hwang AB, 2012, CURR GENOMICS, V13, P519, DOI 10.2174/138920212803251427
   Igarashi M, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.12935
   Jang SY, 2012, J BIOL CHEM, V287, P19304, DOI 10.1074/jbc.M112.363747
   Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100
   Jazwinski SM, 2013, BBA-MOL CELL RES, V1833, P400, DOI 10.1016/j.bbamcr.2012.02.010
   Jiang JC, 2016, GENETICS, V204, P659, DOI 10.1534/genetics.116.188086
   Jitratkosol MHJ, 2012, AIDS, V26, P675, DOI 10.1097/QAD.0b013e32835142eb
   Johnson SC, 2016, HUMAN GENETICS, V0, P1
   Johnson SC, 2019, KIDNEY INT, V95, P455, DOI 10.1016/j.kint.2018.08.038
   Johnson SC, 2017, HUM GENET, V136, P55, DOI 10.1007/s00439-016-1736-9
   Johnson SC, 2015, AGING CELL, V14, P809, DOI 10.1111/acel.12362
   Jovaisaite V, 2015, CURR OPIN CELL BIOL, V33, P74, DOI 10.1016/j.ceb.2014.12.003
   Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296
   Kaeberlein Matt, 2013, F1000PRIME REP, V5, P5, DOI 10.12703/P5-5
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Khayat ZA, 1998, AM J PHYSIOL-CELL PH, V275, PC1487, DOI 10.1152/ajpcell.1998.275.6.C1487
   Kim B, 2016, FREE RADICAL RES, V50, P1065, DOI 10.1080/10715762.2016.1210141
   Knorre DA, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1438, DOI 10.1134/S0006297916120051
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Kühlbrandt W, 2015, BMC BIOL, V13, P0, DOI 10.1186/s12915-015-0201-x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lazcano A, 2017, J THEOR BIOL, V434, P80, DOI 10.1016/j.jtbi.2017.06.036
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee CF, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-39419-4
   Lee HJ, 2008, CLIN CHIM ACTA, V398, P27, DOI 10.1016/j.cca.2008.07.029
   Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001
   Levin L, 2015, ADV EXP MED BIOL, V847, P89, DOI 10.1007/978-1-4939-2404-2_4
   Li M, 2017, HIV MED, V18, P45, DOI 10.1111/hiv.12390
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905
   Lombès A, 2014, BIOCHIMIE, V100, P171, DOI 10.1016/j.biochi.2013.08.012
   Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Luo XY, 2014, CLIN CHIM ACTA, V437, P106, DOI 10.1016/j.cca.2014.07.019
   Lutz-Bonengel S, 2019, P NATL ACAD SCI USA, V116, P1821, DOI 10.1073/pnas.1820533116
   MacArthur J, 2017, NUCLEIC ACIDS RES, V45, PD896, DOI 10.1093/nar/gkw1133
   Mao XR, 2016, CELL DEATH DIS, V7, P0, DOI 10.1038/cddis.2016.5
   Marais AD, 2019, PATHOLOGY, V51, P165, DOI 10.1016/j.pathol.2018.11.002
   McDonnell E, 2015, TRENDS ENDOCRIN MET, V26, P486, DOI 10.1016/j.tem.2015.06.001
   McElroy GS, 2020, CELL METAB, V32, P301, DOI 10.1016/j.cmet.2020.06.003
   McMillan RP, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-42262-2
   Meiklejohn CD, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003238
   Mitchell SJ, 2018, CELL METAB, V27, P667, DOI 10.1016/j.cmet.2018.02.001
   Ayala MAM, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-65381-7
   Munkácsy E, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1006133
   Nacarelli T, 2019, NAT CELL BIOL, V21, P397, DOI 10.1038/s41556-019-0287-4
   Nagao Y, 1998, GENES GENET SYST, V73, P21, DOI 10.1266/ggs.73.21
   Nalbandian A, 2015, MITOCHONDRION, V22, P1, DOI 10.1016/j.mito.2015.02.004
   OSullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897
   Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Parey K, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.39213
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Payne BA, 2015, ANTIVIR THER, V20, P109, DOI 10.3851/IMP2824
   Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150
   Pelletier A, 2005, ENDOCRINOLOGY, V146, P2285, DOI 10.1210/en.2004-1565
   Pérez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672
   Pichaud N, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00130
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Piredda R, 2020, EUR J NEUROL, V27, P229, DOI 10.1111/ene.14115
   Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011
   Ran Q, 2007, J GERONTOL A-BIOL, V62, P932, DOI 10.1093/gerona/62.9.932
   Rana A, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00525-4
   Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110
   Rand DM, 2006, GENETICS, V172, P329, DOI 10.1534/genetics.105.046698
   Rauthan M, 2015, G3-GENES GENOM GENET, V5, P1639, DOI 10.1534/g3.115.018598
   Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259
   Rich PR, 2010, ESSAYS BIOCHEM, V47, P1, DOI 10.1042/BSE0470001
   Ricquier D, 2017, BIOCHIMIE, V134, P3, DOI 10.1016/j.biochi.2016.10.018
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Rodger CE, 2018, FEBS J, V285, P1185, DOI 10.1111/febs.14336
   Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230
   Safiulina D, 2013, PLOS BIOL, V11, P0, DOI 10.1371/journal.pbio.1001755
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Saha AK, 1997, AM J PHYSIOL-ENDOC M, V272, PE641, DOI 10.1152/ajpendo.1997.272.4.E641
   Salminen A, 2014, AGEING RES REV, V16, P45, DOI 10.1016/j.arr.2014.05.004
   Salminen A, 2014, CELL SIGNAL, V26, P1598, DOI 10.1016/j.cellsig.2014.03.030
   Sandhu SK, 2003, BIOGERONTOLOGY, V4, P19, DOI 10.1023/A:1022473219044
   Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303
   Schendzielorz AB, 2017, J CELL BIOL, V216, P83, DOI 10.1083/jcb.201607066
   Schieber M, 2014, CELL REP, V9, P9, DOI 10.1016/j.celrep.2014.08.075
   Schleit J, 2013, AGING CELL, V12, P1050, DOI 10.1111/acel.12130
   SCHLEYER M, 1982, EUR J BIOCHEM, V125, P109, DOI 10.1111/j.1432-1033.1982.tb06657.x
   Sebastián D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003
   Sebastián D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Shi RY, 2018, TRENDS CARDIOVAS MED, V28, P246, DOI 10.1016/j.tcm.2017.11.008
   Shi Y, 2010, INTEGR COMP BIOL, V50, P869, DOI 10.1093/icb/icq079
   Shirakabe A, 2016, CIRC RES, V118, P1563, DOI 10.1161/CIRCRESAHA.116.307474
   Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110
   Sloan DB, 2015, P ROY SOC B-BIOL SCI, V282, P0, DOI 10.1098/rspb.2015.1704
   Slowicka K, 2016, TRENDS IMMUNOL, V37, P621, DOI 10.1016/j.it.2016.07.002
   Smiti P, 2018, PROCEEDINGS OF THE 8TH INTERNATIONAL CONFERENCE CONFLUENCE 2018 ON CLOUD COMPUTING, V0, P360, DOI 10.1109/CONFLUENCE.2018.8442823
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stöckl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Terman A, 2003, EXP GERONTOL, V38, P863, DOI 10.1016/S0531-5565(03)00114-1
   Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tysnes OB, 2017, J NEURAL TRANSM, V124, P901, DOI 10.1007/s00702-017-1686-y
   Viña J, 2018, FREE RADICAL BIO MED, V124, P358, DOI 10.1016/j.freeradbiomed.2018.06.028
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018
   Welter D, 2014, NUCLEIC ACIDS RES, V42, PD1001, DOI 10.1093/nar/gkt1229
   Whitley BN, 2019, MITOCHONDRION, V49, P269, DOI 10.1016/j.mito.2019.06.002
   Wolf DM, 2019, EMBO J, V38, P0, DOI 10.15252/embj.2018101056
   Xu C, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-32025-w
   Yang YX, 2019, BIOMED PHARMACOTHER, V117, P0, DOI 10.1016/j.biopha.2019.109075
   Yarian CS, 2006, MECH AGEING DEV, V127, P79, DOI 10.1016/j.mad.2005.09.028
   Yin YM, 2018, ADV EXP MED BIOL, V1086, P77, DOI 10.1007/978-981-13-1117-8_5
   Ying HY, 2016, EXP EYE RES, V144, P73, DOI 10.1016/j.exer.2015.06.029
   Yoon YS, 2003, J BIOL CHEM, V278, P51577, DOI 10.1074/jbc.M308489200
   Zha SY, 2018, STEM CELL RES THER, V9, P0, DOI 10.1186/s13287-018-0961-7
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zhang L, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep18725
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
   Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009
NR 181
TC 47
Z9 52
U1 1
U2 14
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP 15
PY 2020
VL 54
IS 
BP 72
EP 84
DI 10.1016/j.mito.2020.07.007
PG 13
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA NX5WU
UT WOS:000575782000010
PM 32738358
DA 2024-11-01
ER

PT J
AU Cirigliano, A
   Amelina, A
   Biferali, B
   Macone, A
   Mozzetta, C
   Bianchi, MM
   Mori, M
   Botta, B
   Pick, E
   Negri, R
   Rinaldi, T
AF Cirigliano, Angela
   Amelina, Antonia
   Biferali, Beatrice
   Macone, Alberto
   Mozzetta, Chiara
   Bianchi, Michele Maria
   Mori, Mattia
   Botta, Bruno
   Pick, Elah
   Negri, Rodolfo
   Rinaldi, Teresa
TI Statins interfere with the attachment of <i>S. cerevisiae</i> mtDNA to the inner mitochondrial membrane
SO JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
LA English
DT Article
DE Statins; ergosterol; cholesterol; mitochondrial DNA; myopathy
ID hmg-coa reductase; skeletal-muscle; kluyveromyces-lactis; sterol levels; yeast; impairment; overexpression; mevinolin; mutations; toxicity
AB The 3-hydroxy-3-methylglutaryl-CoA reductase, a key enzyme of the mevalonate pathway for the synthesis of cholesterol in mammals (ergosterol in fungi), is inhibited by statins, a class of cholesterol lowering drugs. Indeed, statins are in a wide medical use, yet statins treatment could induce side effects as hepatotoxicity and myopathy in patients. We used Saccharomyces cerevisiae as a model to investigate the effects of statins on mitochondria. We demonstrate that statins are active in S.cerevisiae by lowering the ergosterol content in cells and interfering with the attachment of mitochondrial DNA to the inner mitochondrial membrane. Experiments on murine myoblasts confirmed these results in mammals. We propose that the instability of mitochondrial DNA is an early indirect target of statins.
C1 [Cirigliano, Angela; Amelina, Antonia; Biferali, Beatrice; Mozzetta, Chiara; Bianchi, Michele Maria; Negri, Rodolfo; Rinaldi, Teresa] Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Piazzale A Moro 5, I-00185 Rome, Italy.
   [Macone, Alberto; Rinaldi, Teresa] Pasteur Inst Cenci Bolognetti Fdn, Rome, Italy.
   [Biferali, Beatrice; Mozzetta, Chiara; Negri, Rodolfo] Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, CNR, Inst Mol Biol & Pathol, Rome, Italy.
   [Macone, Alberto] Sapienza Univ Rome, Dipartimento Sci Biochim A Rossi Fanelli, CNR, Inst Mol Biol & Pathol, Rome, Italy.
   [Mori, Mattia] Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy.
   [Botta, Bruno] Sapienza Univ Rome, Dipartimento Chim & Tecnol Farmaco, Rome, Italy.
   [Pick, Elah] Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Tivon, Israel.
C3 Sapienza University Rome; Fondazione Cenci Bolognetti; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); University of Siena; Sapienza University Rome; University of Haifa
RP Rinaldi, T (corresponding author), Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Piazzale A Moro 5, I-00185 Rome, Italy.
EM teresa.rinaldi@uniroma1.it
FU Ateneo Sapienza, Sapienza University of Rome, Italy [RP11715C541D4BFF, RP11816418C88AAC, RM11816413C50F4B]; Israel Ministry of Science and Technology (MOST)Italy Ministry of Foreign Affairs (MAECI) [3-9022]; Israel Science Foundation [162/17]
CR Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678
   Apostolopoulou M, 2015, EUR J CLIN INVEST, V45, P745, DOI 10.1111/eci.12461
   BARD M, 1988, J GEN MICROBIOL, V134, P1071
   Barrientos A, 2003, IUBMB LIFE, V55, P83, DOI 10.1080/1521654031000098122
   Bianchi MM, 2001, APPL ENVIRON MICROB, V67, P5621, DOI 10.1128/AEM.67.12.5621-5625.2001
   BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846
   Bolotin-Fukuhara M, 2014, YEAST, V31, P279, DOI 10.1002/yea.3019
   Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016
   Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002
   CHARIOT P, 1993, AM J MED, V94, P109, DOI 10.1016/0002-9343(93)90129-D
   CHEN XJ, 1993, GENETICS, V133, P517
   Cirigliano A, 2019, BBA-MOL CELL BIOL L, V1864, P290, DOI 10.1016/j.bbalip.2018.12.002
   Davies BSJ, 2006, GENETICS, V174, P191, DOI 10.1534/genetics.106.059964
   De Angelis L, 2016, MICROBIOL-SGM, V162, P1435, DOI 10.1099/mic.0.000315
   De Luca C, 2009, MITOCHONDRION, V9, P408, DOI 10.1016/j.mito.2009.07.004
   DePinieux G, 1996, BRIT J CLIN PHARMACO, V42, P333, DOI 10.1046/j.1365-2125.1996.04178.x
   Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588
   du Souich P, 2017, PHARMACOL THERAPEUT, V175, P1, DOI 10.1016/j.pharmthera.2017.02.029
   FERGUSON LR, 1992, MUTAT RES, V265, P103, DOI 10.1016/0027-5107(92)90042-Z
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Fowler DM, 2011, MOL BIOSYST, V7, P533, DOI 10.1039/c0mb00166j
   Francisci S, 2017, BBA-MOL CELL RES, V1864, P666, DOI 10.1016/j.bbamcr.2017.01.008
   Friesen JA, 2004, GENOME BIOL, V5, P0, DOI 10.1186/gb-2004-5-11-248
   Gerhold JM, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15292
   Gilkerson R, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011080
   Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004
   He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266
   Istvan ES, 2002, AM HEART J, V144, PS27, DOI 10.1067/mhj.2002.130300
   Kang CH, 2015, FASEB J, V29, P4092, DOI 10.1096/fj.14-266619
   Katz DH, 2014, J CARDIOVASC PHARM T, V19, P533, DOI 10.1177/1074248414529622
   Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z
   Knauer MJ, 2010, CIRC RES, V106, P297, DOI 10.1161/CIRCRESAHA.109.203596
   Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036
   LORENZ RT, 1990, ANTIMICROB AGENTS CH, V34, P1660, DOI 10.1128/AAC.34.9.1660
   Maciejak A, 2013, BMC BIOTECHNOL, V13, P0, DOI 10.1186/1472-6750-13-68
   Matsubara A, 2018, TOXICOL LETT, V291, P184, DOI 10.1016/j.toxlet.2018.04.016
   Montanari A, 2008, RNA, V14, P275, DOI 10.1261/rna.740108
   Murley A, 2013, ELIFE, V2, P0, DOI 10.7554/eLife.00422
   Nadanaciva S, 2007, TOXICOL APPL PHARM, V223, P277, DOI 10.1016/j.taap.2007.06.003
   Ottaviano D, 2015, FEMS YEAST RES, V15, P0, DOI 10.1093/femsyr/fov028
   Peralta S, 2018, J CELL SCI, V131, P0, DOI 10.1242/jcs.217075
   Ramachandran R, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6080075
   Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x
   Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124
   Serratore ND, 2018, GENETICS, V208, P1037, DOI 10.1534/genetics.117.300554
   Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16
   Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710
   Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172
   Sirvent P, 2005, BIOCHEM BIOPH RES CO, V338, P1426, DOI 10.1016/j.bbrc.2005.10.108
   Sirvent P, 2012, TOXICOL APPL PHARM, V259, P263, DOI 10.1016/j.taap.2012.01.008
   Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023
   Tay SKH, 2008, PEDIATR NEUROL, V39, P426, DOI 10.1016/j.pediatrneurol.2008.09.002
   Tomaszewski M, 2011, PHARMACOL REP, V63, P859, DOI 10.1016/S1734-1140(11)70601-6
   Tourlaki A, 2020, J DERMATOL TREAT, V31, P183, DOI 10.1080/09546634.2019.1590520
   Vladutiu GD, 2006, MUSCLE NERVE, V34, P153, DOI 10.1002/mus.20567
   Westermeyer C, 2007, FEMS YEAST RES, V7, P436, DOI 10.1111/j.1567-1364.2006.00194.x
NR 56
TC 7
Z9 7
U1 0
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1475-6366
EI 1475-6374
J9 J ENZYM INHIB MED CH
JI J. Enzym. Inhib. Med. Chem.
PD JAN 1
PY 2020
VL 35
IS 1
BP 
EP 
DI 10.1080/14756366.2019.1687461
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA JK5JI
UT WOS:000494879200001
PM 31694426
DA 2024-11-01
ER

PT J
AU Robinson, KN
   Terrazas, S
   Giordano-Mooga, S
   Xavier, NA
AF Robinson, Katie Nahay
   Terrazas, Sari
   Giordano-Mooga, Samantha
   Xavier, Neena A.
TI THE ROLE OF HETEROPLASMY IN THE DIAGNOSIS AND MANAGEMENT OF MATERNALLY INHERITED DIABETES AND DEAFNESS
SO ENDOCRINE PRACTICE
LA English
DT Review
ID mitochondrial-dna; mutation
AB Objective: Maternally inherited diabetes and deafness (MIDD) is a rare diabetic syndrome mainly caused by a point mutation in the mitochondrial DNA (mtDNA), mt3243 adenine to guanine (A>G). The objective of this paper is to review the genetic inheritance, clinical manifestations, and treatment of patients with MIDD. Methods: The current review used a literature search of scientific papers on this rare syndrome. Results: mtDNA is primarily inherited through the maternal oocyte; therefore, the genetic abnormali-ties in MIDD are associated with maternal inheritance. Mitochondria contain circular mtDNA, which codes for various mitochondria! genes. The mtDNA can be heteroplasmic, containing more than one type of mtDNA sequence; if one of the mtDNAs contains the mt3243 A>G mutation, a patient may develop MIDD. Patients can inherit different amounts of mutated mtDNA and normal mtDNA that affect the severity of the clinical manifestations of MIDD. The most common clinical manifestations include diabetes mellitus, deafness, ophthalmic disease, cardiac disease, renal disease, gastrointestinal disease, short stature, and myopathies. In order to effectively treat patients with MIDD, it is important to recognize the underlying pathophysiology of this specific form of diabetes and the pathophysiology associated with the organ-specific complications present in this disease. Conclusion: The heteroplasmic inheritance of mutated mtDNA plays an important role in the clinical manifestations of various mitochondrial diseases, specifically MIDD. This review will alert endocrinologists of the signs and symptoms of MIDD and important clinical considerations when managing this disease.
C1 [Robinson, Katie Nahay; Xavier, Neena A.] Univ Alabama Birmingham, Phys Assistant Studies Program, Dept Clin & Diagnost Sci, Sch Hlth Profess, Birmingham, AL USA.
   [Terrazas, Sari; Giordano-Mooga, Samantha] Univ Alabama Birmingham, Biomed Sci Program, Dept Clin & Diagnost Sci, Sch Hlth Profess, Birmingham, AL USA.
C3 University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham
RP Xavier, NA (corresponding author), Sch Hlth Profess, Phys Assistant Program, SHP 480,1716 9th Ave South, Birmingham, AL 35294 USA.
EM naxavier@uab.edu
CR Alves D, 2017, ACTA MEDICA PORT, V30, P581, DOI 10.20344/amp.8638
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Cao XY, 2013, INDIAN J PATHOL MICR, V56, P272, DOI 10.4103/0377-4929.120392
   Cui Hang, 2012, J SIGNAL TRANSDUCT, V2012, P646354, DOI 10.1155/2012/646354
   Donovan LE, 2006, J CLIN ENDOCR METAB, V91, P4737, DOI 10.1210/jc.2006-1498
   Dunham-Snary KJ, 2015, SCIENCE, V349, P1449, DOI 10.1126/science.aac5271
   Duran J, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020034
   Geng X, 2019, DIABETIC MED, V36, P776, DOI 10.1111/dme.13874
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Godinho I, 2017, CLIN KIDNEY J, V10, P487, DOI 10.1093/ckj/sfx021
   Li HZ, 2014, FRONT BIOSCI-LANDMRK, V19, P777, DOI 10.2741/4244
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Naing A, 2014, J DIABETES COMPLICAT, V28, P542, DOI 10.1016/j.jdiacomp.2014.03.006
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Yee ML, 2018, ENDOCRINOL DIAB META, V0, P0, DOI DOI 10.1530/EDM-18-0091
NR 19
TC 16
Z9 17
U1 0
U2 7
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1530-891X
EI 1934-2403
J9 ENDOCR PRACT
JI Endocr. Pract.
PD FEB 15
PY 2020
VL 26
IS 2
BP 241
EP 246
DI 10.4158/EP-2019-0270
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA KS8HK
UT WOS:000518547300011
PM 31682520
DA 2024-11-01
ER

PT J
AU Ponsonnard, S
AF Ponsonnard, Sebastien
TI Hereditary spastic paraplegia
SO ANASTHESIOLOGIE & INTENSIVMEDIZIN
LA English
DT Article
DE Strumpell-Lorrain disease (designating one type of HSP called SPG4); familial spastic paraplegia
AB Disease summary: Strumpell-Lorrain disease or hereditary spastic paraplegia describes a group of rare and heterogeneous genetic neurological disorders [1]. In Europe, HSP is estimated to affect 1 to 9 per 100,000 individuals [2-6]. HSP is an inherited neurodegenerative group of disorders which affects primarily the corticospinal tract with a distal to proximal retrograde axonal degeneration. For this reason, in the so-called pure HSP cases, the clinical picture is characterised mainly by a progressive spasticity of the lower limbs leading to paraparesis or paraplegia affecting several members of the same family. Many patients experience only stiffness and weakening of the leg muscles; a few require the use of a wheelchair. The progression of the disease to the rest of the corticospinal tracts, to peripheral nerves, the cerebellum or the brain explains the other additional symptoms commonly found in complicated or complex HSP cases: cerebellar ataxia, dysarthria, extrapyramidal disorder, mental retardation, dementia, epilepsy, retinopathy, deafness, axonal or demyelinating neuropathy and eventually systemic signs. The clinical diagnosis is based on four criteria [7]: exclusion of differential diagnoses, compatible family history (although not obligatory), progressive disturbance of gait and corticospinal tract deficits in the lower limbs with hyperreflexia. Spinal cord atrophy is a common finding in HSP [8]. Conventional brain magnetic resonance imaging findings are usually normal in patients with HSP, but multiple diffusion tensor indices can be disrupted [9]. It can disclose different findings in complicated or complex HSP, such as thin corpus callosum, leukoencephalopathy and hyperintensity sign in the corticospinal tract. Diagnosis must be confirmed by DNA analysis. The most commonly involved genes are the SPG4 and SPG3A which encode for the proteins spastin and atlastin, respectively. Transmission of HSP can be autosomal dominant, autosomal recessive, X-linked or maternally inherited (mitochondrial inheritance) [10]. Mutations in more than 80 distinct loci and more than 50 mutated gene products have been identified in patients with HSP [11,12]. The main pathogenic mechanisms underlying the clinical phenotype include membrane trafficking disturbance, impairment of organelle transport, morphogenesis and distribution in neuronal cells, and mitochondrial dysfunction. Membrane trafficking and organelle morphogenesis and distribution are important for axonal development, maintenance and degeneration [1,13]. There is no specific pharmacological treatment. Treatment is symptomatic and includes physical therapy, benzodiazepines, oral or intrathecal baclofen [14] and injections of botulinum toxin [15] to reduce spasticity. By blocking potassium channels, prolonging action potentials and thereby increasing neurotransmitter release at the neuromuscular junction, dalfampridine may be useful in the treatment of HSP [16,17].
C1 [Ponsonnard, Sebastien] Polyclin Limoges, Limoges, France.
RP Ponsonnard, S (corresponding author), Polyclin Limoges, Limoges, France.
EM sponsonnard@gmail.com
CR Aghakhanyan G, 2014, AM J NEURORADIOL, V35, P1533, DOI 10.3174/ajnr.A3897
   Franco-Hernández JA, 2013, REV BRAS ANESTESIOL, V63, P113, DOI 10.1016/j.bjane.2012.05.002
   Béreau M, 2015, J NEUROL, V262, P1285, DOI 10.1007/s00415-015-7707-6
   Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946
   Braschinsky M, 2009, NEUROEPIDEMIOLOGY, V32, P89, DOI 10.1159/000177033
   CAPRINI JA, 1991, SEMIN THROMB HEMOST, V17, P304
   Dallman M, 2010, INT STUD J NURSE ANE, V9, P28
   Deruddre S, 2006, ANESTH ANALG, V102, P1910, DOI 10.1213/01.ANE.0000215148.29795.70
   Erichsen AK, 2009, BRAIN, V132, P1577, DOI 10.1093/brain/awp056
   Fink JK, 1996, NEUROLOGY, V46, P1507, DOI 10.1212/WNL.46.6.1507
   Hedera P, 2005, NEURORADIOLOGY, V47, P730, DOI 10.1007/s00234-005-1415-3
   HOUSTON T, 1984, BRIT J ANAESTH, V56, P1139, DOI 10.1093/bja/56.10.1139
   Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006
   King AM, 2012, J MED TOXICOL, V8, P314, DOI 10.1007/s13181-012-0248-9
   KOMULAINEN A, 1991, AM J VET RES, V52, P585
   Kunisawa Takayuki, 2002, MASUI, V51, P64
   Lamore R, 2010, P & T, V35, P665
   Ma HC, 2005, ACTA PHARMACOL SIN, V26, P181, DOI 10.1111/j.1745-7254.2005.00521.x
   Margetis K, 2014, CLIN NEUROL NEUROSUR, V123, P142, DOI 10.1016/j.clineuro.2014.05.024
   MARTINEZ-AGUIRRE E, 1980, ACTA ANAESTHESIOLOGICA BELGICA, V31, P289
   Marvulli R, 2016, CURR PHARM DESIGN, V22, P758, DOI 10.2174/1381612822666151204001830
   Mc Monagle P, 2002, J NEUROL NEUROSUR PS, V72, P43, DOI 10.1136/jnnp.72.1.43
   McIver T, 2007, INT J OBSTET ANESTH, V16, P190, DOI 10.1016/j.ijoa.2006.11.002
   McTiernan C, 1999, CAN J ANAESTH, V46, P679, DOI 10.1007/BF03013958
   MIMURA M, 1992, ACTA ANAESTH SCAND, V36, P460, DOI 10.1111/j.1399-6576.1992.tb03497.x
   Mohammed Imran, 2004, BMC CLIN PHARMACOL, V4, P6, DOI 10.1186/1472-6904-4-6
   Naguib M, 1998, DRUG SAFETY, V18, P99, DOI 10.2165/00002018-199818020-00002
   Orsucci D, 2014, CLIN NEUROL NEUROSUR, V120, P14, DOI 10.1016/j.clineuro.2014.02.002
   Ponsonnard S, 2017, EUR J ANAESTH, V34, P562, DOI 10.1097/EJA.0000000000000615
   Richard S, 2017, MEDICINE, V96, P0, DOI 10.1097/MD.0000000000005911
   Ross JC, 2011, NEUROCRIT CARE, V14, P103, DOI 10.1007/s12028-010-9422-6
   Salazar ML, 2008, PEDIATR EMERG CARE, V24, P691, DOI 10.1097/PEC.0b013e318188a952
   Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8
   Santiago-Palma J, 2004, ANESTH ANALG, V99, P227, DOI 10.1213/01.ANE.0000121347.11127.99
   SCHMUTZLER S, 1984, ANAESTHESIST, V33, P294
   de Souza PVS, 2017, CEREBELLUM, V16, P525, DOI 10.1007/s12311-016-0803-z
   SIA RL, 1981, BRIT J ANAESTH, V53, P865, DOI 10.1093/bja/53.8.865
   Silva MC, 1997, J CLIN EPIDEMIOL, V50, P1377, DOI 10.1016/S0895-4356(97)00202-3
   Solowska JM, 2015, BRAIN, V138, P2471, DOI 10.1093/brain/awv178
   Thomas I, 2006, INT J OBSTET ANESTH, V15, P254, DOI 10.1016/j.ijoa.2006.01.002
NR 40
TC 0
Z9 0
U1 1
U2 2
PU AKTIV DRUCK & VERLAG GMBH
PI EBELSBACH
PA AN DER LOHWIESE 36, EBELSBACH, 97500, GERMANY
SN 0170-5334
EI 1439-0256
J9 ANASTH INTENSIVMED
JI Anasthesiol. Intensivmed.
PD JUL-AUG 15
PY 2020
VL 61
IS 
BP 
EP 
DI 10.19224/ai2020.S290
PG 8
WC Anesthesiology; Critical Care Medicine
SC Anesthesiology; General & Internal Medicine
GA VK9FJ
UT WOS:000766083200002
DA 2024-11-01
ER

PT J
AU Braganza, A
   Annarapu, GK
   Shiva, S
AF Braganza, Andrea
   Annarapu, Gowtham K.
   Shiva, Sruti
TI Blood-based bioenergetics: An emerging translational and clinical tool
SO MOLECULAR ASPECTS OF MEDICINE
LA English
DT Review
DE Mitochondria; Bioenergetics; Platelets; Blood cell; Biomarker; Precision medicine
ID mitochondrial-dna mutations; right-ventricular hypertrophy; neutrophil life-span; complex-i activity; skeletal-muscle; pulmonary-hypertension; platelet-aggregation; metabolic-regulation; bipolar disorder; health index
AB Accumulating studies demonstrate that mitochondrial genetics and function are central to determining the susceptibility to, and prognosis of numerous diseases across all organ systems. Despite this recognition, mitochondrial function remains poorly characterized in humans primarily due to the invasiveness of obtaining viable tissue for mitochondrial studies. Recent studies have begun to test the hypothesis that circulating blood cells, which can be obtained by minimally invasive methodology, can be utilized as a biomarker of systemic bioenergetic function in human populations. Here we present the available methodologies for assessing blood cell bioenergetics and review studies that have applied these techniques to healthy and disease populations. We focus on the validation of this methodology in healthy subjects, as well as studies testing whether blood cell bioenergetics are altered in disease, correlate with clinical parameters, and compare with other methodology for assessing human mitochondrial function. Finally, we present the challenges and goals for the development of this emerging approach into a tool for translational research and personalized medicine.
C1 [Braganza, Andrea; Annarapu, Gowtham K.; Shiva, Sruti] Pittsburgh Heart Lung & Blood Vasc Med Inst, Pittsburgh, PA USA.
   [Shiva, Sruti] Dept Pharmacol & Chem Biol, Pittsburgh, PA USA.
   [Shiva, Sruti] Univ Pittsburgh, Sch Med, Ctr Metab & Mitochondrial Med C3M, Pittsburgh, PA USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh
RP Shiva, S (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh Heart Lung Vasc Med Inst, 200 Lothrop St 1240E BST, Pittsburgh, PA 15261 USA.
EM Sss43@pitt.edu
FU NIH [R01 HL133003-01A1]; Hemophilia Center of Western Pennsylvania; AHA [19POST34380956]; Vitalant; American Heart Association (AHA) [19POST34380956] Funding Source: American Heart Association (AHA)
CR Akki A, 2013, AM J PHYSIOL-HEART C, V304, PH633, DOI 10.1152/ajpheart.00771.2011
   Al Badarin FJ, 2019, CURR CARDIOL REP, V21, P0, DOI 10.1007/s11886-019-1146-4
   Aoyama R, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0188479
   Avila C, 2012, EXP CLIN ENDOCR DIAB, V120, P248, DOI 10.1055/s-0031-1285833
   Batt J, 2014, AM J RESP CELL MOL, V50, P74, DOI 10.1165/rcmb.2012-0506OC
   Beadnell TC, 2018, CANCER METAST REV, V37, P615, DOI 10.1007/s10555-018-9772-7
   Ben-Shachar D, 1999, INT J NEUROPSYCHOPH, V2, P245, DOI 10.1017/S1461145799001649
   Ben-Shachar D, 2007, PROG NEURO-PSYCHOPH, V31, P807, DOI 10.1016/j.pnpbp.2006.12.025
   Betancourt AM, 2014, BIOCHEM J, V461, P223, DOI 10.1042/BJ20131433
   Boushel R, 2001, SCAND J MED SCI SPOR, V11, P213, DOI 10.1034/j.1600-0838.2001.110404.x
   Braganza A, 2019, JCI INSIGHT, V4, P0, DOI 10.1172/jci.insight.128248
   Brookes PS, 2002, METHOD ENZYMOL, V359, P305
   Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203
   Burke PJ, 2017, TRENDS CANCER, V3, P857, DOI 10.1016/j.trecan.2017.10.006
   Caccese D, 2000, THROMB HAEMOSTASIS, V83, P485, DOI 10.1055/s-0037-1613841
   Cardena MMSG, 2016, J HUM HYPERTENS, V30, P120, DOI 10.1038/jhh.2015.39
   Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420
   Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2
   Cesari F, 2008, THROMB HAEMOSTASIS, V99, P930, DOI 10.1160/THOS-01-0002
   Chacko B, 2019, MOL GENET METAB REP, V19, P0, DOI 10.1016/j.ymgmr.2019.100451
   Chacko BK, 2019, REDOX BIOL, V22, P0, DOI 10.1016/j.redox.2019.101165
   Chacko BK, 2016, REDOX BIOL, V8, P43, DOI 10.1016/j.redox.2015.12.008
   Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101
   Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53
   Chandel NS, 2014, BMC BIOL, V12, P0, DOI 10.1186/1741-7007-12-34
   Chen EI, 2012, J BIOENERG BIOMEMBR, V44, P619, DOI 10.1007/s10863-012-9465-9
   Chen IY, 2011, CIRCULATION, V123, P425, DOI 10.1161/CIRCULATIONAHA.109.916338
   Chou CH, 2019, INT J CARDIOL, V274, P214, DOI 10.1016/j.ijcard.2018.07.104
   Chung J, 2011, BIOL PHARM BULL, V34, P495, DOI 10.1248/bpb.34.495
   Cochran BJ, 2017, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/55184
   Coen PM, 2013, J GERONTOL A-BIOL, V68, P447, DOI 10.1093/gerona/gls196
   Cohen BH, 2001, CLEV CLIN J MED, V68, P625, DOI 10.3949/ccjm.68.7.625
   Cowan DB, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0160889
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   Culley MK, 2018, J CLIN INVEST, V128, P3704, DOI 10.1172/JCI120847
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   De Boer RJ, 2003, J IMMUNOL, V170, P2479, DOI 10.4049/jimmunol.170.5.2479
   Dezfulian C, 2017, REDOX BIOL, V12, P491, DOI 10.1016/j.redox.2017.03.010
   Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Dunham-Snary KJ, 2018, EBIOMEDICINE, V36, P316, DOI 10.1016/j.ebiom.2018.08.036
   Fetterman JL, 2013, BIOCHEM J, V455, P157, DOI 10.1042/BJ20130029
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Fliedner TM, 2002, CANCER BIOTHER RADIO, V17, P405, DOI 10.1089/108497802760363204
   Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25
   FUKAMI MH, 1973, BLOOD, V42, P913, DOI 10.1182/blood.V42.6.913.913
   Garcia I, 2017, FRONT BIOSCI-LANDMRK, V22, P710, DOI 10.2741/4511
   Garcia-Souza LF, 2014, INT J BIOCHEM CELL B, V50, P156, DOI 10.1016/j.biocel.2014.02.015
   Gomez-Arroyo J, 2013, CIRC-HEART FAIL, V6, P136, DOI 10.1161/CIRCHEARTFAILURE.111.966127
   Granatiero V, 2017, ADV EXP MED BIOL, V982, P25, DOI 10.1007/978-3-319-55330-6_2
   Grove EL, 2011, J THROMB HAEMOST, V9, P185, DOI 10.1111/j.1538-7836.2010.04115.x
   Gründler K, 2014, CRIT CARE, V18, P0, DOI 10.1186/cc13724
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hamaoka T, 1996, J APPL PHYSIOL, V81, P1410
   Harker LA, 2000, BLOOD, V95, P2514
   Hasegawa A, 2009, BLOOD, V114, P2917, DOI 10.1182/blood-2009-02-204263
   Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263
   Japiassú AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c
   Joyce NC, 2012, PHYS MED REH CLIN N, V23, P609, DOI 10.1016/j.pmr.2012.06.006
   Kaufman BA, 2015, MOL ASPECTS MED, V42, P91, DOI 10.1016/j.mam.2015.01.004
   Kaur A, 2019, STEM CELLS INT, V2019, P0, DOI 10.1155/2019/1286054
   Keuper M, 2019, MOL METAB, V20, P28, DOI 10.1016/j.molmet.2018.11.006
   Khare A, 2016, CELL REP, V15, P1700, DOI 10.1016/j.celrep.2016.04.060
   Klimmeck D, 2012, MOL CELL PROTEOMICS, V11, P286, DOI 10.1074/mcp.M111.016790
   Kramer PA, 2015, BIOSCIENCE REP, V35, P0, DOI 10.1042/BSR20150161
   Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026
   Krzywanski DM, 2011, LAB INVEST, V91, P1122, DOI 10.1038/labinvest.2011.95
   Kuznetsov Andrey V, 1998, BIOFACTORS, V7, P221
   Lanza IR, 2010, CURR OPIN CLIN NUTR, V13, P511, DOI 10.1097/MCO.0b013e32833cc93d
   LETELLIER T, 1992, PEDIATR RES, V32, P17, DOI 10.1203/00006450-199207000-00004
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lopaschuk GD, 2017, CAN J CARDIOL, V33, P838, DOI 10.1016/j.cjca.2016.12.013
   Mahapatra G, 2018, CLIN SCI, V132, P2509, DOI 10.1042/CS20180690
   Malenfant S, 2015, J MOL MED, V93, P573, DOI 10.1007/s00109-014-1244-0
   Marshall JD, 2018, AM J PHYSIOL-LUNG C, V314, PL782, DOI 10.1152/ajplung.00331.2017
   Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66
   Romero MM, 2016, CELL MICROBIOL, V18, P875, DOI 10.1111/cmi.12562
   Michalak S, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/9703574
   MONTAGNA P, 1988, HEADACHE, V28, P477, DOI 10.1111/j.1526-4610.1988.hed2807477.x
   Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471
   Nguyen QL, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0220490
   Nguyen QL, 2017, JCI INSIGHT, V2, P0, DOI 10.1172/jci.insight.91415
   Nierenberg AA, 2013, AUST NZ J PSYCHIAT, V47, P26, DOI 10.1177/0004867412449303
   Nishigaki Y, 2010, GERIATR GERONTOL INT, V10, PS221, DOI 10.1111/j.1447-0594.2010.00599.x
   Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025
   Ortiz JMP, 2019, BRIT J PHARMACOL, V176, P3489, DOI 10.1111/bph.14585
   PARKER WD, 1990, NEUROLOGY, V40, P1231, DOI 10.1212/WNL.40.8.1231
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355
   Paulin R, 2014, CIRC RES, V115, P148, DOI 10.1161/CIRCRESAHA.115.301130
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Picado C, 1999, ALLERGY, V54, P569, DOI 10.1034/j.1398-9995.1999.00024.x
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   Pignatelli P, 1998, BLOOD, V91, P484, DOI 10.1182/blood.V91.2.484.484_484_490
   Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028
   Prakash YS, 2017, CHEST, V152, P618, DOI 10.1016/j.chest.2017.03.020
   Qian PX, 2016, CELL STEM CELL, V18, P214, DOI 10.1016/j.stem.2015.11.001
   Quinn KP, 2012, BIOMATERIALS, V33, P5341, DOI 10.1016/j.biomaterials.2012.04.024
   Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141
   Rezania S, 2017, THROMB RES, V155, P106, DOI 10.1016/j.thromres.2017.05.009
   Romero-Moya D, 2013, HAEMATOLOGICA, V98, P1022, DOI 10.3324/haematol.2012.079244
   Rose G, 2001, EUR J HUM GENET, V9, P701, DOI 10.1038/sj.ejhg.5200703
   Ryan J, 2015, J MOL MED, V93, P229, DOI 10.1007/s00109-015-1263-5
   Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018
   Sandoval H, 2018, MITOCHONDRION, V41, P58, DOI 10.1016/j.mito.2017.11.005
   SANGIORGI S, 1994, CEPHALALGIA, V14, P21, DOI 10.1046/j.1468-2982.1994.1401021.x
   Sanz A, 2007, EXP GERONTOL, V42, P173, DOI 10.1016/j.exger.2006.10.003
   Serrano-Teruel Maria E, 2019, ASIAN CARDIOVASC THORAC ANN, V27, P5, DOI 10.1177/0218492318813220
   Shanely RA, 2014, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/51812
   Shi C, 2008, EXP GERONTOL, V43, P589, DOI 10.1016/j.exger.2008.02.004
   Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777
   SIEGEL A, 1971, THROMB DIATH HAEMOST, V25, P252
   Silva AC, 2013, MITOCHONDRION, V13, P801, DOI 10.1016/j.mito.2013.05.006
   Silva AM, 2012, METHODS MOL BIOL, V810, P7, DOI 10.1007/978-1-61779-382-0_2
   Sjövall F, 2010, CRIT CARE, V14, P0, DOI 10.1186/cc9337
   Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711
   Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010
   Sutendra G, 2014, CELL METAB, V19, P558, DOI 10.1016/j.cmet.2014.01.004
   Sutendra G, 2013, J MOL MED, V91, P1315, DOI 10.1007/s00109-013-1059-4
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011
   Tofts PS, 2011, BLOOD, V117, P6050, DOI 10.1182/blood-2010-10-310532
   Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003
   TOUGH DF, 1995, IMMUNOL RES, V14, P1, DOI 10.1007/BF02918494
   Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956
   Tyrrell DJ, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/7317251
   Tyrrell DJ, 2016, REDOX BIOL, V10, P65, DOI 10.1016/j.redox.2016.09.009
   Tyrrell DJ, 2015, J GERONTOL A-BIOL, V70, P1394, DOI 10.1093/gerona/glu096
   Tyrrell DJ, 2015, EXP GERONTOL, V70, P84, DOI 10.1016/j.exger.2015.07.015
   Umbri M, 2019, MITOCHONDRION, V44, P1, DOI 10.1016/j.mito.2017.12.004
   Valkovic L, 2017, ANAL BIOCHEM, V529, P193, DOI 10.1016/j.ab.2017.01.018
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697
   WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wanet A, 2015, STEM CELLS DEV, V24, P1957, DOI 10.1089/scd.2015.0117
   Waters LR, 2018, ISCIENCE, V5, P99, DOI 10.1016/j.isci.2018.07.005
   Weiss K, 2017, CIRC-HEART FAIL, V10, P0, DOI 10.1161/CIRCHEARTFAILURE.117.004129
   Williams J, 2016, UROLOGY, V93, P0, DOI 10.1016/j.urology.2016.03.004
   Willig AL, 2017, REDOX BIOL, V12, P648, DOI 10.1016/j.redox.2017.04.005
   Winnica D, 2019, ANTIOXID REDOX SIGN, V31, P673, DOI 10.1089/ars.2018.7627
   Xu J, 2007, J BIOENERG BIOMEMBR, V39, P195, DOI 10.1007/s10863-007-9077-y
   Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104
   Xu WL, 2016, J CLIN INVEST, V126, P2465, DOI 10.1172/JCI82925
   Xu WL, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0132007
   Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005
   Yu QJ, 2017, ADV EXP MED BIOL, V967, P373, DOI 10.1007/978-3-319-63245-2_24
   Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022
   Zhang JY, 2015, INT J MOL SCI, V16, P4083, DOI 10.3390/ijms16024083
   Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849
   Zifa E, 2012, MOL BIOL REP, V39, P4697, DOI 10.1007/s11033-011-1262-8
NR 161
TC 25
Z9 28
U1 2
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0098-2997
EI 1872-9452
J9 MOL ASPECTS MED
JI Mol. Asp. Med.
PD FEB 15
PY 2020
VL 71
IS 
BP 
EP 
DI 10.1016/j.mam.2019.100835
PG 12
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA KN1YC
UT WOS:000514635900004
PM 31864667
DA 2024-11-01
ER

PT J
AU Vianello, C
   Cocetta, V
   Caicci, F
   Boldrin, F
   Montopoli, M
   Martinuzzi, A
   Carelli, V
   Giacomello, M
AF Vianello, Caterina
   Cocetta, Veronica
   Caicci, Federico
   Boldrin, Francesco
   Montopoli, Monica
   Martinuzzi, Andrea
   Carelli, Valerio
   Giacomello, Marta
TI Interaction between Mitochondrial DNA Variants and Mitochondria/Endoplasmic Reticulum Contact Sites: A Perspective Review
SO DNA AND CELL BIOLOGY
LA English
DT Review
DE mtDNA; mitochondria; ER contacts; LHON disease; haplogroup
ID hereditary optic neuropathy; mtdna mutations; antioxidant defenses; mitofusin 2; complex-i; glutamate transport; lipid-peroxidation; skeletal-muscle; er membranes; risk
AB Mitochondria contain their own genome, mitochondrial DNA (mtDNA), essential to support their fundamental intracellular role in ATP production and other key metabolic and homeostatic pathways. Mitochondria are highly dynamic organelles that communicate with all the other cellular compartments, through sites of high physical proximity. Among all, their crosstalk with the endoplasmic reticulum (ER) appears particularly important as its derangement is tightly implicated with several human disorders. Population-specific mtDNA variants clustered in defining the haplogroups have been shown to exacerbate or mitigate these pathological conditions. The exact mechanisms of the mtDNA background-modifying effect are not completely clear and a possible explanation is the outcome of mitochondrial efficiency on retrograde signaling to the nucleus. However, the possibility that different haplogroups shape the proximity and crosstalk between mitochondria and the ER has never been proposed neither investigated. In this study, we pose and discuss this question and provide preliminary data to answer it. Besides, we also address the possibility that single, disease-causing mtDNA point mutations may act also by reshaping organelle communication. Overall, this perspective review provides a theoretical platform for future studies on the interaction between mtDNA variants and organelle contact sites.
C1 [Vianello, Caterina; Caicci, Federico; Boldrin, Francesco; Giacomello, Marta] Univ Padua, Dept Biol, Via Ugo Bassi 58b, I-35121 Padua, Italy.
   [Cocetta, Veronica; Montopoli, Monica] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.
   [Montopoli, Monica] VIMM Veneto Inst Mol Med, Padua, Italy.
   [Martinuzzi, Andrea] IRCCS E Medea Sci Inst, Dept Neurorehabil, Conegliano Res Ctr, Treviso, Italy.
   [Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Bologna, Italy.
   [Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, Bologna, Italy.
   [Giacomello, Marta] Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58b, I-35121 Padua, Italy.
C3 University of Padua; University of Padua; IRCCS Eugenio Medea; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Padua
RP Giacomello, M (corresponding author), Univ Padua, Dept Biol, Via Ugo Bassi 58b, I-35121 Padua, Italy.; Giacomello, M (corresponding author), Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58b, I-35121 Padua, Italy.
EM marta.giacomello@unipd.it
FU Ministry of Health; CARIPARO Starting Grant 2016 AIFbiol; Unipd STARS Consolidator FIRMESs; PRIN 2017 FS5SHL "RADIUS''; PRID 2018 [MONT_SID18_01]
CR Ademowo OS, 2017, BIOGERONTOLOGY, V18, P859, DOI 10.1007/s10522-017-9710-z
   Anderson EJ, 2012, CLIN EXP PHARMACOL P, V39, P179, DOI 10.1111/j.1440-1681.2011.05641.x
   Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202
   Arruda AP, 2015, CELL METAB, V22, P381, DOI 10.1016/j.cmet.2015.06.010
   Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004
   Bantug GR, 2018, IMMUNITY, V48, P542, DOI 10.1016/j.immuni.2018.02.012
   Barodia SK, 2019, FRONT NEUROSCI-SWITZ, V13, P0, DOI 10.3389/fnins.2019.01171
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Beretta S, 2006, NEUROBIOL DIS, V24, P308, DOI 10.1016/j.nbd.2006.07.016
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020
   Caboni P, 2004, CHEM RES TOXICOL, V17, P1540, DOI 10.1021/tx049867r
   Cárdenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007
   Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623
   Carelli V, 2018, ESSAYS BIOCHEM, V62, P235, DOI 10.1042/EBC20170097
   Carrì MT, 2015, FRONT CELL NEUROSCI, V9, P0, DOI 10.3389/fncel.2015.00041
   Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463
   Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K
   Chakraborty J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809014
   Chinnery PF, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00682
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x
   Csordás G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   ESPOSTI MD, 1994, FEBS LETT, V352, P375, DOI 10.1016/0014-5793(94)00971-6
   Fernández-Caggiano M, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044128
   Floreani M, 2005, FEBS J, V272, P1124, DOI 10.1111/j.1742-4658.2004.04542.x
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Fu ZJ, 2021, J LIPID RES, V62, P0, DOI 10.1194/jlr.TR120000618
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Giacomello M, 2016, CELL DEATH DIFFER, V23, P1417, DOI 10.1038/cdd.2016.52
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gómez-Suaga P, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-017-0079-3
   Granatiero V, 2016, CELL DEATH DIFFER, V23, P231, DOI 10.1038/cdd.2015.84
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910
   Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002
   Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb
   HRUSZKEWYCZ AM, 1988, BIOCHEM BIOPH RES CO, V153, P191, DOI 10.1016/S0006-291X(88)81207-5
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128
   Kofler B, 2009, BMC MED GENET, V10, P0, DOI 10.1186/1471-2350-10-35
   Larrea D, 2019, HUM MOL GENET, V28, P1782, DOI 10.1093/hmg/ddz008
   Lewis SC, 2016, SCIENCE, V353, P0, DOI 10.1126/science.aaf5549
   Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051
   Man PYW, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011247
   Mancuso M, 2004, NEUROSCI LETT, V371, P158, DOI 10.1016/j.neulet.2004.08.060
   Mancuso R, 2015, PROG NEUROBIOL, V133, P1, DOI 10.1016/j.pneurobio.2015.07.004
   Martin WF, 2017, J THEOR BIOL, V434, P2, DOI 10.1016/j.jtbi.2017.01.004
   McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058
   Moltedo O, 2019, FRONT CELL DEV BIOL, V7, P0, DOI 10.3389/fcell.2019.00172
   Mueller EE, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0030874
   Müller-Nedebock AC, 2019, NEUROCHEM INT, V129, P0, DOI 10.1016/j.neuint.2019.104495
   Naon D, 2016, P NATL ACAD SCI USA, V113, P11249, DOI 10.1073/pnas.1606786113
   Nardelli C, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/631082
   Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512
   Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004
   Prudent J, 2017, CURR OPIN CELL BIOL, V47, P52, DOI 10.1016/j.ceb.2017.03.007
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007
   Ravera S, 2019, J NEUROCHEM, V151, P336, DOI 10.1111/jnc.14819
   ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5
   Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   RUSINOL AE, 1994, J BIOL CHEM, V269, P27494
   Sala-Vila A, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep27351
   Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003
   Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sebastián D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   Sood A, 2014, P NATL ACAD SCI USA, V111, P16017, DOI 10.1073/pnas.1408061111
   Strobbe D, 2018, NEUROBIOL DIS, V114, P129, DOI 10.1016/j.nbd.2018.02.010
   Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630
   Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028
   Tambini MD, 2016, EMBO REP, V17, P27, DOI 10.15252/embr.201540614
   Torroni A, 1996, GENETICS, V144, P1835
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Tubbs E, 2017, J MOL ENDOCRINOL, V58, PR87, DOI 10.1530/JME-16-0189
   Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014
   Vergani L, 2004, EUR J BIOCHEM, V271, P3646, DOI 10.1111/j.1432-1033.2004.04298.x
   Vielhaber S, 1999, J NEUROL SCI, V169, P133, DOI 10.1016/S0022-510X(99)00236-1
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Wallace R, 2013, MATHEMATICAL APPROACH TO MULTILEVEL, V0, P1
   Wang YW, 2016, FRONT AGING NEUROSCI, V8, P0, DOI 10.3389/fnagi.2016.00232
   Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x
   Winanto, 2020, CELL DEATH DIS, V11, P0, DOI 10.1038/s41419-020-2383-6
   Wong-Ekkabut J, 2007, BIOPHYS J, V93, P4225, DOI 10.1529/biophysj.107.112565
   Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zhou L, 1997, J NEUROSCI, V17, P7746
NR 112
TC 3
Z9 3
U1 0
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD AUG 1
PY 2020
VL 39
IS 8
BP 1431
EP 1443
DI 10.1089/dna.2020.5614
EA JUN 2020
PG 13
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA MU1AS
UT WOS:000546064200001
PM 32598172
DA 2024-11-01
ER

PT J
AU Pereira, CV
   Peralta, S
   Arguello, T
   Bacman, SR
   Diaz, F
   Moraes, CT
AF Pereira, Claudia, V
   Peralta, Susana
   Arguello, Tania
   Bacman, Sandra R.
   Diaz, Francisca
   Moraes, Carlos T.
TI Myopathy reversion in mice after restauration of mitochondrial complex I
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE adeno-associated virus; complex I; gene therapy; mitochondrial myopathies; NDUFS3
ID adenoassociated virus; skeletal-muscle; mouse model; leigh-syndrome; clinical-features; dna mutations; gene-transfer; deficiency; cardiomyopathy; expression
AB Myopathies are common manifestations of mitochondrial diseases. To investigate whether gene replacement can be used as an effective strategy to treat or cure mitochondrial myopathies, we have generated a complex I conditional knockout mouse model lacking NDUFS3 subunit in skeletal muscle. NDUFS3 protein levels were undetectable in muscle of 15-day-old smKO mice, and myopathy symptoms could be detected by 2 months of age, worsening over time. rAAV9-Ndufs3 delivered systemically into 15- to 18-day-old mice effectively restored NDUFS3 levels in skeletal muscle, precluding the development of the myopathy. To test the ability of rAAV9-mediated gene replacement to revert muscle function after disease onset, we also treated post-symptomatic, 2-month-old mice. The injected mice showed a remarkable improvement of the mitochondrial myopathy and biochemical parameters, which remained for the duration of the study. Our results showed that muscle pathology could be reversed after restoring complex I, which was absent for more than 2 months. These findings have far-reaching implications for the ability of muscle to tolerate a mitochondrial defect and for the treatment of mitochondrial myopathies.
C1 [Pereira, Claudia, V; Peralta, Susana; Arguello, Tania; Bacman, Sandra R.; Diaz, Francisca; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
C3 University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.; Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
FU National Institutes of Health [R01EY0108041, R01AG036871, R01NS079965, R33ES025673]; CHAMP Foundation; Muscular Dystrophy Association
CR Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   Arii J, 2000, AM J NEURORADIOL, V21, P1502
   Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F
   Chen B, 2017, FRONT MOL NEUROSCI, V10, P0, DOI 10.3389/fnmol.2017.00265
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Di Meo I, 2017, GENE THER, V24, P661, DOI 10.1038/gt.2017.53
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   Diaz F, 2009, CURR PROTOC HUM GENE, V0, P0
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Fassone E, 2011, J MED GENET, V48, P691, DOI 10.1136/jmedgenet-2011-100340
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2017, AM J MED GENET A, V173, P1450, DOI 10.1002/ajmg.a.38225
   Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306
   Flierl A, 2005, GENE THER, V12, P570, DOI 10.1038/sj.gt.3302443
   Garone C, 2018, BIOCHEM SOC T, V46, P1247, DOI 10.1042/BST20180134
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Ingraham CA, 2009, MITOCHONDRION, V9, P204, DOI 10.1016/j.mito.2009.02.001
   Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005
   Ke BX, 2012, P NATL ACAD SCI USA, V109, P6165, DOI 10.1073/pnas.1113987109
   Kirches E, 2011, CURR GENOMICS, V12, P44, DOI 10.2174/138920211794520150
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725
   Lou XT, 2018, J HUM GENET, V63, P1283, DOI 10.1038/s10038-018-0517-9
   Lou XT, 2018, J HUM GENET, V63, P1269, DOI 10.1038/s10038-018-0505-0
   LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465
   Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010
   Peralta S, 2016, HUM MOL GENET, V25, P3178, DOI 10.1093/hmg/ddw167
   Peralta S, 2014, HUM MOL GENET, V23, P1399, DOI 10.1093/hmg/ddt526
   Pruchnic R, 2000, HUM GENE THER, V11, P521, DOI 10.1089/10430340050015716
   Quintana A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0042904
   Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rodenburg RJ, 2016, BBA-BIOENERGETICS, V1857, P938, DOI 10.1016/j.bbabio.2016.02.012
   ROWLAND LP, 1991, REV NEUROL-FRANCE, V147, P467
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Suzuki-Hatano S, 2019, HUM GENE THER, V30, P139, DOI 10.1089/hum.2018.020
   Torres-Torronteras J, 2011, GENE THER, V18, P795, DOI 10.1038/gt.2011.24
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996
   Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095
NR 59
TC 26
Z9 28
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD FEB 7
PY 2020
VL 12
IS 2
BP 
EP 
DI 10.15252/emmm.201910674
EA JAN 2020
PG 17
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA KL5VP
UT WOS:000506241800001
PM 31916679
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Laccone, F
AF Finsterer, Josef
   Laccone, Franco
TI Phenotypic Heterogeneity in 5 Family Members with the Mitochondrial Variant m.3243A&gt;G
SO AMERICAN JOURNAL OF CASE REPORTS
LA English
DT Article
DE Cardiomyopathies; MELAS Syndrome; Mitochondrial Diseases
ID melas
AB Objective: Rare disease Background: The pathogenic mitochondrial DNA variant m.3243A>G is associated with a wide range of clinical features, making disease course and prognosis extremely difficult to predict. We aimed to understand the cause of this broad intra-familial phenotypic heterogeneity in a large family carrying the variant m.3243A>G. Cases Reports: Thirteen family members were clinically affected. Clinical manifestations occurred in the brain, eyes, ears, endocrine organs, myocardium, intestines, kidneys, muscle, and nerves. Five family members carried the m.3243A>G variant. The 2 most severely affected patients were the index patient, a 60-year-old woman, and her sister, who was deceased. The phenotypic features most frequently found were hypoacusis and cerebellar atrophy. Hypertrophic cardiomyopathy was diagnosed in 3 family members. Short PQ syndrome and gestosis had not been reported to date. The broad phenotypic heterogeneity was attributed to variable heteroplasmy rates and variable mtDNA copy numbers. All affected patients benefited from symptomatic treatment. Conclusions: The mitochondrial DNA variant m.3243A>G can manifest phenotypically with a non-syndromic, multisystem phenotype with wide intra-familial heterogeneity. Rare manifestations of the m.3243A>G variant are gestosis and short PQ syndrome. The broad intra-familial phenotypic heterogeneity may be related to fluctuating heteroplasmy rates or mitochondrial DNA copy numbers and may lead to misdiagnosis for years.
C1 [Finsterer, Josef] Messerli Inst, Neurol Dept, Klin Landstr, Vienna, Austria.
   [Laccone, Franco] Med Univ Vienna, Inst Med Genet, Vienna, Austria.
C3 Medical University of Vienna
RP Finsterer, J (corresponding author), Messerli Inst, Neurol Dept, Klin Landstr, Vienna, Austria.
EM fifigs1@yahoo.de
CR Bates MGD, 2013, EUR HEART J-CARD IMG, V14, P650, DOI 10.1093/ehjci/jes226
   El-Hattab AW, 2001, GENEREVIEWS R, V0, P1993
   Finsterer J, 2020, HERZ, V45, P356, DOI 10.1007/s00059-018-4739-6
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Jose T, 2011, INT J CARDIOL, V149, PE24, DOI 10.1016/j.ijcard.2009.03.057
   Liu GL, 2020, J NEUROL SCI, V408, P0, DOI 10.1016/j.jns.2019.116562
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 10
TC 7
Z9 7
U1 0
U2 2
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
SN 
EI 1941-5923
J9 AM J CASE REP
JI Am. J. Case Rep.
PD NOV 25
PY 2020
VL 21
IS 
BP 
EP 
DI 10.12659/AJCR.927938
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA OY6KD
UT WOS:000594352700001
PM 33237887
DA 2024-11-01
ER

PT J
AU Frazier, AE
   Vincent, AE
   Turnbull, DM
   Thorburn, DR
   Taylor, RW
AF Frazier, Ann E.
   Vincent, Amy E.
   Turnbull, Doug M.
   Thorburn, David R.
   Taylor, Robert W.
TI Assessment of mitochondrial respiratory chain enzymes in cells and tissues
SO MITOCHONDRIA, 3RD EDITION
LA English
DT Review; Book Chapter
ID complex i deficiency; diagnostic-criteria; prenatal-diagnosis; assembly factor; leigh-syndrome; dna mutations; disorders; muscle; prevalence; biogenesis
AB Measurement of the individual enzymes involved in mitochondrial oxidative phosphorylation (OXPHOS) forms a key part of diagnostic investigations in patients with suspected mitochondrial disease, and can provide crucial information on mitochondrial OXPHOS function in a variety of cells and tissues that are applicable to many research investigations. In this chapter, we present methods for analysis of mitochondrial respiratory chain enzymes in cells and tissues based on assays performed in two geographically separate diagnostic referral centers, as part of clinical diagnostic investigations. Techniques for sample preparation from cells and tissues, and spectrophotometric assays for measurement of the activities of OXPHOS complexes I-V, the combined activity of complexes II+III, and the mitochondrial matrix enzyme citrate synthase, are provided. The activities of mitochondrial respiratory chain enzymes are often expressed relative to citrate synthase activity, since these ratios may be more robust in accounting for variability that may arise due to tissue quality, handling and storage, cell growth conditions, or any mitochondrial proliferation that may be present in tissues from patients with mitochondrial disease. Considerations for adaption of these techniques to other cells, tissues, and organisms are presented, as well as comparisons to alternate methods for analysis of respiratory chain function. In this context, a quantitative immunofluorescence protocol is also provided that is suitable for measurement of the amount of multiple respiratory chain complexes in small diagnostic tissue samples. The analysis and interpretation of OXPHOS enzyme activities are then placed in the context of mitochondrial disease tissue pathology and diagnosis.
C1 [Frazier, Ann E.; Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Brain & Mitochondrial Res, Melbourne, Vic, Australia.
   [Frazier, Ann E.; Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Vincent, Amy E.; Turnbull, Doug M.; Taylor, Robert W.] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Thorburn, David R.] Victorian Clin Genet Serv, Melbourne, Vic, Australia.
   [Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; Newcastle University - UK; Murdoch Children's Research Institute; Victorian Clinical Genetics Services; Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP Taylor, RW (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.; Taylor, RW (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU Wellcome Trust Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease; Mitochondrial Disease Patient Cohort (UK) [G0800674]; Newcastle University Centre for Ageing and Vitality (Medical Research Council) [L016354]; Newcastle University Centre for Ageing and Vitality (Biotechnology and Biological Sciences Research Council); UK NIHR Biomedical Research Centre for Ageing and Agerelated disease award; Lily Foundation; Sir Henry Wellcome Fellowship [215888/Z/19/Z]; Australian National Health & Medical Research Council (NHMRC) [GNT1155244, GNT1164479, GNT1107094, GNT1113531]; Vincent Chiodo Charitable Trust Fellowship; Mito Foundation; Victorian Government's Operational Infrastructure Support Program; MRC [G1100540, G0400074, G0800674, G0502157, G0900652] Funding Source: UKRI
CR Acín-Pérez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   Acosta MJ, 2016, BBA-BIOENERGETICS, V1857, P1079, DOI 10.1016/j.bbabio.2016.03.036
   Ahmed ST, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-14623-2
   Alston CL, 2018, AM J HUM GENET, V103, P592, DOI 10.1016/j.ajhg.2018.08.013
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bick D, 2019, J MED GENET, V56, P783, DOI 10.1136/jmedgenet-2019-106111
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   Bird MJ, 2014, BIOSCIENCE REP, V34, P701, DOI 10.1042/BSR20140151
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Chen XL, 2011, GENET MED, V13, P794, DOI 10.1097/GIM.0b013e31821afca5
   Clark MM, 2018, NPJ GENOM MED, V3, P0, DOI 10.1038/s41525-018-0053-8
   Coughlan MT, 2009, J AM SOC NEPHROL, V20, P742, DOI 10.1681/ASN.2008050514
   Dai N, 2015, CELL METAB, V21, P609, DOI 10.1016/j.cmet.2015.03.006
   DiMauro S, 2012, ADV EXP MED BIOL, V748, P341, DOI 10.1007/978-1-4614-3573-0_14
   Divakaruni Ajit S, 2014, CURR PROTOC TOXICOL, V60, P0, DOI 10.1002/0471140856.tx2502s60
   Faivre L, 2000, PRENATAL DIAG, V20, P732, DOI 10.1002/1097-0223(200009)20:9<732::AID-PD916>3.0.CO;2-#
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Feichtinger RG, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/7202589
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Inoue M, 2019, ANN NEUROL, V86, P193, DOI 10.1002/ana.25517
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   Ke BX, 2012, P NATL ACAD SCI USA, V109, P6165, DOI 10.1073/pnas.1113987109
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Lehmann D, 2019, NUCLEIC ACIDS RES, V47, P7430, DOI 10.1093/nar/gkz472
   Leong DW, 2012, J BIOL CHEM, V287, P20652, DOI 10.1074/jbc.M111.327601
   Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774
   LOWERSON SA, 1992, ANAL BIOCHEM, V205, P372, DOI 10.1016/0003-2697(92)90453-E
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Ng GZ, 2017, HELICOBACTER, V22, P0, DOI 10.1111/hel.12378
   Niers L, 2003, J INHERIT METAB DIS, V26, P647, DOI 10.1023/B:BOLI.0000005605.57420.b4
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   Ogawa E, 2017, J INHERIT METAB DIS, V40, P685, DOI 10.1007/s10545-017-0042-6
   Oláhová M, 2018, AM J HUM GENET, V102, P494, DOI 10.1016/j.ajhg.2018.01.020
   Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033
   Piekutowska-Abramczuk D, 2018, AM J HUM GENET, V102, P460, DOI 10.1016/j.ajhg.2018.01.008
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rodenburg RJT, 2013, MITOCHONDRION, V13, P36, DOI 10.1016/j.mito.2012.11.004
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SANCHEZCANBALLEL, 2016, BIOCHIMICA BIOPHYS A, V1857, P980
   SCH A, 2000, EMBO J, V19, P1777
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   SPERL W, 1992, ANN CLIN BIOCHEM, V29, P638, DOI 10.1177/000456329202900604
   Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754
   Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265
   TAYLOR RW, 1994, J BIOL CHEM, V269, P3523
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Thorburn DR, 2001, J INHERIT METAB DIS, V24, P312, DOI 10.1023/A:1010347808082
   TIRANTI V, 2009, NAT MED, V15, P15
   Wilkins HM, 2014, REDOX BIOL, V2, P619, DOI 10.1016/j.redox.2014.03.006
   Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Zierz CM, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8060789
NR 67
TC 25
Z9 26
U1 3
U2 24
PU ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD
PI LONDON
PA 125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND
SN 0091-679X
EI 
J9 METHOD CELL BIOL
JI Methods Cell Biol.
PD JUN 15
PY 2020
VL 155
IS 
BP 121
EP 156
DI 10.1016/bs.mcb.2019.11.007
PG 36
WC Cell Biology
SC Cell Biology
GA BQ6IA
UT WOS:000611821800006
PM 32183956
DA 2024-11-01
ER

PT J
AU Steele, H
   Gomez-Duran, A
   Pyle, A
   Hopton, S
   Newman, J
   Stefanetti, RJ
   Charman, SJ
   Parikh, JD
   He, LP
   Viscomi, C
   Jakovljevic, DG
   Hollingsworth, KG
   Robinson, AJ
   Taylor, RW
   Bottolo, L
   Horvath, R
   Chinnery, PF
AF Steele, Hannah
   Gomez-Duran, Aurora
   Pyle, Angela
   Hopton, Sila
   Newman, Jane
   Stefanetti, Renae J.
   Charman, Sarah J.
   Parikh, Jehill D.
   He, Langping
   Viscomi, Carlo
   Jakovljevic, Djordje G.
   Hollingsworth, Kieren G.
   Robinson, Alan J.
   Taylor, Robert W.
   Bottolo, Leonardo
   Horvath, Rita
   Chinnery, Patrick F.
TI Metabolic effects of bezafibrate in mitochondrial disease
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE bezafibrate; metabolomics; mitochondrial disorder; mitochondrial DNA; mitochondrial encephalomyopat
ID respiratory-chain complex; false discovery rate; glutamine-metabolism; mouse model; myopathy; progression; activation; deficiency; expression; package
AB Mitochondrial disorders affect 1/5,000 and have no cure. Inducing mitochondrial biogenesis with bezafibrate improves mitochondrial function in animal models, but there are no comparable human studies. We performed an open-label observational experimental medicine study of six patients with mitochondrial myopathy caused by the m.3243A>G MTTL1 mutation. Our primary aim was to determine the effects of bezafibrate on mitochondrial metabolism, whilst providing preliminary evidence of safety and efficacy using biomarkers. The participants received 600-1,200 mg bezafibrate daily for 12 weeks. There were no clinically significant adverse events, and liver function was not affected. We detected a reduction in the number of complex IV-immunodeficient muscle fibres and improved cardiac function. However, this was accompanied by an increase in serum biomarkers of mitochondrial disease, including fibroblast growth factor 21 (FGF-21), growth and differentiation factor 15 (GDF-15), plus dysregulation of fatty acid and amino acid metabolism. Thus, although potentially beneficial in short term, inducing mitochondrial biogenesis with bezafibrate altered the metabolomic signature of mitochondrial disease, raising concerns about long-term sequelae.
C1 [Steele, Hannah; Pyle, Angela] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.
   [Gomez-Duran, Aurora; Horvath, Rita; Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England.
   [Gomez-Duran, Aurora; Viscomi, Carlo; Robinson, Alan J.; Chinnery, Patrick F.] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.
   [Pyle, Angela; Hopton, Sila; Newman, Jane; He, Langping; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Hopton, Sila; He, Langping; Taylor, Robert W.] Newcastle Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne, Tyne & Wear, England.
   [Newman, Jane; Stefanetti, Renae J.; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Charman, Sarah J.; Parikh, Jehill D.; Jakovljevic, Djordje G.; Hollingsworth, Kieren G.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.
   [Bottolo, Leonardo] Univ Cambridge, Dept Med Genet, Cambridge, England.
   [Bottolo, Leonardo] Alan Turing Inst, London, England.
   [Bottolo, Leonardo] Univ Cambridge, MRC Biostat Unit, Cambridge, England.
C3 Newcastle University - UK; University of Cambridge; University of Cambridge; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle University - UK; University of Cambridge; University of Cambridge; MRC Biostatistics Unit
RP Chinnery, PF (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England.; Chinnery, PF (corresponding author), Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.
EM pfc25@cam.ac.uk
FU Medical Research Council Mitochondrial Biology Unit [MC_UU_00015/9, 212219/Z/18/Z]; Evelyn Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease; Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK National Institute for Health Research Biomedical Research Centre in Age and Age-Related Diseases award; MRC/EPSRC Molecular Pathology Node; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; Medical Research Council (UK) [MR/N025431/1, 109915/Z/15/Z]; Newton Fund (UK/Turkey) [MR/N027302/1]; European Research Council [309548]; Wellcome Trust Pathfinder Scheme [201064/Z/16/Z]; Alan Turing Institute under the Engineering and Physical Sciences Research Council [EP/N510129/1]; MRC [G1100160, G0800674, MC_UU_00015/9, MC_U105674181] Funding Source: UKRI
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996
   [Anonymous], 1997, PRACTICAL DATA ANAL, V0, P0
   Bénit P, 2017, EBIOMEDICINE, V17, P75, DOI 10.1016/j.ebiom.2017.02.013
   Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bonnefont JP, 2010, CLIN PHARMACOL THER, V88, P101, DOI 10.1038/clpt.2010.55
   Buzkova J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809091
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Charman SJ, 2016, BMC CARDIOVASC DISOR, V16, P0, DOI 10.1186/s12872-016-0428-7
   Chen QY, 2018, CELL METAB, V27, P1007, DOI 10.1016/j.cmet.2018.03.002
   Chong J, 2018, NUCLEIC ACIDS RES, V46, PW486, DOI 10.1093/nar/gky310
   Crooks DR, 2014, HUM MOL GENET, V23, P24, DOI 10.1093/hmg/ddt393
   de Laat P, 2016, BBA CLIN, V6, P19, DOI 10.1016/j.bbacli.2016.04.007
   Dillon LM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044335
   DUBOIS D, 1989, NUTRITION, V5, P303
   Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97
   Fabregat A, 2018, NUCLEIC ACIDS RES, V46, PD649, DOI 10.1093/nar/gkx1132
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hayashi G, 2017, HUM MOL GENET, V26, P2864, DOI 10.1093/hmg/ddx167
   Hofer A, 2014, HUM MOL GENET, V23, P2400, DOI 10.1093/hmg/ddt631
   Hollander M, 1973, NONPARAMETRIC STAT M, V0, P0
   Hollingsworth KG, 2012, NEUROMUSCULAR DISORD, V22, P592, DOI 10.1016/j.nmd.2012.03.001
   Hothorn T, 2008, J STAT SOFTW, V28, P1
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Jones TW, 2015, BRIT J ANAESTH, V115, P386, DOI 10.1093/bja/aeu560
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Krumsiek J, 2015, METABOLOMICS, V11, P1815, DOI 10.1007/s11306-015-0829-0
   Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Mao YX, 2004, EMBO J, V23, P2963, DOI 10.1038/sj.emboj.7600327
   Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037
   Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Peralta S, 2016, HUM MOL GENET, V25, P3178, DOI 10.1093/hmg/ddw167
   Pyle A, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005040
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, P0, DOI 10.1093/nar/gkv007
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Shah JS, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1547-6
   Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982
   Steele HE, 2017, BRAIN, V140, P2530, DOI 10.1093/brain/awx168
   Sullivan LB, 2018, NAT CELL BIOL, V20, P782, DOI 10.1038/s41556-018-0125-0
   Tan HWS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00369-y
   van Hees VT, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0142533
   van Hees VT, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0061691
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Vo TD, 2007, MOL GENET METAB, V91, P15, DOI 10.1016/j.ymgme.2007.01.012
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
NR 53
TC 47
Z9 47
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD MAR 6
PY 2020
VL 12
IS 3
BP 
EP 
DI 10.15252/emmm.201911589
EA FEB 2020
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA KT8GY
UT WOS:000516812500001
PM 32107855
DA 2024-11-01
ER

PT J
AU Kytovuori, L
   Junttila, J
   Huikuri, H
   Keinanen-Kiukaanniemi, S
   Majamaa, K
   Martikainen, MH
AF Kytovuori, Laura
   Junttila, Juhani
   Huikuri, Heikki
   Keinanen-Kiukaanniemi, Sirkka
   Majamaa, Kari
   Martikainen, Mika H.
TI Mitochondrial DNA variation in sudden cardiac death: a population-based study
SO INTERNATIONAL JOURNAL OF LEGAL MEDICINE
LA English
DT Article
DE Mitochondrial disease; Mitochondrial DNA; Mitochondrial haplogroups; Non-ischaemic; Sudden cardiac death
ID infantile cardiomyopathy; atpase 6; mutation; association; prevalence; disease; longevity; diagnosis; genetics; nuclear
AB Cardiomyopathy and cardiac conduction defects are common manifestations of mitochondrial disease. Previous studies suggest that clinically asymptomatic individuals harbouring pathogenic mitochondrial DNA (mtDNA) mutations in the cardiac muscle may have sudden cardiac death (SCD) as the first manifestation of mitochondrial disease. We investigated the contribution of pathogenic mtDNA point mutations and mtDNA haplogroups in cardiac muscle in a cohort of 280 Finnish subjects that had died from non-ischaemic SCD with the median age of death at 59 years and in 537 population controls. We did not find any common or novel pathogenic mutations, but the frequency of haplogroup H1 was higher in the SCD subjects than that in 537 population controls (odds ratio: 1.76, confidence interval 95%: 1.02-3.04). We conclude that, at the population level, pathogenic point mutations in mtDNA do not contribute to non-ischaemic SCD, but natural variation may modify the risk.
C1 [Kytovuori, Laura; Majamaa, Kari] Univ Oulu, Res Unit Clin Neurosci, POB 5000, Oulu 90014, Finland.
   [Kytovuori, Laura; Junttila, Juhani; Huikuri, Heikki; Keinanen-Kiukaanniemi, Sirkka; Majamaa, Kari] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.
   [Kytovuori, Laura; Junttila, Juhani; Huikuri, Heikki; Keinanen-Kiukaanniemi, Sirkka; Majamaa, Kari] Univ Oulu, Oulu, Finland.
   [Kytovuori, Laura; Majamaa, Kari] Oulu Univ Hosp, Dept Neurol, POB 20, Oulu 90029, Finland.
   [Junttila, Juhani; Huikuri, Heikki] Univ Oulu, Res Unit Internal Med, POB 5000, Oulu 90014, Finland.
   [Keinanen-Kiukaanniemi, Sirkka] Univ Oulu, Ctr Life Course Hlth Res, POB 5000, Oulu 90014, Finland.
   [Keinanen-Kiukaanniemi, Sirkka] Healthcare & Social Serv Selanne, Pyhajarvi, Finland.
   [Martikainen, Mika H.] Univ Turku, Div Clin Neurosci, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland.
   [Martikainen, Mika H.] Turku Univ Hosp, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Turku; University of Turku
RP Kytovuori, L (corresponding author), Univ Oulu, Res Unit Clin Neurosci, POB 5000, Oulu 90014, Finland.; Kytovuori, L (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.; Kytovuori, L (corresponding author), Univ Oulu, Oulu, Finland.; Kytovuori, L (corresponding author), Oulu Univ Hosp, Dept Neurol, POB 20, Oulu 90029, Finland.
EM laura.kytovuori@oulu.fi; juhani.junttila@oulu.fi; heikki.huikuri@oulu.fi; sirkka.keinanen-kiukaanniemi@oulu.fi; kari.majamaa@oulu.fi; mikmar@utu.fi
FU University of Oulu; Oulu University Hospital; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research
CR Anderson JH, 2016, CIRC-CARDIOVASC GENE, V9, P259, DOI 10.1161/CIRCGENETICS.115.001370
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Bendl J, 2014, PLOS COMPUT BIOL, V10, P0, DOI 10.1371/journal.pcbi.1003440
   Bray AW, 2017, CURR OPIN CARDIOL, V32, P267, DOI 10.1097/HCO.0000000000000383
   Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838
   Ebner S, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0135622
   Fernández-Caggiano M, 2013, MITOCHONDRION, V13, P263, DOI 10.1016/j.mito.2013.03.005
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Gallardo ME, 2012, EUR HEART J, V33, P346, DOI 10.1093/eurheartj/ehr280
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hookana E, 2011, HEART RHYTHM, V8, P1570, DOI 10.1016/j.hrthm.2011.06.031
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Imai A, 2016, INT J CARDIOL, V207, P203, DOI 10.1016/j.ijcard.2016.01.026
   Junttila MJ, 2016, CIRC-ARRHYTHMIA ELEC, V9, P0, DOI 10.1161/CIRCEP.115.003723
   Kenney MC, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054339
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Majamaa-Voltti K, 2004, ANN MED, V36, P225, DOI 10.1080/07853890410028456
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, P0, DOI 10.1136/jnnp.2007.122648
   Martikainen MH, 2013, ACTA DIABETOL, V50, P737, DOI 10.1007/s00592-012-0393-2
   Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   RAJALA U, 1995, SCAND J PRIM HEALTH, V13, P222, DOI 10.3109/02813439508996765
   Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186
   Santorelli FM, 1999, AM J HUM GENET, V64, P295, DOI 10.1086/302188
   Sheskin DJ, 2000, HANDBOOK OF PARAMETRIC AND NONPARAMETRIC STATISTICAL PROCEDURES, V0, P0
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Stallmeyer B, 2015, EUR HEART J, V36, P1643, DOI 10.1093/eurheartj/ehv173
   Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227
   Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203
   van Oven M, 2015, FORENS SCI INT-GEN S, V5, PE392, DOI 10.1016/j.fsigss.2015.09.155
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, PW58, DOI 10.1093/nar/gkw233
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zhang YY, 2017, EUR HEART J, V38, P3443, DOI 10.1093/eurheartj/ehx354
NR 39
TC 2
Z9 4
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0937-9827
EI 1437-1596
J9 INT J LEGAL MED
JI Int. J. Legal Med.
PD JAN 15
PY 2020
VL 134
IS 1
BP 39
EP 44
DI 10.1007/s00414-019-02091-4
PG 6
WC Medicine, Legal
SC Legal Medicine
GA KG5BM
UT WOS:000509962400004
PM 31152278
DA 2024-11-01
ER

PT J
AU Saini, SK
   McDermott, MM
   Picca, A
   Li, LY
   Wohlgemuth, SE
   Kosmac, K
   Peterson, CA
   Tian, L
   Ferrucci, L
   Guralnik, JM
   Sufit, RL
   Leeuwenburgh, C
AF Saini, Sunil K.
   McDermott, Mary M.
   Picca, Anna
   Li, Lingyu
   Wohlgemuth, Stephanie E.
   Kosmac, Kate
   Peterson, Charlotte A.
   Tian, Lu
   Ferrucci, Luigi
   Guralnik, Jack M.
   Sufit, Robert L.
   Leeuwenburgh, Christiaan
TI Mitochondrial DNA damage in calf skeletal muscle and walking performance in people with peripheral artery disease
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Ischemia-reperfusion; mtDNA copy number; mtDNA deletion; mtDNA mutations; mtDNA heteroplasmy; Oxidative stress; Peripheral artery disease (PAD)
ID ankle brachial index; calorie restriction; reperfusion injury; physical-activity; oxidative damage; older-people; copy number; association; deletion; brain
AB Background: Peripheral artery disease (PAD) is associated with mitochondrial dysfunction in calf skeletal muscle and a greater abundance of mitochondrial DNA (mtDNA) heteroplasmy. However, it is unknown whether calf skeletal muscle mtDNA of PAD participants harbors a greater abundance of mitochondrial DNA 4977-bp common deletion (mtDNA4977), strand breaks and oxidative damage (i.e., oxidized purines) compared to non PAD participants and whether these mtDNA abnormalities are associated with poor walking performance in participants with PAD. Methods: Calf muscle biopsies were obtained from 50 PAD participants (ankle-brachial index (ABI) < 0.95) and 25 non-PAD participants (ABI = 0.99-1.40) matched by age, sex, and race. The abundance of mtDNA copy number, mtDNA4977 deletion, strand breaks, and oxidized purines in selected mtDNA regions coding for electron transport chain (ETC) constituents and the non-coding D-Loop region was determined in calf muscle. All participants completed measurement of 6-min walk and usual and fast-paced 4-m walking velocity test. Results: Participants with PAD (mean age = 65.4 years, SD = 6.9; 14 (28%) women, 38 (76%) black) and without PAD (mean age = 65.2 years, SD = 6.7; 7 (28%) women, 16 (64%) black) did not differ in the abundance of calf muscle mtDNA4977 deletion, mtDNA strand breaks, and oxidized purines. Though, a greater abundance of mtDNA strand breaks within ND4/5 genes was significantly associated with poorer 6-min walk distance, lower usual-paced 4-m walking velocity, and lower fast-paced 4-m walking velocity in non-PAD participants. Significant associations were also found in the density of strand break damage (i.e., damage per mtDNA copy) within ND1/2, ND4/5 and COII/ATPase 6/8 region with 6-min walk distance, usual-paced 4-m walking velocity and fast-paced 4-m walking velocity in non-PAD participants. Significant interactions were found between PAD presence vs. absence and density of strand break damage within ND1/2, ND4/5, COII/ ATPase 6/8 regions for the associations with 6-min walk distance, usual-paced 4-m walking velocity, fast-paced 4-m walking velocity. Conversely, of the three walking performance measures only the usual-paced 4-m walking velocity showed a significant, although modest, negative association with the abundance of oxidized purines in the D-Loop (P = 0.031) and ND4/5 (P = 0.033) regions in the calf skeletal muscle of people with PAD. Conclusion: Overall, these data suggest that the abundance of calf muscle mtDNA strand breaks and mtDNA4977 common deletion are not associated with walking performance in people with PAD and may not be directly involved in the pathophysiology of PAD. Conversely, strand breaks in specific mtDNA regions may contribute to poor walking performance in people without PAD. Further study is needed to confirm whether usual-paced 4-m walking velocity is associated significantly with a greater abundance of oxidized purines in the D-loop, a "mutational hotspot" for oxidative damage, and why this association may differ from the association with 6-min walk distance and fast-paced 4-m walking velocity.
C1 [Saini, Sunil K.; Wohlgemuth, Stephanie E.; Leeuwenburgh, Christiaan] Univ Florida, Dept Aging & Geriatr Res, Inst Aging, Gainesville, FL USA.
   [Saini, Sunil K.; McDermott, Mary M.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.
   [McDermott, Mary M.; Li, Lingyu; Sufit, Robert L.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.
   [Picca, Anna] Fdn Policlin Univ Agostino Gemelli IRCCS, Rome, Italy.
   [Kosmac, Kate; Peterson, Charlotte A.] Univ Kentucky, Coll Hlth Sci, Dept Epidemiol, Lexington, KY USA.
   [Tian, Lu] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA.
   [Ferrucci, Luigi] NIA, Div Intramural Res, Baltimore, MD 21224 USA.
   [Guralnik, Jack M.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.
C3 State University System of Florida; University of Florida; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Kentucky; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Maryland; University of Maryland Baltimore
RP Leeuwenburgh, C (corresponding author), Off CTRB 3125,2004 Mowry Rd,POB 100107, Gainesville, FL 32611 USA.
EM cleeuwen@ufl.edu
FU AHA SFRN [18SFRN33900136]; American Heart Association (AHA) [18SFRN33900136] Funding Source: American Heart Association (AHA)
CR Andrienko TN, 2017, J MOL CELL CARDIOL, V110, P1, DOI 10.1016/j.yjmcc.2017.06.016
   Bhat HK, 1999, CIRCULATION, V99, P807, DOI 10.1161/01.CIR.99.6.807
   Brass EP, 2000, VASC MED, V5, P225, DOI 10.1177/1358836X0000500405
   Butler TJ, 2020, HUM MOL GENET, V29, P1292, DOI 10.1093/hmg/ddaa043
   Chimienti G, 2018, FREE RADICAL BIO MED, V124, P447, DOI 10.1016/j.freeradbiomed.2018.06.041
   Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849
   Fetterman JL, 2016, CARDIOVASC DIABETOL, V15, P0, DOI 10.1186/s12933-016-0372-y
   Gonzalez-Freire M, 2020, J AM HEART ASSOC, V9, P0, DOI 10.1161/JAHA.119.015197
   Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020
   Groennebaek T, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9030570
   Hernansanz-Agustin P, 2020, NATURE, V0, P1
   Kang D, 2003, CLIN CHEM LAB MED, V41, P1281, DOI 10.1515/CCLM.2003.195
   Koutakis P, 2014, REDOX BIOL, V2, P921, DOI 10.1016/j.redox.2014.07.002
   Lindegard Pedersen B, 2017, INT ANGIOL, V36, P482, DOI 10.23736/S0392-9590.17.03824-X
   Liu J, 2015, CLIN LAB, V61, P661, DOI 10.7754/Clin.Lab.2014.141132
   McDermott MM, 2008, J VASC SURG, V48, P1231, DOI 10.1016/j.jvs.2008.06.050
   McDermott MM, 2020, CIRC RES, V126, P589, DOI 10.1161/CIRCRESAHA.119.315600
   McDermott MM, 2018, VASC MED, V23, P340, DOI 10.1177/1358863X18765667
   McDermott MM, 2017, JAMA CARDIOL, V2, P902, DOI 10.1001/jamacardio.2017.0538
   McDermott MM, 2014, CIRCULATION, V130, P61, DOI 10.1161/CIRCULATIONAHA.114.007002
   McDermott MM, 2015, CIRC RES, V116, P1540, DOI 10.1161/CIRCRESAHA.114.303517
   McDermott M, 2017, JAMA-J AM MED ASSOC, V318, P2089, DOI 10.1001/jama.2017.17437
   McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640
   McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008
   McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Pastukh VM, 2016, FREE RADICAL BIO MED, V96, P78, DOI 10.1016/j.freeradbiomed.2016.04.011
   Pérez-Treviño P, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165761
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, P0, DOI 10.1093/nar/29.9.e45
   Picca A, 2018, REJUV RES, V21, P350, DOI 10.1089/rej.2017.1989
   Picca A, 2014, BBA-GEN SUBJECTS, V1840, P2184, DOI 10.1016/j.bbagen.2014.03.004
   Picca A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074644
   Picca A, 2013, AGE, V35, P1607, DOI 10.1007/s11357-012-9465-z
   Pipinos II, 2006, FREE RADICAL BIO MED, V41, P262, DOI 10.1016/j.freeradbiomed.2006.04.003
   Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkp1082
   Ryan TE, 2018, JCI INSIGHT, V3, P0, DOI 10.1172/jci.insight.123235
   Shadman R, 2004, J AM COLL CARDIOL, V44, P618, DOI 10.1016/j.jacc.2004.04.044
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   Umbria M, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-59631-x
   Vecoli C, 2018, ATHEROSCLEROSIS, V276, P91, DOI 10.1016/j.atherosclerosis.2018.07.015
   White SH, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-1030-6
   Wiersma M, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9051159
   Yu EPK, 2016, FREE RADICAL BIO MED, V100, P223, DOI 10.1016/j.freeradbiomed.2016.06.011
   Zhang RY, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-4287-0
NR 44
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD NOV 20
PY 2020
VL 160
IS 
BP 680
EP 689
DI 10.1016/j.freeradbiomed.2020.09.004
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA OY7PN
UT WOS:000594435300005
PM 32911084
DA 2024-11-01
ER

PT J
AU Wang, YK
   Liu, YW
   Zhao, YQ
   Luo, JJ
AF Wang, Yakun
   Liu, Yuanwu
   Zhao, Yiqiang
   Luo, Junjie
TI Quantification of circadian rhythm in mitochondrial DNA copy number in whole blood, and identification of factors that influence it
SO CELLULAR AND MOLECULAR BIOLOGY
LA English
DT Article
DE mtDNA copy number; Circadian rhythm; Platelets; Sampling time
ID peripheral-blood; ribosomal-rna; risk; cell; dysfunction; leukocytes; association; mutation; platelets; myopathy
AB Mitochondrial DNA (mtDNA), the genetic material in mitochondria, encodes key genes related to the respiratory chain and ATP production. To accurate quantification mtDNA content in whole blood is important for various disease states. Absolute quantitative Real-time PCR and platelet contamination erase method were used for mtDNA copy number analysis in whole blood. In the quantitative study of mtDNA content, it was found that whole blood mtDNA copy number showed a fluctuating rhythm during a 24-h period due to dynamic changes in white blood cells combined with platelets. However, when isolated white blood cells were used, or absolute whole blood mtDNA was calculated, the circadian rhythm pattern of mtDNA disappeared. In this study, a feasible method that can accurately quantify mitochondrial DNA in small blood samples was established, and it was found that two factors which greatly influenced mtDNA copy number were sampling time and platelets in blood.
C1 [Wang, Yakun; Liu, Yuanwu; Zhao, Yiqiang; Luo, Junjie] China Agr Univ, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual, Beijing, Peoples R China.
   [Zhao, Yiqiang] China Agr Univ, Coll Biol Sci, Beijing, Peoples R China.
C3 China Agricultural University; China Agricultural University
RP Luo, JJ (corresponding author), China Agr Univ, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual, Beijing, Peoples R China.
EM luojj@pku.edu.cn
FU Beijing Advanced Innovation Center for Food Nutrition and Human Health; National Natural Science Foundation of China [U1704233]
CR ABO T, 1981, J IMMUNOL, V126, P1360
   [Anonymous], 2016, AUTISM OPEN ACCESS, V0, P0
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664
   Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014
   Banas B, 2004, EUR J MED RES, V9, P371
   Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8
   Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543
   Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013
   Chandel NS, 2014, BMC BIOL, V12, P0, DOI 10.1186/1741-7007-12-34
   Chen N, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep37404
   Chen S, 2015, BMC PSYCHIATRY, V15, P50
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Duffy LM, 2011, NEUROPATH APPL NEURO, V37, P336, DOI 10.1111/j.1365-2990.2011.01166.x
   Giorgi C, 2012, MITOCHONDRION, V12, P77, DOI 10.1016/j.mito.2011.07.004
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   He Y, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0096869
   Hurtado-Roca Y, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0163770
   Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Lee JY, 2014, INT J ENDOCRINOL, V2014, P0, DOI 10.1155/2014/586017
   Lee SH, 2011, METABOLISM, V60, P1677, DOI 10.1016/j.metabol.2011.04.010
   Lei L, 2017, J HUM HYPERTENS, V31, P585, DOI 10.1038/jhh.2017.30
   Leishangthem BD, 2016, LUPUS, V25, P272, DOI 10.1177/0961203315605370
   Lemnrau A, 2015, CANCER RES, V75, P2844, DOI 10.1158/0008-5472.CAN-14-1692
   López-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003
   Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Melkonian SC, 2015, CARCINOGENESIS, V36, P249, DOI 10.1093/carcin/bgu248
   Meng FL, 2018, J BIOL CHEM, V293, P3321, DOI 10.1074/jbc.RA117.000530
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014
   MIYAWAKI T, 1984, CLIN EXP IMMUNOL, V55, P618
   Nemzek JA, 2001, INFLAMM RES, V50, P523, DOI 10.1007/PL00000229
   Patterson HC, 2015, P NATL ACAD SCI USA, V112, PE5679, DOI 10.1073/pnas.1517932112
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Purdue MP, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0043149
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136
   Shen J, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0131649
   SHUSTER RC, 1988, BIOCHEM BIOPH RES CO, V155, P1360, DOI 10.1016/S0006-291X(88)81291-9
   Smith EF, 2019, NEUROSCI LETT, V710, P0, DOI 10.1016/j.neulet.2017.06.052
   Sun J, 2019, J INFECT DIS, V219, P1285, DOI 10.1093/infdis/jiy658
   Sun YH, 2016, MOL CARCINOGEN, V55, P1111, DOI 10.1002/mc.22373
   Tin A, 2016, J AM SOC NEPHROL, V27, P2467, DOI 10.1681/ASN.2015060661
   Tu HK, 2015, ONCOTARGET, V6, P41988, DOI 10.18632/oncotarget.5889
   Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008
   Ward MS, 2013, CURR OPIN PHARMACOL, V13, P654, DOI 10.1016/j.coph.2013.06.009
   Xie H, 2013, CARCINOGENESIS, V34, P1039, DOI 10.1093/carcin/bgt023
   Xu EP, 2013, CARCINOGENESIS, V34, P2521, DOI 10.1093/carcin/bgt230
   Yang Y, 2019, PLOS ONE, V14, P0
   Yoo HJ, 2017, WORLD J BIOL PSYCHIA, V18, P151, DOI 10.1080/15622975.2016.1234069
   Zhang J, 2017, AM J CARDIOL, V119, P473, DOI 10.1016/j.amjcard.2016.10.017
   Zhang P, 2016, MITOCHONDRION, V28, P16, DOI 10.1016/j.mito.2016.03.001
   Zhou WM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0109470
NR 55
TC 2
Z9 2
U1 0
U2 9
PU C M B  ASSOC
PI POITIERS
PA 34 BOULEVARD SOLFERINO, 86000 POITIERS, FRANCE
SN 0145-5680
EI 1165-158X
J9 CELL MOL BIOL
JI Cell. Mol. Biol.
PD JUN 15
PY 2020
VL 66
IS 5
BP 179
EP 184
DI 10.14715/cmb/2020.66.5.30
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA MY8PI
UT WOS:000558679700029
PM 33040833
DA 2024-11-01
ER

PT J
AU Rucheton, B
   Jardel, C
   Filaut, S
   Amador, MD
   Maisonobe, T
   Serre, I
   Romero, NB
   Leonard-Louis, S
   Haraux, F
   Lombès, A
AF Rucheton, Benoit
   Jardel, Claude
   Filaut, Sandrine
   Amador, Maria del Mar
   Maisonobe, Thierry
   Serre, Isabelle
   Romero, Norma Beatriz
   Leonard-Louis, Sarah
   Haraux, Francis
   Lombes, Anne
TI Homoplasmic deleterious <i>MT</i>-<i>ATP6/8</i> mutations in adult patients
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA; ATP synthase; Cybrids; Oxidative phosphorylation; Mitochondrial disease; Homoplasmy
ID human mitochondrial-dna; atp synthase deficiency; cytochrome-c-oxidase; leigh-syndrome; t9176c mutation; gene; ataxia; yeast; mtdna; microdeletion
AB To address the frequency of complex V defects, we systematically sequenced MT-ATP6/8 genes in 512 consecutive patients. We performed functional analysis in muscle or fibroblasts for 12 out of 27 putative homoplasmic mutations and in cybrids for four. Fibroblasts, muscle and cybrids with known deleterious mutations underwent parallel analysis. It included oxidative phosphorylation spectrophotometric assays, western blots, structural analysis, ATP production, glycolysis and cell proliferation evaluation. We demonstrated the deleterious nature of three original mutations. Striking gradation in severity of the mutations consequences and differences between muscle, fibroblasts and cybrids implied a likely under -diagnosis of human complex V defects.
C1 [Rucheton, Benoit; Jardel, Claude; Filaut, Sandrine] CHU Pitie Salpetriere, AP HP, Ctr Genet Mol & Chromosom, Serv Biochim Metab, Paris, France.
   [Amador, Maria del Mar] CHU Pitie Salpetriere, AP HP, Dept Neurol, Paris, France.
   [Maisonobe, Thierry; Leonard-Louis, Sarah] UPMC Univ Paris 06, Sorbonne Univ, CHU Pitie Salpetriere, AP HP,Dept Neurophysiol Clin & Neuropathol, Paris, France.
   [Serre, Isabelle] CHU Reims, Dept Neurol, Reims, France.
   [Romero, Norma Beatriz] UPMC Univ Paris 06, Sorbonne Univ, CHU Pitie Salpetriere, INSERM UMRS974,Ctr Res Myol, Paris, France.
   [Haraux, Francis] Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, CEA,CNRS, Gif Sur Yvette, France.
   [Lombes, Anne] Univ Paris Decartes Paris5, CNRS UMR 8104, Inst Cochin, INSERM U1016, Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite de Reims Champagne-Ardenne; CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite
RP Rucheton, B; Lombès, A (corresponding author), INSERM U1016, Fac Med Cochin, 24 Rue Faubourg St Jacques, F-75014 Paris, France.; Rucheton, B; Lombès, A (corresponding author), CHU Pitie Salpetriere, Ctr Genet Mol & Chromosom, Serv Biochim Metab, 81 Bd Hop, F-75013 Paris, France.
EM benoit.rucheton@aphp.fr; anne.lombes@inserm.fr
FU Fondation pour la Recherche Medicale (FRM) [DPM20121125550]; AFM Telethon; AMMi
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Auré K, 2007, NEUROMUSCULAR DISORD, V17, P368, DOI 10.1016/j.nmd.2007.01.019
   Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Barca E, 2018, HUM MOL GENET, V27, P3305, DOI 10.1093/hmg/ddy231
   Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Bayani J, 2003, GENE CHROMOSOME CANC, V36, P7, DOI 10.1002/gcc.10132
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   CHRETIEN D, 1990, BIOCHEM BIOPH RES CO, V173, P26, DOI 10.1016/S0006-291X(05)81016-2
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Cortés-Hernández P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200
   Craig K, 2007, J MED GENET, V44, P797, DOI 10.1136/jmg.2007.052902
   Dautant A, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.00329
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   Vazquez-Memije ME, 2009, J CELL BIOCHEM, V106, P878, DOI 10.1002/jcb.22055
   Frey S, 2017, BBA-MOL BASIS DIS, V1863, P284, DOI 10.1016/j.bbadis.2016.10.028
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Habersetzer J, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075429
   Haraux F, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0221886
   Havlícková V, 2010, BBA-BIOENERGETICS, V1797, P1124, DOI 10.1016/j.bbabio.2009.12.009
   Hejzlarová K, 2014, PHYSIOL RES, V63, PS57, DOI 10.33549/physiolres.932643
   Hejzlarová K, 2015, BIOCHEM J, V466, P601, DOI 10.1042/BJ20141462
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Kabala AM, 2014, BIOCHIMIE, V100, P200, DOI 10.1016/j.biochi.2013.11.024
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kogelnik AM, 1997, NUCLEIC ACIDS RES, V25, P196, DOI 10.1093/nar/25.1.196
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011
   Macnamara EF, 2019, HUM MUTAT, V40, P532, DOI 10.1002/humu.23722
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Meulemans A, 2010, J BIOL CHEM, V285, P4099, DOI 10.1074/jbc.M109.046920
   Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Mrácek T, 2006, EXP GERONTOL, V41, P683, DOI 10.1016/j.exger.2006.02.009
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75
   Sammut IA, 1998, CRYOBIOLOGY, V36, P49, DOI 10.1006/cryo.1997.2063
   Seneca S, 1996, J INHERIT METAB DIS, V19, P115, DOI 10.1007/BF01799407
   Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273
   Synofzik M, 2012, EUR J NEUROL, V19, Pe114, DOI 10.1111/j.1468-1331.2012.03812.x
   Temperley RJ, 2003, HUM MOL GENET, V12, P2341, DOI 10.1093/hmg/ddg238
   Thompson K, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809060
   TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   Vojtísková A, 2004, TOXICOL MECH METHOD, V14, P7, DOI 10.1080/15376520490257347
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 62
TC 7
Z9 7
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV 15
PY 2020
VL 55
IS 
BP 64
EP 77
DI 10.1016/j.mito.2020.08.004
PG 14
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA PQ1TF
UT WOS:000606333400006
PM 32858252
DA 2024-11-01
ER

PT J
AU Abdullah, H
   Shah, S
   Husain, H
   Hassan, F
   Maqsood, H
AF Abdullah, Hassan
   Shah, Syed
   Husain, Humza
   Hassan, Furqan
   Maqsood, Hamza
TI Late-onset Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-like Episodes (MELAS) Syndrome in a 63-year-old Patient
SO CUREUS JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE melas; stroke; myopathy; encephalopathy; lactic acidosis; seizures; mri; mitochondrial dna mutation
ID encephalopathy; features; myopathy
AB Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) usually manifests in early life. Clinical hallmarks of the disease are mitochondrial myopathies, encephalopathy with stroke-like episodes, seizures, and lactic acidosis. It rarely manifests in late adulthood. Here we present the case of a 63-year-old female patient who developed recurrent stroke-like symptoms with typical resolving and remitting pattern of findings on imaging. Later on, it was confirmed as a case of MELAS upon genetic analysis.
C1 [Abdullah, Hassan; Hassan, Furqan] Nishtar Med Univ, Med, Multan, Pakistan.
   [Abdullah, Hassan] Univ Alabama Birmingham, Neurol, Birmingham, AL 35294 USA.
   [Shah, Syed; Maqsood, Hamza] Nishtar Med Univ, Nishtar Hosp, Med, Multan, Pakistan.
   [Husain, Humza] Nishtar Med Univ, Internal Med, Multan, Pakistan.
C3 University of Alabama System; University of Alabama Birmingham
RP Abdullah, H (corresponding author), Nishtar Med Univ, Med, Multan, Pakistan.; Abdullah, H (corresponding author), Univ Alabama Birmingham, Neurol, Birmingham, AL 35294 USA.
EM dochassanabdullah@gmail.com
CR Brady E, 2018, CLIN IMAG, V47, P80, DOI 10.1016/j.clinimag.2017.08.008
   CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
   Geberhiwot T, 2006, NEW ENGL J MED, V354, P1096
   Gieraerts C, 2013, J COMPUT ASSIST TOMO, V37, P279, DOI 10.1097/RCT.0b013e3182811170
   Malhotra K, 2016, CURR PAIN HEADACHE R, V20, P0, DOI 10.1007/s11916-016-0583-7
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Sinnecker T, 2019, BMC NEUROL, V19, P0, DOI 10.1186/s12883-019-1306-6
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Testai FD, 2010, ARCH NEUROL-CHICAGO, V67, P19, DOI 10.1001/archneurol.2009.309
NR 11
TC 1
Z9 1
U1 0
U2 1
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 
EI 2168-8184
J9 CUREUS J MED SCIENCE
JI Cureus J Med Sci
PD APR 27
PY 2020
VL 12
IS 4
BP 
EP 
DI 10.7759/cureus.7862
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA LH4YC
UT WOS:000528791500019
PM 32483512
DA 2024-11-01
ER

PT J
AU Ronchi, D
   Caporali, L
   Manenti, GF
   Meneri, M
   Mohamed, S
   Bordoni, A
   Tagliavini, F
   Contin, M
   Piga, D
   Sciacco, M
   Saetti, C
   Carelli, V
   Comi, GP
AF Ronchi, Dario
   Caporali, Leonardo
   Manenti, Giulia Francesca
   Meneri, Megi
   Mohamed, Susan
   Bordoni, Andreina
   Tagliavini, Francesca
   Contin, Manuela
   Piga, Daniela
   Sciacco, Monica
   Saetti, Cristina
   Carelli, Valerio
   Comi, Giacomo Pietro
TI <i>TYMP</i>Variants Result in Late-Onset Mitochondrial Myopathy With Altered Muscle Mitochondrial DNA Homeostasis
SO FRONTIERS IN GENETICS
LA English
DT Article
DE mitochondrial myopathy; mitochondrial DNA instability; TYMP; mitochondrial neurogatrointestinal encephalomyopathy; mitochondrial DNA replication
ID phosphorylase gene-mutations; neurogastrointestinal encephalomyopathy; point mutations; thymidine; mngie; defects; mtdna
AB BiallelicTYMPvariants result in the mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), a juvenile-onset disorder with progressive course and fatal outcome. Milder late-onset (>40 years) form has been rarely described. Gene panel sequencing in a cohort of 60 patients featuring muscle accumulation of mitochondrial DNA (mtDNA) deletions detectedTYMPdefects in three subjects (5%), two of them with symptom onset in the fifth decade. One of the patients only displayed ptosis and ophthalmoparesis. Biochemical and molecular studies supported the diagnosis. Screening ofTYMPis recommended in adult patients with muscle mtDNA instability, even in the absence of cardinal MNGIE features.
C1 [Ronchi, Dario; Meneri, Megi; Bordoni, Andreina; Piga, Daniela; Saetti, Cristina] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
   [Ronchi, Dario; Manenti, Giulia Francesca; Saetti, Cristina; Comi, Giacomo Pietro] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Caporali, Leonardo; Mohamed, Susan; Tagliavini, Francesca; Contin, Manuela; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, Bologna, Italy.
   [Contin, Manuela; Carelli, Valerio] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie DIBINEM, Bologna, Italy.
   [Sciacco, Monica; Comi, Giacomo Pietro] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Neuromuscular & Rare Dis Unit, Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; IRCCS Ca Granda Ospedale Maggiore Policlinico
RP Comi, GP (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.; Carelli, V (corresponding author), IRCCS Ist Sci Neurol Bologna, Bologna, Italy.; Carelli, V (corresponding author), Univ Bologna, Dipartimento Sci Biomed & Neuromotorie DIBINEM, Bologna, Italy.; Comi, GP (corresponding author), IRCCS Fdn Ca Granda Osped Maggiore Policlin, Neuromuscular & Rare Dis Unit, Milan, Italy.
EM valerio.carelli@unibo.it; giacomo.comi@unimi.it
FU Italian Ministry of Health; Ministero della Salute (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Ricerca Corrente 2020)
CR Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Bakker JA, 2010, J INHERIT METAB DIS, V33, PS139, DOI 10.1007/s10545-010-9049-y
   Bohr VA, 1999, J BIOENERG BIOMEMBR, V31, P391, DOI 10.1023/A:1005484004167
   da Costa CK, 2007, J NEUROL SCI, V263, P139, DOI 10.1016/j.jns.2007.07.006
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Finkenstedt A, 2013, JIMD REP, V10, P41, DOI 10.1007/8904_2012_199
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hirano M, 2016, GENEREVIEWS, V0, P1993
   Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006
   Li S, 2019, DIAGNOSIS MANAGEMENT, V0, P205
   Martí R, 2005, ANN NEUROL, V58, P649, DOI 10.1002/ana.20615
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Massa R, 2009, NEUROMUSCULAR DISORD, V19, P837, DOI 10.1016/j.nmd.2009.08.013
   Mohamed S, 2014, J CHROMATOGR B, V949, P58, DOI 10.1016/j.jchromb.2014.01.003
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   Ronchi D, 2018, BRAIN, V141, P0, DOI 10.1093/brain/awx302
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Slama A, 2005, MOL GENET METAB, V84, P326, DOI 10.1016/j.ymgme.2004.12.004
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Yadak R, 2017, FRONT CELL NEUROSCI, V11, P0, DOI 10.3389/fncel.2017.00031
NR 27
TC 5
Z9 5
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD AUG 5
PY 2020
VL 11
IS 
BP 
EP 
DI 10.3389/fgene.2020.00860
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA NF3RG
UT WOS:000563215000001
PM 32849836
DA 2024-11-01
ER

PT J
AU Hedberg-Oldfors, C
   Macao, B
   Basu, S
   Lindberg, C
   Peter, B
   Erdinc, D
   Uhler, JP
   Larsson, E
   Falkenberg, M
   Oldfors, A
AF Hedberg-Oldfors, Carola
   Macao, Bertil
   Basu, Swaraj
   Lindberg, Christopher
   Peter, Bradley
   Erdinc, Direnis
   Uhler, Jay P.
   Larsson, Erik
   Falkenberg, Maria
   Oldfors, Anders
TI Deep sequencing of mitochondrial DNA and characterization of a novel <i>POLG</i> mutation in a patient with arPEO
SO NEUROLOGY-GENETICS
LA English
DT Article
ID polymerase gamma; maintenance; deletions; twinkle; gene
AB Objective To determine the pathogenicity of a novel POLG mutation in a man with late-onset autosomal recessive progressive external ophthalmoplegia using clinical, molecular, and biochemical analyses. Methods A multipronged approach with detailed neurologic examinations, muscle biopsy analyses, molecular genetic studies, and in vitro biochemical characterization. Results The patient had slowly progressive bilateral ptosis and severely reduced horizontal and vertical gaze. Muscle biopsy showed slight variability in muscle fiber size, scattered ragged red fibers, and partial cytochrome c oxidase deficiency. Biallelic mutations were identified in the POLG gene encoding the catalytic A subunit of POL gamma. One allele carried a novel mutation in the exonuclease domain (c.590T>C; p.F197S), and the other had a previously characterized null mutation in the polymerase domain (c.2740A>C; p.T914P). Biochemical characterization revealed that the novel F197S mutant protein had reduced exonuclease and DNA polymerase activities and confirmed that T914P was inactive. By deep sequencing of mitochondrial DNA (mtDNA) extracted from muscle, multiple large-scale rearrangements were mapped and quantified. Conclusions The patient's phenotype was caused by biallelic POLG mutations, resulting in one inactive POL gamma A protein (T914P) and one with decreased polymerase and exonuclease activity (F197S). The reduction in polymerase activity explains the presence of multiple pathogenic large-scale deletions in the patient's mtDNA.
C1 [Hedberg-Oldfors, Carola; Oldfors, Anders] Univ Gothenburg, Dept Pathol & Genet, Gothenburg, Sweden.
   [Macao, Bertil; Basu, Swaraj; Peter, Bradley; Erdinc, Direnis; Uhler, Jay P.; Larsson, Erik; Falkenberg, Maria] Univ Gothenburg, Med Biochem & Cell Biol, Gothenburg, Sweden.
   [Lindberg, Christopher] Sahlgrens Univ Hosp, Dept Neurol, Neuromuscular Ctr, Gothenburg, Sweden.
C3 University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital
RP Oldfors, A (corresponding author), Univ Gothenburg, Dept Pathol & Genet, Gothenburg, Sweden.; Falkenberg, M (corresponding author), Univ Gothenburg, Med Biochem & Cell Biol, Gothenburg, Sweden.
EM maria.falkenberg@medkem.gu.se; anders.oldfors@pathology.gu.se
FU Swedish Cancer Foundation; European Research Council; IngaBritt and Arne Lundberg Foundation; Knut and Alice Wallenberg Foundation; Vastra Gotalands Regionen [ALFGBG-727491, ALFGBG716821]
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   [Anonymous], 2013, MUSCLE BIOPSY PRACTI, V0, P0
   Bratic A, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9808
   DeBalsi KL, 2017, J BIOL CHEM, V292, P4198, DOI 10.1074/jbc.M116.773341
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Macao B, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8303
   Persson Ö, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Pitceathly RDS, 2016, EUR RADIOL, V26, P130, DOI 10.1007/s00330-015-3801-5
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Yu CY, 2005, NEUROMUSCULAR DISORD, V15, P17, DOI 10.1016/j.nmd.2004.10.002
   Yu-Wai-Man C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075048
NR 21
TC 7
Z9 7
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
EI 
J9 NEUROL-GENET
JI Neurol.-Genet.
PD FEB 15
PY 2020
VL 6
IS 1
BP 
EP 
DI 10.1212/NXG.0000000000000391
PG 10
WC Genetics & Heredity; Clinical Neurology
SC Genetics & Heredity; Neurosciences & Neurology
GA LJ6PF
UT WOS:000530284200011
PM 32042919
DA 2024-11-01
ER

PT J
AU Yang, Q
   Yu, SY
AF Yang, Qian
   Yu, Shengyuan
TI Clinical features of mitochondrial encephalomyopathies in China: 97 case study and literature review
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Review
DE Mitochondrial encephalomyopathy; MELAS; MERRF; leigh syndrome; CPEO; LHON
ID cytochrome-c-oxidase; stroke-like episodes; lactic-acidosis; neurogastrointestinal encephalomyopathy; partial deficiency; encephalopathy; melas; dna; myopathy; deletions
AB Objective: To comprehensively investigate the mitochondrial encephalomyopathies in China for better diagnosis and treatment. Methods: A total of 97 cases from the PLA General Hospital between January 1993 and September 2012, and 815 cases reported from Wanfang Database, the Chinese National Knowledge Information database, Chinese Biology and Medicine Library Database up to September 2012, were reviewed and analyzed. The information analyzed included general conditions, the first symptom, the way of onset, clinical manifestations, findings from physical examinations, imaging examinations, muscle biopsy and genetic testing. Results: A total 912 cases were identified with a male-to-female ratio of 1.66:1. The age of patients ranged from 56 days to 78 years with a median age of 19 years. The most common type was mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) (50.3%). They frequently reported headaches (46.3%) and presented with an A3243G mitochondrial DNA (mtDNA) mutation (84.3%). Other mitochondrial encephalomyopathies included Leber's hereditary optic neuroretinopathy with decreased vision (95%) and a G11778A mtDNA mutation (42.6%), chronic progressive external ophthalmoplegia with ptosis (76.2%) and ocular movement disorder (79.2%), Leigh syndrome with delayed development (29.2%) and symmetrical abnormalities in the brainstem and basal ganglia (98.2%), myoclonic epilepsy and ragged red fiber with convulsions (35.7%). Many patients had elevated levels of lactic acid, and most showed myogenic injury in the electromyography signals. In the Kearns-Sayre syndrome patients 76.7% showed heart block in the electrocardiograms. Conclusions: Nearly all types of reported mitochondrial encephalomyopathies are present in Chinese population. If the clinical course, neurological findings and imaging features are suggestive of mitochondrial encephalomyopathies, DNA testing may be used for confirmation. If the results are not conclusive, then a muscle biopsy should be performed.
C1 [Yang, Qian] Tianjin Huanhu Hosp, Dept Neurol, 6 Jizhao Rd, Tianjin 300350, Peoples R China.
   [Yu, Shengyuan] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing 100853, Peoples R China.
C3 Chinese People's Liberation Army General Hospital
RP Yang, Q (corresponding author), Tianjin Huanhu Hosp, Dept Neurol, 6 Jizhao Rd, Tianjin 300350, Peoples R China.
EM Bian-zhixing232@126.com
CR Almannai M, 2018, CLIN GENET, V93, P1097, DOI 10.1111/cge.13210
   BARDOSI A, 1987, ACTA NEUROPATHOL, V74, P248, DOI 10.1007/BF00688189
   Bhatia KD, 2020, AM J NEURORADIOL, V41, P167, DOI 10.3174/ajnr.A6325
   Bianco Angelica, 2018, BMC RES NOTES, V11, P911, DOI 10.1186/s13104-018-4025-y
   Catic A, 2018, PROG MOL BIOL TRANSL, V155, P85, DOI 10.1016/bs.pmbts.2017.12.003
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   DAngelo R, 2017, MITOCHONDRION, V34, P101, DOI 10.1016/j.mito.2017.02.006
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Felczak P, 2019, POL J PATHOL, V70, P144, DOI 10.5114/PJP.2019.87106
   Filosto M, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7110389
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   FUKUHARA N, 1995, MUSCLE NERVE, V0, PS90
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   Gueguen A, 2017, CLIN NEUROPHYSIOL, V128, P1258, DOI 10.1016/j.clinph.2017.04.013
   HARDING AE, 1992, J INHERIT METAB DIS, V15, P480, DOI 10.1007/BF01799606
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horbay R, 2016, APOPTOSIS, V21, P1327, DOI 10.1007/s10495-016-1295-5
   HOWELL N, 1992, AM J HUM GENET, V50, P443
   Jancic J, 2020, MITOCHONDRION, V50, P132, DOI 10.1016/j.mito.2019.10.011
   Johns DR, 1996, NAT MED, V2, P1065, DOI 10.1038/nm1096-1065
   JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lee SJ, 2018, YONSEI MED J, V59, P1190
   Li XD, 2018, J CLIN NEUROSCI, V55, P65, DOI 10.1016/j.jocn.2018.06.015
   Liu XQ, 2019, MEDICINE, V98, P0, DOI 10.1097/MD.0000000000015534
   Longo N, 2003, NEUROL CLIN, V21, P817, DOI 10.1016/S0733-8619(03)00015-X
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Malhotra K, 2016, CURR PAIN HEADACHE R, V20, P0, DOI 10.1007/s11916-016-0583-7
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Manickam AH, 2017, INDIAN J OPHTHALMOL, V65, P1087, DOI 10.4103/ijo.IJO_358_17
   Meseguer S, 2019, BBA-MOL CELL RES, V1866, P1433, DOI 10.1016/j.bbamcr.2019.06.004
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Nagata JM, 2017, J ADOLESCENT HEALTH, V61, P661, DOI 10.1016/j.jadohealth.2017.06.023
   Oldfors Anders, 2007, HANDB CLIN NEUROL, V86, P125, DOI 10.1016/S0072-9752(07)86006-4
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pek NMQ, 2019, CELL DEATH DIS, V10, P0, DOI 10.1038/s41419-019-2036-9
   Quintos JB, 2016, J PEDIATR ENDOCR MET, V29, P1319, DOI 10.1515/jpem-2016-0172
   Radelfahr F, 2019, NERVENARZT, V90, P121, DOI 10.1007/s00115-018-0666-2
   Radelfahr F, 2018, FORTSCHR NEUROL PSYC, V86, P584, DOI 10.1055/a-0621-9255
   Ryzhkova AI, 2018, THER CLIN RISK MANAG, V14, P1933, DOI 10.2147/TCRM.S154863
   Schapira AHV, 1999, EUR J CLIN INVEST, V29, P886
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Simon DK, 1999, ANNU REV MED, V50, P111
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Su LJ, 2018, CHINESE MED J-PEKING, V131, P2433, DOI 10.4103/0366-6999.243568
   Tsang SH, 2018, ADV EXP MED BIOL, V1085, P163, DOI 10.1007/978-3-319-95046-4_31
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wallace DC, 2000, AM HEART J, V139, PS70, DOI 10.1067/mhj.2000.103934
   WILLEMS JL, 1977, PEDIATRICS, V60, P850
   Yadak R, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1016-6
   Yadak R, 2017, FRONT CELL NEUROSCI, V11, P0, DOI 10.3389/fncel.2017.00031
NR 59
TC 0
Z9 0
U1 0
U2 1
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
EI 
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PD JUN 15
PY 2020
VL 13
IS 9
BP 6448
EP 6461
DI 
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA NY6WC
UT WOS:000576526000024
DA 2024-11-01
ER

PT J
AU La Morgia, C
   Maresca, A
   Caporali, L
   Valentino, ML
   Carelli, V
AF La Morgia, C.
   Maresca, A.
   Caporali, L.
   Valentino, M. L.
   Carelli, V.
TI Mitochondrial diseases in adults
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Review
DE mitochondrial diseases; mtDNA; mitochondria; neurology; neuromuscular disorders
ID hereditary optic neuropathy; progressive external ophthalmoplegia; transfer-rna synthetase; lactic-acidosis; dna mutation; sideroblastic anemia; prenatal-diagnosis; myoclonus epilepsy; respiratory-chain; mtdna mutation
AB Mitochondrial medicine is a field that expanded exponentially in the last 30 years. Individually rare, mitochondrial diseases as a whole are probably the most frequent genetic disorder in adults. The complexity of their genotype-phenotype correlation, in terms of penetrance and clinical expressivity, natural history and diagnostic algorithm derives from the dual genetic determination. In fact, in addition to the about 1.500 genes encoding mitochondrial proteins that reside in the nuclear genome (nDNA), we have the 13 proteins encoded by the mitochondrial genome (mtDNA), for which 22 specific tRNAs and 2 rRNAs are also needed. Thus, besides Mendelian genetics, we need to consider all peculiarities of how mtDNA is inherited, maintained and expressed to fully understand the pathogenic mechanisms of these disorders. Yet, from the initial restriction to the narrow field of oxidative phosphorylation dysfunction, the landscape of mitochondrial functions impinging on cellular homeostasis, driving life and death, is impressively enlarged. Finally, from the clinical standpoint, starting from the neuromuscular field, where brain and skeletal muscle were the primary targets of mitochondrial dysfunction as energy-dependent tissues, after three decades virtually any subspecialty of medicine is now involved. We will summarize the key clinical pictures and pathogenic mechanisms of mitochondrial diseases in adults.
C1 [La Morgia, C.; Valentino, M. L.; Carelli, V.] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Bologna, Italy.
   [La Morgia, C.; Maresca, A.; Caporali, L.; Valentino, M. L.; Carelli, V.] UOC Clin Neurol, IRCCS Ist Sci Neurol Bologna, Bologna, Italy.
C3 University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB)
RP Carelli, V (corresponding author), Univ Bologna, IRCCS Ist Sci Neurol Bolognavia Altura 3, Dipartimento Sci Biomed & NeuroMotorie, I-40139 Bologna, Italy.
EM valerio.carelli@unibo.it
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Balducci N, 2016, BRIT J OPHTHALMOL, V100, P1232, DOI 10.1136/bjophthalmol-2015-307326
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barboni P, 2010, OPHTHALMOLOGY, V117, P623, DOI 10.1016/j.ophtha.2009.07.026
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Caporali L, 2018, PLOS GENET, V14, P0, DOI 10.1371/journal.pgen.1007210
   Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   CARELLI V, 2016, BRAIN 3, V139, P0, DOI 10.1093/BRAIN/AWV339
   Carelli V, 2018, ESSAYS BIOCHEM, V62, P235, DOI 10.1042/EBC20170097
   Carelli V, 2011, BRAIN, V134, P0, DOI 10.1093/brain/awr180
   Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   De Stefani D, 2016, ANNU REV BIOCHEM, V85, P161, DOI 10.1146/annurev-biochem-060614-034216
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Dionisi-Vici C, 2016, BRAIN, V139, P1045, DOI 10.1093/brain/aww013
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Giordano L, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.364
   Giorgio V, 2012, BBA-BIOENERGETICS, V1817, P363, DOI 10.1016/j.bbabio.2011.10.012
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573
   Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787
   Hällberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   HARDING AE, 1992, AM J HUM GENET, V50, P629
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hildick-Smith GJ, 2013, AM J HUM GENET, V93, P906, DOI 10.1016/j.ajhg.2013.09.011
   HOLME E, 1993, AM J HUM GENET, V52, P551
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Iannielli A, 2018, CELL REP, V22, P2066, DOI 10.1016/j.celrep.2018.01.089
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   JABER L, 1992, J MED GENET, V29, P86, DOI 10.1136/jmg.29.2.86
   Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498
   Karaa A, 2016, MOL GENET METAB, V119, P100, DOI 10.1016/j.ymgme.2016.07.005
   Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kullar PJ, 2018, BRAIN, V141, P55, DOI 10.1093/brain/awx295
   Lane N, 2017, J THEOR BIOL, V434, P58, DOI 10.1016/j.jtbi.2017.04.031
   Lane N, 2013, PHILOS T R SOC B, V368, P0, DOI 10.1098/rstb.2012.0253
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Latorre-Pellicer A, 2019, CELL METAB, V30, P1120, DOI 10.1016/j.cmet.2019.09.007
   Leber T, 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Li JJ, 2019, CELL, V177, P38, DOI 10.1016/j.cell.2019.03.004
   LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Margulis L, 2004, MICROBIOLOGY TODAY, V31, P172
   Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096
   Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704
   MITA S, 1995, MUSCLE NERVE, V0, PS113
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Pacitti D, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00669
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   POULTON J, 1991, AM J HUM GENET, V48, P649
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Reinson K, 2019, EUR J MED GENET, V62, P0, DOI 10.1016/j.ejmg.2018.11.006
   Richter U, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06471-z
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rowe RG, 2019, NAT REV GENET, V20, P377, DOI 10.1038/s41576-019-0100-z
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   RUMMELT V, 1993, OPHTHALMOLOGY, V100, P1757
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553
   Stenton SL, 2020, J INHERIT METAB DIS, V43, P25, DOI 10.1002/jimd.12130
   Stenton SL, 2018, ESSAYS BIOCHEM, V62, P399, DOI 10.1042/EBC20170110
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   TULINIUS MH, 1995, EUR J PEDIATR, V154, P35, DOI 10.1007/BF01972970
   van den Ameele J, 2020, SEMIN CELL DEV BIOL, V97, P156, DOI 10.1016/j.semcdb.2019.10.001
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   van Rahden VA, 2015, AM J HUM GENET, V96, P640, DOI 10.1016/j.ajhg.2015.02.002
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wallace DC, 2013, PHILOS T R SOC B, V368, P0, DOI 10.1098/rstb.2012.0267
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Wild KT, 2020, AM J MED GENET A, V182, P365, DOI 10.1002/ajmg.a.61433
   Wimplinger I, 2006, AM J HUM GENET, V79, P878, DOI 10.1086/508474
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 152
TC 37
Z9 40
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD JUN 15
PY 2020
VL 287
IS 6
BP 592
EP 608
DI 10.1111/joim.13064
PG 17
WC Medicine, General & Internal
SC General & Internal Medicine
GA LS6JN
UT WOS:000536488000002
PM 32463135
DA 2024-11-01
ER

PT J
AU Moore, TM
   Lin, AJ
   Strumwasser, AR
   Cory, K
   Whitney, K
   Ho, T
   Ho, T
   Lee, JL
   Rucker, DH
   Nguyen, CQ
   Yackly, A
   Mahata, SK
   Wanagat, J
   Stiles, L
   Turcotte, LP
   Crosbie, RH
   Zhou, ZQ
AF Moore, Timothy M.
   Lin, Amanda J.
   Strumwasser, Alexander R.
   Cory, Kevin
   Whitney, Kate
   Ho, Theodore
   Ho, Timothy
   Lee, Joseph L.
   Rucker, Daniel H.
   Nguyen, Christina Q.
   Yackly, Aidan
   Mahata, Sushil K.
   Wanagat, Jonathan
   Stiles, Linsey
   Turcotte, Lorraine P.
   Crosbie, Rachelle H.
   Zhou, Zhenqi
TI Mitochondrial Dysfunction Is an Early Consequence of Partial or Complete Dystrophin Loss in <i>mdx</i> Mice
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE muscular dystrophy; Duchenne muscular dystrophy; skeletal muscle; dystrophin; metabolism; mitochondria; autophagy
ID duchenne muscular-dystrophy; dna copy number; skeletal-muscle; cardiac involvement; mouse model; in-vivo; autophagy; metabolism; fusion; leupeptin
AB Duchenne muscular dystrophy (DMD) is characterized by rapid wasting of skeletal muscle. Mitochondrial dysfunction is a well-known pathological feature of DMD. However, whether mitochondrial dysfunction occurs before muscle fiber damage in DMD pathology is not well known. Furthermore, the impact upon heterozygous femalemdxcarriers (mdx/+), who display dystrophin mosaicism, has received little attention. We hypothesized that dystrophin deletion leads to mitochondrial dysfunction, and that this may occur before myofiber necrosis. As a secondary complication to mitochondrial dysfunction, we also hypothesized metabolic abnormalities prior to the onset of muscle damage. In this study, we detected aberrant mitochondrial morphology, reduced cristae number, and large mitochondrial vacuoles from both male and femalemdxmice prior to the onset of muscle damage. Furthermore, we systematically characterized mitochondria during disease progression starting before the onset of muscle damage, noting additional changes in mitochondrial DNA copy number and regulators of mitochondrial size. We further detected mild metabolic and mitochondrial impairments in femalemdxcarrier mice that were exacerbated with high-fat diet feeding. Lastly, inhibition of the strong autophagic program observed in adolescentmdxmale mice via administration of the autophagy inhibitor leupeptin did not improve skeletal muscle pathology. These results are in line with previous data and suggest that before the onset of myofiber necrosis, mitochondrial and metabolic abnormalities are present within themdxmouse.
C1 [Moore, Timothy M.; Turcotte, Lorraine P.] Univ Southern Calif, Dept Biol Sci, Dana & David Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90007 USA.
   [Moore, Timothy M.; Lin, Amanda J.; Strumwasser, Alexander R.; Cory, Kevin; Whitney, Kate; Ho, Theodore; Ho, Timothy; Lee, Joseph L.; Rucker, Daniel H.; Nguyen, Christina Q.; Yackly, Aidan; Stiles, Linsey; Zhou, Zhenqi] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA.
   [Mahata, Sushil K.] VA San Diego Healthcare Syst, San Diego, CA USA.
   [Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Wanagat, Jonathan] Univ Calif Los Angeles, Dept Med, Div Geriatr, Los Angeles, CA 90024 USA.
   [Crosbie, Rachelle H.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA.
   [Crosbie, Rachelle H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.
   [Crosbie, Rachelle H.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.
C3 University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles
RP Zhou, ZQ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA.
EM zhenqizhou@mednet.ucla.edu
FU UCLA Claude Pepper Older Americans Independence Center - National Institute of Aging [5P30AG028748]; NIH/NCATS UCLA CTSI Grant [UL1TR000124]; Wellstone NIH NIAMS Center of Excellence Grant [U54 AR052646]; Kirschstein-NRSA predoctoral fellowship [F31DK108657]; Carl V. Gisolfi Memorial Research grant from the American College of Sports Medicine; Dornsife College at the University of Southern California; UCLA Intercampus Medical Genetics Training Program [T32GM008243]; American Federation for Aging Research; Glenn Foundation for Medical Research; UCLA Hartford Center of Excellence, National Institute on Aging [AG059847, AG055518]; UCLA Older Americans Independence Center [P30 AG028748]; UCSD/UCLA Diabetes Research Center Pilot and Feasibility [DK063491]; Women in Science and Engineering program at USC; Department of Veterans Affairs [I01BX000323]; NIH [R01AR048179, R01HL126204]
CR Ameen Venus, 2010, OPEN CARDIOVASC MED J, V4, P265, DOI 10.2174/1874192401004010265
   Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104
   Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200
   Barker RG, 2018, AM J PHYSIOL-CELL PH, V314, PC483, DOI 10.1152/ajpcell.00046.2017
   Benador IY, 2018, CELL METAB, V27, P869, DOI 10.1016/j.cmet.2018.03.003
   BEREITERHAHN J, 1979, MICROSC ACTA, V82, P239
   Blanchet E, 2012, HUM MOL GENET, V21, P3910, DOI 10.1093/hmg/dds219
   Brioschi S, 2012, BMC MED GENET, V13, P0, DOI 10.1186/1471-2350-13-73
   BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189
   Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8
   Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6
   Ceulemans BP, 2008, PEDIATR NEUROL, V38, P64, DOI 10.1016/j.pediatrneurol.2007.09.006
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chan MC, 2014, SKELET MUSCLE, V4, P0, DOI 10.1186/2044-5040-4-2
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Childers MK, 2017, MUSCLE NERVE, V55, P777, DOI 10.1002/mus.25661
   Childers MK, 2012, FRONT PHARMACOL, V2, P0, DOI 10.3389/fphar.2011.00089
   Cole MA, 2002, NEUROMUSCULAR DISORD, V12, P247, DOI 10.1016/S0960-8966(01)00278-4
   DAVIES KE, 1988, J MUSCLE RES CELL M, V9, P1, DOI 10.1007/BF01682143
   De Palma C, 2012, CELL DEATH DIS, V3, P0, DOI 10.1038/cddis.2012.159
   De Palma C, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00188
   Dickinson A, 2013, CELL DEATH DIFFER, V20, P1644, DOI 10.1038/cdd.2013.115
   Doughty MJ, 1995, TISSUE CELL, V27, P701, DOI 10.1016/S0040-8166(05)80025-4
   Drew BG, 2014, DIABETES, V63, P1488, DOI 10.2337/db13-0665
   Dubowitz V, 2005, LANCET NEUROL, V4, P264, DOI 10.1016/S1474-4422(05)70050-8
   Duddy W, 2015, SKELET MUSCLE, V5, P0, DOI 10.1186/s13395-015-0041-y
   Emery A E, 1989, PROG CLIN BIOL RES, V306, P15
   Esteban-Martínez L, 2015, METHODS, V75, P79, DOI 10.1016/j.ymeth.2015.01.008
   EVEN PC, 1994, BIOCHEM J, V304, P649, DOI 10.1042/bj3040649
   Florian A, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.01770
   Florian A, 2016, EUR HEART J-CARD IMG, V17, P326, DOI 10.1093/ehjci/jev161
   Gaglianone RB, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-38609-4
   Govoni A, 2013, CELL MOL LIFE SCI, V70, P4585, DOI 10.1007/s00018-013-1396-z
   Gulston MK, 2008, J PROTEOME RES, V7, P2069, DOI 10.1021/pr800070p
   Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100
   HOFFMAN EP, 1992, NEUROLOGY, V42, P967, DOI 10.1212/WNL.42.5.967
   Ieronimakis N, 2016, J PATHOL, V240, P410, DOI 10.1002/path.4801
   Ishizaki M, 2018, NEUROMUSCULAR DISORD, V28, P572, DOI 10.1016/j.nmd.2018.04.005
   Jahnke VE, 2012, SKELET MUSCLE, V2, P0, DOI 10.1186/2044-5040-2-16
   Jones D, 2019, NAT BIOTECHNOL, V37, P335, DOI 10.1038/s41587-019-0103-5
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI 10.1042/BSE0470069
   Kang CF, 2018, CARDIOVASC RES, V114, P90, DOI 10.1093/cvr/cvx201
   KEMP GJ, 1993, J NEUROL SCI, V116, P201, DOI 10.1016/0022-510X(93)90326-T
   Khairallah M, 2007, J MOL CELL CARDIOL, V43, P119, DOI 10.1016/j.yjmcc.2007.05.015
   Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002
   Kyrychenko V, 2015, CELL CALCIUM, V58, P186, DOI 10.1016/j.ceca.2015.04.006
   Lackner LL, 2014, BMC BIOL, V12, P0, DOI 10.1186/1741-7007-12-35
   Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   LUCASHERON B, 1990, J NEUROL SCI, V99, P349, DOI 10.1016/0022-510X(90)90169-N
   Mandillo S, 2014, DIS MODEL MECH, V7, P397, DOI 10.1242/dmm.013946
   Marshall JL, 2013, SKELET MUSCLE, V3, P0, DOI 10.1186/2044-5040-3-1
   McIntosh LM, 1998, ANAT RECORD, V252, P311, DOI 10.1002/(SICI)1097-0185(199810)252:2<311::AID-AR17>3.0.CO;2-Q
   McIntosh LM, 1998, BIOCHEM CELL BIOL, V76, P532
   Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Mokhtarian A, 1996, PFLUG ARCH EUR J PHY, V431, P527, DOI 10.1007/s004240050031
   Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9
   Montgomery MK, 2015, ENDOCR CONNECT, V4, P0, DOI 10.1530/EC-14-0092
   Moore TM, 2020, MITOCHONDRIAL DYSFUN, V0, P0, DOI DOI 10.21203/rs.2.23961/v1
   Moore TM, 2019, MOL METAB, V21, P51, DOI 10.1016/j.molmet.2018.11.012
   Muntoni F, 2002, NEUROMUSCULAR DISORD, V12, PS162, DOI 10.1016/S0960-8966(02)00101-3
   Nghiem PP, 2017, YALE J BIOL MED, V90, P351
   Nochez Y, 2009, MOL VIS, V15, P598
   Park Chang Hyun, 2016, APPLIED MICROSCOPY 한국현미경학회지, V46, P188
   Pauly M, 2017, BBA-MOL BASIS DIS, V1863, P2229, DOI 10.1016/j.bbadis.2017.06.009
   Pauly M, 2012, AM J PATHOL, V181, P583, DOI 10.1016/j.ajpath.2012.04.004
   Pejznochova M, 2010, MITOCHONDRION, V10, P321, DOI 10.1016/j.mito.2010.01.006
   Perumal AR, 2015, APPL NEUROPSYCH-CHIL, V4, P49, DOI 10.1080/21622965.2013.802649
   Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59
   Piras A, 2018, NEURAL REGEN RES, V13, P813, DOI 10.4103/1673-5374.232473
   Ribas V, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aad3815
   SALMINEN A, 1984, AM J PATHOL, V117, P64
   Sandri M, 2013, J CELL SCI, V126, P5325, DOI 10.1242/jcs.114041
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Schneider SM, 2018, MOL IMAGING BIOL, V20, P780, DOI 10.1007/s11307-018-1174-2
   Selsby J, 2010, AM J PHYSIOL-REG I, V299, PR1192, DOI 10.1152/ajpregu.00586.2009
   Selsby JT, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0030063
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Shen QF, 2014, MOL BIOL CELL, V25, P145, DOI 10.1091/mbc.E13-09-0525
   Sperl W, 1997, MOL CELL BIOCHEM, V174, P71, DOI 10.1023/A:1006880529195
   Strakova J, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-31753-3
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   van Putten M, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031937
   Viggiano E, 2017, J GENE MED, V19, P0, DOI 10.1002/jgm.2952
   Vila MC, 2017, CELL DEATH DIFFER, V24, P330, DOI 10.1038/cdd.2016.127
   Walcher T, 2010, INT J CARDIOL, V138, P302, DOI 10.1016/j.ijcard.2008.06.084
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Whitehead NP, 2016, AUTOPHAGY, V12, P705, DOI 10.1080/15548627.2016.1144005
   Yoon J, 2011, J KOREAN MED SCI, V26, P587, DOI 10.3346/jkms.2011.26.4.587
   Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhong JZ, 2019, MOL MED REP, V19, P3035, DOI 10.3892/mmr.2019.9982
   Zhou ZQ, 2018, J BIOL CHEM, V293, P4735, DOI 10.1074/jbc.M117.805069
NR 97
TC 64
Z9 68
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-042X
EI 
J9 FRONT PHYSIOL
JI Front. Physiol.
PD JUN 19
PY 2020
VL 11
IS 
BP 
EP 
DI 10.3389/fphys.2020.00690
PG 15
WC Physiology
SC Physiology
GA MK2UN
UT WOS:000548640800001
PM 32636760
DA 2024-11-01
ER

PT J
AU Kripps, KA
   Friederich, MW
   Chen, T
   Larson, AA
   Mirsky, DM
   Wang, Y
   Tanji, K
   Knight, KM
   Wong, LJ
   Van Hove, JLK
AF Kripps, Kimberly A.
   Friederich, Marisa W.
   Chen, Ting
   Larson, Austin A.
   Mirsky, David M.
   Wang, Yue
   Tanji, Kurenai
   Knight, Kaz M.
   Wong, Lee-Jun
   Van Hove, Johan L. K.
TI A novel acceptor stem variant in mitochondrial tRNA<SUP>Tyr</SUP> impairs mitochondrial translation and is associated with a severe phenotype
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondrial tRNA; Mt-tRNA(Tyr); Multisystem mitochondrial disorder; Neurodegenerative disorder; Mitochondrial translation disorder; Pathogenicity of mtDNA variants
ID transfer-rna; mutation; gene; features; disease; melas
AB Genetic defects in mitochondrial DNA encoded tRNA genes impair mitochondrial translation with resultant defects in the mitochondrial respiratory chain and oxidative phosphorylation system. The phenotypic spectrum of disease seen in mitochondrial tRNA defects is variable and proving pathogenicity of new variants is challenging. Only three pathogenic variants have been described previously in the mitochondrial tRNA(Tyr) gene MT-TY, with the reported phenotypes consisting largely of adult onset myopathy and ptosis. We report a patient with a novel MT-TY acceptor stem variant m.5889A>G at high heteroplasmy in muscle, low in blood, and absent in the mother's blood. The phenotype consisted of a childhood-onset severe multi-system disorder characterized by a neurodegenerative course including ataxia and seizures, failure-to-thrive, combined myopathy and neuropathy, and hearing and vision loss. Brain imaging showed progressive atrophy and basal ganglia calcifications. Mitochondrial biomarkers lactate and GDF15 were increased. Functional studies showed a deficient activity of the respiratory chain enzyme complexes containing mtDNA-encoded subunits I, III and IV. There were decreased steady state levels of these mitochondrial complex proteins, and presence of incompletely assembled complex V forms in muscle. These changes are typical of a mitochondrial translational defect. These data support the pathogenicity of this novel variant. Careful review of variants in MT-TY additionally identified two other pathogenic variants, one likely pathogenic variant, nine variants of unknown significance, five likely benign and four benign variants. (C) 2020 Elsevier Inc. All rights reserved.
C1 [Kripps, Kimberly A.; Friederich, Marisa W.; Larson, Austin A.; Knight, Kaz M.; Van Hove, Johan L. K.] Univ Colorado, Dept Pediat, Sect Clin Genet & Metab, Educ 2 South,L28-4114 13121 East 17th Ave, Aurora, CO 80045 USA.
   [Friederich, Marisa W.; Van Hove, Johan L. K.] Childrens Hosp Colorado, Dept Pathol & Lab Med, 13121 East 16th Ave, Aurora, CO USA.
   [Chen, Ting; Wang, Yue; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Chen, Ting] Soochow Univ, Dept Endocrinol Genet & Metab, Childrens Hosp, Suzhou, Peoples R China.
   [Mirsky, David M.] Univ Colorado, Dept Radiol, Aurora, CO 80045 USA.
   [Mirsky, David M.] Childrens Hosp Colorado, Aurora, CO USA.
   [Tanji, Kurenai] Columbia Univ, Div Neuropathol, Med Ctr, New York, NY USA.
   [Kripps, Kimberly A.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA.
C3 University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Baylor College of Medicine; Soochow University - China; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Columbia University; Oregon Health & Science University
RP Van Hove, JLK (corresponding author), Univ Colorado, Dept Pediat, Sect Clin Genet & Metab, Educ 2 South,L28-4114 13121 East 17th Ave, Aurora, CO 80045 USA.
EM Johan.Vanhove@childrenscolorado.org
FU Children's Hospital Colorado Foundation; National Institutes of Health [NIH U54NS078059]; NCATS; NIH/NCATS Colorado CTSA Grant [UL1 TR002535]
CR Abbott JA, 2014, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00158
   Barca E, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000402
   Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6
   Chatfield KC, 2015, MITOCHONDRION, V21, P1, DOI 10.1016/j.mito.2014.12.005
   Coughlin CR, 2015, J MED GENET, V52, P532, DOI 10.1136/jmedgenet-2015-103049
   Finsterer J, 2005, METAB BRAIN DIS, V20, P219, DOI 10.1007/s11011-005-7209-9
   Friederich MW, 2017, HUM MOL GENET, V26, P702, DOI 10.1093/hmg/ddw431
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Kornblum C, 2008, BIOSCIENCE REP, V28, P89, DOI 10.1042/BSR20080004
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Ng YS, 2016, NEUROMUSCULAR DISORD, V26, P702, DOI 10.1016/j.nmd.2016.08.009
   Pulkes T, 2000, NEUROLOGY, V55, P1210, DOI 10.1212/WNL.55.8.1210
   Raffelsberger T, 2001, NEUROLOGY, V57, P2298, DOI 10.1212/WNL.57.12.2298
   Rebelo-Guiomar P, 2019, BBA-GENE REGUL MECH, V1862, P429, DOI 10.1016/j.bbagrm.2018.11.005
   Richter U, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06471-z
   Sahashi K, 2001, J MED GENET, V38, P703, DOI 10.1136/jmg.38.10.703
   Scaglia F, 2003, AM J MED GENET A, V123A, P172, DOI 10.1002/ajmg.a.20315
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Simoncini C, 2018, CASE REP NEUROL MED, V2018, P0, DOI 10.1155/2018/8406712
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Tanji K, 2012, METHODS MOL BIOL, V837, P181, DOI 10.1007/978-1-61779-504-6_12
   Wei FY, 2015, CELL METAB, V21, P428, DOI 10.1016/j.cmet.2015.01.019
   Wong LJC, 2020, GENET MED, V0, P0, DOI DOI 10.1038/s41436-019-0746-0
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 28
TC 2
Z9 2
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD DEC 15
PY 2020
VL 131
IS 4
BP 398
EP 404
DI 10.1016/j.ymgme.2020.11.006
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA PH7WV
UT WOS:000600618800005
PM 33279411
DA 2024-11-01
ER

PT J
AU Jeppesen, TD
AF Jeppesen, Tina Dysgaard
TI Aerobic Exercise Training in Patients With mtDNA-Related Mitochondrial Myopathy
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Review
DE mitochondrial DNA; mitochondrial myopathies; treatment; training; oxidative capacity
ID skeletal-muscle; oxidative capacity; insulin-resistance; blood-pressure; oxygen-uptake; metabolism; lactate; mutation; biogenesis; performance
AB In patients with mitochondrial DNA (mtDNA) mutation, a pathogenic mtDNA mutation is heteroplasmically distributed among tissues. The ratio between wild-type and mutated mtDNA copies determines the mtDNA mutation load of the tissue, which correlates inversively with oxidative capacity of the tissue. In patients with mtDNA mutation, the mutation load is often very high in skeletal muscle compared to other tissues. Additionally, skeletal muscle can increase its oxygen demand up to 100-fold from rest to exercise, which is unmatched by any other tissue. Thus, exercise intolerance is the most common symptom in patients with mtDNA mutation. The impaired oxidative capacity in skeletal muscle in patients with mtDNA mutation results in limitation in physical capacity that interferes with daily activities and impairs quality of life. Additionally, patients with mitochondrial disease due to mtDNA mutation often live a sedentary lifestyle, which further impair oxidative capacity and exercise tolerance. Since aerobic exercise training increase mitochondrial function and volume density in healthy individuals, studies have investigated if aerobic training could be used to counteract the progressive exercise intolerance in patients with mtDNA mutation. Overall studies investigating the effect of aerobic training in patients with mtDNA mutation have shown that aerobic training is an efficient way to improve oxidative capacity in this condition, and aerobic training seems to be safe even for patients with high mtDNA mutation in skeletal muscle.
C1 [Jeppesen, Tina Dysgaard] Univ Copenhagen, Dept Neurol, Copenhagen Neuromuscular Clin, Rigshosp, Copenhagen, Denmark.
C3 University of Copenhagen; Rigshospitalet
RP Jeppesen, TD (corresponding author), Univ Copenhagen, Dept Neurol, Copenhagen Neuromuscular Clin, Rigshosp, Copenhagen, Denmark.
EM tina@dysgaard.dk
CR Abe K, 1997, NEUROLOGY, V49, P837, DOI 10.1212/WNL.49.3.837
   Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, PE672, DOI 10.1152/ajpendo.00043.2007
   ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794
   BABIJ P, 1988, NEWS PHYSIOL SCI, V3, P100
   Balakrishnan VS, 2010, CLIN J AM SOC NEPHRO, V5, P996, DOI 10.2215/CJN.09141209
   Bangsbo J, 2000, AM J PHYSIOL-REG I, V279, PR899, DOI 10.1152/ajpregu.2000.279.3.R899
   Bank W, 1997, MOL CELL BIOCHEM, V174, P7, DOI 10.1023/A:1006887319200
   BANK W, 1994, ANN NEUROL, V36, P830, DOI 10.1002/ana.410360606
   BERGLUND B, 1991, J INTERN MED, V229, P125, DOI 10.1111/j.1365-2796.1991.tb00319.x
   BOOTH FW, 1985, FED PROC, V44, P2293
   Bruce CR, 2004, MED SCI SPORT EXER, V36, P1196, DOI 10.1249/01.MSS.0000074670.03001.98
   BYLUND AC, 1977, EUR J APPL PHYSIOL, V36, P151, DOI 10.1007/BF00421747
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Cornelissen VA, 2013, J HYPERTENS, V31, P639, DOI 10.1097/HJH.0b013e32835ca964
   DAVIS HA, 1983, EUR J APPL PHYSIOL, V50, P383, DOI 10.1007/BF00423244
   DAVIS JA, 1982, MED SCI SPORT EXER, V14, P339
   DEMPSEY JA, 1985, FED PROC, V44, P2260
   Dengler R, 1996, MUSCLE NERVE, V19, P456, DOI 10.1002/(SICI)1097-4598(199604)19:4<456::AID-MUS5>3.0.CO;2-B
   Di Meo S, 2017, J ENDOCRINOL, V234, PR159, DOI 10.1530/JOE-17-0186
   di Prampero PE, 2003, EUR J APPL PHYSIOL, V90, P420, DOI 10.1007/s00421-003-0926-z
   Finsterer J, 1998, J NEUROL SCI, V159, P176, DOI 10.1016/S0022-510X(98)00170-1
   Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P425, DOI 10.1164/ajrccm.164.3.2005110
   Forster H V, 1988, ADV EXP MED BIOL, V227, P257
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Fritzen AM, 2019, CELLS, V12, P0, DOI 10.1021/bk-1986-0294.ch002
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   GOLDSTEIN I, 1975, J APPL PHYSIOL, V39, P697, DOI 10.1152/jappl.1975.39.5.697
   Haller R G, 1978, TRANS AM NEUROL ASSOC, V103, P6
   HALLER RG, 1989, J CLIN INVEST, V84, P155, DOI 10.1172/JCI114135
   HALLER RG, 1984, MED SCI SPORT EXER, V16, P456, DOI 10.1249/00005768-198410000-00006
   Hawley JA, 2011, J APPL PHYSIOL, V110, P834, DOI 10.1152/japplphysiol.00949.2010
   Heinicke K, 2011, AM J PHYSIOL-REG I, V301, PR873, DOI 10.1152/ajpregu.00001.2011
   HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278
   HOLLOSZY JO, 1975, MED SCI SPORT EXER, V7, P155
   Hoppeler H, 2003, MED SCI SPORT EXER, V35, P95, DOI 10.1097/00005768-200301000-00016
   Hoppeler H, 1998, J EXP BIOL, V201, P1051
   Ikawa M, 2009, MITOCHONDRION, V9, P144, DOI 10.1016/j.mito.2009.01.011
   Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jeppesen TD, 2013, NEUROMUSCULAR DISORD, V23, P629, DOI 10.1016/j.nmd.2013.05.007
   Jeppesen TD, 2012, MITOCHONDRION, V12, P414, DOI 10.1016/j.mito.2011.11.003
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jeppesen TD, 2009, ARCH NEUROL-CHICAGO, V66, P365, DOI 10.1001/archneurol.2009.24
   KIENS B, 1993, J PHYSIOL-LONDON, V469, P459, DOI 10.1113/jphysiol.1993.sp019823
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   LARSSON LE, 1964, J NEUROL NEUROSUR PS, V27, P361, DOI 10.1136/jnnp.27.5.361
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Liu CY, 2009, BBA-MOL BASIS DIS, V1792, P783, DOI 10.1016/j.bbadis.2009.05.005
   Lu CY, 2003, MOL GENET METAB, V80, P321, DOI 10.1016/j.ymgme.2003.08.005
   MARTIN BJ, 1979, J APPL PHYSIOL, V46, P322, DOI 10.1152/jappl.1979.46.2.322
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   MITCHELL JH, 1958, J CLIN INVEST, V37, P538, DOI 10.1172/JCI103636
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   OZAWA T, 1995, BIOCHEM BIOPH RES CO, V213, P432, DOI 10.1006/bbrc.1995.2150
   Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448
   Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200
   Porcelli S, 2016, J APPL PHYSIOL, V121, P699, DOI 10.1152/japplphysiol.00885.2015
   Rasmussen UF, 2001, AM J PHYSIOL-ENDOC M, V280, PE301, DOI 10.1152/ajpendo.2001.280.2.E301
   Saltin B, 1981, CIBA FOUND SYMP, V82, P41
   SALTIN B, 1986, ACTA MED SCAND, V0, P11
   SALTIN B, 1993, AM J CLIN NUTR, V57, P752
   SALTIN B, 1992, MED SCI SPORT EXER, V24, P30
   SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583
   Siciliano G, 2000, NEUROMUSCULAR DISORD, V10, P40, DOI 10.1016/S0960-8966(99)00068-1
   Siciliano G, 2012, NEUROMUSCULAR DISORD, V22, PS172, DOI 10.1016/j.nmd.2012.10.005
   Sveen ML, 2007, NEUROLOGY, V68, P59, DOI 10.1212/01.wnl.0000250358.32199.24
   Sveen ML, 2008, BRAIN, V131, P2824, DOI 10.1093/brain/awn189
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Taivassalo T, 1999, MUSCLE NERVE, V22, P1239, DOI 10.1002/(SICI)1097-4598(199909)22:9<1239::AID-MUS11>3.0.CO;2-W
   Taivassalo T, 1998, NEUROLOGY, V50, P1055, DOI 10.1212/WNL.50.4.1055
   Taivassalo T, 1996, NEUROLOGY, V47, P529, DOI 10.1212/WNL.47.2.529
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, PR1271, DOI 10.1152/ajpregu.00472.2006
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Turner DL, 1997, ACTA PHYSIOL SCAND, V161, P459, DOI 10.1046/j.1365-201X.1997.00246.x
   van Hall G, 2003, AM J PHYSIOL-ENDOC M, V284, PE193, DOI 10.1152/ajpendo.00273.2002
   van Moorsel D, 2016, MOL METAB, V5, P635, DOI 10.1016/j.molmet.2016.06.012
   Vissing J, 1998, J CLIN INVEST, V101, P1654, DOI 10.1172/JCI555
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Zoladz JA, 2013, EXP PHYSIOL, V98, P883, DOI 10.1113/expphysiol.2012.069443
NR 88
TC 11
Z9 12
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-042X
EI 
J9 FRONT PHYSIOL
JI Front. Physiol.
PD MAY 21
PY 2020
VL 11
IS 
BP 
EP 
DI 10.3389/fphys.2020.00349
PG 12
WC Physiology
SC Physiology
GA LW9JS
UT WOS:000539458500001
PM 32508662
DA 2024-11-01
ER

PT J
AU Oliveira, MT
   Pontes, CD
   Ciesielski, GL
AF Oliveira, Marcos T.
   Pontes, Carolina de Bovi
   Ciesielski, Grzegorz L.
TI Roles of the mitochondrial replisome in mitochondrial DNA deletion formation
SO GENETICS AND MOLECULAR BIOLOGY
LA English
DT Review
DE Mitochondria; DNA replication; human diseases; Pol gamma; Twinkle
ID progressive external ophthalmoplegia; large-scale deletions; multiple mtdna deletions; polymerase-gamma; helicase twinkle; skeletal-muscle; d-loop; point mutations; replicative dna; g-quadruplexes
AB Mitochondrial DNA (mtDNA) deletions are a common cause of human mitochondrial diseases. Mutations in the genes encoding components of the mitochondrial replisome, such as DNA polymerase gamma (Pol gamma) and the mtDNA helicase Twinkle, have been associated with the accumulation of such deletions and the development of pathological conditions in humans. Recently, we demonstrated that changes in the level of wild-type Twinkle promote mtDNA deletions, which implies that not only mutations in, but also dysregulation of the stoichiometry between the replisome components is potentially pathogenic. The mechanism(s) by which alterations to the replisome function generate mtDNA deletions is(are) currently under debate. It is commonly accepted that stalling of the replication fork at sites likely to form secondary structures precedes the deletion formation. The secondary structural elements can be bypassed by the replication-slippage mechanism. Otherwise, stalling of the replication fork can generate single- and double-strand breaks, which can be repaired through recombination leading to the elimination of segments between the recombination sites. Here, we discuss aberrances of the replisome in the context of the two debated outcomes, and suggest new mechanistic explanations based on replication restart and template switching that could account for all the deletion types reported for patients.
C1 [Oliveira, Marcos T.] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Tecnol, Jaboticabal, SP, Brazil.
   [Pontes, Carolina de Bovi; Ciesielski, Grzegorz L.] Auburn Univ, Dept Chem, Montgomery, AL 36117 USA.
C3 Universidade Estadual Paulista; Auburn University System; Auburn University; Auburn University Montgomery
RP Oliveira, MT (corresponding author), Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Tecnol, Jaboticabal, SP, Brazil.; Ciesielski, GL (corresponding author), Auburn Univ, Dept Chem, Montgomery, AL 36117 USA.
EM marcos.t.oliveira@unesp.br; gciesiel@aum.edu
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [2014/02253-6, 2017/04372-0, 306974/2017-7]; Swedish Research Council [2017-04372] Funding Source: Swedish Research Council
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Avise JC, 2000, PHYLOGEOGRAPHY HIST, V0, P0, DOI DOI 10.2307/J.CTV1NZFGJ7
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Bannwarth S, 2016, MITOCHONDRION, V30, P126, DOI 10.1016/j.mito.2016.02.005
   Bazzicalupi C, 2013, NUCLEIC ACIDS RES, V41, P632, DOI 10.1093/nar/gks1001
   Bebenek K, 2000, COLD SPRING HARB SYM, V65, P81, DOI 10.1101/sqb.2000.65.81
   Belmonte FR, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25186
   Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   BROWN GG, 1986, J MOL BIOL, V192, P503, DOI 10.1016/0022-2836(86)90272-X
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cannan WJ, 2016, J CELL PHYSIOL, V231, P3, DOI 10.1002/jcp.25048
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Cicero AFG, 2016, ADV EXP MED BIOL, V928, P27, DOI 10.1007/978-3-319-41334-1_2
   Ciesielski GL, 2016, ENZYMES, V39, P255, DOI 10.1016/bs.enz.2016.03.006
   Ciesielski GL, 2018, NUCLEIC ACIDS RES, V46, P3034, DOI 10.1093/nar/gky094
   Ciesielski GL, 2015, J BIOL CHEM, V290, P28697, DOI 10.1074/jbc.M115.673707
   Cluett TJ, 2018, NUCLEIC ACIDS RES, V46, P10771, DOI 10.1093/nar/gky852
   Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Damas J, 2014, NUCLEIC ACIDS RES, V42, PD1261, DOI 10.1093/nar/gkt982
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   de Souza-Pinto NC, 2009, MOL CELL BIOL, V29, P4441, DOI 10.1128/MCB.00265-09
   De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Dong DW, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-677
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Fishel ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/j.mrfmmm.2006.06.007
   Montiel-Sosa JF, 2013, MITOCHONDR DNA, V24, P420, DOI 10.3109/19401736.2012.760550
   Fuke S, 2014, ANN CLIN TRANSL NEUR, V1, P909, DOI 10.1002/acn3.133
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   García-Gómez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   Giannattasio M, 2014, NAT STRUCT MOL BIOL, V21, P884, DOI 10.1038/nsmb.2888
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Grier J, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000230
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2
   Holt IJ, 2014, BIOESSAYS, V36, P1024, DOI 10.1002/bies.201400052
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hou JH, 1996, BIOCHEM J, V318, P1065, DOI 10.1042/bj3181065
   Huang WC, 2015, NUCLEIC ACIDS RES, V43, P10102, DOI 10.1093/nar/gkv1061
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804
   Kaguni LS, 2016, CRIT REV BIOCHEM MOL, V51, P53, DOI 10.3109/10409238.2015.1117056
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kalifa L, 2012, GENETICS, V190, P951, DOI 10.1534/genetics.111.138214
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kazak L, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0062340
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kowald A, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9030126
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lee SJ, 2011, CURR OPIN CHEM BIOL, V15, P580, DOI 10.1016/j.cbpa.2011.07.024
   Lehmann D, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000113
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316
   Lovett ST, 2017, DNA REPAIR, V56, P118, DOI 10.1016/j.dnarep.2017.06.014
   Macao B, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8303
   Matic S, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03552-x
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/s1415-47572013000300002
   Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079
   Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   MORAES CT, 1995, MUSCLE NERVE, V0, PS150
   Moretton A, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0176795
   Naeem MM, 2018, TARGETED REDUCTION P, V0, P0, DOI DOI 10.1101/358101
   NELSON I, 1989, NUCLEIC ACIDS RES, V17, P8117, DOI 10.1093/nar/17.20.8117
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nissanka N, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04895-1
   Nurminen A, 2017, BBA CLIN, V7, P147, DOI 10.1016/j.bbacli.2017.04.001
   Oliveira MT, 2015, GENOME BIOL EVOL, V7, P943, DOI 10.1093/gbe/evv042
   Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983
   Oliveira PH, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059907
   Otten ABC, 2018, HUM REPROD, V33, P1331, DOI 10.1093/humrep/dey114
   Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149
   Pallotti F, 1996, AM J HUM GENET, V59, P591
   Peeva V, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04131-w
   Pereira F, 2008, MOL BIOL EVOL, V25, P2759, DOI 10.1093/molbev/msn225
   Pereira GC, 2007, J PHARMACOL EXP THER, V323, P636, DOI 10.1124/jpet.107.128017
   Persson Ö, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Picard M, 2016, CELL METAB, V24, P3, DOI 10.1016/j.cmet.2016.06.024
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pohjoismäki JLO, 2011, MITOCHONDRION, V11, P630, DOI 10.1016/j.mito.2011.04.002
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Qian YF, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00135
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rajakulendran S, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0145500
   Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reyes Aurelio, 2007, METHODS MOL BIOL, V372, P219, DOI 10.1007/978-1-59745-365-3_16
   Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2
   Ribeyre C, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000475
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Russell OM, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-20064-2
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   Saldaña-Martínez A, 2019, GENE, V688, P171, DOI 10.1016/j.gene.2018.11.085
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sen D, 2016, NUCLEIC ACIDS RES, V44, P4200, DOI 10.1093/nar/gkw098
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Song Z, 2011, PLOS COMPUT BIOL, V7, P0, DOI 10.1371/journal.pcbi.1002287
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stiban J, 2014, J BIOL CHEM, V289, P24032, DOI 10.1074/jbc.M114.587774
   Stojkovic G, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep28942
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Torregrosa-Muñumer R, 2017, P NATL ACAD SCI USA, V114, P11398, DOI 10.1073/pnas.1705367114
   Trifunov S, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-30143-z
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Xu WY, 2019, J MOL BIOL, V431, P673, DOI 10.1016/j.jmb.2019.01.002
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 163
TC 11
Z9 11
U1 0
U2 12
PU SOC BRASIL GENETICA
PI RIBEIRAO PRET
PA RUA CAP ADELMIO NORBET DA SILVA, 736, ALTO DA BOA VISTA, 14025-670 RIBEIRAO PRET, BRAZIL
SN 1415-4757
EI 1678-4685
J9 GENET MOL BIOL
JI Genet. Mol. Biol.
PD JUN 15
PY 2020
VL 43
IS 1
BP 
EP 
DI 10.1590/1678-4685-GMB-2019-0069
PG 16
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA KU4QF
UT WOS:000519693500001
PM 32141473
DA 2024-11-01
ER

PT J
AU Castellani, CA
   Longchamps, RJ
   Sun, J
   Guallar, E
   Arking, DE
AF Castellani, Christina A.
   Longchamps, Ryan J.
   Sun, Jing
   Guallar, Eliseo
   Arking, Dan E.
TI Thinking outside the nucleus: Mitochondrial DNA copy number in health and disease
SO MITOCHONDRION
LA English
DT Review
DE mitochondrial DNA; Clinical biomarker; mtDNA; Complex disease
ID peripheral-blood; epigenetic regulation; association; cancer; inflammation; mtdna; depletion; muscle; cells; quantification
AB Mitochondrial DNA copy number (mtDNA-CN) is a biomarker of mitochondrial function and levels of mtDNA-CN have been reproducibly associated with overall mortality and a number of age-related diseases, including cardiovascular disease, chronic kidney disease, and cancer. Recent advancements in techniques for estimating mtDNA-CN, in particular the use of DNA microarrays and next-generation sequencing data, have led to the comprehensive assessment of mtDNA-CN across these and other diseases and traits. The importance of mtDNA-CN measures to disease and these advancing technologies suggest the potential for mtDNA-CN to be a useful biomarker in the clinic. While the exact mechanism(s) underlying the association of mtDNA-CN with disease remain to be elucidated, we review the existing literature which supports roles for inflammatory dynamics, immune function and alterations to cell signaling as consequences of variation in mtDNA-CN. We propose that future studies should focus on characterizing longitudinal, cell-type and cross-tissue profiles of mtDNA-CN as well as improving methods for measuring mtDNA-CN which will expand the potential for its use as a clinical biomarker.
C1 [Castellani, Christina A.; Longchamps, Ryan J.; Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Dept Genet Med, Baltimore, MD USA.
   [Sun, Jing; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA.
C3 Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health
RP Arking, DE (corresponding author), Johns Hopkins Univ, Sch Med, 733 North Broadway,MRB Room 459, Baltimore, MD 21205 USA.
EM arking@jhmi.edu
FU US National Institutes of Health [R01HL131573, R01HL14469]
CR Aggarwal NT, 2013, ANTIOXID REDOX SIGN, V18, P432, DOI 10.1089/ars.2011.4234
   Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6
   Bianco Angelica, 2018, BMC RES NOTES, V11, P911, DOI 10.1186/s13104-018-4025-y
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1821-7
   Cai N, 2015, CURR BIOL, V25, P3170, DOI 10.1016/j.cub.2015.10.065
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen SY, 2014, ATHEROSCLEROSIS, V237, P220, DOI 10.1016/j.atherosclerosis.2014.08.051
   Chen T, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-8
   Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723
   Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082
   CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7
   Cristina D, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000450
   Czaja AJ, 2014, WORLD J GASTROENTERO, V20, P2515, DOI 10.3748/wjg.v20.i10.2515
   Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Eirin A, 2016, HYPERTENSION, V68, P401, DOI 10.1161/HYPERTENSIONAHA.116.07849
   Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008
   Fazzini F, 2019, KIDNEY INT, V96, P480, DOI 10.1016/j.kint.2019.04.021
   Friis RMN, 2014, CELL REP, V7, P565, DOI 10.1016/j.celrep.2014.03.029
   Gandhi S, 2012, OXID MED CELL LONGEV, V2012, P0, DOI 10.1155/2012/428010
   Gasparre G, 2011, BBA-BIOENERGETICS, V1807, P633, DOI 10.1016/j.bbabio.2010.08.006
   Ghosh S, 2014, MITOCHONDRION, V18, P58, DOI 10.1016/j.mito.2014.07.007
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Gu F, 2013, TRANSL PSYCHIAT, V3, P0, DOI 10.1038/tp.2013.68
   Guha M, 2016, CELL DISCOV, V2, P0, DOI 10.1038/celldisc.2016.45
   Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007
   Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003
   Guyatt AL, 2018, MITOCHONDRION, V39, P9, DOI 10.1016/j.mito.2017.08.007
   Hertweck KL, 2017, FRONT ONCOL, V7, P0, DOI 10.3389/fonc.2017.00262
   Hurtado-Roca Y, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0163770
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973
   Jedrak P, 2017, METAB BRAIN DIS, V32, P1237, DOI 10.1007/s11011-017-0026-0
   Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Kamfar S, 2016, HEPAT MON, V16, P0, DOI 10.5812/hepatmon.40774
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Li B, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-29621-1
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Liu LP, 2017, ATHEROSCLEROSIS, V261, P105, DOI 10.1016/j.atherosclerosis.2017.02.013
   Liu M, 2010, CIRC RES, V107, P967, DOI 10.1161/CIRCRESAHA.110.220673
   Lo IC, 2005, J BIOMED SCI, V12, P377, DOI 10.1007/s11373-005-1703-2
   Longchamps RJ, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0228166
   Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mei H, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.78
   Memon Ashfaque A, 2017, BIOMOL DETECT QUANTIF, V13, P32, DOI 10.1016/j.bdq.2017.08.001
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697
   Morgan JT, 2012, BRAIN RES, V1456, P72, DOI 10.1016/j.brainres.2012.03.036
   Muir R, 2016, BIOESSAYS, V38, P150, DOI 10.1002/bies.201500105
   Nacheva E, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0180467
   Neeland IJ, 2012, AM HEART J, V164, P547, DOI 10.1016/j.ahj.2012.07.007
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nicolson GL, 2014, INTEGR MED CLIN J, V13, P35
   OHara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303
   Phillips NR, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep03887
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Pirola CJ, 2015, MEDICINE, V94, P0, DOI 10.1097/MD.0000000000001480
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Qian Y, 2017, BIOINFORMATICS, V33, P1399, DOI 10.1093/bioinformatics/btw835
   Raffoul Julian J, 2012, J ONCOL, V2012, P370481
   Ramos ES, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1008085
   Ravi S, 2014, INT J BIOCHEM CELL B, V53, P202, DOI 10.1016/j.biocel.2014.05.019
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Rodriguez Juan I, 2011, NEURON GLIA BIOL, V7, P205, DOI 10.1017/S1740925X12000142
   Rodríguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698
   Rygiel KA, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09906
   Sánchez-Santos A, 2018, MOL REPROD DEV, V85, P303, DOI 10.1002/mrd.22965
   Savagner F, 2001, J CLIN ENDOCR METAB, V86, P4920, DOI 10.1210/jc.86.10.4920
   Silverstein DM, 2009, PEDIATR NEPHROL, V24, P1445, DOI 10.1007/s00467-008-1046-0
   Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927
   Srinivasan S, 2016, ONCOGENE, V35, P1585, DOI 10.1038/onc.2015.227
   Sun J, 2019, J INFECT DIS, V219, P1285, DOI 10.1093/infdis/jiy658
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T
   Tidwell TR, 2017, AGING DIS, V8, P662, DOI 10.14336/AD.2017.0713
   Tin A, 2016, J AM SOC NEPHROL, V27, P2467, DOI 10.1681/ASN.2015060661
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Vakifahmetoglu-Norberg H, 2017, BIOCHEM BIOPH RES CO, V482, P426, DOI 10.1016/j.bbrc.2016.11.088
   Vats D, 2006, CELL METAB, V4, P255, DOI 10.1016/j.cmet.2006.08.006
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wei PZ, 2018, NEPHROL DIAL TRANSPL, V33, P784, DOI 10.1093/ndt/gfx339
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-016-0404-6
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, PW64, DOI 10.1093/nar/gkw247
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Yamada T, 2016, TRENDS BIOCHEM SCI, V41, P209, DOI 10.1016/j.tibs.2016.02.001
   Ye W, 2017, ANAL BIOANAL CHEM, V409, P2727, DOI 10.1007/s00216-017-0217-x
   Young MJ, 2017, FRONT MOL BIOSCI, V4, P0, DOI 10.3389/fmolb.2017.00074
   Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zhang H, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0105242
   Zhang YY, 2017, EUR HEART J, V38, P3443, DOI 10.1093/eurheartj/ehx354
   Zhang YH, 2017, MITOCHONDRIAL DNA A, V28, P725, DOI 10.1080/24701394.2016.1177038
NR 109
TC 180
Z9 189
U1 4
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2020
VL 53
IS 
BP 214
EP 223
DI 10.1016/j.mito.2020.06.004
PG 10
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA MO6RS
UT WOS:000551651100023
PM 32544465
DA 2024-11-01
ER

PT J
AU Orekhov, AN
   Poznyak, AV
   Sobenin, IA
   Nikifirov, NN
   Ivanova, EA
AF Orekhov, Alexander N.
   Poznyak, Anastasia, V
   Sobenin, Igor A.
   Nikifirov, Nikita N.
   Ivanova, Ekaterina A.
TI Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation
SO CURRENT NEUROPHARMACOLOGY
LA English
DT Review
DE Atherosclerosis; mitochondrion; inflammation; mtDNA; oxidative stress; LDL metabolism
ID intracellular lipid-accumulation; smooth-muscle-cells; induced apoptosis; oxidative stress; vitamin-c; macrophage; disease; risk; dysfunction; metabolism
AB Background: Atherosclerosis is a chronic inflammatory condition that affects different arteries in the human body and often leads to severe neurological complications, such as stroke and its sequelae. Affected blood vessels develop atherosclerotic lesions in the form of focal thickening of the intimal layer, so called atherosclerotic plaques. Objectives: Despite the high priority of atherosclerosis research for global health and the numerous preclinical and clinical studies conducted, currently, there is no effective pharmacological treatment that directly impacts atherosclerotic plaques. Many knowledge gaps exist in our understanding of the mechanisms of plaque formation. In this review, we discuss the role of mitochondria in different cell types involved in atherogenesis and provide information about mtDNA mutations associated with the disease. Results: Mitochondria of blood and arterial wall cells appear to be one of the important factors in disease initiation and development. Significant experimental evidence connects oxidative stress associated with mitochondrial dysfunction and vascular disease. Moreover, mitochondrial DNA (mtDNA) deletions and mutations are being considered as potential disease markers. Further study of mtDNA damage and associated dysfunction may open new perspectives for atherosclerosis treatment. Conclusion: Mitochondria can be considered as important disease-modifying factors in several chronic pathologies. Deletions and mutations of mtDNA may be used as potential disease markers. Mitochondria-targeting antioxidant therapies appear to be promising for the development of treatment of atherosclerosis and other diseases associated with oxidative stress and chronic inflammation.
C1 [Orekhov, Alexander N.; Poznyak, Anastasia, V; Sobenin, Igor A.] Skolkovo Innovat Ctr, Inst Atherosclerosis Res, Moscow 121609, Russia.
   [Orekhov, Alexander N.; Sobenin, Igor A.; Nikifirov, Nikita N.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow 125315, Russia.
   [Orekhov, Alexander N.] Inst Human Morphol, Moscow 117418, Russia.
   [Sobenin, Igor A.; Nikifirov, Nikita N.] Natl Med Res Ctr Cardiol, Lab Med Genet, 15A 3 Rd Cherepkovskaya Str, Moscow 121552, Russia.
   [Nikifirov, Nikita N.] Russian Acad Sci, Ctr Collect Usage, Inst Gene Biol, 34-5 Vavilova St, Moscow 119334, Russia.
   [Ivanova, Ekaterina A.] Keyrus Biopharma, B-1410 Waterloo, Belgium.
C3 Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Russian Academy of Medical Sciences; Research Institute of Human Morphology; National Medical Research Center of Cardiology; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences
RP Orekhov, AN (corresponding author), Inst Human Morphol, Lab Angiopathol, Tsyurupa St 3, Moscow 125315, Russia.
EM a.h.opexob@gmail.com
FU Russian Science Foundation [19-15-00010]; Russian Science Foundation [19-15-00010] Funding Source: Russian Science Foundation
CR Aliev G, 2004, MITOCHONDRION, V4, P649, DOI 10.1016/j.mito.2004.07.018
   Aliev G, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/962984
   Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608
   Alipov VI, 2017, VESSEL PLUS, V0, PP107, DOI 10.20517/2574-1209.2017.20
   Andreeva ER, 1998, TISSUE CELL, V30, P127, DOI 10.1016/S0040-8166(98)80014-1
   Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89
   Bories GFP, 2017, FEBS LETT, V591, P3042, DOI 10.1002/1873-3468.12786
   Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788
   Caja S, 2017, REDOX BIOL, V12, P821, DOI 10.1016/j.redox.2017.04.021
   Chalmers S, 2016, J PHYSIOL-LONDON, V594, P4283, DOI 10.1113/JP271942
   Chen F, 2012, FRONT PHYSIOL, V3, P0, DOI 10.3389/fphys.2012.00412
   Chen S, 2019, INT J BIOL SCI, V15, P1440, DOI 10.7150/ijbs.30193
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Chistiakov DA, 2017, J MOL MED, V95, P1153, DOI 10.1007/s00109-017-1575-8
   De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001
   Dima-Cozma C, 2016, MED-SURG J, V120, P768
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Finucane OM, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-40619-1
   Förstermann U, 2017, CIRC RES, V120, P713, DOI 10.1161/CIRCRESAHA.116.309326
   Fujimoto H, 2008, EUR HEART J, V29, P1267, DOI 10.1093/eurheartj/ehm500
   Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301
   Golub AS, 2011, AM J PHYSIOL-HEART C, V301, PH737, DOI 10.1152/ajpheart.00353.2011
   Gowdar S, 2017, VESSEL PLUS, V1, P129, DOI 10.20517/2574-1209.2017.12
   Graham D, 2009, HYPERTENSION, V54, P322, DOI 10.1161/HYPERTENSIONAHA.109.130351
   Grootaert MOJ, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/7687083
   Haslip M, 2015, ARTERIOSCL THROM VAS, V35, P1166, DOI 10.1161/ATVBAHA.114.304865
   Herrington W, 2016, CIRC RES, V118, P535, DOI 10.1161/CIRCRESAHA.115.307611
   Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016
   Isaev NK, 2016, REV NEUROSCIENCE, V27, P849, DOI 10.1515/revneuro-2016-0036
   Katsouras CS, 2013, BIOMARK MED, V7, P189, DOI 10.2217/bmm.13.4
   Kattoor AJ, 2017, CURR ATHEROSCLER REP, V19, P0, DOI 10.1007/s11883-017-0678-6
   Kieser KJ, 2017, NAT REV IMMUNOL, V17, P376, DOI 10.1038/nri.2017.25
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022
   Liu PS, 2018, MITOCHONDRION, V41, P45, DOI 10.1016/j.mito.2017.11.002
   Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848
   Marulanda-Londoño E, 2016, NEUROL-CLIN PRACT, V6, P252, DOI 10.1212/CPJ.0000000000000247
   Maytin EV, 2018, CLIN CANCER RES, V24, P3026, DOI 10.1158/1078-0432.CCR-17-2020
   Meyer A, 2018, FRONT IMMUNOL, V9, P0, DOI 10.3389/fimmu.2018.00536
   Michels AJ, 2013, NUTRIENTS, V5, P5161, DOI 10.3390/nu5125161
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Ng KK, 2015, CHEM REV, V115, P11012, DOI 10.1021/acs.chemrev.5b00140
   Nicolson GL, 2014, INTEGR MED CLIN J, V13, P35
   Nonnenmacher Y, 2018, CELL MOL LIFE SCI, V75, P2093, DOI 10.1007/s00018-018-2784-1
   ONeill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570
   Orekhov AN, 2015, EXP MOL PATHOL, V99, P672, DOI 10.1016/j.yexmp.2015.11.006
   Orekhov AN, 2017, VESSEL PLUS, V1, P163, DOI 10.20517/2574-1209.2017.33
   Orekhov AN, 2018, CURR PHARM DESIGN, V24, P2883, DOI 10.2174/1381612824666180911120726
   Orekhov AN, 2014, CARDIOVASC RES, V103, P438, DOI 10.1093/cvr/cvu168
   Peng WX, 2019, DNA CELL BIOL, V38, P597, DOI 10.1089/dna.2018.4552
   Pepe S, 2007, MITOCHONDRION, V7, PS154, DOI 10.1016/j.mito.2007.02.005
   Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040
   Price TO, 2017, BBA-MOL BASIS DIS, V1863, P929, DOI 10.1016/j.bbadis.2017.01.025
   Ruparelia N, 2017, NAT REV CARDIOL, V14, P0, DOI 10.1038/nrcardio.2016.185
   Ryabova AV, 2019, VESSEL PLUS, V3, P17
   Salabei JK, 2013, REDOX BIOL, V1, P542, DOI 10.1016/j.redox.2013.10.011
   Sazonova MA, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/4647214
   Sazonova MA, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/6934394
   Sazonova MA, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/825468
   Siasos G, 2018, ANN TRANSL MED, V6, P0, DOI 10.21037/atm.2018.06.21
   Sinyov V V, 2017, VESSEL PLUS, V0, PP145, DOI 10.20517/2574-1209.2016.04
   Sobenin IA, 2015, CURR PHARM DESIGN, V21, P1158, DOI 10.2174/1381612820666141013133000
   Sobenin IA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068070
   Stefano GB, 2017, ADV EXP MED BIOL, V982, P577, DOI 10.1007/978-3-319-55330-6_30
   Summerhill V, 2019, ADV EXP MED BIOL, V1147, P279, DOI 10.1007/978-3-030-16908-4_13
   Swiader A, 2016, ONCOTARGET, V7, P28821, DOI 10.18632/oncotarget.8936
   TERTOV VV, 1992, LAB INVEST, V67, P665
   TERTOV VV, 1989, BIOCHEM BIOPH RES CO, V163, P489, DOI 10.1016/0006-291X(89)92163-3
   Tousoulis D, 2007, HEART, V93, P244, DOI 10.1136/hrt.2006.093112
   Truban D, 2017, J PARKINSON DIS, V7, P13, DOI 10.3233/JPD-160989
   Tur J, 2017, ADV IMMUNOL, V133, P1, DOI 10.1016/bs.ai.2016.12.001
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   van der Bliek AM, 2018, GENETICS, V208, P1673, DOI 10.1534/genetics.118.300816
   van der Bliek AM, 2017, GENETICS, V207, P843, DOI 10.1534/genetics.117.300262
   Vásquez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301
   Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103
   Widlansky ME, 2011, ANTIOXID REDOX SIGN, V15, P1517, DOI 10.1089/ars.2010.3642
   Xu Q, 2014, PLOS ONE, V0, P0
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Zhang JX, 2014, J GERIATR CARDIOL, V11, P141, DOI 10.3969/j.issn.1671-5411.2014.02.003
   Zhang ZY, 2015, IMMUNITY, V43, P1137, DOI 10.1016/j.immuni.2015.10.018
   Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057
NR 82
TC 39
Z9 44
U1 1
U2 23
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1570-159X
EI 1875-6190
J9 CURR NEUROPHARMACOL
JI Curr. Neuropharmacol.
PD JUN 15
PY 2020
VL 18
IS 11
BP 1064
EP 1075
DI 10.2174/1570159X17666191118125018
PG 12
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA OS1PE
UT WOS:000589936500002
PM 31744449
DA 2024-11-01
ER

PT J
AU Nardi, N
   Proulx, F
   Brunel-Guiton, C
   Oligny, LL
   Piché, N
   Mitchell, GA
   Joyal, JS
AF Nardi, Nicolas
   Proulx, Francois
   Brunel-Guiton, Catherine
   Oligny, Luc L.
   Piche, Nelson
   Mitchell, Grant A.
   Joyal, Jean Sebastien
TI Fulminant Necrotizing Enterocolitis and Multiple Organ Dysfunction in a Toddler with Mitochondrial DNA Depletion Syndrome-13
SO JOURNAL OF PEDIATRIC INTENSIVE CARE
LA English
DT Article
DE necrotizing enterocolitis; mitochondrial DNA depletion syndrome; FBXL4; multiple organ dysfunction syndrome
ID critical-care; fbxl4; protein; mutations; therapy
AB Necrotizing enterocolitis (NEC) is exceptional after the neonatal period. A toddler with encephalopathy, mitochondrial myopathy, and hypertrophic cardiomyopathy developed fatal NEC and multiple organ dysfunction within 48 hours of the introduction of enteral feeding. She was subsequently found to have pathogenic mutations in FBXL4 , a cause of mitochondrial DNA depletion syndrome-13. Intestinal dysmotility in the context of deficient mitochondrial respiration may have contributed to the development of NEC. Current paradigms call for early introduction of enteral nutrition to reinstate energy homeostasis. Enteral feeding should be administered with caution during metabolic crises of patients with mitochondrial DNA depletion syndromes.
C1 [Nardi, Nicolas; Proulx, Francois; Brunel-Guiton, Catherine; Mitchell, Grant A.; Joyal, Jean Sebastien] Univ Montreal, St Justine Hosp, Dept Pediat, Montreal, PQ, Canada.
   [Oligny, Luc L.] Univ Montreal, St Justine Hosp, Dept Pediat Pathol, Montreal, PQ, Canada.
   [Piche, Nelson] Univ Montreal, St Justine Hosp, Dept Pediat Surg, Montreal, PQ, Canada.
C3 Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine
RP Joyal, JS (corresponding author), St Justine Hosp, Dept Pediat, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.
EM js.joyal@umontreal.ca
FU BurroughsWellcome Fund Career Award for Medical Scientists [1012321.01]; CIHR [141956, 390615]
CR Ackland G, 2000, CRIT CARE, V4, P269, DOI 10.1186/cc709
   Almannai M, 2017, GENEREVIEWS, V0, P15
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   BALLANCE WA, 1990, J PEDIATR-US, V117, PS6, DOI 10.1016/S0022-3476(05)81124-2
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Diekman EF, 2013, JIMD REP, V7, P1, DOI 10.1007/8904_2012_128
   Ebrahimi-Fakhari D, 2015, PEDIATR NEUROL, V53, P549, DOI 10.1016/j.pediatrneurol.2015.08.018
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Finsterer J, 2017, THER ADV GASTROENTER, V10, P142, DOI 10.1177/1756283X16666806
   Gagnier JJ, 2013, FORSCH KOMPLEMENTARMED, V7, P385, DOI 10.7453/GAHMJ.2013.008
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Guzman JA, 1999, J APPL PHYSIOL, V87, P1102, DOI 10.1152/jappl.1999.87.3.1102
   Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Jouvet P, 2007, EUR J PEDIATR, V166, P461, DOI 10.1007/s00431-006-0265-2
   Li QY, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep43042
   Mehta NM, 2017, PEDIATR CRIT CARE ME, V18, P675, DOI 10.1097/PCC.0000000000001134
   Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408
   Ostlie DJ, 2003, J PEDIATR SURG, V38, P1039, DOI 10.1016/S0022-3468(03)00187-8
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
NR 23
TC 3
Z9 3
U1 0
U2 4
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 2146-4618
EI 2146-4626
J9 J PEDIATR INTENSIVE
JI J. Pediatr. Intensive Care
PD MAR 15
PY 2020
VL 9
IS 1
BP 54
EP 59
DI 10.1055/s-0039-1697620
PG 6
WC Pediatrics
SC Pediatrics
GA KF0BT
UT WOS:000508915000010
PM 31984159
DA 2024-11-01
ER

